data_2wgo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2wgo _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.665 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 32.8 t . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.322 0.106 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 61.94 12.2 4.69 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.805 0.442 . . . . 0.0 110.871 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 tp -90.22 -3.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -168.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.85 HD22 HG11 ' A' ' 76' ' ' VAL . 13.6 tp -174.01 71.99 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.302 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.63 103.55 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.136 0.898 . . . . 0.0 112.032 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.58 32.5 78.8 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.569 -0.741 . . . . 0.0 113.498 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.749 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.3 t0 56.11 76.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.4 0.619 . . . . 0.0 112.135 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.667 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 94.9 mt -112.25 38.24 2.77 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.727 ' HB2' HD23 ' A' ' 3' ' ' LEU . 23.9 tp -71.22 101.03 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.381 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.806 ' HB2' ' HZ3' ' A' ' 9' ' ' LYS . 7.4 mtmp? -105.52 -41.38 5.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.23 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.37 101.69 7.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.544 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -103.86 -81.39 0.52 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.926 0.393 . . . . 0.0 111.586 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.481 HD12 HG12 ' A' ' 17' ' ' ILE . 61.5 tp -147.37 126.13 12.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.027 0.441 . . . . 0.0 110.694 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -122.48 11.27 9.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.203 1.001 . . . . 0.0 108.765 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.3 mt -115.44 171.68 4.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.603 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.44 -157.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.191 2.594 . . . . 0.0 112.544 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.511 HG21 ' HG3' ' A' ' 48' ' ' LYS . 4.4 p -49.84 124.54 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.789 0.804 . . . . 0.0 111.306 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 12' ' ' LEU . 35.0 mt -69.25 152.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.2 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 139.38 57.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 27.0 p-10 -61.6 -26.05 67.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt -56.75 -45.56 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.01 -38.24 90.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.201 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.435 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -69.34 -37.25 79.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.449 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 30.2 mmmt -64.31 -31.22 72.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.24 -47.3 65.11 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.499 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 90.9 mt -52.32 -65.52 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.608 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 23.6 mt -53.37 -27.72 25.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.712 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.88 -40.38 63.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 111.024 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -79.27 -35.88 40.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.112 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 96.4 m-85 -91.99 4.87 52.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.547 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 34.7 tt0 -52.59 -41.9 64.05 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.1 -39.47 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.694 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 2.0 m-20 -67.59 -54.12 22.51 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.562 HG21 ' HB ' ' A' ' 39' ' ' VAL . 65.0 mt -55.89 -35.02 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.204 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.622 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 9.2 tmtm? -81.77 -37.28 27.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.283 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.46 -53.56 50.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.667 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.694 ' HE2' ' HB3' ' A' ' 32' ' ' ASP . 39.1 mttm -69.25 -55.32 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.8 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.563 ' CE2' ' HD3' ' A' ' 84' ' ' ARG . 22.9 m-85 -104.68 -37.08 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.079 0.466 . . . . 0.0 111.422 -171.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.24 63.88 1.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.445 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.622 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 32.1 t -126.12 155.25 35.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -105.55 119.82 40.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 26.4 p -84.67 -11.03 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -71.21 -35.07 71.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.45 -34.53 60.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.349 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.543 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.0 mt -49.01 120.11 3.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.709 0.766 . . . . 0.0 112.433 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 86.1 tttt -92.24 104.01 16.42 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.135 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.53 HG12 HG11 ' A' ' 60' ' ' VAL . 20.0 mt -78.1 130.76 35.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.495 0.664 . . . . 0.0 111.723 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt -99.97 -45.9 5.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.77 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HG3' HG21 ' A' ' 16' ' ' VAL . 58.6 tttm -151.28 110.85 4.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.492 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.5 m -90.04 121.54 32.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -155.08 -167.68 2.64 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -169.94 170.03 7.87 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -116.64 -81.11 0.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.173 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.21 -88.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.91 ' HB3' HG22 ' A' ' 76' ' ' VAL . 85.1 mtt180 -91.86 23.96 3.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.49 0.662 . . . . 0.0 110.677 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' HE2' HG13 ' A' ' 82' ' ' VAL . 54.6 m-85 -147.36 144.58 28.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.673 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.917 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 27.2 m-85 -93.75 152.88 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.535 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 74.7 m-85 -139.09 99.13 3.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.212 0.529 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 t -109.24 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.016 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.0 m -66.61 121.69 15.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.962 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.53 HG11 HG12 ' A' ' 46' ' ' ILE . 21.5 m -137.01 151.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.115 0.483 . . . . 0.0 111.104 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.2 t70 -88.49 115.51 26.06 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 169.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 64' ' ' ASP . . . -77.12 -2.1 32.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.916 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.43 -15.21 13.48 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.471 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 62' ' ' ALA . 25.1 t70 -88.95 -1.98 58.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.503 0.668 . . . . 0.0 110.055 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.63 -15.14 58.8 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.541 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -90.67 140.69 29.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.859 0.362 . . . . 0.0 110.516 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 67.9 mttm -115.08 85.73 2.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.192 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 15.1 t -89.89 142.09 28.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.428 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.4 ttmt -102.69 88.06 3.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.097 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 12.7 m-85 -47.88 123.04 5.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.135 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.972 ' HZ1' HG12 ' A' ' 82' ' ' VAL . 25.9 ttpp -104.71 87.71 2.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.049 0.928 . . . . 0.0 110.217 -173.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.917 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 80.6 mt -87.15 89.94 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.51 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.701 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 13.7 ttt180 -52.89 114.94 1.59 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.776 ' HB2' HG12 ' A' ' 76' ' ' VAL . 53.9 mttp -60.87 170.31 1.57 Allowed 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.694 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.1 t70 -73.2 32.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.934 0.873 . . . . 0.0 110.149 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.91 HG22 ' HB3' ' A' ' 54' ' ' ARG . 31.4 m -76.85 -7.34 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.011 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -171.97 -51.13 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.981 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 28.4 m -108.57 149.05 38.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.263 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -86.81 27.41 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.268 2.645 . . . . 0.0 113.587 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.423 ' HD2' ' NZ ' ' A' ' 36' ' ' LYS . 23.3 pttm -159.41 -178.77 7.38 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.671 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.42 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -83.65 132.4 34.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.014 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.972 HG12 ' HZ1' ' A' ' 71' ' ' LYS . 13.7 p -80.51 -38.85 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.69 -142.93 3.65 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.134 -172.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.858 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 11.8 ptt-85 -172.92 114.58 0.26 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -80.36 81.33 6.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.466 0.651 . . . . 0.0 110.803 -173.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 68.3 m -76.23 -159.16 0.11 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.728 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 62.8 mtp180 . . . . . 0 N--CA 1.456 -0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.667 174.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.766 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 19.1 m . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.647 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -156.56 135.92 12.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.566 0.222 . . . . 0.0 111.501 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.83 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 5.2 tp 167.56 135.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 124.411 1.07 . . . . 0.0 109.23 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.662 HD12 HG21 ' A' ' 2' ' ' ILE . 11.0 mp 82.32 -21.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.609 0.764 . . . . 0.0 111.999 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.523 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 14.3 m-20 62.51 20.82 12.22 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 171.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.885 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 79.34 -0.22 81.09 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.317 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.59 -11.71 44.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.843 0.354 . . . . 0.0 110.448 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.557 ' HA ' HD22 ' A' ' 3' ' ' LEU . 96.9 mt 70.36 32.22 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.134 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.64 93.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.659 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -100.41 71.94 1.57 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.599 0.714 . . . . 0.0 110.291 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.93 -30.71 69.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.292 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -135.96 144.43 45.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.59 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 35.2 tp -167.62 165.55 14.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.59 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 26.4 mttt 64.72 20.01 12.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.4 mt -72.41 155.45 91.28 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.872 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.89 -171.35 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.824 2.349 . . . . 0.0 110.57 169.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG2' ' HA ' ' A' ' 48' ' ' LYS . 7.2 p -65.21 122.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.212 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.826 HG13 ' HB ' ' A' ' 49' ' ' THR . 4.1 pt -105.89 -178.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.799 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 177.47 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -40.02 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 112.919 -1.946 . . . . 0.0 112.891 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 20' ' ' LEU . 22.8 mt 34.65 43.92 0.1 Allowed 'General case' 0 CA--C 1.521 -0.138 0 O-C-N 123.885 0.74 . . . . 0.0 111.987 -173.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.57 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -125.94 -66.76 0.91 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.83 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' CA ' HG23 ' A' ' 49' ' ' THR . . . -64.36 -50.19 61.14 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.36 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.17 -36.59 68.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.916 0.388 . . . . 0.0 110.64 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.557 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.8 mt-10 -65.3 -50.54 65.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.963 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 91.0 mt -47.92 -65.0 0.64 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 123.579 0.55 . . . . 0.0 110.891 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.72 HD13 HG22 ' A' ' 58' ' ' VAL . 7.4 mp -60.95 -38.38 85.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.553 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.72 -33.42 75.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 84.2 mttt -78.48 -46.1 20.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.456 0.646 . . . . 0.0 109.828 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' CE2' HG22 ' A' ' 72' ' ' ILE . 6.8 m-85 -70.33 -9.86 57.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.552 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -52.42 -47.51 66.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.719 0.407 . . . . 0.0 111.806 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -54.84 -39.64 68.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.713 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.23 -43.91 31.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.6 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.449 HD12 ' CE1' ' A' ' 70' ' ' PHE . 55.6 mt -63.42 -33.57 62.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.697 0.76 . . . . 0.0 110.403 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.614 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 71.3 tttt -80.86 -29.15 35.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.596 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.13 -50.48 40.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.089 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 81' ' ' MET . 62.8 mttm -66.33 -50.12 64.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.399 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' HB2' HG22 ' A' ' 39' ' ' VAL . 34.9 m-85 -118.08 -37.62 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.877 0.37 . . . . 0.0 111.605 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.62 62.89 1.02 Allowed Glycine 0 C--N 1.323 -0.179 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.845 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.614 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -126.01 150.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.847 0.356 . . . . 0.0 111.584 -173.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.84 128.13 45.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.621 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 8.2 p -86.41 -9.48 56.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -92.22 -10.1 39.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.577 0.703 . . . . 0.0 109.346 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.69 -29.32 56.26 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.577 1.18 . . . . 0.0 107.872 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.559 HD12 ' CE2' ' A' ' 70' ' ' PHE . 27.4 mt -77.77 109.15 11.54 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 112.848 -1.978 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 55.4 tttm -72.86 111.97 8.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.635 ' HA ' HG13 ' A' ' 60' ' ' VAL . 26.3 mt -74.34 111.67 10.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.587 0.708 . . . . 0.0 110.234 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.491 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.8 mt -86.23 -35.94 19.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.678 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 34.0 tttp -156.88 118.31 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.667 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.826 ' HB ' HG13 ' A' ' 17' ' ' ILE . 2.8 m -106.53 126.13 51.87 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -155.77 170.99 20.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.636 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 14.0 pt-20 -139.59 175.69 9.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.437 0.637 . . . . 0.0 111.814 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 53' ' ' LYS . 9.9 t70 -152.88 -162.2 1.44 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 72.9 mmtt -58.3 103.35 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 77.1 -21.28 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.779 0.674 . . . . 0.0 112.559 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.71 142.05 38.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HD2' ' HG2' ' A' ' 74' ' ' LYS . 4.5 m-85 -109.94 142.44 41.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 166.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 61.0 m-85 -133.01 115.09 14.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.271 0.558 . . . . 0.0 110.678 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.72 HG22 HD13 ' A' ' 26' ' ' LEU . 41.6 t -108.69 98.75 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.565 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.3 m -74.44 128.83 36.53 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.635 HG13 ' HA ' ' A' ' 46' ' ' ILE . 33.3 m -138.25 156.83 30.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.823 0.344 . . . . 0.0 111.143 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.63 110.95 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 1.27 53.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.783 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.29 -112.91 0.27 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.658 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -116.36 79.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.48 4.13 73.96 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -79.25 81.98 5.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 122.087 0.946 . . . . 0.0 109.67 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 28.9 ttmt -82.43 135.54 35.13 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.55 -169.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 26.3 t -138.8 169.11 18.38 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.009 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 39.6 ttpt -146.43 110.81 5.11 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CE2' HD12 ' A' ' 44' ' ' LEU . 36.6 m-85 -68.73 122.62 18.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.443 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.584 ' HD3' ' HA2' ' A' ' 83' ' ' GLY . 83.3 tttt -88.72 71.61 8.73 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.197 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.603 HG22 ' CE2' ' A' ' 29' ' ' PHE . 67.4 mt -80.08 92.76 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.451 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.57 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 46.3 ttt-85 -72.4 8.45 1.37 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.427 0.632 . . . . 0.0 110.087 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.665 ' HG2' ' HD2' ' A' ' 56' ' ' TYR . 64.1 mttt 66.4 172.43 0.24 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.991 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.83 ' HB3' ' H ' ' A' ' 2' ' ' ILE . 2.0 t70 -77.66 87.79 3.94 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.091 0.948 . . . . 0.0 109.131 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.885 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 2.6 p -115.36 100.8 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.156 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.548 ' H ' ' CA ' ' A' ' 5' ' ' GLY . 33.4 t70 78.07 -59.64 0.43 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.644 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.44 146.86 33.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.17 -53.17 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.371 2.048 . . . . 0.0 113.792 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.766 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 11.7 ptpt -65.9 154.29 39.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.392 0.615 . . . . 0.0 112.136 -168.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.452 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -65.07 146.01 55.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.772 -176.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.57 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 7.5 p -81.03 -40.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.542 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.584 ' HA2' ' HD3' ' A' ' 71' ' ' LYS . . . -149.07 161.92 28.83 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.461 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 84' ' ' ARG . 27.5 ttt180 -149.0 92.83 2.02 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -105.35 111.26 23.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 110.586 -172.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 8.1 m -103.54 123.83 47.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 121.769 0.795 . . . . 0.0 110.317 -167.502 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 6.4 t . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -165.89 21.32 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.173 0.511 . . . . 0.0 111.293 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.425 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -101.15 107.73 21.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.709 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 3.2 mm? -120.71 -101.58 0.42 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.026 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 10.2 m-20 70.38 10.21 7.17 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.671 0.607 . . . . 0.0 109.702 -169.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 6' ' ' ASP . . . 69.99 97.14 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.21 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 5' ' ' GLY . 24.5 t70 73.57 -2.87 2.63 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.6 0.714 . . . . 0.0 110.1 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.931 HD23 ' HB2' ' A' ' 74' ' ' LYS . 11.2 mp 75.38 171.97 0.26 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.457 HD21 ' HG2' ' A' ' 11' ' ' LYS . 9.7 tp -78.55 3.05 17.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.578 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 15.9 mmtp 73.99 -74.61 0.08 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.413 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -145.4 135.28 23.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HG2' HD21 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -130.47 16.86 5.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.016 176.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 12' ' ' LEU . 13.2 mt -144.43 93.36 2.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.151 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -95.63 36.15 1.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.536 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.731 ' HB2' HG12 ' A' ' 17' ' ' ILE . 48.6 mt -79.39 128.53 75.05 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.231 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.6 Cg_exo -64.43 116.03 3.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.77 2.313 . . . . 0.0 110.228 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.606 ' HB ' ' HG2' ' A' ' 48' ' ' LYS . 4.3 p 41.23 96.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 123.031 1.396 . . . . 0.0 112.057 -168.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.731 HG12 ' HB2' ' A' ' 14' ' ' LEU . 60.5 mt -74.26 155.42 6.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.225 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -44.76 133.75 5.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 112.206 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -62.73 -29.29 70.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 tp -68.2 -40.33 82.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.726 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.09 -36.52 81.95 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -66.06 -50.32 52.65 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -52.59 -35.77 54.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.441 0.297 . . . . 0.0 110.933 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 8.3 mm-40 -60.19 -54.87 40.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 174.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.2 mt -52.34 -63.73 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.548 0.69 . . . . 0.0 110.313 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.872 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 9.8 mp -56.21 -35.42 67.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.779 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.6 -36.44 83.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.072 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -70.15 -34.43 73.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.286 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.562 ' CE1' HD12 ' A' ' 72' ' ' ILE . 15.0 m-85 -100.54 -1.92 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.083 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.02 -30.81 66.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.737 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.56 -39.18 92.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.781 0.324 . . . . 0.0 110.632 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 2.8 m-20 -84.04 -30.31 26.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.147 0.499 . . . . 0.0 110.276 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.552 HG21 ' HB ' ' A' ' 39' ' ' VAL . 85.7 mt -63.98 -31.83 54.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.776 0.798 . . . . 0.0 109.834 173.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 74.7 tttt -88.69 -38.55 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 17.1 t70 -59.33 -45.58 90.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.392 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -80.63 -52.64 7.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.168 0.508 . . . . 0.0 112.025 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.511 ' HB2' HG21 ' A' ' 39' ' ' VAL . 24.4 m-85 -105.02 -30.83 9.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.572 -167.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.53 51.1 3.57 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.762 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.628 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 16.2 t -121.83 149.71 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 120.617 0.246 . . . . 0.0 110.885 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.525 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.6 t70 -107.57 117.71 34.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.872 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 58.0 p -79.4 -22.43 44.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -171.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.69 -19.86 51.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.91 -26.8 22.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.664 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 91.5 mt -60.36 145.21 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.945 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -97.22 103.98 15.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.931 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.5 HG12 HG11 ' A' ' 60' ' ' VAL . 41.6 mt -76.33 122.04 29.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.72 0.772 . . . . 0.0 110.802 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 61' ' ' ASP . 7.7 mt -91.19 -48.17 7.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.606 ' HG2' ' HB ' ' A' ' 16' ' ' VAL . 23.8 mttp -151.79 109.33 3.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.522 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 11.6 m -81.64 128.92 34.45 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 171.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.41 ' HG ' ' C ' ' A' ' 49' ' ' THR . 21.7 m -154.46 179.28 9.17 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -156.35 160.85 40.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.212 0.53 . . . . 0.0 110.884 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -137.16 -159.18 0.93 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -64.49 107.9 1.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.515 0.198 . . . . 0.0 110.863 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 84.7 mtm180 74.42 -17.76 0.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.07 130.26 55.51 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.876 -0.515 . . . . 0.0 111.609 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 1.008 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 16.2 m-85 -78.95 155.67 28.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.5 91.93 2.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.023 0.439 . . . . 0.0 110.393 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.0 t -97.5 97.67 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.428 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.463 ' HB2' ' HZ1' ' A' ' 69' ' ' LYS . 9.2 t -71.54 116.85 12.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.5 HG11 HG12 ' A' ' 46' ' ' ILE . 5.0 m -131.37 159.04 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.936 0.398 . . . . 0.0 110.797 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.497 ' HB2' HD22 ' A' ' 47' ' ' LEU . 11.7 t70 -107.22 132.81 52.66 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.64 9.18 14.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.418 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.18 -35.09 5.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.509 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -93.68 1.78 56.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.31 0.576 . . . . 0.0 110.691 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.53 -20.96 38.19 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.474 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 139.03 58.72 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -128.12 144.62 51.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.567 0.699 . . . . 0.0 112.083 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.481 ' HB2' HG23 ' A' ' 60' ' ' VAL . 36.9 m -128.18 123.81 35.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.319 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 12.5 tppt? -97.09 68.54 2.27 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 19.2 m-85 -38.08 105.51 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 124.183 0.927 . . . . 0.0 112.331 -169.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 73.8 tttt -90.76 83.76 5.78 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.392 1.092 . . . . 0.0 109.326 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.008 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 70.1 mt -84.03 91.83 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.932 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.966 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.6 ttt180 -57.98 96.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.931 ' HB2' HD23 ' A' ' 7' ' ' LEU . 23.1 mttt -59.4 82.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.328 1.018 . . . . 0.0 112.092 -167.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.47 24.84 0.8 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.778 0.831 . . . . 0.0 111.239 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.966 ' HB ' ' HG2' ' A' ' 73' ' ' ARG . 33.9 t -80.21 119.21 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.682 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 68.03 -70.25 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.072 0.858 . . . . 0.0 111.276 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 79' ' ' PRO . 4.2 m -90.88 175.46 3.61 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.7 ' O ' HG22 ' A' ' 78' ' ' VAL . 8.8 Cg_endo -82.92 178.54 5.9 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.88 1.72 . . . . 0.0 111.379 170.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 29.4 pttt 57.84 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 169.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.573 ' HB3' HG22 ' A' ' 72' ' ' ILE . 6.3 ptt? -168.73 150.11 4.73 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -171.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 12.9 p -76.12 -46.32 34.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.16 137.22 4.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.233 -1.46 . . . . 0.0 114.385 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.593 ' HG3' ' CE1' ' A' ' 70' ' ' PHE . 9.9 ttp180 -72.89 104.33 4.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 64.2 tttm -82.05 63.11 6.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 0.0 112.435 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.583 ' SG ' ' HG2' ' A' ' 84' ' ' ARG . 1.1 m -101.59 138.99 37.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 122.702 1.239 . . . . 0.0 108.744 172.254 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.549 ' H ' HD13 ' A' ' 2' ' ' ILE . 50.8 mt -143.5 82.55 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.549 HD13 ' H ' ' A' ' 1' ' ' LEU . 3.7 mp -150.66 -31.51 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.808 0.337 . . . . 0.0 111.757 -170.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.774 HD23 HG11 ' A' ' 76' ' ' VAL . 1.5 tt -154.78 33.61 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -165.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -48.48 -46.78 38.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.263 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.76 41.81 1.28 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -120.68 -146.32 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.708 -0.246 . . . . 0.0 110.72 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 mt -157.5 -49.63 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.747 0.655 . . . . 0.0 109.974 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.545 HD11 HD11 ' A' ' 3' ' ' LEU . 74.6 mt 68.47 156.11 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.003 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.19 9.35 5.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.734 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.35 139.25 51.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.111 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -151.25 85.16 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.751 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.2 tp 59.25 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.57 0.748 . . . . 0.0 112.764 165.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 27.2 ttpt -78.65 82.81 4.86 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 91.2 mt 74.55 162.45 0.15 Allowed Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 124.012 0.82 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 12.0 Cg_endo -56.35 134.17 62.6 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.715 2.277 . . . . 0.0 112.442 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' A' ' 48' ' ' LYS . 7.7 p 44.16 101.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 122.989 1.376 . . . . 0.0 113.961 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 51.7 mt -73.21 154.05 7.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.993 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.91 155.95 25.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -173.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 8.7 p30 -60.35 -34.06 73.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.693 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mt -57.06 -46.14 82.69 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.249 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.47 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 43.7 t80 -60.1 -41.83 93.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 0.0 110.297 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.487 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -74.27 -26.79 67.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.805 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HB2' HD11 ' A' ' 46' ' ' ILE . 33.4 ttpt -80.89 -29.1 35.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.919 0.39 . . . . 0.0 110.177 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.59 -29.93 68.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.523 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.513 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 66.3 mt -65.31 -70.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.75 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 mt -47.71 -28.77 2.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.626 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.65 -45.82 92.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.999 0.428 . . . . 0.0 110.103 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HD3' ' HB2' ' A' ' 1' ' ' LEU . 92.7 mttt -65.96 -35.49 80.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.623 0.725 . . . . 0.0 109.535 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 10.5 m-85 -79.28 -8.0 58.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.911 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.451 ' HG2' ' HD2' ' A' ' 34' ' ' LYS . 17.3 tt0 -74.44 12.59 0.74 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.456 0.646 . . . . 0.0 110.657 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' PHE . 16.7 t70 -106.48 -30.57 8.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.375 169.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' OD1' ' HE3' ' A' ' 81' ' ' MET . 15.2 t70 -88.87 -57.23 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 ' HB ' ' A' ' 39' ' ' VAL . 67.6 mt -61.23 -27.62 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.72 0.771 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HD2' ' HG2' ' A' ' 30' ' ' GLN . 44.9 tttp -80.66 -33.38 35.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.886 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -75.22 -47.83 26.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 49.2 mttm -69.29 -38.22 78.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.84 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.549 ' HB2' HG21 ' A' ' 39' ' ' VAL . 55.3 m-85 -126.86 -23.09 3.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 87.21 39.41 7.38 Favored Glycine 0 C--N 1.322 -0.216 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.94 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.56 ' HB ' HG21 ' A' ' 33' ' ' ILE . 27.2 t -100.56 152.75 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 16.4 t70 -115.39 122.72 46.7 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.75 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 75.0 p -88.25 -17.56 30.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.919 0.39 . . . . 0.0 111.513 -172.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.692 ' HB2' ' HZ3' ' A' ' 42' ' ' LYS . 4.9 ttmp? -70.46 -33.16 70.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.466 0.651 . . . . 0.0 109.266 175.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.35 -23.4 46.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.016 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 49.1 mt -61.29 139.97 58.06 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.398 0.618 . . . . 0.0 111.594 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 81.0 tttt -101.32 96.51 7.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.511 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 23' ' ' LYS . 46.9 mt -78.26 127.5 38.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.431 0.634 . . . . 0.0 111.112 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 10.9 mt -98.19 -51.44 4.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.133 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HG3' HG22 ' A' ' 16' ' ' VAL . 36.1 ttmt -139.85 117.76 11.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.542 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.411 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 31.6 m -99.32 136.03 39.87 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -153.28 179.03 9.12 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 122.113 -0.367 . . . . 0.0 110.397 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 15.4 pt-20 -154.58 166.73 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.52 78.53 1.27 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.063 0.459 . . . . 0.0 109.907 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 56.33 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.199 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.617 ' HG3' HG13 ' A' ' 76' ' ' VAL . 19.4 ttm180 -85.33 12.41 8.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.516 0.674 . . . . 0.0 110.721 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 97.5 m-85 -136.23 157.73 46.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.752 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 13.9 m-85 -129.55 146.57 51.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.333 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 71' ' ' LYS . 97.8 m-85 -135.69 103.05 5.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 t -109.19 95.17 3.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.652 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.6 t -80.34 129.69 34.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 46' ' ' ILE . 18.5 m -137.99 155.44 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.156 0.503 . . . . 0.0 111.757 -173.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.6 t70 -90.22 126.68 35.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.91 13.24 11.28 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.029 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.11 -40.52 2.66 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.922 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.08 -19.13 65.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.88 -8.96 39.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.78 165.34 24.85 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.351 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -127.85 109.91 12.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.442 0.639 . . . . 0.0 110.279 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 1.9 t -104.62 174.32 5.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.34 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 35.9 ttmt -149.08 104.68 3.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' CE1' HD12 ' A' ' 33' ' ' ILE . 73.5 m-85 -71.23 97.22 1.51 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.694 0.759 . . . . 0.0 109.621 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HG3' ' CE1' ' A' ' 57' ' ' TYR . 46.2 tttp -82.88 85.91 7.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.149 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.752 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 61.6 mt -82.39 137.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.255 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.682 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 18.4 ttt180 -93.16 39.01 1.04 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.62 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 49.5 mttt 57.67 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.253 -170.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.681 ' HB3' ' N ' ' A' ' 3' ' ' LEU . 24.4 t0 178.68 26.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.774 HG11 HD23 ' A' ' 3' ' ' LEU . 9.5 m -61.82 95.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.073 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 22.9 t70 77.13 -38.95 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.844 172.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.513 HG23 ' HG2' ' A' ' 80' ' ' LYS . 9.6 p -110.7 134.28 20.96 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.521 0.677 . . . . 0.0 110.312 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HD2' HG21 ' A' ' 78' ' ' VAL . 85.4 Cg_endo -79.79 30.83 0.48 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 123.897 3.064 . . . . 0.0 114.757 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.513 ' HG2' HG23 ' A' ' 78' ' ' VAL . 57.4 pttt -145.78 153.61 41.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.629 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -70.31 148.66 48.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.52 -173.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 13.7 p -73.07 -43.3 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.666 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -130.39 151.83 19.6 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -174.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 43.13 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.709 0.766 . . . . 0.0 108.939 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -96.2 134.81 38.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.115 -171.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -101.39 125.41 48.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 C--N 1.314 -0.956 0 CA-C-O 122.037 0.923 . . . . 0.0 109.645 -164.155 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.468 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 41.3 t . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.78 40.68 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.553 0.692 . . . . 0.0 110.136 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.61 HD11 ' HE2' ' A' ' 56' ' ' TYR . 18.6 tt -104.61 108.84 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.584 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.661 ' HB3' HD11 ' A' ' 7' ' ' LEU . 4.4 mm? -75.59 5.25 6.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.551 ' HB3' HG12 ' A' ' 2' ' ' ILE . 27.3 t70 -70.7 -5.44 29.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.717 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.413 ' C ' HG13 ' A' ' 76' ' ' VAL . . . -87.02 -87.35 1.08 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.147 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -48.59 -38.79 21.69 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 3' ' ' LEU . 66.2 mt -92.06 26.39 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.65 0.262 . . . . 0.0 111.334 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 7.2 tt -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.938 0.399 . . . . 0.0 110.681 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -120.13 -62.57 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -154.98 116.01 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.918 173.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 17.6 ptmt -129.22 -51.68 1.2 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 71.3 mt -153.22 155.36 36.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -170.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 43.87 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.4 mt -108.03 170.22 5.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.14 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.85 -150.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.86 3.04 . . . . 0.0 113.072 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG22 ' HG3' ' A' ' 48' ' ' LYS . 14.5 p -53.06 125.17 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.19 0.995 . . . . 0.0 111.266 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 mt -96.72 173.04 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.395 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.46 122.06 6.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.681 0.277 . . . . 0.0 111.148 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 25.0 p30 -72.54 -17.21 61.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 110.363 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.23 -39.38 68.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 170.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 63.1 t80 -61.61 -40.38 94.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.629 ' O ' HD11 ' A' ' 26' ' ' LEU . . . -66.92 -44.27 89.33 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.447 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -55.68 -43.26 76.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.653 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.9 mm-40 -57.16 -49.16 76.81 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.583 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 46.1 mt -51.49 -59.54 4.14 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.528 0.68 . . . . 0.0 110.34 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.725 HD12 HG22 ' A' ' 58' ' ' VAL . 6.9 mp -60.82 -38.8 86.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.579 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.18 -31.86 73.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.7 mttm -74.99 -50.01 18.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.201 0.524 . . . . 0.0 110.678 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' HA ' ' A' ' 0' ' ' SER . 7.2 m-85 -92.17 12.14 23.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.797 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -25.89 63.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.278 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.06 -39.97 90.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -36.97 62.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.336 0.589 . . . . 0.0 109.471 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.507 HG12 ' HE1' ' A' ' 81' ' ' MET . 72.8 mt -62.24 -38.84 82.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.555 177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.596 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 35.3 tttm -83.29 -31.69 26.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.359 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.83 -47.8 79.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.82 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -79.42 -52.58 7.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.224 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.571 ' CZ ' ' HD2' ' A' ' 84' ' ' ARG . 6.6 m-85 -108.11 -23.97 11.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -169.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.49 57.59 3.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.952 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.596 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 3.7 t -117.03 145.13 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 121.023 0.439 . . . . 0.0 110.908 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 42' ' ' LYS . 19.8 t70 -80.65 -11.32 59.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.111 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.536 ' H ' HG11 ' A' ' 39' ' ' VAL . 33.1 p 58.73 -37.48 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.014 1.726 . . . . 0.0 114.348 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 40' ' ' ASP . 67.8 mttm -71.18 -18.19 62.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.352 0.596 . . . . 0.0 109.451 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -74.37 -37.25 63.51 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.899 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.37 106.22 0.43 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.224 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 55.1 tttp -69.97 102.27 1.97 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.147 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.634 HD12 HD21 ' A' ' 26' ' ' LEU . 34.6 mt -74.33 111.99 10.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.793 0.806 . . . . 0.0 110.675 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.3 -46.45 16.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.062 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' HG3' HG22 ' A' ' 16' ' ' VAL . 25.8 ttpp -151.5 105.47 3.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.687 -173.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 87.8 m -79.23 125.6 29.68 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -151.8 168.99 23.34 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.24 157.02 35.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 29.4 t70 -100.74 -83.67 0.44 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 52' ' ' ASP . 38.5 mmtm -135.88 -74.85 0.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.689 ' HB3' HG12 ' A' ' 76' ' ' VAL . 98.7 mtt180 -87.93 15.22 7.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.969 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -147.32 137.34 23.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.5 m-85 -98.84 143.84 28.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 167.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.455 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 74.4 m-85 -132.26 100.8 5.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 110.217 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.725 HG22 HD12 ' A' ' 26' ' ' LEU . 26.0 t -99.07 93.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.139 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.438 ' HB2' ' N ' ' A' ' 48' ' ' LYS . 67.8 m -58.51 126.35 27.22 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.303 174.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.563 HG11 HG12 ' A' ' 46' ' ' ILE . 35.7 m -146.71 149.96 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 111.757 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.0 t70 -91.22 122.99 34.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 169.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.98 1.11 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 -13.69 64.97 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.288 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -131.92 41.16 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -27.49 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.976 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.21 128.88 37.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.017 0.436 . . . . 0.0 111.128 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -111.59 114.81 28.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.506 0.67 . . . . 0.0 109.924 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 18.6 t -113.92 178.42 4.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.864 -174.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.993 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 34.8 ttmt -155.54 82.04 1.04 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -50.31 111.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 112.203 -170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.586 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 63.3 tttp -80.76 72.89 7.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.048 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.682 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 60.3 mt -75.89 86.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.221 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 33.2 ttp180 -61.97 113.42 2.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.557 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 81.8 mttt -61.37 174.02 0.79 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.173 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 1.1 m-20 -71.67 64.65 0.46 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.662 0.744 . . . . 0.0 110.192 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.689 HG12 ' HB3' ' A' ' 54' ' ' ARG . 34.7 m -96.77 -1.76 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.198 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -176.87 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.007 -171.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.55 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 7.6 p -117.77 144.7 34.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.865 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 78' ' ' VAL . 39.1 Cg_endo -82.47 53.0 4.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.28 2.653 . . . . 0.0 111.301 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -154.07 135.01 13.8 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.287 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.682 ' HG2' ' HA ' ' A' ' 72' ' ' ILE . 12.7 tmm? -57.56 103.84 0.15 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 11.6 p -60.75 -37.88 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -170.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' ' 81' ' ' MET . . . -175.03 -156.84 15.01 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.641 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.659 ' N ' ' HD3' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -151.37 119.67 6.37 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -168.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.993 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 2.4 tttm -86.94 56.92 4.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.911 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -87.75 126.3 34.92 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 . . . . . 0 C--N 1.306 -1.285 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 179.7 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.985 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 m . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.927 HD22 ' HD3' ' A' ' 28' ' ' LYS . 11.0 tp -174.96 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.611 0.57 . . . . 0.0 112.266 160.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.488 HG23 ' CG ' ' A' ' 75' ' ' ASP . 2.5 tp -66.02 -25.93 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.828 -171.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.789 HD22 ' H ' ' A' ' 8' ' ' LEU . 7.5 tp -140.53 54.59 1.61 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.288 -171.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -54.58 96.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.618 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.09 40.87 52.23 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.821 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.742 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 30.7 t70 -107.82 -60.5 1.7 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.712 0.291 . . . . 0.0 110.496 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 25.7 tp 71.76 99.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.068 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 3' ' ' LEU . 6.7 tt -88.92 117.5 27.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.825 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -112.37 -5.68 14.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.578 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.31 -41.73 89.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 47.2 mmtm -97.65 152.11 19.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.357 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.735 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 5.2 mp -117.73 -72.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.44 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.78 103.83 4.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.357 . . . . 0.0 110.053 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 pp -111.76 163.54 17.32 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.835 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.51 -177.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.946 3.097 . . . . 0.0 113.647 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 48' ' ' LYS . 8.1 p -68.91 121.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.567 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 47.9 mt -77.77 152.66 5.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.587 174.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.81 144.84 42.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 6.5 p30 -56.92 -30.36 63.9 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.766 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.1 tp -60.6 -45.71 92.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.579 0.228 . . . . 0.0 110.946 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 61.5 t80 -62.37 -48.95 77.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.67 ' O ' HD11 ' A' ' 26' ' ' LEU . . . -63.77 -43.87 97.08 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.431 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HB2' HG13 ' A' ' 46' ' ' ILE . 3.8 tptm -58.17 -34.94 70.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.233 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.652 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -55.3 -56.44 20.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.041 175.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.6 mp -51.82 -55.61 18.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.656 0.741 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.68 HD12 HG22 ' A' ' 58' ' ' VAL . 6.7 mp -59.8 -44.91 93.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.011 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' HA ' ' OG1' ' A' ' 41' ' ' THR . 21.3 t70 -63.2 -31.73 72.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.058 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.927 ' HD3' HD22 ' A' ' 1' ' ' LEU . 58.3 mttm -69.37 -33.54 73.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.937 0.398 . . . . 0.0 110.738 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' O ' HG13 ' A' ' 33' ' ' ILE . 15.4 m-85 -99.09 7.95 45.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -50.31 -44.14 54.05 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.284 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.12 -38.38 73.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.554 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.461 ' CG ' ' HZ1' ' A' ' 36' ' ' LYS . 13.4 t70 -75.97 -41.57 50.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.514 HG21 ' HB ' ' A' ' 39' ' ' VAL . 32.4 mt -63.61 -34.08 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.235 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 33.1 ttpt -83.69 -27.74 28.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.099 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.41 -47.04 58.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.496 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HZ1' ' CG ' ' A' ' 32' ' ' ASP . 55.7 mttp -78.02 -62.13 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.068 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' A' ' 39' ' ' VAL . 25.1 m-85 -97.68 -19.2 18.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.116 -167.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.18 46.04 10.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.931 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.591 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 40.3 t -107.48 145.57 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.032 0.444 . . . . 0.0 111.439 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.589 ' OD1' ' HB2' ' A' ' 42' ' ' LYS . 25.7 t70 -109.24 105.17 14.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.515 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 29.1 p -65.07 -16.75 63.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.589 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 3.3 mtpm? -67.23 -28.93 68.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.31 -18.97 28.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.91 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 67.8 mt -65.66 132.43 48.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.327 0.584 . . . . 0.0 111.559 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.598 ' HD2' HD22 ' A' ' 47' ' ' LEU . 2.5 tmtp? -94.48 109.38 21.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.124 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.599 ' HA ' HG11 ' A' ' 60' ' ' VAL . 6.1 mm -73.53 108.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.95 0.405 . . . . 0.0 109.925 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.598 HD22 ' HD2' ' A' ' 45' ' ' LYS . 17.6 mt -80.11 -54.75 5.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.555 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HG3' HG22 ' A' ' 16' ' ' VAL . 87.6 tttt -142.1 119.92 11.93 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.742 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.567 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 35.3 m -98.54 141.53 31.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 169.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -169.51 -174.68 1.97 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' OE1' ' HB2' ' A' ' 11' ' ' LYS . 8.9 pt-20 -147.68 162.46 39.11 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.735 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 5.8 t70 -135.01 -173.29 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.689 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 14.0 mmmm -63.96 111.02 2.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 72.34 -0.97 3.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.169 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.97 152.8 40.53 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.787 0.803 . . . . 0.0 112.989 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.591 ' HD2' ' HA ' ' A' ' 74' ' ' LYS . 6.2 m-85 -114.06 145.08 42.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.368 164.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.549 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 62.8 m-85 -134.23 112.15 10.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.82 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.68 HG22 HD12 ' A' ' 26' ' ' LEU . 5.1 t -111.89 93.47 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.811 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.9 m -76.58 121.83 23.74 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 46' ' ' ILE . 15.8 m -134.44 159.32 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 111.581 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.03 115.67 22.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.426 ' HB1' ' SG ' ' A' ' 68' ' ' CYS . . . -86.0 -18.44 32.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 64' ' ' ASP . . . 108.87 165.51 20.66 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -171.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 9.6 t70 73.11 -52.61 0.71 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.927 0.491 . . . . 0.0 110.457 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.84 -17.18 0.22 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.2 150.85 33.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.915 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -117.56 117.85 30.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.989 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 33.6 m -113.81 133.92 55.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.475 -171.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.0 ttpt -102.96 108.51 19.71 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 43.0 m-85 -68.15 103.55 1.58 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.494 0.664 . . . . 0.0 110.389 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 83' ' ' GLY . 12.8 tttt -88.34 109.45 19.99 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.189 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.47 HG12 ' HG2' ' A' ' 81' ' ' MET . 48.2 mt -123.56 124.79 70.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.478 ' HD2' HG22 ' A' ' 82' ' ' VAL . 16.2 ttt180 -81.01 53.25 1.94 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.459 0.647 . . . . 0.0 110.612 -169.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.591 ' HA ' ' HD2' ' A' ' 56' ' ' TYR . 19.6 mttt 50.75 43.35 28.09 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.017 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.739 ' HA ' ' CB ' ' A' ' 0' ' ' SER . 1.9 m-20 55.46 28.62 11.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.761 0.663 . . . . 0.0 112.558 166.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 73' ' ' ARG . 21.3 m -77.36 122.09 31.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.282 0.563 . . . . 0.0 111.839 -176.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 t70 64.29 -77.31 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG21 ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -82.82 139.72 43.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.985 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 90.8 Cg_endo -80.49 89.19 1.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.179 2.586 . . . . 0.0 112.878 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -176.2 -173.92 0.59 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.586 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.47 ' HG2' HG12 ' A' ' 72' ' ' ILE . 26.6 mtm -100.95 148.96 24.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.531 HG11 ' HE2' ' A' ' 71' ' ' LYS . 7.7 p -89.48 4.41 5.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . 152.3 113.1 0.54 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.727 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -95.43 100.78 12.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -125.14 134.52 52.4 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 7.6 m -93.74 123.49 37.11 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 . . . . . 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.902 . . . . 0.0 108.795 -176.21 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.739 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.8 p . . . . . 0 C--O 1.222 -0.353 0 CA-C-O 119.694 -0.193 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.759 ' H ' HD23 ' A' ' 1' ' ' LEU . 0.3 OUTLIER -49.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.72 0.637 . . . . 0.0 111.667 -174.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.518 HG22 ' HE2' ' A' ' 56' ' ' TYR . 28.3 mm -144.35 -55.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 123.081 0.238 . . . . 0.0 111.525 -174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.905 HD22 ' HA ' ' A' ' 6' ' ' ASP . 1.1 mp -113.6 -3.14 13.65 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.61 45.69 21.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.87 36.76 12.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.647 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.905 ' HA ' HD22 ' A' ' 3' ' ' LEU . 30.3 t70 58.08 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 2.2 pp -148.58 19.69 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.598 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.55 ' HB2' HD13 ' A' ' 3' ' ' LEU . 30.4 tp -78.87 99.7 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.795 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -124.04 6.32 8.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.532 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.71 -77.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HG3' HD22 ' A' ' 8' ' ' LEU . 48.2 pttt -90.2 178.02 6.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.0 tp -171.24 -47.43 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.993 0.425 . . . . 0.0 110.31 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 21.5 mtmt -123.83 93.73 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.291 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.96 157.4 33.73 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.803 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.39 -164.43 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.003 2.469 . . . . 0.0 112.105 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 48' ' ' LYS . 4.8 p -69.3 110.82 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 122.076 0.941 . . . . 0.0 111.601 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.865 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -98.35 170.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.487 173.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 172.65 -8.24 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' PHE . 4.1 m-80 -64.61 63.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.377 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mt 68.74 -27.62 0.15 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.942 0.897 . . . . 0.0 112.454 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' ASN . 7.9 t80 -54.04 -45.0 71.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -172.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -73.94 -38.56 48.48 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.692 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -70.89 -33.3 70.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 7.7 mm-40 -56.98 -50.6 72.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.544 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.475 HD11 ' HA3' ' A' ' 22' ' ' GLY . 60.4 mt -49.72 -67.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.529 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.841 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 39.1 mt -53.3 -34.09 55.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.62 -49.09 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.344 -0.223 . . . . 0.0 111.386 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 36.4 mttm -65.78 -45.07 83.82 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 109.913 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.427 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 3.9 m-85 -93.33 16.14 14.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.78 -171.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.427 ' HB2' ' HG1' ' A' ' 41' ' ' THR . 8.1 tt0 -61.0 -42.24 98.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -58.85 -38.53 78.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.56 -51.28 36.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 109.932 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.92 HG12 ' HE1' ' A' ' 81' ' ' MET . 47.1 mt -66.6 -29.49 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.017 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 38.3 tttp -84.96 -29.34 25.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 110.326 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.28 -47.02 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.393 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.439 ' HE2' ' HG2' ' A' ' 80' ' ' LYS . 27.8 mttm -65.46 -64.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.995 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.507 ' HB2' HG21 ' A' ' 39' ' ' VAL . 30.1 m-85 -107.02 -36.81 6.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.3 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.35 57.89 1.17 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.582 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.564 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 34.7 t -111.67 151.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.962 0.41 . . . . 0.0 111.236 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.69 102.65 12.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.841 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 56.6 p -77.12 -14.09 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.298 0.571 . . . . 0.0 111.513 -173.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -83.97 -8.15 59.23 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.756 0.789 . . . . 0.0 110.134 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.82 -10.35 23.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 57.1 mt -82.66 129.61 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.02 -175.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.55 ' HD3' HD22 ' A' ' 47' ' ' LEU . 11.8 tmtt? -96.89 119.2 34.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.522 ' HA ' HG11 ' A' ' 60' ' ' VAL . 39.3 mt -84.5 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.772 0.796 . . . . 0.0 111.4 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.55 HD22 ' HD3' ' A' ' 45' ' ' LYS . 5.9 mt -97.47 -56.06 2.64 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.656 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HA ' HG22 ' A' ' 16' ' ' VAL . 77.0 tttt -143.17 111.74 6.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.134 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.865 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.9 m -101.26 140.17 35.92 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -156.5 173.66 16.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.607 ' HB2' ' HE2' ' A' ' 74' ' ' LYS . 7.5 pt-20 -141.3 143.67 34.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.36 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 53' ' ' LYS . 11.2 t70 -131.03 -146.8 0.31 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.98 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 35.1 mmtp -65.79 95.47 0.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.659 0.266 . . . . 0.0 110.881 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 67.3 -6.43 0.62 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -116.82 134.5 54.7 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.644 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.671 ' CD2' ' HG2' ' A' ' 74' ' ' LYS . 10.5 m-85 -92.23 147.61 22.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.619 169.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 72.5 m-85 -130.4 97.94 4.55 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.35 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.617 HG21 HG22 ' A' ' 49' ' ' THR . 7.3 t -102.09 93.11 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.143 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.9 t -79.09 117.5 20.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 46' ' ' ILE . 17.3 m -130.02 157.44 42.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.35 126.2 33.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 7.07 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.68 -36.57 4.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.086 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -93.49 -29.99 15.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.239 0.542 . . . . 0.0 111.123 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.81 -18.45 2.77 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.426 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.36 134.77 52.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.32 98.89 7.2 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.893 0.854 . . . . 0.0 110.061 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 1.02 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 10.1 t -93.57 133.88 36.43 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.303 -172.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.1 ttmt -107.43 103.85 13.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.766 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 44.8 m-85 -69.01 115.53 8.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.002 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 86.6 tttt -94.17 98.4 10.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.118 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 95.5 mt -100.43 111.63 30.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.848 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.531 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 10.8 ttt180 -69.88 104.09 2.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.727 ' HB3' HD12 ' A' ' 3' ' ' LEU . 78.1 mttt -47.7 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.241 0.963 . . . . 0.0 111.451 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.831 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 14.0 t70 1.84 77.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 125.194 1.559 . . . . 0.0 112.578 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . 15.7 m -84.03 -11.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.716 -170.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t70 170.63 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.749 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -89.26 148.87 41.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.184 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.543 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 75.4 Cg_endo -83.14 105.75 1.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.628 2.219 . . . . 0.0 112.406 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 79' ' ' PRO . 3.1 mtmm 178.43 157.81 0.47 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.275 0.559 . . . . 0.0 111.309 175.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.92 ' HE1' HG12 ' A' ' 33' ' ' ILE . 2.3 tmm? -89.32 128.03 35.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 5.6 p -66.16 -38.89 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.472 ' HA3' ' HH ' ' A' ' 37' ' ' TYR . . . -178.12 -164.02 30.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.99 -1.576 . . . . 0.0 114.721 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.705 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 11.3 ptt180 -176.05 88.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.552 1.168 . . . . 0.0 107.967 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -78.43 -18.36 55.05 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.921 -170.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 1.02 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.5 m 58.82 100.64 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.939 0.876 . . . . 0.0 109.887 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 . . . . . 0 C--N 1.304 -1.41 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.947 -166.323 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.541 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 13.1 t . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 37.0 mt -121.53 -6.91 9.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.247 0.546 . . . . 0.0 110.452 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.754 HG22 ' HE2' ' A' ' 56' ' ' TYR . 6.8 tp -89.21 135.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.511 -169.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 7' ' ' LEU . 9.8 mp 68.38 91.06 0.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.351 0.407 . . . . 0.0 110.434 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.37 83.22 0.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 51.5 52.09 34.69 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.55 ' H ' ' HA ' ' A' ' 76' ' ' VAL . 7.4 t70 -137.45 -164.0 1.52 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.235 -0.483 . . . . 0.0 110.874 -161.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.589 ' HA ' HD21 ' A' ' 3' ' ' LEU . 2.7 pp -161.61 133.43 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.321 0.581 . . . . 0.0 111.94 -173.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 92.1 mt -123.8 -69.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.134 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 70.92 -67.02 0.27 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.638 0.586 . . . . 0.0 111.527 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -97.99 37.64 1.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.966 0.889 . . . . 0.0 109.505 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.718 ' HB3' ' HB3' ' A' ' 8' ' ' LEU . 20.8 pttt -75.53 -28.38 59.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.393 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.496 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 3.6 pp -101.33 170.36 8.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.086 -173.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -140.86 34.59 1.77 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.506 0.67 . . . . 0.0 109.868 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -129.56 147.85 66.95 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.338 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.79 -25.55 23.69 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.042 1.828 . . . . 0.0 111.531 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.417 HG21 ' HG3' ' A' ' 48' ' ' LYS . 15.3 t -145.61 139.91 21.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.743 175.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 49' ' ' THR . 4.2 mt -88.36 160.73 2.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.39 136.4 57.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -68.23 -13.68 62.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.168 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.6 tp -67.88 -41.95 82.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.964 0.411 . . . . 0.0 109.899 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 78.3 t80 -63.22 -36.97 85.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.78 -50.89 56.15 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.204 174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -52.28 -37.83 56.64 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 122.361 0.264 . . . . 0.0 111.12 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.7 mm-40 -59.51 -50.39 74.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.702 0.401 . . . . 0.0 111.679 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 51.7 mt -53.33 -58.85 5.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.717 0.77 . . . . 0.0 110.316 176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.655 HD13 HG22 ' A' ' 58' ' ' VAL . 8.5 mp -62.54 -35.67 80.17 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.057 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.73 -41.5 81.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 87.8 mttt -70.23 -29.37 66.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 84.3 m-85 -98.27 1.55 47.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -55.16 -43.37 74.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 120.98 0.419 . . . . 0.0 111.002 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.51 -34.13 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.125 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.92 -40.22 28.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.209 0.528 . . . . 0.0 110.166 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.525 HG21 ' HB ' ' A' ' 39' ' ' VAL . 70.1 mt -63.19 -36.88 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.208 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.581 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.9 tttm -80.34 -30.77 38.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.895 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.47 -44.11 89.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.093 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -94.4 -41.48 9.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' HB2' HG21 ' A' ' 39' ' ' VAL . 46.4 m-85 -114.27 -29.66 6.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.0 111.32 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.38 54.26 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.662 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.581 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 18.5 t -117.36 151.36 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 0.0 110.81 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.549 ' OD2' ' HG2' ' A' ' 42' ' ' LYS . 9.7 t70 -107.13 125.04 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 26' ' ' LEU . 13.9 p -76.01 -14.27 60.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.549 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 8.1 ptpp? -77.61 -17.09 58.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.88 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.99 -22.69 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.294 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.77 118.84 10.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.511 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 63.2 tttp -82.77 98.79 9.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.249 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.626 ' HA ' HG11 ' A' ' 60' ' ' VAL . 48.2 mt -73.11 119.73 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.543 0.687 . . . . 0.0 110.747 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.7 mt -90.18 -44.46 9.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.099 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HG3' HG21 ' A' ' 16' ' ' VAL . 58.2 tttm -149.49 106.02 3.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.192 -172.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' HG13 ' A' ' 17' ' ' ILE . 11.0 m -86.88 123.9 32.52 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.0 m -160.47 -178.41 6.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.414 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.3 pt-20 -138.88 152.96 48.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.657 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 30.0 t70 -148.18 125.75 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.436 ' HG3' ' OD1' ' A' ' 52' ' ' ASP . 38.7 mttp 60.17 -138.52 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.825 ' HB3' HG13 ' A' ' 76' ' ' VAL . 73.2 mtm180 -80.16 12.72 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.629 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.596 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 3.8 m-85 -137.15 152.86 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.15 -167.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.754 ' HE2' HG22 ' A' ' 2' ' ' ILE . 14.6 m-85 -91.55 150.71 21.07 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 169.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.657 ' CE2' ' HB3' ' A' ' 52' ' ' ASP . 65.0 m-85 -130.13 98.05 4.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.757 0.313 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.655 HG22 HD13 ' A' ' 26' ' ' LEU . 21.5 t -100.03 93.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 2.1 t -76.71 124.33 27.51 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.626 HG11 ' HA ' ' A' ' 46' ' ' ILE . 11.6 m -134.8 151.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.092 0.473 . . . . 0.0 111.211 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.1 t70 -87.49 117.15 26.09 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.63 -9.43 59.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.811 0.339 . . . . 0.0 111.702 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.74 -28.41 4.46 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.229 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -64.0 -28.03 69.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 0.0 110.065 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.74 -27.92 3.15 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.266 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -83.62 152.99 24.52 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.201 0.524 . . . . 0.0 111.443 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -103.14 111.71 24.21 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 2.4 t -95.76 168.97 10.33 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.605 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 19.1 ttmm -148.04 94.49 2.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -72.56 89.73 1.31 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.899 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 74.2 tttt -78.6 93.01 4.77 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.742 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 80.4 mt -83.03 105.88 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.53 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.669 ' H ' ' HA ' ' A' ' 81' ' ' MET . 14.5 ttt180 -66.03 121.34 14.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.506 ' HE3' ' C ' ' A' ' 55' ' ' PHE . 71.4 mttt -65.73 168.37 7.87 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.301 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.0 7.84 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 0.0 110.542 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 54' ' ' ARG . 2.7 p -53.86 -33.15 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 122.441 1.115 . . . . 0.0 109.3 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.544 ' O ' HG13 ' A' ' 78' ' ' VAL . 27.6 t70 -164.84 118.42 1.29 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.872 -1.967 . . . . 0.0 108.387 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 77' ' ' ASP . 8.9 p 54.79 124.67 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.74 0 O-C-N 125.01 1.444 . . . . 0.0 112.683 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 84.7 Cg_endo -79.04 47.44 2.49 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 123.746 2.964 . . . . 0.0 112.555 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 7.3 mtmt -147.24 146.99 29.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.669 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 8.1 ptt? -57.23 108.47 0.53 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.11 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.652 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 9.1 p -59.91 -40.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.788 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -145.57 91.36 0.15 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.263 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 58.47 1.34 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.018 0.914 . . . . 0.0 108.635 170.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -95.97 119.17 34.0 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.882 -167.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -83.87 124.04 30.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.333 0.587 . . . . 0.0 109.535 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 C--N 1.308 -1.236 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -179.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.408 ' OG ' ' HZ ' ' A' ' 29' ' ' PHE . 58.0 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.052 0.453 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.652 HD21 ' H ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -115.26 97.52 6.24 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.4 tp -163.47 -20.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.041 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.781 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 3.9 mp -116.98 1.03 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 t70 66.97 -62.43 0.3 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.655 0.597 . . . . 0.0 111.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.36 61.14 0.19 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.594 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 25.7 t0 76.75 23.07 1.07 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.649 0.738 . . . . 0.0 111.077 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 6.5 tt -98.08 122.95 41.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.603 HD21 HD22 ' A' ' 7' ' ' LEU . 2.2 pt? -41.04 -66.68 0.31 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -167.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.55 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 31.8 mmtp 65.06 -67.8 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.615 ' HB2' HD21 ' A' ' 12' ' ' LEU . 3.3 p30 -59.17 -54.0 51.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.8 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' HG2' HD13 ' A' ' 8' ' ' LEU . 42.4 mtpt 53.45 43.97 30.59 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.341 0.4 . . . . 0.0 111.043 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' A' ' 10' ' ' ASP . 4.3 mm? -63.52 -86.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.382 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.688 ' N ' ' HE2' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 54.41 61.43 3.02 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 109.991 177.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.595 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 82.8 mt -134.97 174.69 4.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.459 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.2 Cg_endo -63.5 -153.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.896 2.397 . . . . 0.0 111.066 165.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' A' ' 48' ' ' LYS . 23.8 t -58.75 106.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.757 0.789 . . . . 0.0 109.944 175.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.59 156.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.486 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -49.05 133.03 18.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.107 0.479 . . . . 0.0 111.213 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.9 OUTLIER -67.42 -25.52 65.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.729 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.38 -50.39 70.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -59.15 -38.58 80.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.722 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -64.54 -47.04 88.19 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 9.2 mmmm -54.77 -36.92 65.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.314 0.246 . . . . 0.0 111.027 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.575 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.3 mm-40 -60.04 -47.0 87.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.429 0.456 . . . . 0.0 111.492 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 72' ' ' ILE . 89.0 mt -52.46 -63.78 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.462 174.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.61 HD13 HG13 ' A' ' 58' ' ' VAL . 7.7 mp -59.67 -32.33 70.39 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.292 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.42 -40.29 86.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.216 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 50.6 mttm -75.5 -32.36 60.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.625 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 91.8 m-85 -96.44 8.47 43.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -54.04 -39.56 66.31 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.246 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.4 -39.78 94.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.664 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' HZ1' ' A' ' 36' ' ' LYS . 23.3 t70 -76.52 -38.53 54.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 -176.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.15 -26.4 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.288 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 82.0 tttt -83.55 -28.17 28.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.614 0.721 . . . . 0.0 109.84 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.94 -46.39 62.5 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.273 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.478 ' HZ1' ' CG ' ' A' ' 32' ' ' ASP . 52.3 mttp -77.73 -39.75 43.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.761 -177.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.571 ' HB2' HG21 ' A' ' 39' ' ' VAL . 90.0 m-85 -114.88 -48.01 2.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.449 0.642 . . . . 0.0 110.966 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.16 39.05 2.35 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.296 -171.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.64 HG13 ' HG ' ' A' ' 44' ' ' LEU . 13.5 t -109.3 150.82 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.831 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 42' ' ' LYS . 32.0 t70 -92.99 11.17 28.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 0.0 110.132 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.497 ' H ' HG11 ' A' ' 39' ' ' VAL . 46.6 p 56.16 -24.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.7 1.6 . . . . 0.0 114.129 -172.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.788 ' HB2' ' HZ3' ' A' ' 42' ' ' LYS . 4.4 ttmp? -72.83 -12.92 61.17 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 110.517 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.1 -42.5 17.33 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.759 0.79 . . . . 0.0 108.875 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.64 ' HG ' HG13 ' A' ' 39' ' ' VAL . 57.1 mt -61.67 106.11 0.63 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.376 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.612 ' HD3' HD22 ' A' ' 47' ' ' LEU . 6.1 tmtm? -79.91 116.61 20.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.406 ' HA ' HG11 ' A' ' 60' ' ' VAL . 41.3 mt -73.6 128.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.546 0.688 . . . . 0.0 110.956 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.612 HD22 ' HD3' ' A' ' 45' ' ' LYS . 15.3 mt -97.92 -51.5 4.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.889 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.557 ' HA ' HG11 ' A' ' 16' ' ' VAL . 62.4 tttm -144.73 102.86 3.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.461 -173.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.4 m -78.9 121.72 25.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -153.22 -177.78 6.54 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.818 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 1.7 pp20? -162.55 160.83 26.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.808 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.658 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 29.7 t70 -103.78 -86.14 0.45 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.735 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -131.33 -79.23 0.52 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' HB3' HG12 ' A' ' 76' ' ' VAL . 52.5 mtt180 -87.99 16.93 5.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 0.0 110.818 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -144.6 135.62 25.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.9 m-85 -94.88 151.45 19.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.658 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 78.1 m-85 -137.8 109.59 7.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.349 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.61 HG13 HD13 ' A' ' 26' ' ' LEU . 21.8 t -110.7 108.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.1 t -84.27 130.72 34.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 67' ' ' LYS . 26.9 m -135.4 148.29 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.136 0.494 . . . . 0.0 112.167 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.511 ' HB2' HD23 ' A' ' 47' ' ' LEU . 34.7 t70 -90.26 112.88 24.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.93 -63.88 1.13 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.798 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.67 -130.27 2.07 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.096 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.39 -8.14 21.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.098 0.475 . . . . 0.0 109.813 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.73 -33.95 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.603 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.45 136.56 58.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.214 0.53 . . . . 0.0 111.132 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 42.5 mttp -137.17 106.3 6.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.96 -173.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.09 148.0 23.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.352 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.756 ' HZ1' ' HB2' ' A' ' 69' ' ' LYS . 5.0 ttmp? -115.03 102.78 10.26 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.688 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 62.1 m-85 -68.44 127.48 33.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.606 ' HE3' HG13 ' A' ' 82' ' ' VAL . 56.7 tttp -100.71 83.45 2.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.666 0.746 . . . . 0.0 109.938 -175.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 94.8 mt -81.25 89.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.952 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.65 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 39.7 ttt180 -58.9 117.72 4.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HB3' HD12 ' A' ' 3' ' ' LEU . 93.9 mttt -60.9 174.07 0.68 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.569 -176.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.781 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 53.1 t0 -71.89 64.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 0.0 110.513 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.594 ' HA ' ' N ' ' A' ' 6' ' ' ASP . 31.1 m -99.09 -7.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.438 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -175.16 -61.49 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.024 -171.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.1 151.02 37.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.577 . . . . 0.0 111.186 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -90.34 32.74 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.709 2.94 . . . . 0.0 110.977 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.625 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 3.0 ttmt -150.88 -166.18 2.47 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.178 0.513 . . . . 0.0 111.099 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.529 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 67.9 mtm -97.04 127.2 42.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.226 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.65 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 7.6 p -53.01 -33.13 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.455 0.645 . . . . 0.0 109.903 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.76 -143.42 8.41 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.919 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.688 ' HB2' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER 176.3 148.78 0.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -148.49 121.07 8.56 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.945 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.4 m -88.19 130.31 35.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 122.067 0.937 . . . . 0.0 109.893 -172.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.441 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 28.6 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.862 ' H ' ' HE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -125.76 108.59 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.742 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.8 HG23 ' HE1' ' A' ' 56' ' ' TYR . 3.3 tp -176.36 -6.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 8' ' ' LEU . 7.1 tp -144.27 -18.25 0.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.405 -171.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 65.41 9.53 5.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.887 0.475 . . . . 0.0 112.069 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.706 ' HA3' ' H ' ' A' ' 77' ' ' ASP . . . 71.49 18.11 76.79 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.647 -172.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -103.36 -35.25 8.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.549 ' HA ' ' HG ' ' A' ' 3' ' ' LEU . 6.8 mp 71.03 109.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.517 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 3' ' ' LEU . 58.0 tp -109.62 88.37 2.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HA ' HD22 ' A' ' 12' ' ' LEU . 9.5 ptpp? -93.35 14.3 18.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.559 -172.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.526 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 20.5 t70 -88.8 -29.71 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.219 0.533 . . . . 0.0 110.565 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HZ3' ' CD ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -83.6 -20.98 32.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.299 -175.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' ' 9' ' ' LYS . 2.3 pp -87.53 45.57 1.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.847 0.832 . . . . 0.0 111.692 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 10' ' ' ASP . 40.8 mtpt -115.06 21.87 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.965 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.41 154.77 46.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.418 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.55 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.255 2.637 . . . . 0.0 110.966 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 48' ' ' LYS . 3.4 p -54.71 108.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 122.335 1.064 . . . . 0.0 110.38 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.803 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 33.3 mt -75.82 149.57 6.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.3 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.22 139.64 47.17 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.097 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' O ' HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -60.29 -24.55 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.063 -176.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.43 -39.74 74.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' O ' HD11 ' A' ' 25' ' ' LEU . 77.5 t80 -62.02 -43.93 97.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.74 -29.67 73.98 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.431 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -70.05 -37.39 75.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 36.2 mm-40 -59.18 -47.75 84.17 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.693 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD11 ' O ' ' A' ' 21' ' ' PHE . 8.7 mp -50.42 -67.34 0.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.92 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 26.5 mt -50.38 -30.19 11.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.795 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.25 -45.72 46.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.372 -0.205 . . . . 0.0 110.72 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 63.6 mttm -65.88 -46.77 77.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.278 0.561 . . . . 0.0 110.41 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.862 ' HE2' ' H ' ' A' ' 1' ' ' LEU . 19.5 m-85 -91.33 13.21 18.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.787 -174.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.84 -51.43 67.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.7 m-20 -80.74 11.17 4.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.369 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.03 -43.98 5.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.581 HG22 ' HE2' ' A' ' 70' ' ' PHE . 38.8 mt -66.93 -38.2 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.685 174.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -83.05 -22.76 33.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.845 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 15.2 t70 -68.51 -55.3 12.21 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.272 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 81' ' ' MET . 58.2 mttm -69.51 -50.73 42.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.417 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.899 ' HH ' ' HA3' ' A' ' 83' ' ' GLY . 26.9 m-85 -116.71 -6.4 11.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.92 29.28 73.49 Favored Glycine 0 CA--C 1.516 0.136 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.494 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 33' ' ' ILE . 28.2 t -97.93 147.72 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.554 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.23 127.57 50.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.92 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 71.8 p -87.94 -20.11 26.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.816 0.341 . . . . 0.0 111.858 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -68.19 -39.74 82.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -61.05 -29.01 69.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.862 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 64.2 mt -69.52 149.95 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -175.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -115.01 121.15 42.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.432 172.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 26' ' ' LEU . 26.5 mt -84.65 132.25 32.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.512 0.673 . . . . 0.0 111.779 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 61' ' ' ASP . 5.7 mt -101.76 -52.04 3.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.733 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HG3' HG22 ' A' ' 16' ' ' VAL . 38.4 ttmt -146.35 115.3 6.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.059 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.803 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -91.59 139.04 31.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -157.41 -175.41 5.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 13.1 pt-20 -163.74 150.8 12.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.298 0.57 . . . . 0.0 111.962 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.741 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 27.8 t70 -99.55 -158.84 0.7 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 4.0 mptt -73.11 -70.61 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -87.12 13.63 9.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 91.0 m-85 -145.67 152.21 39.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.8 ' HE1' HG23 ' A' ' 2' ' ' ILE . 30.9 m-85 -108.17 147.01 31.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.009 166.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.741 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 66.1 m-85 -130.37 95.7 3.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.818 0.342 . . . . 0.0 110.329 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 22.0 t -104.7 97.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.049 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.2 t -69.02 114.03 6.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.527 HG11 ' HA ' ' A' ' 46' ' ' ILE . 13.7 m -129.28 152.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.429 0.633 . . . . 0.0 111.265 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.55 ' HB2' HD22 ' A' ' 47' ' ' LEU . 12.3 t70 -84.41 115.53 22.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.28 -14.5 60.51 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.297 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.99 -42.76 2.35 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.602 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.18 -30.14 64.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.903 0.481 . . . . 0.0 111.293 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.55 -19.46 1.67 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.453 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.578 ' OE2' ' HB3' ' A' ' 86' ' ' CYS . 6.2 pt-20 -104.71 166.17 10.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.321 0.582 . . . . 0.0 112.345 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -111.92 117.66 33.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.153 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 62.1 m -111.84 114.99 28.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.036 0.446 . . . . 0.0 111.19 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.924 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.5 ttmt -88.82 85.28 6.73 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 170.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.581 ' HE2' HG22 ' A' ' 33' ' ' ILE . 5.9 m-85 -47.91 116.3 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.913 -172.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.744 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 62.4 tttt -95.67 69.79 2.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.242 -174.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.836 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 36.7 mt -74.52 91.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.454 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.809 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 24.4 ttt180 -50.58 117.43 2.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HE3' ' CE1' ' A' ' 56' ' ' TYR . 43.0 mttp -59.4 166.3 2.37 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.03 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 17.9 t0 -67.68 74.75 0.18 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.632 0.73 . . . . 0.0 109.68 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 74' ' ' LYS . 3.7 m -104.31 94.39 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.672 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.706 ' H ' ' HA3' ' A' ' 5' ' ' GLY . 34.5 t70 72.21 -61.14 0.5 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.293 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.67 141.56 22.76 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.322 0.582 . . . . 0.0 110.19 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -91.85 84.29 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.463 2.776 . . . . 0.0 113.62 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.462 ' HD2' ' HZ2' ' A' ' 36' ' ' LYS . 5.2 mtmt -165.51 153.55 11.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.547 176.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.836 ' HG3' ' HA ' ' A' ' 72' ' ' ILE . 4.5 ttp -82.24 121.39 26.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.811 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.809 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.3 p -60.88 -39.4 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.382 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.899 ' HA3' ' HH ' ' A' ' 37' ' ' TYR . . . 178.87 -153.02 11.82 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.895 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.744 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 41.3 mtm180 -151.43 125.75 9.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.924 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 24.5 tptp -76.28 55.57 0.98 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.339 0.59 . . . . 0.0 110.106 -178.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.578 ' HB3' ' OE2' ' A' ' 66' ' ' GLU . 39.3 m -72.47 -164.63 0.16 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.832 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 98.2 mtt180 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 79' ' ' PRO . 11.4 p . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.526 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.1 mp 52.09 -153.05 0.22 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.005 171.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.609 HD11 ' HE2' ' A' ' 56' ' ' TYR . 79.4 mt 79.57 -56.5 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.029 168.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 7' ' ' LEU . 64.9 mt -105.46 -42.89 5.1 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.772 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 29.6 m-20 60.46 71.81 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.672 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.1 31.34 80.46 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.543 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.0 t70 -135.24 -153.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.772 ' HA ' HD12 ' A' ' 3' ' ' LEU . 86.0 mt -154.23 172.29 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 110.668 -171.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.601 HD23 ' HZ1' ' A' ' 74' ' ' LYS . 2.4 pt? -140.4 120.32 13.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -100.92 -18.08 16.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.778 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -94.17 -30.14 14.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HZ3' ' HB2' ' A' ' 11' ' ' LYS . 10.4 mtmp? 57.78 -168.78 0.12 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.807 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.403 HD12 ' CE2' ' A' ' 21' ' ' PHE . 84.1 mt -90.47 -74.71 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.677 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.552 ' HE3' HG21 ' A' ' 17' ' ' ILE . 31.1 pttt -175.93 -161.78 0.09 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -168.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.454 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 10.7 mp -66.76 169.33 8.11 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.367 0.667 . . . . 0.0 112.189 -175.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 98.5 Cg_exo -47.99 159.33 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.811 3.007 . . . . 0.0 113.891 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 49' ' ' THR . 11.0 p 40.96 104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 123.482 1.611 . . . . 0.0 113.432 -173.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.552 HG21 ' HE3' ' A' ' 13' ' ' LYS . 9.8 mt -87.66 -177.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.469 -175.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.507 ' H ' HG23 ' A' ' 17' ' ' ILE . 4.0 m-20 -59.99 -4.93 0.85 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.572 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 12.8 m120 72.9 -44.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.485 0.714 . . . . 0.0 110.981 -176.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -59.82 -31.57 69.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.779 0.432 . . . . 0.0 110.675 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.506 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 38.5 t80 -65.5 -35.63 81.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 109.754 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.11 -27.64 59.76 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -65.59 -37.66 87.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.6 -48.86 77.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.181 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 84.0 mt -49.76 -69.11 0.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.028 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.598 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 33.7 mt -52.78 -26.68 15.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.88 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.99 -48.75 67.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 110.958 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -69.3 -40.98 77.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.192 0.52 . . . . 0.0 110.365 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.36 3.83 52.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.818 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 31.3 tt0 -54.95 -40.56 70.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -65.86 -26.65 67.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.993 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 35' ' ' ASP . 7.9 t70 -85.57 -40.17 16.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.511 0.672 . . . . 0.0 109.681 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.412 HG23 ' HB ' ' A' ' 39' ' ' VAL . 35.5 mt -69.25 -34.03 61.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.412 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 86.4 tttt -75.83 -31.54 59.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 18.7 t70 -59.94 -35.59 75.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.643 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -105.87 -25.31 12.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -173.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.49 ' HB2' HG21 ' A' ' 39' ' ' VAL . 74.0 m-85 -128.14 -31.38 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.54 63.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.111 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 37' ' ' TYR . 46.5 t -120.7 151.51 23.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 -173.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 42' ' ' LYS . 23.1 t70 -108.65 110.14 21.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 17.3 p -72.32 -10.43 59.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.646 ' HZ2' ' HB3' ' A' ' 42' ' ' LYS . 6.3 ttpm? -78.04 -35.0 50.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.039 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.32 -28.62 59.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 109.589 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 41' ' ' THR . 1.4 mp -54.11 115.99 2.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.405 176.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 2.8 ttmp? -86.32 108.55 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.972 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.668 ' HA ' HG11 ' A' ' 60' ' ' VAL . 36.4 mt -80.27 122.6 35.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.445 0.641 . . . . 0.0 111.094 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.1 mt -96.03 -51.71 4.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.956 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -142.43 106.31 4.71 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.265 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 11.3 m -91.04 132.13 36.2 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.415 ' HA ' HG13 ' A' ' 17' ' ' ILE . 69.0 m -152.54 -175.11 5.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 11' ' ' LYS . 12.5 pt-20 -149.64 158.65 44.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.763 0.792 . . . . 0.0 111.519 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.653 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 28.1 t70 -111.56 -164.94 0.95 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 166.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.773 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 1.2 mptt -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.43 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 40.0 mtp180 -83.5 -0.1 48.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.584 -172.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.455 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 m-85 -148.15 159.71 43.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.237 0.541 . . . . 0.0 112.382 -168.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.703 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 36.0 m-85 -109.24 159.75 16.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 163.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.653 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 94.4 m-85 -137.07 93.78 2.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.936 0.398 . . . . 0.0 110.181 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 49' ' ' THR . 13.3 t -102.51 96.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.588 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 12.9 m -78.4 124.44 28.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 46' ' ' ILE . 17.4 m -141.6 160.57 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.543 -173.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 6.0 t70 -92.17 125.33 36.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.489 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -79.81 -13.96 59.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.45 -31.92 7.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.58 8.92 4.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.802 0.334 . . . . 0.0 111.23 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.21 -15.08 63.74 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.625 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 9.6 pt-20 -84.16 142.19 30.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.162 0.506 . . . . 0.0 110.749 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -97.62 134.9 40.2 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 86' ' ' CYS . 8.9 t -126.63 164.66 20.77 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.25 0.548 . . . . 0.0 110.623 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.662 ' H ' ' HA ' ' A' ' 86' ' ' CYS . 35.7 ttmt -147.43 103.87 3.59 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.402 ' CD2' HD23 ' A' ' 26' ' ' LEU . 72.0 m-85 -77.36 88.08 3.76 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.571 0.7 . . . . 0.0 110.529 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 1.034 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 31.1 tttp -71.63 78.02 0.82 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.924 170.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 78.9 mt -74.43 95.84 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.247 -176.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.622 ' HB2' HG11 ' A' ' 82' ' ' VAL . 40.5 ttp180 -61.76 101.64 0.21 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.601 ' HZ1' HD23 ' A' ' 8' ' ' LEU . 88.8 mttt -48.72 152.3 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.369 1.043 . . . . 0.0 109.687 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.772 ' HB3' ' H ' ' A' ' 4' ' ' ASP . 29.3 t0 -69.47 70.78 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.411 0.624 . . . . 0.0 109.56 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 33.7 m -89.2 -4.34 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.865 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 t70 178.57 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.732 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.534 HG21 ' HD2' ' A' ' 79' ' ' PRO . 7.1 p -137.29 138.34 24.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.326 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.534 ' HD2' HG21 ' A' ' 78' ' ' VAL . 68.4 Cg_endo -83.06 62.88 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.493 2.796 . . . . 0.0 112.855 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -145.28 128.28 16.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 111.471 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.481 ' HG3' HG22 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.59 95.63 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.13 177.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.622 HG11 ' HB2' ' A' ' 73' ' ' ARG . 10.0 p -60.58 -41.54 88.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.704 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 1.034 ' HA2' ' HB3' ' A' ' 71' ' ' LYS . . . -89.5 47.76 3.29 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 -173.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -81.77 45.53 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -105.01 -26.28 12.21 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.818 -165.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.662 ' HA ' ' H ' ' A' ' 69' ' ' LYS . 49.4 m 66.35 -178.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.906 -171.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 N--CA 1.437 -1.088 0 CA-C-O 121.546 0.688 . . . . 0.0 109.285 -172.924 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 2' ' ' ILE . 27.2 mt -118.59 -144.43 0.37 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.615 HG23 ' HE2' ' A' ' 56' ' ' TYR . 1.3 tp 81.2 -25.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.981 0.912 . . . . 0.0 112.492 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.796 HD12 ' HA ' ' A' ' 6' ' ' ASP . 30.8 mt -124.0 161.9 24.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.954 0.407 . . . . 0.0 110.659 176.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.569 ' HB3' HD11 ' A' ' 7' ' ' LEU . 18.7 t70 -121.81 81.01 1.76 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.59 43.78 97.49 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.392 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.796 ' HA ' HD12 ' A' ' 3' ' ' LEU . 34.6 t70 67.14 96.73 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.228 0.537 . . . . 0.0 111.951 -177.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 4' ' ' ASP . 75.6 mt -149.4 100.03 2.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.59 HD22 ' HD3' ' A' ' 53' ' ' LYS . 51.7 tp -112.19 -68.19 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 38.0 mtmt 76.77 -66.49 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.564 . . . . 0.0 111.856 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -125.75 134.18 51.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.769 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -149.43 3.54 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.46 128.5 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.165 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 14' ' ' LEU . 59.3 tttt -136.69 165.8 25.07 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.411 ' H ' ' HG2' ' A' ' 13' ' ' LYS . 61.9 mt -55.01 159.15 4.04 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 122.654 0.382 . . . . 0.0 111.342 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.26 138.82 4.45 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.594 2.862 . . . . 0.0 113.5 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 48' ' ' LYS . 10.6 p 43.69 102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 123.129 1.442 . . . . 0.0 113.578 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.88 162.31 4.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.124 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.88 133.31 22.27 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.345 0.403 . . . . 0.0 111.126 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.596 ' HA ' ' HG1' ' A' ' 49' ' ' THR . 30.1 p-10 -64.01 -20.85 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.913 0.387 . . . . 0.0 110.254 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -69.03 -31.55 70.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.418 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HE1' ' HE1' ' A' ' 56' ' ' TYR . 55.5 t80 -68.6 -40.07 80.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 109.698 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.456 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -72.26 -29.85 65.8 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.162 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -67.27 -40.49 86.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.2 mm-40 -52.77 -51.72 59.51 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.744 173.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 72' ' ' ILE . 68.3 mt -53.97 -66.36 0.41 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.839 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 30' ' ' GLN . 20.4 mt -54.06 -28.36 38.34 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.46 -50.23 60.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 72.4 mttt -71.54 -33.77 69.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.816 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -96.88 4.9 51.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.789 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.4 tt0 -56.52 -41.63 77.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.775 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -65.69 -20.99 66.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.551 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -94.61 -39.93 10.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.277 0.561 . . . . 0.0 110.042 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.511 HG21 ' HB ' ' A' ' 39' ' ' VAL . 53.7 mt -67.76 -31.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.313 176.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 44.1 tttp -81.73 -29.15 33.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.306 0.574 . . . . 0.0 109.803 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.39 -52.59 31.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.574 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -71.44 -43.39 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.621 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.579 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 86.6 m-85 -118.59 -23.54 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.14 44.11 7.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.875 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.542 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.3 t -100.99 152.79 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -114.4 116.61 29.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.511 HG21 HD11 ' A' ' 44' ' ' LEU . 39.7 p -76.22 -11.6 59.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -73.68 -20.46 60.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.358 0.599 . . . . 0.0 109.53 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -92.23 -33.0 14.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.327 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD11 HG21 ' A' ' 41' ' ' THR . 86.6 mt -56.67 111.55 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.959 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 75.8 tttt -84.11 104.35 14.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.71 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.571 ' HA ' HG11 ' A' ' 60' ' ' VAL . 37.7 mt -73.73 112.68 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.546 0.688 . . . . 0.0 111.029 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.6 mt -82.25 -43.5 17.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.065 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HA ' HG22 ' A' ' 16' ' ' VAL . 75.6 tttt -154.04 120.38 5.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.347 -173.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.596 ' HG1' ' HA ' ' A' ' 19' ' ' ASN . 29.0 m -102.46 130.21 49.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.401 ' HG ' ' C ' ' A' ' 49' ' ' THR . 49.9 m -157.29 177.03 11.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.595 ' CD ' ' HZ2' ' A' ' 74' ' ' LYS . 1.2 pt-20 -158.61 167.05 30.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 171.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -149.01 89.78 1.7 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.107 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.769 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 5.3 tppp? 70.41 -100.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.726 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.623 ' HB3' HG22 ' A' ' 76' ' ' VAL . 65.8 mtt180 -94.71 20.44 8.64 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.73 -0.606 . . . . 0.0 111.451 -171.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -148.63 121.01 8.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.818 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.759 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.0 m-85 -85.78 150.96 24.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 95.05 3.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.8 t -105.86 93.92 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 110.516 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.1 m -80.02 119.9 23.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.571 HG11 ' HA ' ' A' ' 46' ' ' ILE . 11.5 m -130.29 158.09 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.31 0.576 . . . . 0.0 111.343 -176.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -84.55 123.5 30.37 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.55 4.44 7.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.77 1.32 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.372 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.93 -27.05 39.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.136 0.493 . . . . 0.0 110.473 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.59 -21.62 2.37 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.202 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.95 147.89 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.398 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -109.47 110.3 21.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.049 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 56.2 m -108.18 131.43 54.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 34.8 ttmt -101.48 107.18 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 65.5 m-85 -76.48 84.55 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.184 0.992 . . . . 0.0 110.433 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 1.129 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 21.3 tttp -76.72 89.58 3.39 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.197 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.759 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 mt -87.23 106.22 15.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.494 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.604 ' HB2' HG21 ' A' ' 82' ' ' VAL . 60.3 ttt180 -78.7 18.09 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.462 0.648 . . . . 0.0 110.336 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.616 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.7 mttt 55.43 -157.12 0.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.229 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 32.0 t70 -100.83 56.0 0.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 54' ' ' ARG . 17.9 t -75.44 -13.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.281 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.8 t70 179.92 -54.63 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.315 -171.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG21 ' HD2' ' A' ' 79' ' ' PRO . 10.0 p -120.75 139.03 28.34 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.667 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HD2' HG21 ' A' ' 78' ' ' VAL . 55.5 Cg_endo -75.16 67.39 6.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.664 2.243 . . . . 0.0 111.86 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -142.03 142.24 32.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.628 0.727 . . . . 0.0 111.985 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.459 ' HG3' HG21 ' A' ' 72' ' ' ILE . 1.5 mpp? -80.7 89.45 5.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.587 173.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.604 HG21 ' HB2' ' A' ' 73' ' ' ARG . 35.0 m -58.84 -33.49 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.916 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 1.129 ' HA2' ' HB3' ' A' ' 71' ' ' LYS . . . -92.18 72.8 1.55 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.053 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.579 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -105.39 47.73 0.86 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -115.53 142.1 47.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.979 -170.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.8 m -108.26 132.02 54.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.049 0.452 . . . . 0.0 109.925 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 . . . . . 0 C--N 1.314 -0.958 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.495 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.403 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 26.1 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.291 0.567 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.938 ' HA ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -67.9 131.04 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.597 1.189 . . . . 0.0 113.47 -169.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.579 HG13 HD13 ' A' ' 8' ' ' LEU . 11.1 tp -152.36 15.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.167 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.641 HD12 ' O ' ' A' ' 75' ' ' ASP . 1.8 pp -149.2 157.89 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.462 -1.699 . . . . 0.0 108.184 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.61 -29.31 61.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.318 0.58 . . . . 0.0 109.825 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 40.99 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.587 ' H ' HD11 ' A' ' 3' ' ' LEU . 24.1 p-10 -157.96 -80.26 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.852 -168.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 6' ' ' ASP . 7.7 mt 175.71 174.14 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.139 0.576 . . . . 0.0 110.252 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.579 HD13 HG13 ' A' ' 2' ' ' ILE . 63.8 mt -100.05 131.63 45.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.156 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -98.46 -30.28 12.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 11' ' ' LYS . 6.4 p-10 -80.48 -38.03 30.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.068 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HB2' HD12 ' A' ' 8' ' ' LEU . 57.4 mttp -101.86 67.89 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.652 0.739 . . . . 0.0 109.745 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.653 ' HG ' ' HG2' ' A' ' 13' ' ' LYS . 1.6 pt? -79.25 -36.23 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.344 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.653 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 7.5 ptpt -177.08 101.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.448 0.642 . . . . 0.0 110.851 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 96.0 mt -100.47 167.51 10.79 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.523 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.6 Cg_endo -64.6 -170.61 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.632 2.221 . . . . 0.0 111.998 173.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 48' ' ' LYS . 2.6 p -63.39 105.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.017 175.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 49' ' ' THR . 3.3 pt -106.07 -177.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.804 -174.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.493 ' OD2' ' HB ' ' A' ' 46' ' ' ILE . 7.9 t70 176.68 -39.58 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -40.41 78.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 112.261 -2.245 . . . . 0.0 113.248 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.9 mt 45.7 40.2 5.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.729 0.776 . . . . 0.0 111.035 -175.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.3 m-85 -117.13 -78.06 0.58 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.127 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.41 90.78 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.491 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.547 ' HG2' HD11 ' A' ' 46' ' ' ILE . 30.2 mmmt -66.4 -33.29 75.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.364 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 1.5 mm-40 -65.87 -47.14 75.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.607 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 87.0 mt -50.94 -66.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.838 173.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.849 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 34.0 mt -50.89 -33.19 23.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.444 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.28 -48.46 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.195 -0.316 . . . . 0.0 111.074 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 80.0 mttt -67.7 -38.22 83.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.211 0.529 . . . . 0.0 110.496 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 1.5 m-85 -98.54 12.59 34.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.46 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.659 ' NE2' ' HA ' ' A' ' 40' ' ' ASP . 32.2 tt0 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.63 -33.15 71.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.347 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.658 ' O ' ' HD2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -76.58 -46.88 24.4 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.534 178.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.501 HG23 ' HB ' ' A' ' 39' ' ' VAL . 42.5 mt -65.45 -20.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.613 0.72 . . . . 0.0 110.266 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HG3' ' HA3' ' A' ' 38' ' ' GLY . 46.9 tttm -87.66 -40.18 14.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.645 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.89 -47.91 76.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.906 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.658 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 8.0 mttp -82.5 -28.74 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.26 -175.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.458 ' HB2' HG21 ' A' ' 39' ' ' VAL . 67.8 m-85 -133.67 -52.43 0.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.018 0.437 . . . . 0.0 111.526 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' HA3' ' HG3' ' A' ' 34' ' ' LYS . . . 106.78 62.53 0.59 Allowed Glycine 0 C--N 1.319 -0.393 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.501 ' HB ' HG23 ' A' ' 33' ' ' ILE . 47.3 t -124.45 151.84 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.905 0.383 . . . . 0.0 111.372 -171.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.659 ' HA ' ' NE2' ' A' ' 30' ' ' GLN . 28.7 t70 -103.19 121.33 42.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.54 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.849 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 41.1 p -88.56 -10.69 47.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.946 0.403 . . . . 0.0 112.044 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -68.97 -43.16 75.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -73.84 -24.87 59.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.379 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.7 mt -56.71 123.33 14.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.128 0.49 . . . . 0.0 110.692 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -94.2 111.69 23.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.82 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.612 ' HA ' HG11 ' A' ' 60' ' ' VAL . 12.4 mt -72.53 116.88 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.487 0.661 . . . . 0.0 111.184 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.82 -40.02 15.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.929 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.565 ' HA ' HG22 ' A' ' 16' ' ' VAL . 41.1 tttm -155.0 140.63 17.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.552 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 54.1 m -142.48 127.54 18.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.7 m -156.57 152.53 27.37 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -123.96 162.7 22.86 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 175.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 10.1 t70 -153.69 -98.99 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.672 171.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -93.57 89.79 6.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.912 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.3 mtt180 75.45 -44.84 0.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.657 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 20.5 m-85 -78.98 133.22 36.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.675 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 1.3 m-85 -103.55 121.77 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.718 164.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 49' ' ' THR . 10.7 m-85 -99.07 86.26 3.41 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 18.8 t -96.25 84.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.133 0.492 . . . . 0.0 110.4 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.638 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 23.5 t -82.44 117.57 22.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.612 HG11 ' HA ' ' A' ' 46' ' ' ILE . 15.2 m -129.84 156.26 42.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.248 0.547 . . . . 0.0 111.618 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.0 119.53 21.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.23 2.75 14.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.2 -50.44 3.63 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.916 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.94 -35.97 80.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.019 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.97 -31.48 0.89 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.885 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -71.6 161.06 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.066 0.46 . . . . 0.0 111.411 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -119.22 105.15 11.07 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.534 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 55.9 m -103.62 127.27 51.08 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.468 -173.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.8 ttpt -99.13 104.46 16.45 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.761 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 85.6 m-85 -71.43 95.99 1.43 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.656 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.667 ' HZ2' HG11 ' A' ' 82' ' ' VAL . 34.6 tttm -81.9 78.2 8.64 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.426 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 74' ' ' LYS . 57.5 mt -82.61 101.94 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.306 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 38.4 ttp180 -74.22 21.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.535 0.683 . . . . 0.0 109.827 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.675 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.1 mttt 64.3 174.25 0.19 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.564 -174.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.938 ' HB2' ' HA ' ' A' ' 1' ' ' LEU . 2.2 t70 -77.39 43.44 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.937 0.398 . . . . 0.0 110.37 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.403 HG12 ' HG2' ' A' ' 54' ' ' ARG . 6.9 m -64.17 91.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.248 0.547 . . . . 0.0 110.884 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 76.55 -50.68 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.095 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 34.8 m -107.25 146.23 32.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.382 0.61 . . . . 0.0 111.27 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.0 Cg_endo -90.73 54.61 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.737 2.958 . . . . 0.0 113.915 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -145.46 149.17 34.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.775 0.322 . . . . 0.0 111.221 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.437 ' HE3' ' HB2' ' A' ' 81' ' ' MET . 2.6 mpp? -81.66 102.16 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.667 HG11 ' HZ2' ' A' ' 71' ' ' LYS . 9.5 p -57.85 -31.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.027 0.442 . . . . 0.0 111.288 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.653 ' HA2' ' HB3' ' A' ' 71' ' ' LYS . . . -125.08 148.05 16.67 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.062 -177.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -173.81 54.14 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -98.92 129.05 45.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.226 -168.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -89.79 115.12 26.89 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.603 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 . . . . . 0 C--N 1.308 -1.202 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.045 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.945 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 7.8 t . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.41 78.61 9.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.213 0.53 . . . . 0.0 109.874 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 2' ' ' ILE . 8.9 tp -151.98 87.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 122.085 0.945 . . . . 0.0 110.219 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.9 pt? -127.96 133.4 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.667 0.746 . . . . 0.0 111.705 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.641 ' HB2' ' HA ' ' A' ' 8' ' ' LEU . 10.6 t70 -95.9 -19.91 19.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 168.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.37 71.06 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.079 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.523 ' O ' HG22 ' A' ' 76' ' ' VAL . 19.3 t70 63.46 31.24 15.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.126 0.965 . . . . 0.0 109.159 -175.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.723 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 31.5 tp 179.69 -174.08 0.23 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.723 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 34.8 tp -148.12 107.66 3.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -100.56 -14.3 18.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.919 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.1 -48.74 80.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.443 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.21 133.49 24.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.307 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.903 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 22.7 tp -153.74 142.02 20.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.343 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.903 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 36.4 mtmt 67.33 30.95 6.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.9 mt -66.31 129.36 94.18 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 52.4 Cg_exo -57.11 -62.7 0.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 123.59 2.86 . . . . 0.0 112.181 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.765 HG22 ' HG3' ' A' ' 48' ' ' LYS . 8.7 p -146.42 145.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.266 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.549 HG13 ' HA ' ' A' ' 50' ' ' SER . 2.3 mt -119.05 163.12 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.948 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -54.3 140.78 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -67.98 -25.55 65.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.039 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.9 tp -68.06 -45.26 74.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 79.2 t80 -59.9 -37.07 78.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.64 -51.24 37.28 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.413 ' N ' HD11 ' A' ' 46' ' ' ILE . 2.4 mptp? -51.9 -35.28 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 1.4 mm-40 -59.86 -60.04 4.47 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.463 172.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.41 ' HB2' HD11 ' A' ' 26' ' ' LEU . 63.7 mt -47.89 -56.36 7.71 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.889 0.852 . . . . 0.0 110.62 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 58' ' ' VAL . 8.0 mp -63.39 -28.26 69.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.578 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 t70 -62.99 -43.15 99.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -66.11 -21.19 66.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.961 0.41 . . . . 0.0 110.303 177.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.945 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 65.9 m-85 -107.43 2.64 24.45 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.471 HE22 ' HE3' ' A' ' 42' ' ' LYS . 50.6 tt0 -50.99 -44.5 60.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -173.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -69.88 -35.61 74.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.748 0.309 . . . . 0.0 110.79 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.73 -45.14 65.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.759 0.79 . . . . 0.0 109.794 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.679 HG12 ' HE2' ' A' ' 81' ' ' MET . 91.9 mt -61.18 -40.28 85.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.656 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 27.7 ttpp -78.8 -21.38 47.86 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 110.13 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.75 -48.31 16.95 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -81.87 -34.97 29.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -124.27 -26.44 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 64.85 1.92 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.993 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.647 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -133.34 150.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 122.309 0.244 . . . . 0.0 110.814 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.7 119.53 39.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.91 170.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 26' ' ' LEU . 53.7 p -75.21 -19.47 59.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.981 -175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' HE3' HE22 ' A' ' 30' ' ' GLN . 10.3 mtmp? -67.99 -43.09 79.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.064 0.459 . . . . 0.0 110.192 178.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -82.46 -35.28 27.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.561 HD22 HG22 ' A' ' 60' ' ' VAL . 18.6 tp -50.79 121.5 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.782 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 44.6 tttp -90.8 114.44 26.83 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.812 -171.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.551 ' HA ' HG11 ' A' ' 60' ' ' VAL . 18.0 mt -87.18 125.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.352 0.596 . . . . 0.0 111.361 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.5 mt -100.72 -54.44 2.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.166 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.765 ' HG3' HG22 ' A' ' 16' ' ' VAL . 59.8 tttm -139.41 93.45 2.68 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -74.64 137.53 42.29 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.549 ' HA ' HG13 ' A' ' 17' ' ' ILE . 4.5 p -171.11 -169.31 0.73 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 118.218 0.463 . . . . 0.0 110.962 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.581 ' OE2' ' HA ' ' A' ' 12' ' ' LEU . 7.2 pt-20 -165.45 168.14 16.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.553 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 39.0 t70 -145.68 -76.38 0.21 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 0.0 111.337 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.52 ' HG3' ' OD2' ' A' ' 52' ' ' ASP . 56.5 mttp -113.01 82.27 1.63 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.961 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 66.7 mtt180 72.13 -27.88 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.964 0.506 . . . . 0.0 112.163 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 53' ' ' LYS . 9.6 m-85 -97.11 139.2 33.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.707 0.289 . . . . 0.0 111.361 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.682 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.3 m-85 -82.52 147.83 28.44 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.776 170.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.624 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 58.9 m-85 -131.36 99.83 4.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.163 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 26' ' ' LEU . 27.6 t -103.46 93.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.2 m -73.71 120.82 19.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.561 HG22 HD22 ' A' ' 44' ' ' LEU . 16.1 m -130.34 160.17 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 7.0 t0 -85.23 117.0 23.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.83 -1.7 7.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.74 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.28 60.61 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -121.27 5.45 10.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.305 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.85 -20.24 51.11 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.28 129.53 40.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.561 0.344 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 55.0 mtpt -95.75 86.0 4.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 0.0 109.894 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.935 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 69.4 m -85.79 118.22 25.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.035 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.624 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 36.4 ttmt -92.34 107.2 19.04 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 30.8 m-85 -73.65 120.98 19.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.211 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 85.4 tttt -103.92 90.66 3.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.509 -173.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 64.4 mt -86.71 115.35 27.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.963 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.776 ' H ' ' HA ' ' A' ' 81' ' ' MET . 36.0 ttt180 -85.73 38.21 0.74 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.031 0.443 . . . . 0.0 109.992 -174.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.687 ' HZ2' HD21 ' A' ' 8' ' ' LEU . 52.2 mttt 37.24 -152.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.522 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 22.4 t70 -97.89 17.97 16.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 74' ' ' LYS . 2.5 p -73.87 94.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.816 0.817 . . . . 0.0 109.176 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 25.2 t70 84.49 -67.44 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.342 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 35.9 m -90.75 149.16 39.95 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -90.44 34.85 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.218 2.612 . . . . 0.0 111.084 173.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -148.46 -166.15 2.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.426 0.631 . . . . 0.0 111.251 -168.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.776 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 20.7 ptt? -111.35 126.7 55.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.123 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.614 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 7.7 p -59.72 -37.2 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.886 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.38 -157.81 13.2 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.426 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -176.54 102.58 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -174.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -120.49 121.45 38.5 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.935 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 2.5 m -76.17 116.68 17.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.45 ' HE ' ' HB3' ' A' ' 87' ' ' ARG . 16.2 mtp180 . . . . . 0 C--N 1.307 -1.257 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.699 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' A' ' 3' ' ' LEU . 24.1 mt 72.95 -23.96 0.2 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.7 tp -81.07 25.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.818 0.818 . . . . 0.0 111.603 -170.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.813 HD12 ' H ' ' A' ' 8' ' ' LEU . 9.4 tp 179.51 176.88 0.61 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -147.6 40.54 1.01 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.498 0.666 . . . . 0.0 109.546 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.491 ' HA3' ' H ' ' A' ' 77' ' ' ASP . . . 69.36 16.89 71.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.345 -174.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 11.7 p-10 -96.75 -37.91 10.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.546 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.779 HD12 ' HG3' ' A' ' 54' ' ' ARG . 4.4 mm? 73.98 88.83 0.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.595 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.813 ' H ' HD12 ' A' ' 3' ' ' LEU . 71.8 mt -71.92 -16.69 62.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.827 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 68.48 -74.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.795 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -120.84 126.41 50.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.704 ' HZ3' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.89 -37.26 11.27 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.99 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 13' ' ' LYS . 2.6 pp -120.44 -34.17 3.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.83 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.542 ' N ' HD13 ' A' ' 12' ' ' LEU . 19.2 ttpp 53.38 46.32 26.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.694 0.759 . . . . 0.0 110.966 175.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.537 ' H ' HD13 ' A' ' 12' ' ' LEU . 93.3 mt -105.3 172.3 4.15 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.25 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 51.1 Cg_exo -58.94 -156.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.149 2.566 . . . . 0.0 111.591 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.04 126.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.746 0.784 . . . . 0.0 109.93 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.624 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 3.3 mt -86.76 152.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.077 -173.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.53 139.49 25.27 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.687 0.617 . . . . 0.0 111.24 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.425 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 25.8 p-10 -66.32 -30.05 70.38 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.066 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -63.37 -45.34 91.57 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.242 0.339 . . . . 0.0 110.428 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.509 ' O ' HD11 ' A' ' 25' ' ' LEU . 88.6 t80 -59.95 -42.14 93.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.63 -49.71 70.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.355 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 29.6 mmmt -54.35 -33.37 58.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.667 0.387 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 7.3 mm-40 -60.63 -54.25 47.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.99 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.596 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 10.8 mp -52.88 -60.0 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.68 HD13 HG22 ' A' ' 58' ' ' VAL . 9.4 mp -60.41 -24.6 65.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.565 -173.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.05 -46.97 69.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 82.4 mttt -72.56 -28.65 62.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.18 0.514 . . . . 0.0 110.344 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.699 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 64.0 m-85 -88.97 -3.28 58.78 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.454 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -54.65 -48.9 71.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.581 0.229 . . . . 0.0 111.085 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.93 -33.97 75.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' HA ' ' A' ' 80' ' ' LYS . 4.7 t70 -71.15 -50.38 33.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.963 0.887 . . . . 0.0 109.843 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.66 HG23 ' HE1' ' A' ' 70' ' ' PHE . 62.7 mt -65.04 -30.96 51.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -84.71 -30.91 24.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.05 -51.27 69.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.253 0.549 . . . . 0.0 110.002 171.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -71.26 -58.95 3.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.363 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -107.28 -36.68 6.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.433 -170.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.95 29.33 5.55 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.785 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 41' ' ' THR . 6.9 t -95.36 142.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.1 t70 -105.14 7.49 33.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.451 0.643 . . . . 0.0 110.949 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.503 ' H ' HG13 ' A' ' 39' ' ' VAL . 70.6 p 55.71 -13.78 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 40' ' ' ASP . 49.1 mtpt -58.65 -36.67 74.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.098 0.408 . . . . 0.0 111.946 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -74.58 -32.37 62.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.317 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.62 115.88 3.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.721 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 42.9 tttm -92.25 108.86 20.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.01 171.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.599 ' HA ' HG11 ' A' ' 60' ' ' VAL . 41.6 mt -72.25 119.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.493 0.663 . . . . 0.0 111.664 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 61' ' ' ASP . 12.5 mt -91.44 -42.49 10.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.013 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -156.04 104.77 2.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.922 -174.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.624 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 6.4 m -89.39 132.42 34.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -155.94 173.67 16.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.8 150.33 52.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.423 0.63 . . . . 0.0 110.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -133.02 -174.02 3.36 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.252 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -66.68 113.3 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.779 ' HG3' HD12 ' A' ' 7' ' ' LEU . 24.9 ttt180 75.84 -17.04 0.54 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.729 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.428 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 40.1 m-85 -122.23 147.77 45.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 112.231 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' HD1' ' HG2' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -106.81 150.79 25.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.553 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 89.4 m-85 -134.54 107.15 7.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.68 HG22 HD13 ' A' ' 26' ' ' LEU . 21.9 t -108.59 96.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.397 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 18.1 t -76.45 130.69 38.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 46' ' ' ILE . 28.8 m -140.58 152.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.206 0.527 . . . . 0.0 111.879 -174.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.712 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.3 t70 -76.56 105.86 7.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.99 34.4 1.93 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 167.55 -96.63 0.13 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.079 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -137.39 -4.73 1.84 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.799 0.333 . . . . 0.0 110.688 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.02 -29.63 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.653 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.41 122.38 18.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.352 0.596 . . . . 0.0 111.001 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -101.31 106.69 17.9 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.024 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 4.4 t -99.86 178.04 4.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.622 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.8 ttmt -156.87 113.04 2.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.66 ' HE1' HG23 ' A' ' 33' ' ' ILE . 14.3 m-85 -80.42 114.17 19.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.129 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.428 ' HE2' ' CD2' ' A' ' 55' ' ' PHE . 82.5 tttt -87.98 89.17 7.89 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.746 0.784 . . . . 0.0 109.733 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 29' ' ' PHE . 51.3 mt -81.77 100.02 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.641 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 24.2 ttp180 -68.29 100.93 1.11 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.63 ' HG2' ' HD1' ' A' ' 56' ' ' TYR . 86.0 mttt -47.19 124.59 6.74 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 124.033 0.833 . . . . 0.0 110.69 -172.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 4.6 t70 -23.94 81.77 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.53 1.769 . . . . 0.0 112.9 -170.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.521 HG21 HD22 ' A' ' 7' ' ' LEU . 6.0 p -107.51 106.82 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.439 -171.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' H ' ' HA3' ' A' ' 5' ' ' GLY . 5.0 m-20 71.65 -58.97 0.56 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.697 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.49 ' HB ' ' HD2' ' A' ' 79' ' ' PRO . 13.2 m -122.53 164.08 28.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.218 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 78' ' ' VAL . 23.5 Cg_endo -91.6 104.45 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.163 2.575 . . . . 0.0 113.227 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 9.0 mtmt -179.87 162.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.589 . . . . 0.0 111.698 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.479 ' HE3' ' HB3' ' A' ' 81' ' ' MET . 3.4 ttp -92.15 142.61 27.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.439 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.641 ' HB ' ' HD3' ' A' ' 73' ' ' ARG . 3.6 p -73.33 -53.79 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.651 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.405 ' N ' HG12 ' A' ' 82' ' ' VAL . . . -155.71 159.14 29.04 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.327 -173.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 84' ' ' ARG . 10.6 ttp180 -125.21 95.81 4.61 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -114.57 112.0 22.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.26 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 11.2 m -80.97 138.13 36.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 . . . . . 0 C--N 1.315 -0.925 0 CA-C-O 121.842 0.83 . . . . 0.0 109.509 -177.021 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 34.4 t . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 121.23 0.538 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 38.1 mt -101.54 26.12 7.66 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.592 HG23 ' HG ' ' A' ' 3' ' ' LEU . 1.8 mp -69.32 -31.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.614 -175.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.8 HD11 ' HA ' ' A' ' 6' ' ' ASP . 77.9 mt -132.39 178.01 7.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.101 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -126.23 73.29 1.36 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.78 36.29 37.44 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.555 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.8 ' HA ' HD11 ' A' ' 3' ' ' LEU . 33.3 t70 69.55 97.03 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.493 0.663 . . . . 0.0 112.164 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 3' ' ' LEU . 93.6 mt -126.87 70.98 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' A' ' 54' ' ' ARG . 79.1 mt -64.27 -62.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.944 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 52.87 -99.98 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.89 0.744 . . . . 0.0 110.581 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.06 88.86 4.62 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.321 0.581 . . . . 0.0 109.8 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.659 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -104.4 165.1 11.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.934 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt 59.9 93.67 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.83 0.706 . . . . 0.0 109.229 -174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.33 -153.92 0.41 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.831 -174.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.5 mt -52.48 148.61 12.04 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.54 134.84 54.1 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.993 2.462 . . . . 0.0 111.832 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.572 HG22 ' HA ' ' A' ' 48' ' ' LYS . 5.6 p 39.87 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 123.14 1.448 . . . . 0.0 112.688 -171.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 57.5 mt -68.6 156.32 7.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.431 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -49.74 138.19 14.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -71.25 -19.46 62.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.248 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.39 -45.64 37.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.057 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 81.4 t80 -58.78 -40.46 84.07 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.08 -47.63 86.91 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.127 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -38.55 69.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.25 -47.56 83.2 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.9 mt -56.93 -58.5 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.562 0.696 . . . . 0.0 110.171 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.625 HD13 HG13 ' A' ' 58' ' ' VAL . 9.1 mp -58.8 -34.66 71.73 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.835 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.43 -34.0 74.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.438 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -72.58 -26.96 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.26 3.25 29.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.546 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.41 -50.31 59.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.53 0.732 . . . . 0.0 111.852 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.61 -41.92 82.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.11 -39.7 68.69 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.658 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 94.8 mt -69.42 -20.8 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.51 0.671 . . . . 0.0 110.486 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.5 tttp -89.77 -33.13 16.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.499 0.666 . . . . 0.0 109.882 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.46 -45.04 77.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.311 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.26 -15.35 41.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.475 -173.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.505 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 77.3 m-85 -140.17 -57.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.414 0.626 . . . . 0.0 109.78 177.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 123.38 35.46 0.7 Allowed Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.367 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.522 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 2.8 t -108.27 146.39 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.989 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -98.04 8.91 44.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.621 0.724 . . . . 0.0 110.259 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.512 ' H ' HG11 ' A' ' 39' ' ' VAL . 71.4 p 59.0 -33.69 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.084 1.754 . . . . 0.0 115.253 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -62.83 -29.36 70.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.2 0.524 . . . . 0.0 110.477 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.09 -14.81 60.62 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.185 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.48 HD23 HG13 ' A' ' 39' ' ' VAL . 63.9 mt -81.64 125.0 30.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.292 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HG2' HD21 ' A' ' 47' ' ' LEU . 58.3 tttp -81.47 101.21 9.75 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.538 ' HA ' HG11 ' A' ' 60' ' ' VAL . 57.2 mt -69.98 113.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.413 HD21 ' HG2' ' A' ' 45' ' ' LYS . 26.1 mt -85.07 -40.05 17.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.583 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.572 ' HA ' HG22 ' A' ' 16' ' ' VAL . 24.9 ttpp -160.38 103.56 1.42 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.452 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.484 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 9.3 m -76.61 122.14 24.21 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.8 m -157.3 -172.29 3.94 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.935 -0.478 . . . . 0.0 110.624 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.49 178.77 8.51 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -112.53 -84.13 0.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.659 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 27.8 mtmm -140.66 107.74 5.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 167.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.771 ' HG3' HG12 ' A' ' 76' ' ' VAL . 35.6 ttm180 78.1 -18.15 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.734 0.646 . . . . 0.0 111.463 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.44 123.55 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.616 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 5.4 m-85 -78.13 148.51 34.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.796 0.332 . . . . 0.0 110.409 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.597 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 75.5 m-85 -134.12 94.62 3.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.753 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.625 HG13 HD13 ' A' ' 26' ' ' LEU . 19.3 t -89.06 95.38 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.505 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.429 ' HB2' ' N ' ' A' ' 48' ' ' LYS . 74.2 m -60.08 128.54 37.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.003 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 46' ' ' ILE . 34.8 m -147.57 153.5 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.43 0.634 . . . . 0.0 111.589 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.87 130.73 48.41 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 169.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.728 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -92.44 5.09 52.03 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.152 -173.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.97 -19.23 50.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.646 170.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 32.9 t70 -103.29 18.92 20.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.88 -22.33 12.15 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.728 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 7.0 pt-20 -70.95 150.48 45.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.16 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -122.26 151.51 41.0 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 24.0 t -146.58 170.83 16.11 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.3 ttpt -157.51 89.43 1.04 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CE2' HG23 ' A' ' 60' ' ' VAL . 83.7 m-85 -53.81 112.16 0.88 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.941 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 54.7 tttt -84.92 80.66 9.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.921 0.867 . . . . 0.0 109.385 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 77.5 mt -77.27 102.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.726 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.512 ' HB2' HG11 ' A' ' 82' ' ' VAL . 46.4 ttt180 -71.63 111.96 7.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.591 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 91.7 mttt -57.16 160.12 3.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.353 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 0' ' ' SER . 17.9 t70 -67.37 74.09 0.14 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.66 0.743 . . . . 0.0 109.705 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.771 HG12 ' HG3' ' A' ' 54' ' ' ARG . 35.6 m -98.75 -4.29 9.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.615 0.722 . . . . 0.0 110.074 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 175.3 -62.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.287 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.459 HG21 ' HD2' ' A' ' 79' ' ' PRO . 11.2 p -96.9 137.62 21.33 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.478 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HD2' HG21 ' A' ' 78' ' ' VAL . 45.8 Cg_endo -83.38 42.25 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.591 2.861 . . . . 0.0 112.645 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -137.88 140.59 40.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.228 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.443 ' HE2' ' HB3' ' A' ' 81' ' ' MET . 4.6 tmm? -65.09 123.65 20.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.033 170.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 73' ' ' ARG . 14.5 p -79.47 -38.56 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 0.0 111.634 -173.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 84' ' ' ARG . . . -144.52 179.45 21.73 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.954 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.505 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -153.72 93.55 1.68 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 22.1 tptm -73.91 60.82 0.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.78 0.8 . . . . 0.0 112.317 -166.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -104.5 111.0 23.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 . . . . . 0 C--N 1.314 -0.949 0 CA-C-O 121.892 0.853 . . . . 0.0 109.785 -173.213 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 40.4 t . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.628 HD22 ' H ' ' A' ' 1' ' ' LEU . 0.6 OUTLIER -99.56 109.77 22.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.348 0.594 . . . . 0.0 112.053 -172.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.536 HG22 ' HB3' ' A' ' 74' ' ' LYS . 8.4 tp -173.12 84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.998 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.907 ' HG ' ' H ' ' A' ' 4' ' ' ASP . 1.2 pt? -122.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.177 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.907 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 8.7 m-20 57.64 19.01 5.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.685 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.478 ' O ' ' HG ' ' A' ' 7' ' ' LEU . . . 111.9 42.94 0.98 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.479 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.22 25.89 11.57 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 5' ' ' GLY . 96.0 mt -137.9 166.21 24.61 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 111.332 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.401 HD23 HG12 ' A' ' 2' ' ' ILE . 35.2 tp -178.73 -93.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.737 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.3 mttt 55.82 33.11 20.88 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -76.08 -59.62 2.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 110.476 -174.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.94 35.27 1.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.675 0.75 . . . . 0.0 110.263 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.621 HD22 ' HE3' ' A' ' 13' ' ' LYS . 29.5 tp -70.63 170.14 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.098 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.621 ' HE3' HD22 ' A' ' 12' ' ' LEU . 1.9 mptt 70.09 15.61 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.348 0.659 . . . . 0.0 111.491 176.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.64 139.47 20.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.094 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.39 -56.49 0.66 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 122.521 2.147 . . . . 0.0 110.358 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 48' ' ' LYS . 13.5 p -128.86 128.13 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.461 -1.7 . . . . 0.0 109.898 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 HG23 ' H ' ' A' ' 18' ' ' ASP . 24.5 mt -89.61 177.25 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.258 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.438 ' H ' HG23 ' A' ' 17' ' ' ILE . 4.0 m-20 -50.67 120.24 4.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.492 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -73.21 -36.93 66.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.01 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.482 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 68.0 t80 -62.86 -43.96 97.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.499 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -61.58 -45.95 95.28 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 173.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -52.26 -43.93 64.64 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.0 109.915 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.87 -39.89 93.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.227 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 16.9 mt -60.02 -60.12 4.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.743 HD13 HG22 ' A' ' 58' ' ' VAL . 8.1 mp -60.13 -32.6 71.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.819 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.97 -49.33 77.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.935 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -67.0 -50.48 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.313 0.577 . . . . 0.0 110.291 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 5.7 m-85 -83.2 13.4 4.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.675 -173.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.527 HE21 ' HA ' ' A' ' 40' ' ' ASP . 36.6 tt0 -61.82 -36.28 80.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.76 -35.02 76.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.126 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.639 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 20.7 t70 -74.3 -44.6 51.96 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.16 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.601 ' CG1' ' HE2' ' A' ' 81' ' ' MET . 66.2 mt -69.11 -26.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.406 0.622 . . . . 0.0 110.773 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 54.0 tttp -83.29 -28.93 28.76 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -69.22 -43.14 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.904 170.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.639 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 63.2 mttm -67.85 -47.92 67.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.285 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.659 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 44.0 m-85 -128.4 -56.68 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.481 0.658 . . . . 0.0 110.889 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 34' ' ' LYS . . . 117.42 62.35 0.31 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.789 -170.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 37' ' ' TYR . 45.9 t -124.33 154.59 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.808 0.337 . . . . 0.0 111.143 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.527 ' HA ' HE21 ' A' ' 30' ' ' GLN . 16.4 t70 -105.15 123.38 47.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.564 173.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 24.6 p -88.03 -14.61 38.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.001 0.429 . . . . 0.0 111.725 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -79.76 -7.21 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.951 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -99.76 -21.85 15.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.681 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.1 mt -73.87 124.43 26.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.652 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 82.6 tttt -83.95 112.79 20.48 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.569 ' HA ' HG11 ' A' ' 60' ' ' VAL . 35.4 mt -79.88 116.54 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.692 0.758 . . . . 0.0 111.171 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 61' ' ' ASP . 14.6 mt -85.35 -51.02 6.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.39 -176.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HA ' HG22 ' A' ' 16' ' ' VAL . 39.4 ttpt -146.06 111.13 5.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.827 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.3 m -96.0 127.53 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -146.51 163.56 35.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.648 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -132.33 161.53 33.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 110.239 172.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 53' ' ' LYS . 7.4 t70 -140.21 -157.91 0.81 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.419 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 51.2 mttp -72.13 103.17 3.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.693 ' HG2' HG13 ' A' ' 76' ' ' VAL . 53.0 mtt180 74.27 -14.4 0.7 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.695 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -109.85 149.33 30.02 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.947 -0.471 . . . . 0.0 111.984 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.648 ' CE2' ' HB3' ' A' ' 51' ' ' GLU . 2.6 m-85 -116.58 150.4 38.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.729 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.6 m-85 -128.71 103.42 7.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.373 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.743 HG22 HD13 ' A' ' 26' ' ' LEU . 13.3 t -106.16 94.64 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.709 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -79.96 118.8 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -130.48 155.67 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.653 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.481 ' HB2' HD23 ' A' ' 47' ' ' LEU . 36.2 t70 -86.67 103.66 15.34 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB1' ' HG3' ' A' ' 66' ' ' GLU . . . -64.71 -26.81 68.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.826 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.43 -23.95 13.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.97 -0.634 . . . . 0.0 111.731 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.516 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 25.9 t70 -81.59 -22.7 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.405 0.621 . . . . 0.0 110.21 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.95 -32.33 3.65 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 4.6 pt-20 -62.93 136.26 57.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.637 -0.782 . . . . 0.0 111.842 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -100.38 93.09 5.48 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 79.8 m -89.25 132.27 34.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.06 0.457 . . . . 0.0 110.586 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 22.8 ttmm -109.18 94.26 4.95 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.301 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 80.1 m-85 -63.4 100.0 0.23 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.923 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.772 ' HZ2' HG13 ' A' ' 82' ' ' VAL . 25.0 tttm -80.69 83.26 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.994 0.902 . . . . 0.0 109.047 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.849 ' HA ' ' HB2' ' A' ' 81' ' ' MET . 70.0 mt -77.71 93.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.434 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HB2' HG11 ' A' ' 82' ' ' VAL . 30.4 ttt180 -63.52 123.8 19.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.536 ' HB3' HG22 ' A' ' 2' ' ' ILE . 39.6 mttt -59.56 169.08 1.39 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.798 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 9.9 t0 -72.06 78.36 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.229 1.014 . . . . 0.0 108.904 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.693 HG13 ' HG2' ' A' ' 54' ' ' ARG . 6.4 m -106.11 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.106 174.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.0 t70 84.74 -46.01 0.08 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.891 -175.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.96 146.24 61.27 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 111.119 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HB3' ' OD2' ' A' ' 75' ' ' ASP . 34.1 Cg_endo -92.18 86.17 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.634 2.889 . . . . 0.0 114.138 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HD2' ' HZ3' ' A' ' 36' ' ' LYS . 5.3 mtmm -164.69 161.52 20.8 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.01 -0.431 . . . . 0.0 111.329 173.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.849 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 2.4 ptp -88.1 119.2 28.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.772 HG13 ' HZ2' ' A' ' 71' ' ' LYS . 7.7 p -60.4 -38.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.916 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.06 -177.68 26.88 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.952 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.659 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -164.25 42.8 0.09 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -60.83 121.98 13.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.612 -172.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.4 m -83.21 113.03 20.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 87' ' ' ARG . 17.9 mtp180 . . . . . 0 C--N 1.306 -1.286 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.778 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 34.2 p . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.228 0.061 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 0' ' ' SER . 0.5 OUTLIER 45.97 23.58 0.19 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.766 1.227 . . . . 0.0 113.326 175.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.564 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 10.5 tp -117.02 39.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.012 0.91 . . . . 0.0 110.55 -171.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.817 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 2.5 pt? -92.96 -40.09 10.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.691 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.6 t70 66.57 -60.41 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.97 0.794 . . . . 0.0 110.015 -169.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 54.88 0.24 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.105 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.59 ' HA ' HG13 ' A' ' 76' ' ' VAL . 41.3 m-20 49.84 34.91 8.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.748 0.419 . . . . 0.0 111.476 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.569 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 27.8 tp -141.84 176.57 8.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.64 0.257 . . . . 0.0 110.362 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.569 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 6.2 mp -73.83 -59.33 2.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.22 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp 63.64 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.229 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -126.21 106.7 9.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.217 0.532 . . . . 0.0 110.042 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 3.3 ptmm? -118.09 -163.42 0.94 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.358 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 12' ' ' LEU . 29.5 mt -41.46 115.95 0.7 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -130.63 21.15 5.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.53 168.03 13.3 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.722 -172.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -69.77 -153.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.471 0.162 0 C-N-CA 123.637 2.892 . . . . 0.0 111.856 167.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.692 HG22 ' HG3' ' A' ' 48' ' ' LYS . 5.4 p -51.17 124.31 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.886 0.85 . . . . 0.0 111.147 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 11.9 mt -79.93 151.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.916 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.8 152.47 35.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.209 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -64.12 -25.62 68.18 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.813 -178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.64 -46.67 88.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.17 0.188 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.515 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 87.0 t80 -59.79 -38.6 82.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.423 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -65.52 -49.86 58.12 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 23' ' ' LYS . 12.9 mmmm -56.81 -28.67 61.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 14.3 mm-40 -68.85 -52.63 27.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 173.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 43.8 mt -53.69 -62.49 1.62 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.621 0.724 . . . . 0.0 110.096 175.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.63 HD13 HG22 ' A' ' 58' ' ' VAL . 9.5 mp -59.08 -28.37 66.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.55 -173.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 13.1 t70 -75.24 -46.93 30.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.09 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 66.5 mttm -57.51 -35.74 70.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.303 0.573 . . . . 0.0 110.558 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.778 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 2.4 m-85 -106.1 12.27 30.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.271 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -60.21 -41.33 92.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 -179.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.89 -32.38 73.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' OD1' ' HD3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -73.4 -48.06 36.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.358 0.599 . . . . 0.0 110.153 177.406 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.602 HG12 ' HE2' ' A' ' 81' ' ' MET . 72.0 mt -59.76 -41.48 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.589 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.5 tttt -79.94 -29.59 39.74 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.914 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.88 -50.37 66.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.564 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -76.73 -57.58 3.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.453 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.543 ' HB2' HG21 ' A' ' 39' ' ' VAL . 20.7 m-85 -102.32 -27.37 12.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -169.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.33 52.96 3.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.636 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.589 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.9 t -118.3 149.14 20.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.518 0.199 . . . . 0.0 110.598 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.41 106.09 14.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.533 ' HA ' HD23 ' A' ' 44' ' ' LEU . 65.6 p -65.69 -16.66 63.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -173.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.3 ttpp -72.06 -23.03 61.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -94.3 -5.98 45.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.767 0.794 . . . . 0.0 109.632 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 41' ' ' THR . 5.1 mp -83.29 138.35 33.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.112 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.55 109.73 22.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.594 ' HA ' HG11 ' A' ' 60' ' ' VAL . 40.9 mt -79.33 116.96 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 110.877 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 8.1 mt -85.78 -47.32 9.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.086 -175.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.692 ' HG3' HG22 ' A' ' 16' ' ' VAL . 37.7 ttmt -149.6 108.08 3.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.481 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.522 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 13.5 m -85.0 125.39 32.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.3 m -156.55 -170.94 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -156.11 -176.61 6.05 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.667 ' HB3' ' HE2' ' A' ' 57' ' ' TYR . 14.7 t70 -165.45 93.38 0.58 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.507 ' HG3' HD23 ' A' ' 8' ' ' LEU . 12.4 mptt 68.21 -107.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.921 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HG2' HG12 ' A' ' 76' ' ' VAL . 48.0 mtt180 -91.93 19.55 6.56 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.931 -0.481 . . . . 0.0 111.32 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 76.2 m-85 -138.83 140.67 38.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 -173.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.852 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m-85 -100.3 144.08 29.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 166.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.677 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 71.0 m-85 -129.8 96.32 4.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.63 HG22 HD13 ' A' ' 26' ' ' LEU . 5.6 t -104.43 96.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.4 t -74.39 114.61 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 46' ' ' ILE . 12.9 m -133.13 163.93 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.236 0.541 . . . . 0.0 111.368 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.96 127.14 48.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.97 33.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.09 -46.3 3.06 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.581 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.54 -38.18 68.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.304 0.573 . . . . 0.0 110.934 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -21.85 2.46 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.339 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.38 145.8 33.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 110.804 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -113.96 116.34 29.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.527 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.5 m -117.94 124.96 49.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.824 -171.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 6.1 tppt? -85.12 96.24 9.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.77 113.5 3.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.309 0.576 . . . . 0.0 110.185 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -93.0 80.72 4.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.622 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.852 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 mt -77.68 76.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.642 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.53 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 70.8 ttt180 -53.26 125.79 18.83 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 76' ' ' VAL . 96.3 mttt -59.79 171.0 0.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 123.458 0.474 . . . . 0.0 110.263 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.817 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 1.7 t70 -72.12 26.45 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.372 0.606 . . . . 0.0 110.694 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.59 HG13 ' HA ' ' A' ' 6' ' ' ASP . 30.1 m -78.65 123.12 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.555 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 18.4 t70 70.58 -66.22 0.3 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.548 0.53 . . . . 0.0 111.232 -176.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.594 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 3.4 p -104.28 153.9 38.68 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.663 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.0 Cg_endo -76.32 148.05 29.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.092 1.861 . . . . 0.0 111.515 164.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 4.9 ptpt 73.47 -172.13 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.235 1.014 . . . . 0.0 113.126 167.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.602 ' HE2' HG12 ' A' ' 33' ' ' ILE . 15.5 mtm -77.23 126.89 31.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.178 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.53 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 7.1 p -59.46 -27.81 38.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.56 -161.64 35.36 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.325 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -157.09 151.16 24.83 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.0 tptp -145.25 106.01 4.13 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.942 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.1 m -77.32 111.0 12.52 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 170.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 120.992 0.425 . . . . 0.0 110.593 -169.212 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.726 ' HB3' ' HA ' ' A' ' 75' ' ' ASP . 23.4 t . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.673 0.273 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 28' ' ' LYS . 72.9 mt -83.55 61.94 6.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.004 0.907 . . . . 0.0 112.425 -168.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 74' ' ' LYS . 15.7 tt -160.77 29.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.515 ' O ' HD23 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -72.22 135.46 46.08 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.464 -163.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.31 -18.56 16.03 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 165.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . 134.36 54.02 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.752 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 8.0 m-20 68.86 22.08 7.35 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -143.0 159.72 41.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.024 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 3.1 mm? -116.88 -66.52 1.08 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.643 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.693 ' HZ1' ' HB2' ' A' ' 9' ' ' LYS . 9.6 mtmp? 66.05 17.11 10.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.86 0.838 . . . . 0.0 108.9 -169.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -152.11 69.39 0.89 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.074 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 38.5 pttt -49.08 -50.43 36.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.392 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.604 HD13 ' HG3' ' A' ' 51' ' ' GLU . 52.9 tp -153.16 119.08 5.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -169.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -85.67 -77.41 0.3 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.995 0.426 . . . . 0.0 111.362 -176.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 18.8 mt -136.76 176.65 2.63 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -173.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 32.4 Cg_exo -62.69 -147.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.788 2.992 . . . . 0.0 111.615 169.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 49' ' ' THR . 7.1 p -54.75 122.64 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.839 0.828 . . . . 0.0 110.053 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.759 HG13 ' HB ' ' A' ' 49' ' ' THR . 1.1 pt -108.06 -173.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.882 -171.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.86 134.16 37.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.74 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -72.88 -21.06 60.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.49 -40.23 57.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.151 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.49 ' O ' HD11 ' A' ' 25' ' ' LEU . 80.1 t80 -61.47 -47.07 87.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -62.64 -43.47 98.94 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.238 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -56.42 -36.77 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.306 0.242 . . . . 0.0 110.488 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 4.9 mm-40 -55.81 -53.8 52.29 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.49 HD11 ' O ' ' A' ' 21' ' ' PHE . 10.2 mp -49.86 -59.01 4.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.276 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.624 HD13 HG22 ' A' ' 58' ' ' VAL . 9.2 mp -59.85 -42.17 93.07 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.964 -175.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.97 -33.41 74.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.999 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 22.0 mttp -64.64 -49.99 68.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.391 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.434 ' O ' HG13 ' A' ' 33' ' ' ILE . 58.3 m-85 -98.49 12.49 34.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.573 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.406 ' OE1' ' HE2' ' A' ' 42' ' ' LYS . 4.9 pt20 -59.87 -31.91 70.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.452 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.17 -34.52 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.496 ' OD2' ' HE2' ' A' ' 81' ' ' MET . 22.9 t70 -72.16 -39.68 68.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.752 0.787 . . . . 0.0 109.013 175.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.567 HG21 ' HB ' ' A' ' 39' ' ' VAL . 92.3 mt -61.42 -43.41 96.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.234 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.595 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 24.7 ttpt -82.51 -29.71 30.28 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.669 -174.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.46 -55.81 13.89 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 174.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -79.55 -43.36 23.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.922 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.2 -10.09 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.534 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 68.8 41.2 83.88 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.627 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.595 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 10.8 t -118.24 137.91 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 120.903 0.382 . . . . 0.0 111.113 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -103.47 116.24 32.03 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.485 ' HA ' HD11 ' A' ' 44' ' ' LEU . 30.4 p -70.42 -10.5 59.27 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -170.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.406 ' HE2' ' OE1' ' A' ' 30' ' ' GLN . 66.6 mmtt -71.8 -22.85 61.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.937 0.399 . . . . 0.0 110.333 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.61 -31.23 15.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.463 0.649 . . . . 0.0 110.088 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 41' ' ' THR . 85.5 mt -58.49 126.94 29.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.865 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -92.4 106.07 18.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.474 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.629 ' HA ' HG11 ' A' ' 60' ' ' VAL . 42.7 mt -72.8 107.53 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.774 0.797 . . . . 0.0 110.565 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 61' ' ' ASP . 11.8 mt -80.78 -49.38 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.983 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 48.9 tttm -144.79 101.17 3.62 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.479 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.759 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.6 m -82.39 124.8 30.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.2 m -145.81 -179.78 6.93 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.137 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.604 ' HG3' HD13 ' A' ' 12' ' ' LEU . 7.9 pt-20 -155.45 174.17 15.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.514 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 53' ' ' LYS . 14.8 t70 -150.91 -170.24 3.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -59.49 105.71 0.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 77.18 -9.27 1.55 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.793 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.6 m-85 -114.45 151.08 33.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.117 0.484 . . . . 0.0 111.798 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.799 ' HD1' ' HB3' ' A' ' 74' ' ' LYS . 2.8 m-85 -112.14 143.88 42.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.426 164.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.602 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 32.3 m-85 -131.92 111.67 11.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.413 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.624 HG22 HD13 ' A' ' 26' ' ' LEU . 21.4 t -110.26 108.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -91.7 120.86 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.629 HG11 ' HA ' ' A' ' 46' ' ' ILE . 13.0 m -128.72 154.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.543 ' HB2' HD23 ' A' ' 47' ' ' LEU . 60.1 t0 -90.6 114.67 26.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 169.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.45 ' HA ' HD21 ' A' ' 44' ' ' LEU . . . -72.56 -14.35 61.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.46 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.34 -113.13 0.54 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.39 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.61 76.27 1.68 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 109.637 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.2 -9.71 3.55 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -82.47 170.17 15.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -160.54 107.86 1.56 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.842 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 14.7 t -129.66 138.09 51.0 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.701 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.602 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 31.3 ttmt -111.87 114.28 27.12 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -76.39 120.65 21.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.119 0.485 . . . . 0.0 109.947 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.515 ' HG2' ' CG1' ' A' ' 82' ' ' VAL . 79.2 tttt -94.01 94.6 8.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.075 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 60.3 mt -116.41 89.53 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.511 0.672 . . . . 0.0 109.926 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.793 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 48.7 ttt180 -63.43 99.09 0.19 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.978 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.799 ' HB3' ' HD1' ' A' ' 56' ' ' TYR . 12.1 ptpt -47.45 112.4 0.54 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.801 -173.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.726 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 15.0 t0 37.57 82.16 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.176 177.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.609 HG12 ' HG2' ' A' ' 73' ' ' ARG . 8.7 m -127.26 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.102 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 74.12 -69.18 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.483 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 14.9 p -86.88 141.94 33.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.058 0.456 . . . . 0.0 110.348 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 87.5 Cg_endo -79.72 86.94 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.11 2.54 . . . . 0.0 112.581 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 178.86 -175.72 0.22 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.407 0.623 . . . . 0.0 111.841 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.512 ' HE3' HG12 ' A' ' 33' ' ' ILE . 19.9 ptp -84.04 155.33 22.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.438 171.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.515 ' CG1' ' HG2' ' A' ' 71' ' ' LYS . 12.3 p -83.15 -26.04 7.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.91 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -179.86 -173.15 44.63 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.333 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 84' ' ' ARG . 34.7 ttt-85 -156.56 125.71 6.06 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -149.85 135.74 18.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 25.5 m -97.3 114.96 26.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.507 0.67 . . . . 0.0 111.238 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 -174.676 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.408 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 5.9 t . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 42.3 mt -133.46 12.86 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.674 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.791 HG13 HD21 ' A' ' 3' ' ' LEU . 8.2 tp -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.978 -166.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.96 HD11 ' HB2' ' A' ' 7' ' ' LEU . 2.2 mm? 66.29 57.59 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.93 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.629 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 3.5 p-10 -60.26 -27.17 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.808 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.05 19.63 53.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.234 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.8 ' HA ' HG21 ' A' ' 76' ' ' VAL . 29.2 t70 61.18 75.0 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.783 0.801 . . . . 0.0 110.201 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.96 ' HB2' HD11 ' A' ' 3' ' ' LEU . 67.2 mt -130.97 158.0 41.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.193 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -110.29 -47.27 3.31 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.472 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 64.5 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.934 0.771 . . . . 0.0 110.398 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.84 113.92 14.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.58 ' HB3' ' HZ2' ' A' ' 11' ' ' LYS . 2.8 ttpm? -65.16 -47.66 76.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.742 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.8 tt -146.45 117.58 7.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.573 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 88.8 tttt -88.49 -75.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.445 0.64 . . . . 0.0 111.651 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.573 ' HG ' ' HG2' ' A' ' 13' ' ' LYS . 94.2 mt -106.55 148.78 37.41 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -71.06 120.32 6.94 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 110.08 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 48' ' ' LYS . 3.7 p 40.52 95.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.998 1.38 . . . . 0.0 112.721 -168.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.12 161.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.128 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.36 143.22 56.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.406 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -65.72 -19.06 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.995 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.79 -49.82 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.458 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 67.0 t80 -61.35 -38.22 86.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.705 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.33 -51.38 53.06 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 27.3 mmtp -52.59 -38.96 61.07 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.343 0.257 . . . . 0.0 111.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.668 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.8 mm-40 -55.22 -55.26 33.29 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 123.257 0.348 . . . . 0.0 111.29 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.523 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 38.8 mt -51.84 -61.57 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.403 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.663 HD13 HG22 ' A' ' 58' ' ' VAL . 8.2 mp -62.43 -31.81 72.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.961 -172.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.39 -34.07 76.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.733 0.301 . . . . 0.0 111.033 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 49.9 mttm -77.64 -24.0 49.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 110.682 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.895 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 96.7 m-85 -103.51 5.2 36.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -49.17 -47.37 45.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.137 0.575 . . . . 0.0 112.404 -173.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.84 -39.26 93.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.875 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.9 -40.18 61.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.404 0.621 . . . . 0.0 109.892 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.547 HG21 ' HB ' ' A' ' 39' ' ' VAL . 98.0 mt -61.21 -36.74 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.428 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.581 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.9 tttm -84.68 -30.91 24.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.238 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.57 -44.12 78.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.907 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -85.55 -47.79 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -111.49 -12.12 14.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.3 44.32 52.68 Favored Glycine 0 C--N 1.328 0.114 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.773 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.581 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 18.8 t -114.77 146.88 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.873 0.368 . . . . 0.0 111.381 -175.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.444 ' CG ' ' HZ1' ' A' ' 42' ' ' LYS . 14.1 t70 -103.01 112.85 25.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 72.0 p -73.84 -14.4 61.08 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -81.31 -44.21 17.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.0 109.86 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.42 -21.28 60.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.949 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.718 HD22 HG22 ' A' ' 60' ' ' VAL . 11.1 tp -60.21 133.13 55.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.312 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -95.56 104.6 16.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.151 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.534 ' HA ' HG11 ' A' ' 60' ' ' VAL . 43.6 mt -78.73 121.42 31.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.431 0.634 . . . . 0.0 110.71 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 61' ' ' ASP . 12.2 mt -92.2 -51.28 5.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.266 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.564 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.0 ttmt -143.44 114.41 7.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.646 -176.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.7 m -98.41 130.1 45.04 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.334 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 p -163.96 -178.09 5.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.812 0.339 . . . . 0.0 110.599 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 9.8 pt-20 -140.37 159.7 41.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.475 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.498 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 4.3 t70 -138.95 -148.58 0.26 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.874 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 32.2 mmtp -65.45 91.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.044 0.137 . . . . 0.0 110.791 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.675 ' HB3' HG13 ' A' ' 76' ' ' VAL . 62.5 mtt85 71.98 -12.0 0.72 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.062 0.545 . . . . 0.0 112.359 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.47 146.27 33.41 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.208 -0.307 . . . . 0.0 111.082 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.526 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 7.0 m-85 -97.96 142.87 29.16 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 165.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.6 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 66.8 m-85 -126.63 107.55 10.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.073 0.464 . . . . 0.0 110.747 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.663 HG22 HD13 ' A' ' 26' ' ' LEU . 18.1 t -108.97 99.51 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.532 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 9.5 t -77.31 122.17 24.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.718 HG22 HD22 ' A' ' 44' ' ' LEU . 28.7 m -130.46 155.44 41.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.008 0.432 . . . . 0.0 111.266 -177.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.522 ' HB2' HD23 ' A' ' 47' ' ' LEU . 10.5 t70 -99.88 122.16 42.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.541 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -75.95 -0.96 23.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 -39.0 3.14 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.559 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.87 -15.72 61.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.328 0.585 . . . . 0.0 110.307 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.41 -23.98 5.65 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.671 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.541 ' HG2' ' HB3' ' A' ' 62' ' ' ALA . 8.8 pt-20 -74.81 152.86 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.8 mttp -125.13 108.33 11.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.305 0.574 . . . . 0.0 110.122 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.954 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 60.6 m -107.85 133.13 52.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.77 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.6 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.0 tppp? -97.13 102.98 14.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.525 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 20.8 m-85 -67.36 117.36 9.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HZ2' HG13 ' A' ' 82' ' ' VAL . 31.5 tttm -93.52 72.79 4.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.946 0.879 . . . . 0.0 109.368 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.568 HG12 ' HG2' ' A' ' 81' ' ' MET . 82.9 mt -75.78 91.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.991 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.568 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 24.9 ttt180 -62.6 135.76 57.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.687 ' C ' ' H ' ' A' ' 76' ' ' VAL . 99.0 mttt -59.73 172.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.723 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 43.5 t0 -74.5 28.36 0.08 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.783 1.278 . . . . 0.0 108.871 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.8 HG21 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -74.46 8.87 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 112.967 -1.924 . . . . 0.0 109.901 -174.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.549 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.3 t70 167.46 -43.09 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.842 -168.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.33 142.54 40.45 Favored Pre-proline 0 CA--C 1.502 -0.866 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.03 -171.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -89.07 15.26 2.06 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.262 1.975 . . . . 0.0 111.803 171.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.895 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 21.4 mtmt -143.3 -179.75 6.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.482 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.568 ' HG2' HG12 ' A' ' 72' ' ' ILE . 23.2 mtm -81.21 117.34 21.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.404 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.613 HG13 ' HZ2' ' A' ' 71' ' ' LYS . 9.2 p -56.73 -32.92 39.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.423 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.59 -174.21 34.91 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.643 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -171.97 90.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -107.85 131.5 54.42 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.809 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.954 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 4.0 m -84.88 130.41 34.66 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 . . . . . 0 C--N 1.309 -1.158 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.4 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 29' ' ' PHE . 47.3 t . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.677 0.275 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.83 12.15 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.933 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.466 HG23 ' HE1' ' A' ' 56' ' ' TYR . 2.9 tp -76.72 -13.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.499 0.666 . . . . 0.0 110.69 -171.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.761 HD23 ' HA ' ' A' ' 7' ' ' LEU . 9.7 mp -125.13 -178.71 4.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.9 57.08 1.56 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.884 0.85 . . . . 0.0 109.758 170.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.09 52.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.625 ' CG ' ' H ' ' A' ' 7' ' ' LEU . 7.2 p-10 -130.49 -120.33 0.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.226 -173.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.761 ' HA ' HD23 ' A' ' 3' ' ' LEU . 42.4 tp 175.69 98.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.57 0.623 . . . . 0.0 110.966 -172.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.8 mt -59.81 131.85 52.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.0 110.242 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -124.11 -7.52 7.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.152 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.52 -46.63 89.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -100.5 115.3 29.77 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 166.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.768 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 37.4 tp -178.07 141.61 0.26 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.388 -176.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.768 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 29.0 mtmt 63.91 25.76 14.05 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.957 176.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.23 163.15 19.21 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.573 -174.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -64.74 -158.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.424 2.75 . . . . 0.0 111.942 169.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.49 116.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 122.002 0.906 . . . . 0.0 110.533 175.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.613 HG12 ' HA ' ' A' ' 50' ' ' SER . 10.7 mm -71.41 161.29 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.743 -177.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -49.45 129.75 19.24 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.161 0.288 . . . . 0.0 110.759 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.488 ' HA ' HG23 ' A' ' 46' ' ' ILE . 29.6 p-10 -60.23 -33.97 73.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 6.6 mt -58.75 -44.86 90.67 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.99 173.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.629 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 72.3 t80 -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.748 0.308 . . . . 0.0 110.334 -177.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.41 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -67.13 -45.4 81.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.709 177.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.435 ' HB2' HG13 ' A' ' 46' ' ' ILE . 7.8 tppt? -63.51 -37.05 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.099 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.64 -57.47 11.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.358 177.321 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 3.6 mt -51.95 -55.82 17.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.117 0.484 . . . . 0.0 109.758 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.873 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 21.9 mt -50.9 -48.34 60.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.427 176.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HA ' ' HG1' ' A' ' 41' ' ' THR . 15.5 t70 -63.36 -40.1 96.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 110.381 -178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 11.8 mttp -56.92 -51.1 70.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.343 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 0' ' ' SER . 1.3 m-85 -97.72 13.19 31.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.042 -171.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -31.73 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.592 0.234 . . . . 0.0 111.427 -173.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.52 -31.17 68.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.8 0.333 . . . . 0.0 110.674 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -78.88 -43.3 25.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.334 0.588 . . . . 0.0 109.566 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.54 HG21 ' HB ' ' A' ' 39' ' ' VAL . 97.3 mt -60.62 -34.89 60.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.554 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 1.6 tmtp? -80.9 -40.49 24.57 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 110.051 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.18 -46.3 75.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.995 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.84 -54.81 5.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.463 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.521 ' HB2' HG21 ' A' ' 39' ' ' VAL . 6.5 m-85 -104.98 -31.21 9.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.12 -170.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.51 57.1 2.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.729 -177.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.625 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 22.0 t -124.4 148.4 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.809 0.338 . . . . 0.0 111.055 -175.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' O ' HD12 ' A' ' 44' ' ' LEU . 11.8 t0 -106.48 112.74 25.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 170.172 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.873 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 45.7 p -74.72 -15.75 60.77 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.83 -173.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.18 -25.52 60.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.152 178.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.72 -23.04 25.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.059 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 41' ' ' THR . 3.6 mp -65.66 109.67 2.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.696 -178.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 18.7 tptm -71.71 114.15 9.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.212 174.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.585 ' HA ' HG13 ' A' ' 60' ' ' VAL . 10.2 mm -71.21 107.34 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.526 HD23 ' HB2' ' A' ' 61' ' ' ASP . 14.0 mt -78.71 -57.84 3.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.705 0.764 . . . . 0.0 109.407 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -147.92 110.54 4.71 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.199 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.522 ' CG2' ' HB ' ' A' ' 17' ' ' ILE . 6.5 m -81.87 138.2 35.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.613 ' HA ' HG12 ' A' ' 17' ' ' ILE . 6.1 p -160.57 -175.96 5.3 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -165.05 167.06 18.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.582 0.706 . . . . 0.0 111.321 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.865 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 8.1 t70 -114.97 -157.99 0.65 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 171.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.592 ' HA ' HD12 ' A' ' 12' ' ' LEU . 86.0 mttt -68.22 -71.88 0.2 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.957 176.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -90.65 17.46 7.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.379 -173.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.478 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 97.4 m-85 -146.22 148.32 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -170.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CD1' ' HG2' ' A' ' 74' ' ' LYS . 19.2 m-85 -109.46 143.74 38.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.384 169.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.865 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 76.7 m-85 -129.03 92.05 3.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.997 0.427 . . . . 0.0 110.459 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 t -97.33 98.58 7.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 16.6 m -77.47 124.56 28.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -138.55 143.95 31.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -177.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.526 ' HB2' HD23 ' A' ' 47' ' ' LEU . 9.3 t70 -80.39 97.12 6.92 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 173.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.12 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.751 -171.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.08 -11.03 56.65 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.077 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.43 -32.66 71.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.156 0.503 . . . . 0.0 110.244 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.1 -41.09 0.25 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.45 165.84 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.251 0.548 . . . . 0.0 111.464 -178.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -82.39 115.84 21.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.702 167.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.893 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -96.02 164.84 12.53 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.257 -169.497 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HD3' ' CD1' ' A' ' 57' ' ' TYR . 40.4 ttmt -134.74 102.82 5.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.474 ' CG ' HD23 ' A' ' 26' ' ' LEU . 16.0 m-85 -69.03 106.41 2.77 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.633 0.73 . . . . 0.0 110.179 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.606 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 17.5 tttt -95.42 82.38 3.68 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.838 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.816 HG12 ' HG2' ' A' ' 81' ' ' MET . 52.5 mt -78.68 120.45 29.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.699 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 58.4 ttt180 -79.68 25.01 0.35 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.407 0.622 . . . . 0.0 109.511 -175.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.599 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 93.2 mttt 51.12 -165.46 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.279 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.647 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 11.9 t70 -103.12 47.48 0.88 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 167.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 6' ' ' ASP . 5.3 p -77.64 -2.29 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.14 -174.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 173.0 -54.48 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.983 -168.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 32.4 m -92.15 151.49 41.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.242 175.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 61.6 Cg_endo -92.71 32.21 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.583 2.855 . . . . 0.0 112.558 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' HA ' ' H ' ' A' ' 0' ' ' SER . 63.8 pttt -159.16 -157.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.02 -175.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.816 ' HG2' HG12 ' A' ' 72' ' ' ILE . 5.2 mtm -107.6 132.13 53.62 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.699 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 10.4 p -77.81 -37.27 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.209 0.528 . . . . 0.0 110.177 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 71' ' ' LYS . . . -126.85 164.67 20.34 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.539 -174.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.99 25.71 0.06 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 85' ' ' LYS . 60.7 mmtt -88.4 131.78 34.71 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.285 -167.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.893 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 6.5 m -83.68 136.85 34.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 173.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 . . . . . 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 0.0 109.977 -172.367 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.696 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 29.4 t . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 72.8 mt 64.3 13.38 7.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.299 173.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.512 ' O ' HG21 ' A' ' 2' ' ' ILE . 9.6 tp -115.0 87.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.238 1.018 . . . . 0.0 109.716 176.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.916 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.6 pt? -128.23 -48.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.475 -172.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.486 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.1 m-20 66.34 -64.15 0.23 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 124.017 0.823 . . . . 0.0 110.135 -171.416 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.33 70.62 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 177.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 35.5 t70 61.72 87.33 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.234 0.54 . . . . 0.0 110.419 -172.066 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 54' ' ' ARG . 13.3 mt 75.29 163.99 0.26 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.068 177.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.621 ' HG ' ' H ' ' A' ' 9' ' ' LYS . 2.0 pt? -153.95 -55.11 0.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.709 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.621 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 10.2 mtmp? 75.69 -54.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 167.334 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.44 8.13 35.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -169.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HB2' HD11 ' A' ' 8' ' ' LEU . 30.7 ttpt -61.82 -72.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.754 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.43 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 26.9 mt -109.03 124.8 51.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.767 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -138.25 29.3 2.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 -171.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.02 143.09 25.9 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.461 -177.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.19 130.03 24.46 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.924 2.416 . . . . 0.0 111.72 175.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 48' ' ' LYS . 10.0 p 39.83 99.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 123.367 1.556 . . . . 0.0 114.057 -177.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.06 160.03 4.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.637 176.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.22 157.42 31.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.157 -173.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.477 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.0 p30 -65.26 -20.01 66.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.18 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.5 tp -65.66 -43.94 87.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 178.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HE2' ' HE1' ' A' ' 56' ' ' TYR . 73.8 t80 -64.05 -39.04 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.335 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -71.66 -32.89 63.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.143 176.715 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 23.8 tptt -62.63 -40.75 97.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.6 mm-40 -58.97 -51.49 69.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.101 175.048 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD11 ' HA3' ' A' ' 22' ' ' GLY . 84.3 mt -51.71 -64.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 175.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.854 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.8 mt -55.75 -31.64 62.73 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.798 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.25 -45.69 83.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.069 0.461 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.616 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 56.3 mttm -67.92 -30.57 69.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.696 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 79.7 m-85 -99.42 1.21 44.0 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -53.64 -39.76 65.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.673 0.273 . . . . 0.0 111.093 -177.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.5 -36.03 82.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.627 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 15.0 t70 -80.62 -40.56 25.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.904 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CD1' HD21 ' A' ' 26' ' ' LEU . 80.8 mt -67.12 -30.26 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.412 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 44.5 tttp -83.48 -23.72 32.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 0.0 109.724 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.28 -45.7 65.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.336 170.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.627 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 51.3 mttm -82.13 -27.02 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.888 -173.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.631 ' HB2' HG21 ' A' ' 39' ' ' VAL . 49.1 m-85 -134.06 -33.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -177.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 97.09 19.96 24.78 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.42 -178.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.631 HG21 ' HB2' ' A' ' 37' ' ' TYR . 38.8 t -82.02 153.49 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.146 0.498 . . . . 0.0 111.908 -174.418 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 42' ' ' LYS . 26.8 t70 -108.34 106.96 17.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.91 169.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.854 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 40.6 p -69.11 -16.2 63.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.062 -172.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.726 ' HZ2' ' HB3' ' A' ' 42' ' ' LYS . 7.2 ttpm? -63.89 -21.59 66.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.839 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -105.16 -7.36 19.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.471 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 76.5 mt -66.86 117.26 8.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.851 -179.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 87.4 tttt -74.58 97.04 3.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.574 ' HA ' HG11 ' A' ' 60' ' ' VAL . 53.0 mt -77.13 122.0 30.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.638 0.732 . . . . 0.0 111.133 -175.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -94.16 -50.02 5.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.367 -175.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HA ' HG22 ' A' ' 16' ' ' VAL . 34.5 ttmt -145.64 121.36 10.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.271 -173.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 58' ' ' VAL . 19.0 m -113.98 135.31 54.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.41 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -160.32 174.82 13.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.672 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 12.5 pt-20 -131.25 150.98 51.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.459 0.647 . . . . 0.0 110.322 172.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.27 -151.62 0.48 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -64.75 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.114 177.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.598 ' HA ' HD22 ' A' ' 7' ' ' LEU . 50.7 mtt180 -87.32 11.43 14.39 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.821 -0.55 . . . . 0.0 111.011 178.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 4.2 m-85 -133.18 161.0 35.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.125 -1.03 . . . . 0.0 113.579 -163.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.672 ' CE1' ' HB3' ' A' ' 51' ' ' GLU . 5.5 m-85 -124.18 149.65 46.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.594 169.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.606 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 77.1 m-85 -134.66 102.51 5.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.676 0.274 . . . . 0.0 110.945 -178.222 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.424 HG23 HG21 ' A' ' 49' ' ' THR . 9.9 t -112.51 103.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.535 178.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m -87.28 125.02 33.96 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 46' ' ' ILE . 10.1 m -131.19 152.55 37.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 111.507 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.6 t70 -90.34 121.42 32.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 171.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.86 1.97 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.04 -53.31 4.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.338 176.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.55 -23.4 66.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.299 0.571 . . . . 0.0 110.679 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.35 7.97 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.712 -178.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -75.47 150.99 38.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 34.5 ttmt -127.01 107.2 9.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -176.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.978 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 34.4 m -106.35 132.06 52.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.339 0.59 . . . . 0.0 110.94 -175.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.606 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.5 tppt? -101.07 100.79 11.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -75.16 106.98 6.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.074 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.625 ' HB3' ' O ' ' A' ' 83' ' ' GLY . 81.1 tttt -98.76 108.86 21.65 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.901 0.857 . . . . 0.0 110.3 -178.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 71.0 mt -105.82 114.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.937 -178.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.776 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 28.9 ttp180 -79.35 29.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.366 0.603 . . . . 0.0 110.485 -172.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.55 ' HG2' ' CD2' ' A' ' 56' ' ' TYR . 84.8 mttt 57.56 -178.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.088 -178.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.916 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 2.0 t70 -87.31 42.2 1.02 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.563 . . . . 0.0 109.98 -174.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 73' ' ' ARG . 22.7 m -76.91 105.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.109 0.481 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 69.91 -64.41 0.35 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.294 -175.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -84.96 151.37 57.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.327 . . . . 0.0 110.19 177.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.724 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 60.9 Cg_endo -86.37 29.3 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.039 2.493 . . . . 0.0 111.428 174.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 1.9 ttmm -132.44 -158.6 0.9 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.376 0.608 . . . . 0.0 111.751 -169.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.503 ' SD ' ' HD3' ' A' ' 84' ' ' ARG . 3.6 ptt? -118.53 166.68 12.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.068 -176.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.776 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 3.6 p -81.55 -52.35 13.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 177.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.625 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -177.78 128.21 1.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.247 -177.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.503 ' HD3' ' SD ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -97.83 118.85 35.31 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.382 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -122.49 114.71 21.06 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.982 -169.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.978 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 22.6 m -72.22 122.88 21.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.158 173.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 . . . . . 0 C--N 1.303 -1.419 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.873 179.669 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.745 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 38.8 m . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 121.463 0.649 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.455 ' O ' HD11 ' A' ' 1' ' ' LEU . 3.7 pp -88.5 140.24 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.749 -169.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 2' ' ' ILE . 8.5 tp -166.5 45.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.889 1.328 . . . . 0.0 107.487 175.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.447 ' HG ' ' CG ' ' A' ' 75' ' ' ASP . 13.7 mt -82.25 -174.41 5.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.584 -171.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 166.79 -32.0 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.076 -174.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.93 80.66 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.334 176.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 23.4 t70 73.49 11.03 4.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 121.236 0.541 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 42.2 mt 82.86 172.95 0.09 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.427 173.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.7 119.71 7.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.139 -174.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -80.34 95.45 6.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.182 -176.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -85.84 -86.43 0.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -171.69 138.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 111.217 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.08 115.14 7.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.203 172.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 39.9 ttmt -81.72 106.61 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.522 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.644 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 13.0 mt 58.88 173.99 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 123.487 0.715 . . . . 0.0 112.152 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.644 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 38.8 Cg_endo -69.8 -19.97 35.24 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.91 1.74 . . . . 0.0 111.495 171.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 48' ' ' LYS . 6.7 t -138.49 113.2 8.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.9 176.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 12.3 mt -68.77 175.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.942 -178.009 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.444 ' H ' HG23 ' A' ' 17' ' ' ILE . 9.0 m-20 -51.63 -20.71 2.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 96.3 m-20 73.1 -40.09 0.46 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.389 0.676 . . . . 0.0 110.999 -174.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.59 -35.77 81.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 169.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.55 ' O ' HD11 ' A' ' 25' ' ' LEU . 90.9 t80 -59.13 -42.48 90.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -65.55 -42.65 95.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 175.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -51.78 -41.65 61.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.461 0.304 . . . . 0.0 110.857 176.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.4 mm-40 -57.84 -54.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.001 173.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.55 HD11 ' O ' ' A' ' 21' ' ' PHE . 10.8 mp -47.68 -63.93 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.289 174.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 58' ' ' VAL . 9.6 mp -59.84 -32.18 70.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.28 -174.136 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.19 -42.72 93.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 52.0 mttm -71.73 -42.48 67.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 110.646 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 0' ' ' SER . 2.0 m-30 -87.38 -0.48 56.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.378 -173.42 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 8.0 tt0 -56.43 -36.97 69.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.132 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.15 -36.08 65.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.009 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.86 -50.08 18.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.315 0.579 . . . . 0.0 109.832 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.564 HG21 ' HB ' ' A' ' 39' ' ' VAL . 45.8 mt -62.79 -31.07 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.993 -177.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 66.5 tttt -89.11 -29.17 19.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.43 -174.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.39 -51.77 33.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 0.0 110.566 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.17 -43.1 54.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.671 -172.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.587 ' HB2' HG21 ' A' ' 39' ' ' VAL . 15.9 m-85 -120.07 -17.95 8.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.824 0.345 . . . . 0.0 111.416 -173.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 81.36 30.74 36.09 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 37' ' ' TYR . 16.6 t -92.6 147.33 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.954 0.407 . . . . 0.0 111.418 -175.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -108.99 120.67 43.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 33.4 p -80.07 -13.78 59.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -170.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -74.81 -20.97 59.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.506 0.669 . . . . 0.0 109.566 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -86.77 -41.17 14.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.352 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.5 HD11 HG23 ' A' ' 41' ' ' THR . 91.6 mt -53.56 109.49 0.45 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.246 177.065 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 79.1 tttt -77.36 108.89 10.82 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.548 ' HA ' HG11 ' A' ' 60' ' ' VAL . 42.8 mt -73.54 115.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.482 0.658 . . . . 0.0 110.171 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.8 mt -87.33 -39.11 15.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.196 -175.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HG3' HG21 ' A' ' 16' ' ' VAL . 17.0 ttpp -156.57 104.98 2.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.003 -176.002 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.65 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 14.8 m -83.9 128.78 34.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -155.17 179.2 9.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.35 -177.07 6.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.851 176.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.631 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t70 -132.27 -88.01 0.45 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.631 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 40.9 mmtm -128.57 -81.52 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 54' ' ' ARG . 67.5 mtt85 -88.69 23.7 2.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -142.95 132.37 23.51 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -169.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.864 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 30.3 m-85 -101.65 149.77 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 166.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -134.36 97.47 3.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.859 0.361 . . . . 0.0 110.091 177.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.691 HG22 HD13 ' A' ' 26' ' ' LEU . 14.0 t -105.16 96.64 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.831 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 11.8 t -76.03 126.5 31.11 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 46' ' ' ILE . 26.9 m -135.65 150.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.457 0.646 . . . . 0.0 112.263 -174.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.5 t70 -99.14 123.93 43.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.092 173.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.68 4.94 10.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.883 -171.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.98 -174.07 45.76 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.81 -36.69 79.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 -177.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.67 -6.4 6.62 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.75 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -75.17 119.74 19.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -178.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.618 ' HZ1' ' HB3' ' A' ' 67' ' ' LYS . 7.4 ttpm? -145.1 117.0 8.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.507 -178.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.847 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 3.3 m -127.96 159.97 33.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.451 -175.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.3 ttmt -123.62 106.19 10.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -73.45 96.46 2.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.875 0.845 . . . . 0.0 110.51 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 1.027 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 50.8 tttp -82.95 79.64 9.25 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.312 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.864 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 45.0 mt -75.5 105.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.398 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.571 ' HD2' HG13 ' A' ' 82' ' ' VAL . 43.1 ttt-85 -74.34 9.72 1.57 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.612 0.72 . . . . 0.0 110.184 -175.061 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 72' ' ' ILE . 94.6 mttt 63.5 177.05 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.482 176.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.79 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 8.0 t0 -80.68 64.35 5.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 177.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 4.0 m -85.98 87.16 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.092 175.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 5.1 m-20 74.69 -53.58 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -174.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.438 HG21 ' HD2' ' A' ' 79' ' ' PRO . 14.3 p -114.82 135.57 22.42 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.79 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 23.7 Cg_endo -65.59 -50.78 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.052 2.502 . . . . 0.0 112.918 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -46.71 128.97 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.746 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 159.48 6.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.897 -175.229 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.571 HG13 ' HD2' ' A' ' 73' ' ' ARG . 3.8 p -103.62 -27.97 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.573 177.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 1.027 ' HA2' ' HB3' ' A' ' 71' ' ' LYS . . . -118.76 135.61 11.58 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.946 -170.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -155.23 19.03 0.42 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.033 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -71.53 117.83 13.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.196 -168.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.847 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 60.6 m -84.42 111.03 19.09 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 . . . . . 0 C--N 1.307 -1.264 0 CA-C-O 122.091 0.948 . . . . 0.0 109.425 179.601 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.531 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 26.8 t . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.797 0.808 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 3' ' ' LEU . 89.2 mt -85.55 11.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.088 175.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.449 HD11 ' HD3' ' A' ' 74' ' ' LYS . 9.2 tt -78.06 65.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.013 170.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.563 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -103.29 154.72 19.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.931 -164.732 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.677 ' HB3' HD11 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -174.09 5.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.185 169.149 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.84 62.87 0.71 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -179.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 9.1 t70 70.29 25.45 4.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.117 0.961 . . . . 0.0 108.672 179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.677 HD11 ' HB3' ' A' ' 4' ' ' ASP . 84.0 mt -110.21 109.47 19.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.992 -177.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.736 HD13 ' HD2' ' A' ' 74' ' ' LYS . 2.0 mm? -64.98 -56.34 13.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.134 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 67.52 -62.58 0.33 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.831 0.707 . . . . 0.0 111.178 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.52 85.8 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 0.0 110.576 176.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.72 132.05 55.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 169.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD11 HD13 ' A' ' 14' ' ' LEU . 67.0 mt -82.8 -169.9 2.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.295 0.569 . . . . 0.0 111.89 -171.026 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.76 21.23 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.449 -170.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.446 HD13 HD11 ' A' ' 12' ' ' LEU . 1.3 pp -138.16 162.24 54.91 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.888 -167.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.74 -147.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.86 3.04 . . . . 0.0 112.699 171.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.594 ' HB ' ' HG3' ' A' ' 48' ' ' LYS . 11.0 p -47.09 130.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.235 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -97.78 -73.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.446 -175.938 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.579 ' H ' ' HB ' ' A' ' 49' ' ' THR . 5.4 m-20 64.72 12.23 7.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.776 177.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . 58.2 t30 -81.53 61.16 4.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.14 3.0 0.9 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.312 0.645 . . . . 0.0 110.7 -174.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.769 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 4.4 m-85 -63.69 -61.31 2.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.653 -175.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 49' ' ' THR . . . -62.26 -35.59 91.81 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.847 -177.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -68.2 -36.72 80.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.834 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.1 mm-40 -62.3 -53.95 47.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.04 0.536 . . . . 0.0 111.231 175.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 13.0 mt -52.74 -62.59 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.109 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 33.4 mt -58.7 -26.8 64.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.053 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.0 -43.55 82.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 177.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.2 mttm -72.68 -41.11 65.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.829 -179.162 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.531 ' HZ ' ' HB3' ' A' ' 0' ' ' SER . 96.8 m-85 -90.19 0.46 57.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.757 -176.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -50.9 -44.24 59.9 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.966 0.412 . . . . 0.0 110.792 177.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.72 -31.68 73.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.512 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -84.98 -41.4 15.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.51 0.672 . . . . 0.0 110.184 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.557 HG21 ' HB ' ' A' ' 39' ' ' VAL . 95.9 mt -63.07 -34.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.181 177.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 45.6 tttp -81.76 -34.23 30.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.509 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.94 -47.37 77.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.361 174.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -95.36 -42.45 8.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -172.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.561 ' HB2' HG21 ' A' ' 39' ' ' VAL . 3.3 m-85 -111.06 -13.11 14.11 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.502 -170.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.5 50.09 33.9 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.27 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.6 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 23.6 t -116.79 152.69 18.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 110.921 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -111.69 118.13 34.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 40.1 p -75.2 -14.29 60.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.033 0.444 . . . . 0.0 111.734 -173.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -76.93 -17.46 58.9 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.981 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -99.65 -16.21 18.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.372 0.606 . . . . 0.0 109.849 -179.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.47 HD11 ' HA ' ' A' ' 41' ' ' THR . 96.6 mt -68.09 121.4 16.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 53.4 tptt -85.03 103.08 13.74 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 176.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.578 ' HA ' HG11 ' A' ' 60' ' ' VAL . 34.1 mt -72.77 114.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.459 0.647 . . . . 0.0 109.96 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 61' ' ' ASP . 14.5 mt -87.13 -35.92 18.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.773 -177.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HG3' ' HB ' ' A' ' 16' ' ' VAL . 4.1 ttmp? -159.06 108.95 1.95 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.577 -177.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.579 ' HB ' ' H ' ' A' ' 18' ' ' ASP . 20.0 m -86.1 134.42 33.82 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.169 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 p -162.57 -179.24 6.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.383 . . . . 0.0 110.517 176.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 5.5 pt-20 -155.67 164.37 38.69 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.328 176.165 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -157.5 108.61 2.29 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 56.88 -115.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.097 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.468 ' HG2' HD12 ' A' ' 8' ' ' LEU . 46.4 mtt85 -88.55 16.24 6.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -172.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -138.35 137.6 37.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.924 -171.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.561 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 8.0 m-85 -98.13 140.39 32.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.661 168.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.537 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 97.4 m-85 -124.57 96.49 4.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.415 -178.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 3.4 t -103.26 90.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.6 t -72.97 120.86 19.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 46' ' ' ILE . 16.8 m -133.35 155.91 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.204 0.526 . . . . 0.0 111.048 -177.005 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.474 ' HB2' HD23 ' A' ' 47' ' ' LEU . 16.9 t0 -100.55 127.84 46.79 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.026 173.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -7.33 59.21 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.58 -81.61 1.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.015 172.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.21 -22.94 61.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.038 0.447 . . . . 0.0 111.352 -175.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.3 -90.01 0.75 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.821 -174.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -100.38 177.56 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -128.52 126.51 40.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 167.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 1.041 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.6 t -134.14 -177.83 4.76 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.451 0.643 . . . . 0.0 111.316 -167.31 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 37.6 ttmt -159.39 90.23 0.94 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CD1' HD22 ' A' ' 26' ' ' LEU . 72.2 m-85 -57.12 111.66 1.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.842 -176.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.9 tttt -94.5 77.36 3.84 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.325 -176.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.66 ' HA ' ' CB ' ' A' ' 81' ' ' MET . 78.3 mt -80.26 92.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.572 -177.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 1.012 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 49.3 ttt180 -56.83 127.48 31.9 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.259 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.736 ' HD2' HD13 ' A' ' 8' ' ' LEU . 95.2 mttt -63.57 179.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' CB ' ' HA ' ' A' ' 3' ' ' LEU . 5.9 t70 -61.43 94.02 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.754 0.788 . . . . 0.0 110.516 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 74' ' ' LYS . 12.4 m -138.29 84.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.814 174.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.2 t70 76.9 -49.48 0.55 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.826 -174.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 m -96.67 150.25 36.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.409 0.623 . . . . 0.0 111.136 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -95.21 29.11 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.245 3.297 . . . . 0.0 110.923 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -137.96 -176.6 4.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.557 -171.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.66 ' CB ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.17 146.07 23.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.875 179.614 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 1.012 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.6 p -83.0 -26.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.321 0.581 . . . . 0.0 110.282 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.92 -171.31 23.71 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.036 -175.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.0 ptt-85 -161.17 71.05 0.39 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 18.5 tptm -59.77 80.64 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.86 -167.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 1.041 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 27.8 m -92.54 -116.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 64.6 mtt180 . . . . . 0 C--O 1.233 0.219 0 C-N-CA 123.196 0.598 . . . . 0.0 110.772 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 0' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 56.4 m . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 31.0 mt -102.61 -0.55 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.357 -174.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.581 HG22 ' HB2' ' A' ' 74' ' ' LYS . 5.3 tp -78.28 89.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.752 0.787 . . . . 0.0 109.877 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.846 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -71.23 0.87 6.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.054 -175.448 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.45 39.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.278 1.037 . . . . 0.0 109.313 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 3' ' ' LEU . . . -128.73 -53.81 0.11 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.69 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 28.9 t70 -53.56 -35.78 61.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 166.179 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.78 -57.02 2.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 172.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.6 tp 56.99 72.07 0.53 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.023 0.827 . . . . 0.0 110.962 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.28 -26.4 9.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.067 -177.037 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -154.22 70.97 0.82 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.393 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 11.2 ptmm? -76.96 154.62 33.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.391 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.53 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 4.7 mp -88.95 174.07 8.13 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.259 -173.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -147.89 30.45 0.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.227 -171.028 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.73 147.63 38.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -176.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.7 117.94 4.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.69 2.26 . . . . 0.0 110.858 173.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 48' ' ' LYS . 7.5 p 41.11 99.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.926 1.346 . . . . 0.0 113.162 -171.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.2 mt -65.87 154.34 7.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.925 178.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.48 144.21 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -172.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -62.25 -23.84 66.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.327 -176.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.4 tp -65.68 -41.58 92.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 65.7 t80 -64.67 -39.34 93.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.535 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.591 ' O ' HD11 ' A' ' 26' ' ' LEU . . . -68.23 -44.05 77.26 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.353 176.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -53.29 -44.4 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.67 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.3 mm-40 -54.9 -55.84 26.1 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.66 176.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.2 mt -53.4 -60.55 3.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.882 0.849 . . . . 0.0 110.695 178.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.673 HD21 HD12 ' A' ' 46' ' ' ILE . 9.5 mp -59.2 -40.88 87.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.433 -173.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.48 -32.49 73.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.67 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.2 mttm -67.43 -33.3 74.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.444 ' HE1' ' HA ' ' A' ' 80' ' ' LYS . 92.7 m-85 -95.01 0.95 55.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.73 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -36.1 74.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.509 0.195 . . . . 0.0 111.443 -171.222 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.95 -33.98 76.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.22 -41.43 49.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.492 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.511 HG21 ' HB ' ' A' ' 39' ' ' VAL . 90.9 mt -62.83 -37.14 78.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.753 176.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.606 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 36.3 ttmt -80.87 -22.76 39.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.042 -177.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.79 -47.14 22.45 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.448 172.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.69 -42.92 57.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.282 -175.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -121.2 -28.3 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.735 0.303 . . . . 0.0 111.731 -174.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 91.88 41.78 4.9 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.986 -178.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.606 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 13.1 t -119.42 152.1 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 120.556 0.217 . . . . 0.0 110.838 -176.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.92 136.37 50.04 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 26' ' ' LEU . 32.3 p -79.99 -12.92 59.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -83.31 -3.04 57.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.9 -27.72 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.292 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.516 HD22 HG13 ' A' ' 39' ' ' VAL . 67.8 mt -62.17 125.98 25.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.715 175.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 25.8 tttp -85.79 102.92 14.08 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.415 -178.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.673 HD12 HD21 ' A' ' 26' ' ' LEU . 22.9 mt -75.66 124.42 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.695 0.759 . . . . 0.0 110.931 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.44 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.7 mt -100.1 -53.72 3.07 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.673 -177.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HA ' HG21 ' A' ' 16' ' ' VAL . 36.6 ttmt -142.9 104.26 4.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.871 -174.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.58 ' HG1' HG12 ' A' ' 58' ' ' VAL . 46.6 m -91.69 125.5 36.43 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.9 m -151.8 -179.12 7.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' OE2' ' HB2' ' A' ' 11' ' ' LYS . 9.4 pt-20 -142.14 143.82 33.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 177.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.02 126.62 10.92 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 58.46 -141.27 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.741 -175.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.6 ' HB3' HG12 ' A' ' 76' ' ' VAL . 73.7 mtt180 -77.71 14.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 5.0 m-85 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.313 -169.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.553 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 17.3 m-85 -98.26 143.96 28.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.367 166.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.0 m-85 -124.32 105.49 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.67 HG22 HD12 ' A' ' 26' ' ' LEU . 13.9 t -106.69 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.847 0.356 . . . . 0.0 110.722 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 14.5 t -74.35 128.25 35.08 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.616 HG11 ' HA ' ' A' ' 46' ' ' ILE . 16.9 m -138.22 153.99 27.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.085 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.13 126.62 34.9 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.75 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 -36.23 2.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.586 174.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -70.83 -14.31 62.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.144 0.497 . . . . 0.0 109.978 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.25 -24.92 4.95 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.34 174.26 11.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.912 0.387 . . . . 0.0 110.692 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -138.61 115.74 11.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 1.077 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -107.14 163.26 13.15 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.014 0.435 . . . . 0.0 111.239 -168.395 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.2 ttmt -139.21 93.9 2.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 64.4 m-85 -67.58 108.53 2.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.37 0.605 . . . . 0.0 110.342 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 46.9 tttt -92.2 83.53 5.09 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.044 -176.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.896 HG12 ' HG2' ' A' ' 81' ' ' MET . 55.7 mt -81.05 91.38 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.564 -178.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.679 HH11 HG22 ' A' ' 82' ' ' VAL . 34.8 ttt180 -59.68 111.23 1.35 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.838 ' HG3' HG11 ' A' ' 76' ' ' VAL . 18.6 ptpt -56.43 166.62 0.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.695 0.622 . . . . 0.0 110.461 -179.179 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 3' ' ' LEU . 38.9 t70 -68.65 75.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.508 0.67 . . . . 0.0 110.166 -178.2 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.838 HG11 ' HG3' ' A' ' 74' ' ' LYS . 29.5 m -100.84 -8.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.445 177.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 176.29 -51.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.833 -169.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.408 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -117.15 136.74 23.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.365 0.602 . . . . 0.0 110.323 178.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.517 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 43.9 Cg_endo -86.45 46.2 1.52 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 123.805 3.003 . . . . 0.0 113.341 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.444 ' HA ' ' HE1' ' A' ' 29' ' ' PHE . 27.3 mtmt -150.68 161.7 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.131 0.491 . . . . 0.0 112.19 -177.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.896 ' HG2' HG12 ' A' ' 72' ' ' ILE . 38.2 mtm -63.81 101.51 0.38 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.264 172.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.679 HG22 HH11 ' A' ' 73' ' ' ARG . 9.9 p -55.85 -28.74 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.402 173.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.65 177.41 26.9 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.277 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -177.12 42.27 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.023 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -83.28 120.75 26.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.876 -171.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 1.077 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 29.7 m -65.6 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.569 -177.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.577 0.704 . . . . 0.0 109.245 175.856 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.665 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 32.8 t -101.27 -73.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 0.114 . . . . 0.0 111.008 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 61.94 12.2 4.69 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.805 0.442 . . . . 0.0 110.871 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 tp -90.22 -3.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -168.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.85 HD22 HG11 ' A' ' 76' ' ' VAL . 13.6 tp -174.01 71.99 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.302 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.63 103.55 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.136 0.898 . . . . 0.0 112.032 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.58 32.5 78.8 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.569 -0.741 . . . . 0.0 113.498 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.749 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.3 t0 56.11 76.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.4 0.619 . . . . 0.0 112.135 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.667 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 94.9 mt -112.25 38.24 2.77 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.727 ' HB2' HD23 ' A' ' 3' ' ' LEU . 23.9 tp -71.22 101.03 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.381 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.806 ' HB2' ' HZ3' ' A' ' 9' ' ' LYS . 7.4 mtmp? -105.52 -41.38 5.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.23 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.37 101.69 7.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.544 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -103.86 -81.39 0.52 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.926 0.393 . . . . 0.0 111.586 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.481 HD12 HG12 ' A' ' 17' ' ' ILE . 61.5 tp -147.37 126.13 12.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.027 0.441 . . . . 0.0 110.694 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -122.48 11.27 9.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.203 1.001 . . . . 0.0 108.765 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.3 mt -115.44 171.68 4.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.603 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.44 -157.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.191 2.594 . . . . 0.0 112.544 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.511 HG21 ' HG3' ' A' ' 48' ' ' LYS . 4.4 p -49.84 124.54 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.789 0.804 . . . . 0.0 111.306 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.481 HG12 HD12 ' A' ' 12' ' ' LEU . 35.0 mt -69.25 152.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.2 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 139.38 57.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 27.0 p-10 -61.6 -26.05 67.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt -56.75 -45.56 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.01 -38.24 90.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.201 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -69.34 -37.25 79.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.449 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 30.2 mmmt -64.31 -31.22 72.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.24 -47.3 65.11 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.499 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 90.9 mt -52.32 -65.52 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.608 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 23.6 mt -53.37 -27.72 25.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.712 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.88 -40.38 63.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 111.024 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -79.27 -35.88 40.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.112 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 96.4 m-85 -91.99 4.87 52.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.547 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 34.7 tt0 -52.59 -41.9 64.05 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.1 -39.47 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.694 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 2.0 m-20 -67.59 -54.12 22.51 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.562 HG21 ' HB ' ' A' ' 39' ' ' VAL . 65.0 mt -55.89 -35.02 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.204 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.622 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 9.2 tmtm? -81.77 -37.28 27.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.283 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.46 -53.56 50.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.667 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.694 ' HE2' ' HB3' ' A' ' 32' ' ' ASP . 39.1 mttm -69.25 -55.32 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.8 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.563 ' CE2' ' HD3' ' A' ' 84' ' ' ARG . 22.9 m-85 -104.68 -37.08 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.079 0.466 . . . . 0.0 111.422 -171.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.24 63.88 1.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.445 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.622 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 32.1 t -126.12 155.25 35.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -105.55 119.82 40.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 26.4 p -84.67 -11.03 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -71.21 -35.07 71.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.45 -34.53 60.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.349 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.543 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.0 mt -49.01 120.11 3.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.709 0.766 . . . . 0.0 112.433 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 86.1 tttt -92.24 104.01 16.42 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.135 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.53 HG12 HG11 ' A' ' 60' ' ' VAL . 20.0 mt -78.1 130.76 35.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.495 0.664 . . . . 0.0 111.723 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt -99.97 -45.9 5.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.77 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HG3' HG21 ' A' ' 16' ' ' VAL . 58.6 tttm -151.28 110.85 4.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.492 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.5 m -90.04 121.54 32.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -155.08 -167.68 2.64 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -169.94 170.03 7.87 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -116.64 -81.11 0.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.173 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.21 -88.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.91 ' HB3' HG22 ' A' ' 76' ' ' VAL . 85.1 mtt180 -91.86 23.96 3.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.49 0.662 . . . . 0.0 110.677 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' HE2' HG13 ' A' ' 82' ' ' VAL . 54.6 m-85 -147.36 144.58 28.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.673 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.917 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 27.2 m-85 -93.75 152.88 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.535 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 74.7 m-85 -139.09 99.13 3.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.212 0.529 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 t -109.24 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.016 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.0 m -66.61 121.69 15.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.962 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.53 HG11 HG12 ' A' ' 46' ' ' ILE . 21.5 m -137.01 151.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.115 0.483 . . . . 0.0 111.104 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.2 t70 -88.49 115.51 26.06 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 169.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 64' ' ' ASP . . . -77.12 -2.1 32.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.916 -173.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.43 -15.21 13.48 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.471 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 62' ' ' ALA . 25.1 t70 -88.95 -1.98 58.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.503 0.668 . . . . 0.0 110.055 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.63 -15.14 58.8 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.541 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 8.6 tp10 -90.67 140.69 29.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.859 0.362 . . . . 0.0 110.516 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 67.9 mttm -115.08 85.73 2.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.192 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 15.1 t -89.89 142.09 28.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.428 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.4 ttmt -102.69 88.06 3.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.097 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 12.7 m-85 -47.88 123.04 5.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.135 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.972 ' HZ1' HG12 ' A' ' 82' ' ' VAL . 25.9 ttpp -104.71 87.71 2.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.049 0.928 . . . . 0.0 110.217 -173.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.917 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 80.6 mt -87.15 89.94 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.51 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.701 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 13.7 ttt180 -52.89 114.94 1.59 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.776 ' HB2' HG12 ' A' ' 76' ' ' VAL . 53.9 mttp -60.87 170.31 1.57 Allowed 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.694 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.1 t70 -73.2 32.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.934 0.873 . . . . 0.0 110.149 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.91 HG22 ' HB3' ' A' ' 54' ' ' ARG . 31.4 m -76.85 -7.34 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.011 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -171.97 -51.13 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.981 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 28.4 m -108.57 149.05 38.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.263 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.401 ' O ' ' HA3' ' A' ' -1' ' ' GLY . 77.1 Cg_endo -86.81 27.41 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.268 2.645 . . . . 0.0 113.587 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.423 ' HD2' ' NZ ' ' A' ' 36' ' ' LYS . 23.3 pttm -159.41 -178.77 7.38 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.671 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.42 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -83.65 132.4 34.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.014 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.972 HG12 ' HZ1' ' A' ' 71' ' ' LYS . 13.7 p -80.51 -38.85 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.69 -142.93 3.65 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.134 -172.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.858 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 11.8 ptt-85 -172.92 114.58 0.26 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.522 ' HE3' ' O ' ' A' ' 93' ' ' ASP . 22.0 tptm -80.36 81.33 6.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.466 0.651 . . . . 0.0 110.803 -173.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 68.3 m -76.23 -159.16 0.11 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.728 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 62.8 mtp180 76.13 96.76 0.07 Allowed 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.667 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.77 ' HZ3' ' HB2' ' A' ' 88' ' ' LYS . 7.7 mtmp? -66.57 -73.3 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.745 -166.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.1 -54.69 6.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.074 -169.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -132.42 113.4 13.11 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.133 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.74 173.9 6.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.319 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -140.66 -50.89 0.46 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 1.4 m-20 -53.53 129.61 33.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.379 173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.67 -51.17 7.02 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.66 -174.05 50.15 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 170.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.646 ' HB3' ' CE ' ' A' ' 71' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 118.055 0.927 . . . . 0.0 109.765 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 1' ' ' LEU . . . . . . . . 0 N--CA 1.479 1.512 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.766 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 19.1 m -72.42 113.72 9.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.647 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -156.56 135.92 12.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.566 0.222 . . . . 0.0 111.501 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.83 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 5.2 tp 167.56 135.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 124.411 1.07 . . . . 0.0 109.23 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.662 HD12 HG21 ' A' ' 2' ' ' ILE . 11.0 mp 82.32 -21.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.609 0.764 . . . . 0.0 111.999 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.523 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 14.3 m-20 62.51 20.82 12.22 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 171.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.885 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 79.34 -0.22 81.09 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.317 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.59 -11.71 44.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.843 0.354 . . . . 0.0 110.448 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.557 ' HA ' HD22 ' A' ' 3' ' ' LEU . 96.9 mt 70.36 32.22 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.134 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.64 93.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.659 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -100.41 71.94 1.57 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.599 0.714 . . . . 0.0 110.291 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.93 -30.71 69.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.292 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -135.96 144.43 45.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.59 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 35.2 tp -167.62 165.55 14.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.59 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 26.4 mttt 64.72 20.01 12.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.4 mt -72.41 155.45 91.28 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.872 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.89 -171.35 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.824 2.349 . . . . 0.0 110.57 169.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG2' ' HA ' ' A' ' 48' ' ' LYS . 7.2 p -65.21 122.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.212 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.826 HG13 ' HB ' ' A' ' 49' ' ' THR . 4.1 pt -105.89 -178.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.799 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 177.47 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -40.02 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 112.919 -1.946 . . . . 0.0 112.891 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 20' ' ' LEU . 22.8 mt 34.65 43.92 0.1 Allowed 'General case' 0 CA--C 1.521 -0.138 0 O-C-N 123.885 0.74 . . . . 0.0 111.987 -173.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.57 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -125.94 -66.76 0.91 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.83 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' CA ' HG23 ' A' ' 49' ' ' THR . . . -64.36 -50.19 61.14 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.36 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.17 -36.59 68.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.916 0.388 . . . . 0.0 110.64 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.557 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.8 mt-10 -65.3 -50.54 65.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.963 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 91.0 mt -47.92 -65.0 0.64 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 123.579 0.55 . . . . 0.0 110.891 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.72 HD13 HG22 ' A' ' 58' ' ' VAL . 7.4 mp -60.95 -38.38 85.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.553 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.72 -33.42 75.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 84.2 mttt -78.48 -46.1 20.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.456 0.646 . . . . 0.0 109.828 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' CE2' HG22 ' A' ' 72' ' ' ILE . 6.8 m-85 -70.33 -9.86 57.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.552 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -52.42 -47.51 66.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.719 0.407 . . . . 0.0 111.806 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -54.84 -39.64 68.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.713 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.23 -43.91 31.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.6 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.449 HD12 ' CE1' ' A' ' 70' ' ' PHE . 55.6 mt -63.42 -33.57 62.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.697 0.76 . . . . 0.0 110.403 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.614 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 71.3 tttt -80.86 -29.15 35.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.596 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.13 -50.48 40.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.089 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 81' ' ' MET . 62.8 mttm -66.33 -50.12 64.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.399 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' HB2' HG22 ' A' ' 39' ' ' VAL . 34.9 m-85 -118.08 -37.62 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.877 0.37 . . . . 0.0 111.605 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.62 62.89 1.02 Allowed Glycine 0 C--N 1.323 -0.179 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.845 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.614 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -126.01 150.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.847 0.356 . . . . 0.0 111.584 -173.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.84 128.13 45.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.621 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 8.2 p -86.41 -9.48 56.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -92.22 -10.1 39.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.577 0.703 . . . . 0.0 109.346 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.69 -29.32 56.26 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.577 1.18 . . . . 0.0 107.872 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.559 HD12 ' CE2' ' A' ' 70' ' ' PHE . 27.4 mt -77.77 109.15 11.54 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 112.848 -1.978 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 55.4 tttm -72.86 111.97 8.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.635 ' HA ' HG13 ' A' ' 60' ' ' VAL . 26.3 mt -74.34 111.67 10.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.587 0.708 . . . . 0.0 110.234 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.491 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.8 mt -86.23 -35.94 19.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.678 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 34.0 tttp -156.88 118.31 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.667 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.826 ' HB ' HG13 ' A' ' 17' ' ' ILE . 2.8 m -106.53 126.13 51.87 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -155.77 170.99 20.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.636 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 14.0 pt-20 -139.59 175.69 9.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.437 0.637 . . . . 0.0 111.814 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 53' ' ' LYS . 9.9 t70 -152.88 -162.2 1.44 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 72.9 mmtt -58.3 103.35 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 77.1 -21.28 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.779 0.674 . . . . 0.0 112.559 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.71 142.05 38.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.665 ' HD2' ' HG2' ' A' ' 74' ' ' LYS . 4.5 m-85 -109.94 142.44 41.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 166.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 61.0 m-85 -133.01 115.09 14.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.271 0.558 . . . . 0.0 110.678 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.72 HG22 HD13 ' A' ' 26' ' ' LEU . 41.6 t -108.69 98.75 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.565 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.3 m -74.44 128.83 36.53 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.635 HG13 ' HA ' ' A' ' 46' ' ' ILE . 33.3 m -138.25 156.83 30.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.823 0.344 . . . . 0.0 111.143 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.63 110.95 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 1.27 53.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.783 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.29 -112.91 0.27 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.658 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -116.36 79.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.628 ' O ' ' HE3' ' A' ' 88' ' ' LYS . . . 89.48 4.13 73.96 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.625 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 12.3 mt-10 -79.25 81.98 5.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 122.087 0.946 . . . . 0.0 109.67 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 28.9 ttmt -82.43 135.54 35.13 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.55 -169.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 26.3 t -138.8 169.11 18.38 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.009 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 39.6 ttpt -146.43 110.81 5.11 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CE2' HD12 ' A' ' 44' ' ' LEU . 36.6 m-85 -68.73 122.62 18.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.443 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.584 ' HD3' ' HA2' ' A' ' 83' ' ' GLY . 83.3 tttt -88.72 71.61 8.73 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.197 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.603 HG22 ' CE2' ' A' ' 29' ' ' PHE . 67.4 mt -80.08 92.76 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.451 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.57 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 46.3 ttt-85 -72.4 8.45 1.37 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.427 0.632 . . . . 0.0 110.087 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.665 ' HG2' ' HD2' ' A' ' 56' ' ' TYR . 64.1 mttt 66.4 172.43 0.24 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.991 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.83 ' HB3' ' H ' ' A' ' 2' ' ' ILE . 2.0 t70 -77.66 87.79 3.94 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.091 0.948 . . . . 0.0 109.131 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.885 ' HA ' ' HA3' ' A' ' 5' ' ' GLY . 2.6 p -115.36 100.8 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.156 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.548 ' H ' ' CA ' ' A' ' 5' ' ' GLY . 33.4 t70 78.07 -59.64 0.43 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.644 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.44 146.86 33.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.17 -53.17 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.371 2.048 . . . . 0.0 113.792 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.766 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 11.7 ptpt -65.9 154.29 39.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.392 0.615 . . . . 0.0 112.136 -168.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.452 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -65.07 146.01 55.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.772 -176.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.57 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 7.5 p -81.03 -40.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.542 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.584 ' HA2' ' HD3' ' A' ' 71' ' ' LYS . . . -149.07 161.92 28.83 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.461 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 84' ' ' ARG . 27.5 ttt180 -149.0 92.83 2.02 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.75 ' HE3' ' HB3' ' A' ' 92' ' ' ASP . 9.0 tppt? -105.35 111.26 23.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 110.586 -172.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 8.1 m -103.54 123.83 47.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.729 ' HD3' ' HE2' ' A' ' 96' ' ' TYR . 9.7 mtm180 -87.74 5.01 42.02 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.769 0.795 . . . . 0.0 110.317 -167.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.628 ' HE3' ' O ' ' A' ' 65' ' ' GLY . 57.1 mmtt -90.22 1.04 56.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.751 168.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -125.85 -52.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.467 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -167.02 143.71 4.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.206 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -112.53 132.33 55.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 110.22 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.75 ' HB3' ' HE3' ' A' ' 85' ' ' LYS . 10.2 t70 -124.51 148.65 47.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.286 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -95.47 -6.59 40.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.95 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.29 104.7 3.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 56.71 -118.72 12.51 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.636 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.729 ' HE2' ' HD3' ' A' ' 87' ' ' ARG . 30.9 t80 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.816 0.446 . . . . 0.0 110.807 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 6.4 t -89.73 178.15 6.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -165.89 21.32 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.173 0.511 . . . . 0.0 111.293 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.425 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -101.15 107.73 21.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.709 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 3.2 mm? -120.71 -101.58 0.42 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.026 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 10.2 m-20 70.38 10.21 7.17 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.671 0.607 . . . . 0.0 109.702 -169.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 6' ' ' ASP . . . 69.99 97.14 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.21 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 5' ' ' GLY . 24.5 t70 73.57 -2.87 2.63 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.6 0.714 . . . . 0.0 110.1 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.931 HD23 ' HB2' ' A' ' 74' ' ' LYS . 11.2 mp 75.38 171.97 0.26 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.457 HD21 ' HG2' ' A' ' 11' ' ' LYS . 9.7 tp -78.55 3.05 17.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.578 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 15.9 mmtp 73.99 -74.61 0.08 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.413 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -145.4 135.28 23.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HG2' HD21 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -130.47 16.86 5.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.016 176.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 12' ' ' LEU . 13.2 mt -144.43 93.36 2.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.151 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -95.63 36.15 1.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.536 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.731 ' HB2' HG12 ' A' ' 17' ' ' ILE . 48.6 mt -79.39 128.53 75.05 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.231 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.6 Cg_exo -64.43 116.03 3.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.77 2.313 . . . . 0.0 110.228 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.606 ' HB ' ' HG2' ' A' ' 48' ' ' LYS . 4.3 p 41.23 96.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 123.031 1.396 . . . . 0.0 112.057 -168.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.731 HG12 ' HB2' ' A' ' 14' ' ' LEU . 60.5 mt -74.26 155.42 6.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.225 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -44.76 133.75 5.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 112.206 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -62.73 -29.29 70.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 tp -68.2 -40.33 82.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.726 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.09 -36.52 81.95 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -66.06 -50.32 52.65 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -52.59 -35.77 54.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.441 0.297 . . . . 0.0 110.933 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 8.3 mm-40 -60.19 -54.87 40.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 174.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.2 mt -52.34 -63.73 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.548 0.69 . . . . 0.0 110.313 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.872 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 9.8 mp -56.21 -35.42 67.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.779 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.6 -36.44 83.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.072 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -70.15 -34.43 73.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.286 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.562 ' CE1' HD12 ' A' ' 72' ' ' ILE . 15.0 m-85 -100.54 -1.92 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.083 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.02 -30.81 66.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.737 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.56 -39.18 92.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.781 0.324 . . . . 0.0 110.632 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 2.8 m-20 -84.04 -30.31 26.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.147 0.499 . . . . 0.0 110.276 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.552 HG21 ' HB ' ' A' ' 39' ' ' VAL . 85.7 mt -63.98 -31.83 54.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.776 0.798 . . . . 0.0 109.834 173.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 74.7 tttt -88.69 -38.55 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 17.1 t70 -59.33 -45.58 90.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.392 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -80.63 -52.64 7.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.168 0.508 . . . . 0.0 112.025 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.511 ' HB2' HG21 ' A' ' 39' ' ' VAL . 24.4 m-85 -105.02 -30.83 9.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.572 -167.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.53 51.1 3.57 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.762 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.628 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 16.2 t -121.83 149.71 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 120.617 0.246 . . . . 0.0 110.885 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.525 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.6 t70 -107.57 117.71 34.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.872 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 58.0 p -79.4 -22.43 44.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -171.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.69 -19.86 51.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.91 -26.8 22.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.664 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 91.5 mt -60.36 145.21 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.945 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -97.22 103.98 15.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.931 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.5 HG12 HG11 ' A' ' 60' ' ' VAL . 41.6 mt -76.33 122.04 29.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.72 0.772 . . . . 0.0 110.802 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 61' ' ' ASP . 7.7 mt -91.19 -48.17 7.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.606 ' HG2' ' HB ' ' A' ' 16' ' ' VAL . 23.8 mttp -151.79 109.33 3.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.522 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 11.6 m -81.64 128.92 34.45 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 171.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.41 ' HG ' ' C ' ' A' ' 49' ' ' THR . 21.7 m -154.46 179.28 9.17 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -156.35 160.85 40.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.212 0.53 . . . . 0.0 110.884 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -137.16 -159.18 0.93 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -64.49 107.9 1.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.515 0.198 . . . . 0.0 110.863 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 84.7 mtm180 74.42 -17.76 0.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.07 130.26 55.51 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.876 -0.515 . . . . 0.0 111.609 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 1.008 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 16.2 m-85 -78.95 155.67 28.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.5 91.93 2.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.023 0.439 . . . . 0.0 110.393 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.0 t -97.5 97.67 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.428 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.463 ' HB2' ' HZ1' ' A' ' 69' ' ' LYS . 9.2 t -71.54 116.85 12.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.5 HG11 HG12 ' A' ' 46' ' ' ILE . 5.0 m -131.37 159.04 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.936 0.398 . . . . 0.0 110.797 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.497 ' HB2' HD22 ' A' ' 47' ' ' LEU . 11.7 t70 -107.22 132.81 52.66 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.64 9.18 14.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.418 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.18 -35.09 5.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.509 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -93.68 1.78 56.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.31 0.576 . . . . 0.0 110.691 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.53 -20.96 38.19 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.474 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 139.03 58.72 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -128.12 144.62 51.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.567 0.699 . . . . 0.0 112.083 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.481 ' HB2' HG23 ' A' ' 60' ' ' VAL . 36.9 m -128.18 123.81 35.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.319 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 12.5 tppt? -97.09 68.54 2.27 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.644 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 19.2 m-85 -38.08 105.51 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 124.183 0.927 . . . . 0.0 112.331 -169.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 96' ' ' TYR . 73.8 tttt -90.76 83.76 5.78 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.392 1.092 . . . . 0.0 109.326 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.008 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 70.1 mt -84.03 91.83 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.932 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.966 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.6 ttt180 -57.98 96.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.931 ' HB2' HD23 ' A' ' 7' ' ' LEU . 23.1 mttt -59.4 82.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.328 1.018 . . . . 0.0 112.092 -167.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.47 24.84 0.8 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.778 0.831 . . . . 0.0 111.239 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.966 ' HB ' ' HG2' ' A' ' 73' ' ' ARG . 33.9 t -80.21 119.21 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.682 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 68.03 -70.25 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.072 0.858 . . . . 0.0 111.276 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 79' ' ' PRO . 4.2 m -90.88 175.46 3.61 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.7 ' O ' HG22 ' A' ' 78' ' ' VAL . 8.8 Cg_endo -82.92 178.54 5.9 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.88 1.72 . . . . 0.0 111.379 170.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 29.4 pttt 57.84 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 169.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.573 ' HB3' HG22 ' A' ' 72' ' ' ILE . 6.3 ptt? -168.73 150.11 4.73 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -171.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 12.9 p -76.12 -46.32 34.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.16 137.22 4.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.233 -1.46 . . . . 0.0 114.385 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.593 ' HG3' ' CE1' ' A' ' 70' ' ' PHE . 9.9 ttp180 -72.89 104.33 4.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.79 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 64.2 tttm -82.05 63.11 6.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 0.0 112.435 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.583 ' SG ' ' HG2' ' A' ' 84' ' ' ARG . 1.1 m -101.59 138.99 37.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -172.12 61.26 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 122.702 1.239 . . . . 0.0 108.744 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -97.44 -4.86 37.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.181 -1.827 . . . . 0.0 110.113 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -144.35 -49.78 0.28 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.586 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -82.3 178.86 8.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.758 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -179.65 102.67 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.161 0.505 . . . . 0.0 110.576 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.26 105.87 7.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.452 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.02 105.78 4.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -150.84 104.06 3.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.419 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.15 -61.08 4.41 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.529 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.79 ' CE1' ' HA ' ' A' ' 85' ' ' LYS . 27.1 p90 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.154 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.8 m -77.4 132.4 38.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.549 ' H ' HD13 ' A' ' 2' ' ' ILE . 50.8 mt -143.5 82.55 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.549 HD13 ' H ' ' A' ' 1' ' ' LEU . 3.7 mp -150.66 -31.51 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.808 0.337 . . . . 0.0 111.757 -170.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.774 HD23 HG11 ' A' ' 76' ' ' VAL . 1.5 tt -154.78 33.61 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -165.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -48.48 -46.78 38.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.263 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.76 41.81 1.28 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -120.68 -146.32 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.708 -0.246 . . . . 0.0 110.72 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 mt -157.5 -49.63 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.747 0.655 . . . . 0.0 109.974 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.545 HD11 HD11 ' A' ' 3' ' ' LEU . 74.6 mt 68.47 156.11 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.003 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.19 9.35 5.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.734 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.35 139.25 51.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.111 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -151.25 85.16 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.751 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.2 tp 59.25 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.57 0.748 . . . . 0.0 112.764 165.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 27.2 ttpt -78.65 82.81 4.86 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 91.2 mt 74.55 162.45 0.15 Allowed Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 124.012 0.82 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 12.0 Cg_endo -56.35 134.17 62.6 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.715 2.277 . . . . 0.0 112.442 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' A' ' 48' ' ' LYS . 7.7 p 44.16 101.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 122.989 1.376 . . . . 0.0 113.961 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 51.7 mt -73.21 154.05 7.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.993 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -62.91 155.95 25.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -173.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 8.7 p30 -60.35 -34.06 73.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.693 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mt -57.06 -46.14 82.69 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.249 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.47 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 43.7 t80 -60.1 -41.83 93.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 0.0 110.297 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.487 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -74.27 -26.79 67.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.805 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HB2' HD11 ' A' ' 46' ' ' ILE . 33.4 ttpt -80.89 -29.1 35.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.919 0.39 . . . . 0.0 110.177 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.59 -29.93 68.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.523 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.513 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 66.3 mt -65.31 -70.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.75 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 mt -47.71 -28.77 2.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.626 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.65 -45.82 92.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.999 0.428 . . . . 0.0 110.103 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HD3' ' HB2' ' A' ' 1' ' ' LEU . 92.7 mttt -65.96 -35.49 80.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.623 0.725 . . . . 0.0 109.535 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 10.5 m-85 -79.28 -8.0 58.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.911 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.451 ' HG2' ' HD2' ' A' ' 34' ' ' LYS . 17.3 tt0 -74.44 12.59 0.74 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.456 0.646 . . . . 0.0 110.657 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 29' ' ' PHE . 16.7 t70 -106.48 -30.57 8.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.375 169.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.46 ' OD1' ' HE3' ' A' ' 81' ' ' MET . 15.2 t70 -88.87 -57.23 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 ' HB ' ' A' ' 39' ' ' VAL . 67.6 mt -61.23 -27.62 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.72 0.771 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HD2' ' HG2' ' A' ' 30' ' ' GLN . 44.9 tttp -80.66 -33.38 35.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.886 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -75.22 -47.83 26.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 49.2 mttm -69.29 -38.22 78.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.84 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.549 ' HB2' HG21 ' A' ' 39' ' ' VAL . 55.3 m-85 -126.86 -23.09 3.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 87.21 39.41 7.38 Favored Glycine 0 C--N 1.322 -0.216 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.94 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.56 ' HB ' HG21 ' A' ' 33' ' ' ILE . 27.2 t -100.56 152.75 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 16.4 t70 -115.39 122.72 46.7 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.75 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 75.0 p -88.25 -17.56 30.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.919 0.39 . . . . 0.0 111.513 -172.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.692 ' HB2' ' HZ3' ' A' ' 42' ' ' LYS . 4.9 ttmp? -70.46 -33.16 70.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.466 0.651 . . . . 0.0 109.266 175.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.35 -23.4 46.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.016 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 49.1 mt -61.29 139.97 58.06 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.398 0.618 . . . . 0.0 111.594 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 81.0 tttt -101.32 96.51 7.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.511 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 23' ' ' LYS . 46.9 mt -78.26 127.5 38.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.431 0.634 . . . . 0.0 111.112 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 10.9 mt -98.19 -51.44 4.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.133 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HG3' HG22 ' A' ' 16' ' ' VAL . 36.1 ttmt -139.85 117.76 11.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.542 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.411 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 31.6 m -99.32 136.03 39.87 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -153.28 179.03 9.12 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 122.113 -0.367 . . . . 0.0 110.397 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 15.4 pt-20 -154.58 166.73 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.52 78.53 1.27 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.063 0.459 . . . . 0.0 109.907 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 56.33 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.199 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.617 ' HG3' HG13 ' A' ' 76' ' ' VAL . 19.4 ttm180 -85.33 12.41 8.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.516 0.674 . . . . 0.0 110.721 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 97.5 m-85 -136.23 157.73 46.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.752 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 13.9 m-85 -129.55 146.57 51.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.333 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 71' ' ' LYS . 97.8 m-85 -135.69 103.05 5.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 t -109.19 95.17 3.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.652 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.6 t -80.34 129.69 34.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 46' ' ' ILE . 18.5 m -137.99 155.44 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.156 0.503 . . . . 0.0 111.757 -173.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.6 t70 -90.22 126.68 35.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.91 13.24 11.28 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.029 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.11 -40.52 2.66 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.922 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.08 -19.13 65.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.88 -8.96 39.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 46.4 mt-10 -76.78 165.34 24.85 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.351 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.603 ' H ' ' HB2' ' A' ' 88' ' ' LYS . 40.2 ttmt -127.85 109.91 12.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.442 0.639 . . . . 0.0 110.279 -172.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 1.9 t -104.62 174.32 5.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.34 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 35.9 ttmt -149.08 104.68 3.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' CE1' HD12 ' A' ' 33' ' ' ILE . 73.5 m-85 -71.23 97.22 1.51 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.694 0.759 . . . . 0.0 109.621 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.774 ' HE2' ' HA3' ' A' ' 95' ' ' GLY . 46.2 tttp -82.88 85.91 7.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.149 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.752 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 61.6 mt -82.39 137.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.255 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.682 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 18.4 ttt180 -93.16 39.01 1.04 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.62 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 49.5 mttt 57.67 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.253 -170.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.681 ' HB3' ' N ' ' A' ' 3' ' ' LEU . 24.4 t0 178.68 26.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.774 HG11 HD23 ' A' ' 3' ' ' LEU . 9.5 m -61.82 95.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.073 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 22.9 t70 77.13 -38.95 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.844 172.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.513 HG23 ' HG2' ' A' ' 80' ' ' LYS . 9.6 p -110.7 134.28 20.96 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.521 0.677 . . . . 0.0 110.312 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HD2' HG21 ' A' ' 78' ' ' VAL . 85.4 Cg_endo -79.79 30.83 0.48 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 123.897 3.064 . . . . 0.0 114.757 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.513 ' HG2' HG23 ' A' ' 78' ' ' VAL . 57.4 pttt -145.78 153.61 41.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.629 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -70.31 148.66 48.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.52 -173.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 13.7 p -73.07 -43.3 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.666 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 96' ' ' TYR . . . -130.39 151.83 19.6 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 43.13 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.709 0.766 . . . . 0.0 108.939 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.617 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 34.8 mttp -96.2 134.81 38.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.115 -171.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -101.39 125.41 48.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -121.66 28.55 7.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 122.037 0.923 . . . . 0.0 109.645 -164.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.603 ' HB2' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -63.46 -47.13 83.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.662 -179.044 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.22 -48.57 3.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.476 -175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.33 -174.93 4.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 -172.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -127.88 112.83 15.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.407 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -110.31 177.46 4.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.893 0.378 . . . . 0.0 111.251 -174.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.74 175.09 8.9 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.87 -33.8 75.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.774 ' HA3' ' HE2' ' A' ' 71' ' ' LYS . . . -88.87 122.68 6.49 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.818 173.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.693 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 12.9 m-30 . . . . . 0 C--O 1.244 0.798 0 CA-C-O 118.503 -0.761 . . . . 0.0 110.076 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.468 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 41.3 t -99.05 163.81 12.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.78 40.68 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.553 0.692 . . . . 0.0 110.136 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.61 HD11 ' HE2' ' A' ' 56' ' ' TYR . 18.6 tt -104.61 108.84 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.584 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.661 ' HB3' HD11 ' A' ' 7' ' ' LEU . 4.4 mm? -75.59 5.25 6.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.551 ' HB3' HG12 ' A' ' 2' ' ' ILE . 27.3 t70 -70.7 -5.44 29.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.717 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.413 ' C ' HG13 ' A' ' 76' ' ' VAL . . . -87.02 -87.35 1.08 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.147 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -48.59 -38.79 21.69 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 3' ' ' LEU . 66.2 mt -92.06 26.39 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.65 0.262 . . . . 0.0 111.334 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 7.2 tt -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.938 0.399 . . . . 0.0 110.681 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -120.13 -62.57 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -154.98 116.01 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.918 173.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 17.6 ptmt -129.22 -51.68 1.2 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 71.3 mt -153.22 155.36 36.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -170.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 43.87 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.4 mt -108.03 170.22 5.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.14 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.85 -150.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.86 3.04 . . . . 0.0 113.072 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG22 ' HG3' ' A' ' 48' ' ' LYS . 14.5 p -53.06 125.17 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.19 0.995 . . . . 0.0 111.266 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 mt -96.72 173.04 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.395 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -50.46 122.06 6.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.681 0.277 . . . . 0.0 111.148 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 25.0 p30 -72.54 -17.21 61.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 110.363 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.23 -39.38 68.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 170.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 63.1 t80 -61.61 -40.38 94.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.629 ' O ' HD11 ' A' ' 26' ' ' LEU . . . -66.92 -44.27 89.33 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.447 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -55.68 -43.26 76.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.653 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.9 mm-40 -57.16 -49.16 76.81 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.583 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 46.1 mt -51.49 -59.54 4.14 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.528 0.68 . . . . 0.0 110.34 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.725 HD12 HG22 ' A' ' 58' ' ' VAL . 6.9 mp -60.82 -38.8 86.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.579 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.18 -31.86 73.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.7 mttm -74.99 -50.01 18.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.201 0.524 . . . . 0.0 110.678 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CE2' ' HA ' ' A' ' 0' ' ' SER . 7.2 m-85 -92.17 12.14 23.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.797 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -25.89 63.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.278 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.06 -39.97 90.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -36.97 62.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.336 0.589 . . . . 0.0 109.471 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.507 HG12 ' HE1' ' A' ' 81' ' ' MET . 72.8 mt -62.24 -38.84 82.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.555 177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.596 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 35.3 tttm -83.29 -31.69 26.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.359 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.83 -47.8 79.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.82 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -79.42 -52.58 7.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.224 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.571 ' CZ ' ' HD2' ' A' ' 84' ' ' ARG . 6.6 m-85 -108.11 -23.97 11.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -169.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.49 57.59 3.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.952 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.596 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 3.7 t -117.03 145.13 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 121.023 0.439 . . . . 0.0 110.908 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 42' ' ' LYS . 19.8 t70 -80.65 -11.32 59.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.111 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.536 ' H ' HG11 ' A' ' 39' ' ' VAL . 33.1 p 58.73 -37.48 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.014 1.726 . . . . 0.0 114.348 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 40' ' ' ASP . 67.8 mttm -71.18 -18.19 62.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.352 0.596 . . . . 0.0 109.451 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -74.37 -37.25 63.51 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.899 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.37 106.22 0.43 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.224 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 55.1 tttp -69.97 102.27 1.97 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.147 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.634 HD12 HD21 ' A' ' 26' ' ' LEU . 34.6 mt -74.33 111.99 10.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.793 0.806 . . . . 0.0 110.675 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.3 -46.45 16.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.062 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' HG3' HG22 ' A' ' 16' ' ' VAL . 25.8 ttpp -151.5 105.47 3.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.687 -173.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 87.8 m -79.23 125.6 29.68 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -151.8 168.99 23.34 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.24 157.02 35.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 29.4 t70 -100.74 -83.67 0.44 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 52' ' ' ASP . 38.5 mmtm -135.88 -74.85 0.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.689 ' HB3' HG12 ' A' ' 76' ' ' VAL . 98.7 mtt180 -87.93 15.22 7.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.969 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -147.32 137.34 23.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.68 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.5 m-85 -98.84 143.84 28.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 167.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.455 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 74.4 m-85 -132.26 100.8 5.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 110.217 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.725 HG22 HD12 ' A' ' 26' ' ' LEU . 26.0 t -99.07 93.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.139 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.438 ' HB2' ' N ' ' A' ' 48' ' ' LYS . 67.8 m -58.51 126.35 27.22 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.303 174.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.563 HG11 HG12 ' A' ' 46' ' ' ILE . 35.7 m -146.71 149.96 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 111.757 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.0 t70 -91.22 122.99 34.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 169.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.98 1.11 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 -13.69 64.97 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.288 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -131.92 41.16 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -27.49 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.976 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.624 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 39.6 mt-10 -65.21 128.88 37.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.017 0.436 . . . . 0.0 111.128 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 97.8 mttt -111.59 114.81 28.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.506 0.67 . . . . 0.0 109.924 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 18.6 t -113.92 178.42 4.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.864 -174.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.993 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 34.8 ttmt -155.54 82.04 1.04 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -50.31 111.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 112.203 -170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.586 ' CD ' ' HB3' ' A' ' 96' ' ' TYR . 63.3 tttp -80.76 72.89 7.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.048 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.682 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 60.3 mt -75.89 86.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.221 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 33.2 ttp180 -61.97 113.42 2.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.557 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 81.8 mttt -61.37 174.02 0.79 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.173 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 1.1 m-20 -71.67 64.65 0.46 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.662 0.744 . . . . 0.0 110.192 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.689 HG12 ' HB3' ' A' ' 54' ' ' ARG . 34.7 m -96.77 -1.76 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.198 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -176.87 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.007 -171.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.55 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 7.6 p -117.77 144.7 34.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.865 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 78' ' ' VAL . 39.1 Cg_endo -82.47 53.0 4.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.28 2.653 . . . . 0.0 111.301 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -154.07 135.01 13.8 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.287 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.682 ' HG2' ' HA ' ' A' ' 72' ' ' ILE . 12.7 tmm? -57.56 103.84 0.15 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 11.6 p -60.75 -37.88 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -170.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' ' 81' ' ' MET . . . -175.03 -156.84 15.01 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.641 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.659 ' N ' ' HD3' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -151.37 119.67 6.37 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -168.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.993 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 2.4 tttm -86.94 56.92 4.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.911 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -87.75 126.3 34.92 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -147.71 -23.78 0.37 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.624 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 22.0 ttpp 66.22 13.73 9.3 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.731 165.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -151.22 -69.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.496 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.1 133.43 23.19 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -140.42 80.81 1.78 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.711 0.767 . . . . 0.0 111.261 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.85 -23.38 16.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.286 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.27 97.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.313 176.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.89 -47.78 65.0 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.342 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.48 104.16 0.66 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.791 ' CE1' ' HA ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.38 -173.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.81 ' HA2' ' HA ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.985 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 m -61.27 -58.66 7.36 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.927 HD22 ' HD3' ' A' ' 28' ' ' LYS . 11.0 tp -174.96 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.611 0.57 . . . . 0.0 112.266 160.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.488 HG23 ' CG ' ' A' ' 75' ' ' ASP . 2.5 tp -66.02 -25.93 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.828 -171.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.789 HD22 ' H ' ' A' ' 8' ' ' LEU . 7.5 tp -140.53 54.59 1.61 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.288 -171.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.81 ' HA ' ' HA2' ' A' ' -1' ' ' GLY . 11.8 t0 -54.58 96.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.618 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.09 40.87 52.23 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.821 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.742 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 30.7 t70 -107.82 -60.5 1.7 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.712 0.291 . . . . 0.0 110.496 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 25.7 tp 71.76 99.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.068 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 3' ' ' LEU . 6.7 tt -88.92 117.5 27.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.825 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -112.37 -5.68 14.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.578 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.31 -41.73 89.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 47.2 mmtm -97.65 152.11 19.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.357 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.735 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 5.2 mp -117.73 -72.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.44 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.78 103.83 4.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.357 . . . . 0.0 110.053 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 pp -111.76 163.54 17.32 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.835 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.51 -177.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.946 3.097 . . . . 0.0 113.647 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 48' ' ' LYS . 8.1 p -68.91 121.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.567 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 47.9 mt -77.77 152.66 5.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.587 174.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.81 144.84 42.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 6.5 p30 -56.92 -30.36 63.9 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.766 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.1 tp -60.6 -45.71 92.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.579 0.228 . . . . 0.0 110.946 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 61.5 t80 -62.37 -48.95 77.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.67 ' O ' HD11 ' A' ' 26' ' ' LEU . . . -63.77 -43.87 97.08 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.431 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HB2' HG13 ' A' ' 46' ' ' ILE . 3.8 tptm -58.17 -34.94 70.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.233 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.652 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -55.3 -56.44 20.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.041 175.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.6 mp -51.82 -55.61 18.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.656 0.741 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.68 HD12 HG22 ' A' ' 58' ' ' VAL . 6.7 mp -59.8 -44.91 93.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.011 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' HA ' ' OG1' ' A' ' 41' ' ' THR . 21.3 t70 -63.2 -31.73 72.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.058 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.927 ' HD3' HD22 ' A' ' 1' ' ' LEU . 58.3 mttm -69.37 -33.54 73.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.937 0.398 . . . . 0.0 110.738 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' O ' HG13 ' A' ' 33' ' ' ILE . 15.4 m-85 -99.09 7.95 45.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -50.31 -44.14 54.05 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.284 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.12 -38.38 73.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.554 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.461 ' CG ' ' HZ1' ' A' ' 36' ' ' LYS . 13.4 t70 -75.97 -41.57 50.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.514 HG21 ' HB ' ' A' ' 39' ' ' VAL . 32.4 mt -63.61 -34.08 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.235 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 33.1 ttpt -83.69 -27.74 28.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.099 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.41 -47.04 58.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.496 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HZ1' ' CG ' ' A' ' 32' ' ' ASP . 55.7 mttp -78.02 -62.13 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.068 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' A' ' 39' ' ' VAL . 25.1 m-85 -97.68 -19.2 18.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.116 -167.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.18 46.04 10.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.931 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.591 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 40.3 t -107.48 145.57 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.032 0.444 . . . . 0.0 111.439 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.589 ' OD1' ' HB2' ' A' ' 42' ' ' LYS . 25.7 t70 -109.24 105.17 14.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.515 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 29.1 p -65.07 -16.75 63.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.589 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 3.3 mtpm? -67.23 -28.93 68.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.31 -18.97 28.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.91 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 67.8 mt -65.66 132.43 48.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.327 0.584 . . . . 0.0 111.559 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.598 ' HD2' HD22 ' A' ' 47' ' ' LEU . 2.5 tmtp? -94.48 109.38 21.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.124 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.599 ' HA ' HG11 ' A' ' 60' ' ' VAL . 6.1 mm -73.53 108.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.95 0.405 . . . . 0.0 109.925 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.598 HD22 ' HD2' ' A' ' 45' ' ' LYS . 17.6 mt -80.11 -54.75 5.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.555 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HG3' HG22 ' A' ' 16' ' ' VAL . 87.6 tttt -142.1 119.92 11.93 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.742 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.567 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 35.3 m -98.54 141.53 31.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 169.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -169.51 -174.68 1.97 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' OE1' ' HB2' ' A' ' 11' ' ' LYS . 8.9 pt-20 -147.68 162.46 39.11 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.735 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 5.8 t70 -135.01 -173.29 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.689 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 14.0 mmmm -63.96 111.02 2.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 72.34 -0.97 3.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.169 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.97 152.8 40.53 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.787 0.803 . . . . 0.0 112.989 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.591 ' HD2' ' HA ' ' A' ' 74' ' ' LYS . 6.2 m-85 -114.06 145.08 42.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.368 164.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.549 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 62.8 m-85 -134.23 112.15 10.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.82 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.68 HG22 HD12 ' A' ' 26' ' ' LEU . 5.1 t -111.89 93.47 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.811 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.584 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.9 m -76.58 121.83 23.74 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 46' ' ' ILE . 15.8 m -134.44 159.32 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 111.581 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.03 115.67 22.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.426 ' HB1' ' SG ' ' A' ' 68' ' ' CYS . . . -86.0 -18.44 32.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 64' ' ' ASP . . . 108.87 165.51 20.66 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -171.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 9.6 t70 73.11 -52.61 0.71 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.927 0.491 . . . . 0.0 110.457 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.84 -17.18 0.22 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 42.9 mt-10 -78.2 150.85 33.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.915 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.688 ' H ' ' HB2' ' A' ' 88' ' ' LYS . 98.0 mttt -117.56 117.85 30.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.989 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 33.6 m -113.81 133.92 55.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.475 -171.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.0 ttpt -102.96 108.51 19.71 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 43.0 m-85 -68.15 103.55 1.58 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.494 0.664 . . . . 0.0 110.389 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 1.005 ' HD2' ' HB2' ' A' ' 96' ' ' TYR . 12.8 tttt -88.34 109.45 19.99 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.189 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.47 HG12 ' HG2' ' A' ' 81' ' ' MET . 48.2 mt -123.56 124.79 70.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.478 ' HD2' HG22 ' A' ' 82' ' ' VAL . 16.2 ttt180 -81.01 53.25 1.94 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.459 0.647 . . . . 0.0 110.612 -169.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.591 ' HA ' ' HD2' ' A' ' 56' ' ' TYR . 19.6 mttt 50.75 43.35 28.09 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.017 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.739 ' HA ' ' CB ' ' A' ' 0' ' ' SER . 1.9 m-20 55.46 28.62 11.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.761 0.663 . . . . 0.0 112.558 166.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 73' ' ' ARG . 21.3 m -77.36 122.09 31.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.282 0.563 . . . . 0.0 111.839 -176.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 t70 64.29 -77.31 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG21 ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -82.82 139.72 43.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.985 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 90.8 Cg_endo -80.49 89.19 1.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.179 2.586 . . . . 0.0 112.878 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -176.2 -173.92 0.59 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.586 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.47 ' HG2' HG12 ' A' ' 72' ' ' ILE . 26.6 mtm -100.95 148.96 24.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.531 HG11 ' HE2' ' A' ' 71' ' ' LYS . 7.7 p -89.48 4.41 5.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . 152.3 113.1 0.54 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.727 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -95.43 100.78 12.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 16.2 tptp -125.14 134.52 52.4 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.808 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 7.6 m -93.74 123.49 37.11 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.557 ' HA ' ' HB2' ' A' ' 91' ' ' ASP . 67.0 ttt180 -113.04 37.83 3.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.902 . . . . 0.0 108.795 -176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.688 ' HB2' ' H ' ' A' ' 67' ' ' LYS . 1.4 tmtp? -59.95 115.52 3.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.284 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 75.74 -76.4 0.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.324 1.015 . . . . 0.0 109.394 -166.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -162.33 154.16 18.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.588 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 12.1 t70 -152.24 -80.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -132.65 134.78 45.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 87' ' ' ARG . 26.8 t70 -89.3 -58.56 2.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -171.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -53.85 -51.74 62.63 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.009 0.433 . . . . 0.0 111.837 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.98 -145.53 4.3 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 1.005 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . 14.9 m-85 . . . . . 0 C--O 1.244 0.771 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.917 172.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.739 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.8 p -153.57 32.25 0.46 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.856 0.328 . . . . 0.0 111.281 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.759 ' H ' HD23 ' A' ' 1' ' ' LEU . 0.3 OUTLIER -49.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.72 0.637 . . . . 0.0 111.667 -174.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.518 HG22 ' HE2' ' A' ' 56' ' ' TYR . 28.3 mm -144.35 -55.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 123.081 0.238 . . . . 0.0 111.525 -174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.905 HD22 ' HA ' ' A' ' 6' ' ' ASP . 1.1 mp -113.6 -3.14 13.65 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.61 45.69 21.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.87 36.76 12.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.647 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.905 ' HA ' HD22 ' A' ' 3' ' ' LEU . 30.3 t70 58.08 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 2.2 pp -148.58 19.69 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.598 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.55 ' HB2' HD13 ' A' ' 3' ' ' LEU . 30.4 tp -78.87 99.7 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.795 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -124.04 6.32 8.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.532 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.71 -77.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HG3' HD22 ' A' ' 8' ' ' LEU . 48.2 pttt -90.2 178.02 6.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.0 tp -171.24 -47.43 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.993 0.425 . . . . 0.0 110.31 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 51' ' ' GLU . 21.5 mtmt -123.83 93.73 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.291 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.96 157.4 33.73 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.803 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.39 -164.43 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.003 2.469 . . . . 0.0 112.105 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 48' ' ' LYS . 4.8 p -69.3 110.82 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 122.076 0.941 . . . . 0.0 111.601 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.865 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -98.35 170.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.487 173.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 172.65 -8.24 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 21' ' ' PHE . 4.1 m-80 -64.61 63.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.377 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mt 68.74 -27.62 0.15 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.942 0.897 . . . . 0.0 112.454 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 19' ' ' ASN . 7.9 t80 -54.04 -45.0 71.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -172.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -73.94 -38.56 48.48 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.692 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -70.89 -33.3 70.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 7.7 mm-40 -56.98 -50.6 72.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.544 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.475 HD11 ' HA3' ' A' ' 22' ' ' GLY . 60.4 mt -49.72 -67.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.529 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.841 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 39.1 mt -53.3 -34.09 55.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.62 -49.09 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.344 -0.223 . . . . 0.0 111.386 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 36.4 mttm -65.78 -45.07 83.82 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 109.913 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.427 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 3.9 m-85 -93.33 16.14 14.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.78 -171.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.427 ' HB2' ' HG1' ' A' ' 41' ' ' THR . 8.1 tt0 -61.0 -42.24 98.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -58.85 -38.53 78.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.56 -51.28 36.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 109.932 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.92 HG12 ' HE1' ' A' ' 81' ' ' MET . 47.1 mt -66.6 -29.49 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.017 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 38.3 tttp -84.96 -29.34 25.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 110.326 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.28 -47.02 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.393 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.439 ' HE2' ' HG2' ' A' ' 80' ' ' LYS . 27.8 mttm -65.46 -64.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.995 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.507 ' HB2' HG21 ' A' ' 39' ' ' VAL . 30.1 m-85 -107.02 -36.81 6.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.3 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.35 57.89 1.17 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.582 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.564 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 34.7 t -111.67 151.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.962 0.41 . . . . 0.0 111.236 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.69 102.65 12.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.841 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 56.6 p -77.12 -14.09 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.298 0.571 . . . . 0.0 111.513 -173.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -83.97 -8.15 59.23 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.756 0.789 . . . . 0.0 110.134 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.82 -10.35 23.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 57.1 mt -82.66 129.61 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.02 -175.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.55 ' HD3' HD22 ' A' ' 47' ' ' LEU . 11.8 tmtt? -96.89 119.2 34.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.522 ' HA ' HG11 ' A' ' 60' ' ' VAL . 39.3 mt -84.5 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.772 0.796 . . . . 0.0 111.4 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.55 HD22 ' HD3' ' A' ' 45' ' ' LYS . 5.9 mt -97.47 -56.06 2.64 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.656 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HA ' HG22 ' A' ' 16' ' ' VAL . 77.0 tttt -143.17 111.74 6.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.134 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.865 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.9 m -101.26 140.17 35.92 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -156.5 173.66 16.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.607 ' HB2' ' HE2' ' A' ' 74' ' ' LYS . 7.5 pt-20 -141.3 143.67 34.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.36 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 53' ' ' LYS . 11.2 t70 -131.03 -146.8 0.31 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.98 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 35.1 mmtp -65.79 95.47 0.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.659 0.266 . . . . 0.0 110.881 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 67.3 -6.43 0.62 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -116.82 134.5 54.7 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.644 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.671 ' CD2' ' HG2' ' A' ' 74' ' ' LYS . 10.5 m-85 -92.23 147.61 22.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.619 169.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 72.5 m-85 -130.4 97.94 4.55 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.35 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.617 HG21 HG22 ' A' ' 49' ' ' THR . 7.3 t -102.09 93.11 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.143 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.9 t -79.09 117.5 20.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 46' ' ' ILE . 17.3 m -130.02 157.44 42.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.35 126.2 33.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 7.07 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.68 -36.57 4.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.086 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -93.49 -29.99 15.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.239 0.542 . . . . 0.0 111.123 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.501 ' O ' ' HE3' ' A' ' 88' ' ' LYS . . . 140.81 -18.45 2.77 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.426 -175.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.505 ' CG ' ' HD2' ' A' ' 88' ' ' LYS . 1.6 tt0 -67.36 134.77 52.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.32 98.89 7.2 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.893 0.854 . . . . 0.0 110.061 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 1.02 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 10.1 t -93.57 133.88 36.43 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.303 -172.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.1 ttmt -107.43 103.85 13.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.766 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 44.8 m-85 -69.01 115.53 8.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.002 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.624 ' HD2' ' CD2' ' A' ' 96' ' ' TYR . 86.6 tttt -94.17 98.4 10.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.118 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 95.5 mt -100.43 111.63 30.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.848 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.531 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 10.8 ttt180 -69.88 104.09 2.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.727 ' HB3' HD12 ' A' ' 3' ' ' LEU . 78.1 mttt -47.7 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.241 0.963 . . . . 0.0 111.451 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.831 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 14.0 t70 1.84 77.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 125.194 1.559 . . . . 0.0 112.578 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . 15.7 m -84.03 -11.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.716 -170.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.3 t70 170.63 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.749 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -89.26 148.87 41.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.184 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.633 ' HB2' ' HA3' ' A' ' -1' ' ' GLY . 75.4 Cg_endo -83.14 105.75 1.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.628 2.219 . . . . 0.0 112.406 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 79' ' ' PRO . 3.1 mtmm 178.43 157.81 0.47 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.275 0.559 . . . . 0.0 111.309 175.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.92 ' HE1' HG12 ' A' ' 33' ' ' ILE . 2.3 tmm? -89.32 128.03 35.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 5.6 p -66.16 -38.89 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.578 ' HA2' ' OXT' ' A' ' 96' ' ' TYR . . . -178.12 -164.02 30.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.99 -1.576 . . . . 0.0 114.721 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.705 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 11.3 ptt180 -176.05 88.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.552 1.168 . . . . 0.0 107.967 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.612 ' H ' ' HD1' ' A' ' 96' ' ' TYR . 48.4 tttm -78.43 -18.36 55.05 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.921 -170.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 1.02 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.5 m 58.82 100.64 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.939 0.876 . . . . 0.0 109.887 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.733 ' HG3' ' HB2' ' A' ' 90' ' ' ASP . 22.6 ttt180 -106.52 67.51 0.72 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.947 -166.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.505 ' HD2' ' CG ' ' A' ' 66' ' ' GLU . 61.0 tttt -80.71 -39.11 27.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.778 -175.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -146.13 9.64 1.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.92 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.733 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 2.2 m-20 -66.86 161.45 23.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.77 -87.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.563 -171.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -124.74 115.14 20.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -128.47 120.91 27.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.068 0.461 . . . . 0.0 111.845 -167.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.76 -62.46 1.45 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.744 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.528 ' HA3' ' NZ ' ' A' ' 71' ' ' LYS . . . -89.55 128.56 9.25 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.855 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.624 ' CD2' ' HD2' ' A' ' 71' ' ' LYS . 5.1 m-85 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.004 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.541 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 13.1 t -83.18 133.54 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 37.0 mt -121.53 -6.91 9.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.247 0.546 . . . . 0.0 110.452 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.754 HG22 ' HE2' ' A' ' 56' ' ' TYR . 6.8 tp -89.21 135.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.511 -169.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 7' ' ' LEU . 9.8 mp 68.38 91.06 0.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.351 0.407 . . . . 0.0 110.434 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.37 83.22 0.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' ' 76' ' ' VAL . . . 51.5 52.09 34.69 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.55 ' H ' ' HA ' ' A' ' 76' ' ' VAL . 7.4 t70 -137.45 -164.0 1.52 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.235 -0.483 . . . . 0.0 110.874 -161.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.589 ' HA ' HD21 ' A' ' 3' ' ' LEU . 2.7 pp -161.61 133.43 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.321 0.581 . . . . 0.0 111.94 -173.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 92.1 mt -123.8 -69.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.134 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 70.92 -67.02 0.27 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.638 0.586 . . . . 0.0 111.527 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -97.99 37.64 1.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.966 0.889 . . . . 0.0 109.505 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.718 ' HB3' ' HB3' ' A' ' 8' ' ' LEU . 20.8 pttt -75.53 -28.38 59.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.393 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.496 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 3.6 pp -101.33 170.36 8.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.086 -173.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -140.86 34.59 1.77 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.506 0.67 . . . . 0.0 109.868 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -129.56 147.85 66.95 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.338 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.79 -25.55 23.69 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.042 1.828 . . . . 0.0 111.531 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.417 HG21 ' HG3' ' A' ' 48' ' ' LYS . 15.3 t -145.61 139.91 21.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.743 175.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 49' ' ' THR . 4.2 mt -88.36 160.73 2.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.39 136.4 57.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -68.23 -13.68 62.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.168 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.6 tp -67.88 -41.95 82.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.964 0.411 . . . . 0.0 109.899 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 78.3 t80 -63.22 -36.97 85.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.78 -50.89 56.15 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.204 174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -52.28 -37.83 56.64 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 122.361 0.264 . . . . 0.0 111.12 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.7 mm-40 -59.51 -50.39 74.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.702 0.401 . . . . 0.0 111.679 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 51.7 mt -53.33 -58.85 5.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.717 0.77 . . . . 0.0 110.316 176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.655 HD13 HG22 ' A' ' 58' ' ' VAL . 8.5 mp -62.54 -35.67 80.17 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.057 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.73 -41.5 81.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 87.8 mttt -70.23 -29.37 66.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 84.3 m-85 -98.27 1.55 47.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -55.16 -43.37 74.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 120.98 0.419 . . . . 0.0 111.002 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.51 -34.13 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.125 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.92 -40.22 28.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.209 0.528 . . . . 0.0 110.166 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.525 HG21 ' HB ' ' A' ' 39' ' ' VAL . 70.1 mt -63.19 -36.88 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.208 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.581 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.9 tttm -80.34 -30.77 38.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.895 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.47 -44.11 89.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.093 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -94.4 -41.48 9.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' HB2' HG21 ' A' ' 39' ' ' VAL . 46.4 m-85 -114.27 -29.66 6.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.0 111.32 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.38 54.26 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.662 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.581 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 18.5 t -117.36 151.36 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 0.0 110.81 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.549 ' OD2' ' HG2' ' A' ' 42' ' ' LYS . 9.7 t70 -107.13 125.04 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 26' ' ' LEU . 13.9 p -76.01 -14.27 60.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.549 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 8.1 ptpp? -77.61 -17.09 58.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.88 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.99 -22.69 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.294 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.77 118.84 10.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.511 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 63.2 tttp -82.77 98.79 9.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.249 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.626 ' HA ' HG11 ' A' ' 60' ' ' VAL . 48.2 mt -73.11 119.73 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.543 0.687 . . . . 0.0 110.747 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.7 mt -90.18 -44.46 9.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.099 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HG3' HG21 ' A' ' 16' ' ' VAL . 58.2 tttm -149.49 106.02 3.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.192 -172.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' HG13 ' A' ' 17' ' ' ILE . 11.0 m -86.88 123.9 32.52 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.0 m -160.47 -178.41 6.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.3 pt-20 -138.88 152.96 48.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.657 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 30.0 t70 -148.18 125.75 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.436 ' HG3' ' OD1' ' A' ' 52' ' ' ASP . 38.7 mttp 60.17 -138.52 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.825 ' HB3' HG13 ' A' ' 76' ' ' VAL . 73.2 mtm180 -80.16 12.72 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.629 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.596 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 3.8 m-85 -137.15 152.86 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.15 -167.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.754 ' HE2' HG22 ' A' ' 2' ' ' ILE . 14.6 m-85 -91.55 150.71 21.07 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 169.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.657 ' CE2' ' HB3' ' A' ' 52' ' ' ASP . 65.0 m-85 -130.13 98.05 4.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.757 0.313 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.655 HG22 HD13 ' A' ' 26' ' ' LEU . 21.5 t -100.03 93.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 2.1 t -76.71 124.33 27.51 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.626 HG11 ' HA ' ' A' ' 46' ' ' ILE . 11.6 m -134.8 151.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.092 0.473 . . . . 0.0 111.211 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.1 t70 -87.49 117.15 26.09 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.63 -9.43 59.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.811 0.339 . . . . 0.0 111.702 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.74 -28.41 4.46 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.229 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -64.0 -28.03 69.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 0.0 110.065 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.74 -27.92 3.15 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.266 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.818 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 24.8 mt-10 -83.62 152.99 24.52 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.201 0.524 . . . . 0.0 111.443 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 53.7 mtpt -103.14 111.71 24.21 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 2.4 t -95.76 168.97 10.33 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.605 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 19.1 ttmm -148.04 94.49 2.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -72.56 89.73 1.31 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.899 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.991 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 74.2 tttt -78.6 93.01 4.77 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.742 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 80.4 mt -83.03 105.88 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.53 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.669 ' H ' ' HA ' ' A' ' 81' ' ' MET . 14.5 ttt180 -66.03 121.34 14.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.506 ' HE3' ' C ' ' A' ' 55' ' ' PHE . 71.4 mttt -65.73 168.37 7.87 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.301 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.0 7.84 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 0.0 110.542 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 54' ' ' ARG . 2.7 p -53.86 -33.15 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 122.441 1.115 . . . . 0.0 109.3 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.544 ' O ' HG13 ' A' ' 78' ' ' VAL . 27.6 t70 -164.84 118.42 1.29 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.872 -1.967 . . . . 0.0 108.387 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 77' ' ' ASP . 8.9 p 54.79 124.67 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.74 0 O-C-N 125.01 1.444 . . . . 0.0 112.683 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 84.7 Cg_endo -79.04 47.44 2.49 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 123.746 2.964 . . . . 0.0 112.555 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 7.3 mtmt -147.24 146.99 29.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.669 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 8.1 ptt? -57.23 108.47 0.53 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.11 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.652 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 9.1 p -59.91 -40.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.788 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.692 ' HA2' ' HB3' ' A' ' 96' ' ' TYR . . . -145.57 91.36 0.15 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.263 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 58.47 1.34 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.018 0.914 . . . . 0.0 108.635 170.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.799 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 40.1 mmtm -95.97 119.17 34.0 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.882 -167.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -83.87 124.04 30.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.333 0.587 . . . . 0.0 109.535 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.64 ' HB3' ' HA ' ' A' ' 91' ' ' ASP . 6.3 mtp180 -136.07 93.61 2.94 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.818 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 29.7 tttm -79.59 -64.26 1.23 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.34 -1.754 . . . . 0.0 112.372 -158.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.31 -31.32 58.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.748 0.309 . . . . 0.0 110.757 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -162.86 144.73 10.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.64 ' HA ' ' HB3' ' A' ' 87' ' ' ARG . 13.6 p-10 -101.29 -8.45 22.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.789 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.4 t70 67.82 -76.92 0.05 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.925 0.766 . . . . 0.0 112.981 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 94' ' ' ASP . 10.8 t70 -153.09 -156.39 0.69 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -172.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.475 ' H ' ' CG ' ' A' ' 93' ' ' ASP . 3.2 t70 -79.59 -159.86 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.41 84.35 0.21 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.474 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.991 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 6.8 m-85 . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.082 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 112.316 -0.314 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.408 ' OG ' ' HZ ' ' A' ' 29' ' ' PHE . 58.0 m -82.36 86.77 6.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 0.0 111.203 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.652 HD21 ' H ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -115.26 97.52 6.24 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.4 tp -163.47 -20.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.041 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.781 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 3.9 mp -116.98 1.03 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 t70 66.97 -62.43 0.3 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.655 0.597 . . . . 0.0 111.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.36 61.14 0.19 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.594 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 25.7 t0 76.75 23.07 1.07 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.649 0.738 . . . . 0.0 111.077 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 6.5 tt -98.08 122.95 41.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.603 HD21 HD22 ' A' ' 7' ' ' LEU . 2.2 pt? -41.04 -66.68 0.31 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -167.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.55 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 31.8 mmtp 65.06 -67.8 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.615 ' HB2' HD21 ' A' ' 12' ' ' LEU . 3.3 p30 -59.17 -54.0 51.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.8 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' HG2' HD13 ' A' ' 8' ' ' LEU . 42.4 mtpt 53.45 43.97 30.59 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.341 0.4 . . . . 0.0 111.043 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' A' ' 10' ' ' ASP . 4.3 mm? -63.52 -86.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.382 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.688 ' N ' ' HE2' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 54.41 61.43 3.02 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 109.991 177.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.595 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 82.8 mt -134.97 174.69 4.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.459 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.2 Cg_endo -63.5 -153.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.896 2.397 . . . . 0.0 111.066 165.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' A' ' 48' ' ' LYS . 23.8 t -58.75 106.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.757 0.789 . . . . 0.0 109.944 175.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.59 156.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.486 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -49.05 133.03 18.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.107 0.479 . . . . 0.0 111.213 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.9 OUTLIER -67.42 -25.52 65.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.729 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.38 -50.39 70.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -59.15 -38.58 80.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.722 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -64.54 -47.04 88.19 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 9.2 mmmm -54.77 -36.92 65.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.314 0.246 . . . . 0.0 111.027 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.575 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.3 mm-40 -60.04 -47.0 87.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.429 0.456 . . . . 0.0 111.492 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 72' ' ' ILE . 89.0 mt -52.46 -63.78 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.462 174.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.61 HD13 HG13 ' A' ' 58' ' ' VAL . 7.7 mp -59.67 -32.33 70.39 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.292 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.42 -40.29 86.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.216 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 50.6 mttm -75.5 -32.36 60.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.625 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 91.8 m-85 -96.44 8.47 43.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -54.04 -39.56 66.31 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.246 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.4 -39.78 94.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.664 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' HZ1' ' A' ' 36' ' ' LYS . 23.3 t70 -76.52 -38.53 54.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 -176.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.15 -26.4 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.288 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 82.0 tttt -83.55 -28.17 28.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.614 0.721 . . . . 0.0 109.84 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.94 -46.39 62.5 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.273 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.478 ' HZ1' ' CG ' ' A' ' 32' ' ' ASP . 52.3 mttp -77.73 -39.75 43.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.761 -177.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.571 ' HB2' HG21 ' A' ' 39' ' ' VAL . 90.0 m-85 -114.88 -48.01 2.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.449 0.642 . . . . 0.0 110.966 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.16 39.05 2.35 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.296 -171.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.64 HG13 ' HG ' ' A' ' 44' ' ' LEU . 13.5 t -109.3 150.82 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.831 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 42' ' ' LYS . 32.0 t70 -92.99 11.17 28.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 0.0 110.132 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.497 ' H ' HG11 ' A' ' 39' ' ' VAL . 46.6 p 56.16 -24.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.7 1.6 . . . . 0.0 114.129 -172.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.788 ' HB2' ' HZ3' ' A' ' 42' ' ' LYS . 4.4 ttmp? -72.83 -12.92 61.17 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 110.517 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.1 -42.5 17.33 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.759 0.79 . . . . 0.0 108.875 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.64 ' HG ' HG13 ' A' ' 39' ' ' VAL . 57.1 mt -61.67 106.11 0.63 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.376 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.612 ' HD3' HD22 ' A' ' 47' ' ' LEU . 6.1 tmtm? -79.91 116.61 20.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.406 ' HA ' HG11 ' A' ' 60' ' ' VAL . 41.3 mt -73.6 128.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.546 0.688 . . . . 0.0 110.956 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.612 HD22 ' HD3' ' A' ' 45' ' ' LYS . 15.3 mt -97.92 -51.5 4.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.889 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.557 ' HA ' HG11 ' A' ' 16' ' ' VAL . 62.4 tttm -144.73 102.86 3.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.461 -173.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.4 m -78.9 121.72 25.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -153.22 -177.78 6.54 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.818 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 1.7 pp20? -162.55 160.83 26.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.808 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.658 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 29.7 t70 -103.78 -86.14 0.45 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.735 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -131.33 -79.23 0.52 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' HB3' HG12 ' A' ' 76' ' ' VAL . 52.5 mtt180 -87.99 16.93 5.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 0.0 110.818 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -144.6 135.62 25.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.9 m-85 -94.88 151.45 19.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.658 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 78.1 m-85 -137.8 109.59 7.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.349 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.61 HG13 HD13 ' A' ' 26' ' ' LEU . 21.8 t -110.7 108.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.1 t -84.27 130.72 34.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 67' ' ' LYS . 26.9 m -135.4 148.29 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.136 0.494 . . . . 0.0 112.167 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.511 ' HB2' HD23 ' A' ' 47' ' ' LEU . 34.7 t70 -90.26 112.88 24.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.93 -63.88 1.13 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.798 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.67 -130.27 2.07 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.096 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.39 -8.14 21.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.098 0.475 . . . . 0.0 109.813 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.73 -33.95 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.603 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.625 ' OE2' ' HB2' ' A' ' 88' ' ' LYS . 5.3 tp10 -61.45 136.56 58.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.214 0.53 . . . . 0.0 111.132 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 42.5 mttp -137.17 106.3 6.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.96 -173.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.09 148.0 23.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.352 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.756 ' HZ1' ' HB2' ' A' ' 69' ' ' LYS . 5.0 ttmp? -115.03 102.78 10.26 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.688 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 62.1 m-85 -68.44 127.48 33.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.979 ' HD2' ' HA ' ' A' ' 96' ' ' TYR . 56.7 tttp -100.71 83.45 2.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.666 0.746 . . . . 0.0 109.938 -175.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 94.8 mt -81.25 89.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.952 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.65 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 39.7 ttt180 -58.9 117.72 4.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HB3' HD12 ' A' ' 3' ' ' LEU . 93.9 mttt -60.9 174.07 0.68 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.569 -176.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.781 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 53.1 t0 -71.89 64.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 0.0 110.513 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.594 ' HA ' ' N ' ' A' ' 6' ' ' ASP . 31.1 m -99.09 -7.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.438 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -175.16 -61.49 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.024 -171.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.1 151.02 37.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.577 . . . . 0.0 111.186 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -90.34 32.74 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.709 2.94 . . . . 0.0 110.977 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.625 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 3.0 ttmt -150.88 -166.18 2.47 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.178 0.513 . . . . 0.0 111.099 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.529 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 67.9 mtm -97.04 127.2 42.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.226 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.65 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 7.6 p -53.01 -33.13 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.455 0.645 . . . . 0.0 109.903 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.76 -143.42 8.41 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.919 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.688 ' HB2' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER 176.3 148.78 0.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -148.49 121.07 8.56 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.945 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.4 m -88.19 130.31 35.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -124.28 31.8 5.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.067 0.937 . . . . 0.0 109.893 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.625 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.69 -36.74 62.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.813 175.018 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.47 -65.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.96 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -159.68 -87.14 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.147 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -153.87 159.92 41.97 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -146.72 143.18 28.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.495 0.188 . . . . 0.0 111.287 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -136.95 116.79 13.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.195 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -171.32 -50.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.839 0.828 . . . . 0.0 109.451 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -164.17 -117.44 0.41 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.979 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 44.6 t80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 117.48 -1.247 . . . . 0.0 113.194 164.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.441 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 28.6 t -108.78 126.92 53.54 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.862 ' H ' ' HE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -125.76 108.59 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.742 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.8 HG23 ' HE1' ' A' ' 56' ' ' TYR . 3.3 tp -176.36 -6.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 8' ' ' LEU . 7.1 tp -144.27 -18.25 0.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.405 -171.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 65.41 9.53 5.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.887 0.475 . . . . 0.0 112.069 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.706 ' HA3' ' H ' ' A' ' 77' ' ' ASP . . . 71.49 18.11 76.79 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.647 -172.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -103.36 -35.25 8.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.549 ' HA ' ' HG ' ' A' ' 3' ' ' LEU . 6.8 mp 71.03 109.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.517 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 3' ' ' LEU . 58.0 tp -109.62 88.37 2.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HA ' HD22 ' A' ' 12' ' ' LEU . 9.5 ptpp? -93.35 14.3 18.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.559 -172.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.526 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 20.5 t70 -88.8 -29.71 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.219 0.533 . . . . 0.0 110.565 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HZ3' ' CD ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -83.6 -20.98 32.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.299 -175.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' ' 9' ' ' LYS . 2.3 pp -87.53 45.57 1.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.847 0.832 . . . . 0.0 111.692 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 10' ' ' ASP . 40.8 mtpt -115.06 21.87 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.965 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.41 154.77 46.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.418 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.55 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.255 2.637 . . . . 0.0 110.966 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 48' ' ' LYS . 3.4 p -54.71 108.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 122.335 1.064 . . . . 0.0 110.38 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.803 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 33.3 mt -75.82 149.57 6.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.3 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.22 139.64 47.17 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.097 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' O ' HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -60.29 -24.55 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.063 -176.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.43 -39.74 74.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' O ' HD11 ' A' ' 25' ' ' LEU . 77.5 t80 -62.02 -43.93 97.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.74 -29.67 73.98 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.431 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -70.05 -37.39 75.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 36.2 mm-40 -59.18 -47.75 84.17 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.693 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD11 ' O ' ' A' ' 21' ' ' PHE . 8.7 mp -50.42 -67.34 0.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.92 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 26.5 mt -50.38 -30.19 11.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.795 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.25 -45.72 46.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.372 -0.205 . . . . 0.0 110.72 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 63.6 mttm -65.88 -46.77 77.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.278 0.561 . . . . 0.0 110.41 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.862 ' HE2' ' H ' ' A' ' 1' ' ' LEU . 19.5 m-85 -91.33 13.21 18.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.787 -174.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.84 -51.43 67.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.7 m-20 -80.74 11.17 4.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.369 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.03 -43.98 5.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.581 HG22 ' HE2' ' A' ' 70' ' ' PHE . 38.8 mt -66.93 -38.2 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.685 174.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -83.05 -22.76 33.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.845 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 15.2 t70 -68.51 -55.3 12.21 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.272 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 81' ' ' MET . 58.2 mttm -69.51 -50.73 42.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.417 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.899 ' HH ' ' HA3' ' A' ' 83' ' ' GLY . 26.9 m-85 -116.71 -6.4 11.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.92 29.28 73.49 Favored Glycine 0 CA--C 1.516 0.136 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.494 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 33' ' ' ILE . 28.2 t -97.93 147.72 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.554 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.23 127.57 50.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.92 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 71.8 p -87.94 -20.11 26.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.816 0.341 . . . . 0.0 111.858 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -68.19 -39.74 82.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -61.05 -29.01 69.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.862 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 64.2 mt -69.52 149.95 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -175.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -115.01 121.15 42.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.432 172.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 26' ' ' LEU . 26.5 mt -84.65 132.25 32.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.512 0.673 . . . . 0.0 111.779 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.55 HD22 ' HB2' ' A' ' 61' ' ' ASP . 5.7 mt -101.76 -52.04 3.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.733 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HG3' HG22 ' A' ' 16' ' ' VAL . 38.4 ttmt -146.35 115.3 6.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.059 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.803 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -91.59 139.04 31.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -157.41 -175.41 5.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 13.1 pt-20 -163.74 150.8 12.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.298 0.57 . . . . 0.0 111.962 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.741 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 27.8 t70 -99.55 -158.84 0.7 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 4.0 mptt -73.11 -70.61 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -87.12 13.63 9.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 91.0 m-85 -145.67 152.21 39.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.8 ' HE1' HG23 ' A' ' 2' ' ' ILE . 30.9 m-85 -108.17 147.01 31.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.009 166.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.741 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 66.1 m-85 -130.37 95.7 3.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.818 0.342 . . . . 0.0 110.329 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 22.0 t -104.7 97.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.049 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.663 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.2 t -69.02 114.03 6.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.527 HG11 ' HA ' ' A' ' 46' ' ' ILE . 13.7 m -129.28 152.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.429 0.633 . . . . 0.0 111.265 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.55 ' HB2' HD22 ' A' ' 47' ' ' LEU . 12.3 t70 -84.41 115.53 22.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.28 -14.5 60.51 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.297 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.99 -42.76 2.35 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.602 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.18 -30.14 64.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.903 0.481 . . . . 0.0 111.293 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.55 -19.46 1.67 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.453 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.578 ' OE2' ' HB3' ' A' ' 86' ' ' CYS . 6.2 pt-20 -104.71 166.17 10.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.321 0.582 . . . . 0.0 112.345 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -111.92 117.66 33.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.153 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 62.1 m -111.84 114.99 28.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.036 0.446 . . . . 0.0 111.19 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.924 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.5 ttmt -88.82 85.28 6.73 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 170.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.581 ' HE2' HG22 ' A' ' 33' ' ' ILE . 5.9 m-85 -47.91 116.3 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.913 -172.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.744 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 62.4 tttt -95.67 69.79 2.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.242 -174.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.836 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 36.7 mt -74.52 91.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.454 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.809 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 24.4 ttt180 -50.58 117.43 2.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HE3' ' CE1' ' A' ' 56' ' ' TYR . 43.0 mttp -59.4 166.3 2.37 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.03 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 17.9 t0 -67.68 74.75 0.18 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.632 0.73 . . . . 0.0 109.68 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 74' ' ' LYS . 3.7 m -104.31 94.39 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.672 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.706 ' H ' ' HA3' ' A' ' 5' ' ' GLY . 34.5 t70 72.21 -61.14 0.5 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.293 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.67 141.56 22.76 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.322 0.582 . . . . 0.0 110.19 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -91.85 84.29 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.463 2.776 . . . . 0.0 113.62 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.462 ' HD2' ' HZ2' ' A' ' 36' ' ' LYS . 5.2 mtmt -165.51 153.55 11.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.547 176.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.836 ' HG3' ' HA ' ' A' ' 72' ' ' ILE . 4.5 ttp -82.24 121.39 26.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.811 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.809 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.3 p -60.88 -39.4 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.382 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.899 ' HA3' ' HH ' ' A' ' 37' ' ' TYR . . . 178.87 -153.02 11.82 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.895 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.744 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 41.3 mtm180 -151.43 125.75 9.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.924 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 24.5 tptp -76.28 55.57 0.98 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.339 0.59 . . . . 0.0 110.106 -178.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.578 ' HB3' ' OE2' ' A' ' 66' ' ' GLU . 39.3 m -72.47 -164.63 0.16 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.832 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.671 ' HD2' ' OH ' ' A' ' 96' ' ' TYR . 98.2 mtt180 65.08 97.49 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.715 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 2.2 ttpm? -58.35 -20.62 45.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -164.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -124.05 -170.66 2.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -70.54 91.03 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.271 0.557 . . . . 0.0 110.487 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 31.8 t70 -136.96 13.61 3.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.847 0.832 . . . . 0.0 109.061 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' HA ' HH11 ' A' ' 87' ' ' ARG . 8.8 p-10 -96.9 174.08 6.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.005 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -149.71 -150.05 0.33 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.466 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -54.26 -33.35 58.36 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.915 0.486 . . . . 0.0 110.906 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.83 132.48 17.51 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.874 ' CE2' ' HA ' ' A' ' 85' ' ' LYS . 9.6 p90 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 117.088 -1.435 . . . . 0.0 111.063 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.661 ' HA3' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.691 0 N-CA-C 112.294 -0.322 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 79' ' ' PRO . 11.4 p -108.77 -17.72 13.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.526 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.1 mp 52.09 -153.05 0.22 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.005 171.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.609 HD11 ' HE2' ' A' ' 56' ' ' TYR . 79.4 mt 79.57 -56.5 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.029 168.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' A' ' 7' ' ' LEU . 64.9 mt -105.46 -42.89 5.1 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.772 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 29.6 m-20 60.46 71.81 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.672 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.1 31.34 80.46 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.543 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.0 t70 -135.24 -153.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.772 ' HA ' HD12 ' A' ' 3' ' ' LEU . 86.0 mt -154.23 172.29 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 110.668 -171.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.601 HD23 ' HZ1' ' A' ' 74' ' ' LYS . 2.4 pt? -140.4 120.32 13.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -100.92 -18.08 16.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.778 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -94.17 -30.14 14.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HZ3' ' HB2' ' A' ' 11' ' ' LYS . 10.4 mtmp? 57.78 -168.78 0.12 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.807 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.403 HD12 ' CE2' ' A' ' 21' ' ' PHE . 84.1 mt -90.47 -74.71 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.677 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.552 ' HE3' HG21 ' A' ' 17' ' ' ILE . 31.1 pttt -175.93 -161.78 0.09 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -168.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.454 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 10.7 mp -66.76 169.33 8.11 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.367 0.667 . . . . 0.0 112.189 -175.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 98.5 Cg_exo -47.99 159.33 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.811 3.007 . . . . 0.0 113.891 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 49' ' ' THR . 11.0 p 40.96 104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 123.482 1.611 . . . . 0.0 113.432 -173.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.552 HG21 ' HE3' ' A' ' 13' ' ' LYS . 9.8 mt -87.66 -177.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.469 -175.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.507 ' H ' HG23 ' A' ' 17' ' ' ILE . 4.0 m-20 -59.99 -4.93 0.85 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.572 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 12.8 m120 72.9 -44.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.485 0.714 . . . . 0.0 110.981 -176.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -59.82 -31.57 69.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.779 0.432 . . . . 0.0 110.675 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.506 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 38.5 t80 -65.5 -35.63 81.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 109.754 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.11 -27.64 59.76 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -65.59 -37.66 87.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.6 -48.86 77.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.181 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 84.0 mt -49.76 -69.11 0.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.028 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.598 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 33.7 mt -52.78 -26.68 15.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.88 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.99 -48.75 67.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 110.958 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -69.3 -40.98 77.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.192 0.52 . . . . 0.0 110.365 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.36 3.83 52.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.818 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 31.3 tt0 -54.95 -40.56 70.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -65.86 -26.65 67.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.993 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 35' ' ' ASP . 7.9 t70 -85.57 -40.17 16.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.511 0.672 . . . . 0.0 109.681 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.412 HG23 ' HB ' ' A' ' 39' ' ' VAL . 35.5 mt -69.25 -34.03 61.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.412 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 86.4 tttt -75.83 -31.54 59.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 18.7 t70 -59.94 -35.59 75.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.643 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -105.87 -25.31 12.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -173.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.49 ' HB2' HG21 ' A' ' 39' ' ' VAL . 74.0 m-85 -128.14 -31.38 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.54 63.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.111 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 37' ' ' TYR . 46.5 t -120.7 151.51 23.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 -173.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 42' ' ' LYS . 23.1 t70 -108.65 110.14 21.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 17.3 p -72.32 -10.43 59.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.646 ' HZ2' ' HB3' ' A' ' 42' ' ' LYS . 6.3 ttpm? -78.04 -35.0 50.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.039 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.32 -28.62 59.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 109.589 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 41' ' ' THR . 1.4 mp -54.11 115.99 2.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.405 176.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 2.8 ttmp? -86.32 108.55 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.972 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.668 ' HA ' HG11 ' A' ' 60' ' ' VAL . 36.4 mt -80.27 122.6 35.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.445 0.641 . . . . 0.0 111.094 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.1 mt -96.03 -51.71 4.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.956 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -142.43 106.31 4.71 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.265 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 11.3 m -91.04 132.13 36.2 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.415 ' HA ' HG13 ' A' ' 17' ' ' ILE . 69.0 m -152.54 -175.11 5.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 11' ' ' LYS . 12.5 pt-20 -149.64 158.65 44.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.763 0.792 . . . . 0.0 111.519 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.653 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 28.1 t70 -111.56 -164.94 0.95 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 166.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.773 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 1.2 mptt -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.43 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 40.0 mtp180 -83.5 -0.1 48.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.584 -172.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 m-85 -148.15 159.71 43.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.237 0.541 . . . . 0.0 112.382 -168.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.703 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 36.0 m-85 -109.24 159.75 16.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 163.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.653 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 94.4 m-85 -137.07 93.78 2.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.936 0.398 . . . . 0.0 110.181 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 49' ' ' THR . 13.3 t -102.51 96.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.588 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 12.9 m -78.4 124.44 28.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 46' ' ' ILE . 17.4 m -141.6 160.57 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.543 -173.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 6.0 t70 -92.17 125.33 36.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.489 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -79.81 -13.96 59.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.45 -31.92 7.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.58 8.92 4.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.802 0.334 . . . . 0.0 111.23 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.21 -15.08 63.74 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.625 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 9.6 pt-20 -84.16 142.19 30.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.162 0.506 . . . . 0.0 110.749 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.885 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . 27.8 ttmt -97.62 134.9 40.2 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 86' ' ' CYS . 8.9 t -126.63 164.66 20.77 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.25 0.548 . . . . 0.0 110.623 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.662 ' H ' ' HA ' ' A' ' 86' ' ' CYS . 35.7 ttmt -147.43 103.87 3.59 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.402 ' CD2' HD23 ' A' ' 26' ' ' LEU . 72.0 m-85 -77.36 88.08 3.76 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.571 0.7 . . . . 0.0 110.529 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 1.034 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 31.1 tttp -71.63 78.02 0.82 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.924 170.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 78.9 mt -74.43 95.84 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.247 -176.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.622 ' HB2' HG11 ' A' ' 82' ' ' VAL . 40.5 ttp180 -61.76 101.64 0.21 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.601 ' HZ1' HD23 ' A' ' 8' ' ' LEU . 88.8 mttt -48.72 152.3 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.369 1.043 . . . . 0.0 109.687 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.772 ' HB3' ' H ' ' A' ' 4' ' ' ASP . 29.3 t0 -69.47 70.78 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.411 0.624 . . . . 0.0 109.56 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 33.7 m -89.2 -4.34 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.865 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 t70 178.57 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.732 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.534 HG21 ' HD2' ' A' ' 79' ' ' PRO . 7.1 p -137.29 138.34 24.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.326 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.661 ' O ' ' HA3' ' A' ' -1' ' ' GLY . 68.4 Cg_endo -83.06 62.88 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.493 2.796 . . . . 0.0 112.855 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -145.28 128.28 16.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 111.471 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.481 ' HG3' HG22 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.59 95.63 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.13 177.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.622 HG11 ' HB2' ' A' ' 73' ' ' ARG . 10.0 p -60.58 -41.54 88.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.704 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 1.034 ' HA2' ' HB3' ' A' ' 71' ' ' LYS . . . -89.5 47.76 3.29 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 -173.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -81.77 45.53 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.702 ' HB2' ' HB3' ' A' ' 96' ' ' TYR . 20.6 ttpt -105.01 -26.28 12.21 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.818 -165.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.662 ' HA ' ' H ' ' A' ' 69' ' ' LYS . 49.4 m 66.35 -178.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.906 -171.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.701 ' HG3' ' HB2' ' A' ' 90' ' ' ASP . 63.6 ttt180 -176.86 78.96 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.546 0.688 . . . . 0.0 109.285 -172.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.885 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 22.9 ttpp -81.75 -58.78 2.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.861 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.93 5.16 8.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.439 0.638 . . . . 0.0 109.916 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.701 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 3.2 m-20 -66.66 162.63 20.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.9 -177.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 92' ' ' ASP . 9.1 t70 -96.69 -160.21 0.78 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.455 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 24.0 t70 -69.13 109.99 4.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.161 0.505 . . . . 0.0 111.977 -174.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -112.77 137.82 50.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.533 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.75 -55.95 3.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.82 137.28 13.97 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.011 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.702 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 3.8 m-85 . . . . . 0 C--N 1.32 -0.703 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 43.1 t -88.69 151.36 22.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 2' ' ' ILE . 27.2 mt -118.59 -144.43 0.37 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.615 HG23 ' HE2' ' A' ' 56' ' ' TYR . 1.3 tp 81.2 -25.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.981 0.912 . . . . 0.0 112.492 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.796 HD12 ' HA ' ' A' ' 6' ' ' ASP . 30.8 mt -124.0 161.9 24.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.954 0.407 . . . . 0.0 110.659 176.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.569 ' HB3' HD11 ' A' ' 7' ' ' LEU . 18.7 t70 -121.81 81.01 1.76 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.59 43.78 97.49 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.392 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.796 ' HA ' HD12 ' A' ' 3' ' ' LEU . 34.6 t70 67.14 96.73 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.228 0.537 . . . . 0.0 111.951 -177.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 4' ' ' ASP . 75.6 mt -149.4 100.03 2.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.59 HD22 ' HD3' ' A' ' 53' ' ' LYS . 51.7 tp -112.19 -68.19 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 38.0 mtmt 76.77 -66.49 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.564 . . . . 0.0 111.856 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -125.75 134.18 51.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.769 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -149.43 3.54 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.46 128.5 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.165 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 14' ' ' LEU . 59.3 tttt -136.69 165.8 25.07 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.411 ' H ' ' HG2' ' A' ' 13' ' ' LYS . 61.9 mt -55.01 159.15 4.04 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 122.654 0.382 . . . . 0.0 111.342 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.26 138.82 4.45 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.594 2.862 . . . . 0.0 113.5 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 48' ' ' LYS . 10.6 p 43.69 102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 123.129 1.442 . . . . 0.0 113.578 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.88 162.31 4.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.124 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.88 133.31 22.27 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.345 0.403 . . . . 0.0 111.126 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.596 ' HA ' ' HG1' ' A' ' 49' ' ' THR . 30.1 p-10 -64.01 -20.85 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.913 0.387 . . . . 0.0 110.254 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -69.03 -31.55 70.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.418 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HE1' ' HE1' ' A' ' 56' ' ' TYR . 55.5 t80 -68.6 -40.07 80.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 109.698 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.456 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -72.26 -29.85 65.8 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.162 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -67.27 -40.49 86.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.2 mm-40 -52.77 -51.72 59.51 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.744 173.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 72' ' ' ILE . 68.3 mt -53.97 -66.36 0.41 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.839 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 30' ' ' GLN . 20.4 mt -54.06 -28.36 38.34 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.46 -50.23 60.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 72.4 mttt -71.54 -33.77 69.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.816 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -96.88 4.9 51.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.789 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.4 tt0 -56.52 -41.63 77.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.775 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -65.69 -20.99 66.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.551 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -94.61 -39.93 10.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.277 0.561 . . . . 0.0 110.042 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.511 HG21 ' HB ' ' A' ' 39' ' ' VAL . 53.7 mt -67.76 -31.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.313 176.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 44.1 tttp -81.73 -29.15 33.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.306 0.574 . . . . 0.0 109.803 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.39 -52.59 31.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.574 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -71.44 -43.39 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.621 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.579 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 86.6 m-85 -118.59 -23.54 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.14 44.11 7.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.875 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.542 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.3 t -100.99 152.79 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -114.4 116.61 29.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.511 HG21 HD11 ' A' ' 44' ' ' LEU . 39.7 p -76.22 -11.6 59.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -73.68 -20.46 60.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.358 0.599 . . . . 0.0 109.53 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -92.23 -33.0 14.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.327 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD11 HG21 ' A' ' 41' ' ' THR . 86.6 mt -56.67 111.55 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.959 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 75.8 tttt -84.11 104.35 14.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.71 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.571 ' HA ' HG11 ' A' ' 60' ' ' VAL . 37.7 mt -73.73 112.68 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.546 0.688 . . . . 0.0 111.029 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.6 mt -82.25 -43.5 17.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.065 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HA ' HG22 ' A' ' 16' ' ' VAL . 75.6 tttt -154.04 120.38 5.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.347 -173.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.596 ' HG1' ' HA ' ' A' ' 19' ' ' ASN . 29.0 m -102.46 130.21 49.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.401 ' HG ' ' C ' ' A' ' 49' ' ' THR . 49.9 m -157.29 177.03 11.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.595 ' CD ' ' HZ2' ' A' ' 74' ' ' LYS . 1.2 pt-20 -158.61 167.05 30.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 171.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -149.01 89.78 1.7 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.107 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.769 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 5.3 tppp? 70.41 -100.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.726 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.623 ' HB3' HG22 ' A' ' 76' ' ' VAL . 65.8 mtt180 -94.71 20.44 8.64 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.73 -0.606 . . . . 0.0 111.451 -171.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -148.63 121.01 8.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.818 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.759 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.0 m-85 -85.78 150.96 24.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 95.05 3.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.8 t -105.86 93.92 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 110.516 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.1 m -80.02 119.9 23.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.571 HG11 ' HA ' ' A' ' 46' ' ' ILE . 11.5 m -130.29 158.09 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.31 0.576 . . . . 0.0 111.343 -176.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -84.55 123.5 30.37 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.55 4.44 7.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.77 1.32 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.372 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.93 -27.05 39.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.136 0.493 . . . . 0.0 110.473 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.59 -21.62 2.37 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.202 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.725 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 5.7 mt-10 -66.95 147.89 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.398 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 97.8 mttt -109.47 110.3 21.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.049 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 56.2 m -108.18 131.43 54.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 34.8 ttmt -101.48 107.18 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.548 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 65.5 m-85 -76.48 84.55 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.184 0.992 . . . . 0.0 110.433 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 1.129 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 21.3 tttp -76.72 89.58 3.39 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.197 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.759 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 mt -87.23 106.22 15.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.494 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.604 ' HB2' HG21 ' A' ' 82' ' ' VAL . 60.3 ttt180 -78.7 18.09 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.462 0.648 . . . . 0.0 110.336 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.616 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.7 mttt 55.43 -157.12 0.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.229 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 32.0 t70 -100.83 56.0 0.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 54' ' ' ARG . 17.9 t -75.44 -13.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.281 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.8 t70 179.92 -54.63 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.315 -171.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG21 ' HD2' ' A' ' 79' ' ' PRO . 10.0 p -120.75 139.03 28.34 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.667 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HD2' HG21 ' A' ' 78' ' ' VAL . 55.5 Cg_endo -75.16 67.39 6.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.664 2.243 . . . . 0.0 111.86 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -142.03 142.24 32.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.628 0.727 . . . . 0.0 111.985 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.459 ' HG3' HG21 ' A' ' 72' ' ' ILE . 1.5 mpp? -80.7 89.45 5.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.587 173.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.604 HG21 ' HB2' ' A' ' 73' ' ' ARG . 35.0 m -58.84 -33.49 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.916 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 1.129 ' HA2' ' HB3' ' A' ' 71' ' ' LYS . . . -92.18 72.8 1.55 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.053 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.579 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -105.39 47.73 0.86 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -115.53 142.1 47.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.979 -170.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.8 m -108.26 132.02 54.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.049 0.452 . . . . 0.0 109.925 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.674 ' HD3' ' HA ' ' A' ' 91' ' ' ASP . 94.6 mtt180 -128.42 78.33 1.83 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.725 ' HG3' ' HA ' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -71.2 -41.18 70.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.144 -171.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.41 -59.9 2.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.483 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -171.28 147.54 2.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.674 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 8.6 t70 -108.95 112.08 24.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -72.01 -90.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.072 0.463 . . . . 0.0 110.862 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -116.07 142.33 46.95 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -82.57 114.07 20.71 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.319 0.58 . . . . 0.0 111.62 -172.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.41 77.91 0.19 Allowed Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.82 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 15.1 m-30 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.701 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.646 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.403 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 26.1 p -140.68 29.02 1.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.291 0.567 . . . . 0.0 109.694 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.938 ' HA ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -67.9 131.04 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.597 1.189 . . . . 0.0 113.47 -169.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.579 HG13 HD13 ' A' ' 8' ' ' LEU . 11.1 tp -152.36 15.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.167 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.641 HD12 ' O ' ' A' ' 75' ' ' ASP . 1.8 pp -149.2 157.89 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.462 -1.699 . . . . 0.0 108.184 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.61 -29.31 61.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.318 0.58 . . . . 0.0 109.825 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 40.99 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.587 ' H ' HD11 ' A' ' 3' ' ' LEU . 24.1 p-10 -157.96 -80.26 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.852 -168.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 6' ' ' ASP . 7.7 mt 175.71 174.14 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.139 0.576 . . . . 0.0 110.252 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.579 HD13 HG13 ' A' ' 2' ' ' ILE . 63.8 mt -100.05 131.63 45.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.156 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -98.46 -30.28 12.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.45 ' OD2' ' HG3' ' A' ' 11' ' ' LYS . 6.4 p-10 -80.48 -38.03 30.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.068 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HB2' HD12 ' A' ' 8' ' ' LEU . 57.4 mttp -101.86 67.89 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.652 0.739 . . . . 0.0 109.745 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.653 ' HG ' ' HG2' ' A' ' 13' ' ' LYS . 1.6 pt? -79.25 -36.23 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.344 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.653 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 7.5 ptpt -177.08 101.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.448 0.642 . . . . 0.0 110.851 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 96.0 mt -100.47 167.51 10.79 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.523 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.6 Cg_endo -64.6 -170.61 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.632 2.221 . . . . 0.0 111.998 173.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 48' ' ' LYS . 2.6 p -63.39 105.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.017 175.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 49' ' ' THR . 3.3 pt -106.07 -177.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.804 -174.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.493 ' OD2' ' HB ' ' A' ' 46' ' ' ILE . 7.9 t70 176.68 -39.58 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -40.41 78.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 112.261 -2.245 . . . . 0.0 113.248 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.9 mt 45.7 40.2 5.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.729 0.776 . . . . 0.0 111.035 -175.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.3 m-85 -117.13 -78.06 0.58 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.127 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.41 90.78 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.491 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.547 ' HG2' HD11 ' A' ' 46' ' ' ILE . 30.2 mmmt -66.4 -33.29 75.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.364 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 1.5 mm-40 -65.87 -47.14 75.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.607 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 87.0 mt -50.94 -66.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.838 173.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.849 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 34.0 mt -50.89 -33.19 23.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.444 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.28 -48.46 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.195 -0.316 . . . . 0.0 111.074 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 80.0 mttt -67.7 -38.22 83.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.211 0.529 . . . . 0.0 110.496 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 1.5 m-85 -98.54 12.59 34.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.46 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.659 ' NE2' ' HA ' ' A' ' 40' ' ' ASP . 32.2 tt0 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.63 -33.15 71.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.347 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.658 ' O ' ' HD2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -76.58 -46.88 24.4 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.534 178.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.501 HG23 ' HB ' ' A' ' 39' ' ' VAL . 42.5 mt -65.45 -20.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.613 0.72 . . . . 0.0 110.266 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HG3' ' HA3' ' A' ' 38' ' ' GLY . 46.9 tttm -87.66 -40.18 14.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.645 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.89 -47.91 76.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.906 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.658 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 8.0 mttp -82.5 -28.74 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.26 -175.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.458 ' HB2' HG21 ' A' ' 39' ' ' VAL . 67.8 m-85 -133.67 -52.43 0.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.018 0.437 . . . . 0.0 111.526 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' HA3' ' HG3' ' A' ' 34' ' ' LYS . . . 106.78 62.53 0.59 Allowed Glycine 0 C--N 1.319 -0.393 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.501 ' HB ' HG23 ' A' ' 33' ' ' ILE . 47.3 t -124.45 151.84 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.905 0.383 . . . . 0.0 111.372 -171.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.659 ' HA ' ' NE2' ' A' ' 30' ' ' GLN . 28.7 t70 -103.19 121.33 42.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.54 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.849 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 41.1 p -88.56 -10.69 47.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.946 0.403 . . . . 0.0 112.044 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -68.97 -43.16 75.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -73.84 -24.87 59.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.379 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.7 mt -56.71 123.33 14.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.128 0.49 . . . . 0.0 110.692 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -94.2 111.69 23.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.82 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.612 ' HA ' HG11 ' A' ' 60' ' ' VAL . 12.4 mt -72.53 116.88 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.487 0.661 . . . . 0.0 111.184 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.82 -40.02 15.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.929 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.565 ' HA ' HG22 ' A' ' 16' ' ' VAL . 41.1 tttm -155.0 140.63 17.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.552 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 54.1 m -142.48 127.54 18.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.7 m -156.57 152.53 27.37 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -123.96 162.7 22.86 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 175.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 10.1 t70 -153.69 -98.99 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.672 171.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -93.57 89.79 6.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.912 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.3 mtt180 75.45 -44.84 0.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.657 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 20.5 m-85 -78.98 133.22 36.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.675 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 1.3 m-85 -103.55 121.77 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.718 164.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 49' ' ' THR . 10.7 m-85 -99.07 86.26 3.41 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 18.8 t -96.25 84.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.133 0.492 . . . . 0.0 110.4 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.638 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 23.5 t -82.44 117.57 22.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.612 HG11 ' HA ' ' A' ' 46' ' ' ILE . 15.2 m -129.84 156.26 42.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.248 0.547 . . . . 0.0 111.618 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.0 119.53 21.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.23 2.75 14.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.2 -50.44 3.63 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.916 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.94 -35.97 80.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.019 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.558 ' O ' ' HE3' ' A' ' 88' ' ' LYS . . . 151.97 -31.48 0.89 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.885 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.565 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 33.5 mt-10 -71.6 161.06 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.066 0.46 . . . . 0.0 111.411 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -119.22 105.15 11.07 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.534 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 55.9 m -103.62 127.27 51.08 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.468 -173.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.8 ttpt -99.13 104.46 16.45 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.761 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 85.6 m-85 -71.43 95.99 1.43 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.656 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 1.007 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 34.6 tttm -81.9 78.2 8.64 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.426 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 74' ' ' LYS . 57.5 mt -82.61 101.94 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.306 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 38.4 ttp180 -74.22 21.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.535 0.683 . . . . 0.0 109.827 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.675 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.1 mttt 64.3 174.25 0.19 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.564 -174.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.938 ' HB2' ' HA ' ' A' ' 1' ' ' LEU . 2.2 t70 -77.39 43.44 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.937 0.398 . . . . 0.0 110.37 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.403 HG12 ' HG2' ' A' ' 54' ' ' ARG . 6.9 m -64.17 91.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.248 0.547 . . . . 0.0 110.884 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 76.55 -50.68 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.095 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 34.8 m -107.25 146.23 32.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.382 0.61 . . . . 0.0 111.27 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.0 Cg_endo -90.73 54.61 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.737 2.958 . . . . 0.0 113.915 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -145.46 149.17 34.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.775 0.322 . . . . 0.0 111.221 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.437 ' HE3' ' HB2' ' A' ' 81' ' ' MET . 2.6 mpp? -81.66 102.16 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.667 HG11 ' HZ2' ' A' ' 71' ' ' LYS . 9.5 p -57.85 -31.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.027 0.442 . . . . 0.0 111.288 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.653 ' HA2' ' HB3' ' A' ' 71' ' ' LYS . . . -125.08 148.05 16.67 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.062 -177.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -173.81 54.14 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 96' ' ' TYR . 34.2 tptt -98.92 129.05 45.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.226 -168.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -89.79 115.12 26.89 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.603 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.487 ' HD2' ' OH ' ' A' ' 96' ' ' TYR . 40.9 mtt-85 -119.01 79.91 1.47 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.565 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 48.7 tttt -81.48 -25.71 35.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.606 -171.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -92.58 -55.71 3.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.089 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.02 137.08 32.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.987 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 19.2 t70 -135.73 108.83 7.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.27 0.557 . . . . 0.0 111.717 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.93 2.58 1.35 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.854 0.835 . . . . 0.0 109.27 173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -107.47 130.91 54.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.771 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.467 ' O ' ' HE3' ' A' ' 71' ' ' LYS . 6.6 m-20 -99.6 -10.98 21.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.527 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.32 89.15 1.52 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.537 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 1.007 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 15.1 m-30 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.383 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.961 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.945 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 7.8 t -94.33 84.4 4.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.165 0.482 . . . . 0.0 109.967 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.41 78.61 9.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.213 0.53 . . . . 0.0 109.874 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 2' ' ' ILE . 8.9 tp -151.98 87.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 122.085 0.945 . . . . 0.0 110.219 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.9 pt? -127.96 133.4 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.667 0.746 . . . . 0.0 111.705 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.641 ' HB2' ' HA ' ' A' ' 8' ' ' LEU . 10.6 t70 -95.9 -19.91 19.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 168.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.37 71.06 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.079 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.523 ' O ' HG22 ' A' ' 76' ' ' VAL . 19.3 t70 63.46 31.24 15.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.126 0.965 . . . . 0.0 109.159 -175.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.723 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 31.5 tp 179.69 -174.08 0.23 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.723 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 34.8 tp -148.12 107.66 3.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -100.56 -14.3 18.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.919 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.1 -48.74 80.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.443 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.21 133.49 24.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.307 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.903 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 22.7 tp -153.74 142.02 20.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.343 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.903 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 36.4 mtmt 67.33 30.95 6.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.9 mt -66.31 129.36 94.18 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 52.4 Cg_exo -57.11 -62.7 0.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 123.59 2.86 . . . . 0.0 112.181 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.765 HG22 ' HG3' ' A' ' 48' ' ' LYS . 8.7 p -146.42 145.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.266 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.549 HG13 ' HA ' ' A' ' 50' ' ' SER . 2.3 mt -119.05 163.12 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.948 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -54.3 140.78 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -67.98 -25.55 65.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.039 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.9 tp -68.06 -45.26 74.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 79.2 t80 -59.9 -37.07 78.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.64 -51.24 37.28 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.413 ' N ' HD11 ' A' ' 46' ' ' ILE . 2.4 mptp? -51.9 -35.28 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 1.4 mm-40 -59.86 -60.04 4.47 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.463 172.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.41 ' HB2' HD11 ' A' ' 26' ' ' LEU . 63.7 mt -47.89 -56.36 7.71 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.889 0.852 . . . . 0.0 110.62 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 58' ' ' VAL . 8.0 mp -63.39 -28.26 69.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.578 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 t70 -62.99 -43.15 99.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -66.11 -21.19 66.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.961 0.41 . . . . 0.0 110.303 177.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.945 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 65.9 m-85 -107.43 2.64 24.45 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.471 HE22 ' HE3' ' A' ' 42' ' ' LYS . 50.6 tt0 -50.99 -44.5 60.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -173.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -69.88 -35.61 74.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.748 0.309 . . . . 0.0 110.79 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.73 -45.14 65.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.759 0.79 . . . . 0.0 109.794 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.679 HG12 ' HE2' ' A' ' 81' ' ' MET . 91.9 mt -61.18 -40.28 85.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.656 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 27.7 ttpp -78.8 -21.38 47.86 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 110.13 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.75 -48.31 16.95 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -81.87 -34.97 29.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -124.27 -26.44 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 64.85 1.92 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.993 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.647 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -133.34 150.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 122.309 0.244 . . . . 0.0 110.814 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.7 119.53 39.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.91 170.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 26' ' ' LEU . 53.7 p -75.21 -19.47 59.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.981 -175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' HE3' HE22 ' A' ' 30' ' ' GLN . 10.3 mtmp? -67.99 -43.09 79.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.064 0.459 . . . . 0.0 110.192 178.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -82.46 -35.28 27.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.561 HD22 HG22 ' A' ' 60' ' ' VAL . 18.6 tp -50.79 121.5 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.782 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 44.6 tttp -90.8 114.44 26.83 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.812 -171.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.551 ' HA ' HG11 ' A' ' 60' ' ' VAL . 18.0 mt -87.18 125.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.352 0.596 . . . . 0.0 111.361 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.5 mt -100.72 -54.44 2.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.166 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.765 ' HG3' HG22 ' A' ' 16' ' ' VAL . 59.8 tttm -139.41 93.45 2.68 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.475 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -74.64 137.53 42.29 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.549 ' HA ' HG13 ' A' ' 17' ' ' ILE . 4.5 p -171.11 -169.31 0.73 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 118.218 0.463 . . . . 0.0 110.962 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.581 ' OE2' ' HA ' ' A' ' 12' ' ' LEU . 7.2 pt-20 -165.45 168.14 16.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.553 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 39.0 t70 -145.68 -76.38 0.21 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 0.0 111.337 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.52 ' HG3' ' OD2' ' A' ' 52' ' ' ASP . 56.5 mttp -113.01 82.27 1.63 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.961 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 66.7 mtt180 72.13 -27.88 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.964 0.506 . . . . 0.0 112.163 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 53' ' ' LYS . 9.6 m-85 -97.11 139.2 33.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.707 0.289 . . . . 0.0 111.361 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.682 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.3 m-85 -82.52 147.83 28.44 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.776 170.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.624 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 58.9 m-85 -131.36 99.83 4.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.163 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 26' ' ' LEU . 27.6 t -103.46 93.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.2 m -73.71 120.82 19.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.561 HG22 HD22 ' A' ' 44' ' ' LEU . 16.1 m -130.34 160.17 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 7.0 t0 -85.23 117.0 23.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.83 -1.7 7.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.74 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.28 60.61 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -121.27 5.45 10.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.305 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.85 -20.24 51.11 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 45.3 mt-10 -63.28 129.53 40.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.561 0.344 . . . . 0.0 111.035 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.664 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 55.0 mtpt -95.75 86.0 4.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 0.0 109.894 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.935 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 69.4 m -85.79 118.22 25.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.035 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.624 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 36.4 ttmt -92.34 107.2 19.04 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.549 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 30.8 m-85 -73.65 120.98 19.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.211 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.777 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 85.4 tttt -103.92 90.66 3.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.509 -173.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 64.4 mt -86.71 115.35 27.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.963 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.776 ' H ' ' HA ' ' A' ' 81' ' ' MET . 36.0 ttt180 -85.73 38.21 0.74 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.031 0.443 . . . . 0.0 109.992 -174.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.687 ' HZ2' HD21 ' A' ' 8' ' ' LEU . 52.2 mttt 37.24 -152.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.522 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 22.4 t70 -97.89 17.97 16.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 74' ' ' LYS . 2.5 p -73.87 94.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.816 0.817 . . . . 0.0 109.176 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 25.2 t70 84.49 -67.44 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.342 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 35.9 m -90.75 149.16 39.95 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -90.44 34.85 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.218 2.612 . . . . 0.0 111.084 173.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -148.46 -166.15 2.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.426 0.631 . . . . 0.0 111.251 -168.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.776 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 20.7 ptt? -111.35 126.7 55.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.123 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.614 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 7.7 p -59.72 -37.2 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.886 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.38 -157.81 13.2 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.426 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -176.54 102.58 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -174.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.659 ' HD2' ' HA ' ' A' ' 96' ' ' TYR . 50.4 mttt -120.49 121.45 38.5 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.935 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 2.5 m -76.17 116.68 17.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.499 ' NH2' ' HA ' ' A' ' 91' ' ' ASP . 16.2 mtp180 -128.1 81.17 2.01 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.664 ' HA ' ' HB2' ' A' ' 67' ' ' LYS . 42.8 tttm -77.82 -22.17 50.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.39 -169.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -107.36 59.65 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.799 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.8 t70 69.91 155.57 0.14 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.917 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.499 ' HA ' ' NH2' ' A' ' 87' ' ' ARG . 11.9 p-10 -131.51 130.55 42.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.422 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.46 -75.01 0.51 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.307 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -105.69 169.96 8.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.608 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -90.28 -99.81 0.1 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.51 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 54.07 81.72 0.06 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.535 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.777 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 6.6 m-30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.894 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.587 ' HA3' ' HB2' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.699 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -106.12 -48.24 3.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.955 0.377 . . . . 0.0 111.821 -177.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' A' ' 3' ' ' LEU . 24.1 mt 72.95 -23.96 0.2 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.7 tp -81.07 25.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.818 0.818 . . . . 0.0 111.603 -170.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.813 HD12 ' H ' ' A' ' 8' ' ' LEU . 9.4 tp 179.51 176.88 0.61 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -147.6 40.54 1.01 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.498 0.666 . . . . 0.0 109.546 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.491 ' HA3' ' H ' ' A' ' 77' ' ' ASP . . . 69.36 16.89 71.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.345 -174.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 11.7 p-10 -96.75 -37.91 10.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.546 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.779 HD12 ' HG3' ' A' ' 54' ' ' ARG . 4.4 mm? 73.98 88.83 0.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.595 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.813 ' H ' HD12 ' A' ' 3' ' ' LEU . 71.8 mt -71.92 -16.69 62.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.827 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 68.48 -74.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.795 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -120.84 126.41 50.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.704 ' HZ3' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.89 -37.26 11.27 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.99 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 13' ' ' LYS . 2.6 pp -120.44 -34.17 3.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.83 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.542 ' N ' HD13 ' A' ' 12' ' ' LEU . 19.2 ttpp 53.38 46.32 26.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.694 0.759 . . . . 0.0 110.966 175.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.537 ' H ' HD13 ' A' ' 12' ' ' LEU . 93.3 mt -105.3 172.3 4.15 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.25 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 51.1 Cg_exo -58.94 -156.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.149 2.566 . . . . 0.0 111.591 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.04 126.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.746 0.784 . . . . 0.0 109.93 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.624 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 3.3 mt -86.76 152.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.077 -173.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.53 139.49 25.27 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.687 0.617 . . . . 0.0 111.24 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 25.8 p-10 -66.32 -30.05 70.38 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.066 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -63.37 -45.34 91.57 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.242 0.339 . . . . 0.0 110.428 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.509 ' O ' HD11 ' A' ' 25' ' ' LEU . 88.6 t80 -59.95 -42.14 93.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.63 -49.71 70.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.355 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 29.6 mmmt -54.35 -33.37 58.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.667 0.387 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 7.3 mm-40 -60.63 -54.25 47.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.99 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.596 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 10.8 mp -52.88 -60.0 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.68 HD13 HG22 ' A' ' 58' ' ' VAL . 9.4 mp -60.41 -24.6 65.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.565 -173.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.05 -46.97 69.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 82.4 mttt -72.56 -28.65 62.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.18 0.514 . . . . 0.0 110.344 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.699 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 64.0 m-85 -88.97 -3.28 58.78 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.454 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -54.65 -48.9 71.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.581 0.229 . . . . 0.0 111.085 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.93 -33.97 75.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' HA ' ' A' ' 80' ' ' LYS . 4.7 t70 -71.15 -50.38 33.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.963 0.887 . . . . 0.0 109.843 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.66 HG23 ' HE1' ' A' ' 70' ' ' PHE . 62.7 mt -65.04 -30.96 51.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -84.71 -30.91 24.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.05 -51.27 69.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.253 0.549 . . . . 0.0 110.002 171.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -71.26 -58.95 3.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.363 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -107.28 -36.68 6.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.433 -170.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.95 29.33 5.55 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.785 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 41' ' ' THR . 6.9 t -95.36 142.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.1 t70 -105.14 7.49 33.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.451 0.643 . . . . 0.0 110.949 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.503 ' H ' HG13 ' A' ' 39' ' ' VAL . 70.6 p 55.71 -13.78 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 40' ' ' ASP . 49.1 mtpt -58.65 -36.67 74.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.098 0.408 . . . . 0.0 111.946 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -74.58 -32.37 62.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.317 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.62 115.88 3.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.721 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 42.9 tttm -92.25 108.86 20.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.01 171.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.599 ' HA ' HG11 ' A' ' 60' ' ' VAL . 41.6 mt -72.25 119.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.493 0.663 . . . . 0.0 111.664 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 61' ' ' ASP . 12.5 mt -91.44 -42.49 10.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.013 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -156.04 104.77 2.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.922 -174.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.624 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 6.4 m -89.39 132.42 34.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -155.94 173.67 16.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.8 150.33 52.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.423 0.63 . . . . 0.0 110.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -133.02 -174.02 3.36 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.252 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -66.68 113.3 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.779 ' HG3' HD12 ' A' ' 7' ' ' LEU . 24.9 ttt180 75.84 -17.04 0.54 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.729 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.428 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 40.1 m-85 -122.23 147.77 45.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 112.231 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' HD1' ' HG2' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -106.81 150.79 25.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.553 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 89.4 m-85 -134.54 107.15 7.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.68 HG22 HD13 ' A' ' 26' ' ' LEU . 21.9 t -108.59 96.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.397 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 18.1 t -76.45 130.69 38.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 46' ' ' ILE . 28.8 m -140.58 152.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.206 0.527 . . . . 0.0 111.879 -174.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.712 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.3 t70 -76.56 105.86 7.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.99 34.4 1.93 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 167.55 -96.63 0.13 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.079 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -137.39 -4.73 1.84 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.799 0.333 . . . . 0.0 110.688 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.02 -29.63 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.653 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.621 ' HG2' ' HD3' ' A' ' 88' ' ' LYS . 47.0 mt-10 -68.41 122.38 18.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.352 0.596 . . . . 0.0 111.001 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.482 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 96.2 mttt -101.31 106.69 17.9 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.024 -174.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 4.4 t -99.86 178.04 4.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.622 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.8 ttmt -156.87 113.04 2.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.66 ' HE1' HG23 ' A' ' 33' ' ' ILE . 14.3 m-85 -80.42 114.17 19.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.129 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 1.086 ' HD2' ' HB3' ' A' ' 96' ' ' TYR . 82.5 tttt -87.98 89.17 7.89 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.746 0.784 . . . . 0.0 109.733 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 29' ' ' PHE . 51.3 mt -81.77 100.02 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.641 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 24.2 ttp180 -68.29 100.93 1.11 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.63 ' HG2' ' HD1' ' A' ' 56' ' ' TYR . 86.0 mttt -47.19 124.59 6.74 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 124.033 0.833 . . . . 0.0 110.69 -172.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 4.6 t70 -23.94 81.77 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.53 1.769 . . . . 0.0 112.9 -170.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.521 HG21 HD22 ' A' ' 7' ' ' LEU . 6.0 p -107.51 106.82 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.439 -171.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' H ' ' HA3' ' A' ' 5' ' ' GLY . 5.0 m-20 71.65 -58.97 0.56 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.697 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.49 ' HB ' ' HD2' ' A' ' 79' ' ' PRO . 13.2 m -122.53 164.08 28.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.218 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.587 ' HB2' ' HA3' ' A' ' -1' ' ' GLY . 23.5 Cg_endo -91.6 104.45 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.163 2.575 . . . . 0.0 113.227 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 9.0 mtmt -179.87 162.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.589 . . . . 0.0 111.698 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.479 ' HE3' ' HB3' ' A' ' 81' ' ' MET . 3.4 ttp -92.15 142.61 27.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.439 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.641 ' HB ' ' HD3' ' A' ' 73' ' ' ARG . 3.6 p -73.33 -53.79 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.651 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 96' ' ' TYR . . . -155.71 159.14 29.04 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.327 -173.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 84' ' ' ARG . 10.6 ttp180 -125.21 95.81 4.61 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.61 ' HB2' ' OXT' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -114.57 112.0 22.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.26 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 11.2 m -80.97 138.13 36.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.512 ' HD2' ' HB3' ' A' ' 91' ' ' ASP . 15.9 ptm180 -132.94 65.95 1.58 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.842 0.83 . . . . 0.0 109.509 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.621 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 3.0 ttpm? -63.26 -22.38 66.83 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.355 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -124.28 -76.3 0.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.98 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -125.6 166.49 16.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.636 ' HB2' ' HE2' ' A' ' 96' ' ' TYR . 10.3 p-10 -111.95 -166.65 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.075 0.464 . . . . 0.0 111.508 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.54 -171.9 1.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.505 -173.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.39 -79.49 0.1 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -138.17 -22.71 1.03 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.14 74.74 0.18 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 1.086 ' HB3' ' HD2' ' A' ' 71' ' ' LYS . 26.1 t80 . . . . . 0 N--CA 1.443 -0.786 0 CA-C-O 117.794 -1.098 . . . . 0.0 108.298 -171.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 34.4 t -87.45 96.77 10.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.23 0.538 . . . . 0.0 110.033 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 38.1 mt -101.54 26.12 7.66 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.592 HG23 ' HG ' ' A' ' 3' ' ' LEU . 1.8 mp -69.32 -31.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.614 -175.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.8 HD11 ' HA ' ' A' ' 6' ' ' ASP . 77.9 mt -132.39 178.01 7.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.101 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -126.23 73.29 1.36 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.78 36.29 37.44 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.555 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.8 ' HA ' HD11 ' A' ' 3' ' ' LEU . 33.3 t70 69.55 97.03 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.493 0.663 . . . . 0.0 112.164 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 3' ' ' LEU . 93.6 mt -126.87 70.98 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' A' ' 54' ' ' ARG . 79.1 mt -64.27 -62.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.944 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 52.87 -99.98 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.89 0.744 . . . . 0.0 110.581 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.06 88.86 4.62 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.321 0.581 . . . . 0.0 109.8 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.659 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -104.4 165.1 11.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.934 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt 59.9 93.67 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.83 0.706 . . . . 0.0 109.229 -174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.33 -153.92 0.41 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.831 -174.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.5 mt -52.48 148.61 12.04 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.54 134.84 54.1 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.993 2.462 . . . . 0.0 111.832 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.572 HG22 ' HA ' ' A' ' 48' ' ' LYS . 5.6 p 39.87 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 123.14 1.448 . . . . 0.0 112.688 -171.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 57.5 mt -68.6 156.32 7.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.431 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -49.74 138.19 14.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -71.25 -19.46 62.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.248 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.39 -45.64 37.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.057 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 81.4 t80 -58.78 -40.46 84.07 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.08 -47.63 86.91 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.127 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -38.55 69.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.25 -47.56 83.2 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.9 mt -56.93 -58.5 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.562 0.696 . . . . 0.0 110.171 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.625 HD13 HG13 ' A' ' 58' ' ' VAL . 9.1 mp -58.8 -34.66 71.73 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.835 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.43 -34.0 74.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.438 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -72.58 -26.96 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.26 3.25 29.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.546 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.41 -50.31 59.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.53 0.732 . . . . 0.0 111.852 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.61 -41.92 82.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.11 -39.7 68.69 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.658 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 94.8 mt -69.42 -20.8 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.51 0.671 . . . . 0.0 110.486 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.5 tttp -89.77 -33.13 16.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.499 0.666 . . . . 0.0 109.882 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.46 -45.04 77.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.311 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.26 -15.35 41.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.475 -173.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.505 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 77.3 m-85 -140.17 -57.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.414 0.626 . . . . 0.0 109.78 177.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 123.38 35.46 0.7 Allowed Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.367 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.522 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 2.8 t -108.27 146.39 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.989 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -98.04 8.91 44.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.621 0.724 . . . . 0.0 110.259 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.512 ' H ' HG11 ' A' ' 39' ' ' VAL . 71.4 p 59.0 -33.69 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.084 1.754 . . . . 0.0 115.253 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -62.83 -29.36 70.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.2 0.524 . . . . 0.0 110.477 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.09 -14.81 60.62 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.185 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.48 HD23 HG13 ' A' ' 39' ' ' VAL . 63.9 mt -81.64 125.0 30.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.292 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HG2' HD21 ' A' ' 47' ' ' LEU . 58.3 tttp -81.47 101.21 9.75 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.538 ' HA ' HG11 ' A' ' 60' ' ' VAL . 57.2 mt -69.98 113.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.413 HD21 ' HG2' ' A' ' 45' ' ' LYS . 26.1 mt -85.07 -40.05 17.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.583 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' HA ' HG22 ' A' ' 16' ' ' VAL . 24.9 ttpp -160.38 103.56 1.42 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.452 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.484 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 9.3 m -76.61 122.14 24.21 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.8 m -157.3 -172.29 3.94 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.935 -0.478 . . . . 0.0 110.624 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.49 178.77 8.51 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -112.53 -84.13 0.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.659 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 27.8 mtmm -140.66 107.74 5.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 167.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.771 ' HG3' HG12 ' A' ' 76' ' ' VAL . 35.6 ttm180 78.1 -18.15 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.734 0.646 . . . . 0.0 111.463 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.44 123.55 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.616 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 5.4 m-85 -78.13 148.51 34.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.796 0.332 . . . . 0.0 110.409 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.597 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 75.5 m-85 -134.12 94.62 3.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.753 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.625 HG13 HD13 ' A' ' 26' ' ' LEU . 19.3 t -89.06 95.38 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.505 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.429 ' HB2' ' N ' ' A' ' 48' ' ' LYS . 74.2 m -60.08 128.54 37.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.003 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 46' ' ' ILE . 34.8 m -147.57 153.5 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.43 0.634 . . . . 0.0 111.589 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.87 130.73 48.41 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 169.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.728 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -92.44 5.09 52.03 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.152 -173.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.97 -19.23 50.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.646 170.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 32.9 t70 -103.29 18.92 20.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.88 -22.33 12.15 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.728 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 7.0 pt-20 -70.95 150.48 45.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.16 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.598 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 70.1 mmtt -122.26 151.51 41.0 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -175.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 24.0 t -146.58 170.83 16.11 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.3 ttpt -157.51 89.43 1.04 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CE2' HG23 ' A' ' 60' ' ' VAL . 83.7 m-85 -53.81 112.16 0.88 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.941 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 54.7 tttt -84.92 80.66 9.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.921 0.867 . . . . 0.0 109.385 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 77.5 mt -77.27 102.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.726 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.512 ' HB2' HG11 ' A' ' 82' ' ' VAL . 46.4 ttt180 -71.63 111.96 7.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.591 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 91.7 mttt -57.16 160.12 3.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.353 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 0' ' ' SER . 17.9 t70 -67.37 74.09 0.14 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.66 0.743 . . . . 0.0 109.705 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.771 HG12 ' HG3' ' A' ' 54' ' ' ARG . 35.6 m -98.75 -4.29 9.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.615 0.722 . . . . 0.0 110.074 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 175.3 -62.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.287 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.459 HG21 ' HD2' ' A' ' 79' ' ' PRO . 11.2 p -96.9 137.62 21.33 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.478 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HD2' HG21 ' A' ' 78' ' ' VAL . 45.8 Cg_endo -83.38 42.25 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.591 2.861 . . . . 0.0 112.645 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -137.88 140.59 40.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.228 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.443 ' HE2' ' HB3' ' A' ' 81' ' ' MET . 4.6 tmm? -65.09 123.65 20.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.033 170.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 73' ' ' ARG . 14.5 p -79.47 -38.56 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 0.0 111.634 -173.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 84' ' ' ARG . . . -144.52 179.45 21.73 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.954 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.505 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -153.72 93.55 1.68 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.77 ' HA ' ' CD1' ' A' ' 96' ' ' TYR . 22.1 tptm -73.91 60.82 0.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.78 0.8 . . . . 0.0 112.317 -166.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -104.5 111.0 23.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.611 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 19.9 mmt180 -109.61 17.63 21.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.892 0.853 . . . . 0.0 109.785 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.598 ' HG3' ' H ' ' A' ' 67' ' ' LYS . 43.7 mmtm -75.41 -10.24 59.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.284 -1.325 . . . . 0.0 108.633 168.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -114.79 -144.95 0.39 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.223 -1.353 . . . . 0.0 107.625 172.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.31 144.09 42.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.905 0.383 . . . . 0.0 111.135 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.611 ' HA ' ' HD2' ' A' ' 87' ' ' ARG . 30.9 t70 -118.92 21.97 12.16 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.425 0.631 . . . . 0.0 111.674 -173.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -127.86 125.23 39.32 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.536 -0.728 . . . . 0.0 111.369 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -155.02 175.88 13.25 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.14 -15.21 14.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.981 0.419 . . . . 0.0 110.024 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -96.05 -85.19 1.72 Allowed Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.543 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.77 ' CD1' ' HA ' ' A' ' 85' ' ' LYS . 6.3 p90 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.171 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 40.4 t -141.39 99.63 3.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.628 HD22 ' H ' ' A' ' 1' ' ' LEU . 0.6 OUTLIER -99.56 109.77 22.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.348 0.594 . . . . 0.0 112.053 -172.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.536 HG22 ' HB3' ' A' ' 74' ' ' LYS . 8.4 tp -173.12 84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.998 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.907 ' HG ' ' H ' ' A' ' 4' ' ' ASP . 1.2 pt? -122.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.177 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.907 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 8.7 m-20 57.64 19.01 5.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.685 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.478 ' O ' ' HG ' ' A' ' 7' ' ' LEU . . . 111.9 42.94 0.98 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.479 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.22 25.89 11.57 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 5' ' ' GLY . 96.0 mt -137.9 166.21 24.61 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 111.332 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.401 HD23 HG12 ' A' ' 2' ' ' ILE . 35.2 tp -178.73 -93.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.737 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.3 mttt 55.82 33.11 20.88 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -76.08 -59.62 2.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 110.476 -174.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.94 35.27 1.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.675 0.75 . . . . 0.0 110.263 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.621 HD22 ' HE3' ' A' ' 13' ' ' LYS . 29.5 tp -70.63 170.14 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.098 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.621 ' HE3' HD22 ' A' ' 12' ' ' LEU . 1.9 mptt 70.09 15.61 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.348 0.659 . . . . 0.0 111.491 176.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.64 139.47 20.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.094 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.39 -56.49 0.66 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 122.521 2.147 . . . . 0.0 110.358 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 48' ' ' LYS . 13.5 p -128.86 128.13 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.461 -1.7 . . . . 0.0 109.898 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 HG23 ' H ' ' A' ' 18' ' ' ASP . 24.5 mt -89.61 177.25 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.258 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.438 ' H ' HG23 ' A' ' 17' ' ' ILE . 4.0 m-20 -50.67 120.24 4.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.492 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -73.21 -36.93 66.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.01 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.482 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 68.0 t80 -62.86 -43.96 97.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.499 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -61.58 -45.95 95.28 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 173.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -52.26 -43.93 64.64 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.0 109.915 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.87 -39.89 93.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.227 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 16.9 mt -60.02 -60.12 4.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.743 HD13 HG22 ' A' ' 58' ' ' VAL . 8.1 mp -60.13 -32.6 71.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.819 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.97 -49.33 77.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.935 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -67.0 -50.48 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.313 0.577 . . . . 0.0 110.291 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 5.7 m-85 -83.2 13.4 4.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.675 -173.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.527 HE21 ' HA ' ' A' ' 40' ' ' ASP . 36.6 tt0 -61.82 -36.28 80.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.76 -35.02 76.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.126 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.639 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 20.7 t70 -74.3 -44.6 51.96 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.16 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.601 ' CG1' ' HE2' ' A' ' 81' ' ' MET . 66.2 mt -69.11 -26.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.406 0.622 . . . . 0.0 110.773 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 54.0 tttp -83.29 -28.93 28.76 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -69.22 -43.14 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.904 170.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.639 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 63.2 mttm -67.85 -47.92 67.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.285 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.659 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 44.0 m-85 -128.4 -56.68 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.481 0.658 . . . . 0.0 110.889 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 34' ' ' LYS . . . 117.42 62.35 0.31 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.789 -170.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.524 HG21 ' HB2' ' A' ' 37' ' ' TYR . 45.9 t -124.33 154.59 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.808 0.337 . . . . 0.0 111.143 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.527 ' HA ' HE21 ' A' ' 30' ' ' GLN . 16.4 t70 -105.15 123.38 47.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.564 173.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 24.6 p -88.03 -14.61 38.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.001 0.429 . . . . 0.0 111.725 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -79.76 -7.21 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.951 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -99.76 -21.85 15.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.681 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.1 mt -73.87 124.43 26.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.652 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 82.6 tttt -83.95 112.79 20.48 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.569 ' HA ' HG11 ' A' ' 60' ' ' VAL . 35.4 mt -79.88 116.54 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.692 0.758 . . . . 0.0 111.171 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 61' ' ' ASP . 14.6 mt -85.35 -51.02 6.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.39 -176.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HA ' HG22 ' A' ' 16' ' ' VAL . 39.4 ttpt -146.06 111.13 5.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.827 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.3 m -96.0 127.53 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -146.51 163.56 35.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.648 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -132.33 161.53 33.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 110.239 172.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 53' ' ' LYS . 7.4 t70 -140.21 -157.91 0.81 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.419 ' H ' ' CG ' ' A' ' 52' ' ' ASP . 51.2 mttp -72.13 103.17 3.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.693 ' HG2' HG13 ' A' ' 76' ' ' VAL . 53.0 mtt180 74.27 -14.4 0.7 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.695 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -109.85 149.33 30.02 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.947 -0.471 . . . . 0.0 111.984 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.648 ' CE2' ' HB3' ' A' ' 51' ' ' GLU . 2.6 m-85 -116.58 150.4 38.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.729 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.6 m-85 -128.71 103.42 7.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.373 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.743 HG22 HD13 ' A' ' 26' ' ' LEU . 13.3 t -106.16 94.64 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.709 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -79.96 118.8 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -130.48 155.67 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.653 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.481 ' HB2' HD23 ' A' ' 47' ' ' LEU . 36.2 t70 -86.67 103.66 15.34 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB1' ' HG3' ' A' ' 66' ' ' GLU . . . -64.71 -26.81 68.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.826 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.43 -23.95 13.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.97 -0.634 . . . . 0.0 111.731 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 25.9 t70 -81.59 -22.7 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.405 0.621 . . . . 0.0 110.21 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.95 -32.33 3.65 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 4.6 pt-20 -62.93 136.26 57.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.637 -0.782 . . . . 0.0 111.842 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 51.7 mtpt -100.38 93.09 5.48 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 79.8 m -89.25 132.27 34.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.06 0.457 . . . . 0.0 110.586 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.811 ' HE3' ' HB2' ' A' ' 92' ' ' ASP . 22.8 ttmm -109.18 94.26 4.95 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.301 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 80.1 m-85 -63.4 100.0 0.23 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.923 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 1.036 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 25.0 tttm -80.69 83.26 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.994 0.902 . . . . 0.0 109.047 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.849 ' HA ' ' HB2' ' A' ' 81' ' ' MET . 70.0 mt -77.71 93.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.434 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HB2' HG11 ' A' ' 82' ' ' VAL . 30.4 ttt180 -63.52 123.8 19.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.536 ' HB3' HG22 ' A' ' 2' ' ' ILE . 39.6 mttt -59.56 169.08 1.39 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.798 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 9.9 t0 -72.06 78.36 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.229 1.014 . . . . 0.0 108.904 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.693 HG13 ' HG2' ' A' ' 54' ' ' ARG . 6.4 m -106.11 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.106 174.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.0 t70 84.74 -46.01 0.08 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.891 -175.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.96 146.24 61.27 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 111.119 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HB3' ' OD2' ' A' ' 75' ' ' ASP . 34.1 Cg_endo -92.18 86.17 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.634 2.889 . . . . 0.0 114.138 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' HD2' ' HZ3' ' A' ' 36' ' ' LYS . 5.3 mtmm -164.69 161.52 20.8 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.01 -0.431 . . . . 0.0 111.329 173.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.849 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 2.4 ptp -88.1 119.2 28.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.772 HG13 ' HZ2' ' A' ' 71' ' ' LYS . 7.7 p -60.4 -38.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.916 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.06 -177.68 26.88 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.952 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.659 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -164.25 42.8 0.09 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.832 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 74.7 mttt -60.83 121.98 13.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.612 -172.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.4 m -83.21 113.03 20.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.466 ' HD3' ' OH ' ' A' ' 96' ' ' TYR . 17.9 mtp180 -117.38 85.59 2.36 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.813 ' HZ1' ' HB3' ' A' ' 88' ' ' LYS . 4.8 ttpm? -80.02 109.63 14.65 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.754 -170.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.573 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 7.7 t70 66.87 -156.98 0.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 O-C-N 124.116 0.885 . . . . 0.0 109.763 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.444 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 11.2 m-20 63.2 -95.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -170.64 149.59 3.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.811 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 11.4 p-10 -110.7 128.95 55.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.382 0.611 . . . . 0.0 111.512 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 94' ' ' ASP . 3.7 m-20 -103.41 -155.35 0.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.776 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' A' ' 93' ' ' ASP . 3.7 m-20 -118.49 171.56 8.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.284 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.461 ' C ' ' HD2' ' A' ' 96' ' ' TYR . . . 85.98 69.59 1.34 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.662 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 1.036 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.854 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 112.194 -0.363 . . . . 0.0 112.194 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.778 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 34.2 p -149.99 -32.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.612 0.206 . . . . 0.0 110.86 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 0' ' ' SER . 0.5 OUTLIER 45.97 23.58 0.19 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.766 1.227 . . . . 0.0 113.326 175.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.564 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 10.5 tp -117.02 39.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.012 0.91 . . . . 0.0 110.55 -171.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.817 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 2.5 pt? -92.96 -40.09 10.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.691 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.6 t70 66.57 -60.41 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.97 0.794 . . . . 0.0 110.015 -169.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 54.88 0.24 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.105 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.59 ' HA ' HG13 ' A' ' 76' ' ' VAL . 41.3 m-20 49.84 34.91 8.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.748 0.419 . . . . 0.0 111.476 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.569 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 27.8 tp -141.84 176.57 8.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.64 0.257 . . . . 0.0 110.362 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.569 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 6.2 mp -73.83 -59.33 2.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.22 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp 63.64 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.229 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -126.21 106.7 9.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.217 0.532 . . . . 0.0 110.042 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 3.3 ptmm? -118.09 -163.42 0.94 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.358 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 12' ' ' LEU . 29.5 mt -41.46 115.95 0.7 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -130.63 21.15 5.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.53 168.03 13.3 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.722 -172.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -69.77 -153.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.471 0.162 0 C-N-CA 123.637 2.892 . . . . 0.0 111.856 167.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.692 HG22 ' HG3' ' A' ' 48' ' ' LYS . 5.4 p -51.17 124.31 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.886 0.85 . . . . 0.0 111.147 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 11.9 mt -79.93 151.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.916 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.8 152.47 35.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.209 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -64.12 -25.62 68.18 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.813 -178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.64 -46.67 88.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.17 0.188 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.515 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 87.0 t80 -59.79 -38.6 82.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.423 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -65.52 -49.86 58.12 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 23' ' ' LYS . 12.9 mmmm -56.81 -28.67 61.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 14.3 mm-40 -68.85 -52.63 27.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 173.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 43.8 mt -53.69 -62.49 1.62 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.621 0.724 . . . . 0.0 110.096 175.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.63 HD13 HG22 ' A' ' 58' ' ' VAL . 9.5 mp -59.08 -28.37 66.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.55 -173.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 13.1 t70 -75.24 -46.93 30.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.09 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 66.5 mttm -57.51 -35.74 70.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.303 0.573 . . . . 0.0 110.558 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.778 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 2.4 m-85 -106.1 12.27 30.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.271 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -60.21 -41.33 92.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 -179.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.89 -32.38 73.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' OD1' ' HD3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -73.4 -48.06 36.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.358 0.599 . . . . 0.0 110.153 177.406 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.602 HG12 ' HE2' ' A' ' 81' ' ' MET . 72.0 mt -59.76 -41.48 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.589 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.5 tttt -79.94 -29.59 39.74 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.914 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.88 -50.37 66.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.564 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -76.73 -57.58 3.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.453 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.543 ' HB2' HG21 ' A' ' 39' ' ' VAL . 20.7 m-85 -102.32 -27.37 12.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -169.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.33 52.96 3.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.636 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.589 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.9 t -118.3 149.14 20.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.518 0.199 . . . . 0.0 110.598 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.41 106.09 14.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.533 ' HA ' HD23 ' A' ' 44' ' ' LEU . 65.6 p -65.69 -16.66 63.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -173.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.3 ttpp -72.06 -23.03 61.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -94.3 -5.98 45.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.767 0.794 . . . . 0.0 109.632 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 41' ' ' THR . 5.1 mp -83.29 138.35 33.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.112 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.55 109.73 22.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.594 ' HA ' HG11 ' A' ' 60' ' ' VAL . 40.9 mt -79.33 116.96 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 110.877 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 8.1 mt -85.78 -47.32 9.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.086 -175.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.692 ' HG3' HG22 ' A' ' 16' ' ' VAL . 37.7 ttmt -149.6 108.08 3.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.481 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.522 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 13.5 m -85.0 125.39 32.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.3 m -156.55 -170.94 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -156.11 -176.61 6.05 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.667 ' HB3' ' HE2' ' A' ' 57' ' ' TYR . 14.7 t70 -165.45 93.38 0.58 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.507 ' HG3' HD23 ' A' ' 8' ' ' LEU . 12.4 mptt 68.21 -107.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.921 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HG2' HG12 ' A' ' 76' ' ' VAL . 48.0 mtt180 -91.93 19.55 6.56 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.931 -0.481 . . . . 0.0 111.32 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 76.2 m-85 -138.83 140.67 38.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 -173.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.852 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m-85 -100.3 144.08 29.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 166.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.677 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 71.0 m-85 -129.8 96.32 4.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.63 HG22 HD13 ' A' ' 26' ' ' LEU . 5.6 t -104.43 96.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.4 t -74.39 114.61 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 46' ' ' ILE . 12.9 m -133.13 163.93 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.236 0.541 . . . . 0.0 111.368 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.96 127.14 48.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.97 33.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.09 -46.3 3.06 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.581 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.54 -38.18 68.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.304 0.573 . . . . 0.0 110.934 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -21.85 2.46 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.339 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.449 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 8.7 pt-20 -79.38 145.8 33.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 110.804 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 88' ' ' LYS . 46.6 mttp -113.96 116.34 29.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.527 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.5 m -117.94 124.96 49.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.824 -171.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 6.1 tppt? -85.12 96.24 9.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.77 113.5 3.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.309 0.576 . . . . 0.0 110.185 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.72 ' CD ' ' HA ' ' A' ' 96' ' ' TYR . 13.8 ttmm -93.0 80.72 4.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.622 -174.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.852 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 mt -77.68 76.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.642 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.53 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 70.8 ttt180 -53.26 125.79 18.83 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 76' ' ' VAL . 96.3 mttt -59.79 171.0 0.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 123.458 0.474 . . . . 0.0 110.263 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.817 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 1.7 t70 -72.12 26.45 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.372 0.606 . . . . 0.0 110.694 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.59 HG13 ' HA ' ' A' ' 6' ' ' ASP . 30.1 m -78.65 123.12 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.555 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 18.4 t70 70.58 -66.22 0.3 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.548 0.53 . . . . 0.0 111.232 -176.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.594 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 3.4 p -104.28 153.9 38.68 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.663 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.0 Cg_endo -76.32 148.05 29.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.092 1.861 . . . . 0.0 111.515 164.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 4.9 ptpt 73.47 -172.13 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.235 1.014 . . . . 0.0 113.126 167.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.602 ' HE2' HG12 ' A' ' 33' ' ' ILE . 15.5 mtm -77.23 126.89 31.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.178 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.53 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 7.1 p -59.46 -27.81 38.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.56 -161.64 35.36 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.325 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -157.09 151.16 24.83 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 14.0 tptp -145.25 106.01 4.13 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.942 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.1 m -77.32 111.0 12.52 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 170.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.611 ' HD3' ' CG ' ' A' ' 91' ' ' ASP . 31.2 mtt180 -93.74 29.32 2.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.992 0.425 . . . . 0.0 110.593 -169.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.512 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 12.0 mmmm -76.84 -30.01 56.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.965 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -130.6 -55.23 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.705 0.288 . . . . 0.0 111.229 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -116.18 126.76 54.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 111.454 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.611 ' CG ' ' HD3' ' A' ' 87' ' ' ARG . 17.7 t0 -131.7 86.02 2.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.169 0.509 . . . . 0.0 110.982 175.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -162.9 122.18 2.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.574 173.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 96' ' ' TYR . 16.6 t70 -157.43 153.6 27.44 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -95.32 99.97 11.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.206 0.527 . . . . 0.0 109.916 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.5 -47.3 1.03 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -175.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.72 ' HA ' ' CD ' ' A' ' 71' ' ' LYS . 33.1 t80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.106 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.456 ' C ' ' HA ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.478 1.459 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.726 ' HB3' ' HA ' ' A' ' 75' ' ' ASP . 23.4 t -60.9 164.52 4.79 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 122.401 0.281 . . . . 0.0 110.997 -174.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 28' ' ' LYS . 72.9 mt -83.55 61.94 6.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.004 0.907 . . . . 0.0 112.425 -168.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 74' ' ' LYS . 15.7 tt -160.77 29.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.515 ' O ' HD23 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -72.22 135.46 46.08 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.464 -163.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.31 -18.56 16.03 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 165.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . 134.36 54.02 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.752 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 8.0 m-20 68.86 22.08 7.35 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -143.0 159.72 41.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.024 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 3.1 mm? -116.88 -66.52 1.08 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.643 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.693 ' HZ1' ' HB2' ' A' ' 9' ' ' LYS . 9.6 mtmp? 66.05 17.11 10.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.86 0.838 . . . . 0.0 108.9 -169.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -152.11 69.39 0.89 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.074 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 38.5 pttt -49.08 -50.43 36.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.392 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.604 HD13 ' HG3' ' A' ' 51' ' ' GLU . 52.9 tp -153.16 119.08 5.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -169.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -85.67 -77.41 0.3 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.995 0.426 . . . . 0.0 111.362 -176.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 18.8 mt -136.76 176.65 2.63 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -173.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 32.4 Cg_exo -62.69 -147.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.788 2.992 . . . . 0.0 111.615 169.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 49' ' ' THR . 7.1 p -54.75 122.64 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.839 0.828 . . . . 0.0 110.053 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.759 HG13 ' HB ' ' A' ' 49' ' ' THR . 1.1 pt -108.06 -173.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.882 -171.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.86 134.16 37.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.74 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -72.88 -21.06 60.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.49 -40.23 57.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.151 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' O ' HD11 ' A' ' 25' ' ' LEU . 80.1 t80 -61.47 -47.07 87.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -62.64 -43.47 98.94 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.238 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -56.42 -36.77 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.306 0.242 . . . . 0.0 110.488 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 4.9 mm-40 -55.81 -53.8 52.29 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.49 HD11 ' O ' ' A' ' 21' ' ' PHE . 10.2 mp -49.86 -59.01 4.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.276 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.624 HD13 HG22 ' A' ' 58' ' ' VAL . 9.2 mp -59.85 -42.17 93.07 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.964 -175.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.97 -33.41 74.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.999 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 22.0 mttp -64.64 -49.99 68.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.391 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.434 ' O ' HG13 ' A' ' 33' ' ' ILE . 58.3 m-85 -98.49 12.49 34.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.573 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.406 ' OE1' ' HE2' ' A' ' 42' ' ' LYS . 4.9 pt20 -59.87 -31.91 70.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.452 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.17 -34.52 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.496 ' OD2' ' HE2' ' A' ' 81' ' ' MET . 22.9 t70 -72.16 -39.68 68.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.752 0.787 . . . . 0.0 109.013 175.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.567 HG21 ' HB ' ' A' ' 39' ' ' VAL . 92.3 mt -61.42 -43.41 96.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.234 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.595 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 24.7 ttpt -82.51 -29.71 30.28 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.669 -174.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.46 -55.81 13.89 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 174.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -79.55 -43.36 23.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.922 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.2 -10.09 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.534 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 68.8 41.2 83.88 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.627 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.595 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 10.8 t -118.24 137.91 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 120.903 0.382 . . . . 0.0 111.113 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -103.47 116.24 32.03 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.485 ' HA ' HD11 ' A' ' 44' ' ' LEU . 30.4 p -70.42 -10.5 59.27 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -170.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.406 ' HE2' ' OE1' ' A' ' 30' ' ' GLN . 66.6 mmtt -71.8 -22.85 61.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.937 0.399 . . . . 0.0 110.333 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.61 -31.23 15.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.463 0.649 . . . . 0.0 110.088 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 41' ' ' THR . 85.5 mt -58.49 126.94 29.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.865 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -92.4 106.07 18.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.474 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.629 ' HA ' HG11 ' A' ' 60' ' ' VAL . 42.7 mt -72.8 107.53 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.774 0.797 . . . . 0.0 110.565 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 61' ' ' ASP . 11.8 mt -80.78 -49.38 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.983 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 48.9 tttm -144.79 101.17 3.62 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.479 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.759 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.6 m -82.39 124.8 30.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.2 m -145.81 -179.78 6.93 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.137 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.604 ' HG3' HD13 ' A' ' 12' ' ' LEU . 7.9 pt-20 -155.45 174.17 15.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.514 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 53' ' ' LYS . 14.8 t70 -150.91 -170.24 3.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -59.49 105.71 0.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 77.18 -9.27 1.55 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.793 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.6 m-85 -114.45 151.08 33.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.117 0.484 . . . . 0.0 111.798 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.799 ' HD1' ' HB3' ' A' ' 74' ' ' LYS . 2.8 m-85 -112.14 143.88 42.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.426 164.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.701 ' CE1' ' HA ' ' A' ' 96' ' ' TYR . 32.3 m-85 -131.92 111.67 11.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.413 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.624 HG22 HD13 ' A' ' 26' ' ' LEU . 21.4 t -110.26 108.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -91.7 120.86 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.629 HG11 ' HA ' ' A' ' 46' ' ' ILE . 13.0 m -128.72 154.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.543 ' HB2' HD23 ' A' ' 47' ' ' LEU . 60.1 t0 -90.6 114.67 26.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 169.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.45 ' HA ' HD21 ' A' ' 44' ' ' LEU . . . -72.56 -14.35 61.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.46 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.34 -113.13 0.54 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.39 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.61 76.27 1.68 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 109.637 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.625 ' O ' ' HE2' ' A' ' 88' ' ' LYS . . . 138.2 -9.71 3.55 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.511 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -82.47 170.17 15.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.786 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 48.1 mtpt -160.54 107.86 1.56 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.842 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 14.7 t -129.66 138.09 51.0 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.701 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.602 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 31.3 ttmt -111.87 114.28 27.12 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -76.39 120.65 21.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.119 0.485 . . . . 0.0 109.947 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.785 ' HD2' ' HB2' ' A' ' 96' ' ' TYR . 79.2 tttt -94.01 94.6 8.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.075 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 60.3 mt -116.41 89.53 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.511 0.672 . . . . 0.0 109.926 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.793 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 48.7 ttt180 -63.43 99.09 0.19 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.978 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.799 ' HB3' ' HD1' ' A' ' 56' ' ' TYR . 12.1 ptpt -47.45 112.4 0.54 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.801 -173.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.726 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 15.0 t0 37.57 82.16 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.176 177.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.609 HG12 ' HG2' ' A' ' 73' ' ' ARG . 8.7 m -127.26 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.102 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 74.12 -69.18 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.483 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 14.9 p -86.88 141.94 33.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.058 0.456 . . . . 0.0 110.348 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 87.5 Cg_endo -79.72 86.94 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.11 2.54 . . . . 0.0 112.581 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 178.86 -175.72 0.22 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.407 0.623 . . . . 0.0 111.841 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.512 ' HE3' HG12 ' A' ' 33' ' ' ILE . 19.9 ptp -84.04 155.33 22.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.438 171.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.515 ' CG1' ' HG2' ' A' ' 71' ' ' LYS . 12.3 p -83.15 -26.04 7.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.91 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -179.86 -173.15 44.63 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.333 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 84' ' ' ARG . 34.7 ttt-85 -156.56 125.71 6.06 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.624 ' HB3' ' CE2' ' A' ' 96' ' ' TYR . 38.1 tttt -149.85 135.74 18.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 25.5 m -97.3 114.96 26.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.507 0.67 . . . . 0.0 111.238 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.525 ' HA ' ' HB3' ' A' ' 91' ' ' ASP . 15.2 ttt180 -101.08 77.77 1.85 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 -174.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.786 ' HA ' ' HB2' ' A' ' 67' ' ' LYS . 42.8 tttm -90.21 -45.41 9.1 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.426 -172.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.75 -79.94 0.61 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.426 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -132.1 78.71 1.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.059 0.457 . . . . 0.0 110.628 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.578 ' OD2' ' HG2' ' A' ' 85' ' ' LYS . 28.6 t70 -111.38 88.8 2.88 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.77 154.66 20.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.474 -168.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -163.56 177.86 8.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -76.4 -71.13 0.41 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 96' ' ' TYR . . . -81.14 179.64 53.48 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 168.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.785 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.363 -176.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 CA-C-O 120.41 -0.105 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.408 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 5.9 t -81.58 131.89 35.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -174.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 42.3 mt -133.46 12.86 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.674 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.791 HG13 HD21 ' A' ' 3' ' ' LEU . 8.2 tp -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.978 -166.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.96 HD11 ' HB2' ' A' ' 7' ' ' LEU . 2.2 mm? 66.29 57.59 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.93 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.629 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 3.5 p-10 -60.26 -27.17 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.808 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.05 19.63 53.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.234 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.8 ' HA ' HG21 ' A' ' 76' ' ' VAL . 29.2 t70 61.18 75.0 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.783 0.801 . . . . 0.0 110.201 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.96 ' HB2' HD11 ' A' ' 3' ' ' LEU . 67.2 mt -130.97 158.0 41.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.193 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -110.29 -47.27 3.31 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.472 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 64.5 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.934 0.771 . . . . 0.0 110.398 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.84 113.92 14.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.58 ' HB3' ' HZ2' ' A' ' 11' ' ' LYS . 2.8 ttpm? -65.16 -47.66 76.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.742 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.8 tt -146.45 117.58 7.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.573 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 88.8 tttt -88.49 -75.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.445 0.64 . . . . 0.0 111.651 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.573 ' HG ' ' HG2' ' A' ' 13' ' ' LYS . 94.2 mt -106.55 148.78 37.41 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -71.06 120.32 6.94 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 110.08 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.564 HG21 ' HA ' ' A' ' 48' ' ' LYS . 3.7 p 40.52 95.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.998 1.38 . . . . 0.0 112.721 -168.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.12 161.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.128 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.36 143.22 56.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.406 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -65.72 -19.06 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.995 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.79 -49.82 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.458 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 67.0 t80 -61.35 -38.22 86.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.705 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.33 -51.38 53.06 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 27.3 mmtp -52.59 -38.96 61.07 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.343 0.257 . . . . 0.0 111.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.668 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.8 mm-40 -55.22 -55.26 33.29 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 123.257 0.348 . . . . 0.0 111.29 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.523 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 38.8 mt -51.84 -61.57 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.403 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.663 HD13 HG22 ' A' ' 58' ' ' VAL . 8.2 mp -62.43 -31.81 72.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.961 -172.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.39 -34.07 76.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.733 0.301 . . . . 0.0 111.033 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 49.9 mttm -77.64 -24.0 49.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 110.682 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.895 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 96.7 m-85 -103.51 5.2 36.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -49.17 -47.37 45.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.137 0.575 . . . . 0.0 112.404 -173.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.84 -39.26 93.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.875 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.9 -40.18 61.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.404 0.621 . . . . 0.0 109.892 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.547 HG21 ' HB ' ' A' ' 39' ' ' VAL . 98.0 mt -61.21 -36.74 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.428 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.581 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.9 tttm -84.68 -30.91 24.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.238 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.57 -44.12 78.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.907 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -85.55 -47.79 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -111.49 -12.12 14.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.3 44.32 52.68 Favored Glycine 0 C--N 1.328 0.114 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.773 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.581 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 18.8 t -114.77 146.88 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.873 0.368 . . . . 0.0 111.381 -175.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' CG ' ' HZ1' ' A' ' 42' ' ' LYS . 14.1 t70 -103.01 112.85 25.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 72.0 p -73.84 -14.4 61.08 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -81.31 -44.21 17.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.0 109.86 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.42 -21.28 60.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.949 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.718 HD22 HG22 ' A' ' 60' ' ' VAL . 11.1 tp -60.21 133.13 55.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.312 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -95.56 104.6 16.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.151 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.534 ' HA ' HG11 ' A' ' 60' ' ' VAL . 43.6 mt -78.73 121.42 31.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.431 0.634 . . . . 0.0 110.71 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 61' ' ' ASP . 12.2 mt -92.2 -51.28 5.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.266 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.564 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.0 ttmt -143.44 114.41 7.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.646 -176.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.7 m -98.41 130.1 45.04 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.334 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 p -163.96 -178.09 5.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.812 0.339 . . . . 0.0 110.599 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 9.8 pt-20 -140.37 159.7 41.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.475 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.498 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 4.3 t70 -138.95 -148.58 0.26 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.874 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 32.2 mmtp -65.45 91.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.044 0.137 . . . . 0.0 110.791 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.675 ' HB3' HG13 ' A' ' 76' ' ' VAL . 62.5 mtt85 71.98 -12.0 0.72 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.062 0.545 . . . . 0.0 112.359 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.47 146.27 33.41 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.208 -0.307 . . . . 0.0 111.082 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.526 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 7.0 m-85 -97.96 142.87 29.16 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 165.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.6 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 66.8 m-85 -126.63 107.55 10.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.073 0.464 . . . . 0.0 110.747 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.663 HG22 HD13 ' A' ' 26' ' ' LEU . 18.1 t -108.97 99.51 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.532 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 9.5 t -77.31 122.17 24.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.718 HG22 HD22 ' A' ' 44' ' ' LEU . 28.7 m -130.46 155.44 41.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.008 0.432 . . . . 0.0 111.266 -177.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.522 ' HB2' HD23 ' A' ' 47' ' ' LEU . 10.5 t70 -99.88 122.16 42.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.541 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -75.95 -0.96 23.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 -39.0 3.14 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.559 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.87 -15.72 61.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.328 0.585 . . . . 0.0 110.307 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.41 -23.98 5.65 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.671 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.541 ' HG2' ' HB3' ' A' ' 62' ' ' ALA . 8.8 pt-20 -74.81 152.86 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.8 mttp -125.13 108.33 11.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.305 0.574 . . . . 0.0 110.122 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.954 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 60.6 m -107.85 133.13 52.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.77 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.6 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.0 tppp? -97.13 102.98 14.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.525 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 20.8 m-85 -67.36 117.36 9.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.871 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 31.5 tttm -93.52 72.79 4.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.946 0.879 . . . . 0.0 109.368 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.568 HG12 ' HG2' ' A' ' 81' ' ' MET . 82.9 mt -75.78 91.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.991 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.568 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 24.9 ttt180 -62.6 135.76 57.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.687 ' C ' ' H ' ' A' ' 76' ' ' VAL . 99.0 mttt -59.73 172.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.723 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 43.5 t0 -74.5 28.36 0.08 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.783 1.278 . . . . 0.0 108.871 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.8 HG21 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -74.46 8.87 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 112.967 -1.924 . . . . 0.0 109.901 -174.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.3 t70 167.46 -43.09 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.842 -168.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.33 142.54 40.45 Favored Pre-proline 0 CA--C 1.502 -0.866 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.03 -171.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -89.07 15.26 2.06 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.262 1.975 . . . . 0.0 111.803 171.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.895 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 21.4 mtmt -143.3 -179.75 6.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.482 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.568 ' HG2' HG12 ' A' ' 72' ' ' ILE . 23.2 mtm -81.21 117.34 21.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.404 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.613 HG13 ' HZ2' ' A' ' 71' ' ' LYS . 9.2 p -56.73 -32.92 39.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.423 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.59 -174.21 34.91 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.643 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -171.97 90.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.467 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 24.0 tttp -107.85 131.5 54.42 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.809 -174.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.954 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 4.0 m -84.88 130.41 34.66 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.442 ' HD2' ' OH ' ' A' ' 96' ' ' TYR . 53.1 mtt180 -132.64 83.81 2.1 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.634 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 1.7 ttpm? -90.72 15.41 11.16 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.143 -174.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -140.97 -4.82 1.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.266 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -151.6 153.52 34.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -172.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -122.52 -57.01 1.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.736 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -65.56 108.1 1.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.349 0.595 . . . . 0.0 110.553 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.52 176.58 5.1 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.887 -173.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.43 -63.91 1.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.541 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.551 ' HA3' ' HE3' ' A' ' 71' ' ' LYS . . . -154.23 135.99 5.01 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.085 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.871 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 14.8 m-30 . . . . . 0 C--O 1.245 0.854 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 29' ' ' PHE . 47.3 t -58.65 128.4 36.99 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.39 0.276 . . . . 0.0 110.871 -177.011 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.83 12.15 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.933 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.466 HG23 ' HE1' ' A' ' 56' ' ' TYR . 2.9 tp -76.72 -13.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.499 0.666 . . . . 0.0 110.69 -171.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.761 HD23 ' HA ' ' A' ' 7' ' ' LEU . 9.7 mp -125.13 -178.71 4.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.9 57.08 1.56 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.884 0.85 . . . . 0.0 109.758 170.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.09 52.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.625 ' CG ' ' H ' ' A' ' 7' ' ' LEU . 7.2 p-10 -130.49 -120.33 0.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.226 -173.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.761 ' HA ' HD23 ' A' ' 3' ' ' LEU . 42.4 tp 175.69 98.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.57 0.623 . . . . 0.0 110.966 -172.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.8 mt -59.81 131.85 52.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.0 110.242 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -124.11 -7.52 7.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.152 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.52 -46.63 89.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -100.5 115.3 29.77 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 166.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.768 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 37.4 tp -178.07 141.61 0.26 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.388 -176.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.768 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 29.0 mtmt 63.91 25.76 14.05 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.957 176.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.23 163.15 19.21 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.573 -174.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -64.74 -158.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.424 2.75 . . . . 0.0 111.942 169.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.49 116.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 122.002 0.906 . . . . 0.0 110.533 175.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.613 HG12 ' HA ' ' A' ' 50' ' ' SER . 10.7 mm -71.41 161.29 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.743 -177.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -49.45 129.75 19.24 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.161 0.288 . . . . 0.0 110.759 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.488 ' HA ' HG23 ' A' ' 46' ' ' ILE . 29.6 p-10 -60.23 -33.97 73.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 6.6 mt -58.75 -44.86 90.67 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.99 173.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.629 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 72.3 t80 -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.748 0.308 . . . . 0.0 110.334 -177.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.41 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -67.13 -45.4 81.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.709 177.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.435 ' HB2' HG13 ' A' ' 46' ' ' ILE . 7.8 tppt? -63.51 -37.05 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.099 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.64 -57.47 11.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.358 177.321 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 3.6 mt -51.95 -55.82 17.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.117 0.484 . . . . 0.0 109.758 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.873 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 21.9 mt -50.9 -48.34 60.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.427 176.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' HA ' ' HG1' ' A' ' 41' ' ' THR . 15.5 t70 -63.36 -40.1 96.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 110.381 -178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 11.8 mttp -56.92 -51.1 70.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.343 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 0' ' ' SER . 1.3 m-85 -97.72 13.19 31.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.042 -171.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -31.73 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.592 0.234 . . . . 0.0 111.427 -173.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.52 -31.17 68.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.8 0.333 . . . . 0.0 110.674 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -78.88 -43.3 25.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.334 0.588 . . . . 0.0 109.566 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.54 HG21 ' HB ' ' A' ' 39' ' ' VAL . 97.3 mt -60.62 -34.89 60.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.554 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 1.6 tmtp? -80.9 -40.49 24.57 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 110.051 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.18 -46.3 75.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.995 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.84 -54.81 5.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.463 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.521 ' HB2' HG21 ' A' ' 39' ' ' VAL . 6.5 m-85 -104.98 -31.21 9.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.12 -170.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.51 57.1 2.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.729 -177.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.625 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 22.0 t -124.4 148.4 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.809 0.338 . . . . 0.0 111.055 -175.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' O ' HD12 ' A' ' 44' ' ' LEU . 11.8 t0 -106.48 112.74 25.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 170.172 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.873 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 45.7 p -74.72 -15.75 60.77 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.83 -173.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.18 -25.52 60.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.152 178.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.72 -23.04 25.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.059 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 41' ' ' THR . 3.6 mp -65.66 109.67 2.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.696 -178.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 18.7 tptm -71.71 114.15 9.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.212 174.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.585 ' HA ' HG13 ' A' ' 60' ' ' VAL . 10.2 mm -71.21 107.34 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.526 HD23 ' HB2' ' A' ' 61' ' ' ASP . 14.0 mt -78.71 -57.84 3.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.705 0.764 . . . . 0.0 109.407 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -147.92 110.54 4.71 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.199 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.522 ' CG2' ' HB ' ' A' ' 17' ' ' ILE . 6.5 m -81.87 138.2 35.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.613 ' HA ' HG12 ' A' ' 17' ' ' ILE . 6.1 p -160.57 -175.96 5.3 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -165.05 167.06 18.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.582 0.706 . . . . 0.0 111.321 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.865 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 8.1 t70 -114.97 -157.99 0.65 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 171.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.592 ' HA ' HD12 ' A' ' 12' ' ' LEU . 86.0 mttt -68.22 -71.88 0.2 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.957 176.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -90.65 17.46 7.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.379 -173.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.478 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 97.4 m-85 -146.22 148.32 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -170.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CD1' ' HG2' ' A' ' 74' ' ' LYS . 19.2 m-85 -109.46 143.74 38.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.384 169.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.865 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 76.7 m-85 -129.03 92.05 3.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.997 0.427 . . . . 0.0 110.459 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 t -97.33 98.58 7.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 16.6 m -77.47 124.56 28.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -138.55 143.95 31.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -177.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.526 ' HB2' HD23 ' A' ' 47' ' ' LEU . 9.3 t70 -80.39 97.12 6.92 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 173.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.12 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.751 -171.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.08 -11.03 56.65 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.077 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.43 -32.66 71.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.156 0.503 . . . . 0.0 110.244 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.1 -41.09 0.25 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 37.3 mt-10 -115.45 165.84 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.251 0.548 . . . . 0.0 111.464 -178.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.75 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 47.2 mttp -82.39 115.84 21.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.702 167.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.893 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -96.02 164.84 12.53 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.257 -169.497 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HD3' ' CD1' ' A' ' 57' ' ' TYR . 40.4 ttmt -134.74 102.82 5.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.474 ' CG ' HD23 ' A' ' 26' ' ' LEU . 16.0 m-85 -69.03 106.41 2.77 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.633 0.73 . . . . 0.0 110.179 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.67 ' HD3' ' HA ' ' A' ' 96' ' ' TYR . 17.5 tttt -95.42 82.38 3.68 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.838 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.816 HG12 ' HG2' ' A' ' 81' ' ' MET . 52.5 mt -78.68 120.45 29.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.699 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 58.4 ttt180 -79.68 25.01 0.35 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.407 0.622 . . . . 0.0 109.511 -175.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.599 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 93.2 mttt 51.12 -165.46 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.279 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.647 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 11.9 t70 -103.12 47.48 0.88 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 167.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 6' ' ' ASP . 5.3 p -77.64 -2.29 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.14 -174.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 173.0 -54.48 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.983 -168.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 32.4 m -92.15 151.49 41.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.242 175.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 61.6 Cg_endo -92.71 32.21 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.583 2.855 . . . . 0.0 112.558 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' HA ' ' H ' ' A' ' 0' ' ' SER . 63.8 pttt -159.16 -157.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.02 -175.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.816 ' HG2' HG12 ' A' ' 72' ' ' ILE . 5.2 mtm -107.6 132.13 53.62 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.699 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 10.4 p -77.81 -37.27 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.209 0.528 . . . . 0.0 110.177 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 71' ' ' LYS . . . -126.85 164.67 20.34 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.539 -174.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.99 25.71 0.06 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.712 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 60.7 mmtt -88.4 131.78 34.71 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.285 -167.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.893 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 6.5 m -83.68 136.85 34.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 173.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 91' ' ' ASP . 8.1 ttt180 -129.6 83.21 2.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 0.0 109.977 -172.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.75 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 33.7 mmtm -140.53 -38.26 0.44 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.108 -176.169 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -126.08 73.23 1.34 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.104 0.478 . . . . 0.0 110.175 174.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.5 t70 67.11 117.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.002 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.563 ' HB3' ' HG3' ' A' ' 87' ' ' ARG . 22.6 t70 -140.66 141.6 35.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.229 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -162.27 125.04 2.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.848 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.642 ' HB3' ' HB3' ' A' ' 96' ' ' TYR . 12.6 t70 -146.33 164.02 33.69 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.36 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.32 -26.83 24.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.259 0.552 . . . . 0.0 110.426 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.416 ' CA ' HG23 ' A' ' 82' ' ' VAL . . . -109.76 57.12 0.44 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 177.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.712 ' CD2' ' HB2' ' A' ' 85' ' ' LYS . 24.7 t80 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.434 -171.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.696 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 29.4 t -81.68 -47.93 12.33 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 72.8 mt 64.3 13.38 7.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.299 173.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.512 ' O ' HG21 ' A' ' 2' ' ' ILE . 9.6 tp -115.0 87.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.238 1.018 . . . . 0.0 109.716 176.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.916 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.6 pt? -128.23 -48.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.475 -172.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.486 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.1 m-20 66.34 -64.15 0.23 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 124.017 0.823 . . . . 0.0 110.135 -171.416 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.33 70.62 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 177.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 35.5 t70 61.72 87.33 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.234 0.54 . . . . 0.0 110.419 -172.066 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 54' ' ' ARG . 13.3 mt 75.29 163.99 0.26 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.068 177.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.621 ' HG ' ' H ' ' A' ' 9' ' ' LYS . 2.0 pt? -153.95 -55.11 0.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.709 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.621 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 10.2 mtmp? 75.69 -54.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 167.334 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.44 8.13 35.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -169.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HB2' HD11 ' A' ' 8' ' ' LEU . 30.7 ttpt -61.82 -72.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.754 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.43 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 26.9 mt -109.03 124.8 51.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.767 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -138.25 29.3 2.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 -171.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.02 143.09 25.9 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.461 -177.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.19 130.03 24.46 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.924 2.416 . . . . 0.0 111.72 175.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 48' ' ' LYS . 10.0 p 39.83 99.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 123.367 1.556 . . . . 0.0 114.057 -177.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.06 160.03 4.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.637 176.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.22 157.42 31.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.157 -173.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.477 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.0 p30 -65.26 -20.01 66.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.18 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.5 tp -65.66 -43.94 87.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 178.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HE2' ' HE1' ' A' ' 56' ' ' TYR . 73.8 t80 -64.05 -39.04 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.335 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . -71.66 -32.89 63.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.143 176.715 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 23.8 tptt -62.63 -40.75 97.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.6 mm-40 -58.97 -51.49 69.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.101 175.048 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD11 ' HA3' ' A' ' 22' ' ' GLY . 84.3 mt -51.71 -64.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 175.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.854 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.8 mt -55.75 -31.64 62.73 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.798 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.25 -45.69 83.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.069 0.461 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.616 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 56.3 mttm -67.92 -30.57 69.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.696 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 79.7 m-85 -99.42 1.21 44.0 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -53.64 -39.76 65.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.673 0.273 . . . . 0.0 111.093 -177.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.5 -36.03 82.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.627 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 15.0 t70 -80.62 -40.56 25.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.904 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CD1' HD21 ' A' ' 26' ' ' LEU . 80.8 mt -67.12 -30.26 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.412 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 44.5 tttp -83.48 -23.72 32.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 0.0 109.724 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.28 -45.7 65.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.336 170.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.627 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 51.3 mttm -82.13 -27.02 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.888 -173.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.631 ' HB2' HG21 ' A' ' 39' ' ' VAL . 49.1 m-85 -134.06 -33.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -177.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 97.09 19.96 24.78 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.42 -178.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.631 HG21 ' HB2' ' A' ' 37' ' ' TYR . 38.8 t -82.02 153.49 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.146 0.498 . . . . 0.0 111.908 -174.418 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 42' ' ' LYS . 26.8 t70 -108.34 106.96 17.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.91 169.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.854 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 40.6 p -69.11 -16.2 63.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.062 -172.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.726 ' HZ2' ' HB3' ' A' ' 42' ' ' LYS . 7.2 ttpm? -63.89 -21.59 66.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.839 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -105.16 -7.36 19.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.471 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 76.5 mt -66.86 117.26 8.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.851 -179.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 87.4 tttt -74.58 97.04 3.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.574 ' HA ' HG11 ' A' ' 60' ' ' VAL . 53.0 mt -77.13 122.0 30.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.638 0.732 . . . . 0.0 111.133 -175.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -94.16 -50.02 5.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.367 -175.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HA ' HG22 ' A' ' 16' ' ' VAL . 34.5 ttmt -145.64 121.36 10.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.271 -173.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 58' ' ' VAL . 19.0 m -113.98 135.31 54.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.41 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -160.32 174.82 13.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.672 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 12.5 pt-20 -131.25 150.98 51.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.459 0.647 . . . . 0.0 110.322 172.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.27 -151.62 0.48 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -64.75 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.114 177.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.598 ' HA ' HD22 ' A' ' 7' ' ' LEU . 50.7 mtt180 -87.32 11.43 14.39 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.821 -0.55 . . . . 0.0 111.011 178.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 4.2 m-85 -133.18 161.0 35.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.125 -1.03 . . . . 0.0 113.579 -163.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.672 ' CE1' ' HB3' ' A' ' 51' ' ' GLU . 5.5 m-85 -124.18 149.65 46.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.594 169.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.606 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 77.1 m-85 -134.66 102.51 5.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.676 0.274 . . . . 0.0 110.945 -178.222 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.424 HG23 HG21 ' A' ' 49' ' ' THR . 9.9 t -112.51 103.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.535 178.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m -87.28 125.02 33.96 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 46' ' ' ILE . 10.1 m -131.19 152.55 37.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 111.507 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.6 t70 -90.34 121.42 32.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 171.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.86 1.97 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.04 -53.31 4.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.338 176.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.55 -23.4 66.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.299 0.571 . . . . 0.0 110.679 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.35 7.97 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.712 -178.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.568 ' HA ' ' CD ' ' A' ' 88' ' ' LYS . 36.6 mt-10 -75.47 150.99 38.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 34.5 ttmt -127.01 107.2 9.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -176.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.978 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 34.4 m -106.35 132.06 52.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.339 0.59 . . . . 0.0 110.94 -175.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.606 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.5 tppt? -101.07 100.79 11.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -75.16 106.98 6.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.074 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.846 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 81.1 tttt -98.76 108.86 21.65 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.901 0.857 . . . . 0.0 110.3 -178.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 71.0 mt -105.82 114.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.937 -178.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.776 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 28.9 ttp180 -79.35 29.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.366 0.603 . . . . 0.0 110.485 -172.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.55 ' HG2' ' CD2' ' A' ' 56' ' ' TYR . 84.8 mttt 57.56 -178.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.088 -178.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.916 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 2.0 t70 -87.31 42.2 1.02 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.563 . . . . 0.0 109.98 -174.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 73' ' ' ARG . 22.7 m -76.91 105.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.109 0.481 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 69.91 -64.41 0.35 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.294 -175.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -84.96 151.37 57.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.327 . . . . 0.0 110.19 177.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.724 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 60.9 Cg_endo -86.37 29.3 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.039 2.493 . . . . 0.0 111.428 174.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 1.9 ttmm -132.44 -158.6 0.9 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.376 0.608 . . . . 0.0 111.751 -169.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.503 ' SD ' ' HD3' ' A' ' 84' ' ' ARG . 3.6 ptt? -118.53 166.68 12.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.068 -176.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.776 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 3.6 p -81.55 -52.35 13.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 177.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.625 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -177.78 128.21 1.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.247 -177.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.503 ' HD3' ' SD ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -97.83 118.85 35.31 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.382 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.877 ' HD2' ' HA ' ' A' ' 96' ' ' TYR . 35.9 tttt -122.49 114.71 21.06 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.982 -169.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.978 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 22.6 m -72.22 122.88 21.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.158 173.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 92' ' ' ASP . 11.2 ptm180 -126.61 78.26 1.77 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.873 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.568 ' CD ' ' HA ' ' A' ' 66' ' ' GLU . 29.7 ttpt -74.34 -12.84 60.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.134 -173.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.19 174.35 9.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.585 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -85.53 -20.97 28.83 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -174.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.46 136.09 57.41 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.473 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 87' ' ' ARG . 38.7 t70 -89.98 108.42 19.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.022 0.439 . . . . 0.0 110.599 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 96' ' ' TYR . 7.0 t70 -77.86 154.08 32.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.487 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -124.81 -10.22 7.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.912 0.387 . . . . 0.0 111.025 178.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.56 95.25 0.41 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.877 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 1.7 m-85 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.16 -174.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.487 ' H1 ' ' CG ' ' A' ' 32' ' ' ASP . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.745 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 38.8 m -76.31 66.76 2.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.463 0.649 . . . . 0.0 109.586 175.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.455 ' O ' HD11 ' A' ' 1' ' ' LEU . 3.7 pp -88.5 140.24 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.749 -169.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 2' ' ' ILE . 8.5 tp -166.5 45.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.889 1.328 . . . . 0.0 107.487 175.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.447 ' HG ' ' CG ' ' A' ' 75' ' ' ASP . 13.7 mt -82.25 -174.41 5.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.584 -171.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 166.79 -32.0 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.076 -174.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.93 80.66 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.334 176.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 23.4 t70 73.49 11.03 4.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 121.236 0.541 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 42.2 mt 82.86 172.95 0.09 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.427 173.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.7 119.71 7.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.139 -174.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -80.34 95.45 6.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.182 -176.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -85.84 -86.43 0.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -171.69 138.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 111.217 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.08 115.14 7.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.203 172.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 39.9 ttmt -81.72 106.61 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.522 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.644 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 13.0 mt 58.88 173.99 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 123.487 0.715 . . . . 0.0 112.152 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.644 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 38.8 Cg_endo -69.8 -19.97 35.24 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.91 1.74 . . . . 0.0 111.495 171.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 48' ' ' LYS . 6.7 t -138.49 113.2 8.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.9 176.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 12.3 mt -68.77 175.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.942 -178.009 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.444 ' H ' HG23 ' A' ' 17' ' ' ILE . 9.0 m-20 -51.63 -20.71 2.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 96.3 m-20 73.1 -40.09 0.46 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.389 0.676 . . . . 0.0 110.999 -174.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.59 -35.77 81.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 169.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.55 ' O ' HD11 ' A' ' 25' ' ' LEU . 90.9 t80 -59.13 -42.48 90.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -65.55 -42.65 95.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 175.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -51.78 -41.65 61.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.461 0.304 . . . . 0.0 110.857 176.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.4 mm-40 -57.84 -54.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.001 173.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.55 HD11 ' O ' ' A' ' 21' ' ' PHE . 10.8 mp -47.68 -63.93 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.289 174.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.691 HD13 HG22 ' A' ' 58' ' ' VAL . 9.6 mp -59.84 -32.18 70.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.28 -174.136 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.19 -42.72 93.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 52.0 mttm -71.73 -42.48 67.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 110.646 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.745 ' CD1' ' HA ' ' A' ' 0' ' ' SER . 2.0 m-30 -87.38 -0.48 56.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.378 -173.42 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 8.0 tt0 -56.43 -36.97 69.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.132 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.15 -36.08 65.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.009 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.487 ' CG ' ' H1 ' ' A' ' -1' ' ' GLY . 67.9 m-20 -74.86 -50.08 18.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.315 0.579 . . . . 0.0 109.832 178.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.564 HG21 ' HB ' ' A' ' 39' ' ' VAL . 45.8 mt -62.79 -31.07 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.993 -177.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' O ' ' HA3' ' A' ' 38' ' ' GLY . 66.5 tttt -89.11 -29.17 19.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.43 -174.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.39 -51.77 33.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 0.0 110.566 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.17 -43.1 54.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.671 -172.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.587 ' HB2' HG21 ' A' ' 39' ' ' VAL . 15.9 m-85 -120.07 -17.95 8.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.824 0.345 . . . . 0.0 111.416 -173.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 81.36 30.74 36.09 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 37' ' ' TYR . 16.6 t -92.6 147.33 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.954 0.407 . . . . 0.0 111.418 -175.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -108.99 120.67 43.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 33.4 p -80.07 -13.78 59.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -170.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -74.81 -20.97 59.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.506 0.669 . . . . 0.0 109.566 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -86.77 -41.17 14.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.352 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.5 HD11 HG23 ' A' ' 41' ' ' THR . 91.6 mt -53.56 109.49 0.45 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.246 177.065 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 79.1 tttt -77.36 108.89 10.82 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.548 ' HA ' HG11 ' A' ' 60' ' ' VAL . 42.8 mt -73.54 115.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.482 0.658 . . . . 0.0 110.171 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.8 mt -87.33 -39.11 15.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.196 -175.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HG3' HG21 ' A' ' 16' ' ' VAL . 17.0 ttpp -156.57 104.98 2.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.003 -176.002 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.65 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 14.8 m -83.9 128.78 34.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -155.17 179.2 9.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.35 -177.07 6.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.851 176.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.631 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t70 -132.27 -88.01 0.45 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.631 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 40.9 mmtm -128.57 -81.52 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 54' ' ' ARG . 67.5 mtt85 -88.69 23.7 2.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -142.95 132.37 23.51 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -169.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.864 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 30.3 m-85 -101.65 149.77 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 166.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -134.36 97.47 3.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.859 0.361 . . . . 0.0 110.091 177.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.691 HG22 HD13 ' A' ' 26' ' ' LEU . 14.0 t -105.16 96.64 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.831 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 11.8 t -76.03 126.5 31.11 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 46' ' ' ILE . 26.9 m -135.65 150.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.457 0.646 . . . . 0.0 112.263 -174.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.5 t70 -99.14 123.93 43.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.092 173.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.68 4.94 10.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.883 -171.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.98 -174.07 45.76 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.81 -36.69 79.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 -177.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.67 -6.4 6.62 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.75 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.644 ' HA ' ' CD ' ' A' ' 88' ' ' LYS . 2.6 mp0 -75.17 119.74 19.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -178.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.618 ' HZ1' ' HB3' ' A' ' 67' ' ' LYS . 7.4 ttpm? -145.1 117.0 8.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.507 -178.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.847 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 3.3 m -127.96 159.97 33.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.451 -175.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.3 ttmt -123.62 106.19 10.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -73.45 96.46 2.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.875 0.845 . . . . 0.0 110.51 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 1.027 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 50.8 tttp -82.95 79.64 9.25 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.312 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.864 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 45.0 mt -75.5 105.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.398 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.571 ' HD2' HG13 ' A' ' 82' ' ' VAL . 43.1 ttt-85 -74.34 9.72 1.57 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.612 0.72 . . . . 0.0 110.184 -175.061 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 72' ' ' ILE . 94.6 mttt 63.5 177.05 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.482 176.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.79 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 8.0 t0 -80.68 64.35 5.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 177.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 4.0 m -85.98 87.16 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.092 175.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 5.1 m-20 74.69 -53.58 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -174.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.438 HG21 ' HD2' ' A' ' 79' ' ' PRO . 14.3 p -114.82 135.57 22.42 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.79 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 23.7 Cg_endo -65.59 -50.78 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.052 2.502 . . . . 0.0 112.918 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -46.71 128.97 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.746 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 159.48 6.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.897 -175.229 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.571 HG13 ' HD2' ' A' ' 73' ' ' ARG . 3.8 p -103.62 -27.97 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.573 177.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 1.027 ' HA2' ' HB3' ' A' ' 71' ' ' LYS . . . -118.76 135.61 11.58 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.946 -170.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -155.23 19.03 0.42 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.033 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 96' ' ' TYR . 10.9 tttm -71.53 117.83 13.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.196 -168.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.847 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 60.6 m -84.42 111.03 19.09 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -86.77 66.84 9.64 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 122.091 0.948 . . . . 0.0 109.425 179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.644 ' CD ' ' HA ' ' A' ' 66' ' ' GLU . 51.6 mtmt -92.57 -29.86 15.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.394 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.72 -61.4 1.94 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.583 173.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -168.11 -174.06 2.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -123.08 169.11 11.54 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -108.12 -80.9 0.57 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.497 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.6 t70 179.99 -56.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -176.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -155.99 163.49 39.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.536 176.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.91 75.07 1.02 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -173.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.583 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 27.7 m-85 . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.772 -175.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.542 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . . . . . . 0 N--CA 1.487 2.051 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.531 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 26.8 t -103.07 2.24 34.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.797 0.808 . . . . 0.0 109.161 174.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.472 ' O ' HD13 ' A' ' 3' ' ' LEU . 89.2 mt -85.55 11.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.088 175.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.449 HD11 ' HD3' ' A' ' 74' ' ' LYS . 9.2 tt -78.06 65.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.013 170.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.563 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -103.29 154.72 19.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.931 -164.732 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.677 ' HB3' HD11 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -174.09 5.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.185 169.149 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.84 62.87 0.71 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -179.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 9.1 t70 70.29 25.45 4.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.117 0.961 . . . . 0.0 108.672 179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.677 HD11 ' HB3' ' A' ' 4' ' ' ASP . 84.0 mt -110.21 109.47 19.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.992 -177.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.736 HD13 ' HD2' ' A' ' 74' ' ' LYS . 2.0 mm? -64.98 -56.34 13.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.134 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 67.52 -62.58 0.33 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.831 0.707 . . . . 0.0 111.178 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.52 85.8 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 0.0 110.576 176.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.72 132.05 55.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 169.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD11 HD13 ' A' ' 14' ' ' LEU . 67.0 mt -82.8 -169.9 2.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.295 0.569 . . . . 0.0 111.89 -171.026 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.76 21.23 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.449 -170.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.446 HD13 HD11 ' A' ' 12' ' ' LEU . 1.3 pp -138.16 162.24 54.91 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.888 -167.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.74 -147.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.86 3.04 . . . . 0.0 112.699 171.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.594 ' HB ' ' HG3' ' A' ' 48' ' ' LYS . 11.0 p -47.09 130.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.235 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -97.78 -73.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.446 -175.938 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.579 ' H ' ' HB ' ' A' ' 49' ' ' THR . 5.4 m-20 64.72 12.23 7.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.776 177.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . 58.2 t30 -81.53 61.16 4.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.14 3.0 0.9 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.312 0.645 . . . . 0.0 110.7 -174.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.769 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 4.4 m-85 -63.69 -61.31 2.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.653 -175.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 49' ' ' THR . . . -62.26 -35.59 91.81 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.847 -177.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -68.2 -36.72 80.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.834 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.1 mm-40 -62.3 -53.95 47.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.04 0.536 . . . . 0.0 111.231 175.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 13.0 mt -52.74 -62.59 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.109 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 33.4 mt -58.7 -26.8 64.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.053 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.0 -43.55 82.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 177.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.2 mttm -72.68 -41.11 65.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.829 -179.162 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.531 ' HZ ' ' HB3' ' A' ' 0' ' ' SER . 96.8 m-85 -90.19 0.46 57.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.757 -176.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -50.9 -44.24 59.9 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.966 0.412 . . . . 0.0 110.792 177.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.72 -31.68 73.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.512 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -84.98 -41.4 15.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.51 0.672 . . . . 0.0 110.184 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.557 HG21 ' HB ' ' A' ' 39' ' ' VAL . 95.9 mt -63.07 -34.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.181 177.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 45.6 tttp -81.76 -34.23 30.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.509 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.94 -47.37 77.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.361 174.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -95.36 -42.45 8.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -172.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.561 ' HB2' HG21 ' A' ' 39' ' ' VAL . 3.3 m-85 -111.06 -13.11 14.11 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.502 -170.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.5 50.09 33.9 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.27 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.6 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 23.6 t -116.79 152.69 18.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 110.921 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -111.69 118.13 34.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 40.1 p -75.2 -14.29 60.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.033 0.444 . . . . 0.0 111.734 -173.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -76.93 -17.46 58.9 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.981 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -99.65 -16.21 18.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.372 0.606 . . . . 0.0 109.849 -179.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.47 HD11 ' HA ' ' A' ' 41' ' ' THR . 96.6 mt -68.09 121.4 16.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 53.4 tptt -85.03 103.08 13.74 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 176.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.578 ' HA ' HG11 ' A' ' 60' ' ' VAL . 34.1 mt -72.77 114.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.459 0.647 . . . . 0.0 109.96 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 61' ' ' ASP . 14.5 mt -87.13 -35.92 18.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.773 -177.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HG3' ' HB ' ' A' ' 16' ' ' VAL . 4.1 ttmp? -159.06 108.95 1.95 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.577 -177.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.579 ' HB ' ' H ' ' A' ' 18' ' ' ASP . 20.0 m -86.1 134.42 33.82 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.169 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 p -162.57 -179.24 6.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.383 . . . . 0.0 110.517 176.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 5.5 pt-20 -155.67 164.37 38.69 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.328 176.165 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -157.5 108.61 2.29 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 56.88 -115.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.097 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.468 ' HG2' HD12 ' A' ' 8' ' ' LEU . 46.4 mtt85 -88.55 16.24 6.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -172.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -138.35 137.6 37.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.924 -171.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.561 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 8.0 m-85 -98.13 140.39 32.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.661 168.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.537 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 97.4 m-85 -124.57 96.49 4.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.415 -178.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 3.4 t -103.26 90.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.6 t -72.97 120.86 19.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 46' ' ' ILE . 16.8 m -133.35 155.91 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.204 0.526 . . . . 0.0 111.048 -177.005 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.474 ' HB2' HD23 ' A' ' 47' ' ' LEU . 16.9 t0 -100.55 127.84 46.79 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.026 173.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -7.33 59.21 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.58 -81.61 1.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.015 172.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.21 -22.94 61.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.038 0.447 . . . . 0.0 111.352 -175.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.3 -90.01 0.75 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.821 -174.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -100.38 177.56 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.693 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . 39.9 ttmt -128.52 126.51 40.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 167.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 1.041 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.6 t -134.14 -177.83 4.76 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.451 0.643 . . . . 0.0 111.316 -167.31 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 37.6 ttmt -159.39 90.23 0.94 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CD1' HD22 ' A' ' 26' ' ' LEU . 72.2 m-85 -57.12 111.66 1.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.842 -176.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.9 tttt -94.5 77.36 3.84 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.325 -176.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.66 ' HA ' ' CB ' ' A' ' 81' ' ' MET . 78.3 mt -80.26 92.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.572 -177.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 1.012 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 49.3 ttt180 -56.83 127.48 31.9 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.259 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.736 ' HD2' HD13 ' A' ' 8' ' ' LEU . 95.2 mttt -63.57 179.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' CB ' ' HA ' ' A' ' 3' ' ' LEU . 5.9 t70 -61.43 94.02 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.754 0.788 . . . . 0.0 110.516 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 74' ' ' LYS . 12.4 m -138.29 84.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.814 174.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.2 t70 76.9 -49.48 0.55 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.826 -174.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 m -96.67 150.25 36.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.409 0.623 . . . . 0.0 111.136 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -95.21 29.11 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.245 3.297 . . . . 0.0 110.923 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -137.96 -176.6 4.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.557 -171.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.66 ' CB ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.17 146.07 23.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.875 179.614 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 1.012 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.6 p -83.0 -26.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.321 0.581 . . . . 0.0 110.282 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.92 -171.31 23.71 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.036 -175.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.0 ptt-85 -161.17 71.05 0.39 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.693 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 18.5 tptm -59.77 80.64 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.86 -167.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 1.041 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 27.8 m -92.54 -116.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' A' ' 90' ' ' ASP . 64.6 mtt180 75.47 -17.2 0.52 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.196 0.598 . . . . 0.0 110.772 177.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.693 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 63.6 tttp 75.58 -47.28 0.59 Allowed 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.982 0.801 . . . . 0.0 112.225 168.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.38 39.56 0.82 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.43 0.633 . . . . 0.0 109.812 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 39.0 t70 -153.69 148.79 26.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.835 -176.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -106.2 156.25 18.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.347 -177.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.452 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 7.4 t70 -96.64 -158.61 0.67 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.57 101.7 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.18 -0.325 . . . . 0.0 111.682 -175.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 65.83 -79.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.699 0.8 . . . . 0.0 111.54 176.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.7 -173.97 38.49 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 174.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.693 ' CE1' ' HA ' ' A' ' 85' ' ' LYS . 21.7 t80 . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.709 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.404 ' O ' ' HG ' ' A' ' 1' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.658 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 56.4 m -70.73 98.28 1.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' -1' ' ' GLY . 31.0 mt -102.61 -0.55 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.357 -174.231 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.581 HG22 ' HB2' ' A' ' 74' ' ' LYS . 5.3 tp -78.28 89.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.752 0.787 . . . . 0.0 109.877 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.846 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -71.23 0.87 6.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.054 -175.448 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.45 39.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.278 1.037 . . . . 0.0 109.313 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 3' ' ' LEU . . . -128.73 -53.81 0.11 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.69 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 28.9 t70 -53.56 -35.78 61.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 166.179 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.78 -57.02 2.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 172.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.6 tp 56.99 72.07 0.53 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.023 0.827 . . . . 0.0 110.962 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.28 -26.4 9.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.067 -177.037 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -154.22 70.97 0.82 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.393 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 11.2 ptmm? -76.96 154.62 33.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.391 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.53 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 4.7 mp -88.95 174.07 8.13 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.259 -173.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -147.89 30.45 0.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.227 -171.028 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.73 147.63 38.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -176.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.7 117.94 4.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.69 2.26 . . . . 0.0 110.858 173.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 48' ' ' LYS . 7.5 p 41.11 99.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.926 1.346 . . . . 0.0 113.162 -171.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.2 mt -65.87 154.34 7.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.925 178.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.48 144.21 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -172.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -62.25 -23.84 66.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.327 -176.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.4 tp -65.68 -41.58 92.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 65.7 t80 -64.67 -39.34 93.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.535 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.591 ' O ' HD11 ' A' ' 26' ' ' LEU . . . -68.23 -44.05 77.26 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.353 176.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -53.29 -44.4 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.67 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.3 mm-40 -54.9 -55.84 26.1 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.66 176.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.2 mt -53.4 -60.55 3.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.882 0.849 . . . . 0.0 110.695 178.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.673 HD21 HD12 ' A' ' 46' ' ' ILE . 9.5 mp -59.2 -40.88 87.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.433 -173.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.48 -32.49 73.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.67 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.2 mttm -67.43 -33.3 74.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.444 ' HE1' ' HA ' ' A' ' 80' ' ' LYS . 92.7 m-85 -95.01 0.95 55.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.73 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -36.1 74.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.509 0.195 . . . . 0.0 111.443 -171.222 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.95 -33.98 76.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.22 -41.43 49.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.492 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.511 HG21 ' HB ' ' A' ' 39' ' ' VAL . 90.9 mt -62.83 -37.14 78.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.753 176.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.606 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 36.3 ttmt -80.87 -22.76 39.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.042 -177.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.79 -47.14 22.45 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.448 172.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.69 -42.92 57.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.282 -175.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -121.2 -28.3 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.735 0.303 . . . . 0.0 111.731 -174.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 91.88 41.78 4.9 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.986 -178.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.606 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 13.1 t -119.42 152.1 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 120.556 0.217 . . . . 0.0 110.838 -176.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.92 136.37 50.04 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 26' ' ' LEU . 32.3 p -79.99 -12.92 59.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -83.31 -3.04 57.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.9 -27.72 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.292 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.516 HD22 HG13 ' A' ' 39' ' ' VAL . 67.8 mt -62.17 125.98 25.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.715 175.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 25.8 tttp -85.79 102.92 14.08 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.415 -178.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.673 HD12 HD21 ' A' ' 26' ' ' LEU . 22.9 mt -75.66 124.42 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.695 0.759 . . . . 0.0 110.931 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.44 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.7 mt -100.1 -53.72 3.07 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.673 -177.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HA ' HG21 ' A' ' 16' ' ' VAL . 36.6 ttmt -142.9 104.26 4.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.871 -174.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.58 ' HG1' HG12 ' A' ' 58' ' ' VAL . 46.6 m -91.69 125.5 36.43 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.9 m -151.8 -179.12 7.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' OE2' ' HB2' ' A' ' 11' ' ' LYS . 9.4 pt-20 -142.14 143.82 33.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 177.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.02 126.62 10.92 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 58.46 -141.27 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.741 -175.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.6 ' HB3' HG12 ' A' ' 76' ' ' VAL . 73.7 mtt180 -77.71 14.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 5.0 m-85 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.313 -169.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.553 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 17.3 m-85 -98.26 143.96 28.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.367 166.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.0 m-85 -124.32 105.49 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.67 HG22 HD12 ' A' ' 26' ' ' LEU . 13.9 t -106.69 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.847 0.356 . . . . 0.0 110.722 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 14.5 t -74.35 128.25 35.08 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.616 HG11 ' HA ' ' A' ' 46' ' ' ILE . 16.9 m -138.22 153.99 27.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.085 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.13 126.62 34.9 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.75 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 -36.23 2.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.586 174.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -70.83 -14.31 62.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.144 0.497 . . . . 0.0 109.978 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.25 -24.92 4.95 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.559 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 2.3 tp10 -78.34 174.26 11.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.912 0.387 . . . . 0.0 110.692 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -138.61 115.74 11.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 1.077 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -107.14 163.26 13.15 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.014 0.435 . . . . 0.0 111.239 -168.395 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.2 ttmt -139.21 93.9 2.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 64.4 m-85 -67.58 108.53 2.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.37 0.605 . . . . 0.0 110.342 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 1.04 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 46.9 tttt -92.2 83.53 5.09 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.044 -176.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.896 HG12 ' HG2' ' A' ' 81' ' ' MET . 55.7 mt -81.05 91.38 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.564 -178.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.679 HH11 HG22 ' A' ' 82' ' ' VAL . 34.8 ttt180 -59.68 111.23 1.35 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.838 ' HG3' HG11 ' A' ' 76' ' ' VAL . 18.6 ptpt -56.43 166.62 0.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.695 0.622 . . . . 0.0 110.461 -179.179 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 3' ' ' LEU . 38.9 t70 -68.65 75.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.508 0.67 . . . . 0.0 110.166 -178.2 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.838 HG11 ' HG3' ' A' ' 74' ' ' LYS . 29.5 m -100.84 -8.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.445 177.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 176.29 -51.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.833 -169.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.408 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -117.15 136.74 23.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.365 0.602 . . . . 0.0 110.323 178.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.517 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 43.9 Cg_endo -86.45 46.2 1.52 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 123.805 3.003 . . . . 0.0 113.341 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.444 ' HA ' ' HE1' ' A' ' 29' ' ' PHE . 27.3 mtmt -150.68 161.7 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.131 0.491 . . . . 0.0 112.19 -177.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.896 ' HG2' HG12 ' A' ' 72' ' ' ILE . 38.2 mtm -63.81 101.51 0.38 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.264 172.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.679 HG22 HH11 ' A' ' 73' ' ' ARG . 9.9 p -55.85 -28.74 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.402 173.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.65 177.41 26.9 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.277 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -177.12 42.27 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.023 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.843 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 68.7 mmtt -83.28 120.75 26.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.876 -171.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 1.077 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 29.7 m -65.6 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.569 -177.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 99.7 mtt180 65.94 65.08 0.53 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.577 0.704 . . . . 0.0 109.245 175.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 71.7 tttt -69.54 -66.23 0.61 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.597 -174.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 24.5 t70 -121.24 103.0 8.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.712 -178.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 89' ' ' ASP . 37.1 t70 173.04 -82.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.871 0.732 . . . . 0.0 110.073 174.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -179.77 165.83 1.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 10.8 p-10 -127.84 121.26 29.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.383 0.611 . . . . 0.0 111.357 -179.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.13 157.34 37.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.495 173.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -52.89 -45.55 67.58 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 110.284 176.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.27 141.89 17.08 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.9 -178.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 1.04 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 4.0 m-85 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.18 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.674 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 32.8 t . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.322 0.106 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.453 HD22 ' H2 ' ' A' ' 0' ' ' SER . 1.0 OUTLIER 61.94 12.2 4.69 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.805 0.442 . . . . 0.0 110.871 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 tp -90.22 -3.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -168.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.849 HD23 HG12 ' A' ' 76' ' ' VAL . 13.6 tp -174.01 71.99 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.302 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.63 103.55 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.136 0.898 . . . . 0.0 112.032 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.58 32.5 78.8 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.569 -0.741 . . . . 0.0 113.498 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.758 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.3 t0 56.11 76.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.4 0.619 . . . . 0.0 112.135 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.688 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 94.9 mt -112.25 38.24 2.77 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 3' ' ' LEU . 23.9 tp -71.22 101.03 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.381 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 9' ' ' LYS . 7.4 mtmp? -105.52 -41.38 5.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.23 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.37 101.69 7.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.544 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -103.86 -81.39 0.52 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.926 0.393 . . . . 0.0 111.586 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 17' ' ' ILE . 61.5 tp -147.37 126.13 12.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.027 0.441 . . . . 0.0 110.694 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -122.48 11.27 9.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.203 1.001 . . . . 0.0 108.765 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.3 mt -115.44 171.68 4.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.603 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.44 -157.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.191 2.594 . . . . 0.0 112.544 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.534 HG23 ' HG3' ' A' ' 48' ' ' LYS . 4.4 p -49.84 124.54 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.789 0.804 . . . . 0.0 111.306 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.481 HG12 HD13 ' A' ' 12' ' ' LEU . 35.0 mt -69.25 152.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.2 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 139.38 57.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 27.0 p-10 -61.6 -26.05 67.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt -56.75 -45.56 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.01 -38.24 90.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.201 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -69.34 -37.25 79.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.449 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 30.2 mmmt -64.31 -31.22 72.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.24 -47.3 65.11 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 90.9 mt -52.32 -65.52 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 23.6 mt -53.37 -27.72 25.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.712 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.88 -40.38 63.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 111.024 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -79.27 -35.88 40.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.112 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.674 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 96.4 m-85 -91.99 4.87 52.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.547 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 34.7 tt0 -52.59 -41.9 64.05 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.1 -39.47 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.702 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.0 m-20 -67.59 -54.12 22.51 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.63 HG22 ' HB ' ' A' ' 39' ' ' VAL . 65.0 mt -55.89 -35.02 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.204 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 9.2 tmtm? -81.77 -37.28 27.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.283 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.46 -53.56 50.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.667 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.702 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 39.1 mttm -69.25 -55.32 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.8 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 84' ' ' ARG . 22.9 m-85 -104.68 -37.08 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.079 0.466 . . . . 0.0 111.422 -171.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.24 63.88 1.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.445 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.63 ' HB ' HG22 ' A' ' 33' ' ' ILE . 32.1 t -126.12 155.25 35.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -105.55 119.82 40.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.632 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 26.4 p -84.67 -11.03 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -71.21 -35.07 71.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.45 -34.53 60.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.349 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.0 mt -49.01 120.11 3.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.709 0.766 . . . . 0.0 112.433 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 86.1 tttt -92.24 104.01 16.42 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.135 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.644 HG12 HG12 ' A' ' 60' ' ' VAL . 20.0 mt -78.1 130.76 35.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.495 0.664 . . . . 0.0 111.723 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt -99.97 -45.9 5.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.77 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HG3' HG23 ' A' ' 16' ' ' VAL . 58.6 tttm -151.28 110.85 4.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.492 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.5 m -90.04 121.54 32.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -155.08 -167.68 2.64 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -169.94 170.03 7.87 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -116.64 -81.11 0.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.173 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.21 -88.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.922 ' HB3' HG21 ' A' ' 76' ' ' VAL . 85.1 mtt180 -91.86 23.96 3.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.49 0.662 . . . . 0.0 110.677 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.489 ' HE2' HG11 ' A' ' 82' ' ' VAL . 54.6 m-85 -147.36 144.58 28.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.673 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.936 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 27.2 m-85 -93.75 152.88 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 74.7 m-85 -139.09 99.13 3.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.212 0.529 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 t -109.24 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.016 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.0 m -66.61 121.69 15.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.962 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.644 HG12 HG12 ' A' ' 46' ' ' ILE . 21.5 m -137.01 151.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.115 0.483 . . . . 0.0 111.104 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.2 t70 -88.49 115.51 26.06 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 169.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.12 -2.1 32.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.916 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.43 -15.21 13.48 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.471 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.95 -1.98 58.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.503 0.668 . . . . 0.0 110.055 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.63 -15.14 58.8 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.541 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -90.67 140.69 29.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.859 0.362 . . . . 0.0 110.516 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 67.9 mttm -115.08 85.73 2.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.192 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 15.1 t -89.89 142.09 28.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.428 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 40.4 ttmt -102.69 88.06 3.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.097 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 12.7 m-85 -47.88 123.04 5.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.135 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.909 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 25.9 ttpp -104.71 87.71 2.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.049 0.928 . . . . 0.0 110.217 -173.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.936 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 80.6 mt -87.15 89.94 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.51 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.716 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 13.7 ttt180 -52.89 114.94 1.59 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.793 ' HB2' HG13 ' A' ' 76' ' ' VAL . 53.9 mttp -60.87 170.31 1.57 Allowed 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.694 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.1 t70 -73.2 32.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.934 0.873 . . . . 0.0 110.149 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.922 HG21 ' HB3' ' A' ' 54' ' ' ARG . 31.4 m -76.85 -7.34 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.011 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -171.97 -51.13 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.981 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 28.4 m -108.57 149.05 38.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.263 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 77.1 Cg_endo -86.81 27.41 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.268 2.645 . . . . 0.0 113.587 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HD2' ' NZ ' ' A' ' 36' ' ' LYS . 23.3 pttm -159.41 -178.77 7.38 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.671 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.432 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -83.65 132.4 34.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.014 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 13.7 p -80.51 -38.85 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.69 -142.93 3.65 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.134 -172.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.909 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 11.8 ptt-85 -172.92 114.58 0.26 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -80.36 81.33 6.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.466 0.651 . . . . 0.0 110.803 -173.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 68.3 m -76.23 -159.16 0.11 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.728 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 62.8 mtp180 . . . . . 0 N--CA 1.456 -0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.667 174.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.778 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 19.1 m . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.65 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -156.56 135.92 12.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.566 0.222 . . . . 0.0 111.501 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.877 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 5.2 tp 167.56 135.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 124.411 1.07 . . . . 0.0 109.23 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.697 HD13 HG23 ' A' ' 2' ' ' ILE . 11.0 mp 82.32 -21.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.609 0.764 . . . . 0.0 111.999 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.542 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 14.3 m-20 62.51 20.82 12.22 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 171.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.91 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . 79.34 -0.22 81.09 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.317 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.59 -11.71 44.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.843 0.354 . . . . 0.0 110.448 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.586 ' HA ' HD23 ' A' ' 3' ' ' LEU . 96.9 mt 70.36 32.22 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.134 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.64 93.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.659 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HG2' ' H ' ' A' ' 9' ' ' LYS . 8.7 pttt -100.41 71.94 1.57 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.599 0.714 . . . . 0.0 110.291 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.93 -30.71 69.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.292 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HB3' HD11 ' A' ' 14' ' ' LEU . 45.4 mmtm -135.96 144.43 45.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.623 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 35.2 tp -167.62 165.55 14.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 26.4 mttt 64.72 20.01 12.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 11' ' ' LYS . 59.4 mt -72.41 155.45 91.28 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.872 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.89 -171.35 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.824 2.349 . . . . 0.0 110.57 169.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG2' ' HA ' ' A' ' 48' ' ' LYS . 7.2 p -65.21 122.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.212 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.834 HG13 ' HB ' ' A' ' 49' ' ' THR . 4.1 pt -105.89 -178.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.799 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 177.47 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -40.02 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 112.919 -1.946 . . . . 0.0 112.891 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 20' ' ' LEU . 22.8 mt 34.65 43.92 0.1 Allowed 'General case' 0 CA--C 1.521 -0.138 0 O-C-N 123.885 0.74 . . . . 0.0 111.987 -173.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -125.94 -66.76 0.91 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.83 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' CA ' HG21 ' A' ' 49' ' ' THR . . . -64.36 -50.19 61.14 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.36 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.17 -36.59 68.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.916 0.388 . . . . 0.0 110.64 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.8 mt-10 -65.3 -50.54 65.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.963 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 91.0 mt -47.92 -65.0 0.64 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 123.579 0.55 . . . . 0.0 110.891 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 58' ' ' VAL . 7.4 mp -60.95 -38.38 85.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.553 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.72 -33.42 75.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 84.2 mttt -78.48 -46.1 20.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.456 0.646 . . . . 0.0 109.828 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.612 ' CE2' HG23 ' A' ' 72' ' ' ILE . 6.8 m-85 -70.33 -9.86 57.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.552 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -52.42 -47.51 66.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.719 0.407 . . . . 0.0 111.806 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -54.84 -39.64 68.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.713 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.23 -43.91 31.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.6 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.439 HD13 ' CE1' ' A' ' 70' ' ' PHE . 55.6 mt -63.42 -33.57 62.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.697 0.76 . . . . 0.0 110.403 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 71.3 tttt -80.86 -29.15 35.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.596 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.13 -50.48 40.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.089 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HE3' ' O ' ' A' ' 81' ' ' MET . 62.8 mttm -66.33 -50.12 64.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.399 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.451 ' HB2' HG23 ' A' ' 39' ' ' VAL . 34.9 m-85 -118.08 -37.62 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.877 0.37 . . . . 0.0 111.605 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.62 62.89 1.02 Allowed Glycine 0 C--N 1.323 -0.179 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.845 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.612 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -126.01 150.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.847 0.356 . . . . 0.0 111.584 -173.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.84 128.13 45.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 8.2 p -86.41 -9.48 56.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -92.22 -10.1 39.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.577 0.703 . . . . 0.0 109.346 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.69 -29.32 56.26 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.577 1.18 . . . . 0.0 107.872 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.564 HD13 ' CE2' ' A' ' 70' ' ' PHE . 27.4 mt -77.77 109.15 11.54 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 112.848 -1.978 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 55.4 tttm -72.86 111.97 8.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.679 ' HA ' HG12 ' A' ' 60' ' ' VAL . 26.3 mt -74.34 111.67 10.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.587 0.708 . . . . 0.0 110.234 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.8 mt -86.23 -35.94 19.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.678 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 34.0 tttp -156.88 118.31 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.667 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.834 ' HB ' HG13 ' A' ' 17' ' ' ILE . 2.8 m -106.53 126.13 51.87 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -155.77 170.99 20.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.65 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 14.0 pt-20 -139.59 175.69 9.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.437 0.637 . . . . 0.0 111.814 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -152.88 -162.2 1.44 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -58.3 103.35 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 77.1 -21.28 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.779 0.674 . . . . 0.0 112.559 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.71 142.05 38.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HD2' ' HG2' ' A' ' 74' ' ' LYS . 4.5 m-85 -109.94 142.44 41.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 166.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 61.0 m-85 -133.01 115.09 14.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.271 0.558 . . . . 0.0 110.678 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.734 HG22 HG23 ' A' ' 49' ' ' THR . 41.6 t -108.69 98.75 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.565 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.3 m -74.44 128.83 36.53 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 46' ' ' ILE . 33.3 m -138.25 156.83 30.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.823 0.344 . . . . 0.0 111.143 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.63 110.95 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 1.27 53.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.783 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.29 -112.91 0.27 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.658 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -116.36 79.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.48 4.13 73.96 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -79.25 81.98 5.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 122.087 0.946 . . . . 0.0 109.67 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 28.9 ttmt -82.43 135.54 35.13 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.55 -169.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 26.3 t -138.8 169.11 18.38 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.009 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 39.6 ttpt -146.43 110.81 5.11 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.564 ' CE2' HD13 ' A' ' 44' ' ' LEU . 36.6 m-85 -68.73 122.62 18.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.443 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HD3' ' HA3' ' A' ' 83' ' ' GLY . 83.3 tttt -88.72 71.61 8.73 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.197 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.612 HG23 ' CE2' ' A' ' 29' ' ' PHE . 67.4 mt -80.08 92.76 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.451 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.585 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 46.3 ttt-85 -72.4 8.45 1.37 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.427 0.632 . . . . 0.0 110.087 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.674 ' HG2' ' HD2' ' A' ' 56' ' ' TYR . 64.1 mttt 66.4 172.43 0.24 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.991 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.877 ' HB3' ' H ' ' A' ' 2' ' ' ILE . 2.0 t70 -77.66 87.79 3.94 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.091 0.948 . . . . 0.0 109.131 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.91 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 2.6 p -115.36 100.8 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.156 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.574 ' H ' ' CA ' ' A' ' 5' ' ' GLY . 33.4 t70 78.07 -59.64 0.43 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.644 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.44 146.86 33.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.17 -53.17 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.371 2.048 . . . . 0.0 113.792 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.778 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 11.7 ptpt -65.9 154.29 39.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.392 0.615 . . . . 0.0 112.136 -168.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.468 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -65.07 146.01 55.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.772 -176.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 7.5 p -81.03 -40.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.542 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.597 ' HA3' ' HD3' ' A' ' 71' ' ' LYS . . . -149.07 161.92 28.83 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.461 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 84' ' ' ARG . 27.5 ttt180 -149.0 92.83 2.02 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -105.35 111.26 23.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 110.586 -172.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 8.1 m -103.54 123.83 47.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 121.769 0.795 . . . . 0.0 110.317 -167.502 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 6.4 t . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -165.89 21.32 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.173 0.511 . . . . 0.0 111.293 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -101.15 107.73 21.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 3.2 mm? -120.71 -101.58 0.42 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.026 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 10.2 m-20 70.38 10.21 7.17 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.671 0.607 . . . . 0.0 109.702 -169.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 6' ' ' ASP . . . 69.99 97.14 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.21 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.491 ' HB3' ' O ' ' A' ' 5' ' ' GLY . 24.5 t70 73.57 -2.87 2.63 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.6 0.714 . . . . 0.0 110.1 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.945 HD21 ' HB2' ' A' ' 74' ' ' LYS . 11.2 mp 75.38 171.97 0.26 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.462 HD23 ' HG2' ' A' ' 11' ' ' LYS . 9.7 tp -78.55 3.05 17.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.578 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 15.9 mmtp 73.99 -74.61 0.08 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.413 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -145.4 135.28 23.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HG2' HD23 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -130.47 16.86 5.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.016 176.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 12' ' ' LEU . 13.2 mt -144.43 93.36 2.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.151 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -95.63 36.15 1.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.536 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.755 ' HB2' HG12 ' A' ' 17' ' ' ILE . 48.6 mt -79.39 128.53 75.05 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.231 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.6 Cg_exo -64.43 116.03 3.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.77 2.313 . . . . 0.0 110.228 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 48' ' ' LYS . 4.3 p 41.23 96.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 123.031 1.396 . . . . 0.0 112.057 -168.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.755 HG12 ' HB2' ' A' ' 14' ' ' LEU . 60.5 mt -74.26 155.42 6.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.225 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -44.76 133.75 5.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 112.206 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -62.73 -29.29 70.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 tp -68.2 -40.33 82.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.726 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.09 -36.52 81.95 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.5 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -66.06 -50.32 52.65 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -52.59 -35.77 54.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.441 0.297 . . . . 0.0 110.933 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.577 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 8.3 mm-40 -60.19 -54.87 40.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 174.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.2 mt -52.34 -63.73 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.548 0.69 . . . . 0.0 110.313 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.895 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 9.8 mp -56.21 -35.42 67.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.779 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.6 -36.44 83.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.072 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -70.15 -34.43 73.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.286 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 72' ' ' ILE . 15.0 m-85 -100.54 -1.92 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.083 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.02 -30.81 66.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.737 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.56 -39.18 92.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.781 0.324 . . . . 0.0 110.632 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 2.8 m-20 -84.04 -30.31 26.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.147 0.499 . . . . 0.0 110.276 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 39' ' ' VAL . 85.7 mt -63.98 -31.83 54.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.776 0.798 . . . . 0.0 109.834 173.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.643 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 74.7 tttt -88.69 -38.55 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 17.1 t70 -59.33 -45.58 90.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.392 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -80.63 -52.64 7.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.168 0.508 . . . . 0.0 112.025 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.554 ' HB2' HG23 ' A' ' 39' ' ' VAL . 24.4 m-85 -105.02 -30.83 9.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.572 -167.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.53 51.1 3.57 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.762 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.643 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 16.2 t -121.83 149.71 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 120.617 0.246 . . . . 0.0 110.885 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.535 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.6 t70 -107.57 117.71 34.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.895 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 58.0 p -79.4 -22.43 44.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -171.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.69 -19.86 51.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.91 -26.8 22.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.664 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 91.5 mt -60.36 145.21 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.945 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -97.22 103.98 15.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.931 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 60' ' ' VAL . 41.6 mt -76.33 122.04 29.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.72 0.772 . . . . 0.0 110.802 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 61' ' ' ASP . 7.7 mt -91.19 -48.17 7.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HG2' ' HB ' ' A' ' 16' ' ' VAL . 23.8 mttp -151.79 109.33 3.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.522 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.488 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 11.6 m -81.64 128.92 34.45 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 171.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 m -154.46 179.28 9.17 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -156.35 160.85 40.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.212 0.53 . . . . 0.0 110.884 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -137.16 -159.18 0.93 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -64.49 107.9 1.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.515 0.198 . . . . 0.0 110.863 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.533 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 84.7 mtm180 74.42 -17.76 0.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.07 130.26 55.51 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.876 -0.515 . . . . 0.0 111.609 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 1.017 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 16.2 m-85 -78.95 155.67 28.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.5 91.93 2.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.023 0.439 . . . . 0.0 110.393 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.676 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.0 t -97.5 97.67 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.428 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 9.2 t -71.54 116.85 12.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 46' ' ' ILE . 5.0 m -131.37 159.04 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.936 0.398 . . . . 0.0 110.797 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.526 ' HB2' HD21 ' A' ' 47' ' ' LEU . 11.7 t70 -107.22 132.81 52.66 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.64 9.18 14.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.418 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.18 -35.09 5.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.509 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -93.68 1.78 56.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.31 0.576 . . . . 0.0 110.691 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.53 -20.96 38.19 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.474 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 139.03 58.72 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -128.12 144.62 51.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.567 0.699 . . . . 0.0 112.083 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.5 ' HB2' HG22 ' A' ' 60' ' ' VAL . 36.9 m -128.18 123.81 35.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.319 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 12.5 tppt? -97.09 68.54 2.27 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.676 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 19.2 m-85 -38.08 105.51 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 124.183 0.927 . . . . 0.0 112.331 -169.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 73.8 tttt -90.76 83.76 5.78 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.392 1.092 . . . . 0.0 109.326 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.017 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 70.1 mt -84.03 91.83 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.932 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.993 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.6 ttt180 -57.98 96.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.945 ' HB2' HD21 ' A' ' 7' ' ' LEU . 23.1 mttt -59.4 82.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.328 1.018 . . . . 0.0 112.092 -167.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.47 24.84 0.8 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.778 0.831 . . . . 0.0 111.239 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.993 ' HB ' ' HG2' ' A' ' 73' ' ' ARG . 33.9 t -80.21 119.21 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.682 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 68.03 -70.25 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.072 0.858 . . . . 0.0 111.276 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 79' ' ' PRO . 4.2 m -90.88 175.46 3.61 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.688 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 8.8 Cg_endo -82.92 178.54 5.9 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.88 1.72 . . . . 0.0 111.379 170.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 29.4 pttt 57.84 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 169.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.598 ' HB3' HG23 ' A' ' 72' ' ' ILE . 6.3 ptt? -168.73 150.11 4.73 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -171.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.716 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 12.9 p -76.12 -46.32 34.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.16 137.22 4.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.233 -1.46 . . . . 0.0 114.385 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.601 ' HG3' ' CE1' ' A' ' 70' ' ' PHE . 9.9 ttp180 -72.89 104.33 4.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 64.2 tttm -82.05 63.11 6.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 0.0 112.435 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.586 ' SG ' ' HG2' ' A' ' 84' ' ' ARG . 1.1 m -101.59 138.99 37.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 122.702 1.239 . . . . 0.0 108.744 172.254 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 2' ' ' ILE . 50.8 mt -143.5 82.55 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.59 HD12 ' H ' ' A' ' 1' ' ' LEU . 3.7 mp -150.66 -31.51 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.808 0.337 . . . . 0.0 111.757 -170.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.777 HD22 HG12 ' A' ' 76' ' ' VAL . 1.5 tt -154.78 33.61 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -165.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -48.48 -46.78 38.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.263 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.76 41.81 1.28 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -120.68 -146.32 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.708 -0.246 . . . . 0.0 110.72 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 mt -157.5 -49.63 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.747 0.655 . . . . 0.0 109.974 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 3' ' ' LEU . 74.6 mt 68.47 156.11 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.003 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.19 9.35 5.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.734 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.35 139.25 51.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.111 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -151.25 85.16 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.751 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.461 ' H ' ' CG ' ' A' ' 51' ' ' GLU . 12.2 tp 59.25 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.57 0.748 . . . . 0.0 112.764 165.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 27.2 ttpt -78.65 82.81 4.86 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 91.2 mt 74.55 162.45 0.15 Allowed Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 124.012 0.82 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 12.0 Cg_endo -56.35 134.17 62.6 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.715 2.277 . . . . 0.0 112.442 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.416 ' CG2' ' HG3' ' A' ' 48' ' ' LYS . 7.7 p 44.16 101.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 122.989 1.376 . . . . 0.0 113.961 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 51.7 mt -73.21 154.05 7.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.993 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 20' ' ' LEU . 28.3 t70 -62.91 155.95 25.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.605 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 8.7 p30 -60.35 -34.06 73.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.693 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' HB2' ' OD1' ' A' ' 18' ' ' ASP . 3.1 mt -57.06 -46.14 82.69 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.249 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 43.7 t80 -60.1 -41.83 93.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 0.0 110.297 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -74.27 -26.79 67.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.805 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.644 ' HB2' HD12 ' A' ' 46' ' ' ILE . 33.4 ttpt -80.89 -29.1 35.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.919 0.39 . . . . 0.0 110.177 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.59 -29.93 68.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.523 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.556 HD12 ' HA2' ' A' ' 22' ' ' GLY . 66.3 mt -65.31 -70.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 mt -47.71 -28.77 2.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.626 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.65 -45.82 92.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.999 0.428 . . . . 0.0 110.103 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.554 ' HD3' ' HB2' ' A' ' 1' ' ' LEU . 92.7 mttt -65.96 -35.49 80.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.623 0.725 . . . . 0.0 109.535 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.599 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 10.5 m-85 -79.28 -8.0 58.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.911 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.497 ' HG2' ' HD2' ' A' ' 34' ' ' LYS . 17.3 tt0 -74.44 12.59 0.74 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.456 0.646 . . . . 0.0 110.657 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -106.48 -30.57 8.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.375 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 15.2 t70 -88.87 -57.23 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 39' ' ' VAL . 67.6 mt -61.23 -27.62 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.72 0.771 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' HD2' ' HG2' ' A' ' 30' ' ' GLN . 44.9 tttp -80.66 -33.38 35.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.886 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -75.22 -47.83 26.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 49.2 mttm -69.29 -38.22 78.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.84 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.605 ' HB2' HG23 ' A' ' 39' ' ' VAL . 55.3 m-85 -126.86 -23.09 3.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 87.21 39.41 7.38 Favored Glycine 0 C--N 1.322 -0.216 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.94 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 33' ' ' ILE . 27.2 t -100.56 152.75 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.423 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 16.4 t70 -115.39 122.72 46.7 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.765 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 75.0 p -88.25 -17.56 30.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.919 0.39 . . . . 0.0 111.513 -172.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.517 ' HB2' ' NZ ' ' A' ' 42' ' ' LYS . 4.9 ttmp? -70.46 -33.16 70.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.466 0.651 . . . . 0.0 109.266 175.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.35 -23.4 46.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.016 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 49.1 mt -61.29 139.97 58.06 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.398 0.618 . . . . 0.0 111.594 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 81.0 tttt -101.32 96.51 7.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.511 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.644 HD12 ' HB2' ' A' ' 23' ' ' LYS . 46.9 mt -78.26 127.5 38.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.431 0.634 . . . . 0.0 111.112 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 10.9 mt -98.19 -51.44 4.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.133 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 36.1 ttmt -139.85 117.76 11.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.542 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.44 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 31.6 m -99.32 136.03 39.87 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -153.28 179.03 9.12 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 122.113 -0.367 . . . . 0.0 110.397 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 15.4 pt-20 -154.58 166.73 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.52 78.53 1.27 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.063 0.459 . . . . 0.0 109.907 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HE2' ' HB2' ' A' ' 53' ' ' LYS . 2.7 mppt? 56.33 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.199 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.641 ' HG3' HG11 ' A' ' 76' ' ' VAL . 19.4 ttm180 -85.33 12.41 8.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.516 0.674 . . . . 0.0 110.721 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 97.5 m-85 -136.23 157.73 46.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 13.9 m-85 -129.55 146.57 51.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.333 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.436 ' CE1' ' HG3' ' A' ' 71' ' ' LYS . 97.8 m-85 -135.69 103.05 5.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 19.1 t -109.19 95.17 3.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.652 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.6 t -80.34 129.69 34.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.5 m -137.99 155.44 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.156 0.503 . . . . 0.0 111.757 -173.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.6 t70 -90.22 126.68 35.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.91 13.24 11.28 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.029 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.11 -40.52 2.66 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.922 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.08 -19.13 65.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.88 -8.96 39.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.78 165.34 24.85 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.351 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -127.85 109.91 12.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.442 0.639 . . . . 0.0 110.279 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 1.9 t -104.62 174.32 5.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.34 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 35.9 ttmt -149.08 104.68 3.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.423 ' CE1' HD13 ' A' ' 33' ' ' ILE . 73.5 m-85 -71.23 97.22 1.51 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.694 0.759 . . . . 0.0 109.621 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HG3' ' CE1' ' A' ' 57' ' ' TYR . 46.2 tttp -82.88 85.91 7.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.149 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.781 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 61.6 mt -82.39 137.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.255 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 18.4 ttt180 -93.16 39.01 1.04 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.624 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 49.5 mttt 57.67 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.253 -170.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.689 ' HB3' ' N ' ' A' ' 3' ' ' LEU . 24.4 t0 178.68 26.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.777 HG12 HD22 ' A' ' 3' ' ' LEU . 9.5 m -61.82 95.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.073 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 22.9 t70 77.13 -38.95 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.844 172.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 80' ' ' LYS . 9.6 p -110.7 134.28 20.96 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.521 0.677 . . . . 0.0 110.312 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 78' ' ' VAL . 85.4 Cg_endo -79.79 30.83 0.48 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 123.897 3.064 . . . . 0.0 114.757 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' HG2' HG22 ' A' ' 78' ' ' VAL . 57.4 pttt -145.78 153.61 41.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.651 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -70.31 148.66 48.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.52 -173.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 13.7 p -73.07 -43.3 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.666 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -130.39 151.83 19.6 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -174.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 43.13 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.709 0.766 . . . . 0.0 108.939 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -96.2 134.81 38.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.115 -171.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -101.39 125.41 48.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 C--N 1.314 -0.956 0 CA-C-O 122.037 0.923 . . . . 0.0 109.645 -164.155 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.486 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 41.3 t . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.78 40.68 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.553 0.692 . . . . 0.0 110.136 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 56' ' ' TYR . 18.6 tt -104.61 108.84 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.584 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 7' ' ' LEU . 4.4 mm? -75.59 5.25 6.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.561 ' HB3' HG12 ' A' ' 2' ' ' ILE . 27.3 t70 -70.7 -5.44 29.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.717 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 76' ' ' VAL . . . -87.02 -87.35 1.08 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.147 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -48.59 -38.79 21.69 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 3' ' ' LEU . 66.2 mt -92.06 26.39 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.65 0.262 . . . . 0.0 111.334 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 7.2 tt -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.938 0.399 . . . . 0.0 110.681 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -120.13 -62.57 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -154.98 116.01 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.918 173.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 17.6 ptmt -129.22 -51.68 1.2 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.522 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 71.3 mt -153.22 155.36 36.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -170.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 43.87 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 82.4 mt -108.03 170.22 5.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.14 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 50.2 Cg_exo -58.85 -150.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.86 3.04 . . . . 0.0 113.072 170.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.422 HG23 ' HG3' ' A' ' 48' ' ' LYS . 14.5 p -53.06 125.17 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.19 0.995 . . . . 0.0 111.266 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 18' ' ' ASP . 11.7 mt -96.72 173.04 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.395 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' H ' HG22 ' A' ' 17' ' ' ILE . 1.6 m-20 -50.46 122.06 6.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.681 0.277 . . . . 0.0 111.148 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.558 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 25.0 p30 -72.54 -17.21 61.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 110.363 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.23 -39.38 68.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 170.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.569 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 63.1 t80 -61.61 -40.38 94.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.621 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -66.92 -44.27 89.33 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.447 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -55.68 -43.26 76.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.664 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.9 mm-40 -57.16 -49.16 76.81 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.583 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 46.1 mt -51.49 -59.54 4.14 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.528 0.68 . . . . 0.0 110.34 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 58' ' ' VAL . 6.9 mp -60.82 -38.8 86.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.579 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.18 -31.86 73.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.664 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.7 mttm -74.99 -50.01 18.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.201 0.524 . . . . 0.0 110.678 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 0' ' ' SER . 7.2 m-85 -92.17 12.14 23.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.797 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -25.89 63.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.278 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.06 -39.97 90.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -36.97 62.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.336 0.589 . . . . 0.0 109.471 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.8 mt -62.24 -38.84 82.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.555 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 35.3 tttm -83.29 -31.69 26.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.359 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.83 -47.8 79.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.82 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -79.42 -52.58 7.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.224 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.578 ' CZ ' ' HD2' ' A' ' 84' ' ' ARG . 6.6 m-85 -108.11 -23.97 11.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -169.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.49 57.59 3.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.952 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 41' ' ' THR . 3.7 t -117.03 145.13 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 121.023 0.439 . . . . 0.0 110.908 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.65 -11.32 59.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.111 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.669 ' H ' HG12 ' A' ' 39' ' ' VAL . 33.1 p 58.73 -37.48 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.014 1.726 . . . . 0.0 114.348 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -71.18 -18.19 62.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.352 0.596 . . . . 0.0 109.451 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -74.37 -37.25 63.51 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.899 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.37 106.22 0.43 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.224 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 55.1 tttp -69.97 102.27 1.97 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.147 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.637 HG12 HG12 ' A' ' 60' ' ' VAL . 34.6 mt -74.33 111.99 10.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.793 0.806 . . . . 0.0 110.675 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.3 -46.45 16.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.062 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 59' ' ' SER . 25.8 ttpp -151.5 105.47 3.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.687 -173.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.558 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 87.8 m -79.23 125.6 29.68 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -151.8 168.99 23.34 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.24 157.02 35.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 29.4 t70 -100.74 -83.67 0.44 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 52' ' ' ASP . 38.5 mmtm -135.88 -74.85 0.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.697 ' HB3' HG11 ' A' ' 76' ' ' VAL . 98.7 mtt180 -87.93 15.22 7.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.969 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -147.32 137.34 23.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.717 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.5 m-85 -98.84 143.84 28.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 167.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.472 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 74.4 m-85 -132.26 100.8 5.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 110.217 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 26' ' ' LEU . 26.0 t -99.07 93.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.139 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.491 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 67.8 m -58.51 126.35 27.22 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.303 174.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.637 HG12 HG12 ' A' ' 46' ' ' ILE . 35.7 m -146.71 149.96 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 111.757 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.0 t70 -91.22 122.99 34.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 169.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . . . -79.98 1.11 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 -13.69 64.97 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.288 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -131.92 41.16 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -27.49 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.976 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 39.6 mt-10 -65.21 128.88 37.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.017 0.436 . . . . 0.0 111.128 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -111.59 114.81 28.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.506 0.67 . . . . 0.0 109.924 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 18.6 t -113.92 178.42 4.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.864 -174.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 1.008 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 34.8 ttmt -155.54 82.04 1.04 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 25.6 m-85 -50.31 111.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 112.203 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.597 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 63.3 tttp -80.76 72.89 7.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.048 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.717 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 60.3 mt -75.89 86.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.221 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.472 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 33.2 ttp180 -61.97 113.42 2.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 81.8 mttt -61.37 174.02 0.79 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.173 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 1.1 m-20 -71.67 64.65 0.46 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.662 0.744 . . . . 0.0 110.192 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.697 HG11 ' HB3' ' A' ' 54' ' ' ARG . 34.7 m -96.77 -1.76 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.198 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -176.87 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.007 -171.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.544 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 7.6 p -117.77 144.7 34.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.865 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 78' ' ' VAL . 39.1 Cg_endo -82.47 53.0 4.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.28 2.653 . . . . 0.0 111.301 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -154.07 135.01 13.8 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.287 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.716 ' HG2' ' HA ' ' A' ' 72' ' ' ILE . 12.7 tmm? -57.56 103.84 0.15 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 11.6 p -60.75 -37.88 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -170.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' ' 81' ' ' MET . . . -175.03 -156.84 15.01 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.641 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.664 ' N ' ' HD3' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -151.37 119.67 6.37 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -168.168 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 1.008 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 2.4 tttm -86.94 56.92 4.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.911 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -87.75 126.3 34.92 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 . . . . . 0 C--N 1.306 -1.285 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 179.7 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.978 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 m . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.947 HD23 ' HD3' ' A' ' 28' ' ' LYS . 11.0 tp -174.96 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.611 0.57 . . . . 0.0 112.266 160.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.49 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.5 tp -66.02 -25.93 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.828 -171.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.802 HD21 ' H ' ' A' ' 8' ' ' LEU . 7.5 tp -140.53 54.59 1.61 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.288 -171.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -54.58 96.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.618 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.09 40.87 52.23 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.821 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.754 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 30.7 t70 -107.82 -60.5 1.7 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.712 0.291 . . . . 0.0 110.496 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.457 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 25.7 tp 71.76 99.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.068 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.802 ' H ' HD21 ' A' ' 3' ' ' LEU . 6.7 tt -88.92 117.5 27.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.825 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -112.37 -5.68 14.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.578 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.31 -41.73 89.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 47.2 mmtm -97.65 152.11 19.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.357 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 5.2 mp -117.73 -72.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.44 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.78 103.83 4.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.357 . . . . 0.0 110.053 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.402 HD11 ' HG2' ' A' ' 51' ' ' GLU . 1.1 pp -111.76 163.54 17.32 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.835 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.51 -177.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.946 3.097 . . . . 0.0 113.647 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 48' ' ' LYS . 8.1 p -68.91 121.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.594 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 47.9 mt -77.77 152.66 5.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.587 174.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.81 144.84 42.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.571 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 6.5 p30 -56.92 -30.36 63.9 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.766 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.1 tp -60.6 -45.71 92.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.579 0.228 . . . . 0.0 110.946 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 61.5 t80 -62.37 -48.95 77.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.669 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -63.77 -43.87 97.08 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.431 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HB2' HG13 ' A' ' 46' ' ' ILE . 3.8 tptm -58.17 -34.94 70.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.233 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.648 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -55.3 -56.44 20.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.041 175.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.6 mp -51.82 -55.61 18.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.656 0.741 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.669 HD13 ' O ' ' A' ' 22' ' ' GLY . 6.7 mp -59.8 -44.91 93.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.011 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HA ' ' OG1' ' A' ' 41' ' ' THR . 21.3 t70 -63.2 -31.73 72.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.058 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.947 ' HD3' HD23 ' A' ' 1' ' ' LEU . 58.3 mttm -69.37 -33.54 73.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.937 0.398 . . . . 0.0 110.738 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' O ' HG13 ' A' ' 33' ' ' ILE . 15.4 m-85 -99.09 7.95 45.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -50.31 -44.14 54.05 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.284 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.12 -38.38 73.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.554 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.97 -41.57 50.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.563 HG22 ' HB ' ' A' ' 39' ' ' VAL . 32.4 mt -63.61 -34.08 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.235 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 33.1 ttpt -83.69 -27.74 28.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.099 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.41 -47.04 58.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.496 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -78.02 -62.13 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.068 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HB2' HG23 ' A' ' 39' ' ' VAL . 25.1 m-85 -97.68 -19.2 18.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.116 -167.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.18 46.04 10.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.931 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.607 HG23 ' HB2' ' A' ' 37' ' ' TYR . 40.3 t -107.48 145.57 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.032 0.444 . . . . 0.0 111.439 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.593 ' OD1' ' HB2' ' A' ' 42' ' ' LYS . 25.7 t70 -109.24 105.17 14.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.542 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 29.1 p -65.07 -16.75 63.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.593 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 3.3 mtpm? -67.23 -28.93 68.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.31 -18.97 28.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.91 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 67.8 mt -65.66 132.43 48.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.327 0.584 . . . . 0.0 111.559 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.62 ' HD2' HD23 ' A' ' 47' ' ' LEU . 2.5 tmtp? -94.48 109.38 21.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.124 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.631 ' HA ' HG12 ' A' ' 60' ' ' VAL . 6.1 mm -73.53 108.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.95 0.405 . . . . 0.0 109.925 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 45' ' ' LYS . 17.6 mt -80.11 -54.75 5.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.555 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.491 ' HG3' HG23 ' A' ' 16' ' ' VAL . 87.6 tttt -142.1 119.92 11.93 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.742 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.594 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 35.3 m -98.54 141.53 31.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 169.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -169.51 -174.68 1.97 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' OE1' ' HB2' ' A' ' 11' ' ' LYS . 8.9 pt-20 -147.68 162.46 39.11 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.726 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 5.8 t70 -135.01 -173.29 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.713 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 14.0 mmmm -63.96 111.02 2.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 72.34 -0.97 3.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.169 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.97 152.8 40.53 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.787 0.803 . . . . 0.0 112.989 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.601 ' HD2' ' HA ' ' A' ' 74' ' ' LYS . 6.2 m-85 -114.06 145.08 42.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.368 164.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.547 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 62.8 m-85 -134.23 112.15 10.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.82 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 5.1 t -111.89 93.47 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.811 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.9 m -76.58 121.83 23.74 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 46' ' ' ILE . 15.8 m -134.44 159.32 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 111.581 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.03 115.67 22.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . . . -86.0 -18.44 32.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 64' ' ' ASP . . . 108.87 165.51 20.66 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -171.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 9.6 t70 73.11 -52.61 0.71 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.927 0.491 . . . . 0.0 110.457 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.84 -17.18 0.22 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.2 150.85 33.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.915 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -117.56 117.85 30.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.989 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 33.6 m -113.81 133.92 55.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.475 -171.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.0 ttpt -102.96 108.51 19.71 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.642 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 43.0 m-85 -68.15 103.55 1.58 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.494 0.664 . . . . 0.0 110.389 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.548 ' HB3' ' O ' ' A' ' 83' ' ' GLY . 12.8 tttt -88.34 109.45 19.99 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.189 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.457 HG12 ' HG2' ' A' ' 81' ' ' MET . 48.2 mt -123.56 124.79 70.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.517 ' HD2' HG21 ' A' ' 82' ' ' VAL . 16.2 ttt180 -81.01 53.25 1.94 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.459 0.647 . . . . 0.0 110.612 -169.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.601 ' HA ' ' HD2' ' A' ' 56' ' ' TYR . 19.6 mttt 50.75 43.35 28.09 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.017 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.738 ' HA ' ' CB ' ' A' ' 0' ' ' SER . 1.9 m-20 55.46 28.62 11.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.761 0.663 . . . . 0.0 112.558 166.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 73' ' ' ARG . 21.3 m -77.36 122.09 31.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.282 0.563 . . . . 0.0 111.839 -176.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 t70 64.29 -77.31 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.456 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -82.82 139.72 43.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.978 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 90.8 Cg_endo -80.49 89.19 1.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.179 2.586 . . . . 0.0 112.878 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -176.2 -173.92 0.59 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.586 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.459 ' SD ' HG12 ' A' ' 33' ' ' ILE . 26.6 mtm -100.95 148.96 24.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.524 HG13 ' HE2' ' A' ' 71' ' ' LYS . 7.7 p -89.48 4.41 5.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . 152.3 113.1 0.54 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.727 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -95.43 100.78 12.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -125.14 134.52 52.4 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 7.6 m -93.74 123.49 37.11 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 . . . . . 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.902 . . . . 0.0 108.795 -176.21 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.8 p . . . . . 0 C--O 1.222 -0.353 0 CA-C-O 119.694 -0.193 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.848 HD22 ' H ' ' A' ' 1' ' ' LEU . 0.3 OUTLIER -49.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.72 0.637 . . . . 0.0 111.667 -174.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' A' ' 56' ' ' TYR . 28.3 mm -144.35 -55.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 123.081 0.238 . . . . 0.0 111.525 -174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.913 HD23 ' HA ' ' A' ' 6' ' ' ASP . 1.1 mp -113.6 -3.14 13.65 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.61 45.69 21.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.87 36.76 12.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.647 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.913 ' HA ' HD23 ' A' ' 3' ' ' LEU . 30.3 t70 58.08 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 2.2 pp -148.58 19.69 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.598 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 3' ' ' LEU . 30.4 tp -78.87 99.7 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.795 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -124.04 6.32 8.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.532 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.71 -77.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HG2' HD11 ' A' ' 8' ' ' LEU . 48.2 pttt -90.2 178.02 6.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.0 tp -171.24 -47.43 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.993 0.425 . . . . 0.0 110.31 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 21.5 mtmt -123.83 93.73 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.291 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.96 157.4 33.73 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.803 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.39 -164.43 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.003 2.469 . . . . 0.0 112.105 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.8 p -69.3 110.82 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 122.076 0.941 . . . . 0.0 111.601 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.885 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -98.35 170.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.487 173.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 172.65 -8.24 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 21' ' ' PHE . 4.1 m-80 -64.61 63.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.377 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mt 68.74 -27.62 0.15 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.942 0.897 . . . . 0.0 112.454 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' A' ' 19' ' ' ASN . 7.9 t80 -54.04 -45.0 71.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -172.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -73.94 -38.56 48.48 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.692 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -70.89 -33.3 70.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 7.7 mm-40 -56.98 -50.6 72.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.544 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.546 HD12 ' HA2' ' A' ' 22' ' ' GLY . 60.4 mt -49.72 -67.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.529 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.859 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 39.1 mt -53.3 -34.09 55.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.62 -49.09 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.344 -0.223 . . . . 0.0 111.386 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 36.4 mttm -65.78 -45.07 83.82 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 109.913 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.444 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 3.9 m-85 -93.33 16.14 14.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.78 -171.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -61.0 -42.24 98.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -58.85 -38.53 78.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.56 -51.28 36.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 109.932 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.531 HG21 ' HE1' ' A' ' 70' ' ' PHE . 47.1 mt -66.6 -29.49 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.017 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.541 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 38.3 tttp -84.96 -29.34 25.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 110.326 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.28 -47.02 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.393 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.808 ' HD3' ' HE3' ' A' ' 81' ' ' MET . 27.8 mttm -65.46 -64.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.995 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.538 ' HB2' HG23 ' A' ' 39' ' ' VAL . 30.1 m-85 -107.02 -36.81 6.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.3 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.35 57.89 1.17 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.582 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 34.7 t -111.67 151.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.962 0.41 . . . . 0.0 111.236 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.69 102.65 12.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 56.6 p -77.12 -14.09 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.298 0.571 . . . . 0.0 111.513 -173.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -83.97 -8.15 59.23 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.756 0.789 . . . . 0.0 110.134 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.82 -10.35 23.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 57.1 mt -82.66 129.61 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.02 -175.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.551 ' HD3' HD23 ' A' ' 47' ' ' LEU . 11.8 tmtt? -96.89 119.2 34.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.561 ' HA ' HG12 ' A' ' 60' ' ' VAL . 39.3 mt -84.5 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.772 0.796 . . . . 0.0 111.4 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.551 HD23 ' HD3' ' A' ' 45' ' ' LYS . 5.9 mt -97.47 -56.06 2.64 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.656 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HA ' HG23 ' A' ' 16' ' ' VAL . 77.0 tttt -143.17 111.74 6.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.134 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.885 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.9 m -101.26 140.17 35.92 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -156.5 173.66 16.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.629 ' HB2' ' HE2' ' A' ' 74' ' ' LYS . 7.5 pt-20 -141.3 143.67 34.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.36 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -131.03 -146.8 0.31 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.98 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -65.79 95.47 0.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.659 0.266 . . . . 0.0 110.881 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 67.3 -6.43 0.62 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -116.82 134.5 54.7 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.644 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.685 ' CD2' ' HG2' ' A' ' 74' ' ' LYS . 10.5 m-85 -92.23 147.61 22.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.619 169.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.539 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 72.5 m-85 -130.4 97.94 4.55 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.35 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.629 HG22 HG23 ' A' ' 49' ' ' THR . 7.3 t -102.09 93.11 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.143 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.9 t -79.09 117.5 20.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 46' ' ' ILE . 17.3 m -130.02 157.44 42.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.35 126.2 33.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 7.07 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.68 -36.57 4.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.086 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -93.49 -29.99 15.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.239 0.542 . . . . 0.0 111.123 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.81 -18.45 2.77 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.426 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.36 134.77 52.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.32 98.89 7.2 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.893 0.854 . . . . 0.0 110.061 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 1.039 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 10.1 t -93.57 133.88 36.43 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.303 -172.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.1 ttmt -107.43 103.85 13.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.766 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.594 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 44.8 m-85 -69.01 115.53 8.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.002 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 86.6 tttt -94.17 98.4 10.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.118 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 95.5 mt -100.43 111.63 30.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.848 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 10.8 ttt180 -69.88 104.09 2.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.748 ' HB3' HD13 ' A' ' 3' ' ' LEU . 78.1 mttt -47.7 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.241 0.963 . . . . 0.0 111.451 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.903 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 14.0 t70 1.84 77.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 125.194 1.559 . . . . 0.0 112.578 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.528 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . 15.7 m -84.03 -11.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.716 -170.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 26.3 t70 170.63 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.749 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -89.26 148.87 41.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.184 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.602 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 75.4 Cg_endo -83.14 105.75 1.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.628 2.219 . . . . 0.0 112.406 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HG2' ' HE2' ' A' ' 36' ' ' LYS . 3.1 mtmm 178.43 157.81 0.47 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.275 0.559 . . . . 0.0 111.309 175.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.808 ' HE3' ' HD3' ' A' ' 36' ' ' LYS . 2.3 tmm? -89.32 128.03 35.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 5.6 p -66.16 -38.89 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -178.12 -164.02 30.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.99 -1.576 . . . . 0.0 114.721 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.717 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 11.3 ptt180 -176.05 88.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.552 1.168 . . . . 0.0 107.967 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -78.43 -18.36 55.05 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.921 -170.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.039 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.5 m 58.82 100.64 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.939 0.876 . . . . 0.0 109.887 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 . . . . . 0 C--N 1.304 -1.41 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.947 -166.323 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.613 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 13.1 t . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 37.0 mt -121.53 -6.91 9.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.247 0.546 . . . . 0.0 110.452 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.741 HG21 ' HE2' ' A' ' 56' ' ' TYR . 6.8 tp -89.21 135.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.511 -169.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.651 HD23 ' HA ' ' A' ' 7' ' ' LEU . 9.8 mp 68.38 91.06 0.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.351 0.407 . . . . 0.0 110.434 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.37 83.22 0.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . 51.5 52.09 34.69 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.489 ' H ' ' HA ' ' A' ' 76' ' ' VAL . 7.4 t70 -137.45 -164.0 1.52 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.235 -0.483 . . . . 0.0 110.874 -161.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.651 ' HA ' HD23 ' A' ' 3' ' ' LEU . 2.7 pp -161.61 133.43 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.321 0.581 . . . . 0.0 111.94 -173.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 92.1 mt -123.8 -69.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.134 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 70.92 -67.02 0.27 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.638 0.586 . . . . 0.0 111.527 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -97.99 37.64 1.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.966 0.889 . . . . 0.0 109.505 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.739 ' HB3' ' HB3' ' A' ' 8' ' ' LEU . 20.8 pttt -75.53 -28.38 59.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.393 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 3.6 pp -101.33 170.36 8.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.086 -173.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -140.86 34.59 1.77 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.506 0.67 . . . . 0.0 109.868 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -129.56 147.85 66.95 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.338 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.79 -25.55 23.69 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.042 1.828 . . . . 0.0 111.531 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.468 HG22 ' HG3' ' A' ' 48' ' ' LYS . 15.3 t -145.61 139.91 21.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.743 175.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 49' ' ' THR . 4.2 mt -88.36 160.73 2.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.39 136.4 57.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -68.23 -13.68 62.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.168 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.6 tp -67.88 -41.95 82.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.964 0.411 . . . . 0.0 109.899 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 78.3 t80 -63.22 -36.97 85.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -64.78 -50.89 56.15 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.204 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -52.28 -37.83 56.64 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 122.361 0.264 . . . . 0.0 111.12 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.7 mm-40 -59.51 -50.39 74.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.702 0.401 . . . . 0.0 111.679 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 51.7 mt -53.33 -58.85 5.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.717 0.77 . . . . 0.0 110.316 176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.757 HD11 HG11 ' A' ' 58' ' ' VAL . 8.5 mp -62.54 -35.67 80.17 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.057 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.73 -41.5 81.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 87.8 mttt -70.23 -29.37 66.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.503 ' HE1' ' HA ' ' A' ' 80' ' ' LYS . 84.3 m-85 -98.27 1.55 47.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -55.16 -43.37 74.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 120.98 0.419 . . . . 0.0 111.002 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.51 -34.13 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.125 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.92 -40.22 28.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.209 0.528 . . . . 0.0 110.166 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.583 HG22 ' HB ' ' A' ' 39' ' ' VAL . 70.1 mt -63.19 -36.88 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.208 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.9 tttm -80.34 -30.77 38.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.895 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.47 -44.11 89.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.093 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -94.4 -41.48 9.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.468 ' HB2' HG23 ' A' ' 39' ' ' VAL . 46.4 m-85 -114.27 -29.66 6.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.0 111.32 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.38 54.26 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.662 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 33' ' ' ILE . 18.5 t -117.36 151.36 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 0.0 110.81 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' OD2' ' HG2' ' A' ' 42' ' ' LYS . 9.7 t70 -107.13 125.04 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 26' ' ' LEU . 13.9 p -76.01 -14.27 60.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 8.1 ptpp? -77.61 -17.09 58.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.88 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.99 -22.69 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.294 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.77 118.84 10.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.511 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 63.2 tttp -82.77 98.79 9.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.249 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.652 ' HA ' HG12 ' A' ' 60' ' ' VAL . 48.2 mt -73.11 119.73 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.543 0.687 . . . . 0.0 110.747 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.7 mt -90.18 -44.46 9.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.099 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.468 ' HG3' HG22 ' A' ' 16' ' ' VAL . 58.2 tttm -149.49 106.02 3.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.192 -172.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 17' ' ' ILE . 11.0 m -86.88 123.9 32.52 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.0 m -160.47 -178.41 6.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.3 pt-20 -138.88 152.96 48.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.669 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 30.0 t70 -148.18 125.75 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HG3' ' OD1' ' A' ' 52' ' ' ASP . 38.7 mttp 60.17 -138.52 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.844 ' HB3' HG11 ' A' ' 76' ' ' VAL . 73.2 mtm180 -80.16 12.72 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.629 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.617 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 3.8 m-85 -137.15 152.86 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.15 -167.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.741 ' HE2' HG21 ' A' ' 2' ' ' ILE . 14.6 m-85 -91.55 150.71 21.07 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 169.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.669 ' CE2' ' HB3' ' A' ' 52' ' ' ASP . 65.0 m-85 -130.13 98.05 4.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.757 0.313 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.757 HG11 HD11 ' A' ' 26' ' ' LEU . 21.5 t -100.03 93.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 2.1 t -76.71 124.33 27.51 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 46' ' ' ILE . 11.6 m -134.8 151.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.092 0.473 . . . . 0.0 111.211 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.1 t70 -87.49 117.15 26.09 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.63 -9.43 59.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.811 0.339 . . . . 0.0 111.702 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.74 -28.41 4.46 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.229 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -64.0 -28.03 69.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 0.0 110.065 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.74 -27.92 3.15 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.266 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -83.62 152.99 24.52 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.201 0.524 . . . . 0.0 111.443 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -103.14 111.71 24.21 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 2.4 t -95.76 168.97 10.33 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.605 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 19.1 ttmm -148.04 94.49 2.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 79.0 m-85 -72.56 89.73 1.31 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.899 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 74.2 tttt -78.6 93.01 4.77 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.742 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 80.4 mt -83.03 105.88 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.53 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.662 ' H ' ' HA ' ' A' ' 81' ' ' MET . 14.5 ttt180 -66.03 121.34 14.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.521 ' HE3' ' C ' ' A' ' 55' ' ' PHE . 71.4 mttt -65.73 168.37 7.87 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.301 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.0 7.84 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 0.0 110.542 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.844 HG11 ' HB3' ' A' ' 54' ' ' ARG . 2.7 p -53.86 -33.15 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 122.441 1.115 . . . . 0.0 109.3 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.561 ' O ' HG12 ' A' ' 78' ' ' VAL . 27.6 t70 -164.84 118.42 1.29 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.872 -1.967 . . . . 0.0 108.387 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 77' ' ' ASP . 8.9 p 54.79 124.67 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.74 0 O-C-N 125.01 1.444 . . . . 0.0 112.683 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 84.7 Cg_endo -79.04 47.44 2.49 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 123.746 2.964 . . . . 0.0 112.555 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 7.3 mtmt -147.24 146.99 29.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.662 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 8.1 ptt? -57.23 108.47 0.53 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.11 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.659 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 9.1 p -59.91 -40.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.788 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -145.57 91.36 0.15 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.263 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -76.49 58.47 1.34 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.018 0.914 . . . . 0.0 108.635 170.413 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -95.97 119.17 34.0 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.882 -167.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -83.87 124.04 30.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.333 0.587 . . . . 0.0 109.535 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 C--N 1.308 -1.236 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -179.45 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.409 ' OG ' ' HZ ' ' A' ' 29' ' ' PHE . 58.0 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.052 0.453 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.732 HD22 ' H ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -115.26 97.52 6.24 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.413 HG23 ' CD1' ' A' ' 3' ' ' LEU . 5.4 tp -163.47 -20.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.041 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.884 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 3.9 mp -116.98 1.03 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 t70 66.97 -62.43 0.3 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.655 0.597 . . . . 0.0 111.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.36 61.14 0.19 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.599 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 25.7 t0 76.75 23.07 1.07 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.649 0.738 . . . . 0.0 111.077 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 6.5 tt -98.08 122.95 41.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.617 HD23 HD23 ' A' ' 7' ' ' LEU . 2.2 pt? -41.04 -66.68 0.31 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -167.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.576 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 31.8 mmtp 65.06 -67.8 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.614 ' HB2' HD23 ' A' ' 12' ' ' LEU . 3.3 p30 -59.17 -54.0 51.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.8 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG2' HD12 ' A' ' 8' ' ' LEU . 42.4 mtpt 53.45 43.97 30.59 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.341 0.4 . . . . 0.0 111.043 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.614 HD23 ' HB2' ' A' ' 10' ' ' ASP . 4.3 mm? -63.52 -86.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.382 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.686 ' N ' ' HE2' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 54.41 61.43 3.02 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 109.991 177.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 82.8 mt -134.97 174.69 4.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.459 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.2 Cg_endo -63.5 -153.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.896 2.397 . . . . 0.0 111.066 165.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 48' ' ' LYS . 23.8 t -58.75 106.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.757 0.789 . . . . 0.0 109.944 175.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.59 156.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.486 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -49.05 133.03 18.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.107 0.479 . . . . 0.0 111.213 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -67.42 -25.52 65.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.729 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.38 -50.39 70.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 50.8 t80 -59.15 -38.58 80.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.722 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -64.54 -47.04 88.19 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 9.2 mmmm -54.77 -36.92 65.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.314 0.246 . . . . 0.0 111.027 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.3 mm-40 -60.04 -47.0 87.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.429 0.456 . . . . 0.0 111.492 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 72' ' ' ILE . 89.0 mt -52.46 -63.78 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.462 174.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.761 HD11 HG11 ' A' ' 58' ' ' VAL . 7.7 mp -59.67 -32.33 70.39 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.292 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.42 -40.29 86.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.216 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 50.6 mttm -75.5 -32.36 60.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.644 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 91.8 m-85 -96.44 8.47 43.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -54.04 -39.56 66.31 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.246 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.4 -39.78 94.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.664 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.52 -38.53 54.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.15 -26.4 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.288 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 82.0 tttt -83.55 -28.17 28.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.614 0.721 . . . . 0.0 109.84 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.94 -46.39 62.5 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.273 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -77.73 -39.75 43.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.761 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.625 ' HB2' HG23 ' A' ' 39' ' ' VAL . 90.0 m-85 -114.88 -48.01 2.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.449 0.642 . . . . 0.0 110.966 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.16 39.05 2.35 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.296 -171.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG12 ' H ' ' A' ' 41' ' ' THR . 13.5 t -109.3 150.82 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.831 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 42' ' ' LYS . 32.0 t70 -92.99 11.17 28.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 0.0 110.132 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.647 ' H ' HG12 ' A' ' 39' ' ' VAL . 46.6 p 56.16 -24.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.7 1.6 . . . . 0.0 114.129 -172.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 42' ' ' LYS . 4.4 ttmp? -72.83 -12.92 61.17 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 110.517 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.1 -42.5 17.33 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.759 0.79 . . . . 0.0 108.875 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.62 ' HG ' HG11 ' A' ' 39' ' ' VAL . 57.1 mt -61.67 106.11 0.63 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.376 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.632 ' HD3' HD23 ' A' ' 47' ' ' LEU . 6.1 tmtm? -79.91 116.61 20.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.403 ' HA ' HG12 ' A' ' 60' ' ' VAL . 41.3 mt -73.6 128.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.546 0.688 . . . . 0.0 110.956 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.632 HD23 ' HD3' ' A' ' 45' ' ' LYS . 15.3 mt -97.92 -51.5 4.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.889 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.581 ' HA ' HG13 ' A' ' 16' ' ' VAL . 62.4 tttm -144.73 102.86 3.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.461 -173.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.4 m -78.9 121.72 25.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -153.22 -177.78 6.54 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.818 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 1.7 pp20? -162.55 160.83 26.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.808 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.681 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 29.7 t70 -103.78 -86.14 0.45 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.735 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -131.33 -79.23 0.52 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' HB3' HG11 ' A' ' 76' ' ' VAL . 52.5 mtt180 -87.99 16.93 5.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 0.0 110.818 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -144.6 135.62 25.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.684 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.9 m-85 -94.88 151.45 19.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.681 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 78.1 m-85 -137.8 109.59 7.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.349 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 26' ' ' LEU . 21.8 t -110.7 108.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.1 t -84.27 130.72 34.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 67' ' ' LYS . 26.9 m -135.4 148.29 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.136 0.494 . . . . 0.0 112.167 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.537 ' HB2' HD21 ' A' ' 47' ' ' LEU . 34.7 t70 -90.26 112.88 24.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.93 -63.88 1.13 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.798 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.67 -130.27 2.07 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.096 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.39 -8.14 21.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.098 0.475 . . . . 0.0 109.813 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.73 -33.95 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.603 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.45 136.56 58.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.214 0.53 . . . . 0.0 111.132 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 42.5 mttp -137.17 106.3 6.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.96 -173.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 1.9 t -96.09 148.0 23.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.352 -173.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 5.0 ttmp? -115.03 102.78 10.26 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.71 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 62.1 m-85 -68.44 127.48 33.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.659 ' HE3' HG11 ' A' ' 82' ' ' VAL . 56.7 tttp -100.71 83.45 2.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.666 0.746 . . . . 0.0 109.938 -175.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 94.8 mt -81.25 89.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.952 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.654 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 39.7 ttt180 -58.9 117.72 4.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HB3' HD13 ' A' ' 3' ' ' LEU . 93.9 mttt -60.9 174.07 0.68 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.569 -176.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.884 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 53.1 t0 -71.89 64.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 0.0 110.513 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.599 ' HA ' ' N ' ' A' ' 6' ' ' ASP . 31.1 m -99.09 -7.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.438 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -175.16 -61.49 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.024 -171.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.1 151.02 37.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.577 . . . . 0.0 111.186 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -90.34 32.74 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.709 2.94 . . . . 0.0 110.977 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.644 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 3.0 ttmt -150.88 -166.18 2.47 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.178 0.513 . . . . 0.0 111.099 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.546 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 67.9 mtm -97.04 127.2 42.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.226 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG11 ' HE3' ' A' ' 71' ' ' LYS . 7.6 p -53.01 -33.13 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.455 0.645 . . . . 0.0 109.903 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.76 -143.42 8.41 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.919 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.71 ' HB2' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER 176.3 148.78 0.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -148.49 121.07 8.56 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.945 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 1.4 m -88.19 130.31 35.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 122.067 0.937 . . . . 0.0 109.893 -172.989 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.459 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 28.6 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.822 ' H ' ' HE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -125.76 108.59 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.742 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.808 HG21 ' HE1' ' A' ' 56' ' ' TYR . 3.3 tp -176.36 -6.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.645 HD11 ' H ' ' A' ' 8' ' ' LEU . 7.1 tp -144.27 -18.25 0.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.405 -171.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 65.41 9.53 5.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.887 0.475 . . . . 0.0 112.069 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.719 ' HA2' ' H ' ' A' ' 77' ' ' ASP . . . 71.49 18.11 76.79 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.647 -172.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -103.36 -35.25 8.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.562 ' HA ' ' HG ' ' A' ' 3' ' ' LEU . 6.8 mp 71.03 109.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.517 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.645 ' H ' HD11 ' A' ' 3' ' ' LEU . 58.0 tp -109.62 88.37 2.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.586 ' HA ' HD21 ' A' ' 12' ' ' LEU . 9.5 ptpp? -93.35 14.3 18.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.559 -172.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.534 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 20.5 t70 -88.8 -29.71 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.219 0.533 . . . . 0.0 110.565 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 -20.98 32.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.299 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.586 HD21 ' HA ' ' A' ' 9' ' ' LYS . 2.3 pp -87.53 45.57 1.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.847 0.832 . . . . 0.0 111.692 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.534 ' HD3' ' O ' ' A' ' 10' ' ' ASP . 40.8 mtpt -115.06 21.87 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.965 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.41 154.77 46.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.418 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.55 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.255 2.637 . . . . 0.0 110.966 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' CG2' ' HG3' ' A' ' 48' ' ' LYS . 3.4 p -54.71 108.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 122.335 1.064 . . . . 0.0 110.38 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.822 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 33.3 mt -75.82 149.57 6.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.3 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.22 139.64 47.17 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.097 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.494 ' O ' HD12 ' A' ' 46' ' ' ILE . 21.4 p-10 -60.29 -24.55 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.063 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 20' ' ' LEU . 2.6 tm? -70.43 -39.74 74.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.581 ' O ' HD13 ' A' ' 25' ' ' LEU . 77.5 t80 -62.02 -43.93 97.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -67.74 -29.67 73.98 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.431 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -70.05 -37.39 75.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 36.2 mm-40 -59.18 -47.75 84.17 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.693 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 21' ' ' PHE . 8.7 mp -50.42 -67.34 0.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.943 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 26.5 mt -50.38 -30.19 11.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.795 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.25 -45.72 46.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.372 -0.205 . . . . 0.0 110.72 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 63.6 mttm -65.88 -46.77 77.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.278 0.561 . . . . 0.0 110.41 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.822 ' HE2' ' H ' ' A' ' 1' ' ' LEU . 19.5 m-85 -91.33 13.21 18.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.787 -174.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.84 -51.43 67.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.7 m-20 -80.74 11.17 4.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.369 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.03 -43.98 5.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.581 HG21 ' HE2' ' A' ' 70' ' ' PHE . 38.8 mt -66.93 -38.2 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.685 174.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -83.05 -22.76 33.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.845 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 15.2 t70 -68.51 -55.3 12.21 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.272 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 81' ' ' MET . 58.2 mttm -69.51 -50.73 42.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.417 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.533 ' OH ' ' HA2' ' A' ' 83' ' ' GLY . 26.9 m-85 -116.71 -6.4 11.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.92 29.28 73.49 Favored Glycine 0 CA--C 1.516 0.136 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.494 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 33' ' ' ILE . 28.2 t -97.93 147.72 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.554 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.23 127.57 50.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.943 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 71.8 p -87.94 -20.11 26.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.816 0.341 . . . . 0.0 111.858 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -68.19 -39.74 82.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -61.05 -29.01 69.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.862 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 64.2 mt -69.52 149.95 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -175.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -115.01 121.15 42.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.432 172.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.606 HG12 HG12 ' A' ' 60' ' ' VAL . 26.5 mt -84.65 132.25 32.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.512 0.673 . . . . 0.0 111.779 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 61' ' ' ASP . 5.7 mt -101.76 -52.04 3.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.733 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 38.4 ttmt -146.35 115.3 6.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.059 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.822 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -91.59 139.04 31.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -157.41 -175.41 5.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 12' ' ' LEU . 13.1 pt-20 -163.74 150.8 12.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.298 0.57 . . . . 0.0 111.962 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.76 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 27.8 t70 -99.55 -158.84 0.7 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.793 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 4.0 mptt -73.11 -70.61 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -87.12 13.63 9.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 91.0 m-85 -145.67 152.21 39.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.808 ' HE1' HG21 ' A' ' 2' ' ' ILE . 30.9 m-85 -108.17 147.01 31.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.009 166.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.76 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 66.1 m-85 -130.37 95.7 3.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.818 0.342 . . . . 0.0 110.329 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 22.0 t -104.7 97.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.049 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.693 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.2 t -69.02 114.03 6.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 46' ' ' ILE . 13.7 m -129.28 152.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.429 0.633 . . . . 0.0 111.265 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.6 ' HB2' HD21 ' A' ' 47' ' ' LEU . 12.3 t70 -84.41 115.53 22.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.28 -14.5 60.51 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.297 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.99 -42.76 2.35 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.602 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.18 -30.14 64.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.903 0.481 . . . . 0.0 111.293 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.55 -19.46 1.67 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.453 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.587 ' OE2' ' HB3' ' A' ' 86' ' ' CYS . 6.2 pt-20 -104.71 166.17 10.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.321 0.582 . . . . 0.0 112.345 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -111.92 117.66 33.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.153 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 62.1 m -111.84 114.99 28.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.036 0.446 . . . . 0.0 111.19 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.933 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.5 ttmt -88.82 85.28 6.73 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 170.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.581 ' HE2' HG21 ' A' ' 33' ' ' ILE . 5.9 m-85 -47.91 116.3 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.913 -172.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.766 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 62.4 tttt -95.67 69.79 2.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.242 -174.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.842 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 36.7 mt -74.52 91.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.454 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.822 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 24.4 ttt180 -50.58 117.43 2.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.45 ' HE3' ' CE1' ' A' ' 56' ' ' TYR . 43.0 mttp -59.4 166.3 2.37 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.03 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 17.9 t0 -67.68 74.75 0.18 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.632 0.73 . . . . 0.0 109.68 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 74' ' ' LYS . 3.7 m -104.31 94.39 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.672 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.719 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 34.5 t70 72.21 -61.14 0.5 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.293 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.67 141.56 22.76 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.322 0.582 . . . . 0.0 110.19 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HB2' ' H2 ' ' A' ' 0' ' ' SER . 23.1 Cg_endo -91.85 84.29 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.463 2.776 . . . . 0.0 113.62 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 5.2 mtmt -165.51 153.55 11.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.547 176.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.842 ' HG3' ' HA ' ' A' ' 72' ' ' ILE . 4.5 ttp -82.24 121.39 26.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.811 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.822 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.3 p -60.88 -39.4 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.382 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.533 ' HA2' ' OH ' ' A' ' 37' ' ' TYR . . . 178.87 -153.02 11.82 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.895 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.766 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 41.3 mtm180 -151.43 125.75 9.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.933 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 24.5 tptp -76.28 55.57 0.98 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.339 0.59 . . . . 0.0 110.106 -178.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.587 ' HB3' ' OE2' ' A' ' 66' ' ' GLU . 39.3 m -72.47 -164.63 0.16 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.832 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 98.2 mtt180 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 79' ' ' PRO . 11.4 p . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.1 mp 52.09 -153.05 0.22 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.005 171.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.616 HD13 ' HE2' ' A' ' 56' ' ' TYR . 79.4 mt 79.57 -56.5 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.029 168.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.785 HD13 ' HA ' ' A' ' 7' ' ' LEU . 64.9 mt -105.46 -42.89 5.1 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.848 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 29.6 m-20 60.46 71.81 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.672 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.1 31.34 80.46 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.543 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.0 t70 -135.24 -153.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.785 ' HA ' HD13 ' A' ' 3' ' ' LEU . 86.0 mt -154.23 172.29 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 110.668 -171.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.686 HD21 ' HZ3' ' A' ' 74' ' ' LYS . 2.4 pt? -140.4 120.32 13.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -100.92 -18.08 16.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.778 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -94.17 -30.14 14.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HA ' HD12 ' A' ' 8' ' ' LEU . 10.4 mtmp? 57.78 -168.78 0.12 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.807 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.41 HD11 ' CE2' ' A' ' 21' ' ' PHE . 84.1 mt -90.47 -74.71 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.677 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HE3' HG23 ' A' ' 17' ' ' ILE . 31.1 pttt -175.93 -161.78 0.09 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -168.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.469 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 10.7 mp -66.76 169.33 8.11 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.367 0.667 . . . . 0.0 112.189 -175.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 98.5 Cg_exo -47.99 159.33 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.811 3.007 . . . . 0.0 113.891 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 49' ' ' THR . 11.0 p 40.96 104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 123.482 1.611 . . . . 0.0 113.432 -173.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.732 HG22 ' H ' ' A' ' 18' ' ' ASP . 9.8 mt -87.66 -177.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.469 -175.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.732 ' H ' HG22 ' A' ' 17' ' ' ILE . 4.0 m-20 -59.99 -4.93 0.85 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.58 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 90.0 m-20 72.9 -44.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.485 0.714 . . . . 0.0 110.981 -176.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -59.82 -31.57 69.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.779 0.432 . . . . 0.0 110.675 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.521 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 38.5 t80 -65.5 -35.63 81.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 109.754 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -77.11 -27.64 59.76 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 177.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -65.59 -37.66 87.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.6 -48.86 77.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.181 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 84.0 mt -49.76 -69.11 0.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.028 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 33.7 mt -52.78 -26.68 15.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.88 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.99 -48.75 67.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 110.958 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -69.3 -40.98 77.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.192 0.52 . . . . 0.0 110.365 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.36 3.83 52.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.818 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 31.3 tt0 -54.95 -40.56 70.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -65.86 -26.65 67.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.993 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 35' ' ' ASP . 7.9 t70 -85.57 -40.17 16.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.511 0.672 . . . . 0.0 109.681 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.422 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.5 mt -69.25 -34.03 61.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.412 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.492 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 86.4 tttt -75.83 -31.54 59.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 18.7 t70 -59.94 -35.59 75.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.643 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -105.87 -25.31 12.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -173.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' HB2' HG23 ' A' ' 39' ' ' VAL . 74.0 m-85 -128.14 -31.38 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.54 63.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.111 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 37' ' ' TYR . 46.5 t -120.7 151.51 23.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 -173.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 42' ' ' LYS . 23.1 t70 -108.65 110.14 21.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 17.3 p -72.32 -10.43 59.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.501 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 6.3 ttpm? -78.04 -35.0 50.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.039 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.32 -28.62 59.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 109.589 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 41' ' ' THR . 1.4 mp -54.11 115.99 2.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.405 176.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 2.8 ttmp? -86.32 108.55 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.972 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.676 ' HA ' HG12 ' A' ' 60' ' ' VAL . 36.4 mt -80.27 122.6 35.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.445 0.641 . . . . 0.0 111.094 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.1 mt -96.03 -51.71 4.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.956 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -142.43 106.31 4.71 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.265 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 11.3 m -91.04 132.13 36.2 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' HG13 ' A' ' 17' ' ' ILE . 69.0 m -152.54 -175.11 5.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 11' ' ' LYS . 12.5 pt-20 -149.64 158.65 44.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.763 0.792 . . . . 0.0 111.519 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.671 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 28.1 t70 -111.56 -164.94 0.95 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 166.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.854 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 1.2 mptt -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 40.0 mtp180 -83.5 -0.1 48.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.584 -172.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.455 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 m-85 -148.15 159.71 43.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.237 0.541 . . . . 0.0 112.382 -168.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.731 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 36.0 m-85 -109.24 159.75 16.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 163.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.671 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 94.4 m-85 -137.07 93.78 2.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.936 0.398 . . . . 0.0 110.181 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 49' ' ' THR . 13.3 t -102.51 96.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.588 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 12.9 m -78.4 124.44 28.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 46' ' ' ILE . 17.4 m -141.6 160.57 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.543 -173.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 6.0 t70 -92.17 125.33 36.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.544 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -79.81 -13.96 59.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.45 -31.92 7.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.58 8.92 4.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.802 0.334 . . . . 0.0 111.23 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.21 -15.08 63.74 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.625 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.544 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 9.6 pt-20 -84.16 142.19 30.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.162 0.506 . . . . 0.0 110.749 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -97.62 134.9 40.2 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.9 t -126.63 164.66 20.77 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.25 0.548 . . . . 0.0 110.623 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.637 ' H ' ' HA ' ' A' ' 86' ' ' CYS . 35.7 ttmt -147.43 103.87 3.59 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 26' ' ' LEU . 72.0 m-85 -77.36 88.08 3.76 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.571 0.7 . . . . 0.0 110.529 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 1.05 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 31.1 tttp -71.63 78.02 0.82 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.924 170.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.731 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 78.9 mt -74.43 95.84 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.247 -176.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.783 ' HB2' HG12 ' A' ' 82' ' ' VAL . 40.5 ttp180 -61.76 101.64 0.21 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.686 ' HZ3' HD21 ' A' ' 8' ' ' LEU . 88.8 mttt -48.72 152.3 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.369 1.043 . . . . 0.0 109.687 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.848 ' HB3' ' H ' ' A' ' 4' ' ' ASP . 29.3 t0 -69.47 70.78 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.411 0.624 . . . . 0.0 109.56 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 33.7 m -89.2 -4.34 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.865 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 t70 178.57 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.732 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.51 HG23 ' HD2' ' A' ' 79' ' ' PRO . 7.1 p -137.29 138.34 24.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.326 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.536 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 68.4 Cg_endo -83.06 62.88 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.493 2.796 . . . . 0.0 112.855 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -145.28 128.28 16.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 111.471 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.515 ' HG3' HG23 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.59 95.63 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.13 177.183 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.783 HG12 ' HB2' ' A' ' 73' ' ' ARG . 10.0 p -60.58 -41.54 88.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.704 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 1.05 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -89.5 47.76 3.29 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 -173.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -81.77 45.53 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -105.01 -26.28 12.21 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.818 -165.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.637 ' HA ' ' H ' ' A' ' 69' ' ' LYS . 49.4 m 66.35 -178.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.906 -171.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 N--CA 1.437 -1.088 0 CA-C-O 121.546 0.688 . . . . 0.0 109.285 -172.924 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 2' ' ' ILE . 27.2 mt -118.59 -144.43 0.37 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.627 HG21 ' HE2' ' A' ' 56' ' ' TYR . 1.3 tp 81.2 -25.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.981 0.912 . . . . 0.0 112.492 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.821 HD13 ' HA ' ' A' ' 6' ' ' ASP . 30.8 mt -124.0 161.9 24.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.954 0.407 . . . . 0.0 110.659 176.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.588 ' HB3' HD12 ' A' ' 7' ' ' LEU . 18.7 t70 -121.81 81.01 1.76 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.59 43.78 97.49 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.392 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.821 ' HA ' HD13 ' A' ' 3' ' ' LEU . 34.6 t70 67.14 96.73 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.228 0.537 . . . . 0.0 111.951 -177.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 4' ' ' ASP . 75.6 mt -149.4 100.03 2.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.62 HD23 ' HD3' ' A' ' 53' ' ' LYS . 51.7 tp -112.19 -68.19 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 38.0 mtmt 76.77 -66.49 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.564 . . . . 0.0 111.856 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -125.75 134.18 51.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.856 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -149.43 3.54 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.552 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.46 128.5 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.165 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 14' ' ' LEU . 59.3 tttt -136.69 165.8 25.07 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' H ' ' HG2' ' A' ' 13' ' ' LYS . 61.9 mt -55.01 159.15 4.04 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 122.654 0.382 . . . . 0.0 111.342 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.26 138.82 4.45 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.594 2.862 . . . . 0.0 113.5 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p 43.69 102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 123.129 1.442 . . . . 0.0 113.578 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.88 162.31 4.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.124 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.88 133.31 22.27 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.345 0.403 . . . . 0.0 111.126 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -64.01 -20.85 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.913 0.387 . . . . 0.0 110.254 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -69.03 -31.55 70.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.418 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HE1' ' HE1' ' A' ' 56' ' ' TYR . 55.5 t80 -68.6 -40.07 80.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 109.698 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -72.26 -29.85 65.8 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.162 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -67.27 -40.49 86.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.2 mm-40 -52.77 -51.72 59.51 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.744 173.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.514 HD13 HD12 ' A' ' 72' ' ' ILE . 68.3 mt -53.97 -66.36 0.41 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.839 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.549 HD22 HG22 ' A' ' 41' ' ' THR . 20.4 mt -54.06 -28.36 38.34 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.46 -50.23 60.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 72.4 mttt -71.54 -33.77 69.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.816 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -96.88 4.9 51.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.789 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.4 tt0 -56.52 -41.63 77.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.775 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -65.69 -20.99 66.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.551 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -94.61 -39.93 10.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.277 0.561 . . . . 0.0 110.042 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.538 HG22 ' HB ' ' A' ' 39' ' ' VAL . 53.7 mt -67.76 -31.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.313 176.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 44.1 tttp -81.73 -29.15 33.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.306 0.574 . . . . 0.0 109.803 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.39 -52.59 31.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.574 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -71.44 -43.39 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.621 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.576 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 86.6 m-85 -118.59 -23.54 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.14 44.11 7.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.875 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.556 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.3 t -100.99 152.79 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -114.4 116.61 29.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.554 HG22 HD12 ' A' ' 44' ' ' LEU . 39.7 p -76.22 -11.6 59.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -73.68 -20.46 60.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.358 0.599 . . . . 0.0 109.53 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -92.23 -33.0 14.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.327 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.554 HD12 HG22 ' A' ' 41' ' ' THR . 86.6 mt -56.67 111.55 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.959 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 75.8 tttt -84.11 104.35 14.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.71 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.618 ' HA ' HG12 ' A' ' 60' ' ' VAL . 37.7 mt -73.73 112.68 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.546 0.688 . . . . 0.0 111.029 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.6 mt -82.25 -43.5 17.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.065 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -154.04 120.38 5.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.347 -173.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -102.46 130.21 49.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.9 m -157.29 177.03 11.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 11' ' ' LYS . 1.2 pt-20 -158.61 167.05 30.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 171.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -149.01 89.78 1.7 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.107 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.856 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 5.3 tppp? 70.41 -100.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.726 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.625 ' HB3' HG21 ' A' ' 76' ' ' VAL . 65.8 mtt180 -94.71 20.44 8.64 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.73 -0.606 . . . . 0.0 111.451 -171.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -148.63 121.01 8.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.818 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.779 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.0 m-85 -85.78 150.96 24.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 95.05 3.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.8 t -105.86 93.92 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 110.516 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.1 m -80.02 119.9 23.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 46' ' ' ILE . 11.5 m -130.29 158.09 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.31 0.576 . . . . 0.0 111.343 -176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -84.55 123.5 30.37 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.55 4.44 7.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.77 1.32 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.372 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.93 -27.05 39.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.136 0.493 . . . . 0.0 110.473 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.59 -21.62 2.37 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.202 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.95 147.89 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.398 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -109.47 110.3 21.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.049 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 56.2 m -108.18 131.43 54.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 34.8 ttmt -101.48 107.18 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.575 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 65.5 m-85 -76.48 84.55 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.184 0.992 . . . . 0.0 110.433 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 1.116 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 21.3 tttp -76.72 89.58 3.39 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.197 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.779 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 mt -87.23 106.22 15.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.494 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.729 ' HB2' HG22 ' A' ' 82' ' ' VAL . 60.3 ttt180 -78.7 18.09 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.462 0.648 . . . . 0.0 110.336 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.624 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.7 mttt 55.43 -157.12 0.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.229 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 32.0 t70 -100.83 56.0 0.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.625 HG21 ' HB3' ' A' ' 54' ' ' ARG . 17.9 t -75.44 -13.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.281 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.8 t70 179.92 -54.63 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.315 -171.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' HD2' ' A' ' 79' ' ' PRO . 10.0 p -120.75 139.03 28.34 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.667 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 78' ' ' VAL . 55.5 Cg_endo -75.16 67.39 6.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.664 2.243 . . . . 0.0 111.86 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -142.03 142.24 32.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.628 0.727 . . . . 0.0 111.985 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.521 ' HG3' HG23 ' A' ' 72' ' ' ILE . 1.5 mpp? -80.7 89.45 5.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.587 173.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 73' ' ' ARG . 35.0 m -58.84 -33.49 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.916 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 1.116 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -92.18 72.8 1.55 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.053 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.576 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -105.39 47.73 0.86 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.369 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -115.53 142.1 47.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.979 -170.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.8 m -108.26 132.02 54.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.049 0.452 . . . . 0.0 109.925 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 . . . . . 0 C--N 1.314 -0.958 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.495 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.412 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 26.1 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.291 0.567 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.964 ' HA ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -67.9 131.04 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.597 1.189 . . . . 0.0 113.47 -169.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.614 HG13 HD11 ' A' ' 8' ' ' LEU . 11.1 tp -152.36 15.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.167 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 75' ' ' ASP . 1.8 pp -149.2 157.89 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.462 -1.699 . . . . 0.0 108.184 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.61 -29.31 61.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.318 0.58 . . . . 0.0 109.825 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 40.99 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 24.1 p-10 -157.96 -80.26 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.852 -168.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 6' ' ' ASP . 7.7 mt 175.71 174.14 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.139 0.576 . . . . 0.0 110.252 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.614 HD11 HG13 ' A' ' 2' ' ' ILE . 63.8 mt -100.05 131.63 45.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.156 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -98.46 -30.28 12.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' OD2' ' HG3' ' A' ' 11' ' ' LYS . 6.4 p-10 -80.48 -38.03 30.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.068 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HB2' HD13 ' A' ' 8' ' ' LEU . 57.4 mttp -101.86 67.89 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.652 0.739 . . . . 0.0 109.745 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.763 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.6 pt? -79.25 -36.23 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.344 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.671 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 7.5 ptpt -177.08 101.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.448 0.642 . . . . 0.0 110.851 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.525 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 96.0 mt -100.47 167.51 10.79 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.523 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.6 Cg_endo -64.6 -170.61 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.632 2.221 . . . . 0.0 111.998 173.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 48' ' ' LYS . 2.6 p -63.39 105.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.017 175.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 49' ' ' THR . 3.3 pt -106.07 -177.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.804 -174.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.509 ' OD2' ' HB ' ' A' ' 46' ' ' ILE . 7.9 t70 176.68 -39.58 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -40.41 78.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 112.261 -2.245 . . . . 0.0 113.248 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 78.9 mt 45.7 40.2 5.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.729 0.776 . . . . 0.0 111.035 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.512 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.3 m-85 -117.13 -78.06 0.58 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.127 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.41 90.78 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.491 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HG2' HD12 ' A' ' 46' ' ' ILE . 30.2 mmmt -66.4 -33.29 75.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.364 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 1.5 mm-40 -65.87 -47.14 75.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.607 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 87.0 mt -50.94 -66.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.838 173.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.877 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 34.0 mt -50.89 -33.19 23.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.444 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.28 -48.46 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.195 -0.316 . . . . 0.0 111.074 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 80.0 mttt -67.7 -38.22 83.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.211 0.529 . . . . 0.0 110.496 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 1.5 m-85 -98.54 12.59 34.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.46 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.515 ' OE1' ' HA ' ' A' ' 40' ' ' ASP . 5.8 tt0 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.63 -33.15 71.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.347 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.661 ' O ' ' HD2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -76.58 -46.88 24.4 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.534 178.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.511 HG22 ' HB ' ' A' ' 39' ' ' VAL . 42.5 mt -65.45 -20.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.613 0.72 . . . . 0.0 110.266 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 46.9 tttm -87.66 -40.18 14.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.645 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.89 -47.91 76.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.906 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.661 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 8.0 mttp -82.5 -28.74 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.26 -175.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.492 ' HB2' HG23 ' A' ' 39' ' ' VAL . 67.8 m-85 -133.67 -52.43 0.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.018 0.437 . . . . 0.0 111.526 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.53 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . 106.78 62.53 0.59 Allowed Glycine 0 C--N 1.319 -0.393 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 33' ' ' ILE . 47.3 t -124.45 151.84 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.905 0.383 . . . . 0.0 111.372 -171.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.515 ' HA ' ' OE1' ' A' ' 30' ' ' GLN . 28.7 t70 -103.19 121.33 42.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.54 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.877 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 41.1 p -88.56 -10.69 47.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.946 0.403 . . . . 0.0 112.044 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -68.97 -43.16 75.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -73.84 -24.87 59.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.379 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.7 mt -56.71 123.33 14.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.128 0.49 . . . . 0.0 110.692 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -94.2 111.69 23.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.82 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 60' ' ' VAL . 12.4 mt -72.53 116.88 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.487 0.661 . . . . 0.0 111.184 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.3 mt -86.82 -40.02 15.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.929 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HA ' HG23 ' A' ' 16' ' ' VAL . 41.1 tttm -155.0 140.63 17.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.552 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 54.1 m -142.48 127.54 18.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.7 m -156.57 152.53 27.37 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -123.96 162.7 22.86 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 175.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 10.1 t70 -153.69 -98.99 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.672 171.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -93.57 89.79 6.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.912 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.3 mtt180 75.45 -44.84 0.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.657 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 20.5 m-85 -78.98 133.22 36.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.684 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 1.3 m-85 -103.55 121.77 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.718 164.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 49' ' ' THR . 10.7 m-85 -99.07 86.26 3.41 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 18.8 t -96.25 84.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.133 0.492 . . . . 0.0 110.4 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 23.5 t -82.44 117.57 22.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 46' ' ' ILE . 15.2 m -129.84 156.26 42.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.248 0.547 . . . . 0.0 111.618 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.0 119.53 21.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.23 2.75 14.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.2 -50.44 3.63 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.916 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.94 -35.97 80.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.019 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.97 -31.48 0.89 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.885 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -71.6 161.06 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.066 0.46 . . . . 0.0 111.411 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -119.22 105.15 11.07 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.534 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 55.9 m -103.62 127.27 51.08 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.468 -173.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.8 ttpt -99.13 104.46 16.45 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.761 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 85.6 m-85 -71.43 95.99 1.43 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.656 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.647 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 34.6 tttm -81.9 78.2 8.64 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.426 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 74' ' ' LYS . 57.5 mt -82.61 101.94 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.306 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 38.4 ttp180 -74.22 21.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.535 0.683 . . . . 0.0 109.827 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.684 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.1 mttt 64.3 174.25 0.19 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.564 -174.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.964 ' HB2' ' HA ' ' A' ' 1' ' ' LEU . 2.2 t70 -77.39 43.44 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.937 0.398 . . . . 0.0 110.37 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.406 HG11 ' HG2' ' A' ' 54' ' ' ARG . 6.9 m -64.17 91.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.248 0.547 . . . . 0.0 110.884 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 76.55 -50.68 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.095 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 34.8 m -107.25 146.23 32.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.382 0.61 . . . . 0.0 111.27 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.583 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.0 Cg_endo -90.73 54.61 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.737 2.958 . . . . 0.0 113.915 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -145.46 149.17 34.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.775 0.322 . . . . 0.0 111.221 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.419 ' CG ' HG12 ' A' ' 72' ' ' ILE . 2.6 mpp? -81.66 102.16 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 9.5 p -57.85 -31.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.027 0.442 . . . . 0.0 111.288 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -125.08 148.05 16.67 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.062 -177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -173.81 54.14 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -98.92 129.05 45.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.226 -168.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -89.79 115.12 26.89 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.603 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 . . . . . 0 C--N 1.308 -1.202 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.045 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.961 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 7.8 t . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.41 78.61 9.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.213 0.53 . . . . 0.0 109.874 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 2' ' ' ILE . 8.9 tp -151.98 87.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 122.085 0.945 . . . . 0.0 110.219 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.9 pt? -127.96 133.4 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.667 0.746 . . . . 0.0 111.705 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' A' ' 8' ' ' LEU . 10.6 t70 -95.9 -19.91 19.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 168.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.37 71.06 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.079 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.3 t70 63.46 31.24 15.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.126 0.965 . . . . 0.0 109.159 -175.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.741 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 31.5 tp 179.69 -174.08 0.23 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.741 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 34.8 tp -148.12 107.66 3.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -100.56 -14.3 18.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.919 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.1 -48.74 80.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.443 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.21 133.49 24.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.307 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.915 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 22.7 tp -153.74 142.02 20.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.343 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.915 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 36.4 mtmt 67.33 30.95 6.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.9 mt -66.31 129.36 94.18 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 52.4 Cg_exo -57.11 -62.7 0.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 123.59 2.86 . . . . 0.0 112.181 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.696 HG23 ' HG3' ' A' ' 48' ' ' LYS . 8.7 p -146.42 145.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.266 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.547 HG13 ' HA ' ' A' ' 50' ' ' SER . 2.3 mt -119.05 163.12 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.948 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -54.3 140.78 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -67.98 -25.55 65.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.039 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.9 tp -68.06 -45.26 74.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.422 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 79.2 t80 -59.9 -37.07 78.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.473 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -67.64 -51.24 37.28 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.419 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.4 mptp? -51.9 -35.28 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 1.4 mm-40 -59.86 -60.04 4.47 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.463 172.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 63.7 mt -47.89 -56.36 7.71 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.889 0.852 . . . . 0.0 110.62 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.655 HD11 HG11 ' A' ' 58' ' ' VAL . 8.0 mp -63.39 -28.26 69.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.578 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 t70 -62.99 -43.15 99.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.536 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -66.11 -21.19 66.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.961 0.41 . . . . 0.0 110.303 177.174 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.961 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 65.9 m-85 -107.43 2.64 24.45 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -50.99 -44.5 60.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -69.88 -35.61 74.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.748 0.309 . . . . 0.0 110.79 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.73 -45.14 65.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.759 0.79 . . . . 0.0 109.794 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.576 HG22 ' HB ' ' A' ' 39' ' ' VAL . 91.9 mt -61.18 -40.28 85.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.656 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.624 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 27.7 ttpp -78.8 -21.38 47.86 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 110.13 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.75 -48.31 16.95 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HE2' ' HE3' ' A' ' 81' ' ' MET . 9.7 mtpp -81.87 -34.97 29.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -124.27 -26.44 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 64.85 1.92 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.993 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.624 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -133.34 150.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 122.309 0.244 . . . . 0.0 110.814 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.7 119.53 39.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.91 170.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 26' ' ' LEU . 53.7 p -75.21 -19.47 59.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.981 -175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -67.99 -43.09 79.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.064 0.459 . . . . 0.0 110.192 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -82.46 -35.28 27.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 60' ' ' VAL . 18.6 tp -50.79 121.5 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.782 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 44.6 tttp -90.8 114.44 26.83 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.812 -171.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.607 ' HA ' HG12 ' A' ' 60' ' ' VAL . 18.0 mt -87.18 125.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.352 0.596 . . . . 0.0 111.361 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.5 mt -100.72 -54.44 2.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.166 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.696 ' HG3' HG23 ' A' ' 16' ' ' VAL . 59.8 tttm -139.41 93.45 2.68 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.487 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -74.64 137.53 42.29 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.547 ' HA ' HG13 ' A' ' 17' ' ' ILE . 4.5 p -171.11 -169.31 0.73 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 118.218 0.463 . . . . 0.0 110.962 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.593 ' OE2' ' HA ' ' A' ' 12' ' ' LEU . 7.2 pt-20 -165.45 168.14 16.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.553 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 39.0 t70 -145.68 -76.38 0.21 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 0.0 111.337 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HG3' ' OD2' ' A' ' 52' ' ' ASP . 56.5 mttp -113.01 82.27 1.63 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.961 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.502 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 66.7 mtt180 72.13 -27.88 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.964 0.506 . . . . 0.0 112.163 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 53' ' ' LYS . 9.6 m-85 -97.11 139.2 33.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.707 0.289 . . . . 0.0 111.361 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.7 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.3 m-85 -82.52 147.83 28.44 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.776 170.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.624 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 58.9 m-85 -131.36 99.83 4.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.163 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.655 HG11 HD11 ' A' ' 26' ' ' LEU . 27.6 t -103.46 93.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.2 m -73.71 120.82 19.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.1 m -130.34 160.17 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.619 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 7.0 t0 -85.23 117.0 23.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.83 -1.7 7.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.74 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.28 60.61 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -121.27 5.45 10.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.305 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.85 -20.24 51.11 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.28 129.53 40.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.561 0.344 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 55.0 mtpt -95.75 86.0 4.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 0.0 109.894 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.969 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 69.4 m -85.79 118.22 25.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.035 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.624 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 36.4 ttmt -92.34 107.2 19.04 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.573 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 30.8 m-85 -73.65 120.98 19.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.211 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 85.4 tttt -103.92 90.66 3.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.509 -173.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.7 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 64.4 mt -86.71 115.35 27.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.963 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.809 ' H ' ' HA ' ' A' ' 81' ' ' MET . 36.0 ttt180 -85.73 38.21 0.74 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.031 0.443 . . . . 0.0 109.992 -174.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.549 ' HB2' HG12 ' A' ' 76' ' ' VAL . 52.2 mttt 37.24 -152.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.522 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 22.4 t70 -97.89 17.97 16.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 74' ' ' LYS . 2.5 p -73.87 94.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.816 0.817 . . . . 0.0 109.176 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 25.2 t70 84.49 -67.44 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.342 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 35.9 m -90.75 149.16 39.95 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -90.44 34.85 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.218 2.612 . . . . 0.0 111.084 173.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -148.46 -166.15 2.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.426 0.631 . . . . 0.0 111.251 -168.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.809 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 20.7 ptt? -111.35 126.7 55.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.123 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.624 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 7.7 p -59.72 -37.2 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.886 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.38 -157.81 13.2 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.426 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -176.54 102.58 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -174.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -120.49 121.45 38.5 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.969 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 2.5 m -76.17 116.68 17.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.451 ' HE ' ' HB3' ' A' ' 87' ' ' ARG . 16.2 mtp180 . . . . . 0 C--N 1.307 -1.257 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.711 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 3' ' ' LEU . 24.1 mt 72.95 -23.96 0.2 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 2' ' ' ILE . 7.7 tp -81.07 25.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.818 0.818 . . . . 0.0 111.603 -170.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.808 HD11 ' H ' ' A' ' 8' ' ' LEU . 9.4 tp 179.51 176.88 0.61 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -147.6 40.54 1.01 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.498 0.666 . . . . 0.0 109.546 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.52 ' HA2' ' H ' ' A' ' 77' ' ' ASP . . . 69.36 16.89 71.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.345 -174.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 11.7 p-10 -96.75 -37.91 10.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.546 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.806 HD11 ' HG3' ' A' ' 54' ' ' ARG . 4.4 mm? 73.98 88.83 0.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.595 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.808 ' H ' HD11 ' A' ' 3' ' ' LEU . 71.8 mt -71.92 -16.69 62.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.827 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 34.2 mmtp 68.48 -74.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.795 -173.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -120.84 126.41 50.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.516 ' HD3' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -94.89 -37.26 11.27 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.99 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 13' ' ' LYS . 2.6 pp -120.44 -34.17 3.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.83 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.552 ' N ' HD12 ' A' ' 12' ' ' LEU . 19.2 ttpp 53.38 46.32 26.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.694 0.759 . . . . 0.0 110.966 175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 12' ' ' LEU . 93.3 mt -105.3 172.3 4.15 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.25 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 51.1 Cg_exo -58.94 -156.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.149 2.566 . . . . 0.0 111.591 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 48' ' ' LYS . 7.8 p -56.04 126.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.746 0.784 . . . . 0.0 109.93 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.639 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 3.3 mt -86.76 152.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.077 -173.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.53 139.49 25.27 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.687 0.617 . . . . 0.0 111.24 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 25.8 p-10 -66.32 -30.05 70.38 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.066 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -63.37 -45.34 91.57 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.242 0.339 . . . . 0.0 110.428 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 88.6 t80 -59.95 -42.14 93.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -62.63 -49.71 70.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.355 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 29.6 mmmt -54.35 -33.37 58.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.667 0.387 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 7.3 mm-40 -60.63 -54.25 47.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.99 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.595 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 10.8 mp -52.88 -60.0 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.697 HD11 HG11 ' A' ' 58' ' ' VAL . 9.4 mp -60.41 -24.6 65.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.565 -173.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.05 -46.97 69.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 82.4 mttt -72.56 -28.65 62.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.18 0.514 . . . . 0.0 110.344 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.711 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 64.0 m-85 -88.97 -3.28 58.78 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.454 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -54.65 -48.9 71.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.581 0.229 . . . . 0.0 111.085 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.93 -33.97 75.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 80' ' ' LYS . 4.7 t70 -71.15 -50.38 33.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.963 0.887 . . . . 0.0 109.843 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.688 HG21 ' HE1' ' A' ' 70' ' ' PHE . 62.7 mt -65.04 -30.96 51.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 48.3 tttm -84.71 -30.91 24.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.05 -51.27 69.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.253 0.549 . . . . 0.0 110.002 171.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -71.26 -58.95 3.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.363 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -107.28 -36.68 6.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.433 -170.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 34' ' ' LYS . . . 103.95 29.33 5.55 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.785 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 41' ' ' THR . 6.9 t -95.36 142.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.1 t70 -105.14 7.49 33.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.451 0.643 . . . . 0.0 110.949 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.612 ' H ' HG12 ' A' ' 39' ' ' VAL . 70.6 p 55.71 -13.78 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 49.1 mtpt -58.65 -36.67 74.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.098 0.408 . . . . 0.0 111.946 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -74.58 -32.37 62.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.317 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.62 115.88 3.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.721 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.736 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 42.9 tttm -92.25 108.86 20.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.01 171.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.597 ' HA ' HG12 ' A' ' 60' ' ' VAL . 41.6 mt -72.25 119.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.493 0.663 . . . . 0.0 111.664 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 61' ' ' ASP . 12.5 mt -91.44 -42.49 10.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.013 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HG3' HG23 ' A' ' 16' ' ' VAL . 63.5 tttm -156.04 104.77 2.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.922 -174.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.639 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 6.4 m -89.39 132.42 34.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -155.94 173.67 16.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.8 150.33 52.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.423 0.63 . . . . 0.0 110.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -133.02 -174.02 3.36 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.252 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -66.68 113.3 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.806 ' HG3' HD11 ' A' ' 7' ' ' LEU . 24.9 ttt180 75.84 -17.04 0.54 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.729 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.445 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 40.1 m-85 -122.23 147.77 45.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 112.231 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.653 ' HD1' ' HG2' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -106.81 150.79 25.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.113 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.548 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 89.4 m-85 -134.54 107.15 7.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 26' ' ' LEU . 21.9 t -108.59 96.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.397 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 18.1 t -76.45 130.69 38.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 46' ' ' ILE . 28.8 m -140.58 152.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.206 0.527 . . . . 0.0 111.879 -174.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.3 t70 -76.56 105.86 7.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.99 34.4 1.93 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 167.55 -96.63 0.13 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.079 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -137.39 -4.73 1.84 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.799 0.333 . . . . 0.0 110.688 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.02 -29.63 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.653 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.41 122.38 18.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.352 0.596 . . . . 0.0 111.001 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -101.31 106.69 17.9 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.024 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 4.4 t -99.86 178.04 4.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.622 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.8 ttmt -156.87 113.04 2.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.688 ' HE1' HG21 ' A' ' 33' ' ' ILE . 14.3 m-85 -80.42 114.17 19.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.129 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HE2' ' CD2' ' A' ' 55' ' ' PHE . 82.5 tttt -87.98 89.17 7.89 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.746 0.784 . . . . 0.0 109.733 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.414 HG23 ' CE1' ' A' ' 29' ' ' PHE . 51.3 mt -81.77 100.02 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.624 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 24.2 ttp180 -68.29 100.93 1.11 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.653 ' HG2' ' HD1' ' A' ' 56' ' ' TYR . 86.0 mttt -47.19 124.59 6.74 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 124.033 0.833 . . . . 0.0 110.69 -172.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 4.6 t70 -23.94 81.77 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.53 1.769 . . . . 0.0 112.9 -170.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.553 HG23 HD21 ' A' ' 7' ' ' LEU . 6.0 p -107.51 106.82 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.439 -171.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.52 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 5.0 m-20 71.65 -58.97 0.56 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.697 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.515 ' HB ' ' HD2' ' A' ' 79' ' ' PRO . 13.2 m -122.53 164.08 28.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.218 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HD2' ' HB ' ' A' ' 78' ' ' VAL . 23.5 Cg_endo -91.6 104.45 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.163 2.575 . . . . 0.0 113.227 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 9.0 mtmt -179.87 162.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.589 . . . . 0.0 111.698 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.4 ttp -92.15 142.61 27.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.439 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.624 ' HB ' ' HD3' ' A' ' 73' ' ' ARG . 3.6 p -73.33 -53.79 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.651 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 82' ' ' VAL . . . -155.71 159.14 29.04 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.327 -173.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 84' ' ' ARG . 10.6 ttp180 -125.21 95.81 4.61 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -114.57 112.0 22.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.26 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 11.2 m -80.97 138.13 36.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 . . . . . 0 C--N 1.315 -0.925 0 CA-C-O 121.842 0.83 . . . . 0.0 109.509 -177.021 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 34.4 t . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 121.23 0.538 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 38.1 mt -101.54 26.12 7.66 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.611 HG22 ' HG ' ' A' ' 3' ' ' LEU . 1.8 mp -69.32 -31.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.614 -175.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.796 HD13 ' HA ' ' A' ' 6' ' ' ASP . 77.9 mt -132.39 178.01 7.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.101 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -126.23 73.29 1.36 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.78 36.29 37.44 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.555 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.796 ' HA ' HD13 ' A' ' 3' ' ' LEU . 33.3 t70 69.55 97.03 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.493 0.663 . . . . 0.0 112.164 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.541 ' H ' HD22 ' A' ' 3' ' ' LEU . 93.6 mt -126.87 70.98 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.696 HD11 ' HB2' ' A' ' 54' ' ' ARG . 79.1 mt -64.27 -62.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.944 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 52.87 -99.98 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.89 0.744 . . . . 0.0 110.581 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.06 88.86 4.62 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.321 0.581 . . . . 0.0 109.8 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.718 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -104.4 165.1 11.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.934 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt 59.9 93.67 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.83 0.706 . . . . 0.0 109.229 -174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.33 -153.92 0.41 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.831 -174.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.5 mt -52.48 148.61 12.04 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.54 134.84 54.1 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.993 2.462 . . . . 0.0 111.832 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 48' ' ' LYS . 5.6 p 39.87 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 123.14 1.448 . . . . 0.0 112.688 -171.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.508 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 57.5 mt -68.6 156.32 7.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.431 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -49.74 138.19 14.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -71.25 -19.46 62.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.248 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.39 -45.64 37.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.057 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.481 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 81.4 t80 -58.78 -40.46 84.07 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -63.08 -47.63 86.91 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.127 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -38.55 69.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.25 -47.56 83.2 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.9 mt -56.93 -58.5 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.562 0.696 . . . . 0.0 110.171 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.813 HD11 HG11 ' A' ' 58' ' ' VAL . 9.1 mp -58.8 -34.66 71.73 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.835 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.43 -34.0 74.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.438 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -72.58 -26.96 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.26 3.25 29.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.546 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.41 -50.31 59.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.53 0.732 . . . . 0.0 111.852 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.61 -41.92 82.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.11 -39.7 68.69 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.658 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 94.8 mt -69.42 -20.8 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.51 0.671 . . . . 0.0 110.486 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.5 tttp -89.77 -33.13 16.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.499 0.666 . . . . 0.0 109.882 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.46 -45.04 77.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.311 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.26 -15.35 41.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.475 -173.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.514 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 77.3 m-85 -140.17 -57.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.414 0.626 . . . . 0.0 109.78 177.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 123.38 35.46 0.7 Allowed Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.367 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 41' ' ' THR . 2.8 t -108.27 146.39 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.989 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -98.04 8.91 44.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.621 0.724 . . . . 0.0 110.259 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.643 ' H ' HG12 ' A' ' 39' ' ' VAL . 71.4 p 59.0 -33.69 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.084 1.754 . . . . 0.0 115.253 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -62.83 -29.36 70.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.2 0.524 . . . . 0.0 110.477 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.09 -14.81 60.62 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.185 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.535 HD21 HG11 ' A' ' 39' ' ' VAL . 63.9 mt -81.64 125.0 30.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.292 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG2' HD23 ' A' ' 47' ' ' LEU . 58.3 tttp -81.47 101.21 9.75 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.56 ' HA ' HG12 ' A' ' 60' ' ' VAL . 57.2 mt -69.98 113.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 45' ' ' LYS . 26.1 mt -85.07 -40.05 17.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.583 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HA ' HG23 ' A' ' 16' ' ' VAL . 24.9 ttpp -160.38 103.56 1.42 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.452 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 9.3 m -76.61 122.14 24.21 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.8 m -157.3 -172.29 3.94 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.935 -0.478 . . . . 0.0 110.624 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.49 178.77 8.51 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -112.53 -84.13 0.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.718 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 27.8 mtmm -140.66 107.74 5.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 167.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.792 ' HG3' HG11 ' A' ' 76' ' ' VAL . 35.6 ttm180 78.1 -18.15 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.734 0.646 . . . . 0.0 111.463 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.44 123.55 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 5.4 m-85 -78.13 148.51 34.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.796 0.332 . . . . 0.0 110.409 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.602 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 75.5 m-85 -134.12 94.62 3.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.753 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.813 HG11 HD11 ' A' ' 26' ' ' LEU . 19.3 t -89.06 95.38 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.505 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB2' ' N ' ' A' ' 48' ' ' LYS . 74.2 m -60.08 128.54 37.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.003 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 46' ' ' ILE . 34.8 m -147.57 153.5 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.43 0.634 . . . . 0.0 111.589 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.87 130.73 48.41 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 169.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.751 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -92.44 5.09 52.03 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.152 -173.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.97 -19.23 50.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.646 170.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.639 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 32.9 t70 -103.29 18.92 20.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.88 -22.33 12.15 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.751 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 7.0 pt-20 -70.95 150.48 45.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.16 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -122.26 151.51 41.0 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 24.0 t -146.58 170.83 16.11 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.3 ttpt -157.51 89.43 1.04 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CD1' ' HG2' ' A' ' 84' ' ' ARG . 83.7 m-85 -53.81 112.16 0.88 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.941 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 54.7 tttt -84.92 80.66 9.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.921 0.867 . . . . 0.0 109.385 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 77.5 mt -77.27 102.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.726 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HB2' HG12 ' A' ' 82' ' ' VAL . 46.4 ttt180 -71.63 111.96 7.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.599 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 91.7 mttt -57.16 160.12 3.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.353 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 0' ' ' SER . 17.9 t70 -67.37 74.09 0.14 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.66 0.743 . . . . 0.0 109.705 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.792 HG11 ' HG3' ' A' ' 54' ' ' ARG . 35.6 m -98.75 -4.29 9.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.615 0.722 . . . . 0.0 110.074 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 175.3 -62.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.287 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 79' ' ' PRO . 11.2 p -96.9 137.62 21.33 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.478 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 78' ' ' VAL . 45.8 Cg_endo -83.38 42.25 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.591 2.861 . . . . 0.0 112.645 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -137.88 140.59 40.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.228 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.45 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 4.6 tmm? -65.09 123.65 20.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.033 170.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.533 HG12 ' HB2' ' A' ' 73' ' ' ARG . 14.5 p -79.47 -38.56 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 0.0 111.634 -173.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 84' ' ' ARG . . . -144.52 179.45 21.73 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.954 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.514 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -153.72 93.55 1.68 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.405 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 22.1 tptm -73.91 60.82 0.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.78 0.8 . . . . 0.0 112.317 -166.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -104.5 111.0 23.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 . . . . . 0 C--N 1.314 -0.949 0 CA-C-O 121.892 0.853 . . . . 0.0 109.785 -173.213 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.595 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 40.4 t . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 1' ' ' LEU . 0.6 OUTLIER -99.56 109.77 22.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.348 0.594 . . . . 0.0 112.053 -172.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.519 HG23 ' HB3' ' A' ' 74' ' ' LYS . 8.4 tp -173.12 84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.998 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.908 ' HG ' ' H ' ' A' ' 4' ' ' ASP . 1.2 pt? -122.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.177 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.908 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 8.7 m-20 57.64 19.01 5.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.685 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 7' ' ' LEU . . . 111.9 42.94 0.98 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.479 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.22 25.89 11.57 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 5' ' ' GLY . 96.0 mt -137.9 166.21 24.61 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 111.332 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.414 HD22 HG12 ' A' ' 2' ' ' ILE . 35.2 tp -178.73 -93.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.737 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.3 mttt 55.82 33.11 20.88 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -76.08 -59.62 2.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 110.476 -174.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.94 35.27 1.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.675 0.75 . . . . 0.0 110.263 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.639 HD23 ' HE3' ' A' ' 13' ' ' LYS . 29.5 tp -70.63 170.14 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.098 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.639 ' HE3' HD23 ' A' ' 12' ' ' LEU . 1.9 mptt 70.09 15.61 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.348 0.659 . . . . 0.0 111.491 176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.64 139.47 20.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.094 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.39 -56.49 0.66 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 122.521 2.147 . . . . 0.0 110.358 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 48' ' ' LYS . 13.5 p -128.86 128.13 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.461 -1.7 . . . . 0.0 109.898 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 18' ' ' ASP . 24.5 mt -89.61 177.25 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.258 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.577 ' H ' HG22 ' A' ' 17' ' ' ILE . 4.0 m-20 -50.67 120.24 4.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.492 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -73.21 -36.93 66.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.01 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 68.0 t80 -62.86 -43.96 97.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.563 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -61.58 -45.95 95.28 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 173.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -52.26 -43.93 64.64 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.0 109.915 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.87 -39.89 93.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.227 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 16.9 mt -60.02 -60.12 4.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 58' ' ' VAL . 8.1 mp -60.13 -32.6 71.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.819 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.97 -49.33 77.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.935 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -67.0 -50.48 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.313 0.577 . . . . 0.0 110.291 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.595 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 5.7 m-85 -83.2 13.4 4.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.675 -173.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 40' ' ' ASP . 36.6 tt0 -61.82 -36.28 80.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.76 -35.02 76.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.126 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.647 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 20.7 t70 -74.3 -44.6 51.96 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.16 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' HB ' ' A' ' 39' ' ' VAL . 66.2 mt -69.11 -26.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.406 0.622 . . . . 0.0 110.773 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 54.0 tttp -83.29 -28.93 28.76 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -69.22 -43.14 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.904 170.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.647 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 63.2 mttm -67.85 -47.92 67.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.285 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.663 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 44.0 m-85 -128.4 -56.68 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.481 0.658 . . . . 0.0 110.889 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 34' ' ' LYS . . . 117.42 62.35 0.31 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.789 -170.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG23 ' HB2' ' A' ' 37' ' ' TYR . 45.9 t -124.33 154.59 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.808 0.337 . . . . 0.0 111.143 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.576 ' HA ' HE21 ' A' ' 30' ' ' GLN . 16.4 t70 -105.15 123.38 47.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.564 173.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 24.6 p -88.03 -14.61 38.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.001 0.429 . . . . 0.0 111.725 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -79.76 -7.21 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.951 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -99.76 -21.85 15.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.681 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.1 mt -73.87 124.43 26.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.652 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 82.6 tttt -83.95 112.79 20.48 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.586 ' HA ' HG12 ' A' ' 60' ' ' VAL . 35.4 mt -79.88 116.54 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.692 0.758 . . . . 0.0 111.171 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.6 mt -85.35 -51.02 6.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.39 -176.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HA ' HG23 ' A' ' 16' ' ' VAL . 39.4 ttpt -146.06 111.13 5.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.827 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.3 m -96.0 127.53 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -146.51 163.56 35.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -132.33 161.53 33.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 110.239 172.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.21 -157.91 0.81 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 54' ' ' ARG . 51.2 mttp -72.13 103.17 3.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.679 ' HG2' HG11 ' A' ' 76' ' ' VAL . 53.0 mtt180 74.27 -14.4 0.7 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.695 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -109.85 149.33 30.02 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.947 -0.471 . . . . 0.0 111.984 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 51' ' ' GLU . 2.6 m-85 -116.58 150.4 38.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.738 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.6 m-85 -128.71 103.42 7.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.373 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.729 HG21 HD11 ' A' ' 26' ' ' LEU . 13.3 t -106.16 94.64 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.709 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -79.96 118.8 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -130.48 155.67 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.653 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.512 ' HB2' HD21 ' A' ' 47' ' ' LEU . 36.2 t70 -86.67 103.66 15.34 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -64.71 -26.81 68.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.826 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.43 -23.95 13.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.97 -0.634 . . . . 0.0 111.731 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 25.9 t70 -81.59 -22.7 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.405 0.621 . . . . 0.0 110.21 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.95 -32.33 3.65 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 4.6 pt-20 -62.93 136.26 57.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.637 -0.782 . . . . 0.0 111.842 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -100.38 93.09 5.48 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.914 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 79.8 m -89.25 132.27 34.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.06 0.457 . . . . 0.0 110.586 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 22.8 ttmm -109.18 94.26 4.95 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.301 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 80.1 m-85 -63.4 100.0 0.23 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.923 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.738 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 25.0 tttm -80.69 83.26 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.994 0.902 . . . . 0.0 109.047 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.872 ' HA ' ' HB2' ' A' ' 81' ' ' MET . 70.0 mt -77.71 93.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.434 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.577 ' HB2' HG12 ' A' ' 82' ' ' VAL . 30.4 ttt180 -63.52 123.8 19.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 2' ' ' ILE . 39.6 mttt -59.56 169.08 1.39 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.798 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.721 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 9.9 t0 -72.06 78.36 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.229 1.014 . . . . 0.0 108.904 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.679 HG11 ' HG2' ' A' ' 54' ' ' ARG . 6.4 m -106.11 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.106 174.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.0 t70 84.74 -46.01 0.08 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.891 -175.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.96 146.24 61.27 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 111.119 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HB3' ' OD2' ' A' ' 75' ' ' ASP . 34.1 Cg_endo -92.18 86.17 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.634 2.889 . . . . 0.0 114.138 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -164.69 161.52 20.8 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.01 -0.431 . . . . 0.0 111.329 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.872 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 2.4 ptp -88.1 119.2 28.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.577 HG12 ' HB2' ' A' ' 73' ' ' ARG . 7.7 p -60.4 -38.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.916 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.06 -177.68 26.88 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.952 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.663 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -164.25 42.8 0.09 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -60.83 121.98 13.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.612 -172.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.914 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.4 m -83.21 113.03 20.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 87' ' ' ARG . 17.9 mtp180 . . . . . 0 C--N 1.306 -1.286 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.784 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 34.2 p . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.228 0.061 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 0' ' ' SER . 0.5 OUTLIER 45.97 23.58 0.19 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.766 1.227 . . . . 0.0 113.326 175.53 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.604 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 10.5 tp -117.02 39.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.012 0.91 . . . . 0.0 110.55 -171.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.822 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 2.5 pt? -92.96 -40.09 10.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.691 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 12.6 t70 66.57 -60.41 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.97 0.794 . . . . 0.0 110.015 -169.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 54.88 0.24 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.105 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.609 ' HA ' HG12 ' A' ' 76' ' ' VAL . 41.3 m-20 49.84 34.91 8.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.748 0.419 . . . . 0.0 111.476 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.582 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 27.8 tp -141.84 176.57 8.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.64 0.257 . . . . 0.0 110.362 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.582 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 6.2 mp -73.83 -59.33 2.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.22 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp 63.64 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.229 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -126.21 106.7 9.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.217 0.532 . . . . 0.0 110.042 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 3.3 ptmm? -118.09 -163.42 0.94 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.358 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.5 mt -41.46 115.95 0.7 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -130.63 21.15 5.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.53 168.03 13.3 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.722 -172.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -69.77 -153.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.471 0.162 0 C-N-CA 123.637 2.892 . . . . 0.0 111.856 167.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.682 HG23 ' HG3' ' A' ' 48' ' ' LYS . 5.4 p -51.17 124.31 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.886 0.85 . . . . 0.0 111.147 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.547 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 11.9 mt -79.93 151.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.916 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.8 152.47 35.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.209 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -64.12 -25.62 68.18 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.813 -178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.64 -46.67 88.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.17 0.188 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 87.0 t80 -59.79 -38.6 82.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -65.52 -49.86 58.12 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 12.9 mmmm -56.81 -28.67 61.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 14.3 mm-40 -68.85 -52.63 27.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 173.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 43.8 mt -53.69 -62.49 1.62 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.621 0.724 . . . . 0.0 110.096 175.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.706 HD11 HG11 ' A' ' 58' ' ' VAL . 9.5 mp -59.08 -28.37 66.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.55 -173.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 13.1 t70 -75.24 -46.93 30.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.09 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 66.5 mttm -57.51 -35.74 70.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.303 0.573 . . . . 0.0 110.558 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.784 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 2.4 m-85 -106.1 12.27 30.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.271 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -60.21 -41.33 92.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 -179.325 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.89 -32.38 73.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' HD3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -73.4 -48.06 36.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.358 0.599 . . . . 0.0 110.153 177.406 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.665 HG12 ' HE1' ' A' ' 81' ' ' MET . 72.0 mt -59.76 -41.48 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.559 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.5 tttt -79.94 -29.59 39.74 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.914 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.88 -50.37 66.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.564 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -76.73 -57.58 3.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.453 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 39' ' ' VAL . 20.7 m-85 -102.32 -27.37 12.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -169.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.33 52.96 3.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.636 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 33' ' ' ILE . 21.9 t -118.3 149.14 20.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.518 0.199 . . . . 0.0 110.598 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.41 106.09 14.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.534 ' HA ' HD22 ' A' ' 44' ' ' LEU . 65.6 p -65.69 -16.66 63.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -173.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.3 ttpp -72.06 -23.03 61.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -94.3 -5.98 45.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.767 0.794 . . . . 0.0 109.632 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 41' ' ' THR . 5.1 mp -83.29 138.35 33.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.112 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.55 109.73 22.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.612 ' HA ' HG12 ' A' ' 60' ' ' VAL . 40.9 mt -79.33 116.96 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 110.877 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.439 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 8.1 mt -85.78 -47.32 9.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.086 -175.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.682 ' HG3' HG23 ' A' ' 16' ' ' VAL . 37.7 ttmt -149.6 108.08 3.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.481 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.547 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 13.5 m -85.0 125.39 32.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.3 m -156.55 -170.94 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.464 ' OE2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -156.11 -176.61 6.05 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.69 ' HB3' ' HE2' ' A' ' 57' ' ' TYR . 14.7 t70 -165.45 93.38 0.58 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HG3' HD21 ' A' ' 8' ' ' LEU . 12.4 mptt 68.21 -107.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.921 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.539 ' HG2' HG11 ' A' ' 76' ' ' VAL . 48.0 mtt180 -91.93 19.55 6.56 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.931 -0.481 . . . . 0.0 111.32 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 76.2 m-85 -138.83 140.67 38.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 -173.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.873 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m-85 -100.3 144.08 29.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 166.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.699 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 71.0 m-85 -129.8 96.32 4.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.706 HG11 HD11 ' A' ' 26' ' ' LEU . 5.6 t -104.43 96.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.4 t -74.39 114.61 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 46' ' ' ILE . 12.9 m -133.13 163.93 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.236 0.541 . . . . 0.0 111.368 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.96 127.14 48.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.97 33.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -173.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.09 -46.3 3.06 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.581 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.54 -38.18 68.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.304 0.573 . . . . 0.0 110.934 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -21.85 2.46 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.339 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.38 145.8 33.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 110.804 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -113.96 116.34 29.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.527 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.5 m -117.94 124.96 49.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.824 -171.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.699 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 6.1 tppt? -85.12 96.24 9.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.77 113.5 3.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.309 0.576 . . . . 0.0 110.185 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -93.0 80.72 4.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.622 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.873 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 mt -77.68 76.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.642 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.535 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 70.8 ttt180 -53.26 125.79 18.83 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' A' ' 76' ' ' VAL . 96.3 mttt -59.79 171.0 0.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 123.458 0.474 . . . . 0.0 110.263 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 1.7 t70 -72.12 26.45 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.372 0.606 . . . . 0.0 110.694 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 6' ' ' ASP . 30.1 m -78.65 123.12 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.555 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 18.4 t70 70.58 -66.22 0.3 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.548 0.53 . . . . 0.0 111.232 -176.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.586 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 3.4 p -104.28 153.9 38.68 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.656 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.0 Cg_endo -76.32 148.05 29.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.092 1.861 . . . . 0.0 111.515 164.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 4.9 ptpt 73.47 -172.13 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.235 1.014 . . . . 0.0 113.126 167.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.665 ' HE1' HG12 ' A' ' 33' ' ' ILE . 15.5 mtm -77.23 126.89 31.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.178 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.535 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 7.1 p -59.46 -27.81 38.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.56 -161.64 35.36 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.325 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -157.09 151.16 24.83 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.0 tptp -145.25 106.01 4.13 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.942 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.1 m -77.32 111.0 12.52 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 170.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 120.992 0.425 . . . . 0.0 110.593 -169.212 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.742 ' HB3' ' HA ' ' A' ' 75' ' ' ASP . 23.4 t . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.673 0.273 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 28' ' ' LYS . 72.9 mt -83.55 61.94 6.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.004 0.907 . . . . 0.0 112.425 -168.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 74' ' ' LYS . 15.7 tt -160.77 29.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.578 ' CD1' ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -72.22 135.46 46.08 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.464 -163.5 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.31 -18.56 16.03 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 165.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . 134.36 54.02 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.752 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 8.0 m-20 68.86 22.08 7.35 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -143.0 159.72 41.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.024 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.88 -66.52 1.08 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.643 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HB2' ' HZ2' ' A' ' 9' ' ' LYS . 9.6 mtmp? 66.05 17.11 10.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.86 0.838 . . . . 0.0 108.9 -169.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -152.11 69.39 0.89 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.074 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.61 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 38.5 pttt -49.08 -50.43 36.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.392 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.614 HD12 ' HG3' ' A' ' 51' ' ' GLU . 52.9 tp -153.16 119.08 5.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -169.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -85.67 -77.41 0.3 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.995 0.426 . . . . 0.0 111.362 -176.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 18.8 mt -136.76 176.65 2.63 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -173.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 32.4 Cg_exo -62.69 -147.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.788 2.992 . . . . 0.0 111.615 169.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 49' ' ' THR . 7.1 p -54.75 122.64 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.839 0.828 . . . . 0.0 110.053 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.77 HG13 ' HB ' ' A' ' 49' ' ' THR . 1.1 pt -108.06 -173.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.882 -171.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.86 134.16 37.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.74 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 31.1 p30 -72.88 -21.06 60.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.49 -40.23 57.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.151 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 25' ' ' LEU . 80.1 t80 -61.47 -47.07 87.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -62.64 -43.47 98.94 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.238 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 23.7 tptm -56.42 -36.77 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.306 0.242 . . . . 0.0 110.488 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 4.9 mm-40 -55.81 -53.8 52.29 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 10.2 mp -49.86 -59.01 4.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.276 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.727 HD11 HG11 ' A' ' 58' ' ' VAL . 9.2 mp -59.85 -42.17 93.07 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.964 -175.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.97 -33.41 74.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.999 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 22.0 mttp -64.64 -49.99 68.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.391 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.428 ' O ' HG13 ' A' ' 33' ' ' ILE . 58.3 m-85 -98.49 12.49 34.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.573 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.418 ' OE1' ' HE2' ' A' ' 42' ' ' LYS . 4.9 pt20 -59.87 -31.91 70.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.452 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.17 -34.52 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.16 -39.68 68.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.752 0.787 . . . . 0.0 109.013 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.595 HG22 ' HB ' ' A' ' 39' ' ' VAL . 92.3 mt -61.42 -43.41 96.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.234 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 24.7 ttpt -82.51 -29.71 30.28 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.669 -174.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.46 -55.81 13.89 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 174.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -79.55 -43.36 23.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.922 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.2 -10.09 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.534 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 68.8 41.2 83.88 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.627 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 33' ' ' ILE . 10.8 t -118.24 137.91 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 120.903 0.382 . . . . 0.0 111.113 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -103.47 116.24 32.03 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.467 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.4 p -70.42 -10.5 59.27 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -170.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HE2' ' OE1' ' A' ' 30' ' ' GLN . 66.6 mmtt -71.8 -22.85 61.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.937 0.399 . . . . 0.0 110.333 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.61 -31.23 15.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.463 0.649 . . . . 0.0 110.088 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 41' ' ' THR . 85.5 mt -58.49 126.94 29.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.865 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 57.2 tttm -92.4 106.07 18.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.474 174.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.661 ' HA ' HG12 ' A' ' 60' ' ' VAL . 42.7 mt -72.8 107.53 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.774 0.797 . . . . 0.0 110.565 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 61' ' ' ASP . 11.8 mt -80.78 -49.38 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.983 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 48.9 tttm -144.79 101.17 3.62 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.479 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.77 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.6 m -82.39 124.8 30.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.2 m -145.81 -179.78 6.93 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.137 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.614 ' HG3' HD12 ' A' ' 12' ' ' LEU . 7.9 pt-20 -155.45 174.17 15.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.514 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -150.91 -170.24 3.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -59.49 105.71 0.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 77.18 -9.27 1.55 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.804 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.6 m-85 -114.45 151.08 33.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.117 0.484 . . . . 0.0 111.798 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.813 ' HD1' ' HB3' ' A' ' 74' ' ' LYS . 2.8 m-85 -112.14 143.88 42.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.426 164.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.592 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 32.3 m-85 -131.92 111.67 11.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.413 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 26' ' ' LEU . 21.4 t -110.26 108.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -91.7 120.86 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 46' ' ' ILE . 13.0 m -128.72 154.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.572 ' HB2' HD21 ' A' ' 47' ' ' LEU . 60.1 t0 -90.6 114.67 26.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 169.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HA ' HD23 ' A' ' 44' ' ' LEU . . . -72.56 -14.35 61.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.46 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.34 -113.13 0.54 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.39 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.61 76.27 1.68 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 109.637 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.2 -9.71 3.55 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -82.47 170.17 15.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -160.54 107.86 1.56 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.842 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 14.7 t -129.66 138.09 51.0 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.701 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.592 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 31.3 ttmt -111.87 114.28 27.12 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -76.39 120.65 21.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.119 0.485 . . . . 0.0 109.947 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.506 ' HG2' ' CG1' ' A' ' 82' ' ' VAL . 79.2 tttt -94.01 94.6 8.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.075 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 60.3 mt -116.41 89.53 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.511 0.672 . . . . 0.0 109.926 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 48.7 ttt180 -63.43 99.09 0.19 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.978 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.813 ' HB3' ' HD1' ' A' ' 56' ' ' TYR . 12.1 ptpt -47.45 112.4 0.54 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.801 -173.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.742 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 15.0 t0 37.57 82.16 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.176 177.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.621 HG11 ' HG2' ' A' ' 73' ' ' ARG . 8.7 m -127.26 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.102 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 74.12 -69.18 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.48 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.9 p -86.88 141.94 33.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.058 0.456 . . . . 0.0 110.348 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 87.5 Cg_endo -79.72 86.94 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.11 2.54 . . . . 0.0 112.581 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 178.86 -175.72 0.22 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.407 0.623 . . . . 0.0 111.841 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 19.9 ptp -84.04 155.33 22.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.438 171.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.506 ' CG1' ' HG2' ' A' ' 71' ' ' LYS . 12.3 p -83.15 -26.04 7.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.91 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -179.86 -173.15 44.63 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.333 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 84' ' ' ARG . 34.7 ttt-85 -156.56 125.71 6.06 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -149.85 135.74 18.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 25.5 m -97.3 114.96 26.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.507 0.67 . . . . 0.0 111.238 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 -174.676 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 5.9 t . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 42.3 mt -133.46 12.86 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.674 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.81 HG13 HD22 ' A' ' 3' ' ' LEU . 8.2 tp -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.978 -166.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 7' ' ' LEU . 2.2 mm? 66.29 57.59 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.93 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.641 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 3.5 p-10 -60.26 -27.17 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.808 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.05 19.63 53.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.234 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.723 ' HA ' HG22 ' A' ' 76' ' ' VAL . 29.2 t70 61.18 75.0 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.783 0.801 . . . . 0.0 110.201 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.986 ' HB2' HD12 ' A' ' 3' ' ' LEU . 67.2 mt -130.97 158.0 41.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.193 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -110.29 -47.27 3.31 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.472 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 64.5 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.934 0.771 . . . . 0.0 110.398 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.84 113.92 14.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 2.8 ttpm? -65.16 -47.66 76.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.742 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.8 tt -146.45 117.58 7.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.572 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 88.8 tttt -88.49 -75.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.445 0.64 . . . . 0.0 111.651 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.572 ' HG ' ' HG2' ' A' ' 13' ' ' LYS . 94.2 mt -106.55 148.78 37.41 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -71.06 120.32 6.94 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 110.08 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.608 HG23 ' HA ' ' A' ' 48' ' ' LYS . 3.7 p 40.52 95.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.998 1.38 . . . . 0.0 112.721 -168.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.12 161.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.128 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.36 143.22 56.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.406 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -65.72 -19.06 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.995 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.79 -49.82 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 67.0 t80 -61.35 -38.22 86.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.705 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.463 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -64.33 -51.38 53.06 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 174.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 27.3 mmtp -52.59 -38.96 61.07 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.343 0.257 . . . . 0.0 111.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.672 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.8 mm-40 -55.22 -55.26 33.29 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 123.257 0.348 . . . . 0.0 111.29 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.524 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 38.8 mt -51.84 -61.57 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.403 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.662 HD11 HG11 ' A' ' 58' ' ' VAL . 8.2 mp -62.43 -31.81 72.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.961 -172.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.39 -34.07 76.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.733 0.301 . . . . 0.0 111.033 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 49.9 mttm -77.64 -24.0 49.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 110.682 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.908 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 96.7 m-85 -103.51 5.2 36.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -49.17 -47.37 45.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.137 0.575 . . . . 0.0 112.404 -173.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.84 -39.26 93.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.875 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.9 -40.18 61.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.404 0.621 . . . . 0.0 109.892 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.588 HG22 ' HB ' ' A' ' 39' ' ' VAL . 98.0 mt -61.21 -36.74 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.428 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.587 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.9 tttm -84.68 -30.91 24.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.238 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.57 -44.12 78.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.907 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -85.55 -47.79 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -111.49 -12.12 14.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.3 44.32 52.68 Favored Glycine 0 C--N 1.328 0.114 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.773 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 33' ' ' ILE . 18.8 t -114.77 146.88 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.873 0.368 . . . . 0.0 111.381 -175.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -103.01 112.85 25.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 72.0 p -73.84 -14.4 61.08 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -81.31 -44.21 17.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.0 109.86 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.42 -21.28 60.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.949 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.721 HD21 HG21 ' A' ' 60' ' ' VAL . 11.1 tp -60.21 133.13 55.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.312 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -95.56 104.6 16.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.151 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.544 ' HA ' HG12 ' A' ' 60' ' ' VAL . 43.6 mt -78.73 121.42 31.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.431 0.634 . . . . 0.0 110.71 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 61' ' ' ASP . 12.2 mt -92.2 -51.28 5.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.266 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HA ' HG23 ' A' ' 16' ' ' VAL . 6.0 ttmt -143.44 114.41 7.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.646 -176.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.7 m -98.41 130.1 45.04 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.334 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 p -163.96 -178.09 5.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.812 0.339 . . . . 0.0 110.599 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 9.8 pt-20 -140.37 159.7 41.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.475 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.509 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 4.3 t70 -138.95 -148.58 0.26 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.874 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 32.2 mmtp -65.45 91.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.044 0.137 . . . . 0.0 110.791 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.698 ' HB3' HG11 ' A' ' 76' ' ' VAL . 62.5 mtt85 71.98 -12.0 0.72 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.062 0.545 . . . . 0.0 112.359 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.47 146.27 33.41 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.208 -0.307 . . . . 0.0 111.082 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.544 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 7.0 m-85 -97.96 142.87 29.16 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 165.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.619 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 66.8 m-85 -126.63 107.55 10.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.073 0.464 . . . . 0.0 110.747 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 26' ' ' LEU . 18.1 t -108.97 99.51 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.532 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 9.5 t -77.31 122.17 24.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.721 HG21 HD21 ' A' ' 44' ' ' LEU . 28.7 m -130.46 155.44 41.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.008 0.432 . . . . 0.0 111.266 -177.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB2' HD21 ' A' ' 47' ' ' LEU . 10.5 t70 -99.88 122.16 42.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -75.95 -0.96 23.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 -39.0 3.14 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.559 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.87 -15.72 61.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.328 0.585 . . . . 0.0 110.307 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.41 -23.98 5.65 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.671 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 62' ' ' ALA . 8.8 pt-20 -74.81 152.86 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.8 mttp -125.13 108.33 11.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.305 0.574 . . . . 0.0 110.122 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.984 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 60.6 m -107.85 133.13 52.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.77 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.619 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.0 tppp? -97.13 102.98 14.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.545 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 20.8 m-85 -67.36 117.36 9.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HG2' ' CG1' ' A' ' 82' ' ' VAL . 31.5 tttm -93.52 72.79 4.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.946 0.879 . . . . 0.0 109.368 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.574 HG12 ' HG2' ' A' ' 81' ' ' MET . 82.9 mt -75.78 91.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.991 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.646 ' HB2' HG12 ' A' ' 82' ' ' VAL . 24.9 ttt180 -62.6 135.76 57.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.667 ' HD3' HD23 ' A' ' 3' ' ' LEU . 99.0 mttt -59.73 172.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.718 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 43.5 t0 -74.5 28.36 0.08 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.783 1.278 . . . . 0.0 108.871 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -74.46 8.87 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 112.967 -1.924 . . . . 0.0 109.901 -174.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.3 t70 167.46 -43.09 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.842 -168.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.33 142.54 40.45 Favored Pre-proline 0 CA--C 1.502 -0.866 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.03 -171.196 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 67.5 Cg_endo -89.07 15.26 2.06 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.262 1.975 . . . . 0.0 111.803 171.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.908 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 21.4 mtmt -143.3 -179.75 6.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.482 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' HG12 ' A' ' 72' ' ' ILE . 23.2 mtm -81.21 117.34 21.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.404 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' ' 73' ' ' ARG . 9.2 p -56.73 -32.92 39.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.423 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.59 -174.21 34.91 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.643 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -171.97 90.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -107.85 131.5 54.42 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.809 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.984 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 4.0 m -84.88 130.41 34.66 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 . . . . . 0 C--N 1.309 -1.158 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.4 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 29' ' ' PHE . 47.3 t . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.677 0.275 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.83 12.15 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.933 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.479 HG21 ' HE1' ' A' ' 56' ' ' TYR . 2.9 tp -76.72 -13.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.499 0.666 . . . . 0.0 110.69 -171.35 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.781 HD21 ' HA ' ' A' ' 7' ' ' LEU . 9.7 mp -125.13 -178.71 4.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.9 57.08 1.56 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.884 0.85 . . . . 0.0 109.758 170.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.09 52.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.583 ' CG ' ' H ' ' A' ' 7' ' ' LEU . 7.2 p-10 -130.49 -120.33 0.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.226 -173.307 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.781 ' HA ' HD21 ' A' ' 3' ' ' LEU . 42.4 tp 175.69 98.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.57 0.623 . . . . 0.0 110.966 -172.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.8 mt -59.81 131.85 52.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.0 110.242 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -124.11 -7.52 7.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.152 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.52 -46.63 89.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -100.5 115.3 29.77 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 166.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.777 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 37.4 tp -178.07 141.61 0.26 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.388 -176.046 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.777 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 29.0 mtmt 63.91 25.76 14.05 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.957 176.175 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.23 163.15 19.21 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.573 -174.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -64.74 -158.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.424 2.75 . . . . 0.0 111.942 169.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.49 116.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 122.002 0.906 . . . . 0.0 110.533 175.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.632 HG12 ' HA ' ' A' ' 50' ' ' SER . 10.7 mm -71.41 161.29 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.743 -177.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -49.45 129.75 19.24 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.161 0.288 . . . . 0.0 110.759 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' HA ' HG21 ' A' ' 46' ' ' ILE . 29.6 p-10 -60.23 -33.97 73.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 20' ' ' LEU . 6.6 mt -58.75 -44.86 90.67 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.99 173.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.644 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 72.3 t80 -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.748 0.308 . . . . 0.0 110.334 -177.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -67.13 -45.4 81.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.709 177.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HB2' HG13 ' A' ' 46' ' ' ILE . 7.8 tppt? -63.51 -37.05 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.099 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.64 -57.47 11.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.358 177.321 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 3.6 mt -51.95 -55.82 17.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.117 0.484 . . . . 0.0 109.758 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.894 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 21.9 mt -50.9 -48.34 60.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.427 176.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.36 -40.1 96.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 110.381 -178.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 11.8 mttp -56.92 -51.1 70.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.343 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 0' ' ' SER . 1.3 m-85 -97.72 13.19 31.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.042 -171.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -31.73 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.592 0.234 . . . . 0.0 111.427 -173.688 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.52 -31.17 68.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.8 0.333 . . . . 0.0 110.674 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -78.88 -43.3 25.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.334 0.588 . . . . 0.0 109.566 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 ' HB ' ' A' ' 39' ' ' VAL . 97.3 mt -60.62 -34.89 60.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.554 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.622 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 1.6 tmtp? -80.9 -40.49 24.57 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 110.051 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.18 -46.3 75.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.995 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.84 -54.81 5.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.463 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.558 ' HB2' HG23 ' A' ' 39' ' ' VAL . 6.5 m-85 -104.98 -31.21 9.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.12 -170.242 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.51 57.1 2.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.729 -177.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.622 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 22.0 t -124.4 148.4 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.809 0.338 . . . . 0.0 111.055 -175.196 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.438 ' O ' HD13 ' A' ' 44' ' ' LEU . 11.8 t0 -106.48 112.74 25.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 170.172 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.894 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 45.7 p -74.72 -15.75 60.77 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.83 -173.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.18 -25.52 60.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.152 178.048 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.72 -23.04 25.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.059 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 41' ' ' THR . 3.6 mp -65.66 109.67 2.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.696 -178.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 18.7 tptm -71.71 114.15 9.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.212 174.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.641 ' HA ' HG12 ' A' ' 60' ' ' VAL . 10.2 mm -71.21 107.34 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.0 mt -78.71 -57.84 3.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.705 0.764 . . . . 0.0 109.407 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -147.92 110.54 4.71 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.199 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 6.5 m -81.87 138.2 35.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.632 ' HA ' HG12 ' A' ' 17' ' ' ILE . 6.1 p -160.57 -175.96 5.3 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.391 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 15.2 pt-20 -165.05 167.06 18.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.582 0.706 . . . . 0.0 111.321 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.885 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 8.1 t70 -114.97 -157.99 0.65 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 171.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.605 ' HA ' HD11 ' A' ' 12' ' ' LEU . 86.0 mttt -68.22 -71.88 0.2 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.957 176.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -90.65 17.46 7.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.379 -173.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 97.4 m-85 -146.22 148.32 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -170.361 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.623 ' CD1' ' HG2' ' A' ' 74' ' ' LYS . 19.2 m-85 -109.46 143.74 38.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.384 169.026 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.885 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 76.7 m-85 -129.03 92.05 3.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.997 0.427 . . . . 0.0 110.459 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 t -97.33 98.58 7.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 16.6 m -77.47 124.56 28.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -138.55 143.95 31.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -177.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.552 ' HB2' HD21 ' A' ' 47' ' ' LEU . 9.3 t70 -80.39 97.12 6.92 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 173.069 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.12 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.751 -171.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.08 -11.03 56.65 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.077 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.43 -32.66 71.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.156 0.503 . . . . 0.0 110.244 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.1 -41.09 0.25 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.45 165.84 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.251 0.548 . . . . 0.0 111.464 -178.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -82.39 115.84 21.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.702 167.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -96.02 164.84 12.53 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.257 -169.497 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.533 ' HD3' ' CD1' ' A' ' 57' ' ' TYR . 40.4 ttmt -134.74 102.82 5.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.549 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.484 ' CG ' HD21 ' A' ' 26' ' ' LEU . 16.0 m-85 -69.03 106.41 2.77 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.633 0.73 . . . . 0.0 110.179 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.603 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 17.5 tttt -95.42 82.38 3.68 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.838 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.807 HG12 ' HG2' ' A' ' 81' ' ' MET . 52.5 mt -78.68 120.45 29.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.721 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 58.4 ttt180 -79.68 25.01 0.35 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.407 0.622 . . . . 0.0 109.511 -175.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.623 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 93.2 mttt 51.12 -165.46 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.279 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.672 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 11.9 t70 -103.12 47.48 0.88 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 167.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 6' ' ' ASP . 5.3 p -77.64 -2.29 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.14 -174.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 173.0 -54.48 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.983 -168.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 32.4 m -92.15 151.49 41.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.242 175.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.5 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 61.6 Cg_endo -92.71 32.21 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.583 2.855 . . . . 0.0 112.558 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -159.16 -157.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.02 -175.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.807 ' HG2' HG12 ' A' ' 72' ' ' ILE . 5.2 mtm -107.6 132.13 53.62 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 10.4 p -77.81 -37.27 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.209 0.528 . . . . 0.0 110.177 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.603 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -126.85 164.67 20.34 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.539 -174.129 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.99 25.71 0.06 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 85' ' ' LYS . 60.7 mmtt -88.4 131.78 34.71 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.285 -167.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 6.5 m -83.68 136.85 34.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 173.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 . . . . . 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 0.0 109.977 -172.367 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.684 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 29.4 t . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 72.8 mt 64.3 13.38 7.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.299 173.126 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 2' ' ' ILE . 9.6 tp -115.0 87.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.238 1.018 . . . . 0.0 109.716 176.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.6 pt? -128.23 -48.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.475 -172.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.506 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.1 m-20 66.34 -64.15 0.23 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 124.017 0.823 . . . . 0.0 110.135 -171.416 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.33 70.62 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 177.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 35.5 t70 61.72 87.33 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.234 0.54 . . . . 0.0 110.419 -172.066 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 54' ' ' ARG . 13.3 mt 75.29 163.99 0.26 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.068 177.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.63 ' HG ' ' H ' ' A' ' 9' ' ' LYS . 2.0 pt? -153.95 -55.11 0.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.709 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.63 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 10.2 mtmp? 75.69 -54.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 167.334 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.44 8.13 35.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -169.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.7 ttpt -61.82 -72.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.754 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.436 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 26.9 mt -109.03 124.8 51.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.767 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -138.25 29.3 2.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 -171.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -102.02 143.09 25.9 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.461 -177.22 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 26.9 Cg_exo -65.19 130.03 24.46 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.924 2.416 . . . . 0.0 111.72 175.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' A' ' 48' ' ' LYS . 10.0 p 39.83 99.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 123.367 1.556 . . . . 0.0 114.057 -177.166 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.06 160.03 4.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.637 176.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.22 157.42 31.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.157 -173.222 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.0 p30 -65.26 -20.01 66.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.18 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.5 tp -65.66 -43.94 87.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 178.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' HE2' ' HE1' ' A' ' 56' ' ' TYR . 73.8 t80 -64.05 -39.04 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.335 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -71.66 -32.89 63.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.143 176.715 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 23.8 tptt -62.63 -40.75 97.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.6 mm-40 -58.97 -51.49 69.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.101 175.048 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.514 HD12 ' HA2' ' A' ' 22' ' ' GLY . 84.3 mt -51.71 -64.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 175.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.879 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.8 mt -55.75 -31.64 62.73 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.798 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.25 -45.69 83.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.069 0.461 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 56.3 mttm -67.92 -30.57 69.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.684 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 79.7 m-85 -99.42 1.21 44.0 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -53.64 -39.76 65.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.673 0.273 . . . . 0.0 111.093 -177.099 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.5 -36.03 82.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.632 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 15.0 t70 -80.62 -40.56 25.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.904 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' CD1' HD23 ' A' ' 26' ' ' LEU . 80.8 mt -67.12 -30.26 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.412 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 44.5 tttp -83.48 -23.72 32.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 0.0 109.724 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.28 -45.7 65.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.336 170.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.632 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 51.3 mttm -82.13 -27.02 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.888 -173.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.718 ' HB2' HG23 ' A' ' 39' ' ' VAL . 49.1 m-85 -134.06 -33.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -177.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 97.09 19.96 24.78 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.42 -178.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.718 HG23 ' HB2' ' A' ' 37' ' ' TYR . 38.8 t -82.02 153.49 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.146 0.498 . . . . 0.0 111.908 -174.418 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.507 ' OD2' ' HB3' ' A' ' 42' ' ' LYS . 26.8 t70 -108.34 106.96 17.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.91 169.438 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.879 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 40.6 p -69.11 -16.2 63.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.062 -172.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 7.2 ttpm? -63.89 -21.59 66.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.839 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -105.16 -7.36 19.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 76.5 mt -66.86 117.26 8.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.851 -179.301 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.605 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 87.4 tttt -74.58 97.04 3.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.587 ' HA ' HG12 ' A' ' 60' ' ' VAL . 53.0 mt -77.13 122.0 30.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.638 0.732 . . . . 0.0 111.133 -175.703 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -94.16 -50.02 5.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.367 -175.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HA ' HG23 ' A' ' 16' ' ' VAL . 34.5 ttmt -145.64 121.36 10.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.271 -173.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.434 HG23 HG22 ' A' ' 58' ' ' VAL . 19.0 m -113.98 135.31 54.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.41 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -160.32 174.82 13.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.686 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 12.5 pt-20 -131.25 150.98 51.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.459 0.647 . . . . 0.0 110.322 172.284 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.27 -151.62 0.48 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -64.75 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.114 177.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.609 ' HA ' HD21 ' A' ' 7' ' ' LEU . 50.7 mtt180 -87.32 11.43 14.39 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.821 -0.55 . . . . 0.0 111.011 178.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 4.2 m-85 -133.18 161.0 35.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.125 -1.03 . . . . 0.0 113.579 -163.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.686 ' CE1' ' HB3' ' A' ' 51' ' ' GLU . 5.5 m-85 -124.18 149.65 46.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.594 169.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.623 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 77.1 m-85 -134.66 102.51 5.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.676 0.274 . . . . 0.0 110.945 -178.222 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 49' ' ' THR . 9.9 t -112.51 103.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.535 178.53 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m -87.28 125.02 33.96 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 46' ' ' ILE . 10.1 m -131.19 152.55 37.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 111.507 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.6 t70 -90.34 121.42 32.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 171.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.86 1.97 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.192 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.04 -53.31 4.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.338 176.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.55 -23.4 66.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.299 0.571 . . . . 0.0 110.679 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.35 7.97 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.712 -178.326 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -75.47 150.99 38.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 34.5 ttmt -127.01 107.2 9.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -176.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 34.4 m -106.35 132.06 52.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.339 0.59 . . . . 0.0 110.94 -175.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.623 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.5 tppt? -101.07 100.79 11.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 67.3 m-85 -75.16 106.98 6.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.074 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.636 ' HB3' ' O ' ' A' ' 83' ' ' GLY . 81.1 tttt -98.76 108.86 21.65 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.901 0.857 . . . . 0.0 110.3 -178.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 71.0 mt -105.82 114.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.937 -178.199 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.803 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 28.9 ttp180 -79.35 29.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.366 0.603 . . . . 0.0 110.485 -172.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.566 ' HG2' ' CD2' ' A' ' 56' ' ' TYR . 84.8 mttt 57.56 -178.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.088 -178.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 2.0 t70 -87.31 42.2 1.02 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.563 . . . . 0.0 109.98 -174.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 73' ' ' ARG . 22.7 m -76.91 105.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.109 0.481 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 69.91 -64.41 0.35 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.294 -175.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -84.96 151.37 57.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.327 . . . . 0.0 110.19 177.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.725 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 60.9 Cg_endo -86.37 29.3 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.039 2.493 . . . . 0.0 111.428 174.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.423 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 1.9 ttmm -132.44 -158.6 0.9 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.376 0.608 . . . . 0.0 111.751 -169.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.522 ' SD ' ' HD3' ' A' ' 84' ' ' ARG . 3.6 ptt? -118.53 166.68 12.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.068 -176.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.803 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 3.6 p -81.55 -52.35 13.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 177.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -177.78 128.21 1.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.247 -177.339 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.522 ' HD3' ' SD ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -97.83 118.85 35.31 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.382 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -122.49 114.71 21.06 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.982 -169.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 22.6 m -72.22 122.88 21.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.158 173.318 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 . . . . . 0 C--N 1.303 -1.419 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.873 179.669 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.765 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 38.8 m . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 121.463 0.649 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 1' ' ' LEU . 3.7 pp -88.5 140.24 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.749 -169.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 2' ' ' ILE . 8.5 tp -166.5 45.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.889 1.328 . . . . 0.0 107.487 175.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.452 ' HG ' ' CG ' ' A' ' 75' ' ' ASP . 13.7 mt -82.25 -174.41 5.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.584 -171.337 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 166.79 -32.0 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.076 -174.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.93 80.66 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.334 176.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 23.4 t70 73.49 11.03 4.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 121.236 0.541 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 42.2 mt 82.86 172.95 0.09 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.427 173.491 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.7 119.71 7.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.139 -174.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -80.34 95.45 6.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.182 -176.089 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -85.84 -86.43 0.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -171.69 138.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 111.217 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.08 115.14 7.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.203 172.223 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 39.9 ttmt -81.72 106.61 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.522 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.64 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 13.0 mt 58.88 173.99 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 123.487 0.715 . . . . 0.0 112.152 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 38.8 Cg_endo -69.8 -19.97 35.24 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.91 1.74 . . . . 0.0 111.495 171.461 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' A' ' 48' ' ' LYS . 6.7 t -138.49 113.2 8.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.9 176.32 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.65 HG22 ' H ' ' A' ' 18' ' ' ASP . 12.3 mt -68.77 175.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.942 -178.009 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.65 ' H ' HG22 ' A' ' 17' ' ' ILE . 9.0 m-20 -51.63 -20.71 2.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.362 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.663 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 96.3 m-20 73.1 -40.09 0.46 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.389 0.676 . . . . 0.0 110.999 -174.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.59 -35.77 81.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 169.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' O ' HD13 ' A' ' 25' ' ' LEU . 90.9 t80 -59.13 -42.48 90.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -65.55 -42.65 95.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 175.43 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -51.78 -41.65 61.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.461 0.304 . . . . 0.0 110.857 176.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.4 mm-40 -57.84 -54.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.001 173.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 21' ' ' PHE . 10.8 mp -47.68 -63.93 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.289 174.127 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.66 HD11 HG21 ' A' ' 58' ' ' VAL . 9.6 mp -59.84 -32.18 70.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.28 -174.136 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.19 -42.72 93.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 52.0 mttm -71.73 -42.48 67.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 110.646 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CD1' ' HA ' ' A' ' 0' ' ' SER . 2.0 m-30 -87.38 -0.48 56.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.378 -173.42 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 8.0 tt0 -56.43 -36.97 69.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.132 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.15 -36.08 65.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.009 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.86 -50.08 18.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.315 0.579 . . . . 0.0 109.832 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.655 HG22 ' HB ' ' A' ' 39' ' ' VAL . 45.8 mt -62.79 -31.07 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.993 -177.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 66.5 tttt -89.11 -29.17 19.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.43 -174.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.39 -51.77 33.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 0.0 110.566 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.17 -43.1 54.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.671 -172.487 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.652 ' HB2' HG23 ' A' ' 39' ' ' VAL . 15.9 m-85 -120.07 -17.95 8.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.824 0.345 . . . . 0.0 111.416 -173.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 81.36 30.74 36.09 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.655 ' HB ' HG22 ' A' ' 33' ' ' ILE . 16.6 t -92.6 147.33 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.954 0.407 . . . . 0.0 111.418 -175.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -108.99 120.67 43.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 44' ' ' LEU . 33.4 p -80.07 -13.78 59.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -170.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -74.81 -20.97 59.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.506 0.669 . . . . 0.0 109.566 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -86.77 -41.17 14.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.352 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 41' ' ' THR . 91.6 mt -53.56 109.49 0.45 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.246 177.065 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 79.1 tttt -77.36 108.89 10.82 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.55 ' HA ' HG12 ' A' ' 60' ' ' VAL . 42.8 mt -73.54 115.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.482 0.658 . . . . 0.0 110.171 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.8 mt -87.33 -39.11 15.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.196 -175.303 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.52 ' HG3' HG22 ' A' ' 16' ' ' VAL . 17.0 ttpp -156.57 104.98 2.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.003 -176.002 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.663 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 14.8 m -83.9 128.78 34.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.387 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -155.17 179.2 9.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 12.2 pt-20 -155.35 -177.07 6.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.851 176.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.641 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t70 -132.27 -88.01 0.45 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.641 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 40.9 mmtm -128.57 -81.52 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 54' ' ' ARG . 67.5 mtt85 -88.69 23.7 2.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.356 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 38.8 m-85 -142.95 132.37 23.51 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -169.599 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.886 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 30.3 m-85 -101.65 149.77 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 166.144 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -134.36 97.47 3.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.859 0.361 . . . . 0.0 110.091 177.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.66 HG21 HD11 ' A' ' 26' ' ' LEU . 14.0 t -105.16 96.64 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.831 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 11.8 t -76.03 126.5 31.11 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.15 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 46' ' ' ILE . 26.9 m -135.65 150.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.457 0.646 . . . . 0.0 112.263 -174.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.5 t70 -99.14 123.93 43.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.092 173.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.68 4.94 10.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.883 -171.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.98 -174.07 45.76 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.81 -36.69 79.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 -177.137 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.67 -6.4 6.62 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.75 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -75.17 119.74 19.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -178.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -145.1 117.0 8.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.507 -178.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 3.3 m -127.96 159.97 33.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.451 -175.237 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.3 ttmt -123.62 106.19 10.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 52.6 m-85 -73.45 96.46 2.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.875 0.845 . . . . 0.0 110.51 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 1.017 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 50.8 tttp -82.95 79.64 9.25 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.312 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 45.0 mt -75.5 105.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.398 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.559 ' HD2' HG11 ' A' ' 82' ' ' VAL . 43.1 ttt-85 -74.34 9.72 1.57 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.612 0.72 . . . . 0.0 110.184 -175.061 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 72' ' ' ILE . 94.6 mttt 63.5 177.05 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.482 176.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.856 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 8.0 t0 -80.68 64.35 5.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 177.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 4.0 m -85.98 87.16 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.092 175.471 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 5.1 m-20 74.69 -53.58 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -174.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.3 p -114.82 135.57 22.42 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.856 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 23.7 Cg_endo -65.59 -50.78 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.052 2.502 . . . . 0.0 112.918 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -46.71 128.97 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.766 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 159.48 6.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.897 -175.229 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.559 HG11 ' HD2' ' A' ' 73' ' ' ARG . 3.8 p -103.62 -27.97 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.573 177.09 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 1.017 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -118.76 135.61 11.58 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.946 -170.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -155.23 19.03 0.42 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.033 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -71.53 117.83 13.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.196 -168.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 60.6 m -84.42 111.03 19.09 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 . . . . . 0 C--N 1.307 -1.264 0 CA-C-O 122.091 0.948 . . . . 0.0 109.425 179.601 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.551 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 26.8 t . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.797 0.808 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 1' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 3' ' ' LEU . 89.2 mt -85.55 11.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.088 175.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.462 HD13 ' HD3' ' A' ' 74' ' ' LYS . 9.2 tt -78.06 65.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.013 170.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.551 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -103.29 154.72 19.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.931 -164.732 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.676 ' HB3' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -174.09 5.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.185 169.149 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.84 62.87 0.71 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -179.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.1 t70 70.29 25.45 4.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.117 0.961 . . . . 0.0 108.672 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.676 HD12 ' HB3' ' A' ' 4' ' ' ASP . 84.0 mt -110.21 109.47 19.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.992 -177.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.723 HD12 ' HD2' ' A' ' 74' ' ' LYS . 2.0 mm? -64.98 -56.34 13.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.134 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 67.52 -62.58 0.33 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.831 0.707 . . . . 0.0 111.178 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.52 85.8 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 0.0 110.576 176.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HA ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -112.72 132.05 55.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 169.224 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 14' ' ' LEU . 67.0 mt -82.8 -169.9 2.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.295 0.569 . . . . 0.0 111.89 -171.026 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.76 21.23 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.449 -170.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.443 HD11 HD13 ' A' ' 12' ' ' LEU . 1.3 pp -138.16 162.24 54.91 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.888 -167.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.74 -147.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.86 3.04 . . . . 0.0 112.699 171.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.618 ' HB ' ' HG3' ' A' ' 48' ' ' LYS . 11.0 p -47.09 130.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.235 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -97.78 -73.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.446 -175.938 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.653 ' H ' ' HB ' ' A' ' 49' ' ' THR . 5.4 m-20 64.72 12.23 7.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.776 177.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . 58.2 t30 -81.53 61.16 4.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.14 3.0 0.9 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.312 0.645 . . . . 0.0 110.7 -174.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.784 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 4.4 m-85 -63.69 -61.31 2.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.653 -175.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.42 ' N ' HG21 ' A' ' 49' ' ' THR . . . -62.26 -35.59 91.81 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.847 -177.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -68.2 -36.72 80.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.834 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.1 mm-40 -62.3 -53.95 47.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.04 0.536 . . . . 0.0 111.231 175.131 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 13.0 mt -52.74 -62.59 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.109 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.631 HD22 HG22 ' A' ' 41' ' ' THR . 33.4 mt -58.7 -26.8 64.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.053 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.0 -43.55 82.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 177.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.2 mttm -72.68 -41.11 65.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.829 -179.162 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.551 ' HZ ' ' HB3' ' A' ' 0' ' ' SER . 96.8 m-85 -90.19 0.46 57.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.757 -176.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 34.1 tt0 -50.9 -44.24 59.9 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.966 0.412 . . . . 0.0 110.792 177.492 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.72 -31.68 73.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.512 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -84.98 -41.4 15.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.51 0.672 . . . . 0.0 110.184 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.681 HG22 ' HB ' ' A' ' 39' ' ' VAL . 95.9 mt -63.07 -34.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.181 177.112 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 45.6 tttp -81.76 -34.23 30.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.509 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.94 -47.37 77.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.361 174.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -95.36 -42.45 8.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -172.552 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.626 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 m-85 -111.06 -13.11 14.11 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.502 -170.677 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.5 50.09 33.9 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.27 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.681 ' HB ' HG22 ' A' ' 33' ' ' ILE . 23.6 t -116.79 152.69 18.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 110.921 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -111.69 118.13 34.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.075 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.631 HG22 HD22 ' A' ' 26' ' ' LEU . 40.1 p -75.2 -14.29 60.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.033 0.444 . . . . 0.0 111.734 -173.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -76.93 -17.46 58.9 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.981 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -99.65 -16.21 18.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.372 0.606 . . . . 0.0 109.849 -179.17 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 41' ' ' THR . 96.6 mt -68.09 121.4 16.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 53.4 tptt -85.03 103.08 13.74 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 176.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.604 ' HA ' HG12 ' A' ' 60' ' ' VAL . 34.1 mt -72.77 114.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.459 0.647 . . . . 0.0 109.96 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.5 mt -87.13 -35.92 18.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.773 -177.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.618 ' HG3' ' HB ' ' A' ' 16' ' ' VAL . 4.1 ttmp? -159.06 108.95 1.95 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.577 -177.072 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.653 ' HB ' ' H ' ' A' ' 18' ' ' ASP . 20.0 m -86.1 134.42 33.82 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.169 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 p -162.57 -179.24 6.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.383 . . . . 0.0 110.517 176.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 5.5 pt-20 -155.67 164.37 38.69 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.328 176.165 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HB3' ' HE2' ' A' ' 57' ' ' TYR . 10.2 t70 -157.5 108.61 2.29 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 56.88 -115.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.097 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.476 ' HG2' HD11 ' A' ' 8' ' ' LEU . 46.4 mtt85 -88.55 16.24 6.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -172.738 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -138.35 137.6 37.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.924 -171.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.572 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 8.0 m-85 -98.13 140.39 32.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.661 168.066 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.537 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 97.4 m-85 -124.57 96.49 4.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.415 -178.333 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 3.4 t -103.26 90.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.6 t -72.97 120.86 19.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.8 m -133.35 155.91 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.204 0.526 . . . . 0.0 111.048 -177.005 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.496 ' HB2' HD21 ' A' ' 47' ' ' LEU . 16.9 t0 -100.55 127.84 46.79 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.026 173.683 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -7.33 59.21 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.58 -81.61 1.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.015 172.268 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.21 -22.94 61.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.038 0.447 . . . . 0.0 111.352 -175.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.3 -90.01 0.75 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.821 -174.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -100.38 177.56 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -128.52 126.51 40.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 167.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 1.063 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.6 t -134.14 -177.83 4.76 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.451 0.643 . . . . 0.0 111.316 -167.31 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 37.6 ttmt -159.39 90.23 0.94 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.494 ' CD1' HD21 ' A' ' 26' ' ' LEU . 72.2 m-85 -57.12 111.66 1.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.842 -176.181 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.9 tttt -94.5 77.36 3.84 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.325 -176.383 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.673 ' HA ' ' CB ' ' A' ' 81' ' ' MET . 78.3 mt -80.26 92.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.572 -177.231 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 1.04 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 49.3 ttt180 -56.83 127.48 31.9 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.259 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.723 ' HD2' HD12 ' A' ' 8' ' ' LEU . 95.2 mttt -63.57 179.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' CB ' ' HA ' ' A' ' 3' ' ' LEU . 5.9 t70 -61.43 94.02 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.754 0.788 . . . . 0.0 110.516 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 74' ' ' LYS . 12.4 m -138.29 84.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.814 174.607 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.2 t70 76.9 -49.48 0.55 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.826 -174.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 m -96.67 150.25 36.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.409 0.623 . . . . 0.0 111.136 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -95.21 29.11 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.245 3.297 . . . . 0.0 110.923 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -137.96 -176.6 4.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.557 -171.362 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.673 ' CB ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.17 146.07 23.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.875 179.614 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.04 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.6 p -83.0 -26.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.321 0.581 . . . . 0.0 110.282 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.92 -171.31 23.71 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.036 -175.422 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 24.0 ptt-85 -161.17 71.05 0.39 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.157 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 18.5 tptm -59.77 80.64 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.86 -167.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.063 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 27.8 m -92.54 -116.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.159 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 64.6 mtt180 . . . . . 0 C--O 1.233 0.219 0 C-N-CA 123.196 0.598 . . . . 0.0 110.772 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 0' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 56.4 m . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 31.0 mt -102.61 -0.55 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.357 -174.231 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.601 HG23 ' HB2' ' A' ' 74' ' ' LYS . 5.3 tp -78.28 89.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.752 0.787 . . . . 0.0 109.877 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.955 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -71.23 0.87 6.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.054 -175.448 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.45 39.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.278 1.037 . . . . 0.0 109.313 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.569 ' CA ' HG12 ' A' ' 76' ' ' VAL . . . -128.73 -53.81 0.11 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.699 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 28.9 t70 -53.56 -35.78 61.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 166.179 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 7' ' ' LEU . 3.6 mm? -92.78 -57.02 2.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 172.476 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.6 tp 56.99 72.07 0.53 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.023 0.827 . . . . 0.0 110.962 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.28 -26.4 9.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.067 -177.037 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -154.22 70.97 0.82 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.393 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 11.2 ptmm? -76.96 154.62 33.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.391 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 4.7 mp -88.95 174.07 8.13 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.259 -173.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -147.89 30.45 0.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.227 -171.028 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.2 mm? -89.73 147.63 38.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -176.204 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.7 117.94 4.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.69 2.26 . . . . 0.0 110.858 173.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 48' ' ' LYS . 7.5 p 41.11 99.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.926 1.346 . . . . 0.0 113.162 -171.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 49' ' ' THR . 25.2 mt -65.87 154.34 7.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.925 178.058 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.48 144.21 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -172.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -62.25 -23.84 66.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.327 -176.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.4 tp -65.68 -41.58 92.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.589 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 65.7 t80 -64.67 -39.34 93.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.535 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.574 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -68.23 -44.05 77.26 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.353 176.527 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HD2' HD12 ' A' ' 46' ' ' ILE . 4.3 mptp? -53.29 -44.4 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.678 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.3 mm-40 -54.9 -55.84 26.1 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.66 176.364 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.2 mt -53.4 -60.55 3.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.882 0.849 . . . . 0.0 110.695 178.608 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.685 HD22 HD11 ' A' ' 46' ' ' ILE . 9.5 mp -59.2 -40.88 87.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.433 -173.114 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.48 -32.49 73.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.678 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.2 mttm -67.43 -33.3 74.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' HZ ' ' H1 ' ' A' ' 0' ' ' SER . 92.7 m-85 -95.01 0.95 55.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.73 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -36.1 74.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.509 0.195 . . . . 0.0 111.443 -171.222 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.95 -33.98 76.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.22 -41.43 49.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.492 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.534 HG22 ' HB ' ' A' ' 39' ' ' VAL . 90.9 mt -62.83 -37.14 78.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.753 176.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 36.3 ttmt -80.87 -22.76 39.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.042 -177.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.79 -47.14 22.45 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.448 172.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.69 -42.92 57.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.282 -175.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.406 ' HB2' HG23 ' A' ' 39' ' ' VAL . 59.8 m-85 -121.2 -28.3 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.735 0.303 . . . . 0.0 111.731 -174.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 91.88 41.78 4.9 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.986 -178.552 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 13.1 t -119.42 152.1 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 120.556 0.217 . . . . 0.0 110.838 -176.267 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.92 136.37 50.04 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.507 HG21 ' O ' ' A' ' 26' ' ' LEU . 32.3 p -79.99 -12.92 59.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -83.31 -3.04 57.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.9 -27.72 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.292 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.53 HD21 HG11 ' A' ' 39' ' ' VAL . 67.8 mt -62.17 125.98 25.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.715 175.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -85.79 102.92 14.08 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.415 -178.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.685 HD11 HD22 ' A' ' 26' ' ' LEU . 22.9 mt -75.66 124.42 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.695 0.759 . . . . 0.0 110.931 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.7 mt -100.1 -53.72 3.07 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.673 -177.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.563 ' HA ' HG23 ' A' ' 16' ' ' VAL . 36.6 ttmt -142.9 104.26 4.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.871 -174.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 58' ' ' VAL . 46.6 m -91.69 125.5 36.43 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.9 m -151.8 -179.12 7.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.033 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' OE2' ' HB2' ' A' ' 11' ' ' LYS . 9.4 pt-20 -142.14 143.82 33.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 177.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.02 126.62 10.92 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 58.46 -141.27 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.741 -175.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.586 ' HB3' HG11 ' A' ' 76' ' ' VAL . 73.7 mtt180 -77.71 14.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.527 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 5.0 m-85 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.313 -169.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.569 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 17.3 m-85 -98.26 143.96 28.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.367 166.599 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.0 m-85 -124.32 105.49 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 26' ' ' LEU . 13.9 t -106.69 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.847 0.356 . . . . 0.0 110.722 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 14.5 t -74.35 128.25 35.08 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.9 m -138.22 153.99 27.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.085 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.13 126.62 34.9 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.75 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 -36.23 2.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.586 174.049 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -70.83 -14.31 62.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.144 0.497 . . . . 0.0 109.978 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.25 -24.92 4.95 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.34 174.26 11.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.912 0.387 . . . . 0.0 110.692 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -138.61 115.74 11.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 1.074 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -107.14 163.26 13.15 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.014 0.435 . . . . 0.0 111.239 -168.395 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.2 ttmt -139.21 93.9 2.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 64.4 m-85 -67.58 108.53 2.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.37 0.605 . . . . 0.0 110.342 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 46.9 tttt -92.2 83.53 5.09 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.044 -176.467 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.905 HG12 ' HG2' ' A' ' 81' ' ' MET . 55.7 mt -81.05 91.38 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.564 -178.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.703 HH11 HG21 ' A' ' 82' ' ' VAL . 34.8 ttt180 -59.68 111.23 1.35 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.389 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.865 ' HG3' HG13 ' A' ' 76' ' ' VAL . 18.6 ptpt -56.43 166.62 0.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.695 0.622 . . . . 0.0 110.461 -179.179 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 3' ' ' LEU . 38.9 t70 -68.65 75.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.508 0.67 . . . . 0.0 110.166 -178.2 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.865 HG13 ' HG3' ' A' ' 74' ' ' LYS . 29.5 m -100.84 -8.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.445 177.598 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 176.29 -51.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.833 -169.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -117.15 136.74 23.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.365 0.602 . . . . 0.0 110.323 178.663 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 43.9 Cg_endo -86.45 46.2 1.52 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 123.805 3.003 . . . . 0.0 113.341 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HA ' ' HE1' ' A' ' 29' ' ' PHE . 27.3 mtmt -150.68 161.7 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.131 0.491 . . . . 0.0 112.19 -177.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.905 ' HG2' HG12 ' A' ' 72' ' ' ILE . 38.2 mtm -63.81 101.51 0.38 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.264 172.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.703 HG21 HH11 ' A' ' 73' ' ' ARG . 9.9 p -55.85 -28.74 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.402 173.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.65 177.41 26.9 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.277 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -177.12 42.27 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.023 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -83.28 120.75 26.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.876 -171.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 1.074 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 29.7 m -65.6 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.569 -177.072 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.577 0.704 . . . . 0.0 109.245 175.856 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.674 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 32.8 t -101.27 -73.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 0.114 . . . . 0.0 111.008 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 61.94 12.2 4.69 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.805 0.442 . . . . 0.0 110.871 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 tp -90.22 -3.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -168.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.849 HD23 HG12 ' A' ' 76' ' ' VAL . 13.6 tp -174.01 71.99 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.302 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.63 103.55 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.136 0.898 . . . . 0.0 112.032 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.58 32.5 78.8 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.569 -0.741 . . . . 0.0 113.498 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.758 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.3 t0 56.11 76.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.4 0.619 . . . . 0.0 112.135 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.688 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 94.9 mt -112.25 38.24 2.77 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 3' ' ' LEU . 23.9 tp -71.22 101.03 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.381 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 9' ' ' LYS . 7.4 mtmp? -105.52 -41.38 5.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.23 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.37 101.69 7.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.544 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -103.86 -81.39 0.52 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.926 0.393 . . . . 0.0 111.586 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 17' ' ' ILE . 61.5 tp -147.37 126.13 12.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.027 0.441 . . . . 0.0 110.694 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -122.48 11.27 9.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.203 1.001 . . . . 0.0 108.765 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.3 mt -115.44 171.68 4.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.603 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.44 -157.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.191 2.594 . . . . 0.0 112.544 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.534 HG23 ' HG3' ' A' ' 48' ' ' LYS . 4.4 p -49.84 124.54 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.789 0.804 . . . . 0.0 111.306 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.481 HG12 HD13 ' A' ' 12' ' ' LEU . 35.0 mt -69.25 152.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.2 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 139.38 57.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 27.0 p-10 -61.6 -26.05 67.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt -56.75 -45.56 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.01 -38.24 90.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.201 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -69.34 -37.25 79.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.449 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 30.2 mmmt -64.31 -31.22 72.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.24 -47.3 65.11 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 90.9 mt -52.32 -65.52 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 23.6 mt -53.37 -27.72 25.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.712 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.88 -40.38 63.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 111.024 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -79.27 -35.88 40.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.112 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.674 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 96.4 m-85 -91.99 4.87 52.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.547 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 34.7 tt0 -52.59 -41.9 64.05 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.1 -39.47 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.702 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.0 m-20 -67.59 -54.12 22.51 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.63 HG22 ' HB ' ' A' ' 39' ' ' VAL . 65.0 mt -55.89 -35.02 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.204 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 9.2 tmtm? -81.77 -37.28 27.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.283 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.46 -53.56 50.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.667 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.702 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 39.1 mttm -69.25 -55.32 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.8 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 84' ' ' ARG . 22.9 m-85 -104.68 -37.08 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.079 0.466 . . . . 0.0 111.422 -171.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.24 63.88 1.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.445 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.63 ' HB ' HG22 ' A' ' 33' ' ' ILE . 32.1 t -126.12 155.25 35.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -105.55 119.82 40.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.632 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 26.4 p -84.67 -11.03 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -71.21 -35.07 71.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.45 -34.53 60.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.349 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.0 mt -49.01 120.11 3.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.709 0.766 . . . . 0.0 112.433 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 86.1 tttt -92.24 104.01 16.42 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.135 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.644 HG12 HG12 ' A' ' 60' ' ' VAL . 20.0 mt -78.1 130.76 35.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.495 0.664 . . . . 0.0 111.723 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt -99.97 -45.9 5.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.77 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HG3' HG23 ' A' ' 16' ' ' VAL . 58.6 tttm -151.28 110.85 4.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.492 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.5 m -90.04 121.54 32.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -155.08 -167.68 2.64 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -169.94 170.03 7.87 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -116.64 -81.11 0.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.173 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.21 -88.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.922 ' HB3' HG21 ' A' ' 76' ' ' VAL . 85.1 mtt180 -91.86 23.96 3.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.49 0.662 . . . . 0.0 110.677 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.489 ' HE2' HG11 ' A' ' 82' ' ' VAL . 54.6 m-85 -147.36 144.58 28.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.673 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.936 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 27.2 m-85 -93.75 152.88 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 74.7 m-85 -139.09 99.13 3.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.212 0.529 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 t -109.24 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.016 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.0 m -66.61 121.69 15.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.962 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.644 HG12 HG12 ' A' ' 46' ' ' ILE . 21.5 m -137.01 151.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.115 0.483 . . . . 0.0 111.104 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.2 t70 -88.49 115.51 26.06 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 169.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.12 -2.1 32.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.916 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.43 -15.21 13.48 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.471 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.95 -1.98 58.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.503 0.668 . . . . 0.0 110.055 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.63 -15.14 58.8 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.541 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 8.6 tp10 -90.67 140.69 29.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.859 0.362 . . . . 0.0 110.516 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' H ' ' HG2' ' A' ' 88' ' ' LYS . 67.9 mttm -115.08 85.73 2.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.192 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 15.1 t -89.89 142.09 28.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.428 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 40.4 ttmt -102.69 88.06 3.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.097 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 12.7 m-85 -47.88 123.04 5.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.135 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.909 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 25.9 ttpp -104.71 87.71 2.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.049 0.928 . . . . 0.0 110.217 -173.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.936 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 80.6 mt -87.15 89.94 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.51 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.716 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 13.7 ttt180 -52.89 114.94 1.59 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.793 ' HB2' HG13 ' A' ' 76' ' ' VAL . 53.9 mttp -60.87 170.31 1.57 Allowed 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.694 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.1 t70 -73.2 32.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.934 0.873 . . . . 0.0 110.149 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.922 HG21 ' HB3' ' A' ' 54' ' ' ARG . 31.4 m -76.85 -7.34 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.011 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -171.97 -51.13 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.981 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 28.4 m -108.57 149.05 38.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.263 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.413 ' O ' ' HA2' ' A' ' -1' ' ' GLY . 77.1 Cg_endo -86.81 27.41 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.268 2.645 . . . . 0.0 113.587 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HD2' ' NZ ' ' A' ' 36' ' ' LYS . 23.3 pttm -159.41 -178.77 7.38 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.671 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.432 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -83.65 132.4 34.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.014 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 13.7 p -80.51 -38.85 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.69 -142.93 3.65 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.134 -172.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.909 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 11.8 ptt-85 -172.92 114.58 0.26 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 93' ' ' ASP . 22.0 tptm -80.36 81.33 6.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.466 0.651 . . . . 0.0 110.803 -173.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 68.3 m -76.23 -159.16 0.11 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.728 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 62.8 mtp180 76.13 96.76 0.07 Allowed 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.667 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.498 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 7.7 mtmp? -66.57 -73.3 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.745 -166.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.1 -54.69 6.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.074 -169.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -132.42 113.4 13.11 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.133 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.74 173.9 6.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.319 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -140.66 -50.89 0.46 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 1.4 m-20 -53.53 129.61 33.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.379 173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.67 -51.17 7.02 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.66 -174.05 50.15 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 170.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.667 ' HB3' ' CE ' ' A' ' 71' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 118.055 0.927 . . . . 0.0 109.765 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 1' ' ' LEU . . . . . . . . 0 N--CA 1.479 1.512 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.778 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 19.1 m -72.42 113.72 9.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.65 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -156.56 135.92 12.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.566 0.222 . . . . 0.0 111.501 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.877 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 5.2 tp 167.56 135.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 124.411 1.07 . . . . 0.0 109.23 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.697 HD13 HG23 ' A' ' 2' ' ' ILE . 11.0 mp 82.32 -21.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.609 0.764 . . . . 0.0 111.999 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.542 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 14.3 m-20 62.51 20.82 12.22 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 171.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.91 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . 79.34 -0.22 81.09 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.317 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.59 -11.71 44.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.843 0.354 . . . . 0.0 110.448 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.586 ' HA ' HD23 ' A' ' 3' ' ' LEU . 96.9 mt 70.36 32.22 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.134 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.64 93.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.659 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HG2' ' H ' ' A' ' 9' ' ' LYS . 8.7 pttt -100.41 71.94 1.57 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.599 0.714 . . . . 0.0 110.291 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.93 -30.71 69.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.292 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HB3' HD11 ' A' ' 14' ' ' LEU . 45.4 mmtm -135.96 144.43 45.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.623 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 35.2 tp -167.62 165.55 14.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 26.4 mttt 64.72 20.01 12.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 11' ' ' LYS . 59.4 mt -72.41 155.45 91.28 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.872 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.89 -171.35 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.824 2.349 . . . . 0.0 110.57 169.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG2' ' HA ' ' A' ' 48' ' ' LYS . 7.2 p -65.21 122.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.212 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.834 HG13 ' HB ' ' A' ' 49' ' ' THR . 4.1 pt -105.89 -178.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.799 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 177.47 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -40.02 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 112.919 -1.946 . . . . 0.0 112.891 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 20' ' ' LEU . 22.8 mt 34.65 43.92 0.1 Allowed 'General case' 0 CA--C 1.521 -0.138 0 O-C-N 123.885 0.74 . . . . 0.0 111.987 -173.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -125.94 -66.76 0.91 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.83 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' CA ' HG21 ' A' ' 49' ' ' THR . . . -64.36 -50.19 61.14 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.36 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.17 -36.59 68.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.916 0.388 . . . . 0.0 110.64 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.8 mt-10 -65.3 -50.54 65.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.963 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 91.0 mt -47.92 -65.0 0.64 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 123.579 0.55 . . . . 0.0 110.891 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 58' ' ' VAL . 7.4 mp -60.95 -38.38 85.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.553 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.72 -33.42 75.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 84.2 mttt -78.48 -46.1 20.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.456 0.646 . . . . 0.0 109.828 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.612 ' CE2' HG23 ' A' ' 72' ' ' ILE . 6.8 m-85 -70.33 -9.86 57.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.552 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -52.42 -47.51 66.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.719 0.407 . . . . 0.0 111.806 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -54.84 -39.64 68.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.713 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.23 -43.91 31.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.6 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.439 HD13 ' CE1' ' A' ' 70' ' ' PHE . 55.6 mt -63.42 -33.57 62.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.697 0.76 . . . . 0.0 110.403 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 71.3 tttt -80.86 -29.15 35.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.596 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.13 -50.48 40.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.089 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HE3' ' O ' ' A' ' 81' ' ' MET . 62.8 mttm -66.33 -50.12 64.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.399 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.451 ' HB2' HG23 ' A' ' 39' ' ' VAL . 34.9 m-85 -118.08 -37.62 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.877 0.37 . . . . 0.0 111.605 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.62 62.89 1.02 Allowed Glycine 0 C--N 1.323 -0.179 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.845 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.612 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -126.01 150.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.847 0.356 . . . . 0.0 111.584 -173.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.84 128.13 45.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 8.2 p -86.41 -9.48 56.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -92.22 -10.1 39.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.577 0.703 . . . . 0.0 109.346 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.69 -29.32 56.26 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.577 1.18 . . . . 0.0 107.872 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.564 HD13 ' CE2' ' A' ' 70' ' ' PHE . 27.4 mt -77.77 109.15 11.54 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 112.848 -1.978 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 55.4 tttm -72.86 111.97 8.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.679 ' HA ' HG12 ' A' ' 60' ' ' VAL . 26.3 mt -74.34 111.67 10.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.587 0.708 . . . . 0.0 110.234 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.8 mt -86.23 -35.94 19.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.678 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 34.0 tttp -156.88 118.31 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.667 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.834 ' HB ' HG13 ' A' ' 17' ' ' ILE . 2.8 m -106.53 126.13 51.87 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -155.77 170.99 20.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.65 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 14.0 pt-20 -139.59 175.69 9.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.437 0.637 . . . . 0.0 111.814 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -152.88 -162.2 1.44 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -58.3 103.35 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 77.1 -21.28 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.779 0.674 . . . . 0.0 112.559 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.71 142.05 38.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HD2' ' HG2' ' A' ' 74' ' ' LYS . 4.5 m-85 -109.94 142.44 41.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 166.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 61.0 m-85 -133.01 115.09 14.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.271 0.558 . . . . 0.0 110.678 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.734 HG22 HG23 ' A' ' 49' ' ' THR . 41.6 t -108.69 98.75 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.565 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.3 m -74.44 128.83 36.53 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 46' ' ' ILE . 33.3 m -138.25 156.83 30.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.823 0.344 . . . . 0.0 111.143 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.63 110.95 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 1.27 53.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.783 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.29 -112.91 0.27 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.658 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -116.36 79.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.622 ' O ' ' HE3' ' A' ' 88' ' ' LYS . . . 89.48 4.13 73.96 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.641 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 12.3 mt-10 -79.25 81.98 5.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 122.087 0.946 . . . . 0.0 109.67 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.509 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 28.9 ttmt -82.43 135.54 35.13 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.55 -169.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 26.3 t -138.8 169.11 18.38 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.009 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 39.6 ttpt -146.43 110.81 5.11 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.564 ' CE2' HD13 ' A' ' 44' ' ' LEU . 36.6 m-85 -68.73 122.62 18.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.443 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HD3' ' HA3' ' A' ' 83' ' ' GLY . 83.3 tttt -88.72 71.61 8.73 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.197 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.612 HG23 ' CE2' ' A' ' 29' ' ' PHE . 67.4 mt -80.08 92.76 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.451 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.585 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 46.3 ttt-85 -72.4 8.45 1.37 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.427 0.632 . . . . 0.0 110.087 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.674 ' HG2' ' HD2' ' A' ' 56' ' ' TYR . 64.1 mttt 66.4 172.43 0.24 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.991 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.877 ' HB3' ' H ' ' A' ' 2' ' ' ILE . 2.0 t70 -77.66 87.79 3.94 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.091 0.948 . . . . 0.0 109.131 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.91 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 2.6 p -115.36 100.8 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.156 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.574 ' H ' ' CA ' ' A' ' 5' ' ' GLY . 33.4 t70 78.07 -59.64 0.43 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.644 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.44 146.86 33.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.17 -53.17 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.371 2.048 . . . . 0.0 113.792 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.778 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 11.7 ptpt -65.9 154.29 39.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.392 0.615 . . . . 0.0 112.136 -168.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.468 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -65.07 146.01 55.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.772 -176.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 7.5 p -81.03 -40.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.542 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.597 ' HA3' ' HD3' ' A' ' 71' ' ' LYS . . . -149.07 161.92 28.83 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.461 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 84' ' ' ARG . 27.5 ttt180 -149.0 92.83 2.02 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.768 ' HE3' ' HB3' ' A' ' 92' ' ' ASP . 9.0 tppt? -105.35 111.26 23.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 110.586 -172.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 8.1 m -103.54 123.83 47.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.743 ' HD3' ' HE2' ' A' ' 96' ' ' TYR . 9.7 mtm180 -87.74 5.01 42.02 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.769 0.795 . . . . 0.0 110.317 -167.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.641 ' HG3' ' HA ' ' A' ' 66' ' ' GLU . 57.1 mmtt -90.22 1.04 56.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.751 168.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -125.85 -52.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.467 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -167.02 143.71 4.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.206 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -112.53 132.33 55.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 110.22 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.768 ' HB3' ' HE3' ' A' ' 85' ' ' LYS . 10.2 t70 -124.51 148.65 47.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.286 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -95.47 -6.59 40.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.95 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.29 104.7 3.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 56.71 -118.72 12.51 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.636 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.743 ' HE2' ' HD3' ' A' ' 87' ' ' ARG . 30.9 t80 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.816 0.446 . . . . 0.0 110.807 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 6.4 t -89.73 178.15 6.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -165.89 21.32 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.173 0.511 . . . . 0.0 111.293 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -101.15 107.73 21.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 3.2 mm? -120.71 -101.58 0.42 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.026 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 10.2 m-20 70.38 10.21 7.17 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.671 0.607 . . . . 0.0 109.702 -169.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 6' ' ' ASP . . . 69.99 97.14 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.21 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.491 ' HB3' ' O ' ' A' ' 5' ' ' GLY . 24.5 t70 73.57 -2.87 2.63 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.6 0.714 . . . . 0.0 110.1 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.945 HD21 ' HB2' ' A' ' 74' ' ' LYS . 11.2 mp 75.38 171.97 0.26 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.462 HD23 ' HG2' ' A' ' 11' ' ' LYS . 9.7 tp -78.55 3.05 17.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.578 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 15.9 mmtp 73.99 -74.61 0.08 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.413 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -145.4 135.28 23.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HG2' HD23 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -130.47 16.86 5.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.016 176.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 12' ' ' LEU . 13.2 mt -144.43 93.36 2.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.151 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -95.63 36.15 1.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.536 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.755 ' HB2' HG12 ' A' ' 17' ' ' ILE . 48.6 mt -79.39 128.53 75.05 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.231 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.6 Cg_exo -64.43 116.03 3.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.77 2.313 . . . . 0.0 110.228 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 48' ' ' LYS . 4.3 p 41.23 96.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 123.031 1.396 . . . . 0.0 112.057 -168.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.755 HG12 ' HB2' ' A' ' 14' ' ' LEU . 60.5 mt -74.26 155.42 6.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.225 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -44.76 133.75 5.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 112.206 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -62.73 -29.29 70.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 tp -68.2 -40.33 82.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.726 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.09 -36.52 81.95 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.5 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -66.06 -50.32 52.65 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -52.59 -35.77 54.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.441 0.297 . . . . 0.0 110.933 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.577 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 8.3 mm-40 -60.19 -54.87 40.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 174.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.2 mt -52.34 -63.73 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.548 0.69 . . . . 0.0 110.313 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.895 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 9.8 mp -56.21 -35.42 67.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.779 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.6 -36.44 83.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.072 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -70.15 -34.43 73.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.286 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 72' ' ' ILE . 15.0 m-85 -100.54 -1.92 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.083 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.02 -30.81 66.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.737 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.56 -39.18 92.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.781 0.324 . . . . 0.0 110.632 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 2.8 m-20 -84.04 -30.31 26.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.147 0.499 . . . . 0.0 110.276 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 39' ' ' VAL . 85.7 mt -63.98 -31.83 54.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.776 0.798 . . . . 0.0 109.834 173.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.643 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 74.7 tttt -88.69 -38.55 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 17.1 t70 -59.33 -45.58 90.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.392 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -80.63 -52.64 7.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.168 0.508 . . . . 0.0 112.025 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.554 ' HB2' HG23 ' A' ' 39' ' ' VAL . 24.4 m-85 -105.02 -30.83 9.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.572 -167.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.53 51.1 3.57 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.762 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.643 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 16.2 t -121.83 149.71 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 120.617 0.246 . . . . 0.0 110.885 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.535 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.6 t70 -107.57 117.71 34.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.895 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 58.0 p -79.4 -22.43 44.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -171.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.69 -19.86 51.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.91 -26.8 22.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.664 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 91.5 mt -60.36 145.21 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.945 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -97.22 103.98 15.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.931 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 60' ' ' VAL . 41.6 mt -76.33 122.04 29.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.72 0.772 . . . . 0.0 110.802 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 61' ' ' ASP . 7.7 mt -91.19 -48.17 7.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HG2' ' HB ' ' A' ' 16' ' ' VAL . 23.8 mttp -151.79 109.33 3.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.522 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.488 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 11.6 m -81.64 128.92 34.45 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 171.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 m -154.46 179.28 9.17 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -156.35 160.85 40.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.212 0.53 . . . . 0.0 110.884 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -137.16 -159.18 0.93 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -64.49 107.9 1.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.515 0.198 . . . . 0.0 110.863 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.533 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 84.7 mtm180 74.42 -17.76 0.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.07 130.26 55.51 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.876 -0.515 . . . . 0.0 111.609 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 1.017 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 16.2 m-85 -78.95 155.67 28.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.5 91.93 2.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.023 0.439 . . . . 0.0 110.393 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.676 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.0 t -97.5 97.67 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.428 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 9.2 t -71.54 116.85 12.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 46' ' ' ILE . 5.0 m -131.37 159.04 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.936 0.398 . . . . 0.0 110.797 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.526 ' HB2' HD21 ' A' ' 47' ' ' LEU . 11.7 t70 -107.22 132.81 52.66 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.64 9.18 14.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.418 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.18 -35.09 5.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.509 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -93.68 1.78 56.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.31 0.576 . . . . 0.0 110.691 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.53 -20.96 38.19 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.474 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 139.03 58.72 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 53.7 mttp -128.12 144.62 51.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.567 0.699 . . . . 0.0 112.083 -170.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.5 ' HB2' HG22 ' A' ' 60' ' ' VAL . 36.9 m -128.18 123.81 35.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.319 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 12.5 tppt? -97.09 68.54 2.27 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.676 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 19.2 m-85 -38.08 105.51 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 124.183 0.927 . . . . 0.0 112.331 -169.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HD3' ' HA ' ' A' ' 96' ' ' TYR . 73.8 tttt -90.76 83.76 5.78 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.392 1.092 . . . . 0.0 109.326 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.017 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 70.1 mt -84.03 91.83 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.932 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.993 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.6 ttt180 -57.98 96.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.945 ' HB2' HD21 ' A' ' 7' ' ' LEU . 23.1 mttt -59.4 82.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.328 1.018 . . . . 0.0 112.092 -167.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.47 24.84 0.8 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.778 0.831 . . . . 0.0 111.239 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.993 ' HB ' ' HG2' ' A' ' 73' ' ' ARG . 33.9 t -80.21 119.21 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.682 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 68.03 -70.25 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.072 0.858 . . . . 0.0 111.276 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 79' ' ' PRO . 4.2 m -90.88 175.46 3.61 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.688 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 8.8 Cg_endo -82.92 178.54 5.9 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.88 1.72 . . . . 0.0 111.379 170.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 29.4 pttt 57.84 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 169.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.598 ' HB3' HG23 ' A' ' 72' ' ' ILE . 6.3 ptt? -168.73 150.11 4.73 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -171.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.716 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 12.9 p -76.12 -46.32 34.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.16 137.22 4.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.233 -1.46 . . . . 0.0 114.385 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.601 ' HG3' ' CE1' ' A' ' 70' ' ' PHE . 9.9 ttp180 -72.89 104.33 4.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.799 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 64.2 tttm -82.05 63.11 6.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 0.0 112.435 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.586 ' SG ' ' HG2' ' A' ' 84' ' ' ARG . 1.1 m -101.59 138.99 37.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -172.12 61.26 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 122.702 1.239 . . . . 0.0 108.744 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.474 ' HG3' ' H ' ' A' ' 67' ' ' LYS . 51.7 mmtt -97.44 -4.86 37.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.181 -1.827 . . . . 0.0 110.113 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -144.35 -49.78 0.28 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.586 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -82.3 178.86 8.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.758 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -179.65 102.67 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.161 0.505 . . . . 0.0 110.576 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.26 105.87 7.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.452 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.02 105.78 4.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -150.84 104.06 3.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.419 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.15 -61.08 4.41 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.529 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.799 ' CE1' ' HA ' ' A' ' 85' ' ' LYS . 27.1 p90 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.154 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.8 m -77.4 132.4 38.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 2' ' ' ILE . 50.8 mt -143.5 82.55 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.59 HD12 ' H ' ' A' ' 1' ' ' LEU . 3.7 mp -150.66 -31.51 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.808 0.337 . . . . 0.0 111.757 -170.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.777 HD22 HG12 ' A' ' 76' ' ' VAL . 1.5 tt -154.78 33.61 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -165.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -48.48 -46.78 38.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.263 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.76 41.81 1.28 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -120.68 -146.32 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.708 -0.246 . . . . 0.0 110.72 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 mt -157.5 -49.63 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.747 0.655 . . . . 0.0 109.974 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 3' ' ' LEU . 74.6 mt 68.47 156.11 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.003 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.19 9.35 5.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.734 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.35 139.25 51.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.111 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -151.25 85.16 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.751 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.461 ' H ' ' CG ' ' A' ' 51' ' ' GLU . 12.2 tp 59.25 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.57 0.748 . . . . 0.0 112.764 165.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 27.2 ttpt -78.65 82.81 4.86 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 91.2 mt 74.55 162.45 0.15 Allowed Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 124.012 0.82 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 12.0 Cg_endo -56.35 134.17 62.6 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.715 2.277 . . . . 0.0 112.442 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.416 ' CG2' ' HG3' ' A' ' 48' ' ' LYS . 7.7 p 44.16 101.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 122.989 1.376 . . . . 0.0 113.961 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 51.7 mt -73.21 154.05 7.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.993 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 20' ' ' LEU . 28.3 t70 -62.91 155.95 25.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.605 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 8.7 p30 -60.35 -34.06 73.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.693 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' HB2' ' OD1' ' A' ' 18' ' ' ASP . 3.1 mt -57.06 -46.14 82.69 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.249 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 43.7 t80 -60.1 -41.83 93.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 0.0 110.297 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -74.27 -26.79 67.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.805 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.644 ' HB2' HD12 ' A' ' 46' ' ' ILE . 33.4 ttpt -80.89 -29.1 35.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.919 0.39 . . . . 0.0 110.177 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.59 -29.93 68.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.523 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.556 HD12 ' HA2' ' A' ' 22' ' ' GLY . 66.3 mt -65.31 -70.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 mt -47.71 -28.77 2.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.626 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.65 -45.82 92.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.999 0.428 . . . . 0.0 110.103 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' HD3' ' HB2' ' A' ' 1' ' ' LEU . 92.7 mttt -65.96 -35.49 80.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.623 0.725 . . . . 0.0 109.535 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.599 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 10.5 m-85 -79.28 -8.0 58.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.911 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.497 ' HG2' ' HD2' ' A' ' 34' ' ' LYS . 17.3 tt0 -74.44 12.59 0.74 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.456 0.646 . . . . 0.0 110.657 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -106.48 -30.57 8.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.375 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 15.2 t70 -88.87 -57.23 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 39' ' ' VAL . 67.6 mt -61.23 -27.62 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.72 0.771 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' HD2' ' HG2' ' A' ' 30' ' ' GLN . 44.9 tttp -80.66 -33.38 35.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.886 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -75.22 -47.83 26.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 49.2 mttm -69.29 -38.22 78.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.84 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.605 ' HB2' HG23 ' A' ' 39' ' ' VAL . 55.3 m-85 -126.86 -23.09 3.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 87.21 39.41 7.38 Favored Glycine 0 C--N 1.322 -0.216 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.94 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 33' ' ' ILE . 27.2 t -100.56 152.75 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 16.4 t70 -115.39 122.72 46.7 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.765 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 75.0 p -88.25 -17.56 30.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.919 0.39 . . . . 0.0 111.513 -172.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.517 ' HB2' ' NZ ' ' A' ' 42' ' ' LYS . 4.9 ttmp? -70.46 -33.16 70.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.466 0.651 . . . . 0.0 109.266 175.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.35 -23.4 46.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.016 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 49.1 mt -61.29 139.97 58.06 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.398 0.618 . . . . 0.0 111.594 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 81.0 tttt -101.32 96.51 7.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.511 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.644 HD12 ' HB2' ' A' ' 23' ' ' LYS . 46.9 mt -78.26 127.5 38.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.431 0.634 . . . . 0.0 111.112 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 10.9 mt -98.19 -51.44 4.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.133 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 36.1 ttmt -139.85 117.76 11.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.542 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.44 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 31.6 m -99.32 136.03 39.87 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -153.28 179.03 9.12 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 122.113 -0.367 . . . . 0.0 110.397 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 15.4 pt-20 -154.58 166.73 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.52 78.53 1.27 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.063 0.459 . . . . 0.0 109.907 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HE2' ' HB2' ' A' ' 53' ' ' LYS . 2.7 mppt? 56.33 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.199 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.641 ' HG3' HG11 ' A' ' 76' ' ' VAL . 19.4 ttm180 -85.33 12.41 8.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.516 0.674 . . . . 0.0 110.721 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 97.5 m-85 -136.23 157.73 46.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 13.9 m-85 -129.55 146.57 51.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.333 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.436 ' CE1' ' HG3' ' A' ' 71' ' ' LYS . 97.8 m-85 -135.69 103.05 5.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 19.1 t -109.19 95.17 3.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.652 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.6 t -80.34 129.69 34.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.5 m -137.99 155.44 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.156 0.503 . . . . 0.0 111.757 -173.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.6 t70 -90.22 126.68 35.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.91 13.24 11.28 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.029 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.11 -40.52 2.66 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.922 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.08 -19.13 65.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.88 -8.96 39.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.475 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 46.4 mt-10 -76.78 165.34 24.85 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.351 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.681 ' H ' ' HB2' ' A' ' 88' ' ' LYS . 40.2 ttmt -127.85 109.91 12.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.442 0.639 . . . . 0.0 110.279 -172.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 1.9 t -104.62 174.32 5.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.34 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 35.9 ttmt -149.08 104.68 3.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.423 ' CE1' HD13 ' A' ' 33' ' ' ILE . 73.5 m-85 -71.23 97.22 1.51 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.694 0.759 . . . . 0.0 109.621 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.779 ' HE2' ' HA2' ' A' ' 95' ' ' GLY . 46.2 tttp -82.88 85.91 7.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.149 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.781 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 61.6 mt -82.39 137.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.255 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 18.4 ttt180 -93.16 39.01 1.04 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.624 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 49.5 mttt 57.67 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.253 -170.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.689 ' HB3' ' N ' ' A' ' 3' ' ' LEU . 24.4 t0 178.68 26.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.777 HG12 HD22 ' A' ' 3' ' ' LEU . 9.5 m -61.82 95.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.073 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 22.9 t70 77.13 -38.95 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.844 172.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 80' ' ' LYS . 9.6 p -110.7 134.28 20.96 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.521 0.677 . . . . 0.0 110.312 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 78' ' ' VAL . 85.4 Cg_endo -79.79 30.83 0.48 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 123.897 3.064 . . . . 0.0 114.757 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' HG2' HG22 ' A' ' 78' ' ' VAL . 57.4 pttt -145.78 153.61 41.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.651 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -70.31 148.66 48.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.52 -173.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 13.7 p -73.07 -43.3 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.666 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.57 ' HA3' ' HB2' ' A' ' 96' ' ' TYR . . . -130.39 151.83 19.6 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 43.13 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.709 0.766 . . . . 0.0 108.939 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.621 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 34.8 mttp -96.2 134.81 38.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.115 -171.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -101.39 125.41 48.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -121.66 28.55 7.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 122.037 0.923 . . . . 0.0 109.645 -164.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.681 ' HB2' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -63.46 -47.13 83.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.662 -179.044 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.22 -48.57 3.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.476 -175.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.33 -174.93 4.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 -172.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -127.88 112.83 15.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.407 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -110.31 177.46 4.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.893 0.378 . . . . 0.0 111.251 -174.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.74 175.09 8.9 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.87 -33.8 75.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.779 ' HA2' ' HE2' ' A' ' 71' ' ' LYS . . . -88.87 122.68 6.49 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.818 173.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.706 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 12.9 m-30 . . . . . 0 C--O 1.244 0.798 0 CA-C-O 118.503 -0.761 . . . . 0.0 110.076 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.486 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 41.3 t -99.05 163.81 12.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.78 40.68 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.553 0.692 . . . . 0.0 110.136 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 56' ' ' TYR . 18.6 tt -104.61 108.84 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.584 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 7' ' ' LEU . 4.4 mm? -75.59 5.25 6.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.561 ' HB3' HG12 ' A' ' 2' ' ' ILE . 27.3 t70 -70.7 -5.44 29.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.717 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 76' ' ' VAL . . . -87.02 -87.35 1.08 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.147 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -48.59 -38.79 21.69 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 3' ' ' LEU . 66.2 mt -92.06 26.39 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.65 0.262 . . . . 0.0 111.334 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 7.2 tt -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.938 0.399 . . . . 0.0 110.681 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -120.13 -62.57 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -154.98 116.01 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.918 173.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 17.6 ptmt -129.22 -51.68 1.2 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 71.3 mt -153.22 155.36 36.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -170.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 43.87 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 82.4 mt -108.03 170.22 5.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.14 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 50.2 Cg_exo -58.85 -150.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.86 3.04 . . . . 0.0 113.072 170.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.422 HG23 ' HG3' ' A' ' 48' ' ' LYS . 14.5 p -53.06 125.17 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.19 0.995 . . . . 0.0 111.266 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 18' ' ' ASP . 11.7 mt -96.72 173.04 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.395 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' H ' HG22 ' A' ' 17' ' ' ILE . 1.6 m-20 -50.46 122.06 6.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.681 0.277 . . . . 0.0 111.148 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.558 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 25.0 p30 -72.54 -17.21 61.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 110.363 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.23 -39.38 68.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 170.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.569 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 63.1 t80 -61.61 -40.38 94.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.621 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -66.92 -44.27 89.33 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.447 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -55.68 -43.26 76.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.664 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.9 mm-40 -57.16 -49.16 76.81 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.583 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 46.1 mt -51.49 -59.54 4.14 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.528 0.68 . . . . 0.0 110.34 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 58' ' ' VAL . 6.9 mp -60.82 -38.8 86.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.579 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.18 -31.86 73.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.664 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.7 mttm -74.99 -50.01 18.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.201 0.524 . . . . 0.0 110.678 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 0' ' ' SER . 7.2 m-85 -92.17 12.14 23.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.797 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -25.89 63.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.278 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.06 -39.97 90.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -36.97 62.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.336 0.589 . . . . 0.0 109.471 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.8 mt -62.24 -38.84 82.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.555 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 35.3 tttm -83.29 -31.69 26.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.359 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.83 -47.8 79.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.82 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -79.42 -52.58 7.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.224 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.578 ' CZ ' ' HD2' ' A' ' 84' ' ' ARG . 6.6 m-85 -108.11 -23.97 11.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -169.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.49 57.59 3.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.952 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 41' ' ' THR . 3.7 t -117.03 145.13 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 121.023 0.439 . . . . 0.0 110.908 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.65 -11.32 59.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.111 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.669 ' H ' HG12 ' A' ' 39' ' ' VAL . 33.1 p 58.73 -37.48 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.014 1.726 . . . . 0.0 114.348 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -71.18 -18.19 62.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.352 0.596 . . . . 0.0 109.451 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -74.37 -37.25 63.51 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.899 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.37 106.22 0.43 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.224 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 55.1 tttp -69.97 102.27 1.97 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.147 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.637 HG12 HG12 ' A' ' 60' ' ' VAL . 34.6 mt -74.33 111.99 10.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.793 0.806 . . . . 0.0 110.675 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.3 -46.45 16.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.062 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 59' ' ' SER . 25.8 ttpp -151.5 105.47 3.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.687 -173.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.558 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 87.8 m -79.23 125.6 29.68 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -151.8 168.99 23.34 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.24 157.02 35.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 29.4 t70 -100.74 -83.67 0.44 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 52' ' ' ASP . 38.5 mmtm -135.88 -74.85 0.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.697 ' HB3' HG11 ' A' ' 76' ' ' VAL . 98.7 mtt180 -87.93 15.22 7.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.969 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -147.32 137.34 23.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.717 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.5 m-85 -98.84 143.84 28.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 167.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.472 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 74.4 m-85 -132.26 100.8 5.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 110.217 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 26' ' ' LEU . 26.0 t -99.07 93.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.139 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.491 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 67.8 m -58.51 126.35 27.22 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.303 174.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.637 HG12 HG12 ' A' ' 46' ' ' ILE . 35.7 m -146.71 149.96 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 111.757 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.0 t70 -91.22 122.99 34.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 169.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . . . -79.98 1.11 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 -13.69 64.97 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.288 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -131.92 41.16 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -27.49 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.976 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.659 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 39.6 mt-10 -65.21 128.88 37.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.017 0.436 . . . . 0.0 111.128 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 97.8 mttt -111.59 114.81 28.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.506 0.67 . . . . 0.0 109.924 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 18.6 t -113.92 178.42 4.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.864 -174.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 1.008 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 34.8 ttmt -155.54 82.04 1.04 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 25.6 m-85 -50.31 111.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 112.203 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.6 ' CD ' ' HB3' ' A' ' 96' ' ' TYR . 63.3 tttp -80.76 72.89 7.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.048 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.717 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 60.3 mt -75.89 86.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.221 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.472 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 33.2 ttp180 -61.97 113.42 2.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 81.8 mttt -61.37 174.02 0.79 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.173 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 1.1 m-20 -71.67 64.65 0.46 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.662 0.744 . . . . 0.0 110.192 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.697 HG11 ' HB3' ' A' ' 54' ' ' ARG . 34.7 m -96.77 -1.76 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.198 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -176.87 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.007 -171.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.544 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 7.6 p -117.77 144.7 34.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.865 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 78' ' ' VAL . 39.1 Cg_endo -82.47 53.0 4.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.28 2.653 . . . . 0.0 111.301 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -154.07 135.01 13.8 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.287 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.716 ' HG2' ' HA ' ' A' ' 72' ' ' ILE . 12.7 tmm? -57.56 103.84 0.15 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 11.6 p -60.75 -37.88 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -170.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' ' 81' ' ' MET . . . -175.03 -156.84 15.01 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.641 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.664 ' N ' ' HD3' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -151.37 119.67 6.37 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -168.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 1.008 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 2.4 tttm -86.94 56.92 4.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.911 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -87.75 126.3 34.92 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -147.71 -23.78 0.37 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.659 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 22.0 ttpp 66.22 13.73 9.3 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.731 165.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -151.22 -69.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.496 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.1 133.43 23.19 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -140.42 80.81 1.78 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.711 0.767 . . . . 0.0 111.261 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.85 -23.38 16.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.286 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.27 97.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.313 176.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.89 -47.78 65.0 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.342 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.48 104.16 0.66 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.804 ' CE1' ' HA ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.38 -173.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.822 ' HA3' ' HA ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.978 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 m -61.27 -58.66 7.36 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.947 HD23 ' HD3' ' A' ' 28' ' ' LYS . 11.0 tp -174.96 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.611 0.57 . . . . 0.0 112.266 160.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.49 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.5 tp -66.02 -25.93 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.828 -171.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.802 HD21 ' H ' ' A' ' 8' ' ' LEU . 7.5 tp -140.53 54.59 1.61 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.288 -171.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.822 ' HA ' ' HA3' ' A' ' -1' ' ' GLY . 11.8 t0 -54.58 96.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.618 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.09 40.87 52.23 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.821 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.754 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 30.7 t70 -107.82 -60.5 1.7 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.712 0.291 . . . . 0.0 110.496 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.457 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 25.7 tp 71.76 99.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.068 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.802 ' H ' HD21 ' A' ' 3' ' ' LEU . 6.7 tt -88.92 117.5 27.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.825 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -112.37 -5.68 14.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.578 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.31 -41.73 89.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 47.2 mmtm -97.65 152.11 19.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.357 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 5.2 mp -117.73 -72.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.44 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.78 103.83 4.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.357 . . . . 0.0 110.053 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.402 HD11 ' HG2' ' A' ' 51' ' ' GLU . 1.1 pp -111.76 163.54 17.32 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.835 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.51 -177.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.946 3.097 . . . . 0.0 113.647 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 48' ' ' LYS . 8.1 p -68.91 121.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.594 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 47.9 mt -77.77 152.66 5.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.587 174.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.81 144.84 42.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.571 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 6.5 p30 -56.92 -30.36 63.9 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.766 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.1 tp -60.6 -45.71 92.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.579 0.228 . . . . 0.0 110.946 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 61.5 t80 -62.37 -48.95 77.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.669 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -63.77 -43.87 97.08 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.431 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HB2' HG13 ' A' ' 46' ' ' ILE . 3.8 tptm -58.17 -34.94 70.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.233 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.648 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -55.3 -56.44 20.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.041 175.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.6 mp -51.82 -55.61 18.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.656 0.741 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.669 HD13 ' O ' ' A' ' 22' ' ' GLY . 6.7 mp -59.8 -44.91 93.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.011 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HA ' ' OG1' ' A' ' 41' ' ' THR . 21.3 t70 -63.2 -31.73 72.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.058 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.947 ' HD3' HD23 ' A' ' 1' ' ' LEU . 58.3 mttm -69.37 -33.54 73.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.937 0.398 . . . . 0.0 110.738 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' O ' HG13 ' A' ' 33' ' ' ILE . 15.4 m-85 -99.09 7.95 45.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -50.31 -44.14 54.05 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.284 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.12 -38.38 73.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.554 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.97 -41.57 50.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.563 HG22 ' HB ' ' A' ' 39' ' ' VAL . 32.4 mt -63.61 -34.08 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.235 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 33.1 ttpt -83.69 -27.74 28.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.099 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.41 -47.04 58.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.496 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -78.02 -62.13 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.068 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HB2' HG23 ' A' ' 39' ' ' VAL . 25.1 m-85 -97.68 -19.2 18.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.116 -167.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.18 46.04 10.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.931 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.607 HG23 ' HB2' ' A' ' 37' ' ' TYR . 40.3 t -107.48 145.57 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.032 0.444 . . . . 0.0 111.439 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.593 ' OD1' ' HB2' ' A' ' 42' ' ' LYS . 25.7 t70 -109.24 105.17 14.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.542 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 29.1 p -65.07 -16.75 63.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.593 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 3.3 mtpm? -67.23 -28.93 68.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.31 -18.97 28.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.91 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 67.8 mt -65.66 132.43 48.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.327 0.584 . . . . 0.0 111.559 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.62 ' HD2' HD23 ' A' ' 47' ' ' LEU . 2.5 tmtp? -94.48 109.38 21.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.124 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.631 ' HA ' HG12 ' A' ' 60' ' ' VAL . 6.1 mm -73.53 108.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.95 0.405 . . . . 0.0 109.925 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 45' ' ' LYS . 17.6 mt -80.11 -54.75 5.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.555 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.491 ' HG3' HG23 ' A' ' 16' ' ' VAL . 87.6 tttt -142.1 119.92 11.93 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.742 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.594 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 35.3 m -98.54 141.53 31.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 169.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -169.51 -174.68 1.97 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' OE1' ' HB2' ' A' ' 11' ' ' LYS . 8.9 pt-20 -147.68 162.46 39.11 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.726 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 5.8 t70 -135.01 -173.29 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.713 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 14.0 mmmm -63.96 111.02 2.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 72.34 -0.97 3.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.169 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.97 152.8 40.53 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.787 0.803 . . . . 0.0 112.989 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.601 ' HD2' ' HA ' ' A' ' 74' ' ' LYS . 6.2 m-85 -114.06 145.08 42.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.368 164.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.547 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 62.8 m-85 -134.23 112.15 10.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.82 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 5.1 t -111.89 93.47 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.811 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.9 m -76.58 121.83 23.74 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 46' ' ' ILE . 15.8 m -134.44 159.32 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 111.581 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.03 115.67 22.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . . . -86.0 -18.44 32.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 64' ' ' ASP . . . 108.87 165.51 20.66 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -171.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 9.6 t70 73.11 -52.61 0.71 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.927 0.491 . . . . 0.0 110.457 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.84 -17.18 0.22 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 42.9 mt-10 -78.2 150.85 33.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.915 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.722 ' H ' ' HB2' ' A' ' 88' ' ' LYS . 98.0 mttt -117.56 117.85 30.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.989 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 33.6 m -113.81 133.92 55.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.475 -171.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.0 ttpt -102.96 108.51 19.71 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.642 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 43.0 m-85 -68.15 103.55 1.58 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.494 0.664 . . . . 0.0 110.389 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.016 ' HD2' ' HB2' ' A' ' 96' ' ' TYR . 12.8 tttt -88.34 109.45 19.99 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.189 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.457 HG12 ' HG2' ' A' ' 81' ' ' MET . 48.2 mt -123.56 124.79 70.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.517 ' HD2' HG21 ' A' ' 82' ' ' VAL . 16.2 ttt180 -81.01 53.25 1.94 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.459 0.647 . . . . 0.0 110.612 -169.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.601 ' HA ' ' HD2' ' A' ' 56' ' ' TYR . 19.6 mttt 50.75 43.35 28.09 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.017 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.738 ' HA ' ' CB ' ' A' ' 0' ' ' SER . 1.9 m-20 55.46 28.62 11.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.761 0.663 . . . . 0.0 112.558 166.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 73' ' ' ARG . 21.3 m -77.36 122.09 31.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.282 0.563 . . . . 0.0 111.839 -176.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 t70 64.29 -77.31 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.456 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -82.82 139.72 43.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.978 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 90.8 Cg_endo -80.49 89.19 1.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.179 2.586 . . . . 0.0 112.878 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -176.2 -173.92 0.59 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.586 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.459 ' SD ' HG12 ' A' ' 33' ' ' ILE . 26.6 mtm -100.95 148.96 24.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG13 ' HE2' ' A' ' 71' ' ' LYS . 7.7 p -89.48 4.41 5.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . 152.3 113.1 0.54 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.727 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -95.43 100.78 12.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 16.2 tptp -125.14 134.52 52.4 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 7.6 m -93.74 123.49 37.11 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.583 ' HA ' ' HB2' ' A' ' 91' ' ' ASP . 67.0 ttt180 -113.04 37.83 3.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.902 . . . . 0.0 108.795 -176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.722 ' HB2' ' H ' ' A' ' 67' ' ' LYS . 1.4 tmtp? -59.95 115.52 3.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.284 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 75.74 -76.4 0.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.324 1.015 . . . . 0.0 109.394 -166.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -162.33 154.16 18.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.588 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.583 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 12.1 t70 -152.24 -80.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -132.65 134.78 45.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 87' ' ' ARG . 26.8 t70 -89.3 -58.56 2.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -171.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -53.85 -51.74 62.63 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.009 0.433 . . . . 0.0 111.837 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.98 -145.53 4.3 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 1.016 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . 14.9 m-85 . . . . . 0 C--O 1.244 0.771 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.917 172.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.8 p -153.57 32.25 0.46 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.856 0.328 . . . . 0.0 111.281 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.848 HD22 ' H ' ' A' ' 1' ' ' LEU . 0.3 OUTLIER -49.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.72 0.637 . . . . 0.0 111.667 -174.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' A' ' 56' ' ' TYR . 28.3 mm -144.35 -55.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 123.081 0.238 . . . . 0.0 111.525 -174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.913 HD23 ' HA ' ' A' ' 6' ' ' ASP . 1.1 mp -113.6 -3.14 13.65 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.61 45.69 21.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.87 36.76 12.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.647 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.913 ' HA ' HD23 ' A' ' 3' ' ' LEU . 30.3 t70 58.08 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 2.2 pp -148.58 19.69 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.598 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 3' ' ' LEU . 30.4 tp -78.87 99.7 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.795 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -124.04 6.32 8.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.532 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.71 -77.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HG2' HD11 ' A' ' 8' ' ' LEU . 48.2 pttt -90.2 178.02 6.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.0 tp -171.24 -47.43 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.993 0.425 . . . . 0.0 110.31 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 21.5 mtmt -123.83 93.73 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.291 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.96 157.4 33.73 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.803 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.39 -164.43 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.003 2.469 . . . . 0.0 112.105 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.8 p -69.3 110.82 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 122.076 0.941 . . . . 0.0 111.601 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.885 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -98.35 170.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.487 173.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 172.65 -8.24 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 21' ' ' PHE . 4.1 m-80 -64.61 63.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.377 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mt 68.74 -27.62 0.15 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.942 0.897 . . . . 0.0 112.454 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' A' ' 19' ' ' ASN . 7.9 t80 -54.04 -45.0 71.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -172.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -73.94 -38.56 48.48 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.692 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -70.89 -33.3 70.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 7.7 mm-40 -56.98 -50.6 72.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.544 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.546 HD12 ' HA2' ' A' ' 22' ' ' GLY . 60.4 mt -49.72 -67.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.529 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.859 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 39.1 mt -53.3 -34.09 55.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.62 -49.09 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.344 -0.223 . . . . 0.0 111.386 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 36.4 mttm -65.78 -45.07 83.82 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 109.913 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.444 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 3.9 m-85 -93.33 16.14 14.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.78 -171.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -61.0 -42.24 98.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -58.85 -38.53 78.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.56 -51.28 36.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 109.932 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.531 HG21 ' HE1' ' A' ' 70' ' ' PHE . 47.1 mt -66.6 -29.49 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.017 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.541 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 38.3 tttp -84.96 -29.34 25.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 110.326 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.28 -47.02 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.393 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.808 ' HD3' ' HE3' ' A' ' 81' ' ' MET . 27.8 mttm -65.46 -64.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.995 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.538 ' HB2' HG23 ' A' ' 39' ' ' VAL . 30.1 m-85 -107.02 -36.81 6.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.3 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.35 57.89 1.17 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.582 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 34.7 t -111.67 151.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.962 0.41 . . . . 0.0 111.236 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.69 102.65 12.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 56.6 p -77.12 -14.09 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.298 0.571 . . . . 0.0 111.513 -173.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -83.97 -8.15 59.23 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.756 0.789 . . . . 0.0 110.134 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.82 -10.35 23.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 57.1 mt -82.66 129.61 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.02 -175.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.551 ' HD3' HD23 ' A' ' 47' ' ' LEU . 11.8 tmtt? -96.89 119.2 34.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.561 ' HA ' HG12 ' A' ' 60' ' ' VAL . 39.3 mt -84.5 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.772 0.796 . . . . 0.0 111.4 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.551 HD23 ' HD3' ' A' ' 45' ' ' LYS . 5.9 mt -97.47 -56.06 2.64 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.656 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HA ' HG23 ' A' ' 16' ' ' VAL . 77.0 tttt -143.17 111.74 6.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.134 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.885 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.9 m -101.26 140.17 35.92 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -156.5 173.66 16.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.629 ' HB2' ' HE2' ' A' ' 74' ' ' LYS . 7.5 pt-20 -141.3 143.67 34.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.36 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -131.03 -146.8 0.31 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.98 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -65.79 95.47 0.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.659 0.266 . . . . 0.0 110.881 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 67.3 -6.43 0.62 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -116.82 134.5 54.7 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.644 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.685 ' CD2' ' HG2' ' A' ' 74' ' ' LYS . 10.5 m-85 -92.23 147.61 22.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.619 169.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.539 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 72.5 m-85 -130.4 97.94 4.55 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.35 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.629 HG22 HG23 ' A' ' 49' ' ' THR . 7.3 t -102.09 93.11 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.143 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.9 t -79.09 117.5 20.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 46' ' ' ILE . 17.3 m -130.02 157.44 42.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.35 126.2 33.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 7.07 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.68 -36.57 4.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.086 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -93.49 -29.99 15.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.239 0.542 . . . . 0.0 111.123 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.516 ' O ' ' HE3' ' A' ' 88' ' ' LYS . . . 140.81 -18.45 2.77 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.426 -175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.517 ' CG ' ' HD2' ' A' ' 88' ' ' LYS . 1.6 tt0 -67.36 134.77 52.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 99.1 mttt -114.32 98.89 7.2 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.893 0.854 . . . . 0.0 110.061 -174.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 1.039 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 10.1 t -93.57 133.88 36.43 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.303 -172.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.1 ttmt -107.43 103.85 13.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.766 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.594 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 44.8 m-85 -69.01 115.53 8.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.002 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.636 ' HD2' ' CD2' ' A' ' 96' ' ' TYR . 86.6 tttt -94.17 98.4 10.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.118 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 95.5 mt -100.43 111.63 30.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.848 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 10.8 ttt180 -69.88 104.09 2.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.748 ' HB3' HD13 ' A' ' 3' ' ' LEU . 78.1 mttt -47.7 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.241 0.963 . . . . 0.0 111.451 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.903 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 14.0 t70 1.84 77.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 125.194 1.559 . . . . 0.0 112.578 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.528 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . 15.7 m -84.03 -11.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.716 -170.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 26.3 t70 170.63 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.749 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -89.26 148.87 41.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.184 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.656 ' HB2' ' HA2' ' A' ' -1' ' ' GLY . 75.4 Cg_endo -83.14 105.75 1.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.628 2.219 . . . . 0.0 112.406 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HG2' ' HE2' ' A' ' 36' ' ' LYS . 3.1 mtmm 178.43 157.81 0.47 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.275 0.559 . . . . 0.0 111.309 175.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.808 ' HE3' ' HD3' ' A' ' 36' ' ' LYS . 2.3 tmm? -89.32 128.03 35.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 5.6 p -66.16 -38.89 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.584 ' HA3' ' OXT' ' A' ' 96' ' ' TYR . . . -178.12 -164.02 30.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.99 -1.576 . . . . 0.0 114.721 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.717 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 11.3 ptt180 -176.05 88.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.552 1.168 . . . . 0.0 107.967 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.677 ' H ' ' HD1' ' A' ' 96' ' ' TYR . 48.4 tttm -78.43 -18.36 55.05 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.921 -170.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.039 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.5 m 58.82 100.64 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.939 0.876 . . . . 0.0 109.887 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.759 ' HG3' ' HB2' ' A' ' 90' ' ' ASP . 22.6 ttt180 -106.52 67.51 0.72 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.947 -166.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.517 ' HD2' ' CG ' ' A' ' 66' ' ' GLU . 61.0 tttt -80.71 -39.11 27.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.778 -175.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -146.13 9.64 1.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.92 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.759 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 2.2 m-20 -66.86 161.45 23.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.77 -87.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.563 -171.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -124.74 115.14 20.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -128.47 120.91 27.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.068 0.461 . . . . 0.0 111.845 -167.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.76 -62.46 1.45 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.744 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.532 ' HA2' ' NZ ' ' A' ' 71' ' ' LYS . . . -89.55 128.56 9.25 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.855 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.677 ' HD1' ' H ' ' A' ' 85' ' ' LYS . 5.1 m-85 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.004 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.613 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 13.1 t -83.18 133.54 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 37.0 mt -121.53 -6.91 9.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.247 0.546 . . . . 0.0 110.452 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.741 HG21 ' HE2' ' A' ' 56' ' ' TYR . 6.8 tp -89.21 135.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.511 -169.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.651 HD23 ' HA ' ' A' ' 7' ' ' LEU . 9.8 mp 68.38 91.06 0.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.351 0.407 . . . . 0.0 110.434 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.37 83.22 0.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . 51.5 52.09 34.69 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' H ' ' HA ' ' A' ' 76' ' ' VAL . 7.4 t70 -137.45 -164.0 1.52 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.235 -0.483 . . . . 0.0 110.874 -161.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.651 ' HA ' HD23 ' A' ' 3' ' ' LEU . 2.7 pp -161.61 133.43 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.321 0.581 . . . . 0.0 111.94 -173.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 92.1 mt -123.8 -69.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.134 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 70.92 -67.02 0.27 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.638 0.586 . . . . 0.0 111.527 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -97.99 37.64 1.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.966 0.889 . . . . 0.0 109.505 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.739 ' HB3' ' HB3' ' A' ' 8' ' ' LEU . 20.8 pttt -75.53 -28.38 59.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.393 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 3.6 pp -101.33 170.36 8.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.086 -173.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -140.86 34.59 1.77 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.506 0.67 . . . . 0.0 109.868 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -129.56 147.85 66.95 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.338 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.79 -25.55 23.69 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.042 1.828 . . . . 0.0 111.531 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.468 HG22 ' HG3' ' A' ' 48' ' ' LYS . 15.3 t -145.61 139.91 21.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.743 175.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 49' ' ' THR . 4.2 mt -88.36 160.73 2.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.39 136.4 57.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -68.23 -13.68 62.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.168 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.6 tp -67.88 -41.95 82.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.964 0.411 . . . . 0.0 109.899 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 78.3 t80 -63.22 -36.97 85.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -64.78 -50.89 56.15 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.204 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -52.28 -37.83 56.64 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 122.361 0.264 . . . . 0.0 111.12 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.7 mm-40 -59.51 -50.39 74.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.702 0.401 . . . . 0.0 111.679 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 51.7 mt -53.33 -58.85 5.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.717 0.77 . . . . 0.0 110.316 176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.757 HD11 HG11 ' A' ' 58' ' ' VAL . 8.5 mp -62.54 -35.67 80.17 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.057 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.73 -41.5 81.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 87.8 mttt -70.23 -29.37 66.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.503 ' HE1' ' HA ' ' A' ' 80' ' ' LYS . 84.3 m-85 -98.27 1.55 47.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -55.16 -43.37 74.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 120.98 0.419 . . . . 0.0 111.002 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.51 -34.13 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.125 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.92 -40.22 28.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.209 0.528 . . . . 0.0 110.166 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.583 HG22 ' HB ' ' A' ' 39' ' ' VAL . 70.1 mt -63.19 -36.88 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.208 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.9 tttm -80.34 -30.77 38.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.895 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.47 -44.11 89.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.093 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -94.4 -41.48 9.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.468 ' HB2' HG23 ' A' ' 39' ' ' VAL . 46.4 m-85 -114.27 -29.66 6.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.0 111.32 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.38 54.26 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.662 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 33' ' ' ILE . 18.5 t -117.36 151.36 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 0.0 110.81 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' OD2' ' HG2' ' A' ' 42' ' ' LYS . 9.7 t70 -107.13 125.04 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 26' ' ' LEU . 13.9 p -76.01 -14.27 60.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 8.1 ptpp? -77.61 -17.09 58.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.88 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.99 -22.69 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.294 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.77 118.84 10.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.511 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 63.2 tttp -82.77 98.79 9.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.249 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.652 ' HA ' HG12 ' A' ' 60' ' ' VAL . 48.2 mt -73.11 119.73 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.543 0.687 . . . . 0.0 110.747 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.7 mt -90.18 -44.46 9.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.099 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.468 ' HG3' HG22 ' A' ' 16' ' ' VAL . 58.2 tttm -149.49 106.02 3.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.192 -172.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 17' ' ' ILE . 11.0 m -86.88 123.9 32.52 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.0 m -160.47 -178.41 6.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.3 pt-20 -138.88 152.96 48.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.669 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 30.0 t70 -148.18 125.75 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HG3' ' OD1' ' A' ' 52' ' ' ASP . 38.7 mttp 60.17 -138.52 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.844 ' HB3' HG11 ' A' ' 76' ' ' VAL . 73.2 mtm180 -80.16 12.72 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.629 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.617 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 3.8 m-85 -137.15 152.86 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.15 -167.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.741 ' HE2' HG21 ' A' ' 2' ' ' ILE . 14.6 m-85 -91.55 150.71 21.07 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 169.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.669 ' CE2' ' HB3' ' A' ' 52' ' ' ASP . 65.0 m-85 -130.13 98.05 4.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.757 0.313 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.757 HG11 HD11 ' A' ' 26' ' ' LEU . 21.5 t -100.03 93.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 2.1 t -76.71 124.33 27.51 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 46' ' ' ILE . 11.6 m -134.8 151.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.092 0.473 . . . . 0.0 111.211 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.1 t70 -87.49 117.15 26.09 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.63 -9.43 59.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.811 0.339 . . . . 0.0 111.702 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.74 -28.41 4.46 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.229 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -64.0 -28.03 69.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 0.0 110.065 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.74 -27.92 3.15 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.266 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.826 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 24.8 mt-10 -83.62 152.99 24.52 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.201 0.524 . . . . 0.0 111.443 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 53.7 mtpt -103.14 111.71 24.21 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 2.4 t -95.76 168.97 10.33 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.605 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 19.1 ttmm -148.04 94.49 2.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 79.0 m-85 -72.56 89.73 1.31 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.899 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.005 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 74.2 tttt -78.6 93.01 4.77 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.742 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 80.4 mt -83.03 105.88 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.53 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.662 ' H ' ' HA ' ' A' ' 81' ' ' MET . 14.5 ttt180 -66.03 121.34 14.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.521 ' HE3' ' C ' ' A' ' 55' ' ' PHE . 71.4 mttt -65.73 168.37 7.87 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.301 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.0 7.84 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 0.0 110.542 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.844 HG11 ' HB3' ' A' ' 54' ' ' ARG . 2.7 p -53.86 -33.15 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 122.441 1.115 . . . . 0.0 109.3 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.561 ' O ' HG12 ' A' ' 78' ' ' VAL . 27.6 t70 -164.84 118.42 1.29 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.872 -1.967 . . . . 0.0 108.387 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 77' ' ' ASP . 8.9 p 54.79 124.67 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.74 0 O-C-N 125.01 1.444 . . . . 0.0 112.683 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 84.7 Cg_endo -79.04 47.44 2.49 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 123.746 2.964 . . . . 0.0 112.555 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 7.3 mtmt -147.24 146.99 29.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.662 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 8.1 ptt? -57.23 108.47 0.53 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.11 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.659 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 9.1 p -59.91 -40.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.788 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.722 ' HA3' ' HB3' ' A' ' 96' ' ' TYR . . . -145.57 91.36 0.15 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.263 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -76.49 58.47 1.34 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.018 0.914 . . . . 0.0 108.635 170.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.814 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 40.1 mmtm -95.97 119.17 34.0 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.882 -167.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -83.87 124.04 30.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.333 0.587 . . . . 0.0 109.535 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.656 ' HB3' ' HA ' ' A' ' 91' ' ' ASP . 6.3 mtp180 -136.07 93.61 2.94 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.826 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 29.7 tttm -79.59 -64.26 1.23 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.34 -1.754 . . . . 0.0 112.372 -158.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.31 -31.32 58.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.748 0.309 . . . . 0.0 110.757 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -162.86 144.73 10.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.656 ' HA ' ' HB3' ' A' ' 87' ' ' ARG . 13.6 p-10 -101.29 -8.45 22.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.789 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.4 t70 67.82 -76.92 0.05 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.925 0.766 . . . . 0.0 112.981 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 94' ' ' ASP . 10.8 t70 -153.09 -156.39 0.69 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -172.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 93' ' ' ASP . 3.2 t70 -79.59 -159.86 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.41 84.35 0.21 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.474 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 1.005 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 6.8 m-85 . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.082 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 112.316 -0.314 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 79' ' ' PRO . 58.0 m -82.36 86.77 6.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 0.0 111.203 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.732 HD22 ' H ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -115.26 97.52 6.24 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.413 HG23 ' CD1' ' A' ' 3' ' ' LEU . 5.4 tp -163.47 -20.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.041 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.884 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 3.9 mp -116.98 1.03 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 t70 66.97 -62.43 0.3 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.655 0.597 . . . . 0.0 111.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.36 61.14 0.19 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.599 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 25.7 t0 76.75 23.07 1.07 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.649 0.738 . . . . 0.0 111.077 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 6.5 tt -98.08 122.95 41.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.617 HD23 HD23 ' A' ' 7' ' ' LEU . 2.2 pt? -41.04 -66.68 0.31 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -167.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.576 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 31.8 mmtp 65.06 -67.8 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.614 ' HB2' HD23 ' A' ' 12' ' ' LEU . 3.3 p30 -59.17 -54.0 51.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.8 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG2' HD12 ' A' ' 8' ' ' LEU . 42.4 mtpt 53.45 43.97 30.59 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.341 0.4 . . . . 0.0 111.043 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.614 HD23 ' HB2' ' A' ' 10' ' ' ASP . 4.3 mm? -63.52 -86.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.382 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.686 ' N ' ' HE2' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 54.41 61.43 3.02 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 109.991 177.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 82.8 mt -134.97 174.69 4.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.459 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.2 Cg_endo -63.5 -153.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.896 2.397 . . . . 0.0 111.066 165.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 48' ' ' LYS . 23.8 t -58.75 106.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.757 0.789 . . . . 0.0 109.944 175.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.59 156.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.486 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -49.05 133.03 18.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.107 0.479 . . . . 0.0 111.213 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -67.42 -25.52 65.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.729 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.38 -50.39 70.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 50.8 t80 -59.15 -38.58 80.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.722 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -64.54 -47.04 88.19 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 9.2 mmmm -54.77 -36.92 65.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.314 0.246 . . . . 0.0 111.027 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.3 mm-40 -60.04 -47.0 87.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.429 0.456 . . . . 0.0 111.492 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 72' ' ' ILE . 89.0 mt -52.46 -63.78 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.462 174.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.761 HD11 HG11 ' A' ' 58' ' ' VAL . 7.7 mp -59.67 -32.33 70.39 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.292 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.42 -40.29 86.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.216 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 50.6 mttm -75.5 -32.36 60.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.644 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 91.8 m-85 -96.44 8.47 43.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -54.04 -39.56 66.31 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.246 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.4 -39.78 94.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.664 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.52 -38.53 54.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.15 -26.4 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.288 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 82.0 tttt -83.55 -28.17 28.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.614 0.721 . . . . 0.0 109.84 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.94 -46.39 62.5 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.273 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -77.73 -39.75 43.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.761 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.625 ' HB2' HG23 ' A' ' 39' ' ' VAL . 90.0 m-85 -114.88 -48.01 2.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.449 0.642 . . . . 0.0 110.966 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.16 39.05 2.35 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.296 -171.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG12 ' H ' ' A' ' 41' ' ' THR . 13.5 t -109.3 150.82 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.831 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 42' ' ' LYS . 32.0 t70 -92.99 11.17 28.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 0.0 110.132 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.647 ' H ' HG12 ' A' ' 39' ' ' VAL . 46.6 p 56.16 -24.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.7 1.6 . . . . 0.0 114.129 -172.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 42' ' ' LYS . 4.4 ttmp? -72.83 -12.92 61.17 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 110.517 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.1 -42.5 17.33 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.759 0.79 . . . . 0.0 108.875 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.62 ' HG ' HG11 ' A' ' 39' ' ' VAL . 57.1 mt -61.67 106.11 0.63 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.376 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.632 ' HD3' HD23 ' A' ' 47' ' ' LEU . 6.1 tmtm? -79.91 116.61 20.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.403 ' HA ' HG12 ' A' ' 60' ' ' VAL . 41.3 mt -73.6 128.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.546 0.688 . . . . 0.0 110.956 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.632 HD23 ' HD3' ' A' ' 45' ' ' LYS . 15.3 mt -97.92 -51.5 4.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.889 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.581 ' HA ' HG13 ' A' ' 16' ' ' VAL . 62.4 tttm -144.73 102.86 3.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.461 -173.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.4 m -78.9 121.72 25.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -153.22 -177.78 6.54 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.818 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 1.7 pp20? -162.55 160.83 26.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.808 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.681 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 29.7 t70 -103.78 -86.14 0.45 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.735 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -131.33 -79.23 0.52 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' HB3' HG11 ' A' ' 76' ' ' VAL . 52.5 mtt180 -87.99 16.93 5.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 0.0 110.818 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -144.6 135.62 25.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.684 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.9 m-85 -94.88 151.45 19.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.681 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 78.1 m-85 -137.8 109.59 7.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.349 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 26' ' ' LEU . 21.8 t -110.7 108.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.1 t -84.27 130.72 34.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 67' ' ' LYS . 26.9 m -135.4 148.29 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.136 0.494 . . . . 0.0 112.167 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.537 ' HB2' HD21 ' A' ' 47' ' ' LEU . 34.7 t70 -90.26 112.88 24.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.93 -63.88 1.13 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.798 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.67 -130.27 2.07 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.096 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.39 -8.14 21.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.098 0.475 . . . . 0.0 109.813 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.73 -33.95 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.603 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.636 ' OE2' ' HB2' ' A' ' 88' ' ' LYS . 5.3 tp10 -61.45 136.56 58.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.214 0.53 . . . . 0.0 111.132 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 42.5 mttp -137.17 106.3 6.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.96 -173.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 1.9 t -96.09 148.0 23.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.352 -173.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 5.0 ttmp? -115.03 102.78 10.26 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.71 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 62.1 m-85 -68.44 127.48 33.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.978 ' HD2' ' HA ' ' A' ' 96' ' ' TYR . 56.7 tttp -100.71 83.45 2.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.666 0.746 . . . . 0.0 109.938 -175.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 94.8 mt -81.25 89.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.952 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.654 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 39.7 ttt180 -58.9 117.72 4.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HB3' HD13 ' A' ' 3' ' ' LEU . 93.9 mttt -60.9 174.07 0.68 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.569 -176.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.884 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 53.1 t0 -71.89 64.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 0.0 110.513 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.599 ' HA ' ' N ' ' A' ' 6' ' ' ASP . 31.1 m -99.09 -7.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.438 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -175.16 -61.49 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.024 -171.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.1 151.02 37.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.577 . . . . 0.0 111.186 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 0' ' ' SER . 43.3 Cg_endo -90.34 32.74 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.709 2.94 . . . . 0.0 110.977 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.644 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 3.0 ttmt -150.88 -166.18 2.47 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.178 0.513 . . . . 0.0 111.099 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.546 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 67.9 mtm -97.04 127.2 42.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.226 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG11 ' HE3' ' A' ' 71' ' ' LYS . 7.6 p -53.01 -33.13 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.455 0.645 . . . . 0.0 109.903 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.76 -143.42 8.41 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.919 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.71 ' HB2' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER 176.3 148.78 0.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -148.49 121.07 8.56 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.945 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 1.4 m -88.19 130.31 35.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -124.28 31.8 5.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.067 0.937 . . . . 0.0 109.893 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.636 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.69 -36.74 62.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.813 175.018 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.47 -65.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.96 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -159.68 -87.14 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.147 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -153.87 159.92 41.97 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -146.72 143.18 28.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.495 0.188 . . . . 0.0 111.287 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -136.95 116.79 13.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.195 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -171.32 -50.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.839 0.828 . . . . 0.0 109.451 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -164.17 -117.44 0.41 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.978 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 44.6 t80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 117.48 -1.247 . . . . 0.0 113.194 164.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.459 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 28.6 t -108.78 126.92 53.54 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.822 ' H ' ' HE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -125.76 108.59 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.742 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.808 HG21 ' HE1' ' A' ' 56' ' ' TYR . 3.3 tp -176.36 -6.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.645 HD11 ' H ' ' A' ' 8' ' ' LEU . 7.1 tp -144.27 -18.25 0.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.405 -171.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 65.41 9.53 5.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.887 0.475 . . . . 0.0 112.069 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.719 ' HA2' ' H ' ' A' ' 77' ' ' ASP . . . 71.49 18.11 76.79 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.647 -172.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -103.36 -35.25 8.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.562 ' HA ' ' HG ' ' A' ' 3' ' ' LEU . 6.8 mp 71.03 109.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.517 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.645 ' H ' HD11 ' A' ' 3' ' ' LEU . 58.0 tp -109.62 88.37 2.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.586 ' HA ' HD21 ' A' ' 12' ' ' LEU . 9.5 ptpp? -93.35 14.3 18.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.559 -172.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.534 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 20.5 t70 -88.8 -29.71 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.219 0.533 . . . . 0.0 110.565 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 -20.98 32.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.299 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.586 HD21 ' HA ' ' A' ' 9' ' ' LYS . 2.3 pp -87.53 45.57 1.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.847 0.832 . . . . 0.0 111.692 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.534 ' HD3' ' O ' ' A' ' 10' ' ' ASP . 40.8 mtpt -115.06 21.87 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.965 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.41 154.77 46.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.418 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.55 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.255 2.637 . . . . 0.0 110.966 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' CG2' ' HG3' ' A' ' 48' ' ' LYS . 3.4 p -54.71 108.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 122.335 1.064 . . . . 0.0 110.38 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.822 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 33.3 mt -75.82 149.57 6.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.3 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.22 139.64 47.17 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.097 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.494 ' O ' HD12 ' A' ' 46' ' ' ILE . 21.4 p-10 -60.29 -24.55 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.063 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 20' ' ' LEU . 2.6 tm? -70.43 -39.74 74.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.581 ' O ' HD13 ' A' ' 25' ' ' LEU . 77.5 t80 -62.02 -43.93 97.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -67.74 -29.67 73.98 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.431 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -70.05 -37.39 75.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 36.2 mm-40 -59.18 -47.75 84.17 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.693 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 21' ' ' PHE . 8.7 mp -50.42 -67.34 0.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.943 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 26.5 mt -50.38 -30.19 11.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.795 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.25 -45.72 46.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.372 -0.205 . . . . 0.0 110.72 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 63.6 mttm -65.88 -46.77 77.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.278 0.561 . . . . 0.0 110.41 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.822 ' HE2' ' H ' ' A' ' 1' ' ' LEU . 19.5 m-85 -91.33 13.21 18.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.787 -174.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.84 -51.43 67.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.7 m-20 -80.74 11.17 4.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.369 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.03 -43.98 5.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.581 HG21 ' HE2' ' A' ' 70' ' ' PHE . 38.8 mt -66.93 -38.2 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.685 174.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -83.05 -22.76 33.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.845 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 15.2 t70 -68.51 -55.3 12.21 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.272 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 81' ' ' MET . 58.2 mttm -69.51 -50.73 42.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.417 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.533 ' OH ' ' HA2' ' A' ' 83' ' ' GLY . 26.9 m-85 -116.71 -6.4 11.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.92 29.28 73.49 Favored Glycine 0 CA--C 1.516 0.136 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.494 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 33' ' ' ILE . 28.2 t -97.93 147.72 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.554 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.23 127.57 50.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.943 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 71.8 p -87.94 -20.11 26.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.816 0.341 . . . . 0.0 111.858 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -68.19 -39.74 82.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -61.05 -29.01 69.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.862 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 64.2 mt -69.52 149.95 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -175.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -115.01 121.15 42.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.432 172.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.606 HG12 HG12 ' A' ' 60' ' ' VAL . 26.5 mt -84.65 132.25 32.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.512 0.673 . . . . 0.0 111.779 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 61' ' ' ASP . 5.7 mt -101.76 -52.04 3.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.733 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 38.4 ttmt -146.35 115.3 6.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.059 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.822 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -91.59 139.04 31.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -157.41 -175.41 5.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 12' ' ' LEU . 13.1 pt-20 -163.74 150.8 12.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.298 0.57 . . . . 0.0 111.962 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.76 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 27.8 t70 -99.55 -158.84 0.7 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.793 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 4.0 mptt -73.11 -70.61 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -87.12 13.63 9.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 91.0 m-85 -145.67 152.21 39.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.808 ' HE1' HG21 ' A' ' 2' ' ' ILE . 30.9 m-85 -108.17 147.01 31.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.009 166.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.76 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 66.1 m-85 -130.37 95.7 3.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.818 0.342 . . . . 0.0 110.329 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 22.0 t -104.7 97.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.049 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.693 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.2 t -69.02 114.03 6.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 46' ' ' ILE . 13.7 m -129.28 152.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.429 0.633 . . . . 0.0 111.265 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.6 ' HB2' HD21 ' A' ' 47' ' ' LEU . 12.3 t70 -84.41 115.53 22.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.28 -14.5 60.51 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.297 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.99 -42.76 2.35 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.602 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.18 -30.14 64.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.903 0.481 . . . . 0.0 111.293 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.55 -19.46 1.67 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.453 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.587 ' OE2' ' HB3' ' A' ' 86' ' ' CYS . 6.2 pt-20 -104.71 166.17 10.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.321 0.582 . . . . 0.0 112.345 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -111.92 117.66 33.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.153 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 62.1 m -111.84 114.99 28.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.036 0.446 . . . . 0.0 111.19 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.933 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.5 ttmt -88.82 85.28 6.73 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 170.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.581 ' HE2' HG21 ' A' ' 33' ' ' ILE . 5.9 m-85 -47.91 116.3 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.913 -172.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.766 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 62.4 tttt -95.67 69.79 2.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.242 -174.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.842 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 36.7 mt -74.52 91.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.454 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.822 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 24.4 ttt180 -50.58 117.43 2.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.45 ' HE3' ' CE1' ' A' ' 56' ' ' TYR . 43.0 mttp -59.4 166.3 2.37 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.03 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 17.9 t0 -67.68 74.75 0.18 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.632 0.73 . . . . 0.0 109.68 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 74' ' ' LYS . 3.7 m -104.31 94.39 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.672 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.719 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 34.5 t70 72.21 -61.14 0.5 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.293 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.67 141.56 22.76 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.322 0.582 . . . . 0.0 110.19 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -91.85 84.29 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.463 2.776 . . . . 0.0 113.62 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 5.2 mtmt -165.51 153.55 11.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.547 176.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.842 ' HG3' ' HA ' ' A' ' 72' ' ' ILE . 4.5 ttp -82.24 121.39 26.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.811 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.822 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.3 p -60.88 -39.4 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.382 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 96' ' ' TYR . . . 178.87 -153.02 11.82 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.895 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.766 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 41.3 mtm180 -151.43 125.75 9.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.933 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 24.5 tptp -76.28 55.57 0.98 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.339 0.59 . . . . 0.0 110.106 -178.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.587 ' HB3' ' OE2' ' A' ' 66' ' ' GLU . 39.3 m -72.47 -164.63 0.16 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.832 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.666 ' HD2' ' OH ' ' A' ' 96' ' ' TYR . 98.2 mtt180 65.08 97.49 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 2.2 ttpm? -58.35 -20.62 45.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -164.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -124.05 -170.66 2.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -70.54 91.03 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.271 0.557 . . . . 0.0 110.487 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 31.8 t70 -136.96 13.61 3.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.847 0.832 . . . . 0.0 109.061 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.508 ' HA ' HH11 ' A' ' 87' ' ' ARG . 8.8 p-10 -96.9 174.08 6.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.005 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -149.71 -150.05 0.33 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.466 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -54.26 -33.35 58.36 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.915 0.486 . . . . 0.0 110.906 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.83 132.48 17.51 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.879 ' CE2' ' HA ' ' A' ' 85' ' ' LYS . 9.6 p90 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 117.088 -1.435 . . . . 0.0 111.063 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.691 0 N-CA-C 112.294 -0.322 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 79' ' ' PRO . 11.4 p -108.77 -17.72 13.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.1 mp 52.09 -153.05 0.22 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.005 171.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.616 HD13 ' HE2' ' A' ' 56' ' ' TYR . 79.4 mt 79.57 -56.5 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.029 168.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.785 HD13 ' HA ' ' A' ' 7' ' ' LEU . 64.9 mt -105.46 -42.89 5.1 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.848 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 29.6 m-20 60.46 71.81 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.672 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.1 31.34 80.46 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.543 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.0 t70 -135.24 -153.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.785 ' HA ' HD13 ' A' ' 3' ' ' LEU . 86.0 mt -154.23 172.29 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 110.668 -171.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.686 HD21 ' HZ3' ' A' ' 74' ' ' LYS . 2.4 pt? -140.4 120.32 13.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -100.92 -18.08 16.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.778 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -94.17 -30.14 14.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HA ' HD12 ' A' ' 8' ' ' LEU . 10.4 mtmp? 57.78 -168.78 0.12 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.807 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.41 HD11 ' CE2' ' A' ' 21' ' ' PHE . 84.1 mt -90.47 -74.71 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.677 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HE3' HG23 ' A' ' 17' ' ' ILE . 31.1 pttt -175.93 -161.78 0.09 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -168.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.469 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 10.7 mp -66.76 169.33 8.11 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.367 0.667 . . . . 0.0 112.189 -175.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 98.5 Cg_exo -47.99 159.33 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.811 3.007 . . . . 0.0 113.891 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 49' ' ' THR . 11.0 p 40.96 104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 123.482 1.611 . . . . 0.0 113.432 -173.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.732 HG22 ' H ' ' A' ' 18' ' ' ASP . 9.8 mt -87.66 -177.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.469 -175.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.732 ' H ' HG22 ' A' ' 17' ' ' ILE . 4.0 m-20 -59.99 -4.93 0.85 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.58 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 90.0 m-20 72.9 -44.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.485 0.714 . . . . 0.0 110.981 -176.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -59.82 -31.57 69.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.779 0.432 . . . . 0.0 110.675 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.521 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 38.5 t80 -65.5 -35.63 81.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 109.754 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -77.11 -27.64 59.76 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 177.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -65.59 -37.66 87.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.6 -48.86 77.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.181 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 84.0 mt -49.76 -69.11 0.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.028 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 33.7 mt -52.78 -26.68 15.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.88 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.99 -48.75 67.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 110.958 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -69.3 -40.98 77.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.192 0.52 . . . . 0.0 110.365 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.36 3.83 52.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.818 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 31.3 tt0 -54.95 -40.56 70.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -65.86 -26.65 67.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.993 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 35' ' ' ASP . 7.9 t70 -85.57 -40.17 16.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.511 0.672 . . . . 0.0 109.681 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.422 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.5 mt -69.25 -34.03 61.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.412 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.492 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 86.4 tttt -75.83 -31.54 59.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 18.7 t70 -59.94 -35.59 75.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.643 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -105.87 -25.31 12.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -173.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' HB2' HG23 ' A' ' 39' ' ' VAL . 74.0 m-85 -128.14 -31.38 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.54 63.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.111 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 37' ' ' TYR . 46.5 t -120.7 151.51 23.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 -173.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 42' ' ' LYS . 23.1 t70 -108.65 110.14 21.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 17.3 p -72.32 -10.43 59.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.501 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 6.3 ttpm? -78.04 -35.0 50.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.039 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.32 -28.62 59.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 109.589 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 41' ' ' THR . 1.4 mp -54.11 115.99 2.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.405 176.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 2.8 ttmp? -86.32 108.55 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.972 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.676 ' HA ' HG12 ' A' ' 60' ' ' VAL . 36.4 mt -80.27 122.6 35.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.445 0.641 . . . . 0.0 111.094 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.1 mt -96.03 -51.71 4.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.956 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -142.43 106.31 4.71 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.265 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 11.3 m -91.04 132.13 36.2 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' HG13 ' A' ' 17' ' ' ILE . 69.0 m -152.54 -175.11 5.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 11' ' ' LYS . 12.5 pt-20 -149.64 158.65 44.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.763 0.792 . . . . 0.0 111.519 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.671 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 28.1 t70 -111.56 -164.94 0.95 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 166.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.854 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 1.2 mptt -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 40.0 mtp180 -83.5 -0.1 48.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.584 -172.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 m-85 -148.15 159.71 43.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.237 0.541 . . . . 0.0 112.382 -168.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.731 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 36.0 m-85 -109.24 159.75 16.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 163.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.671 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 94.4 m-85 -137.07 93.78 2.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.936 0.398 . . . . 0.0 110.181 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 49' ' ' THR . 13.3 t -102.51 96.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.588 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 12.9 m -78.4 124.44 28.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 46' ' ' ILE . 17.4 m -141.6 160.57 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.543 -173.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 6.0 t70 -92.17 125.33 36.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.544 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -79.81 -13.96 59.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.45 -31.92 7.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.58 8.92 4.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.802 0.334 . . . . 0.0 111.23 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.21 -15.08 63.74 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.625 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.571 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 9.6 pt-20 -84.16 142.19 30.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.162 0.506 . . . . 0.0 110.749 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.904 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . 27.8 ttmt -97.62 134.9 40.2 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.9 t -126.63 164.66 20.77 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.25 0.548 . . . . 0.0 110.623 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.637 ' H ' ' HA ' ' A' ' 86' ' ' CYS . 35.7 ttmt -147.43 103.87 3.59 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 26' ' ' LEU . 72.0 m-85 -77.36 88.08 3.76 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.571 0.7 . . . . 0.0 110.529 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.05 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 31.1 tttp -71.63 78.02 0.82 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.924 170.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.731 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 78.9 mt -74.43 95.84 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.247 -176.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.783 ' HB2' HG12 ' A' ' 82' ' ' VAL . 40.5 ttp180 -61.76 101.64 0.21 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.686 ' HZ3' HD21 ' A' ' 8' ' ' LEU . 88.8 mttt -48.72 152.3 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.369 1.043 . . . . 0.0 109.687 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.848 ' HB3' ' H ' ' A' ' 4' ' ' ASP . 29.3 t0 -69.47 70.78 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.411 0.624 . . . . 0.0 109.56 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 33.7 m -89.2 -4.34 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.865 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 t70 178.57 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.732 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.51 HG23 ' HD2' ' A' ' 79' ' ' PRO . 7.1 p -137.29 138.34 24.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.326 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.668 ' O ' ' HA2' ' A' ' -1' ' ' GLY . 68.4 Cg_endo -83.06 62.88 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.493 2.796 . . . . 0.0 112.855 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -145.28 128.28 16.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 111.471 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.515 ' HG3' HG23 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.59 95.63 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.13 177.183 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.783 HG12 ' HB2' ' A' ' 73' ' ' ARG . 10.0 p -60.58 -41.54 88.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.704 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 1.05 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -89.5 47.76 3.29 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 -173.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -81.77 45.53 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.707 ' HB2' ' HB3' ' A' ' 96' ' ' TYR . 20.6 ttpt -105.01 -26.28 12.21 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.818 -165.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.637 ' HA ' ' H ' ' A' ' 69' ' ' LYS . 49.4 m 66.35 -178.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.906 -171.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.727 ' HG3' ' HB2' ' A' ' 90' ' ' ASP . 63.6 ttt180 -176.86 78.96 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.546 0.688 . . . . 0.0 109.285 -172.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.904 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 22.9 ttpp -81.75 -58.78 2.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.861 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.93 5.16 8.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.439 0.638 . . . . 0.0 109.916 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.727 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 3.2 m-20 -66.66 162.63 20.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.9 -177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 92' ' ' ASP . 9.1 t70 -96.69 -160.21 0.78 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.42 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 24.0 t70 -69.13 109.99 4.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.161 0.505 . . . . 0.0 111.977 -174.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -112.77 137.82 50.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.533 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.75 -55.95 3.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.82 137.28 13.97 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.011 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.707 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 3.8 m-85 . . . . . 0 C--N 1.32 -0.703 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 79' ' ' PRO . 43.1 t -88.69 151.36 22.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 2' ' ' ILE . 27.2 mt -118.59 -144.43 0.37 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.627 HG21 ' HE2' ' A' ' 56' ' ' TYR . 1.3 tp 81.2 -25.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.981 0.912 . . . . 0.0 112.492 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.821 HD13 ' HA ' ' A' ' 6' ' ' ASP . 30.8 mt -124.0 161.9 24.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.954 0.407 . . . . 0.0 110.659 176.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.588 ' HB3' HD12 ' A' ' 7' ' ' LEU . 18.7 t70 -121.81 81.01 1.76 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.59 43.78 97.49 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.392 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.821 ' HA ' HD13 ' A' ' 3' ' ' LEU . 34.6 t70 67.14 96.73 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.228 0.537 . . . . 0.0 111.951 -177.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 4' ' ' ASP . 75.6 mt -149.4 100.03 2.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.62 HD23 ' HD3' ' A' ' 53' ' ' LYS . 51.7 tp -112.19 -68.19 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 38.0 mtmt 76.77 -66.49 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.564 . . . . 0.0 111.856 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -125.75 134.18 51.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.856 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -149.43 3.54 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.552 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.46 128.5 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.165 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 14' ' ' LEU . 59.3 tttt -136.69 165.8 25.07 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' H ' ' HG2' ' A' ' 13' ' ' LYS . 61.9 mt -55.01 159.15 4.04 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 122.654 0.382 . . . . 0.0 111.342 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.26 138.82 4.45 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.594 2.862 . . . . 0.0 113.5 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p 43.69 102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 123.129 1.442 . . . . 0.0 113.578 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.88 162.31 4.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.124 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.88 133.31 22.27 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.345 0.403 . . . . 0.0 111.126 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -64.01 -20.85 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.913 0.387 . . . . 0.0 110.254 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -69.03 -31.55 70.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.418 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HE1' ' HE1' ' A' ' 56' ' ' TYR . 55.5 t80 -68.6 -40.07 80.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 109.698 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -72.26 -29.85 65.8 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.162 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -67.27 -40.49 86.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.2 mm-40 -52.77 -51.72 59.51 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.744 173.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.514 HD13 HD12 ' A' ' 72' ' ' ILE . 68.3 mt -53.97 -66.36 0.41 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.839 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.549 HD22 HG22 ' A' ' 41' ' ' THR . 20.4 mt -54.06 -28.36 38.34 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.46 -50.23 60.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 72.4 mttt -71.54 -33.77 69.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.816 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -96.88 4.9 51.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.789 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.4 tt0 -56.52 -41.63 77.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.775 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -65.69 -20.99 66.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.551 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -94.61 -39.93 10.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.277 0.561 . . . . 0.0 110.042 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.538 HG22 ' HB ' ' A' ' 39' ' ' VAL . 53.7 mt -67.76 -31.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.313 176.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 44.1 tttp -81.73 -29.15 33.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.306 0.574 . . . . 0.0 109.803 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.39 -52.59 31.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.574 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -71.44 -43.39 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.621 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.576 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 86.6 m-85 -118.59 -23.54 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.14 44.11 7.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.875 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.556 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.3 t -100.99 152.79 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -114.4 116.61 29.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.554 HG22 HD12 ' A' ' 44' ' ' LEU . 39.7 p -76.22 -11.6 59.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -73.68 -20.46 60.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.358 0.599 . . . . 0.0 109.53 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -92.23 -33.0 14.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.327 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.554 HD12 HG22 ' A' ' 41' ' ' THR . 86.6 mt -56.67 111.55 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.959 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 75.8 tttt -84.11 104.35 14.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.71 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.618 ' HA ' HG12 ' A' ' 60' ' ' VAL . 37.7 mt -73.73 112.68 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.546 0.688 . . . . 0.0 111.029 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.6 mt -82.25 -43.5 17.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.065 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -154.04 120.38 5.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.347 -173.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -102.46 130.21 49.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.9 m -157.29 177.03 11.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 11' ' ' LYS . 1.2 pt-20 -158.61 167.05 30.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 171.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -149.01 89.78 1.7 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.107 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.856 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 5.3 tppp? 70.41 -100.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.726 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.625 ' HB3' HG21 ' A' ' 76' ' ' VAL . 65.8 mtt180 -94.71 20.44 8.64 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.73 -0.606 . . . . 0.0 111.451 -171.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -148.63 121.01 8.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.818 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.779 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.0 m-85 -85.78 150.96 24.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 95.05 3.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.8 t -105.86 93.92 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 110.516 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.1 m -80.02 119.9 23.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 46' ' ' ILE . 11.5 m -130.29 158.09 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.31 0.576 . . . . 0.0 111.343 -176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -84.55 123.5 30.37 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.55 4.44 7.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.77 1.32 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.372 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.93 -27.05 39.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.136 0.493 . . . . 0.0 110.473 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.59 -21.62 2.37 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.202 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.778 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 5.7 mt-10 -66.95 147.89 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.398 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 97.8 mttt -109.47 110.3 21.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.049 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 56.2 m -108.18 131.43 54.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 34.8 ttmt -101.48 107.18 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.575 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 65.5 m-85 -76.48 84.55 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.184 0.992 . . . . 0.0 110.433 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.116 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 21.3 tttp -76.72 89.58 3.39 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.197 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.779 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 mt -87.23 106.22 15.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.494 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.729 ' HB2' HG22 ' A' ' 82' ' ' VAL . 60.3 ttt180 -78.7 18.09 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.462 0.648 . . . . 0.0 110.336 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.624 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.7 mttt 55.43 -157.12 0.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.229 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 32.0 t70 -100.83 56.0 0.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.625 HG21 ' HB3' ' A' ' 54' ' ' ARG . 17.9 t -75.44 -13.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.281 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.8 t70 179.92 -54.63 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.315 -171.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' HD2' ' A' ' 79' ' ' PRO . 10.0 p -120.75 139.03 28.34 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.667 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 78' ' ' VAL . 55.5 Cg_endo -75.16 67.39 6.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.664 2.243 . . . . 0.0 111.86 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -142.03 142.24 32.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.628 0.727 . . . . 0.0 111.985 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.521 ' HG3' HG23 ' A' ' 72' ' ' ILE . 1.5 mpp? -80.7 89.45 5.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.587 173.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 73' ' ' ARG . 35.0 m -58.84 -33.49 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.916 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 1.116 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -92.18 72.8 1.55 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.053 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.576 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -105.39 47.73 0.86 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.369 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -115.53 142.1 47.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.979 -170.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.8 m -108.26 132.02 54.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.049 0.452 . . . . 0.0 109.925 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.702 ' HD3' ' HA ' ' A' ' 91' ' ' ASP . 94.6 mtt180 -128.42 78.33 1.83 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.778 ' HG3' ' HA ' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -71.2 -41.18 70.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.144 -171.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.41 -59.9 2.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.483 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -171.28 147.54 2.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.702 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 8.6 t70 -108.95 112.08 24.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -72.01 -90.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.072 0.463 . . . . 0.0 110.862 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -116.07 142.33 46.95 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -82.57 114.07 20.71 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.319 0.58 . . . . 0.0 111.62 -172.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.41 77.91 0.19 Allowed Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.83 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 15.1 m-30 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.701 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.488 ' HA2' ' HB2' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.646 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.412 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 26.1 p -140.68 29.02 1.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.291 0.567 . . . . 0.0 109.694 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.964 ' HA ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -67.9 131.04 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.597 1.189 . . . . 0.0 113.47 -169.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.614 HG13 HD11 ' A' ' 8' ' ' LEU . 11.1 tp -152.36 15.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.167 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 75' ' ' ASP . 1.8 pp -149.2 157.89 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.462 -1.699 . . . . 0.0 108.184 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.61 -29.31 61.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.318 0.58 . . . . 0.0 109.825 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 40.99 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 24.1 p-10 -157.96 -80.26 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.852 -168.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 6' ' ' ASP . 7.7 mt 175.71 174.14 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.139 0.576 . . . . 0.0 110.252 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.614 HD11 HG13 ' A' ' 2' ' ' ILE . 63.8 mt -100.05 131.63 45.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.156 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -98.46 -30.28 12.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' OD2' ' HG3' ' A' ' 11' ' ' LYS . 6.4 p-10 -80.48 -38.03 30.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.068 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HB2' HD13 ' A' ' 8' ' ' LEU . 57.4 mttp -101.86 67.89 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.652 0.739 . . . . 0.0 109.745 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.763 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.6 pt? -79.25 -36.23 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.344 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.671 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 7.5 ptpt -177.08 101.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.448 0.642 . . . . 0.0 110.851 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.525 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 96.0 mt -100.47 167.51 10.79 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.523 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.6 Cg_endo -64.6 -170.61 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.632 2.221 . . . . 0.0 111.998 173.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 48' ' ' LYS . 2.6 p -63.39 105.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.017 175.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 49' ' ' THR . 3.3 pt -106.07 -177.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.804 -174.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.509 ' OD2' ' HB ' ' A' ' 46' ' ' ILE . 7.9 t70 176.68 -39.58 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -40.41 78.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 112.261 -2.245 . . . . 0.0 113.248 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 78.9 mt 45.7 40.2 5.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.729 0.776 . . . . 0.0 111.035 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.512 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.3 m-85 -117.13 -78.06 0.58 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.127 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.41 90.78 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.491 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HG2' HD12 ' A' ' 46' ' ' ILE . 30.2 mmmt -66.4 -33.29 75.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.364 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 1.5 mm-40 -65.87 -47.14 75.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.607 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 87.0 mt -50.94 -66.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.838 173.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.877 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 34.0 mt -50.89 -33.19 23.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.444 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.28 -48.46 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.195 -0.316 . . . . 0.0 111.074 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 80.0 mttt -67.7 -38.22 83.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.211 0.529 . . . . 0.0 110.496 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 1.5 m-85 -98.54 12.59 34.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.46 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.515 ' OE1' ' HA ' ' A' ' 40' ' ' ASP . 5.8 tt0 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.63 -33.15 71.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.347 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.661 ' O ' ' HD2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -76.58 -46.88 24.4 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.534 178.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.511 HG22 ' HB ' ' A' ' 39' ' ' VAL . 42.5 mt -65.45 -20.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.613 0.72 . . . . 0.0 110.266 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 46.9 tttm -87.66 -40.18 14.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.645 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.89 -47.91 76.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.906 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.661 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 8.0 mttp -82.5 -28.74 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.26 -175.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.492 ' HB2' HG23 ' A' ' 39' ' ' VAL . 67.8 m-85 -133.67 -52.43 0.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.018 0.437 . . . . 0.0 111.526 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.53 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . 106.78 62.53 0.59 Allowed Glycine 0 C--N 1.319 -0.393 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 33' ' ' ILE . 47.3 t -124.45 151.84 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.905 0.383 . . . . 0.0 111.372 -171.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.515 ' HA ' ' OE1' ' A' ' 30' ' ' GLN . 28.7 t70 -103.19 121.33 42.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.54 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.877 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 41.1 p -88.56 -10.69 47.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.946 0.403 . . . . 0.0 112.044 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -68.97 -43.16 75.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -73.84 -24.87 59.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.379 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.7 mt -56.71 123.33 14.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.128 0.49 . . . . 0.0 110.692 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -94.2 111.69 23.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.82 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 60' ' ' VAL . 12.4 mt -72.53 116.88 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.487 0.661 . . . . 0.0 111.184 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.3 mt -86.82 -40.02 15.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.929 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HA ' HG23 ' A' ' 16' ' ' VAL . 41.1 tttm -155.0 140.63 17.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.552 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 54.1 m -142.48 127.54 18.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.7 m -156.57 152.53 27.37 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -123.96 162.7 22.86 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 175.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 10.1 t70 -153.69 -98.99 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.672 171.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -93.57 89.79 6.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.912 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.3 mtt180 75.45 -44.84 0.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.657 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 20.5 m-85 -78.98 133.22 36.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.684 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 1.3 m-85 -103.55 121.77 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.718 164.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 49' ' ' THR . 10.7 m-85 -99.07 86.26 3.41 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 18.8 t -96.25 84.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.133 0.492 . . . . 0.0 110.4 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 23.5 t -82.44 117.57 22.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 46' ' ' ILE . 15.2 m -129.84 156.26 42.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.248 0.547 . . . . 0.0 111.618 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.0 119.53 21.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.23 2.75 14.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.2 -50.44 3.63 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.916 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.94 -35.97 80.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.019 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.554 ' O ' ' HE3' ' A' ' 88' ' ' LYS . . . 151.97 -31.48 0.89 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.885 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.562 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 33.5 mt-10 -71.6 161.06 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.066 0.46 . . . . 0.0 111.411 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -119.22 105.15 11.07 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.534 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 55.9 m -103.62 127.27 51.08 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.468 -173.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.8 ttpt -99.13 104.46 16.45 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.761 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 85.6 m-85 -71.43 95.99 1.43 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.656 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.024 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 34.6 tttm -81.9 78.2 8.64 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.426 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 74' ' ' LYS . 57.5 mt -82.61 101.94 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.306 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 38.4 ttp180 -74.22 21.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.535 0.683 . . . . 0.0 109.827 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.684 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.1 mttt 64.3 174.25 0.19 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.564 -174.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.964 ' HB2' ' HA ' ' A' ' 1' ' ' LEU . 2.2 t70 -77.39 43.44 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.937 0.398 . . . . 0.0 110.37 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.406 HG11 ' HG2' ' A' ' 54' ' ' ARG . 6.9 m -64.17 91.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.248 0.547 . . . . 0.0 110.884 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 76.55 -50.68 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.095 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 34.8 m -107.25 146.23 32.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.382 0.61 . . . . 0.0 111.27 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.583 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.0 Cg_endo -90.73 54.61 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.737 2.958 . . . . 0.0 113.915 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -145.46 149.17 34.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.775 0.322 . . . . 0.0 111.221 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.419 ' CG ' HG12 ' A' ' 72' ' ' ILE . 2.6 mpp? -81.66 102.16 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 9.5 p -57.85 -31.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.027 0.442 . . . . 0.0 111.288 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -125.08 148.05 16.67 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.062 -177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -173.81 54.14 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 96' ' ' TYR . 34.2 tptt -98.92 129.05 45.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.226 -168.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -89.79 115.12 26.89 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.603 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.494 ' HD2' ' OH ' ' A' ' 96' ' ' TYR . 40.9 mtt-85 -119.01 79.91 1.47 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.562 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 48.7 tttt -81.48 -25.71 35.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.606 -171.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -92.58 -55.71 3.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.089 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.02 137.08 32.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.987 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 19.2 t70 -135.73 108.83 7.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.27 0.557 . . . . 0.0 111.717 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.93 2.58 1.35 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.854 0.835 . . . . 0.0 109.27 173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -107.47 130.91 54.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.771 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.472 ' O ' ' HE3' ' A' ' 71' ' ' LYS . 6.6 m-20 -99.6 -10.98 21.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.527 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.32 89.15 1.52 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.537 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 1.024 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 15.1 m-30 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.383 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.961 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.961 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 7.8 t -94.33 84.4 4.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.165 0.482 . . . . 0.0 109.967 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.41 78.61 9.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.213 0.53 . . . . 0.0 109.874 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 2' ' ' ILE . 8.9 tp -151.98 87.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 122.085 0.945 . . . . 0.0 110.219 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.9 pt? -127.96 133.4 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.667 0.746 . . . . 0.0 111.705 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' A' ' 8' ' ' LEU . 10.6 t70 -95.9 -19.91 19.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 168.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.37 71.06 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.079 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.3 t70 63.46 31.24 15.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.126 0.965 . . . . 0.0 109.159 -175.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.741 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 31.5 tp 179.69 -174.08 0.23 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.741 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 34.8 tp -148.12 107.66 3.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -100.56 -14.3 18.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.919 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.1 -48.74 80.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.443 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.21 133.49 24.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.307 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.915 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 22.7 tp -153.74 142.02 20.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.343 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.915 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 36.4 mtmt 67.33 30.95 6.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.9 mt -66.31 129.36 94.18 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 52.4 Cg_exo -57.11 -62.7 0.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 123.59 2.86 . . . . 0.0 112.181 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.696 HG23 ' HG3' ' A' ' 48' ' ' LYS . 8.7 p -146.42 145.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.266 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.547 HG13 ' HA ' ' A' ' 50' ' ' SER . 2.3 mt -119.05 163.12 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.948 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -54.3 140.78 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -67.98 -25.55 65.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.039 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.9 tp -68.06 -45.26 74.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.422 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 79.2 t80 -59.9 -37.07 78.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.473 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -67.64 -51.24 37.28 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.419 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.4 mptp? -51.9 -35.28 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 1.4 mm-40 -59.86 -60.04 4.47 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.463 172.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 63.7 mt -47.89 -56.36 7.71 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.889 0.852 . . . . 0.0 110.62 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.655 HD11 HG11 ' A' ' 58' ' ' VAL . 8.0 mp -63.39 -28.26 69.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.578 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 t70 -62.99 -43.15 99.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.536 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -66.11 -21.19 66.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.961 0.41 . . . . 0.0 110.303 177.174 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.961 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 65.9 m-85 -107.43 2.64 24.45 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -50.99 -44.5 60.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -69.88 -35.61 74.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.748 0.309 . . . . 0.0 110.79 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.73 -45.14 65.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.759 0.79 . . . . 0.0 109.794 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.576 HG22 ' HB ' ' A' ' 39' ' ' VAL . 91.9 mt -61.18 -40.28 85.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.656 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.624 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 27.7 ttpp -78.8 -21.38 47.86 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 110.13 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.75 -48.31 16.95 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HE2' ' HE3' ' A' ' 81' ' ' MET . 9.7 mtpp -81.87 -34.97 29.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -124.27 -26.44 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 64.85 1.92 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.993 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.624 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -133.34 150.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 122.309 0.244 . . . . 0.0 110.814 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.7 119.53 39.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.91 170.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 26' ' ' LEU . 53.7 p -75.21 -19.47 59.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.981 -175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -67.99 -43.09 79.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.064 0.459 . . . . 0.0 110.192 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -82.46 -35.28 27.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 60' ' ' VAL . 18.6 tp -50.79 121.5 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.782 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 44.6 tttp -90.8 114.44 26.83 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.812 -171.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.607 ' HA ' HG12 ' A' ' 60' ' ' VAL . 18.0 mt -87.18 125.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.352 0.596 . . . . 0.0 111.361 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.5 mt -100.72 -54.44 2.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.166 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.696 ' HG3' HG23 ' A' ' 16' ' ' VAL . 59.8 tttm -139.41 93.45 2.68 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.487 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -74.64 137.53 42.29 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.547 ' HA ' HG13 ' A' ' 17' ' ' ILE . 4.5 p -171.11 -169.31 0.73 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 118.218 0.463 . . . . 0.0 110.962 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.593 ' OE2' ' HA ' ' A' ' 12' ' ' LEU . 7.2 pt-20 -165.45 168.14 16.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.553 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 39.0 t70 -145.68 -76.38 0.21 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 0.0 111.337 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HG3' ' OD2' ' A' ' 52' ' ' ASP . 56.5 mttp -113.01 82.27 1.63 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.961 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.502 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 66.7 mtt180 72.13 -27.88 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.964 0.506 . . . . 0.0 112.163 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 53' ' ' LYS . 9.6 m-85 -97.11 139.2 33.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.707 0.289 . . . . 0.0 111.361 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.7 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.3 m-85 -82.52 147.83 28.44 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.776 170.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.624 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 58.9 m-85 -131.36 99.83 4.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.163 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.655 HG11 HD11 ' A' ' 26' ' ' LEU . 27.6 t -103.46 93.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.2 m -73.71 120.82 19.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.1 m -130.34 160.17 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.619 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 7.0 t0 -85.23 117.0 23.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.83 -1.7 7.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.74 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.28 60.61 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -121.27 5.45 10.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.305 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.85 -20.24 51.11 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 45.3 mt-10 -63.28 129.53 40.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.561 0.344 . . . . 0.0 111.035 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.662 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 55.0 mtpt -95.75 86.0 4.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 0.0 109.894 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.969 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 69.4 m -85.79 118.22 25.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.035 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.624 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 36.4 ttmt -92.34 107.2 19.04 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.573 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 30.8 m-85 -73.65 120.98 19.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.211 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.795 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 85.4 tttt -103.92 90.66 3.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.509 -173.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.7 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 64.4 mt -86.71 115.35 27.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.963 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.809 ' H ' ' HA ' ' A' ' 81' ' ' MET . 36.0 ttt180 -85.73 38.21 0.74 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.031 0.443 . . . . 0.0 109.992 -174.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.549 ' HB2' HG12 ' A' ' 76' ' ' VAL . 52.2 mttt 37.24 -152.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.522 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 22.4 t70 -97.89 17.97 16.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 74' ' ' LYS . 2.5 p -73.87 94.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.816 0.817 . . . . 0.0 109.176 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 25.2 t70 84.49 -67.44 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.342 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 35.9 m -90.75 149.16 39.95 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -90.44 34.85 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.218 2.612 . . . . 0.0 111.084 173.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -148.46 -166.15 2.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.426 0.631 . . . . 0.0 111.251 -168.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.809 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 20.7 ptt? -111.35 126.7 55.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.123 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.624 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 7.7 p -59.72 -37.2 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.886 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.38 -157.81 13.2 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.426 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -176.54 102.58 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -174.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.67 ' HD2' ' HA ' ' A' ' 96' ' ' TYR . 50.4 mttt -120.49 121.45 38.5 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.969 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 2.5 m -76.17 116.68 17.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.504 ' NH2' ' HA ' ' A' ' 91' ' ' ASP . 16.2 mtp180 -128.1 81.17 2.01 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.662 ' HA ' ' HB2' ' A' ' 67' ' ' LYS . 42.8 tttm -77.82 -22.17 50.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.39 -169.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -107.36 59.65 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.799 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.8 t70 69.91 155.57 0.14 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.917 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.504 ' HA ' ' NH2' ' A' ' 87' ' ' ARG . 11.9 p-10 -131.51 130.55 42.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.422 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.46 -75.01 0.51 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.307 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -105.69 169.96 8.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.608 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -90.28 -99.81 0.1 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.51 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 54.07 81.72 0.06 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.535 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.795 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 6.6 m-30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.894 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.6 ' HA2' ' HB2' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.711 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -106.12 -48.24 3.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.955 0.377 . . . . 0.0 111.821 -177.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 3' ' ' LEU . 24.1 mt 72.95 -23.96 0.2 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 2' ' ' ILE . 7.7 tp -81.07 25.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.818 0.818 . . . . 0.0 111.603 -170.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.808 HD11 ' H ' ' A' ' 8' ' ' LEU . 9.4 tp 179.51 176.88 0.61 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -147.6 40.54 1.01 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.498 0.666 . . . . 0.0 109.546 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.52 ' HA2' ' H ' ' A' ' 77' ' ' ASP . . . 69.36 16.89 71.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.345 -174.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 11.7 p-10 -96.75 -37.91 10.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.546 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.806 HD11 ' HG3' ' A' ' 54' ' ' ARG . 4.4 mm? 73.98 88.83 0.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.595 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.808 ' H ' HD11 ' A' ' 3' ' ' LEU . 71.8 mt -71.92 -16.69 62.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.827 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 34.2 mmtp 68.48 -74.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.795 -173.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -120.84 126.41 50.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.516 ' HD3' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -94.89 -37.26 11.27 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.99 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 13' ' ' LYS . 2.6 pp -120.44 -34.17 3.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.83 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.552 ' N ' HD12 ' A' ' 12' ' ' LEU . 19.2 ttpp 53.38 46.32 26.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.694 0.759 . . . . 0.0 110.966 175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 12' ' ' LEU . 93.3 mt -105.3 172.3 4.15 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.25 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 51.1 Cg_exo -58.94 -156.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.149 2.566 . . . . 0.0 111.591 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 48' ' ' LYS . 7.8 p -56.04 126.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.746 0.784 . . . . 0.0 109.93 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.639 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 3.3 mt -86.76 152.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.077 -173.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.53 139.49 25.27 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.687 0.617 . . . . 0.0 111.24 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 25.8 p-10 -66.32 -30.05 70.38 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.066 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -63.37 -45.34 91.57 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.242 0.339 . . . . 0.0 110.428 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 88.6 t80 -59.95 -42.14 93.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -62.63 -49.71 70.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.355 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 29.6 mmmt -54.35 -33.37 58.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.667 0.387 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 7.3 mm-40 -60.63 -54.25 47.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.99 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.595 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 10.8 mp -52.88 -60.0 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.697 HD11 HG11 ' A' ' 58' ' ' VAL . 9.4 mp -60.41 -24.6 65.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.565 -173.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.05 -46.97 69.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 82.4 mttt -72.56 -28.65 62.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.18 0.514 . . . . 0.0 110.344 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.711 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 64.0 m-85 -88.97 -3.28 58.78 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.454 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -54.65 -48.9 71.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.581 0.229 . . . . 0.0 111.085 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.93 -33.97 75.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 80' ' ' LYS . 4.7 t70 -71.15 -50.38 33.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.963 0.887 . . . . 0.0 109.843 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.688 HG21 ' HE1' ' A' ' 70' ' ' PHE . 62.7 mt -65.04 -30.96 51.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 48.3 tttm -84.71 -30.91 24.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.05 -51.27 69.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.253 0.549 . . . . 0.0 110.002 171.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -71.26 -58.95 3.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.363 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -107.28 -36.68 6.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.433 -170.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 34' ' ' LYS . . . 103.95 29.33 5.55 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.785 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 41' ' ' THR . 6.9 t -95.36 142.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.1 t70 -105.14 7.49 33.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.451 0.643 . . . . 0.0 110.949 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.612 ' H ' HG12 ' A' ' 39' ' ' VAL . 70.6 p 55.71 -13.78 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 49.1 mtpt -58.65 -36.67 74.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.098 0.408 . . . . 0.0 111.946 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -74.58 -32.37 62.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.317 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.62 115.88 3.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.721 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.736 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 42.9 tttm -92.25 108.86 20.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.01 171.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.597 ' HA ' HG12 ' A' ' 60' ' ' VAL . 41.6 mt -72.25 119.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.493 0.663 . . . . 0.0 111.664 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 61' ' ' ASP . 12.5 mt -91.44 -42.49 10.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.013 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HG3' HG23 ' A' ' 16' ' ' VAL . 63.5 tttm -156.04 104.77 2.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.922 -174.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.639 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 6.4 m -89.39 132.42 34.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -155.94 173.67 16.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.8 150.33 52.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.423 0.63 . . . . 0.0 110.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -133.02 -174.02 3.36 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.252 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -66.68 113.3 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.806 ' HG3' HD11 ' A' ' 7' ' ' LEU . 24.9 ttt180 75.84 -17.04 0.54 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.729 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.445 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 40.1 m-85 -122.23 147.77 45.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 112.231 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.653 ' HD1' ' HG2' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -106.81 150.79 25.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.113 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.548 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 89.4 m-85 -134.54 107.15 7.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 26' ' ' LEU . 21.9 t -108.59 96.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.397 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 18.1 t -76.45 130.69 38.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 46' ' ' ILE . 28.8 m -140.58 152.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.206 0.527 . . . . 0.0 111.879 -174.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.3 t70 -76.56 105.86 7.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.99 34.4 1.93 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 167.55 -96.63 0.13 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.079 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -137.39 -4.73 1.84 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.799 0.333 . . . . 0.0 110.688 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.02 -29.63 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.653 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.644 ' HG2' ' HD3' ' A' ' 88' ' ' LYS . 47.0 mt-10 -68.41 122.38 18.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.352 0.596 . . . . 0.0 111.001 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 96.2 mttt -101.31 106.69 17.9 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.024 -174.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 4.4 t -99.86 178.04 4.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.622 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.8 ttmt -156.87 113.04 2.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.688 ' HE1' HG21 ' A' ' 33' ' ' ILE . 14.3 m-85 -80.42 114.17 19.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.129 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.081 ' HD2' ' HB3' ' A' ' 96' ' ' TYR . 82.5 tttt -87.98 89.17 7.89 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.746 0.784 . . . . 0.0 109.733 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.414 HG23 ' CE1' ' A' ' 29' ' ' PHE . 51.3 mt -81.77 100.02 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.624 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 24.2 ttp180 -68.29 100.93 1.11 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.653 ' HG2' ' HD1' ' A' ' 56' ' ' TYR . 86.0 mttt -47.19 124.59 6.74 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 124.033 0.833 . . . . 0.0 110.69 -172.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 4.6 t70 -23.94 81.77 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.53 1.769 . . . . 0.0 112.9 -170.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.553 HG23 HD21 ' A' ' 7' ' ' LEU . 6.0 p -107.51 106.82 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.439 -171.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.52 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 5.0 m-20 71.65 -58.97 0.56 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.697 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.515 ' HB ' ' HD2' ' A' ' 79' ' ' PRO . 13.2 m -122.53 164.08 28.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.218 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HB2' ' HA2' ' A' ' -1' ' ' GLY . 23.5 Cg_endo -91.6 104.45 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.163 2.575 . . . . 0.0 113.227 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 9.0 mtmt -179.87 162.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.589 . . . . 0.0 111.698 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.4 ttp -92.15 142.61 27.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.439 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.624 ' HB ' ' HD3' ' A' ' 73' ' ' ARG . 3.6 p -73.33 -53.79 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.651 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 96' ' ' TYR . . . -155.71 159.14 29.04 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.327 -173.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 84' ' ' ARG . 10.6 ttp180 -125.21 95.81 4.61 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.615 ' HB2' ' OXT' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -114.57 112.0 22.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.26 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 11.2 m -80.97 138.13 36.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 91' ' ' ASP . 15.9 ptm180 -132.94 65.95 1.58 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.842 0.83 . . . . 0.0 109.509 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.644 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 3.0 ttpm? -63.26 -22.38 66.83 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.355 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -124.28 -76.3 0.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.98 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -125.6 166.49 16.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.654 ' HB2' ' HE2' ' A' ' 96' ' ' TYR . 10.3 p-10 -111.95 -166.65 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.075 0.464 . . . . 0.0 111.508 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.54 -171.9 1.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.505 -173.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.39 -79.49 0.1 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -138.17 -22.71 1.03 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.14 74.74 0.18 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 1.081 ' HB3' ' HD2' ' A' ' 71' ' ' LYS . 26.1 t80 . . . . . 0 N--CA 1.443 -0.786 0 CA-C-O 117.794 -1.098 . . . . 0.0 108.298 -171.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 34.4 t -87.45 96.77 10.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.23 0.538 . . . . 0.0 110.033 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 38.1 mt -101.54 26.12 7.66 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.611 HG22 ' HG ' ' A' ' 3' ' ' LEU . 1.8 mp -69.32 -31.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.614 -175.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.796 HD13 ' HA ' ' A' ' 6' ' ' ASP . 77.9 mt -132.39 178.01 7.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.101 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -126.23 73.29 1.36 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.78 36.29 37.44 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.555 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.796 ' HA ' HD13 ' A' ' 3' ' ' LEU . 33.3 t70 69.55 97.03 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.493 0.663 . . . . 0.0 112.164 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.541 ' H ' HD22 ' A' ' 3' ' ' LEU . 93.6 mt -126.87 70.98 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.696 HD11 ' HB2' ' A' ' 54' ' ' ARG . 79.1 mt -64.27 -62.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.944 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 52.87 -99.98 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.89 0.744 . . . . 0.0 110.581 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.06 88.86 4.62 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.321 0.581 . . . . 0.0 109.8 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.718 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -104.4 165.1 11.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.934 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt 59.9 93.67 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.83 0.706 . . . . 0.0 109.229 -174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.33 -153.92 0.41 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.831 -174.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.5 mt -52.48 148.61 12.04 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.54 134.84 54.1 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.993 2.462 . . . . 0.0 111.832 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 48' ' ' LYS . 5.6 p 39.87 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 123.14 1.448 . . . . 0.0 112.688 -171.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.508 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 57.5 mt -68.6 156.32 7.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.431 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -49.74 138.19 14.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -71.25 -19.46 62.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.248 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.39 -45.64 37.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.057 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.481 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 81.4 t80 -58.78 -40.46 84.07 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -63.08 -47.63 86.91 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.127 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -38.55 69.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.25 -47.56 83.2 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.9 mt -56.93 -58.5 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.562 0.696 . . . . 0.0 110.171 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.813 HD11 HG11 ' A' ' 58' ' ' VAL . 9.1 mp -58.8 -34.66 71.73 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.835 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.43 -34.0 74.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.438 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -72.58 -26.96 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.26 3.25 29.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.546 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.41 -50.31 59.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.53 0.732 . . . . 0.0 111.852 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.61 -41.92 82.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.11 -39.7 68.69 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.658 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 94.8 mt -69.42 -20.8 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.51 0.671 . . . . 0.0 110.486 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.5 tttp -89.77 -33.13 16.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.499 0.666 . . . . 0.0 109.882 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.46 -45.04 77.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.311 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.26 -15.35 41.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.475 -173.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.514 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 77.3 m-85 -140.17 -57.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.414 0.626 . . . . 0.0 109.78 177.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 123.38 35.46 0.7 Allowed Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.367 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 41' ' ' THR . 2.8 t -108.27 146.39 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.989 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -98.04 8.91 44.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.621 0.724 . . . . 0.0 110.259 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.643 ' H ' HG12 ' A' ' 39' ' ' VAL . 71.4 p 59.0 -33.69 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.084 1.754 . . . . 0.0 115.253 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -62.83 -29.36 70.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.2 0.524 . . . . 0.0 110.477 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.09 -14.81 60.62 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.185 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.535 HD21 HG11 ' A' ' 39' ' ' VAL . 63.9 mt -81.64 125.0 30.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.292 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG2' HD23 ' A' ' 47' ' ' LEU . 58.3 tttp -81.47 101.21 9.75 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.56 ' HA ' HG12 ' A' ' 60' ' ' VAL . 57.2 mt -69.98 113.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 45' ' ' LYS . 26.1 mt -85.07 -40.05 17.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.583 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HA ' HG23 ' A' ' 16' ' ' VAL . 24.9 ttpp -160.38 103.56 1.42 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.452 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 9.3 m -76.61 122.14 24.21 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.8 m -157.3 -172.29 3.94 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.935 -0.478 . . . . 0.0 110.624 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.49 178.77 8.51 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -112.53 -84.13 0.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.718 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 27.8 mtmm -140.66 107.74 5.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 167.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.792 ' HG3' HG11 ' A' ' 76' ' ' VAL . 35.6 ttm180 78.1 -18.15 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.734 0.646 . . . . 0.0 111.463 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.44 123.55 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 5.4 m-85 -78.13 148.51 34.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.796 0.332 . . . . 0.0 110.409 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.602 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 75.5 m-85 -134.12 94.62 3.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.753 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.813 HG11 HD11 ' A' ' 26' ' ' LEU . 19.3 t -89.06 95.38 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.505 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB2' ' N ' ' A' ' 48' ' ' LYS . 74.2 m -60.08 128.54 37.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.003 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 46' ' ' ILE . 34.8 m -147.57 153.5 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.43 0.634 . . . . 0.0 111.589 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.87 130.73 48.41 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 169.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.751 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -92.44 5.09 52.03 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.152 -173.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.97 -19.23 50.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.646 170.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.639 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 32.9 t70 -103.29 18.92 20.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.88 -22.33 12.15 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.751 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 7.0 pt-20 -70.95 150.48 45.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.16 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.594 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 70.1 mmtt -122.26 151.51 41.0 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -175.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 24.0 t -146.58 170.83 16.11 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.3 ttpt -157.51 89.43 1.04 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CD1' ' HG2' ' A' ' 84' ' ' ARG . 83.7 m-85 -53.81 112.16 0.88 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.941 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.632 ' HD3' ' HB3' ' A' ' 96' ' ' TYR . 54.7 tttt -84.92 80.66 9.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.921 0.867 . . . . 0.0 109.385 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 77.5 mt -77.27 102.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.726 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HB2' HG12 ' A' ' 82' ' ' VAL . 46.4 ttt180 -71.63 111.96 7.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.599 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 91.7 mttt -57.16 160.12 3.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.353 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 0' ' ' SER . 17.9 t70 -67.37 74.09 0.14 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.66 0.743 . . . . 0.0 109.705 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.792 HG11 ' HG3' ' A' ' 54' ' ' ARG . 35.6 m -98.75 -4.29 9.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.615 0.722 . . . . 0.0 110.074 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 175.3 -62.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.287 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 79' ' ' PRO . 11.2 p -96.9 137.62 21.33 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.478 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 78' ' ' VAL . 45.8 Cg_endo -83.38 42.25 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.591 2.861 . . . . 0.0 112.645 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -137.88 140.59 40.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.228 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.45 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 4.6 tmm? -65.09 123.65 20.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.033 170.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.533 HG12 ' HB2' ' A' ' 73' ' ' ARG . 14.5 p -79.47 -38.56 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 0.0 111.634 -173.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 84' ' ' ARG . . . -144.52 179.45 21.73 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.954 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.514 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -153.72 93.55 1.68 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.405 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.76 ' HA ' ' CD1' ' A' ' 96' ' ' TYR . 22.1 tptm -73.91 60.82 0.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.78 0.8 . . . . 0.0 112.317 -166.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -104.5 111.0 23.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.619 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 19.9 mmt180 -109.61 17.63 21.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.892 0.853 . . . . 0.0 109.785 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.594 ' HG3' ' H ' ' A' ' 67' ' ' LYS . 43.7 mmtm -75.41 -10.24 59.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.284 -1.325 . . . . 0.0 108.633 168.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -114.79 -144.95 0.39 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.223 -1.353 . . . . 0.0 107.625 172.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.31 144.09 42.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.905 0.383 . . . . 0.0 111.135 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.619 ' HA ' ' HD2' ' A' ' 87' ' ' ARG . 30.9 t70 -118.92 21.97 12.16 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.425 0.631 . . . . 0.0 111.674 -173.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -127.86 125.23 39.32 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.536 -0.728 . . . . 0.0 111.369 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -155.02 175.88 13.25 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.14 -15.21 14.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.981 0.419 . . . . 0.0 110.024 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -96.05 -85.19 1.72 Allowed Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.543 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.76 ' CD1' ' HA ' ' A' ' 85' ' ' LYS . 6.3 p90 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.171 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.595 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 40.4 t -141.39 99.63 3.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 1' ' ' LEU . 0.6 OUTLIER -99.56 109.77 22.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.348 0.594 . . . . 0.0 112.053 -172.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.519 HG23 ' HB3' ' A' ' 74' ' ' LYS . 8.4 tp -173.12 84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.998 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.908 ' HG ' ' H ' ' A' ' 4' ' ' ASP . 1.2 pt? -122.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.177 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.908 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 8.7 m-20 57.64 19.01 5.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.685 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 7' ' ' LEU . . . 111.9 42.94 0.98 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.479 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.22 25.89 11.57 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 5' ' ' GLY . 96.0 mt -137.9 166.21 24.61 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 111.332 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.414 HD22 HG12 ' A' ' 2' ' ' ILE . 35.2 tp -178.73 -93.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.737 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.3 mttt 55.82 33.11 20.88 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -76.08 -59.62 2.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 110.476 -174.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.94 35.27 1.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.675 0.75 . . . . 0.0 110.263 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.639 HD23 ' HE3' ' A' ' 13' ' ' LYS . 29.5 tp -70.63 170.14 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.098 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.639 ' HE3' HD23 ' A' ' 12' ' ' LEU . 1.9 mptt 70.09 15.61 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.348 0.659 . . . . 0.0 111.491 176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.64 139.47 20.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.094 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.39 -56.49 0.66 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 122.521 2.147 . . . . 0.0 110.358 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 48' ' ' LYS . 13.5 p -128.86 128.13 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.461 -1.7 . . . . 0.0 109.898 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 18' ' ' ASP . 24.5 mt -89.61 177.25 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.258 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.577 ' H ' HG22 ' A' ' 17' ' ' ILE . 4.0 m-20 -50.67 120.24 4.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.492 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -73.21 -36.93 66.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.01 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 68.0 t80 -62.86 -43.96 97.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.563 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -61.58 -45.95 95.28 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 173.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -52.26 -43.93 64.64 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.0 109.915 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.87 -39.89 93.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.227 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 16.9 mt -60.02 -60.12 4.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 58' ' ' VAL . 8.1 mp -60.13 -32.6 71.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.819 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.97 -49.33 77.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.935 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -67.0 -50.48 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.313 0.577 . . . . 0.0 110.291 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.595 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 5.7 m-85 -83.2 13.4 4.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.675 -173.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 40' ' ' ASP . 36.6 tt0 -61.82 -36.28 80.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.76 -35.02 76.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.126 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.647 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 20.7 t70 -74.3 -44.6 51.96 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.16 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' HB ' ' A' ' 39' ' ' VAL . 66.2 mt -69.11 -26.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.406 0.622 . . . . 0.0 110.773 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 54.0 tttp -83.29 -28.93 28.76 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -69.22 -43.14 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.904 170.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.647 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 63.2 mttm -67.85 -47.92 67.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.285 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.663 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 44.0 m-85 -128.4 -56.68 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.481 0.658 . . . . 0.0 110.889 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 34' ' ' LYS . . . 117.42 62.35 0.31 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.789 -170.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG23 ' HB2' ' A' ' 37' ' ' TYR . 45.9 t -124.33 154.59 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.808 0.337 . . . . 0.0 111.143 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.576 ' HA ' HE21 ' A' ' 30' ' ' GLN . 16.4 t70 -105.15 123.38 47.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.564 173.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 24.6 p -88.03 -14.61 38.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.001 0.429 . . . . 0.0 111.725 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -79.76 -7.21 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.951 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -99.76 -21.85 15.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.681 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.1 mt -73.87 124.43 26.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.652 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 82.6 tttt -83.95 112.79 20.48 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.586 ' HA ' HG12 ' A' ' 60' ' ' VAL . 35.4 mt -79.88 116.54 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.692 0.758 . . . . 0.0 111.171 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.6 mt -85.35 -51.02 6.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.39 -176.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HA ' HG23 ' A' ' 16' ' ' VAL . 39.4 ttpt -146.06 111.13 5.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.827 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.3 m -96.0 127.53 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -146.51 163.56 35.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -132.33 161.53 33.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 110.239 172.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.21 -157.91 0.81 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 54' ' ' ARG . 51.2 mttp -72.13 103.17 3.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.679 ' HG2' HG11 ' A' ' 76' ' ' VAL . 53.0 mtt180 74.27 -14.4 0.7 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.695 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -109.85 149.33 30.02 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.947 -0.471 . . . . 0.0 111.984 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 51' ' ' GLU . 2.6 m-85 -116.58 150.4 38.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.738 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.6 m-85 -128.71 103.42 7.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.373 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.729 HG21 HD11 ' A' ' 26' ' ' LEU . 13.3 t -106.16 94.64 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.709 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -79.96 118.8 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -130.48 155.67 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.653 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.512 ' HB2' HD21 ' A' ' 47' ' ' LEU . 36.2 t70 -86.67 103.66 15.34 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -64.71 -26.81 68.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.826 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.43 -23.95 13.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.97 -0.634 . . . . 0.0 111.731 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 25.9 t70 -81.59 -22.7 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.405 0.621 . . . . 0.0 110.21 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.95 -32.33 3.65 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 4.6 pt-20 -62.93 136.26 57.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.637 -0.782 . . . . 0.0 111.842 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 89' ' ' ASP . 51.7 mtpt -100.38 93.09 5.48 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.914 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 79.8 m -89.25 132.27 34.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.06 0.457 . . . . 0.0 110.586 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.838 ' HE3' ' HB2' ' A' ' 92' ' ' ASP . 22.8 ttmm -109.18 94.26 4.95 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.301 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 80.1 m-85 -63.4 100.0 0.23 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.923 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.072 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 25.0 tttm -80.69 83.26 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.994 0.902 . . . . 0.0 109.047 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.872 ' HA ' ' HB2' ' A' ' 81' ' ' MET . 70.0 mt -77.71 93.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.434 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.577 ' HB2' HG12 ' A' ' 82' ' ' VAL . 30.4 ttt180 -63.52 123.8 19.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 2' ' ' ILE . 39.6 mttt -59.56 169.08 1.39 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.798 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.721 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 9.9 t0 -72.06 78.36 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.229 1.014 . . . . 0.0 108.904 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.679 HG11 ' HG2' ' A' ' 54' ' ' ARG . 6.4 m -106.11 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.106 174.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.0 t70 84.74 -46.01 0.08 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.891 -175.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.96 146.24 61.27 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 111.119 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HB3' ' OD2' ' A' ' 75' ' ' ASP . 34.1 Cg_endo -92.18 86.17 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.634 2.889 . . . . 0.0 114.138 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -164.69 161.52 20.8 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.01 -0.431 . . . . 0.0 111.329 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.872 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 2.4 ptp -88.1 119.2 28.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.577 HG12 ' HB2' ' A' ' 73' ' ' ARG . 7.7 p -60.4 -38.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.916 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.06 -177.68 26.88 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.952 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.663 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -164.25 42.8 0.09 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.846 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 74.7 mttt -60.83 121.98 13.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.612 -172.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.914 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.4 m -83.21 113.03 20.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.478 ' HD3' ' OH ' ' A' ' 96' ' ' TYR . 17.9 mtp180 -117.38 85.59 2.36 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 67' ' ' LYS . 4.8 ttpm? -80.02 109.63 14.65 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.754 -170.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.617 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 7.7 t70 66.87 -156.98 0.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 O-C-N 124.116 0.885 . . . . 0.0 109.763 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 11.2 m-20 63.2 -95.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -170.64 149.59 3.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.838 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 11.4 p-10 -110.7 128.95 55.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.382 0.611 . . . . 0.0 111.512 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.513 ' HB3' ' H ' ' A' ' 94' ' ' ASP . 3.7 m-20 -103.41 -155.35 0.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.776 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.513 ' H ' ' HB3' ' A' ' 93' ' ' ASP . 3.7 m-20 -118.49 171.56 8.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.284 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' C ' ' HD2' ' A' ' 96' ' ' TYR . . . 85.98 69.59 1.34 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.662 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 1.072 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.854 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 112.194 -0.363 . . . . 0.0 112.194 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.784 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 34.2 p -149.99 -32.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.612 0.206 . . . . 0.0 110.86 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 0' ' ' SER . 0.5 OUTLIER 45.97 23.58 0.19 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.766 1.227 . . . . 0.0 113.326 175.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.604 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 10.5 tp -117.02 39.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.012 0.91 . . . . 0.0 110.55 -171.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.822 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 2.5 pt? -92.96 -40.09 10.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.691 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 12.6 t70 66.57 -60.41 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.97 0.794 . . . . 0.0 110.015 -169.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 54.88 0.24 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.105 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.609 ' HA ' HG12 ' A' ' 76' ' ' VAL . 41.3 m-20 49.84 34.91 8.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.748 0.419 . . . . 0.0 111.476 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.582 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 27.8 tp -141.84 176.57 8.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.64 0.257 . . . . 0.0 110.362 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.582 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 6.2 mp -73.83 -59.33 2.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.22 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp 63.64 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.229 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -126.21 106.7 9.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.217 0.532 . . . . 0.0 110.042 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 3.3 ptmm? -118.09 -163.42 0.94 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.358 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.5 mt -41.46 115.95 0.7 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -130.63 21.15 5.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.53 168.03 13.3 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.722 -172.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -69.77 -153.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.471 0.162 0 C-N-CA 123.637 2.892 . . . . 0.0 111.856 167.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.682 HG23 ' HG3' ' A' ' 48' ' ' LYS . 5.4 p -51.17 124.31 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.886 0.85 . . . . 0.0 111.147 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.547 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 11.9 mt -79.93 151.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.916 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.8 152.47 35.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.209 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -64.12 -25.62 68.18 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.813 -178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.64 -46.67 88.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.17 0.188 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 87.0 t80 -59.79 -38.6 82.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -65.52 -49.86 58.12 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 12.9 mmmm -56.81 -28.67 61.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 14.3 mm-40 -68.85 -52.63 27.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 173.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 43.8 mt -53.69 -62.49 1.62 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.621 0.724 . . . . 0.0 110.096 175.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD11 HG11 ' A' ' 58' ' ' VAL . 9.5 mp -59.08 -28.37 66.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.55 -173.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 13.1 t70 -75.24 -46.93 30.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.09 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 66.5 mttm -57.51 -35.74 70.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.303 0.573 . . . . 0.0 110.558 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.784 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 2.4 m-85 -106.1 12.27 30.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.271 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -60.21 -41.33 92.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 -179.325 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.89 -32.38 73.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' HD3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -73.4 -48.06 36.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.358 0.599 . . . . 0.0 110.153 177.406 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.665 HG12 ' HE1' ' A' ' 81' ' ' MET . 72.0 mt -59.76 -41.48 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.559 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.5 tttt -79.94 -29.59 39.74 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.914 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.88 -50.37 66.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.564 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -76.73 -57.58 3.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.453 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 39' ' ' VAL . 20.7 m-85 -102.32 -27.37 12.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -169.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.33 52.96 3.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.636 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 33' ' ' ILE . 21.9 t -118.3 149.14 20.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.518 0.199 . . . . 0.0 110.598 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.41 106.09 14.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.534 ' HA ' HD22 ' A' ' 44' ' ' LEU . 65.6 p -65.69 -16.66 63.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -173.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.3 ttpp -72.06 -23.03 61.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -94.3 -5.98 45.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.767 0.794 . . . . 0.0 109.632 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 41' ' ' THR . 5.1 mp -83.29 138.35 33.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.112 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.55 109.73 22.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.612 ' HA ' HG12 ' A' ' 60' ' ' VAL . 40.9 mt -79.33 116.96 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 110.877 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.439 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 8.1 mt -85.78 -47.32 9.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.086 -175.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.682 ' HG3' HG23 ' A' ' 16' ' ' VAL . 37.7 ttmt -149.6 108.08 3.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.481 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.547 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 13.5 m -85.0 125.39 32.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.3 m -156.55 -170.94 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.464 ' OE2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -156.11 -176.61 6.05 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.69 ' HB3' ' HE2' ' A' ' 57' ' ' TYR . 14.7 t70 -165.45 93.38 0.58 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HG3' HD21 ' A' ' 8' ' ' LEU . 12.4 mptt 68.21 -107.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.921 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.539 ' HG2' HG11 ' A' ' 76' ' ' VAL . 48.0 mtt180 -91.93 19.55 6.56 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.931 -0.481 . . . . 0.0 111.32 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 76.2 m-85 -138.83 140.67 38.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 -173.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.873 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m-85 -100.3 144.08 29.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 166.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.699 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 71.0 m-85 -129.8 96.32 4.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.706 HG11 HD11 ' A' ' 26' ' ' LEU . 5.6 t -104.43 96.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.4 t -74.39 114.61 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 46' ' ' ILE . 12.9 m -133.13 163.93 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.236 0.541 . . . . 0.0 111.368 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.96 127.14 48.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.97 33.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -173.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.09 -46.3 3.06 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.581 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.54 -38.18 68.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.304 0.573 . . . . 0.0 110.934 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -21.85 2.46 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.339 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 8.7 pt-20 -79.38 145.8 33.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 110.804 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' H ' ' CG ' ' A' ' 88' ' ' LYS . 46.6 mttp -113.96 116.34 29.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.527 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.5 m -117.94 124.96 49.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.824 -171.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.699 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 6.1 tppt? -85.12 96.24 9.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.77 113.5 3.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.309 0.576 . . . . 0.0 110.185 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.737 ' CD ' ' HA ' ' A' ' 96' ' ' TYR . 13.8 ttmm -93.0 80.72 4.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.622 -174.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.873 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 mt -77.68 76.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.642 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.535 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 70.8 ttt180 -53.26 125.79 18.83 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' A' ' 76' ' ' VAL . 96.3 mttt -59.79 171.0 0.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 123.458 0.474 . . . . 0.0 110.263 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 1.7 t70 -72.12 26.45 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.372 0.606 . . . . 0.0 110.694 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 6' ' ' ASP . 30.1 m -78.65 123.12 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.555 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 18.4 t70 70.58 -66.22 0.3 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.548 0.53 . . . . 0.0 111.232 -176.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.586 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 3.4 p -104.28 153.9 38.68 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.656 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.0 Cg_endo -76.32 148.05 29.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.092 1.861 . . . . 0.0 111.515 164.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 4.9 ptpt 73.47 -172.13 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.235 1.014 . . . . 0.0 113.126 167.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.665 ' HE1' HG12 ' A' ' 33' ' ' ILE . 15.5 mtm -77.23 126.89 31.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.178 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.535 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 7.1 p -59.46 -27.81 38.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.56 -161.64 35.36 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.325 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -157.09 151.16 24.83 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.564 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 14.0 tptp -145.25 106.01 4.13 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.942 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.1 m -77.32 111.0 12.52 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 170.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.621 ' HD3' ' CG ' ' A' ' 91' ' ' ASP . 31.2 mtt180 -93.74 29.32 2.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.992 0.425 . . . . 0.0 110.593 -169.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.555 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 12.0 mmmm -76.84 -30.01 56.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.965 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -130.6 -55.23 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.705 0.288 . . . . 0.0 111.229 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -116.18 126.76 54.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 111.454 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' CG ' ' HD3' ' A' ' 87' ' ' ARG . 17.7 t0 -131.7 86.02 2.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.169 0.509 . . . . 0.0 110.982 175.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -162.9 122.18 2.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.574 173.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.668 ' HB3' ' HB3' ' A' ' 96' ' ' TYR . 16.6 t70 -157.43 153.6 27.44 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -95.32 99.97 11.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.206 0.527 . . . . 0.0 109.916 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.5 -47.3 1.03 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -175.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.737 ' HA ' ' CD ' ' A' ' 71' ' ' LYS . 33.1 t80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.106 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.404 ' C ' ' HA ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.478 1.459 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.742 ' HB3' ' HA ' ' A' ' 75' ' ' ASP . 23.4 t -60.9 164.52 4.79 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 122.401 0.281 . . . . 0.0 110.997 -174.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 28' ' ' LYS . 72.9 mt -83.55 61.94 6.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.004 0.907 . . . . 0.0 112.425 -168.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 74' ' ' LYS . 15.7 tt -160.77 29.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.578 ' CD1' ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -72.22 135.46 46.08 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.464 -163.5 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.31 -18.56 16.03 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 165.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . 134.36 54.02 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.752 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 8.0 m-20 68.86 22.08 7.35 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -143.0 159.72 41.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.024 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.88 -66.52 1.08 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.643 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HB2' ' HZ2' ' A' ' 9' ' ' LYS . 9.6 mtmp? 66.05 17.11 10.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.86 0.838 . . . . 0.0 108.9 -169.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -152.11 69.39 0.89 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.074 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.61 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 38.5 pttt -49.08 -50.43 36.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.392 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.614 HD12 ' HG3' ' A' ' 51' ' ' GLU . 52.9 tp -153.16 119.08 5.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -169.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -85.67 -77.41 0.3 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.995 0.426 . . . . 0.0 111.362 -176.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 18.8 mt -136.76 176.65 2.63 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -173.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 32.4 Cg_exo -62.69 -147.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.788 2.992 . . . . 0.0 111.615 169.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 49' ' ' THR . 7.1 p -54.75 122.64 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.839 0.828 . . . . 0.0 110.053 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.77 HG13 ' HB ' ' A' ' 49' ' ' THR . 1.1 pt -108.06 -173.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.882 -171.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.86 134.16 37.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.74 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 31.1 p30 -72.88 -21.06 60.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.49 -40.23 57.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.151 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 25' ' ' LEU . 80.1 t80 -61.47 -47.07 87.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -62.64 -43.47 98.94 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.238 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 23.7 tptm -56.42 -36.77 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.306 0.242 . . . . 0.0 110.488 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 4.9 mm-40 -55.81 -53.8 52.29 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 10.2 mp -49.86 -59.01 4.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.276 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.727 HD11 HG11 ' A' ' 58' ' ' VAL . 9.2 mp -59.85 -42.17 93.07 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.964 -175.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.97 -33.41 74.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.999 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 22.0 mttp -64.64 -49.99 68.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.391 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' O ' HG13 ' A' ' 33' ' ' ILE . 58.3 m-85 -98.49 12.49 34.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.573 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.418 ' OE1' ' HE2' ' A' ' 42' ' ' LYS . 4.9 pt20 -59.87 -31.91 70.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.452 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.17 -34.52 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.16 -39.68 68.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.752 0.787 . . . . 0.0 109.013 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.595 HG22 ' HB ' ' A' ' 39' ' ' VAL . 92.3 mt -61.42 -43.41 96.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.234 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 24.7 ttpt -82.51 -29.71 30.28 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.669 -174.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.46 -55.81 13.89 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 174.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -79.55 -43.36 23.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.922 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.2 -10.09 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.534 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 68.8 41.2 83.88 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.627 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 33' ' ' ILE . 10.8 t -118.24 137.91 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 120.903 0.382 . . . . 0.0 111.113 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -103.47 116.24 32.03 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.467 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.4 p -70.42 -10.5 59.27 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -170.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HE2' ' OE1' ' A' ' 30' ' ' GLN . 66.6 mmtt -71.8 -22.85 61.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.937 0.399 . . . . 0.0 110.333 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.61 -31.23 15.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.463 0.649 . . . . 0.0 110.088 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 41' ' ' THR . 85.5 mt -58.49 126.94 29.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.865 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 57.2 tttm -92.4 106.07 18.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.474 174.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.661 ' HA ' HG12 ' A' ' 60' ' ' VAL . 42.7 mt -72.8 107.53 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.774 0.797 . . . . 0.0 110.565 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 61' ' ' ASP . 11.8 mt -80.78 -49.38 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.983 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 48.9 tttm -144.79 101.17 3.62 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.479 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.77 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.6 m -82.39 124.8 30.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.2 m -145.81 -179.78 6.93 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.137 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.614 ' HG3' HD12 ' A' ' 12' ' ' LEU . 7.9 pt-20 -155.45 174.17 15.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.514 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -150.91 -170.24 3.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -59.49 105.71 0.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 77.18 -9.27 1.55 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.804 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.6 m-85 -114.45 151.08 33.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.117 0.484 . . . . 0.0 111.798 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.813 ' HD1' ' HB3' ' A' ' 74' ' ' LYS . 2.8 m-85 -112.14 143.88 42.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.426 164.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.705 ' CE1' ' HA ' ' A' ' 96' ' ' TYR . 32.3 m-85 -131.92 111.67 11.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.413 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 26' ' ' LEU . 21.4 t -110.26 108.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -91.7 120.86 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 46' ' ' ILE . 13.0 m -128.72 154.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.572 ' HB2' HD21 ' A' ' 47' ' ' LEU . 60.1 t0 -90.6 114.67 26.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 169.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HA ' HD23 ' A' ' 44' ' ' LEU . . . -72.56 -14.35 61.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.46 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.34 -113.13 0.54 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.39 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.61 76.27 1.68 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 109.637 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.632 ' O ' ' HE2' ' A' ' 88' ' ' LYS . . . 138.2 -9.71 3.55 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.511 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -82.47 170.17 15.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.825 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 48.1 mtpt -160.54 107.86 1.56 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.842 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 14.7 t -129.66 138.09 51.0 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.701 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.592 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 31.3 ttmt -111.87 114.28 27.12 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -76.39 120.65 21.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.119 0.485 . . . . 0.0 109.947 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.789 ' HD2' ' HB2' ' A' ' 96' ' ' TYR . 79.2 tttt -94.01 94.6 8.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.075 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 60.3 mt -116.41 89.53 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.511 0.672 . . . . 0.0 109.926 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 48.7 ttt180 -63.43 99.09 0.19 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.978 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.813 ' HB3' ' HD1' ' A' ' 56' ' ' TYR . 12.1 ptpt -47.45 112.4 0.54 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.801 -173.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.742 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 15.0 t0 37.57 82.16 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.176 177.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.621 HG11 ' HG2' ' A' ' 73' ' ' ARG . 8.7 m -127.26 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.102 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 74.12 -69.18 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.48 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.9 p -86.88 141.94 33.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.058 0.456 . . . . 0.0 110.348 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 87.5 Cg_endo -79.72 86.94 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.11 2.54 . . . . 0.0 112.581 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 178.86 -175.72 0.22 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.407 0.623 . . . . 0.0 111.841 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 19.9 ptp -84.04 155.33 22.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.438 171.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.506 ' CG1' ' HG2' ' A' ' 71' ' ' LYS . 12.3 p -83.15 -26.04 7.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.91 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -179.86 -173.15 44.63 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.333 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 84' ' ' ARG . 34.7 ttt-85 -156.56 125.71 6.06 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.644 ' HB3' ' CE2' ' A' ' 96' ' ' TYR . 38.1 tttt -149.85 135.74 18.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 25.5 m -97.3 114.96 26.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.507 0.67 . . . . 0.0 111.238 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.566 ' HA ' ' HB3' ' A' ' 91' ' ' ASP . 15.2 ttt180 -101.08 77.77 1.85 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 -174.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.825 ' HA ' ' HB2' ' A' ' 67' ' ' LYS . 42.8 tttm -90.21 -45.41 9.1 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.426 -172.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.75 -79.94 0.61 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.426 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -132.1 78.71 1.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.059 0.457 . . . . 0.0 110.628 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.576 ' OD2' ' HG2' ' A' ' 85' ' ' LYS . 28.6 t70 -111.38 88.8 2.88 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.77 154.66 20.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.474 -168.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -163.56 177.86 8.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -76.4 -71.13 0.41 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 96' ' ' TYR . . . -81.14 179.64 53.48 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 168.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.789 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.363 -176.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 CA-C-O 120.41 -0.105 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 5.9 t -81.58 131.89 35.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -174.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 42.3 mt -133.46 12.86 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.674 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.81 HG13 HD22 ' A' ' 3' ' ' LEU . 8.2 tp -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.978 -166.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 7' ' ' LEU . 2.2 mm? 66.29 57.59 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.93 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.641 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 3.5 p-10 -60.26 -27.17 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.808 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.05 19.63 53.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.234 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.723 ' HA ' HG22 ' A' ' 76' ' ' VAL . 29.2 t70 61.18 75.0 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.783 0.801 . . . . 0.0 110.201 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.986 ' HB2' HD12 ' A' ' 3' ' ' LEU . 67.2 mt -130.97 158.0 41.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.193 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -110.29 -47.27 3.31 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.472 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 64.5 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.934 0.771 . . . . 0.0 110.398 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.84 113.92 14.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 2.8 ttpm? -65.16 -47.66 76.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.742 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.8 tt -146.45 117.58 7.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.572 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 88.8 tttt -88.49 -75.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.445 0.64 . . . . 0.0 111.651 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.572 ' HG ' ' HG2' ' A' ' 13' ' ' LYS . 94.2 mt -106.55 148.78 37.41 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -71.06 120.32 6.94 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 110.08 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.608 HG23 ' HA ' ' A' ' 48' ' ' LYS . 3.7 p 40.52 95.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.998 1.38 . . . . 0.0 112.721 -168.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.12 161.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.128 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.36 143.22 56.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.406 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -65.72 -19.06 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.995 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.79 -49.82 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 67.0 t80 -61.35 -38.22 86.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.705 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.463 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -64.33 -51.38 53.06 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 174.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 27.3 mmtp -52.59 -38.96 61.07 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.343 0.257 . . . . 0.0 111.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.672 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.8 mm-40 -55.22 -55.26 33.29 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 123.257 0.348 . . . . 0.0 111.29 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.524 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 38.8 mt -51.84 -61.57 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.403 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.662 HD11 HG11 ' A' ' 58' ' ' VAL . 8.2 mp -62.43 -31.81 72.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.961 -172.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.39 -34.07 76.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.733 0.301 . . . . 0.0 111.033 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 49.9 mttm -77.64 -24.0 49.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 110.682 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.908 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 96.7 m-85 -103.51 5.2 36.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -49.17 -47.37 45.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.137 0.575 . . . . 0.0 112.404 -173.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.84 -39.26 93.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.875 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.9 -40.18 61.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.404 0.621 . . . . 0.0 109.892 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.588 HG22 ' HB ' ' A' ' 39' ' ' VAL . 98.0 mt -61.21 -36.74 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.428 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.587 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.9 tttm -84.68 -30.91 24.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.238 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.57 -44.12 78.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.907 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -85.55 -47.79 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -111.49 -12.12 14.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.3 44.32 52.68 Favored Glycine 0 C--N 1.328 0.114 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.773 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 33' ' ' ILE . 18.8 t -114.77 146.88 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.873 0.368 . . . . 0.0 111.381 -175.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -103.01 112.85 25.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 72.0 p -73.84 -14.4 61.08 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -81.31 -44.21 17.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.0 109.86 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.42 -21.28 60.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.949 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.721 HD21 HG21 ' A' ' 60' ' ' VAL . 11.1 tp -60.21 133.13 55.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.312 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -95.56 104.6 16.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.151 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.544 ' HA ' HG12 ' A' ' 60' ' ' VAL . 43.6 mt -78.73 121.42 31.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.431 0.634 . . . . 0.0 110.71 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 61' ' ' ASP . 12.2 mt -92.2 -51.28 5.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.266 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HA ' HG23 ' A' ' 16' ' ' VAL . 6.0 ttmt -143.44 114.41 7.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.646 -176.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.7 m -98.41 130.1 45.04 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.334 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 p -163.96 -178.09 5.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.812 0.339 . . . . 0.0 110.599 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 9.8 pt-20 -140.37 159.7 41.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.475 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.509 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 4.3 t70 -138.95 -148.58 0.26 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.874 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 32.2 mmtp -65.45 91.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.044 0.137 . . . . 0.0 110.791 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.698 ' HB3' HG11 ' A' ' 76' ' ' VAL . 62.5 mtt85 71.98 -12.0 0.72 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.062 0.545 . . . . 0.0 112.359 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.47 146.27 33.41 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.208 -0.307 . . . . 0.0 111.082 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.544 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 7.0 m-85 -97.96 142.87 29.16 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 165.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.619 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 66.8 m-85 -126.63 107.55 10.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.073 0.464 . . . . 0.0 110.747 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 26' ' ' LEU . 18.1 t -108.97 99.51 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.532 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 9.5 t -77.31 122.17 24.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.721 HG21 HD21 ' A' ' 44' ' ' LEU . 28.7 m -130.46 155.44 41.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.008 0.432 . . . . 0.0 111.266 -177.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB2' HD21 ' A' ' 47' ' ' LEU . 10.5 t70 -99.88 122.16 42.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -75.95 -0.96 23.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 -39.0 3.14 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.559 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.87 -15.72 61.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.328 0.585 . . . . 0.0 110.307 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.41 -23.98 5.65 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.671 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 62' ' ' ALA . 8.8 pt-20 -74.81 152.86 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.8 mttp -125.13 108.33 11.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.305 0.574 . . . . 0.0 110.122 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.984 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 60.6 m -107.85 133.13 52.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.77 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.619 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.0 tppp? -97.13 102.98 14.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.545 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 20.8 m-85 -67.36 117.36 9.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.888 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 31.5 tttm -93.52 72.79 4.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.946 0.879 . . . . 0.0 109.368 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.574 HG12 ' HG2' ' A' ' 81' ' ' MET . 82.9 mt -75.78 91.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.991 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.646 ' HB2' HG12 ' A' ' 82' ' ' VAL . 24.9 ttt180 -62.6 135.76 57.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.667 ' HD3' HD23 ' A' ' 3' ' ' LEU . 99.0 mttt -59.73 172.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.718 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 43.5 t0 -74.5 28.36 0.08 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.783 1.278 . . . . 0.0 108.871 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -74.46 8.87 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 112.967 -1.924 . . . . 0.0 109.901 -174.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.3 t70 167.46 -43.09 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.842 -168.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.33 142.54 40.45 Favored Pre-proline 0 CA--C 1.502 -0.866 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.03 -171.196 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 67.5 Cg_endo -89.07 15.26 2.06 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.262 1.975 . . . . 0.0 111.803 171.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.908 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 21.4 mtmt -143.3 -179.75 6.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.482 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' HG12 ' A' ' 72' ' ' ILE . 23.2 mtm -81.21 117.34 21.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.404 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' ' 73' ' ' ARG . 9.2 p -56.73 -32.92 39.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.423 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.59 -174.21 34.91 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.643 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -171.97 90.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.467 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 24.0 tttp -107.85 131.5 54.42 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.809 -174.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.984 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 4.0 m -84.88 130.41 34.66 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.435 ' HD2' ' OH ' ' A' ' 96' ' ' TYR . 53.1 mtt180 -132.64 83.81 2.1 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 1.7 ttpm? -90.72 15.41 11.16 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.143 -174.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -140.97 -4.82 1.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.266 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -151.6 153.52 34.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -172.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -122.52 -57.01 1.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.736 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -65.56 108.1 1.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.349 0.595 . . . . 0.0 110.553 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.52 176.58 5.1 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.887 -173.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.43 -63.91 1.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.541 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.565 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . -154.23 135.99 5.01 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.085 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.888 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 14.8 m-30 . . . . . 0 C--O 1.245 0.854 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.621 ' H ' ' HA ' ' A' ' 80' ' ' LYS . 47.3 t -58.65 128.4 36.99 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.39 0.276 . . . . 0.0 110.871 -177.011 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.83 12.15 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.933 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.479 HG21 ' HE1' ' A' ' 56' ' ' TYR . 2.9 tp -76.72 -13.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.499 0.666 . . . . 0.0 110.69 -171.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.781 HD21 ' HA ' ' A' ' 7' ' ' LEU . 9.7 mp -125.13 -178.71 4.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.9 57.08 1.56 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.884 0.85 . . . . 0.0 109.758 170.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.09 52.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.583 ' CG ' ' H ' ' A' ' 7' ' ' LEU . 7.2 p-10 -130.49 -120.33 0.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.226 -173.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.781 ' HA ' HD21 ' A' ' 3' ' ' LEU . 42.4 tp 175.69 98.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.57 0.623 . . . . 0.0 110.966 -172.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.8 mt -59.81 131.85 52.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.0 110.242 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -124.11 -7.52 7.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.152 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.52 -46.63 89.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -100.5 115.3 29.77 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 166.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.777 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 37.4 tp -178.07 141.61 0.26 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.388 -176.046 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.777 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 29.0 mtmt 63.91 25.76 14.05 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.957 176.175 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.23 163.15 19.21 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.573 -174.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -64.74 -158.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.424 2.75 . . . . 0.0 111.942 169.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.49 116.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 122.002 0.906 . . . . 0.0 110.533 175.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.632 HG12 ' HA ' ' A' ' 50' ' ' SER . 10.7 mm -71.41 161.29 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.743 -177.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -49.45 129.75 19.24 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.161 0.288 . . . . 0.0 110.759 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' HA ' HG21 ' A' ' 46' ' ' ILE . 29.6 p-10 -60.23 -33.97 73.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 20' ' ' LEU . 6.6 mt -58.75 -44.86 90.67 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.99 173.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.644 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 72.3 t80 -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.748 0.308 . . . . 0.0 110.334 -177.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -67.13 -45.4 81.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.709 177.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HB2' HG13 ' A' ' 46' ' ' ILE . 7.8 tppt? -63.51 -37.05 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.099 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.64 -57.47 11.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.358 177.321 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 3.6 mt -51.95 -55.82 17.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.117 0.484 . . . . 0.0 109.758 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.894 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 21.9 mt -50.9 -48.34 60.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.427 176.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.36 -40.1 96.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 110.381 -178.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 11.8 mttp -56.92 -51.1 70.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.343 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 0' ' ' SER . 1.3 m-85 -97.72 13.19 31.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.042 -171.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -31.73 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.592 0.234 . . . . 0.0 111.427 -173.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.52 -31.17 68.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.8 0.333 . . . . 0.0 110.674 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -78.88 -43.3 25.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.334 0.588 . . . . 0.0 109.566 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 ' HB ' ' A' ' 39' ' ' VAL . 97.3 mt -60.62 -34.89 60.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.554 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.622 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 1.6 tmtp? -80.9 -40.49 24.57 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 110.051 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.18 -46.3 75.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.995 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.84 -54.81 5.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.463 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.558 ' HB2' HG23 ' A' ' 39' ' ' VAL . 6.5 m-85 -104.98 -31.21 9.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.12 -170.242 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.51 57.1 2.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.729 -177.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.622 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 22.0 t -124.4 148.4 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.809 0.338 . . . . 0.0 111.055 -175.196 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.438 ' O ' HD13 ' A' ' 44' ' ' LEU . 11.8 t0 -106.48 112.74 25.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 170.172 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.894 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 45.7 p -74.72 -15.75 60.77 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.83 -173.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.18 -25.52 60.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.152 178.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.72 -23.04 25.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.059 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 41' ' ' THR . 3.6 mp -65.66 109.67 2.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.696 -178.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 18.7 tptm -71.71 114.15 9.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.212 174.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.641 ' HA ' HG12 ' A' ' 60' ' ' VAL . 10.2 mm -71.21 107.34 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.0 mt -78.71 -57.84 3.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.705 0.764 . . . . 0.0 109.407 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -147.92 110.54 4.71 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.199 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 6.5 m -81.87 138.2 35.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.632 ' HA ' HG12 ' A' ' 17' ' ' ILE . 6.1 p -160.57 -175.96 5.3 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.391 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 15.2 pt-20 -165.05 167.06 18.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.582 0.706 . . . . 0.0 111.321 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.885 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 8.1 t70 -114.97 -157.99 0.65 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 171.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.605 ' HA ' HD11 ' A' ' 12' ' ' LEU . 86.0 mttt -68.22 -71.88 0.2 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.957 176.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -90.65 17.46 7.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.379 -173.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 97.4 m-85 -146.22 148.32 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -170.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.623 ' CD1' ' HG2' ' A' ' 74' ' ' LYS . 19.2 m-85 -109.46 143.74 38.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.384 169.026 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.885 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 76.7 m-85 -129.03 92.05 3.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.997 0.427 . . . . 0.0 110.459 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 t -97.33 98.58 7.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 16.6 m -77.47 124.56 28.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -138.55 143.95 31.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -177.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.552 ' HB2' HD21 ' A' ' 47' ' ' LEU . 9.3 t70 -80.39 97.12 6.92 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 173.069 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.12 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.751 -171.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.08 -11.03 56.65 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.077 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.43 -32.66 71.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.156 0.503 . . . . 0.0 110.244 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.1 -41.09 0.25 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 37.3 mt-10 -115.45 165.84 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.251 0.548 . . . . 0.0 111.464 -178.063 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.766 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 47.2 mttp -82.39 115.84 21.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.702 167.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -96.02 164.84 12.53 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.257 -169.497 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.533 ' HD3' ' CD1' ' A' ' 57' ' ' TYR . 40.4 ttmt -134.74 102.82 5.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.549 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.484 ' CG ' HD21 ' A' ' 26' ' ' LEU . 16.0 m-85 -69.03 106.41 2.77 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.633 0.73 . . . . 0.0 110.179 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.7 ' HD3' ' HA ' ' A' ' 96' ' ' TYR . 17.5 tttt -95.42 82.38 3.68 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.838 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.807 HG12 ' HG2' ' A' ' 81' ' ' MET . 52.5 mt -78.68 120.45 29.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.721 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 58.4 ttt180 -79.68 25.01 0.35 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.407 0.622 . . . . 0.0 109.511 -175.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.623 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 93.2 mttt 51.12 -165.46 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.279 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.672 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 11.9 t70 -103.12 47.48 0.88 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 167.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 6' ' ' ASP . 5.3 p -77.64 -2.29 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.14 -174.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 173.0 -54.48 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.983 -168.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 32.4 m -92.15 151.49 41.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.242 175.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.5 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 61.6 Cg_endo -92.71 32.21 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.583 2.855 . . . . 0.0 112.558 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.621 ' HA ' ' H ' ' A' ' 0' ' ' SER . 63.8 pttt -159.16 -157.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.02 -175.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.807 ' HG2' HG12 ' A' ' 72' ' ' ILE . 5.2 mtm -107.6 132.13 53.62 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 10.4 p -77.81 -37.27 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.209 0.528 . . . . 0.0 110.177 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.603 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -126.85 164.67 20.34 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.539 -174.129 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.99 25.71 0.06 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.704 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 60.7 mmtt -88.4 131.78 34.71 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.285 -167.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 6.5 m -83.68 136.85 34.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 173.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.575 ' HG3' ' HB3' ' A' ' 91' ' ' ASP . 8.1 ttt180 -129.6 83.21 2.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 0.0 109.977 -172.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.766 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 33.7 mmtm -140.53 -38.26 0.44 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.108 -176.169 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -126.08 73.23 1.34 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.104 0.478 . . . . 0.0 110.175 174.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.5 t70 67.11 117.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.002 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 87' ' ' ARG . 22.6 t70 -140.66 141.6 35.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.229 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -162.27 125.04 2.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.848 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.681 ' HB3' ' HB3' ' A' ' 96' ' ' TYR . 12.6 t70 -146.33 164.02 33.69 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.36 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.32 -26.83 24.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.259 0.552 . . . . 0.0 110.426 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.419 ' CA ' HG22 ' A' ' 82' ' ' VAL . . . -109.76 57.12 0.44 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 177.175 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.704 ' CD2' ' HB2' ' A' ' 85' ' ' LYS . 24.7 t80 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.434 -171.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.684 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 29.4 t -81.68 -47.93 12.33 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 72.8 mt 64.3 13.38 7.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.299 173.126 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 2' ' ' ILE . 9.6 tp -115.0 87.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.238 1.018 . . . . 0.0 109.716 176.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.6 pt? -128.23 -48.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.475 -172.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.506 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.1 m-20 66.34 -64.15 0.23 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 124.017 0.823 . . . . 0.0 110.135 -171.416 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.33 70.62 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 177.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 35.5 t70 61.72 87.33 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.234 0.54 . . . . 0.0 110.419 -172.066 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 54' ' ' ARG . 13.3 mt 75.29 163.99 0.26 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.068 177.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.63 ' HG ' ' H ' ' A' ' 9' ' ' LYS . 2.0 pt? -153.95 -55.11 0.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.709 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.63 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 10.2 mtmp? 75.69 -54.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 167.334 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.44 8.13 35.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -169.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.7 ttpt -61.82 -72.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.754 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.436 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 26.9 mt -109.03 124.8 51.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.767 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -138.25 29.3 2.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 -171.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -102.02 143.09 25.9 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.461 -177.22 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 26.9 Cg_exo -65.19 130.03 24.46 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.924 2.416 . . . . 0.0 111.72 175.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' A' ' 48' ' ' LYS . 10.0 p 39.83 99.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 123.367 1.556 . . . . 0.0 114.057 -177.166 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.06 160.03 4.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.637 176.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.22 157.42 31.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.157 -173.222 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.0 p30 -65.26 -20.01 66.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.18 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.5 tp -65.66 -43.94 87.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 178.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' HE2' ' HE1' ' A' ' 56' ' ' TYR . 73.8 t80 -64.05 -39.04 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.335 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -71.66 -32.89 63.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.143 176.715 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 23.8 tptt -62.63 -40.75 97.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.6 mm-40 -58.97 -51.49 69.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.101 175.048 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.514 HD12 ' HA2' ' A' ' 22' ' ' GLY . 84.3 mt -51.71 -64.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 175.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.879 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.8 mt -55.75 -31.64 62.73 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.798 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.25 -45.69 83.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.069 0.461 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 56.3 mttm -67.92 -30.57 69.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.684 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 79.7 m-85 -99.42 1.21 44.0 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -53.64 -39.76 65.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.673 0.273 . . . . 0.0 111.093 -177.099 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.5 -36.03 82.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.632 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 15.0 t70 -80.62 -40.56 25.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.904 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' CD1' HD23 ' A' ' 26' ' ' LEU . 80.8 mt -67.12 -30.26 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.412 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 44.5 tttp -83.48 -23.72 32.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 0.0 109.724 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.28 -45.7 65.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.336 170.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.632 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 51.3 mttm -82.13 -27.02 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.888 -173.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.718 ' HB2' HG23 ' A' ' 39' ' ' VAL . 49.1 m-85 -134.06 -33.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -177.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 97.09 19.96 24.78 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.42 -178.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.718 HG23 ' HB2' ' A' ' 37' ' ' TYR . 38.8 t -82.02 153.49 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.146 0.498 . . . . 0.0 111.908 -174.418 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.507 ' OD2' ' HB3' ' A' ' 42' ' ' LYS . 26.8 t70 -108.34 106.96 17.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.91 169.438 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.879 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 40.6 p -69.11 -16.2 63.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.062 -172.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 7.2 ttpm? -63.89 -21.59 66.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.839 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -105.16 -7.36 19.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 76.5 mt -66.86 117.26 8.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.851 -179.301 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.605 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 87.4 tttt -74.58 97.04 3.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.587 ' HA ' HG12 ' A' ' 60' ' ' VAL . 53.0 mt -77.13 122.0 30.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.638 0.732 . . . . 0.0 111.133 -175.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -94.16 -50.02 5.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.367 -175.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HA ' HG23 ' A' ' 16' ' ' VAL . 34.5 ttmt -145.64 121.36 10.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.271 -173.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.434 HG23 HG22 ' A' ' 58' ' ' VAL . 19.0 m -113.98 135.31 54.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.41 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -160.32 174.82 13.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.686 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 12.5 pt-20 -131.25 150.98 51.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.459 0.647 . . . . 0.0 110.322 172.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.27 -151.62 0.48 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -64.75 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.114 177.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.609 ' HA ' HD21 ' A' ' 7' ' ' LEU . 50.7 mtt180 -87.32 11.43 14.39 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.821 -0.55 . . . . 0.0 111.011 178.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 4.2 m-85 -133.18 161.0 35.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.125 -1.03 . . . . 0.0 113.579 -163.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.686 ' CE1' ' HB3' ' A' ' 51' ' ' GLU . 5.5 m-85 -124.18 149.65 46.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.594 169.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.623 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 77.1 m-85 -134.66 102.51 5.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.676 0.274 . . . . 0.0 110.945 -178.222 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 49' ' ' THR . 9.9 t -112.51 103.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.535 178.53 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m -87.28 125.02 33.96 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 46' ' ' ILE . 10.1 m -131.19 152.55 37.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 111.507 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.6 t70 -90.34 121.42 32.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 171.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.86 1.97 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.192 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.04 -53.31 4.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.338 176.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.55 -23.4 66.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.299 0.571 . . . . 0.0 110.679 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.35 7.97 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.712 -178.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.577 ' HA ' ' CD ' ' A' ' 88' ' ' LYS . 36.6 mt-10 -75.47 150.99 38.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 34.5 ttmt -127.01 107.2 9.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -176.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 34.4 m -106.35 132.06 52.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.339 0.59 . . . . 0.0 110.94 -175.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.623 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.5 tppt? -101.07 100.79 11.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 67.3 m-85 -75.16 106.98 6.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.074 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.855 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 81.1 tttt -98.76 108.86 21.65 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.901 0.857 . . . . 0.0 110.3 -178.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 71.0 mt -105.82 114.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.937 -178.199 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.803 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 28.9 ttp180 -79.35 29.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.366 0.603 . . . . 0.0 110.485 -172.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.566 ' HG2' ' CD2' ' A' ' 56' ' ' TYR . 84.8 mttt 57.56 -178.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.088 -178.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 2.0 t70 -87.31 42.2 1.02 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.563 . . . . 0.0 109.98 -174.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 73' ' ' ARG . 22.7 m -76.91 105.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.109 0.481 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 69.91 -64.41 0.35 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.294 -175.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -84.96 151.37 57.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.327 . . . . 0.0 110.19 177.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.725 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 60.9 Cg_endo -86.37 29.3 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.039 2.493 . . . . 0.0 111.428 174.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.423 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 1.9 ttmm -132.44 -158.6 0.9 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.376 0.608 . . . . 0.0 111.751 -169.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.522 ' SD ' ' HD3' ' A' ' 84' ' ' ARG . 3.6 ptt? -118.53 166.68 12.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.068 -176.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.803 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 3.6 p -81.55 -52.35 13.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 177.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -177.78 128.21 1.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.247 -177.339 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.522 ' HD3' ' SD ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -97.83 118.85 35.31 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.382 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.903 ' HD2' ' HA ' ' A' ' 96' ' ' TYR . 35.9 tttt -122.49 114.71 21.06 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.982 -169.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 22.6 m -72.22 122.88 21.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.158 173.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.477 ' CZ ' ' HA ' ' A' ' 92' ' ' ASP . 11.2 ptm180 -126.61 78.26 1.77 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.873 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.577 ' CD ' ' HA ' ' A' ' 66' ' ' GLU . 29.7 ttpt -74.34 -12.84 60.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.134 -173.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.19 174.35 9.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.585 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -85.53 -20.97 28.83 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -174.05 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.46 136.09 57.41 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.473 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 87' ' ' ARG . 38.7 t70 -89.98 108.42 19.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.022 0.439 . . . . 0.0 110.599 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 96' ' ' TYR . 7.0 t70 -77.86 154.08 32.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.487 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -124.81 -10.22 7.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.912 0.387 . . . . 0.0 111.025 178.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.56 95.25 0.41 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.903 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 1.7 m-85 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.16 -174.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.765 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 38.8 m -76.31 66.76 2.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.463 0.649 . . . . 0.0 109.586 175.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 1' ' ' LEU . 3.7 pp -88.5 140.24 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.749 -169.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 2' ' ' ILE . 8.5 tp -166.5 45.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.889 1.328 . . . . 0.0 107.487 175.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.452 ' HG ' ' CG ' ' A' ' 75' ' ' ASP . 13.7 mt -82.25 -174.41 5.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.584 -171.337 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 166.79 -32.0 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.076 -174.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.93 80.66 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.334 176.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 23.4 t70 73.49 11.03 4.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 121.236 0.541 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 42.2 mt 82.86 172.95 0.09 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.427 173.491 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.7 119.71 7.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.139 -174.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -80.34 95.45 6.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.182 -176.089 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -85.84 -86.43 0.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -171.69 138.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 111.217 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.08 115.14 7.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.203 172.223 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 39.9 ttmt -81.72 106.61 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.522 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.64 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 13.0 mt 58.88 173.99 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 123.487 0.715 . . . . 0.0 112.152 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 38.8 Cg_endo -69.8 -19.97 35.24 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.91 1.74 . . . . 0.0 111.495 171.461 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' A' ' 48' ' ' LYS . 6.7 t -138.49 113.2 8.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.9 176.32 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.65 HG22 ' H ' ' A' ' 18' ' ' ASP . 12.3 mt -68.77 175.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.942 -178.009 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.65 ' H ' HG22 ' A' ' 17' ' ' ILE . 9.0 m-20 -51.63 -20.71 2.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.362 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.663 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 96.3 m-20 73.1 -40.09 0.46 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.389 0.676 . . . . 0.0 110.999 -174.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.59 -35.77 81.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 169.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' O ' HD13 ' A' ' 25' ' ' LEU . 90.9 t80 -59.13 -42.48 90.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -65.55 -42.65 95.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 175.43 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -51.78 -41.65 61.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.461 0.304 . . . . 0.0 110.857 176.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.4 mm-40 -57.84 -54.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.001 173.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 21' ' ' PHE . 10.8 mp -47.68 -63.93 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.289 174.127 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.66 HD11 HG21 ' A' ' 58' ' ' VAL . 9.6 mp -59.84 -32.18 70.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.28 -174.136 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.19 -42.72 93.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 52.0 mttm -71.73 -42.48 67.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 110.646 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CD1' ' HA ' ' A' ' 0' ' ' SER . 2.0 m-30 -87.38 -0.48 56.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.378 -173.42 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 8.0 tt0 -56.43 -36.97 69.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.132 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.15 -36.08 65.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.009 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.86 -50.08 18.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.315 0.579 . . . . 0.0 109.832 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.655 HG22 ' HB ' ' A' ' 39' ' ' VAL . 45.8 mt -62.79 -31.07 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.993 -177.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 66.5 tttt -89.11 -29.17 19.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.43 -174.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.39 -51.77 33.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 0.0 110.566 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.17 -43.1 54.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.671 -172.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.652 ' HB2' HG23 ' A' ' 39' ' ' VAL . 15.9 m-85 -120.07 -17.95 8.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.824 0.345 . . . . 0.0 111.416 -173.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 81.36 30.74 36.09 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.655 ' HB ' HG22 ' A' ' 33' ' ' ILE . 16.6 t -92.6 147.33 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.954 0.407 . . . . 0.0 111.418 -175.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -108.99 120.67 43.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 44' ' ' LEU . 33.4 p -80.07 -13.78 59.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -170.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -74.81 -20.97 59.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.506 0.669 . . . . 0.0 109.566 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -86.77 -41.17 14.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.352 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 41' ' ' THR . 91.6 mt -53.56 109.49 0.45 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.246 177.065 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 79.1 tttt -77.36 108.89 10.82 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.55 ' HA ' HG12 ' A' ' 60' ' ' VAL . 42.8 mt -73.54 115.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.482 0.658 . . . . 0.0 110.171 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.8 mt -87.33 -39.11 15.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.196 -175.303 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.52 ' HG3' HG22 ' A' ' 16' ' ' VAL . 17.0 ttpp -156.57 104.98 2.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.003 -176.002 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.663 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 14.8 m -83.9 128.78 34.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.387 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -155.17 179.2 9.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 12.2 pt-20 -155.35 -177.07 6.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.851 176.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.641 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t70 -132.27 -88.01 0.45 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.641 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 40.9 mmtm -128.57 -81.52 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 54' ' ' ARG . 67.5 mtt85 -88.69 23.7 2.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.356 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 38.8 m-85 -142.95 132.37 23.51 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -169.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.886 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 30.3 m-85 -101.65 149.77 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 166.144 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -134.36 97.47 3.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.859 0.361 . . . . 0.0 110.091 177.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.66 HG21 HD11 ' A' ' 26' ' ' LEU . 14.0 t -105.16 96.64 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.831 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 11.8 t -76.03 126.5 31.11 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.15 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 46' ' ' ILE . 26.9 m -135.65 150.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.457 0.646 . . . . 0.0 112.263 -174.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.5 t70 -99.14 123.93 43.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.092 173.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.68 4.94 10.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.883 -171.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.98 -174.07 45.76 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.81 -36.69 79.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 -177.137 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.67 -6.4 6.62 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.75 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.656 ' HA ' ' CD ' ' A' ' 88' ' ' LYS . 2.6 mp0 -75.17 119.74 19.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -178.526 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.576 ' H ' ' HG2' ' A' ' 88' ' ' LYS . 7.4 ttpm? -145.1 117.0 8.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.507 -178.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 3.3 m -127.96 159.97 33.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.451 -175.237 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.3 ttmt -123.62 106.19 10.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 52.6 m-85 -73.45 96.46 2.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.875 0.845 . . . . 0.0 110.51 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.017 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 50.8 tttp -82.95 79.64 9.25 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.312 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 45.0 mt -75.5 105.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.398 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.559 ' HD2' HG11 ' A' ' 82' ' ' VAL . 43.1 ttt-85 -74.34 9.72 1.57 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.612 0.72 . . . . 0.0 110.184 -175.061 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 72' ' ' ILE . 94.6 mttt 63.5 177.05 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.482 176.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.856 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 8.0 t0 -80.68 64.35 5.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 177.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 4.0 m -85.98 87.16 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.092 175.471 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 5.1 m-20 74.69 -53.58 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -174.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.3 p -114.82 135.57 22.42 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.856 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 23.7 Cg_endo -65.59 -50.78 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.052 2.502 . . . . 0.0 112.918 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -46.71 128.97 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.766 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 159.48 6.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.897 -175.229 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.559 HG11 ' HD2' ' A' ' 73' ' ' ARG . 3.8 p -103.62 -27.97 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.573 177.09 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 1.017 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -118.76 135.61 11.58 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.946 -170.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -155.23 19.03 0.42 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.033 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.581 ' HB2' ' HB3' ' A' ' 96' ' ' TYR . 10.9 tttm -71.53 117.83 13.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.196 -168.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 60.6 m -84.42 111.03 19.09 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -86.77 66.84 9.64 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 122.091 0.948 . . . . 0.0 109.425 179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.656 ' CD ' ' HA ' ' A' ' 66' ' ' GLU . 51.6 mtmt -92.57 -29.86 15.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.394 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.72 -61.4 1.94 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.583 173.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -168.11 -174.06 2.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -123.08 169.11 11.54 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -108.12 -80.9 0.57 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.497 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.6 t70 179.99 -56.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -176.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -155.99 163.49 39.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.536 176.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.91 75.07 1.02 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -173.126 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.637 ' H ' ' HD3' ' A' ' 71' ' ' LYS . 27.7 m-85 . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.772 -175.192 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.577 ' HA2' HD22 ' A' ' 25' ' ' LEU . . . . . . . . 0 N--CA 1.487 2.051 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.551 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 26.8 t -103.07 2.24 34.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.797 0.808 . . . . 0.0 109.161 174.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 3' ' ' LEU . 89.2 mt -85.55 11.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.088 175.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.462 HD13 ' HD3' ' A' ' 74' ' ' LYS . 9.2 tt -78.06 65.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.013 170.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.551 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -103.29 154.72 19.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.931 -164.732 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.676 ' HB3' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -174.09 5.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.185 169.149 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.84 62.87 0.71 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -179.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.1 t70 70.29 25.45 4.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.117 0.961 . . . . 0.0 108.672 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.676 HD12 ' HB3' ' A' ' 4' ' ' ASP . 84.0 mt -110.21 109.47 19.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.992 -177.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.723 HD12 ' HD2' ' A' ' 74' ' ' LYS . 2.0 mm? -64.98 -56.34 13.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.134 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 67.52 -62.58 0.33 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.831 0.707 . . . . 0.0 111.178 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.52 85.8 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 0.0 110.576 176.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HA ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -112.72 132.05 55.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 169.224 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 14' ' ' LEU . 67.0 mt -82.8 -169.9 2.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.295 0.569 . . . . 0.0 111.89 -171.026 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.76 21.23 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.449 -170.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.443 HD11 HD13 ' A' ' 12' ' ' LEU . 1.3 pp -138.16 162.24 54.91 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.888 -167.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.74 -147.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.86 3.04 . . . . 0.0 112.699 171.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.618 ' HB ' ' HG3' ' A' ' 48' ' ' LYS . 11.0 p -47.09 130.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.235 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -97.78 -73.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.446 -175.938 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.653 ' H ' ' HB ' ' A' ' 49' ' ' THR . 5.4 m-20 64.72 12.23 7.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.776 177.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . 58.2 t30 -81.53 61.16 4.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.14 3.0 0.9 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.312 0.645 . . . . 0.0 110.7 -174.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.784 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 4.4 m-85 -63.69 -61.31 2.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.653 -175.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.42 ' N ' HG21 ' A' ' 49' ' ' THR . . . -62.26 -35.59 91.81 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.847 -177.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -68.2 -36.72 80.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.834 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.1 mm-40 -62.3 -53.95 47.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.04 0.536 . . . . 0.0 111.231 175.131 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 13.0 mt -52.74 -62.59 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.109 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.631 HD22 HG22 ' A' ' 41' ' ' THR . 33.4 mt -58.7 -26.8 64.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.053 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.0 -43.55 82.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 177.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.2 mttm -72.68 -41.11 65.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.829 -179.162 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.551 ' HZ ' ' HB3' ' A' ' 0' ' ' SER . 96.8 m-85 -90.19 0.46 57.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.757 -176.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 34.1 tt0 -50.9 -44.24 59.9 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.966 0.412 . . . . 0.0 110.792 177.492 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.72 -31.68 73.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.512 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -84.98 -41.4 15.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.51 0.672 . . . . 0.0 110.184 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.681 HG22 ' HB ' ' A' ' 39' ' ' VAL . 95.9 mt -63.07 -34.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.181 177.112 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 45.6 tttp -81.76 -34.23 30.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.509 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.94 -47.37 77.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.361 174.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -95.36 -42.45 8.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -172.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.626 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 m-85 -111.06 -13.11 14.11 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.502 -170.677 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.5 50.09 33.9 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.27 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.681 ' HB ' HG22 ' A' ' 33' ' ' ILE . 23.6 t -116.79 152.69 18.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 110.921 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -111.69 118.13 34.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.631 HG22 HD22 ' A' ' 26' ' ' LEU . 40.1 p -75.2 -14.29 60.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.033 0.444 . . . . 0.0 111.734 -173.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -76.93 -17.46 58.9 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.981 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -99.65 -16.21 18.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.372 0.606 . . . . 0.0 109.849 -179.17 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 41' ' ' THR . 96.6 mt -68.09 121.4 16.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 53.4 tptt -85.03 103.08 13.74 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 176.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.604 ' HA ' HG12 ' A' ' 60' ' ' VAL . 34.1 mt -72.77 114.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.459 0.647 . . . . 0.0 109.96 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.5 mt -87.13 -35.92 18.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.773 -177.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.618 ' HG3' ' HB ' ' A' ' 16' ' ' VAL . 4.1 ttmp? -159.06 108.95 1.95 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.577 -177.072 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.653 ' HB ' ' H ' ' A' ' 18' ' ' ASP . 20.0 m -86.1 134.42 33.82 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.169 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 p -162.57 -179.24 6.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.383 . . . . 0.0 110.517 176.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 5.5 pt-20 -155.67 164.37 38.69 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.328 176.165 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HB3' ' HE2' ' A' ' 57' ' ' TYR . 10.2 t70 -157.5 108.61 2.29 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 56.88 -115.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.097 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.476 ' HG2' HD11 ' A' ' 8' ' ' LEU . 46.4 mtt85 -88.55 16.24 6.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -172.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -138.35 137.6 37.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.924 -171.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.572 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 8.0 m-85 -98.13 140.39 32.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.661 168.066 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.537 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 97.4 m-85 -124.57 96.49 4.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.415 -178.333 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 3.4 t -103.26 90.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.6 t -72.97 120.86 19.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.8 m -133.35 155.91 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.204 0.526 . . . . 0.0 111.048 -177.005 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.496 ' HB2' HD21 ' A' ' 47' ' ' LEU . 16.9 t0 -100.55 127.84 46.79 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.026 173.683 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -7.33 59.21 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.58 -81.61 1.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.015 172.268 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.21 -22.94 61.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.038 0.447 . . . . 0.0 111.352 -175.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.3 -90.01 0.75 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.821 -174.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -100.38 177.56 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.726 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . 39.9 ttmt -128.52 126.51 40.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 167.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 1.063 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.6 t -134.14 -177.83 4.76 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.451 0.643 . . . . 0.0 111.316 -167.31 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 37.6 ttmt -159.39 90.23 0.94 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.494 ' CD1' HD21 ' A' ' 26' ' ' LEU . 72.2 m-85 -57.12 111.66 1.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.842 -176.181 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.9 tttt -94.5 77.36 3.84 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.325 -176.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.673 ' HA ' ' CB ' ' A' ' 81' ' ' MET . 78.3 mt -80.26 92.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.572 -177.231 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 1.04 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 49.3 ttt180 -56.83 127.48 31.9 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.259 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.723 ' HD2' HD12 ' A' ' 8' ' ' LEU . 95.2 mttt -63.57 179.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' CB ' ' HA ' ' A' ' 3' ' ' LEU . 5.9 t70 -61.43 94.02 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.754 0.788 . . . . 0.0 110.516 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 74' ' ' LYS . 12.4 m -138.29 84.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.814 174.607 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.2 t70 76.9 -49.48 0.55 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.826 -174.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 m -96.67 150.25 36.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.409 0.623 . . . . 0.0 111.136 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -95.21 29.11 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.245 3.297 . . . . 0.0 110.923 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -137.96 -176.6 4.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.557 -171.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.673 ' CB ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.17 146.07 23.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.875 179.614 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.04 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.6 p -83.0 -26.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.321 0.581 . . . . 0.0 110.282 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.92 -171.31 23.71 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.036 -175.422 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 24.0 ptt-85 -161.17 71.05 0.39 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.157 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.702 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 18.5 tptm -59.77 80.64 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.86 -167.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.063 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 27.8 m -92.54 -116.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.159 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 90' ' ' ASP . 64.6 mtt180 75.47 -17.2 0.52 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.196 0.598 . . . . 0.0 110.772 177.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.726 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 63.6 tttp 75.58 -47.28 0.59 Allowed 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.982 0.801 . . . . 0.0 112.225 168.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.38 39.56 0.82 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.43 0.633 . . . . 0.0 109.812 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 39.0 t70 -153.69 148.79 26.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.835 -176.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -106.2 156.25 18.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.347 -177.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.47 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 7.4 t70 -96.64 -158.61 0.67 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.57 101.7 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.18 -0.325 . . . . 0.0 111.682 -175.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 65.83 -79.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.699 0.8 . . . . 0.0 111.54 176.273 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.7 -173.97 38.49 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 174.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.702 ' CE1' ' HA ' ' A' ' 85' ' ' LYS . 21.7 t80 . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.709 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 1' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.658 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 56.4 m -70.73 98.28 1.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' -1' ' ' GLY . 31.0 mt -102.61 -0.55 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.357 -174.231 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.601 HG23 ' HB2' ' A' ' 74' ' ' LYS . 5.3 tp -78.28 89.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.752 0.787 . . . . 0.0 109.877 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.955 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -71.23 0.87 6.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.054 -175.448 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.45 39.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.278 1.037 . . . . 0.0 109.313 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.569 ' CA ' HG12 ' A' ' 76' ' ' VAL . . . -128.73 -53.81 0.11 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.699 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 28.9 t70 -53.56 -35.78 61.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 166.179 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 7' ' ' LEU . 3.6 mm? -92.78 -57.02 2.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 172.476 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.6 tp 56.99 72.07 0.53 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.023 0.827 . . . . 0.0 110.962 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.28 -26.4 9.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.067 -177.037 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -154.22 70.97 0.82 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.393 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 11.2 ptmm? -76.96 154.62 33.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.391 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 4.7 mp -88.95 174.07 8.13 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.259 -173.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -147.89 30.45 0.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.227 -171.028 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.2 mm? -89.73 147.63 38.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -176.204 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.7 117.94 4.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.69 2.26 . . . . 0.0 110.858 173.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 48' ' ' LYS . 7.5 p 41.11 99.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.926 1.346 . . . . 0.0 113.162 -171.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 49' ' ' THR . 25.2 mt -65.87 154.34 7.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.925 178.058 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.48 144.21 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -172.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -62.25 -23.84 66.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.327 -176.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.4 tp -65.68 -41.58 92.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.589 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 65.7 t80 -64.67 -39.34 93.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.535 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.574 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -68.23 -44.05 77.26 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.353 176.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HD2' HD12 ' A' ' 46' ' ' ILE . 4.3 mptp? -53.29 -44.4 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.678 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.3 mm-40 -54.9 -55.84 26.1 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.66 176.364 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.2 mt -53.4 -60.55 3.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.882 0.849 . . . . 0.0 110.695 178.608 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.685 HD22 HD11 ' A' ' 46' ' ' ILE . 9.5 mp -59.2 -40.88 87.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.433 -173.114 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.48 -32.49 73.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.678 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.2 mttm -67.43 -33.3 74.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' HE1' ' HA ' ' A' ' 80' ' ' LYS . 92.7 m-85 -95.01 0.95 55.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.73 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -36.1 74.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.509 0.195 . . . . 0.0 111.443 -171.222 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.95 -33.98 76.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.22 -41.43 49.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.492 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.534 HG22 ' HB ' ' A' ' 39' ' ' VAL . 90.9 mt -62.83 -37.14 78.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.753 176.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 36.3 ttmt -80.87 -22.76 39.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.042 -177.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.79 -47.14 22.45 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.448 172.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.69 -42.92 57.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.282 -175.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' HB2' HG23 ' A' ' 39' ' ' VAL . 59.8 m-85 -121.2 -28.3 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.735 0.303 . . . . 0.0 111.731 -174.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 91.88 41.78 4.9 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.986 -178.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 13.1 t -119.42 152.1 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 120.556 0.217 . . . . 0.0 110.838 -176.267 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.92 136.37 50.04 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.507 HG21 ' O ' ' A' ' 26' ' ' LEU . 32.3 p -79.99 -12.92 59.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -83.31 -3.04 57.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.9 -27.72 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.292 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.53 HD21 HG11 ' A' ' 39' ' ' VAL . 67.8 mt -62.17 125.98 25.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.715 175.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -85.79 102.92 14.08 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.415 -178.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.685 HD11 HD22 ' A' ' 26' ' ' LEU . 22.9 mt -75.66 124.42 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.695 0.759 . . . . 0.0 110.931 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.7 mt -100.1 -53.72 3.07 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.673 -177.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.563 ' HA ' HG23 ' A' ' 16' ' ' VAL . 36.6 ttmt -142.9 104.26 4.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.871 -174.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 58' ' ' VAL . 46.6 m -91.69 125.5 36.43 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.9 m -151.8 -179.12 7.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.033 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' OE2' ' HB2' ' A' ' 11' ' ' LYS . 9.4 pt-20 -142.14 143.82 33.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 177.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.02 126.62 10.92 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 58.46 -141.27 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.741 -175.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.586 ' HB3' HG11 ' A' ' 76' ' ' VAL . 73.7 mtt180 -77.71 14.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.527 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 5.0 m-85 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.313 -169.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.569 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 17.3 m-85 -98.26 143.96 28.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.367 166.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.0 m-85 -124.32 105.49 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 26' ' ' LEU . 13.9 t -106.69 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.847 0.356 . . . . 0.0 110.722 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 14.5 t -74.35 128.25 35.08 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.9 m -138.22 153.99 27.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.085 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.13 126.62 34.9 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.75 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 -36.23 2.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.586 174.049 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -70.83 -14.31 62.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.144 0.497 . . . . 0.0 109.978 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.25 -24.92 4.95 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.59 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 2.3 tp10 -78.34 174.26 11.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.912 0.387 . . . . 0.0 110.692 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -138.61 115.74 11.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 1.074 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -107.14 163.26 13.15 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.014 0.435 . . . . 0.0 111.239 -168.395 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.2 ttmt -139.21 93.9 2.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 64.4 m-85 -67.58 108.53 2.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.37 0.605 . . . . 0.0 110.342 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.022 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 46.9 tttt -92.2 83.53 5.09 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.044 -176.467 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.905 HG12 ' HG2' ' A' ' 81' ' ' MET . 55.7 mt -81.05 91.38 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.564 -178.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.703 HH11 HG21 ' A' ' 82' ' ' VAL . 34.8 ttt180 -59.68 111.23 1.35 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.389 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.865 ' HG3' HG13 ' A' ' 76' ' ' VAL . 18.6 ptpt -56.43 166.62 0.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.695 0.622 . . . . 0.0 110.461 -179.179 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 3' ' ' LEU . 38.9 t70 -68.65 75.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.508 0.67 . . . . 0.0 110.166 -178.2 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.865 HG13 ' HG3' ' A' ' 74' ' ' LYS . 29.5 m -100.84 -8.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.445 177.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 176.29 -51.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.833 -169.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -117.15 136.74 23.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.365 0.602 . . . . 0.0 110.323 178.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 43.9 Cg_endo -86.45 46.2 1.52 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 123.805 3.003 . . . . 0.0 113.341 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HA ' ' HE1' ' A' ' 29' ' ' PHE . 27.3 mtmt -150.68 161.7 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.131 0.491 . . . . 0.0 112.19 -177.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.905 ' HG2' HG12 ' A' ' 72' ' ' ILE . 38.2 mtm -63.81 101.51 0.38 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.264 172.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.703 HG21 HH11 ' A' ' 73' ' ' ARG . 9.9 p -55.85 -28.74 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.402 173.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.65 177.41 26.9 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.277 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -177.12 42.27 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.023 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.845 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 68.7 mmtt -83.28 120.75 26.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.876 -171.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 1.074 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 29.7 m -65.6 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.569 -177.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.484 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 99.7 mtt180 65.94 65.08 0.53 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.577 0.704 . . . . 0.0 109.245 175.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.59 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 71.7 tttt -69.54 -66.23 0.61 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.597 -174.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 24.5 t70 -121.24 103.0 8.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.712 -178.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 89' ' ' ASP . 37.1 t70 173.04 -82.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.871 0.732 . . . . 0.0 110.073 174.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -179.77 165.83 1.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 10.8 p-10 -127.84 121.26 29.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.383 0.611 . . . . 0.0 111.357 -179.088 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.13 157.34 37.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.495 173.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -52.89 -45.55 67.58 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 110.284 176.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.27 141.89 17.08 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.9 -178.525 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 1.022 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 4.0 m-85 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.18 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.674 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 32.8 t . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.322 0.106 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.453 HD22 ' H2 ' ' A' ' 0' ' ' SER . 1.0 OUTLIER 61.94 12.2 4.69 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.805 0.442 . . . . 0.0 110.871 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 tp -90.22 -3.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -168.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.849 HD23 HG12 ' A' ' 76' ' ' VAL . 13.6 tp -174.01 71.99 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.302 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.63 103.55 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.136 0.898 . . . . 0.0 112.032 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.58 32.5 78.8 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.569 -0.741 . . . . 0.0 113.498 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.758 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.3 t0 56.11 76.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.4 0.619 . . . . 0.0 112.135 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.688 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 94.9 mt -112.25 38.24 2.77 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 3' ' ' LEU . 23.9 tp -71.22 101.03 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.381 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 9' ' ' LYS . 7.4 mtmp? -105.52 -41.38 5.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.23 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.37 101.69 7.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.544 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -103.86 -81.39 0.52 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.926 0.393 . . . . 0.0 111.586 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 17' ' ' ILE . 61.5 tp -147.37 126.13 12.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.027 0.441 . . . . 0.0 110.694 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -122.48 11.27 9.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.203 1.001 . . . . 0.0 108.765 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.3 mt -115.44 171.68 4.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.603 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.44 -157.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.191 2.594 . . . . 0.0 112.544 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.534 HG23 ' HG3' ' A' ' 48' ' ' LYS . 4.4 p -49.84 124.54 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.789 0.804 . . . . 0.0 111.306 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.481 HG12 HD13 ' A' ' 12' ' ' LEU . 35.0 mt -69.25 152.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.2 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 139.38 57.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 27.0 p-10 -61.6 -26.05 67.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt -56.75 -45.56 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.01 -38.24 90.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.201 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -69.34 -37.25 79.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.449 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 30.2 mmmt -64.31 -31.22 72.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.24 -47.3 65.11 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 90.9 mt -52.32 -65.52 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 23.6 mt -53.37 -27.72 25.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.712 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.88 -40.38 63.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 111.024 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -79.27 -35.88 40.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.112 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.674 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 96.4 m-85 -91.99 4.87 52.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.547 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 34.7 tt0 -52.59 -41.9 64.05 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.1 -39.47 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.702 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.0 m-20 -67.59 -54.12 22.51 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.63 HG22 ' HB ' ' A' ' 39' ' ' VAL . 65.0 mt -55.89 -35.02 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.204 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 9.2 tmtm? -81.77 -37.28 27.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.283 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.46 -53.56 50.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.667 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.702 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 39.1 mttm -69.25 -55.32 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.8 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 84' ' ' ARG . 22.9 m-85 -104.68 -37.08 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.079 0.466 . . . . 0.0 111.422 -171.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.24 63.88 1.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.445 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.63 ' HB ' HG22 ' A' ' 33' ' ' ILE . 32.1 t -126.12 155.25 35.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -105.55 119.82 40.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.632 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 26.4 p -84.67 -11.03 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -71.21 -35.07 71.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.45 -34.53 60.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.349 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.0 mt -49.01 120.11 3.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.709 0.766 . . . . 0.0 112.433 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 86.1 tttt -92.24 104.01 16.42 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.135 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.644 HG12 HG12 ' A' ' 60' ' ' VAL . 20.0 mt -78.1 130.76 35.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.495 0.664 . . . . 0.0 111.723 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt -99.97 -45.9 5.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.77 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HG3' HG23 ' A' ' 16' ' ' VAL . 58.6 tttm -151.28 110.85 4.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.492 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.5 m -90.04 121.54 32.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -155.08 -167.68 2.64 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -169.94 170.03 7.87 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -116.64 -81.11 0.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.173 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.21 -88.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.922 ' HB3' HG21 ' A' ' 76' ' ' VAL . 85.1 mtt180 -91.86 23.96 3.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.49 0.662 . . . . 0.0 110.677 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.489 ' HE2' HG11 ' A' ' 82' ' ' VAL . 54.6 m-85 -147.36 144.58 28.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.673 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.936 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 27.2 m-85 -93.75 152.88 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 74.7 m-85 -139.09 99.13 3.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.212 0.529 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 t -109.24 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.016 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.0 m -66.61 121.69 15.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.962 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.644 HG12 HG12 ' A' ' 46' ' ' ILE . 21.5 m -137.01 151.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.115 0.483 . . . . 0.0 111.104 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.2 t70 -88.49 115.51 26.06 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 169.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.12 -2.1 32.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.916 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.43 -15.21 13.48 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.471 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.95 -1.98 58.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.503 0.668 . . . . 0.0 110.055 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.63 -15.14 58.8 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.541 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -90.67 140.69 29.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.859 0.362 . . . . 0.0 110.516 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 67.9 mttm -115.08 85.73 2.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.192 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 15.1 t -89.89 142.09 28.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.428 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 40.4 ttmt -102.69 88.06 3.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.097 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 12.7 m-85 -47.88 123.04 5.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.135 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.909 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 25.9 ttpp -104.71 87.71 2.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.049 0.928 . . . . 0.0 110.217 -173.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.936 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 80.6 mt -87.15 89.94 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.51 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.716 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 13.7 ttt180 -52.89 114.94 1.59 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.793 ' HB2' HG13 ' A' ' 76' ' ' VAL . 53.9 mttp -60.87 170.31 1.57 Allowed 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.694 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.1 t70 -73.2 32.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.934 0.873 . . . . 0.0 110.149 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.922 HG21 ' HB3' ' A' ' 54' ' ' ARG . 31.4 m -76.85 -7.34 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.011 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -171.97 -51.13 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.981 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 28.4 m -108.57 149.05 38.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.263 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 77.1 Cg_endo -86.81 27.41 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.268 2.645 . . . . 0.0 113.587 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HD2' ' NZ ' ' A' ' 36' ' ' LYS . 23.3 pttm -159.41 -178.77 7.38 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.671 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.432 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -83.65 132.4 34.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 13.7 p -80.51 -38.85 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.69 -142.93 3.65 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.134 -172.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.909 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 11.8 ptt-85 -172.92 114.58 0.26 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -80.36 81.33 6.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.466 0.651 . . . . 0.0 110.803 -173.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 68.3 m -76.23 -159.16 0.11 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.728 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 62.8 mtp180 . . . . . 0 N--CA 1.456 -0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.667 174.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.778 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 19.1 m . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.65 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -156.56 135.92 12.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.566 0.222 . . . . 0.0 111.501 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.877 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 5.2 tp 167.56 135.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 124.411 1.07 . . . . 0.0 109.23 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.697 HD13 HG23 ' A' ' 2' ' ' ILE . 11.0 mp 82.32 -21.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.609 0.764 . . . . 0.0 111.999 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.542 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 14.3 m-20 62.51 20.82 12.22 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 171.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.91 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . 79.34 -0.22 81.09 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.317 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.59 -11.71 44.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.843 0.354 . . . . 0.0 110.448 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.586 ' HA ' HD23 ' A' ' 3' ' ' LEU . 96.9 mt 70.36 32.22 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.134 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.64 93.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.659 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HG2' ' H ' ' A' ' 9' ' ' LYS . 8.7 pttt -100.41 71.94 1.57 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.599 0.714 . . . . 0.0 110.291 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.93 -30.71 69.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.292 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HB3' HD11 ' A' ' 14' ' ' LEU . 45.4 mmtm -135.96 144.43 45.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.623 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 35.2 tp -167.62 165.55 14.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 26.4 mttt 64.72 20.01 12.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 11' ' ' LYS . 59.4 mt -72.41 155.45 91.28 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.872 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.89 -171.35 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.824 2.349 . . . . 0.0 110.57 169.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG2' ' HA ' ' A' ' 48' ' ' LYS . 7.2 p -65.21 122.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.212 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.834 HG13 ' HB ' ' A' ' 49' ' ' THR . 4.1 pt -105.89 -178.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.799 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 177.47 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -40.02 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 112.919 -1.946 . . . . 0.0 112.891 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 20' ' ' LEU . 22.8 mt 34.65 43.92 0.1 Allowed 'General case' 0 CA--C 1.521 -0.138 0 O-C-N 123.885 0.74 . . . . 0.0 111.987 -173.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -125.94 -66.76 0.91 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.83 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' CA ' HG21 ' A' ' 49' ' ' THR . . . -64.36 -50.19 61.14 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.36 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.17 -36.59 68.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.916 0.388 . . . . 0.0 110.64 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.8 mt-10 -65.3 -50.54 65.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.963 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 91.0 mt -47.92 -65.0 0.64 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 123.579 0.55 . . . . 0.0 110.891 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 58' ' ' VAL . 7.4 mp -60.95 -38.38 85.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.553 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.72 -33.42 75.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 84.2 mttt -78.48 -46.1 20.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.456 0.646 . . . . 0.0 109.828 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.612 ' CE2' HG23 ' A' ' 72' ' ' ILE . 6.8 m-85 -70.33 -9.86 57.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.552 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -52.42 -47.51 66.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.719 0.407 . . . . 0.0 111.806 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -54.84 -39.64 68.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.713 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.23 -43.91 31.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.6 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.439 HD13 ' CE1' ' A' ' 70' ' ' PHE . 55.6 mt -63.42 -33.57 62.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.697 0.76 . . . . 0.0 110.403 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 71.3 tttt -80.86 -29.15 35.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.596 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.13 -50.48 40.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.089 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HE3' ' O ' ' A' ' 81' ' ' MET . 62.8 mttm -66.33 -50.12 64.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.399 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.451 ' HB2' HG23 ' A' ' 39' ' ' VAL . 34.9 m-85 -118.08 -37.62 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.877 0.37 . . . . 0.0 111.605 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.62 62.89 1.02 Allowed Glycine 0 C--N 1.323 -0.179 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.845 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.612 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -126.01 150.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.847 0.356 . . . . 0.0 111.584 -173.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.84 128.13 45.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 8.2 p -86.41 -9.48 56.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -92.22 -10.1 39.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.577 0.703 . . . . 0.0 109.346 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.69 -29.32 56.26 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.577 1.18 . . . . 0.0 107.872 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.564 HD13 ' CE2' ' A' ' 70' ' ' PHE . 27.4 mt -77.77 109.15 11.54 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 112.848 -1.978 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 55.4 tttm -72.86 111.97 8.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.679 ' HA ' HG12 ' A' ' 60' ' ' VAL . 26.3 mt -74.34 111.67 10.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.587 0.708 . . . . 0.0 110.234 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.8 mt -86.23 -35.94 19.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.678 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 34.0 tttp -156.88 118.31 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.667 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.834 ' HB ' HG13 ' A' ' 17' ' ' ILE . 2.8 m -106.53 126.13 51.87 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -155.77 170.99 20.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.65 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 14.0 pt-20 -139.59 175.69 9.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.437 0.637 . . . . 0.0 111.814 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -152.88 -162.2 1.44 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -58.3 103.35 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 77.1 -21.28 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.779 0.674 . . . . 0.0 112.559 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.71 142.05 38.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HD2' ' HG2' ' A' ' 74' ' ' LYS . 4.5 m-85 -109.94 142.44 41.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 166.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 61.0 m-85 -133.01 115.09 14.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.271 0.558 . . . . 0.0 110.678 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.734 HG22 HG23 ' A' ' 49' ' ' THR . 41.6 t -108.69 98.75 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.565 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.3 m -74.44 128.83 36.53 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 46' ' ' ILE . 33.3 m -138.25 156.83 30.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.823 0.344 . . . . 0.0 111.143 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.63 110.95 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 1.27 53.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.783 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.29 -112.91 0.27 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.658 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -116.36 79.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.48 4.13 73.96 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -79.25 81.98 5.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 122.087 0.946 . . . . 0.0 109.67 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 28.9 ttmt -82.43 135.54 35.13 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.55 -169.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 26.3 t -138.8 169.11 18.38 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.009 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 39.6 ttpt -146.43 110.81 5.11 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.564 ' CE2' HD13 ' A' ' 44' ' ' LEU . 36.6 m-85 -68.73 122.62 18.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.443 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HD3' ' HA3' ' A' ' 83' ' ' GLY . 83.3 tttt -88.72 71.61 8.73 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.197 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.612 HG23 ' CE2' ' A' ' 29' ' ' PHE . 67.4 mt -80.08 92.76 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.451 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.585 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 46.3 ttt-85 -72.4 8.45 1.37 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.427 0.632 . . . . 0.0 110.087 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.674 ' HG2' ' HD2' ' A' ' 56' ' ' TYR . 64.1 mttt 66.4 172.43 0.24 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.991 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.877 ' HB3' ' H ' ' A' ' 2' ' ' ILE . 2.0 t70 -77.66 87.79 3.94 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.091 0.948 . . . . 0.0 109.131 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.91 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 2.6 p -115.36 100.8 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.156 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.574 ' H ' ' CA ' ' A' ' 5' ' ' GLY . 33.4 t70 78.07 -59.64 0.43 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.644 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.44 146.86 33.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.17 -53.17 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.371 2.048 . . . . 0.0 113.792 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.778 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 11.7 ptpt -65.9 154.29 39.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.392 0.615 . . . . 0.0 112.136 -168.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.468 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -65.07 146.01 55.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.772 -176.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 7.5 p -81.03 -40.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.542 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.597 ' HA3' ' HD3' ' A' ' 71' ' ' LYS . . . -149.07 161.92 28.83 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.461 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 84' ' ' ARG . 27.5 ttt180 -149.0 92.83 2.02 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -105.35 111.26 23.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 110.586 -172.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 8.1 m -103.54 123.83 47.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 . . . . . 0 C--N 1.318 -0.775 0 CA-C-O 121.769 0.795 . . . . 0.0 110.317 -167.502 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 6.4 t . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -165.89 21.32 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.173 0.511 . . . . 0.0 111.293 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -101.15 107.73 21.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 3.2 mm? -120.71 -101.58 0.42 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.026 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 10.2 m-20 70.38 10.21 7.17 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.671 0.607 . . . . 0.0 109.702 -169.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 6' ' ' ASP . . . 69.99 97.14 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.21 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.491 ' HB3' ' O ' ' A' ' 5' ' ' GLY . 24.5 t70 73.57 -2.87 2.63 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.6 0.714 . . . . 0.0 110.1 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.945 HD21 ' HB2' ' A' ' 74' ' ' LYS . 11.2 mp 75.38 171.97 0.26 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.462 HD23 ' HG2' ' A' ' 11' ' ' LYS . 9.7 tp -78.55 3.05 17.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.578 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 15.9 mmtp 73.99 -74.61 0.08 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.413 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -145.4 135.28 23.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HG2' HD23 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -130.47 16.86 5.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.016 176.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 12' ' ' LEU . 13.2 mt -144.43 93.36 2.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.151 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -95.63 36.15 1.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.536 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.755 ' HB2' HG12 ' A' ' 17' ' ' ILE . 48.6 mt -79.39 128.53 75.05 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.231 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.6 Cg_exo -64.43 116.03 3.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.77 2.313 . . . . 0.0 110.228 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 48' ' ' LYS . 4.3 p 41.23 96.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 123.031 1.396 . . . . 0.0 112.057 -168.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.755 HG12 ' HB2' ' A' ' 14' ' ' LEU . 60.5 mt -74.26 155.42 6.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.225 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -44.76 133.75 5.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 112.206 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -62.73 -29.29 70.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 tp -68.2 -40.33 82.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.726 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.09 -36.52 81.95 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.5 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -66.06 -50.32 52.65 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -52.59 -35.77 54.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.441 0.297 . . . . 0.0 110.933 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.577 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 8.3 mm-40 -60.19 -54.87 40.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 174.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.2 mt -52.34 -63.73 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.548 0.69 . . . . 0.0 110.313 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.895 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 9.8 mp -56.21 -35.42 67.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.779 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.6 -36.44 83.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.072 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -70.15 -34.43 73.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.286 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 72' ' ' ILE . 15.0 m-85 -100.54 -1.92 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.083 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.02 -30.81 66.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.737 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.56 -39.18 92.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.781 0.324 . . . . 0.0 110.632 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 2.8 m-20 -84.04 -30.31 26.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.147 0.499 . . . . 0.0 110.276 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 39' ' ' VAL . 85.7 mt -63.98 -31.83 54.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.776 0.798 . . . . 0.0 109.834 173.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.643 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 74.7 tttt -88.69 -38.55 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 17.1 t70 -59.33 -45.58 90.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.392 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -80.63 -52.64 7.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.168 0.508 . . . . 0.0 112.025 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.554 ' HB2' HG23 ' A' ' 39' ' ' VAL . 24.4 m-85 -105.02 -30.83 9.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.572 -167.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.53 51.1 3.57 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.762 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.643 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 16.2 t -121.83 149.71 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 120.617 0.246 . . . . 0.0 110.885 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.535 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.6 t70 -107.57 117.71 34.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.895 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 58.0 p -79.4 -22.43 44.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -171.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.69 -19.86 51.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.91 -26.8 22.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.664 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 91.5 mt -60.36 145.21 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.945 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -97.22 103.98 15.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.931 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 60' ' ' VAL . 41.6 mt -76.33 122.04 29.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.72 0.772 . . . . 0.0 110.802 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 61' ' ' ASP . 7.7 mt -91.19 -48.17 7.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HG2' ' HB ' ' A' ' 16' ' ' VAL . 23.8 mttp -151.79 109.33 3.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.522 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.488 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 11.6 m -81.64 128.92 34.45 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 171.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 m -154.46 179.28 9.17 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -156.35 160.85 40.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.212 0.53 . . . . 0.0 110.884 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -137.16 -159.18 0.93 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -64.49 107.9 1.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.515 0.198 . . . . 0.0 110.863 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.533 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 84.7 mtm180 74.42 -17.76 0.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.07 130.26 55.51 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.876 -0.515 . . . . 0.0 111.609 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 1.017 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 16.2 m-85 -78.95 155.67 28.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.5 91.93 2.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.023 0.439 . . . . 0.0 110.393 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.676 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.0 t -97.5 97.67 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.428 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 9.2 t -71.54 116.85 12.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 46' ' ' ILE . 5.0 m -131.37 159.04 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.936 0.398 . . . . 0.0 110.797 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.526 ' HB2' HD21 ' A' ' 47' ' ' LEU . 11.7 t70 -107.22 132.81 52.66 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.64 9.18 14.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.418 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.18 -35.09 5.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.509 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -93.68 1.78 56.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.31 0.576 . . . . 0.0 110.691 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.53 -20.96 38.19 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.474 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 139.03 58.72 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -128.12 144.62 51.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.567 0.699 . . . . 0.0 112.083 -170.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.5 ' HB2' HG22 ' A' ' 60' ' ' VAL . 36.9 m -128.18 123.81 35.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.319 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 12.5 tppt? -97.09 68.54 2.27 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.676 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 19.2 m-85 -38.08 105.51 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 124.183 0.927 . . . . 0.0 112.331 -169.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 73.8 tttt -90.76 83.76 5.78 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.392 1.092 . . . . 0.0 109.326 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.017 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 70.1 mt -84.03 91.83 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.932 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.993 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.6 ttt180 -57.98 96.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.945 ' HB2' HD21 ' A' ' 7' ' ' LEU . 23.1 mttt -59.4 82.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.328 1.018 . . . . 0.0 112.092 -167.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.47 24.84 0.8 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.778 0.831 . . . . 0.0 111.239 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.993 ' HB ' ' HG2' ' A' ' 73' ' ' ARG . 33.9 t -80.21 119.21 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.682 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 68.03 -70.25 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.072 0.858 . . . . 0.0 111.276 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 79' ' ' PRO . 4.2 m -90.88 175.46 3.61 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.688 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 8.8 Cg_endo -82.92 178.54 5.9 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.88 1.72 . . . . 0.0 111.379 170.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 29.4 pttt 57.84 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 169.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.598 ' HB3' HG23 ' A' ' 72' ' ' ILE . 6.3 ptt? -168.73 150.11 4.73 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -171.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.716 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 12.9 p -76.12 -46.32 34.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.16 137.22 4.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.233 -1.46 . . . . 0.0 114.385 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.601 ' HG3' ' CE1' ' A' ' 70' ' ' PHE . 9.9 ttp180 -72.89 104.33 4.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 64.2 tttm -82.05 63.11 6.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 0.0 112.435 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.586 ' SG ' ' HG2' ' A' ' 84' ' ' ARG . 1.1 m -101.59 138.99 37.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 122.702 1.239 . . . . 0.0 108.744 172.254 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 2' ' ' ILE . 50.8 mt -143.5 82.55 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.59 HD12 ' H ' ' A' ' 1' ' ' LEU . 3.7 mp -150.66 -31.51 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.808 0.337 . . . . 0.0 111.757 -170.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.777 HD22 HG12 ' A' ' 76' ' ' VAL . 1.5 tt -154.78 33.61 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -165.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -48.48 -46.78 38.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.263 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.76 41.81 1.28 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -120.68 -146.32 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.708 -0.246 . . . . 0.0 110.72 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 mt -157.5 -49.63 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.747 0.655 . . . . 0.0 109.974 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 3' ' ' LEU . 74.6 mt 68.47 156.11 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.003 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.19 9.35 5.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.734 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.35 139.25 51.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.111 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -151.25 85.16 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.751 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.461 ' H ' ' CG ' ' A' ' 51' ' ' GLU . 12.2 tp 59.25 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.57 0.748 . . . . 0.0 112.764 165.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 27.2 ttpt -78.65 82.81 4.86 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 91.2 mt 74.55 162.45 0.15 Allowed Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 124.012 0.82 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 12.0 Cg_endo -56.35 134.17 62.6 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.715 2.277 . . . . 0.0 112.442 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.416 ' CG2' ' HG3' ' A' ' 48' ' ' LYS . 7.7 p 44.16 101.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 122.989 1.376 . . . . 0.0 113.961 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 51.7 mt -73.21 154.05 7.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.993 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 20' ' ' LEU . 28.3 t70 -62.91 155.95 25.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.605 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 8.7 p30 -60.35 -34.06 73.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.693 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' HB2' ' OD1' ' A' ' 18' ' ' ASP . 3.1 mt -57.06 -46.14 82.69 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.249 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 43.7 t80 -60.1 -41.83 93.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 0.0 110.297 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -74.27 -26.79 67.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.805 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.644 ' HB2' HD12 ' A' ' 46' ' ' ILE . 33.4 ttpt -80.89 -29.1 35.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.919 0.39 . . . . 0.0 110.177 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.59 -29.93 68.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.523 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.556 HD12 ' HA2' ' A' ' 22' ' ' GLY . 66.3 mt -65.31 -70.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 mt -47.71 -28.77 2.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.626 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.65 -45.82 92.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.999 0.428 . . . . 0.0 110.103 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.554 ' HD3' ' HB2' ' A' ' 1' ' ' LEU . 92.7 mttt -65.96 -35.49 80.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.623 0.725 . . . . 0.0 109.535 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.599 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 10.5 m-85 -79.28 -8.0 58.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.911 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.497 ' HG2' ' HD2' ' A' ' 34' ' ' LYS . 17.3 tt0 -74.44 12.59 0.74 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.456 0.646 . . . . 0.0 110.657 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -106.48 -30.57 8.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.375 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 15.2 t70 -88.87 -57.23 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 39' ' ' VAL . 67.6 mt -61.23 -27.62 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.72 0.771 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' HD2' ' HG2' ' A' ' 30' ' ' GLN . 44.9 tttp -80.66 -33.38 35.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.886 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -75.22 -47.83 26.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 49.2 mttm -69.29 -38.22 78.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.84 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.605 ' HB2' HG23 ' A' ' 39' ' ' VAL . 55.3 m-85 -126.86 -23.09 3.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 87.21 39.41 7.38 Favored Glycine 0 C--N 1.322 -0.216 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.94 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 33' ' ' ILE . 27.2 t -100.56 152.75 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.423 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 16.4 t70 -115.39 122.72 46.7 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.765 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 75.0 p -88.25 -17.56 30.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.919 0.39 . . . . 0.0 111.513 -172.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.517 ' HB2' ' NZ ' ' A' ' 42' ' ' LYS . 4.9 ttmp? -70.46 -33.16 70.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.466 0.651 . . . . 0.0 109.266 175.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.35 -23.4 46.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.016 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 49.1 mt -61.29 139.97 58.06 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.398 0.618 . . . . 0.0 111.594 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 81.0 tttt -101.32 96.51 7.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.511 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.644 HD12 ' HB2' ' A' ' 23' ' ' LYS . 46.9 mt -78.26 127.5 38.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.431 0.634 . . . . 0.0 111.112 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 10.9 mt -98.19 -51.44 4.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.133 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 36.1 ttmt -139.85 117.76 11.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.542 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.44 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 31.6 m -99.32 136.03 39.87 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -153.28 179.03 9.12 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 122.113 -0.367 . . . . 0.0 110.397 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 15.4 pt-20 -154.58 166.73 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.52 78.53 1.27 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.063 0.459 . . . . 0.0 109.907 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HE2' ' HB2' ' A' ' 53' ' ' LYS . 2.7 mppt? 56.33 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.199 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.641 ' HG3' HG11 ' A' ' 76' ' ' VAL . 19.4 ttm180 -85.33 12.41 8.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.516 0.674 . . . . 0.0 110.721 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 97.5 m-85 -136.23 157.73 46.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 13.9 m-85 -129.55 146.57 51.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.333 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.436 ' CE1' ' HG3' ' A' ' 71' ' ' LYS . 97.8 m-85 -135.69 103.05 5.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 19.1 t -109.19 95.17 3.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.652 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.6 t -80.34 129.69 34.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.5 m -137.99 155.44 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.156 0.503 . . . . 0.0 111.757 -173.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.6 t70 -90.22 126.68 35.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.91 13.24 11.28 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.029 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.11 -40.52 2.66 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.922 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.08 -19.13 65.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.88 -8.96 39.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.78 165.34 24.85 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.351 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -127.85 109.91 12.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.442 0.639 . . . . 0.0 110.279 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 1.9 t -104.62 174.32 5.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.34 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 35.9 ttmt -149.08 104.68 3.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.423 ' CE1' HD13 ' A' ' 33' ' ' ILE . 73.5 m-85 -71.23 97.22 1.51 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.694 0.759 . . . . 0.0 109.621 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HG3' ' CE1' ' A' ' 57' ' ' TYR . 46.2 tttp -82.88 85.91 7.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.149 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.781 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 61.6 mt -82.39 137.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.255 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 18.4 ttt180 -93.16 39.01 1.04 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.624 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 49.5 mttt 57.67 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.253 -170.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.689 ' HB3' ' N ' ' A' ' 3' ' ' LEU . 24.4 t0 178.68 26.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.777 HG12 HD22 ' A' ' 3' ' ' LEU . 9.5 m -61.82 95.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.073 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 22.9 t70 77.13 -38.95 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.844 172.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 80' ' ' LYS . 9.6 p -110.7 134.28 20.96 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.521 0.677 . . . . 0.0 110.312 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 78' ' ' VAL . 85.4 Cg_endo -79.79 30.83 0.48 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 123.897 3.064 . . . . 0.0 114.757 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' HG2' HG22 ' A' ' 78' ' ' VAL . 57.4 pttt -145.78 153.61 41.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.651 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -70.31 148.66 48.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.52 -173.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 13.7 p -73.07 -43.3 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.666 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -130.39 151.83 19.6 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -174.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 43.13 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.709 0.766 . . . . 0.0 108.939 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -96.2 134.81 38.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.115 -171.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -101.39 125.41 48.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 C--N 1.314 -0.956 0 CA-C-O 122.037 0.923 . . . . 0.0 109.645 -164.155 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.486 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 41.3 t . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.78 40.68 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.553 0.692 . . . . 0.0 110.136 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 56' ' ' TYR . 18.6 tt -104.61 108.84 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.584 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 7' ' ' LEU . 4.4 mm? -75.59 5.25 6.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.561 ' HB3' HG12 ' A' ' 2' ' ' ILE . 27.3 t70 -70.7 -5.44 29.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.717 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 76' ' ' VAL . . . -87.02 -87.35 1.08 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.147 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -48.59 -38.79 21.69 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 3' ' ' LEU . 66.2 mt -92.06 26.39 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.65 0.262 . . . . 0.0 111.334 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 7.2 tt -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.938 0.399 . . . . 0.0 110.681 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -120.13 -62.57 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -154.98 116.01 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.918 173.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 17.6 ptmt -129.22 -51.68 1.2 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.522 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 71.3 mt -153.22 155.36 36.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -170.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 43.87 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 82.4 mt -108.03 170.22 5.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.14 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 50.2 Cg_exo -58.85 -150.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.86 3.04 . . . . 0.0 113.072 170.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.422 HG23 ' HG3' ' A' ' 48' ' ' LYS . 14.5 p -53.06 125.17 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.19 0.995 . . . . 0.0 111.266 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 18' ' ' ASP . 11.7 mt -96.72 173.04 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.395 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' H ' HG22 ' A' ' 17' ' ' ILE . 1.6 m-20 -50.46 122.06 6.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.681 0.277 . . . . 0.0 111.148 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.558 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 25.0 p30 -72.54 -17.21 61.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 110.363 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.23 -39.38 68.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 170.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.569 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 63.1 t80 -61.61 -40.38 94.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.621 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -66.92 -44.27 89.33 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.447 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -55.68 -43.26 76.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.664 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.9 mm-40 -57.16 -49.16 76.81 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.583 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 46.1 mt -51.49 -59.54 4.14 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.528 0.68 . . . . 0.0 110.34 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 58' ' ' VAL . 6.9 mp -60.82 -38.8 86.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.579 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.18 -31.86 73.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.664 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.7 mttm -74.99 -50.01 18.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.201 0.524 . . . . 0.0 110.678 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 0' ' ' SER . 7.2 m-85 -92.17 12.14 23.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.797 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -25.89 63.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.278 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.06 -39.97 90.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -36.97 62.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.336 0.589 . . . . 0.0 109.471 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.8 mt -62.24 -38.84 82.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.555 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 35.3 tttm -83.29 -31.69 26.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.359 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.83 -47.8 79.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.82 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -79.42 -52.58 7.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.224 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.578 ' CZ ' ' HD2' ' A' ' 84' ' ' ARG . 6.6 m-85 -108.11 -23.97 11.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -169.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.49 57.59 3.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.952 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 41' ' ' THR . 3.7 t -117.03 145.13 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 121.023 0.439 . . . . 0.0 110.908 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.65 -11.32 59.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.111 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.669 ' H ' HG12 ' A' ' 39' ' ' VAL . 33.1 p 58.73 -37.48 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.014 1.726 . . . . 0.0 114.348 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -71.18 -18.19 62.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.352 0.596 . . . . 0.0 109.451 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -74.37 -37.25 63.51 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.899 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.37 106.22 0.43 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.224 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 55.1 tttp -69.97 102.27 1.97 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.147 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.637 HG12 HG12 ' A' ' 60' ' ' VAL . 34.6 mt -74.33 111.99 10.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.793 0.806 . . . . 0.0 110.675 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.3 -46.45 16.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.062 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 59' ' ' SER . 25.8 ttpp -151.5 105.47 3.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.687 -173.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.558 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 87.8 m -79.23 125.6 29.68 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -151.8 168.99 23.34 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.24 157.02 35.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 29.4 t70 -100.74 -83.67 0.44 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 52' ' ' ASP . 38.5 mmtm -135.88 -74.85 0.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.697 ' HB3' HG11 ' A' ' 76' ' ' VAL . 98.7 mtt180 -87.93 15.22 7.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.969 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -147.32 137.34 23.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.717 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.5 m-85 -98.84 143.84 28.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 167.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.472 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 74.4 m-85 -132.26 100.8 5.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 110.217 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 26' ' ' LEU . 26.0 t -99.07 93.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.139 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.491 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 67.8 m -58.51 126.35 27.22 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.303 174.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.637 HG12 HG12 ' A' ' 46' ' ' ILE . 35.7 m -146.71 149.96 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 111.757 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.0 t70 -91.22 122.99 34.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 169.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . . . -79.98 1.11 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 -13.69 64.97 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.288 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -131.92 41.16 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -27.49 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.976 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 39.6 mt-10 -65.21 128.88 37.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.017 0.436 . . . . 0.0 111.128 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -111.59 114.81 28.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.506 0.67 . . . . 0.0 109.924 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 18.6 t -113.92 178.42 4.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.864 -174.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 1.008 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 34.8 ttmt -155.54 82.04 1.04 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 25.6 m-85 -50.31 111.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 112.203 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.597 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 63.3 tttp -80.76 72.89 7.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.048 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.717 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 60.3 mt -75.89 86.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.221 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.472 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 33.2 ttp180 -61.97 113.42 2.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 81.8 mttt -61.37 174.02 0.79 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.173 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 1.1 m-20 -71.67 64.65 0.46 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.662 0.744 . . . . 0.0 110.192 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.697 HG11 ' HB3' ' A' ' 54' ' ' ARG . 34.7 m -96.77 -1.76 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.198 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -176.87 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.007 -171.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.544 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 7.6 p -117.77 144.7 34.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.865 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 78' ' ' VAL . 39.1 Cg_endo -82.47 53.0 4.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.28 2.653 . . . . 0.0 111.301 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -154.07 135.01 13.8 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.287 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.716 ' HG2' ' HA ' ' A' ' 72' ' ' ILE . 12.7 tmm? -57.56 103.84 0.15 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 11.6 p -60.75 -37.88 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -170.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' ' 81' ' ' MET . . . -175.03 -156.84 15.01 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.641 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.664 ' N ' ' HD3' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -151.37 119.67 6.37 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -168.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 1.008 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 2.4 tttm -86.94 56.92 4.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.911 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -87.75 126.3 34.92 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 . . . . . 0 C--N 1.306 -1.285 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 179.7 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.978 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 m . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.947 HD23 ' HD3' ' A' ' 28' ' ' LYS . 11.0 tp -174.96 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.611 0.57 . . . . 0.0 112.266 160.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.49 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.5 tp -66.02 -25.93 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.828 -171.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.802 HD21 ' H ' ' A' ' 8' ' ' LEU . 7.5 tp -140.53 54.59 1.61 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.288 -171.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -54.58 96.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.618 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.09 40.87 52.23 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.821 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.754 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 30.7 t70 -107.82 -60.5 1.7 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.712 0.291 . . . . 0.0 110.496 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.457 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 25.7 tp 71.76 99.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.068 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.802 ' H ' HD21 ' A' ' 3' ' ' LEU . 6.7 tt -88.92 117.5 27.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.825 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -112.37 -5.68 14.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.578 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.31 -41.73 89.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 47.2 mmtm -97.65 152.11 19.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.357 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 5.2 mp -117.73 -72.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.44 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.78 103.83 4.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.357 . . . . 0.0 110.053 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.402 HD11 ' HG2' ' A' ' 51' ' ' GLU . 1.1 pp -111.76 163.54 17.32 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.835 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.51 -177.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.946 3.097 . . . . 0.0 113.647 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 48' ' ' LYS . 8.1 p -68.91 121.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.594 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 47.9 mt -77.77 152.66 5.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.587 174.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.81 144.84 42.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.571 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 6.5 p30 -56.92 -30.36 63.9 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.766 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.1 tp -60.6 -45.71 92.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.579 0.228 . . . . 0.0 110.946 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 61.5 t80 -62.37 -48.95 77.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.669 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -63.77 -43.87 97.08 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.431 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HB2' HG13 ' A' ' 46' ' ' ILE . 3.8 tptm -58.17 -34.94 70.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.233 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.648 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -55.3 -56.44 20.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.041 175.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.6 mp -51.82 -55.61 18.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.656 0.741 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.669 HD13 ' O ' ' A' ' 22' ' ' GLY . 6.7 mp -59.8 -44.91 93.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.011 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HA ' ' OG1' ' A' ' 41' ' ' THR . 21.3 t70 -63.2 -31.73 72.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.058 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.947 ' HD3' HD23 ' A' ' 1' ' ' LEU . 58.3 mttm -69.37 -33.54 73.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.937 0.398 . . . . 0.0 110.738 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' O ' HG13 ' A' ' 33' ' ' ILE . 15.4 m-85 -99.09 7.95 45.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -50.31 -44.14 54.05 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.284 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.12 -38.38 73.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.554 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.97 -41.57 50.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.563 HG22 ' HB ' ' A' ' 39' ' ' VAL . 32.4 mt -63.61 -34.08 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.235 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 33.1 ttpt -83.69 -27.74 28.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.099 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.41 -47.04 58.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.496 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -78.02 -62.13 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.068 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HB2' HG23 ' A' ' 39' ' ' VAL . 25.1 m-85 -97.68 -19.2 18.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.116 -167.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.18 46.04 10.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.931 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.607 HG23 ' HB2' ' A' ' 37' ' ' TYR . 40.3 t -107.48 145.57 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.032 0.444 . . . . 0.0 111.439 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.593 ' OD1' ' HB2' ' A' ' 42' ' ' LYS . 25.7 t70 -109.24 105.17 14.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.542 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 29.1 p -65.07 -16.75 63.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.593 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 3.3 mtpm? -67.23 -28.93 68.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.31 -18.97 28.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.91 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 67.8 mt -65.66 132.43 48.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.327 0.584 . . . . 0.0 111.559 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.62 ' HD2' HD23 ' A' ' 47' ' ' LEU . 2.5 tmtp? -94.48 109.38 21.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.124 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.631 ' HA ' HG12 ' A' ' 60' ' ' VAL . 6.1 mm -73.53 108.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.95 0.405 . . . . 0.0 109.925 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 45' ' ' LYS . 17.6 mt -80.11 -54.75 5.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.555 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.491 ' HG3' HG23 ' A' ' 16' ' ' VAL . 87.6 tttt -142.1 119.92 11.93 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.742 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.594 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 35.3 m -98.54 141.53 31.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 169.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -169.51 -174.68 1.97 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' OE1' ' HB2' ' A' ' 11' ' ' LYS . 8.9 pt-20 -147.68 162.46 39.11 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.726 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 5.8 t70 -135.01 -173.29 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.713 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 14.0 mmmm -63.96 111.02 2.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 72.34 -0.97 3.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.169 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.97 152.8 40.53 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.787 0.803 . . . . 0.0 112.989 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.601 ' HD2' ' HA ' ' A' ' 74' ' ' LYS . 6.2 m-85 -114.06 145.08 42.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.368 164.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.547 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 62.8 m-85 -134.23 112.15 10.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.82 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 5.1 t -111.89 93.47 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.811 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.9 m -76.58 121.83 23.74 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 46' ' ' ILE . 15.8 m -134.44 159.32 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 111.581 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.03 115.67 22.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . . . -86.0 -18.44 32.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 64' ' ' ASP . . . 108.87 165.51 20.66 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -171.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 9.6 t70 73.11 -52.61 0.71 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.927 0.491 . . . . 0.0 110.457 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.84 -17.18 0.22 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.2 150.85 33.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.915 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -117.56 117.85 30.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.989 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 33.6 m -113.81 133.92 55.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.475 -171.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.0 ttpt -102.96 108.51 19.71 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.642 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 43.0 m-85 -68.15 103.55 1.58 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.494 0.664 . . . . 0.0 110.389 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.548 ' HB3' ' O ' ' A' ' 83' ' ' GLY . 12.8 tttt -88.34 109.45 19.99 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.189 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.457 HG12 ' HG2' ' A' ' 81' ' ' MET . 48.2 mt -123.56 124.79 70.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.517 ' HD2' HG21 ' A' ' 82' ' ' VAL . 16.2 ttt180 -81.01 53.25 1.94 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.459 0.647 . . . . 0.0 110.612 -169.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.601 ' HA ' ' HD2' ' A' ' 56' ' ' TYR . 19.6 mttt 50.75 43.35 28.09 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.017 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.738 ' HA ' ' CB ' ' A' ' 0' ' ' SER . 1.9 m-20 55.46 28.62 11.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.761 0.663 . . . . 0.0 112.558 166.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 73' ' ' ARG . 21.3 m -77.36 122.09 31.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.282 0.563 . . . . 0.0 111.839 -176.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 t70 64.29 -77.31 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.456 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -82.82 139.72 43.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.978 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 90.8 Cg_endo -80.49 89.19 1.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.179 2.586 . . . . 0.0 112.878 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -176.2 -173.92 0.59 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.586 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.459 ' SD ' HG12 ' A' ' 33' ' ' ILE . 26.6 mtm -100.95 148.96 24.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.524 HG13 ' HE2' ' A' ' 71' ' ' LYS . 7.7 p -89.48 4.41 5.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . 152.3 113.1 0.54 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.727 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -95.43 100.78 12.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -125.14 134.52 52.4 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 7.6 m -93.74 123.49 37.11 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 . . . . . 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.902 . . . . 0.0 108.795 -176.21 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.8 p . . . . . 0 C--O 1.222 -0.353 0 CA-C-O 119.694 -0.193 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.848 HD22 ' H ' ' A' ' 1' ' ' LEU . 0.3 OUTLIER -49.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.72 0.637 . . . . 0.0 111.667 -174.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' A' ' 56' ' ' TYR . 28.3 mm -144.35 -55.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 123.081 0.238 . . . . 0.0 111.525 -174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.913 HD23 ' HA ' ' A' ' 6' ' ' ASP . 1.1 mp -113.6 -3.14 13.65 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.61 45.69 21.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.87 36.76 12.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.647 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.913 ' HA ' HD23 ' A' ' 3' ' ' LEU . 30.3 t70 58.08 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 2.2 pp -148.58 19.69 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.598 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 3' ' ' LEU . 30.4 tp -78.87 99.7 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.795 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -124.04 6.32 8.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.532 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.71 -77.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HG2' HD11 ' A' ' 8' ' ' LEU . 48.2 pttt -90.2 178.02 6.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.0 tp -171.24 -47.43 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.993 0.425 . . . . 0.0 110.31 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 21.5 mtmt -123.83 93.73 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.291 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.96 157.4 33.73 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.803 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.39 -164.43 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.003 2.469 . . . . 0.0 112.105 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.8 p -69.3 110.82 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 122.076 0.941 . . . . 0.0 111.601 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.885 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -98.35 170.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.487 173.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 172.65 -8.24 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 21' ' ' PHE . 4.1 m-80 -64.61 63.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.377 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mt 68.74 -27.62 0.15 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.942 0.897 . . . . 0.0 112.454 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' A' ' 19' ' ' ASN . 7.9 t80 -54.04 -45.0 71.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -172.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -73.94 -38.56 48.48 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.692 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -70.89 -33.3 70.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 7.7 mm-40 -56.98 -50.6 72.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.544 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.546 HD12 ' HA2' ' A' ' 22' ' ' GLY . 60.4 mt -49.72 -67.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.529 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.859 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 39.1 mt -53.3 -34.09 55.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.62 -49.09 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.344 -0.223 . . . . 0.0 111.386 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 36.4 mttm -65.78 -45.07 83.82 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 109.913 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.444 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 3.9 m-85 -93.33 16.14 14.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.78 -171.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -61.0 -42.24 98.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -58.85 -38.53 78.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.56 -51.28 36.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 109.932 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.531 HG21 ' HE1' ' A' ' 70' ' ' PHE . 47.1 mt -66.6 -29.49 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.017 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.541 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 38.3 tttp -84.96 -29.34 25.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 110.326 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.28 -47.02 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.393 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.808 ' HD3' ' HE3' ' A' ' 81' ' ' MET . 27.8 mttm -65.46 -64.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.995 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.538 ' HB2' HG23 ' A' ' 39' ' ' VAL . 30.1 m-85 -107.02 -36.81 6.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.3 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.35 57.89 1.17 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.582 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 34.7 t -111.67 151.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.962 0.41 . . . . 0.0 111.236 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.69 102.65 12.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 56.6 p -77.12 -14.09 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.298 0.571 . . . . 0.0 111.513 -173.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -83.97 -8.15 59.23 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.756 0.789 . . . . 0.0 110.134 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.82 -10.35 23.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 57.1 mt -82.66 129.61 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.02 -175.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.551 ' HD3' HD23 ' A' ' 47' ' ' LEU . 11.8 tmtt? -96.89 119.2 34.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.561 ' HA ' HG12 ' A' ' 60' ' ' VAL . 39.3 mt -84.5 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.772 0.796 . . . . 0.0 111.4 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.551 HD23 ' HD3' ' A' ' 45' ' ' LYS . 5.9 mt -97.47 -56.06 2.64 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.656 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HA ' HG23 ' A' ' 16' ' ' VAL . 77.0 tttt -143.17 111.74 6.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.134 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.885 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.9 m -101.26 140.17 35.92 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -156.5 173.66 16.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.629 ' HB2' ' HE2' ' A' ' 74' ' ' LYS . 7.5 pt-20 -141.3 143.67 34.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.36 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -131.03 -146.8 0.31 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.98 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -65.79 95.47 0.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.659 0.266 . . . . 0.0 110.881 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 67.3 -6.43 0.62 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -116.82 134.5 54.7 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.644 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.685 ' CD2' ' HG2' ' A' ' 74' ' ' LYS . 10.5 m-85 -92.23 147.61 22.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.619 169.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.539 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 72.5 m-85 -130.4 97.94 4.55 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.35 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.629 HG22 HG23 ' A' ' 49' ' ' THR . 7.3 t -102.09 93.11 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.143 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.9 t -79.09 117.5 20.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 46' ' ' ILE . 17.3 m -130.02 157.44 42.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.35 126.2 33.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 7.07 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.68 -36.57 4.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.086 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -93.49 -29.99 15.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.239 0.542 . . . . 0.0 111.123 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.81 -18.45 2.77 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.426 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.36 134.77 52.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.32 98.89 7.2 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.893 0.854 . . . . 0.0 110.061 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 1.039 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 10.1 t -93.57 133.88 36.43 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.303 -172.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.1 ttmt -107.43 103.85 13.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.766 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.594 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 44.8 m-85 -69.01 115.53 8.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.002 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 86.6 tttt -94.17 98.4 10.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.118 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 95.5 mt -100.43 111.63 30.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.848 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 10.8 ttt180 -69.88 104.09 2.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.748 ' HB3' HD13 ' A' ' 3' ' ' LEU . 78.1 mttt -47.7 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.241 0.963 . . . . 0.0 111.451 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.903 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 14.0 t70 1.84 77.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 125.194 1.559 . . . . 0.0 112.578 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.528 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . 15.7 m -84.03 -11.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.716 -170.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 26.3 t70 170.63 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.749 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -89.26 148.87 41.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.184 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.602 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 75.4 Cg_endo -83.14 105.75 1.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.628 2.219 . . . . 0.0 112.406 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HG2' ' HE2' ' A' ' 36' ' ' LYS . 3.1 mtmm 178.43 157.81 0.47 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.275 0.559 . . . . 0.0 111.309 175.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.808 ' HE3' ' HD3' ' A' ' 36' ' ' LYS . 2.3 tmm? -89.32 128.03 35.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 5.6 p -66.16 -38.89 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -178.12 -164.02 30.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.99 -1.576 . . . . 0.0 114.721 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.717 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 11.3 ptt180 -176.05 88.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.552 1.168 . . . . 0.0 107.967 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -78.43 -18.36 55.05 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.921 -170.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.039 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.5 m 58.82 100.64 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.939 0.876 . . . . 0.0 109.887 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 . . . . . 0 C--N 1.304 -1.41 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.947 -166.323 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.613 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 13.1 t . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 37.0 mt -121.53 -6.91 9.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.247 0.546 . . . . 0.0 110.452 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.741 HG21 ' HE2' ' A' ' 56' ' ' TYR . 6.8 tp -89.21 135.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.511 -169.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.651 HD23 ' HA ' ' A' ' 7' ' ' LEU . 9.8 mp 68.38 91.06 0.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.351 0.407 . . . . 0.0 110.434 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.37 83.22 0.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . 51.5 52.09 34.69 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.489 ' H ' ' HA ' ' A' ' 76' ' ' VAL . 7.4 t70 -137.45 -164.0 1.52 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.235 -0.483 . . . . 0.0 110.874 -161.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.651 ' HA ' HD23 ' A' ' 3' ' ' LEU . 2.7 pp -161.61 133.43 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.321 0.581 . . . . 0.0 111.94 -173.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 92.1 mt -123.8 -69.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.134 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 70.92 -67.02 0.27 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.638 0.586 . . . . 0.0 111.527 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -97.99 37.64 1.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.966 0.889 . . . . 0.0 109.505 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.739 ' HB3' ' HB3' ' A' ' 8' ' ' LEU . 20.8 pttt -75.53 -28.38 59.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.393 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 3.6 pp -101.33 170.36 8.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.086 -173.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -140.86 34.59 1.77 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.506 0.67 . . . . 0.0 109.868 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -129.56 147.85 66.95 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.338 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.79 -25.55 23.69 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.042 1.828 . . . . 0.0 111.531 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.468 HG22 ' HG3' ' A' ' 48' ' ' LYS . 15.3 t -145.61 139.91 21.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.743 175.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 49' ' ' THR . 4.2 mt -88.36 160.73 2.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.39 136.4 57.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -68.23 -13.68 62.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.168 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.6 tp -67.88 -41.95 82.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.964 0.411 . . . . 0.0 109.899 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 78.3 t80 -63.22 -36.97 85.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -64.78 -50.89 56.15 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.204 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -52.28 -37.83 56.64 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 122.361 0.264 . . . . 0.0 111.12 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.7 mm-40 -59.51 -50.39 74.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.702 0.401 . . . . 0.0 111.679 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 51.7 mt -53.33 -58.85 5.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.717 0.77 . . . . 0.0 110.316 176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.757 HD11 HG11 ' A' ' 58' ' ' VAL . 8.5 mp -62.54 -35.67 80.17 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.057 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.73 -41.5 81.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 87.8 mttt -70.23 -29.37 66.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.503 ' HE1' ' HA ' ' A' ' 80' ' ' LYS . 84.3 m-85 -98.27 1.55 47.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -55.16 -43.37 74.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 120.98 0.419 . . . . 0.0 111.002 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.51 -34.13 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.125 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.92 -40.22 28.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.209 0.528 . . . . 0.0 110.166 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.583 HG22 ' HB ' ' A' ' 39' ' ' VAL . 70.1 mt -63.19 -36.88 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.208 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.9 tttm -80.34 -30.77 38.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.895 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.47 -44.11 89.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.093 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -94.4 -41.48 9.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.468 ' HB2' HG23 ' A' ' 39' ' ' VAL . 46.4 m-85 -114.27 -29.66 6.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.0 111.32 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.38 54.26 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.662 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 33' ' ' ILE . 18.5 t -117.36 151.36 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 0.0 110.81 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.543 ' OD2' ' HG2' ' A' ' 42' ' ' LYS . 9.7 t70 -107.13 125.04 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 26' ' ' LEU . 13.9 p -76.01 -14.27 60.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 8.1 ptpp? -77.61 -17.09 58.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.88 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.99 -22.69 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.294 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.77 118.84 10.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.511 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 63.2 tttp -82.77 98.79 9.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.249 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.652 ' HA ' HG12 ' A' ' 60' ' ' VAL . 48.2 mt -73.11 119.73 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.543 0.687 . . . . 0.0 110.747 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.7 mt -90.18 -44.46 9.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.099 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.468 ' HG3' HG22 ' A' ' 16' ' ' VAL . 58.2 tttm -149.49 106.02 3.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.192 -172.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 17' ' ' ILE . 11.0 m -86.88 123.9 32.52 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.0 m -160.47 -178.41 6.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.3 pt-20 -138.88 152.96 48.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.669 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 30.0 t70 -148.18 125.75 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HG3' ' OD1' ' A' ' 52' ' ' ASP . 38.7 mttp 60.17 -138.52 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.844 ' HB3' HG11 ' A' ' 76' ' ' VAL . 73.2 mtm180 -80.16 12.72 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.629 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.617 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 3.8 m-85 -137.15 152.86 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.15 -167.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.741 ' HE2' HG21 ' A' ' 2' ' ' ILE . 14.6 m-85 -91.55 150.71 21.07 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 169.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.669 ' CE2' ' HB3' ' A' ' 52' ' ' ASP . 65.0 m-85 -130.13 98.05 4.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.757 0.313 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.757 HG11 HD11 ' A' ' 26' ' ' LEU . 21.5 t -100.03 93.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 2.1 t -76.71 124.33 27.51 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 46' ' ' ILE . 11.6 m -134.8 151.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.092 0.473 . . . . 0.0 111.211 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.1 t70 -87.49 117.15 26.09 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.63 -9.43 59.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.811 0.339 . . . . 0.0 111.702 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.74 -28.41 4.46 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.229 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -64.0 -28.03 69.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 0.0 110.065 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.74 -27.92 3.15 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.266 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -83.62 152.99 24.52 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.201 0.524 . . . . 0.0 111.443 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -103.14 111.71 24.21 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 2.4 t -95.76 168.97 10.33 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.605 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 19.1 ttmm -148.04 94.49 2.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 79.0 m-85 -72.56 89.73 1.31 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.899 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 74.2 tttt -78.6 93.01 4.77 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.742 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 80.4 mt -83.03 105.88 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.53 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.662 ' H ' ' HA ' ' A' ' 81' ' ' MET . 14.5 ttt180 -66.03 121.34 14.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.521 ' HE3' ' C ' ' A' ' 55' ' ' PHE . 71.4 mttt -65.73 168.37 7.87 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.301 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.0 7.84 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 0.0 110.542 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.844 HG11 ' HB3' ' A' ' 54' ' ' ARG . 2.7 p -53.86 -33.15 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 122.441 1.115 . . . . 0.0 109.3 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.561 ' O ' HG12 ' A' ' 78' ' ' VAL . 27.6 t70 -164.84 118.42 1.29 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.872 -1.967 . . . . 0.0 108.387 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 77' ' ' ASP . 8.9 p 54.79 124.67 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.74 0 O-C-N 125.01 1.444 . . . . 0.0 112.683 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 84.7 Cg_endo -79.04 47.44 2.49 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 123.746 2.964 . . . . 0.0 112.555 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 7.3 mtmt -147.24 146.99 29.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.662 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 8.1 ptt? -57.23 108.47 0.53 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.11 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.659 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 9.1 p -59.91 -40.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.788 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -145.57 91.36 0.15 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.263 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -76.49 58.47 1.34 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.018 0.914 . . . . 0.0 108.635 170.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -95.97 119.17 34.0 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.882 -167.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -83.87 124.04 30.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.333 0.587 . . . . 0.0 109.535 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 . . . . . 0 C--N 1.308 -1.236 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -179.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.409 ' OG ' ' HZ ' ' A' ' 29' ' ' PHE . 58.0 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.052 0.453 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.732 HD22 ' H ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -115.26 97.52 6.24 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.413 HG23 ' CD1' ' A' ' 3' ' ' LEU . 5.4 tp -163.47 -20.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.041 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.884 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 3.9 mp -116.98 1.03 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 t70 66.97 -62.43 0.3 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.655 0.597 . . . . 0.0 111.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.36 61.14 0.19 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.599 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 25.7 t0 76.75 23.07 1.07 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.649 0.738 . . . . 0.0 111.077 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 6.5 tt -98.08 122.95 41.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.617 HD23 HD23 ' A' ' 7' ' ' LEU . 2.2 pt? -41.04 -66.68 0.31 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -167.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.576 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 31.8 mmtp 65.06 -67.8 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.614 ' HB2' HD23 ' A' ' 12' ' ' LEU . 3.3 p30 -59.17 -54.0 51.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.8 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG2' HD12 ' A' ' 8' ' ' LEU . 42.4 mtpt 53.45 43.97 30.59 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.341 0.4 . . . . 0.0 111.043 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.614 HD23 ' HB2' ' A' ' 10' ' ' ASP . 4.3 mm? -63.52 -86.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.382 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.686 ' N ' ' HE2' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 54.41 61.43 3.02 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 109.991 177.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 82.8 mt -134.97 174.69 4.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.459 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.2 Cg_endo -63.5 -153.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.896 2.397 . . . . 0.0 111.066 165.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 48' ' ' LYS . 23.8 t -58.75 106.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.757 0.789 . . . . 0.0 109.944 175.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.59 156.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.486 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -49.05 133.03 18.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.107 0.479 . . . . 0.0 111.213 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -67.42 -25.52 65.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.729 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.38 -50.39 70.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 50.8 t80 -59.15 -38.58 80.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.722 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -64.54 -47.04 88.19 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 9.2 mmmm -54.77 -36.92 65.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.314 0.246 . . . . 0.0 111.027 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.3 mm-40 -60.04 -47.0 87.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.429 0.456 . . . . 0.0 111.492 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 72' ' ' ILE . 89.0 mt -52.46 -63.78 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.462 174.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.761 HD11 HG11 ' A' ' 58' ' ' VAL . 7.7 mp -59.67 -32.33 70.39 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.292 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.42 -40.29 86.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.216 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 50.6 mttm -75.5 -32.36 60.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.644 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 91.8 m-85 -96.44 8.47 43.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -54.04 -39.56 66.31 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.246 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.4 -39.78 94.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.664 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.52 -38.53 54.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.15 -26.4 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.288 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 82.0 tttt -83.55 -28.17 28.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.614 0.721 . . . . 0.0 109.84 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.94 -46.39 62.5 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.273 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -77.73 -39.75 43.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.761 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.625 ' HB2' HG23 ' A' ' 39' ' ' VAL . 90.0 m-85 -114.88 -48.01 2.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.449 0.642 . . . . 0.0 110.966 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.16 39.05 2.35 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.296 -171.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG12 ' H ' ' A' ' 41' ' ' THR . 13.5 t -109.3 150.82 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.831 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 42' ' ' LYS . 32.0 t70 -92.99 11.17 28.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 0.0 110.132 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.647 ' H ' HG12 ' A' ' 39' ' ' VAL . 46.6 p 56.16 -24.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.7 1.6 . . . . 0.0 114.129 -172.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 42' ' ' LYS . 4.4 ttmp? -72.83 -12.92 61.17 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 110.517 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.1 -42.5 17.33 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.759 0.79 . . . . 0.0 108.875 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.62 ' HG ' HG11 ' A' ' 39' ' ' VAL . 57.1 mt -61.67 106.11 0.63 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.376 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.632 ' HD3' HD23 ' A' ' 47' ' ' LEU . 6.1 tmtm? -79.91 116.61 20.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.403 ' HA ' HG12 ' A' ' 60' ' ' VAL . 41.3 mt -73.6 128.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.546 0.688 . . . . 0.0 110.956 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.632 HD23 ' HD3' ' A' ' 45' ' ' LYS . 15.3 mt -97.92 -51.5 4.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.889 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.581 ' HA ' HG13 ' A' ' 16' ' ' VAL . 62.4 tttm -144.73 102.86 3.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.461 -173.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.4 m -78.9 121.72 25.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -153.22 -177.78 6.54 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.818 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 1.7 pp20? -162.55 160.83 26.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.808 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.681 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 29.7 t70 -103.78 -86.14 0.45 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.735 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -131.33 -79.23 0.52 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' HB3' HG11 ' A' ' 76' ' ' VAL . 52.5 mtt180 -87.99 16.93 5.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 0.0 110.818 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -144.6 135.62 25.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.684 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.9 m-85 -94.88 151.45 19.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.681 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 78.1 m-85 -137.8 109.59 7.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.349 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 26' ' ' LEU . 21.8 t -110.7 108.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.1 t -84.27 130.72 34.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 67' ' ' LYS . 26.9 m -135.4 148.29 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.136 0.494 . . . . 0.0 112.167 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.537 ' HB2' HD21 ' A' ' 47' ' ' LEU . 34.7 t70 -90.26 112.88 24.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.93 -63.88 1.13 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.798 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.67 -130.27 2.07 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.096 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.39 -8.14 21.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.098 0.475 . . . . 0.0 109.813 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.73 -33.95 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.603 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.45 136.56 58.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.214 0.53 . . . . 0.0 111.132 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 42.5 mttp -137.17 106.3 6.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.96 -173.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 1.9 t -96.09 148.0 23.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.352 -173.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 5.0 ttmp? -115.03 102.78 10.26 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.71 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 62.1 m-85 -68.44 127.48 33.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.659 ' HE3' HG11 ' A' ' 82' ' ' VAL . 56.7 tttp -100.71 83.45 2.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.666 0.746 . . . . 0.0 109.938 -175.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 94.8 mt -81.25 89.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.952 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.654 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 39.7 ttt180 -58.9 117.72 4.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HB3' HD13 ' A' ' 3' ' ' LEU . 93.9 mttt -60.9 174.07 0.68 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.569 -176.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.884 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 53.1 t0 -71.89 64.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 0.0 110.513 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.599 ' HA ' ' N ' ' A' ' 6' ' ' ASP . 31.1 m -99.09 -7.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.438 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -175.16 -61.49 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.024 -171.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.1 151.02 37.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.577 . . . . 0.0 111.186 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -90.34 32.74 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.709 2.94 . . . . 0.0 110.977 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.644 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 3.0 ttmt -150.88 -166.18 2.47 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.178 0.513 . . . . 0.0 111.099 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.546 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 67.9 mtm -97.04 127.2 42.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.226 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG11 ' HE3' ' A' ' 71' ' ' LYS . 7.6 p -53.01 -33.13 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.455 0.645 . . . . 0.0 109.903 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.76 -143.42 8.41 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.919 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.71 ' HB2' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER 176.3 148.78 0.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -148.49 121.07 8.56 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.945 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 1.4 m -88.19 130.31 35.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 . . . . . 0 C--N 1.319 -0.721 0 CA-C-O 122.067 0.937 . . . . 0.0 109.893 -172.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.459 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 28.6 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.822 ' H ' ' HE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -125.76 108.59 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.742 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.808 HG21 ' HE1' ' A' ' 56' ' ' TYR . 3.3 tp -176.36 -6.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.645 HD11 ' H ' ' A' ' 8' ' ' LEU . 7.1 tp -144.27 -18.25 0.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.405 -171.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 65.41 9.53 5.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.887 0.475 . . . . 0.0 112.069 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.719 ' HA2' ' H ' ' A' ' 77' ' ' ASP . . . 71.49 18.11 76.79 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.647 -172.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -103.36 -35.25 8.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.562 ' HA ' ' HG ' ' A' ' 3' ' ' LEU . 6.8 mp 71.03 109.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.517 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.645 ' H ' HD11 ' A' ' 3' ' ' LEU . 58.0 tp -109.62 88.37 2.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.586 ' HA ' HD21 ' A' ' 12' ' ' LEU . 9.5 ptpp? -93.35 14.3 18.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.559 -172.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.534 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 20.5 t70 -88.8 -29.71 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.219 0.533 . . . . 0.0 110.565 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 -20.98 32.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.299 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.586 HD21 ' HA ' ' A' ' 9' ' ' LYS . 2.3 pp -87.53 45.57 1.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.847 0.832 . . . . 0.0 111.692 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.534 ' HD3' ' O ' ' A' ' 10' ' ' ASP . 40.8 mtpt -115.06 21.87 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.965 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.41 154.77 46.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.418 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.55 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.255 2.637 . . . . 0.0 110.966 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' CG2' ' HG3' ' A' ' 48' ' ' LYS . 3.4 p -54.71 108.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 122.335 1.064 . . . . 0.0 110.38 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.822 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 33.3 mt -75.82 149.57 6.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.3 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.22 139.64 47.17 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.097 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.494 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -60.29 -24.55 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.063 -176.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 20' ' ' LEU . 2.6 tm? -70.43 -39.74 74.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.581 ' O ' HD13 ' A' ' 25' ' ' LEU . 77.5 t80 -62.02 -43.93 97.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -67.74 -29.67 73.98 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.431 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -70.05 -37.39 75.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 36.2 mm-40 -59.18 -47.75 84.17 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.693 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 21' ' ' PHE . 8.7 mp -50.42 -67.34 0.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.943 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 26.5 mt -50.38 -30.19 11.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.795 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.25 -45.72 46.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.372 -0.205 . . . . 0.0 110.72 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 63.6 mttm -65.88 -46.77 77.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.278 0.561 . . . . 0.0 110.41 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.822 ' HE2' ' H ' ' A' ' 1' ' ' LEU . 19.5 m-85 -91.33 13.21 18.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.787 -174.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.84 -51.43 67.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.7 m-20 -80.74 11.17 4.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.369 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.03 -43.98 5.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.581 HG21 ' HE2' ' A' ' 70' ' ' PHE . 38.8 mt -66.93 -38.2 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.685 174.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -83.05 -22.76 33.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.845 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 15.2 t70 -68.51 -55.3 12.21 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.272 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 81' ' ' MET . 58.2 mttm -69.51 -50.73 42.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.417 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.533 ' OH ' ' HA2' ' A' ' 83' ' ' GLY . 26.9 m-85 -116.71 -6.4 11.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.92 29.28 73.49 Favored Glycine 0 CA--C 1.516 0.136 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.494 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 33' ' ' ILE . 28.2 t -97.93 147.72 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.554 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.23 127.57 50.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.943 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 71.8 p -87.94 -20.11 26.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.816 0.341 . . . . 0.0 111.858 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -68.19 -39.74 82.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -61.05 -29.01 69.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.862 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 64.2 mt -69.52 149.95 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -175.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -115.01 121.15 42.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.432 172.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.606 HG12 HG12 ' A' ' 60' ' ' VAL . 26.5 mt -84.65 132.25 32.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.512 0.673 . . . . 0.0 111.779 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 61' ' ' ASP . 5.7 mt -101.76 -52.04 3.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.733 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 38.4 ttmt -146.35 115.3 6.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.059 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.822 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -91.59 139.04 31.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -157.41 -175.41 5.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 12' ' ' LEU . 13.1 pt-20 -163.74 150.8 12.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.298 0.57 . . . . 0.0 111.962 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.76 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 27.8 t70 -99.55 -158.84 0.7 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.793 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 4.0 mptt -73.11 -70.61 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -87.12 13.63 9.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 91.0 m-85 -145.67 152.21 39.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.808 ' HE1' HG21 ' A' ' 2' ' ' ILE . 30.9 m-85 -108.17 147.01 31.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.009 166.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.76 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 66.1 m-85 -130.37 95.7 3.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.818 0.342 . . . . 0.0 110.329 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 22.0 t -104.7 97.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.049 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.693 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.2 t -69.02 114.03 6.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 46' ' ' ILE . 13.7 m -129.28 152.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.429 0.633 . . . . 0.0 111.265 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.6 ' HB2' HD21 ' A' ' 47' ' ' LEU . 12.3 t70 -84.41 115.53 22.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.28 -14.5 60.51 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.297 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.99 -42.76 2.35 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.602 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.18 -30.14 64.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.903 0.481 . . . . 0.0 111.293 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.55 -19.46 1.67 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.453 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.587 ' OE2' ' HB3' ' A' ' 86' ' ' CYS . 6.2 pt-20 -104.71 166.17 10.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.321 0.582 . . . . 0.0 112.345 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -111.92 117.66 33.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.153 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 62.1 m -111.84 114.99 28.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.036 0.446 . . . . 0.0 111.19 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.933 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.5 ttmt -88.82 85.28 6.73 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 170.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.581 ' HE2' HG21 ' A' ' 33' ' ' ILE . 5.9 m-85 -47.91 116.3 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.913 -172.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.766 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 62.4 tttt -95.67 69.79 2.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.242 -174.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.842 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 36.7 mt -74.52 91.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.454 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.822 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 24.4 ttt180 -50.58 117.43 2.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.45 ' HE3' ' CE1' ' A' ' 56' ' ' TYR . 43.0 mttp -59.4 166.3 2.37 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.03 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 17.9 t0 -67.68 74.75 0.18 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.632 0.73 . . . . 0.0 109.68 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 74' ' ' LYS . 3.7 m -104.31 94.39 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.672 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.719 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 34.5 t70 72.21 -61.14 0.5 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.293 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.67 141.56 22.76 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.322 0.582 . . . . 0.0 110.19 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HB2' ' H2 ' ' A' ' 0' ' ' SER . 23.1 Cg_endo -91.85 84.29 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.463 2.776 . . . . 0.0 113.62 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 5.2 mtmt -165.51 153.55 11.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.547 176.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.842 ' HG3' ' HA ' ' A' ' 72' ' ' ILE . 4.5 ttp -82.24 121.39 26.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.811 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.822 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.3 p -60.88 -39.4 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.382 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.533 ' HA2' ' OH ' ' A' ' 37' ' ' TYR . . . 178.87 -153.02 11.82 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.895 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.766 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 41.3 mtm180 -151.43 125.75 9.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.933 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 24.5 tptp -76.28 55.57 0.98 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.339 0.59 . . . . 0.0 110.106 -178.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.587 ' HB3' ' OE2' ' A' ' 66' ' ' GLU . 39.3 m -72.47 -164.63 0.16 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.832 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 98.2 mtt180 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 79' ' ' PRO . 11.4 p . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.1 mp 52.09 -153.05 0.22 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.005 171.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.616 HD13 ' HE2' ' A' ' 56' ' ' TYR . 79.4 mt 79.57 -56.5 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.029 168.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.785 HD13 ' HA ' ' A' ' 7' ' ' LEU . 64.9 mt -105.46 -42.89 5.1 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.848 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 29.6 m-20 60.46 71.81 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.672 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.1 31.34 80.46 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.543 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.0 t70 -135.24 -153.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.785 ' HA ' HD13 ' A' ' 3' ' ' LEU . 86.0 mt -154.23 172.29 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 110.668 -171.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.686 HD21 ' HZ3' ' A' ' 74' ' ' LYS . 2.4 pt? -140.4 120.32 13.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -100.92 -18.08 16.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.778 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -94.17 -30.14 14.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HA ' HD12 ' A' ' 8' ' ' LEU . 10.4 mtmp? 57.78 -168.78 0.12 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.807 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.41 HD11 ' CE2' ' A' ' 21' ' ' PHE . 84.1 mt -90.47 -74.71 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.677 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HE3' HG23 ' A' ' 17' ' ' ILE . 31.1 pttt -175.93 -161.78 0.09 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -168.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.469 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 10.7 mp -66.76 169.33 8.11 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.367 0.667 . . . . 0.0 112.189 -175.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 98.5 Cg_exo -47.99 159.33 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.811 3.007 . . . . 0.0 113.891 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 49' ' ' THR . 11.0 p 40.96 104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 123.482 1.611 . . . . 0.0 113.432 -173.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.732 HG22 ' H ' ' A' ' 18' ' ' ASP . 9.8 mt -87.66 -177.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.469 -175.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.732 ' H ' HG22 ' A' ' 17' ' ' ILE . 4.0 m-20 -59.99 -4.93 0.85 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.58 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 12.8 m120 72.9 -44.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.485 0.714 . . . . 0.0 110.981 -176.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -59.82 -31.57 69.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.779 0.432 . . . . 0.0 110.675 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.521 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 38.5 t80 -65.5 -35.63 81.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 109.754 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -77.11 -27.64 59.76 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 177.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -65.59 -37.66 87.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.6 -48.86 77.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.181 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 84.0 mt -49.76 -69.11 0.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.028 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 33.7 mt -52.78 -26.68 15.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.88 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.99 -48.75 67.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 110.958 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -69.3 -40.98 77.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.192 0.52 . . . . 0.0 110.365 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.36 3.83 52.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.818 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 31.3 tt0 -54.95 -40.56 70.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -65.86 -26.65 67.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.993 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 35' ' ' ASP . 7.9 t70 -85.57 -40.17 16.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.511 0.672 . . . . 0.0 109.681 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.422 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.5 mt -69.25 -34.03 61.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.412 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.492 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 86.4 tttt -75.83 -31.54 59.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 18.7 t70 -59.94 -35.59 75.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.643 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -105.87 -25.31 12.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -173.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' HB2' HG23 ' A' ' 39' ' ' VAL . 74.0 m-85 -128.14 -31.38 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.54 63.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.111 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 37' ' ' TYR . 46.5 t -120.7 151.51 23.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 -173.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 42' ' ' LYS . 23.1 t70 -108.65 110.14 21.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 17.3 p -72.32 -10.43 59.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.501 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 6.3 ttpm? -78.04 -35.0 50.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.039 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.32 -28.62 59.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 109.589 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 41' ' ' THR . 1.4 mp -54.11 115.99 2.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.405 176.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 2.8 ttmp? -86.32 108.55 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.972 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.676 ' HA ' HG12 ' A' ' 60' ' ' VAL . 36.4 mt -80.27 122.6 35.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.445 0.641 . . . . 0.0 111.094 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.1 mt -96.03 -51.71 4.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.956 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -142.43 106.31 4.71 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.265 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 11.3 m -91.04 132.13 36.2 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' HG13 ' A' ' 17' ' ' ILE . 69.0 m -152.54 -175.11 5.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 11' ' ' LYS . 12.5 pt-20 -149.64 158.65 44.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.763 0.792 . . . . 0.0 111.519 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.671 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 28.1 t70 -111.56 -164.94 0.95 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 166.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.854 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 1.2 mptt -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 40.0 mtp180 -83.5 -0.1 48.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.584 -172.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.455 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 m-85 -148.15 159.71 43.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.237 0.541 . . . . 0.0 112.382 -168.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.731 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 36.0 m-85 -109.24 159.75 16.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 163.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.671 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 94.4 m-85 -137.07 93.78 2.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.936 0.398 . . . . 0.0 110.181 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 49' ' ' THR . 13.3 t -102.51 96.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.588 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 12.9 m -78.4 124.44 28.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 46' ' ' ILE . 17.4 m -141.6 160.57 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.543 -173.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 6.0 t70 -92.17 125.33 36.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.544 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -79.81 -13.96 59.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.45 -31.92 7.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.58 8.92 4.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.802 0.334 . . . . 0.0 111.23 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.21 -15.08 63.74 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.625 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.544 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 9.6 pt-20 -84.16 142.19 30.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.162 0.506 . . . . 0.0 110.749 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -97.62 134.9 40.2 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.9 t -126.63 164.66 20.77 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.25 0.548 . . . . 0.0 110.623 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.637 ' H ' ' HA ' ' A' ' 86' ' ' CYS . 35.7 ttmt -147.43 103.87 3.59 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 26' ' ' LEU . 72.0 m-85 -77.36 88.08 3.76 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.571 0.7 . . . . 0.0 110.529 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 1.05 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 31.1 tttp -71.63 78.02 0.82 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.924 170.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.731 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 78.9 mt -74.43 95.84 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.247 -176.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.783 ' HB2' HG12 ' A' ' 82' ' ' VAL . 40.5 ttp180 -61.76 101.64 0.21 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.686 ' HZ3' HD21 ' A' ' 8' ' ' LEU . 88.8 mttt -48.72 152.3 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.369 1.043 . . . . 0.0 109.687 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.848 ' HB3' ' H ' ' A' ' 4' ' ' ASP . 29.3 t0 -69.47 70.78 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.411 0.624 . . . . 0.0 109.56 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 33.7 m -89.2 -4.34 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.865 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 t70 178.57 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.732 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.51 HG23 ' HD2' ' A' ' 79' ' ' PRO . 7.1 p -137.29 138.34 24.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.326 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.536 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 68.4 Cg_endo -83.06 62.88 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.493 2.796 . . . . 0.0 112.855 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -145.28 128.28 16.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 111.471 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.515 ' HG3' HG23 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.59 95.63 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.13 177.183 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.783 HG12 ' HB2' ' A' ' 73' ' ' ARG . 10.0 p -60.58 -41.54 88.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.704 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 1.05 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -89.5 47.76 3.29 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 -173.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -81.77 45.53 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -105.01 -26.28 12.21 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.818 -165.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.637 ' HA ' ' H ' ' A' ' 69' ' ' LYS . 49.4 m 66.35 -178.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.906 -171.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 N--CA 1.437 -1.088 0 CA-C-O 121.546 0.688 . . . . 0.0 109.285 -172.924 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 2' ' ' ILE . 27.2 mt -118.59 -144.43 0.37 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.627 HG21 ' HE2' ' A' ' 56' ' ' TYR . 1.3 tp 81.2 -25.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.981 0.912 . . . . 0.0 112.492 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.821 HD13 ' HA ' ' A' ' 6' ' ' ASP . 30.8 mt -124.0 161.9 24.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.954 0.407 . . . . 0.0 110.659 176.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.588 ' HB3' HD12 ' A' ' 7' ' ' LEU . 18.7 t70 -121.81 81.01 1.76 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.59 43.78 97.49 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.392 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.821 ' HA ' HD13 ' A' ' 3' ' ' LEU . 34.6 t70 67.14 96.73 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.228 0.537 . . . . 0.0 111.951 -177.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 4' ' ' ASP . 75.6 mt -149.4 100.03 2.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.62 HD23 ' HD3' ' A' ' 53' ' ' LYS . 51.7 tp -112.19 -68.19 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 38.0 mtmt 76.77 -66.49 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.564 . . . . 0.0 111.856 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -125.75 134.18 51.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.856 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -149.43 3.54 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.46 128.5 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.165 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 14' ' ' LEU . 59.3 tttt -136.69 165.8 25.07 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' H ' ' HG2' ' A' ' 13' ' ' LYS . 61.9 mt -55.01 159.15 4.04 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 122.654 0.382 . . . . 0.0 111.342 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.26 138.82 4.45 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.594 2.862 . . . . 0.0 113.5 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p 43.69 102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 123.129 1.442 . . . . 0.0 113.578 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.88 162.31 4.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.124 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.88 133.31 22.27 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.345 0.403 . . . . 0.0 111.126 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -64.01 -20.85 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.913 0.387 . . . . 0.0 110.254 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -69.03 -31.55 70.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.418 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HE1' ' HE1' ' A' ' 56' ' ' TYR . 55.5 t80 -68.6 -40.07 80.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 109.698 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -72.26 -29.85 65.8 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.162 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -67.27 -40.49 86.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.2 mm-40 -52.77 -51.72 59.51 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.744 173.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.514 HD13 HD12 ' A' ' 72' ' ' ILE . 68.3 mt -53.97 -66.36 0.41 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.839 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.549 HD22 HG22 ' A' ' 41' ' ' THR . 20.4 mt -54.06 -28.36 38.34 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.46 -50.23 60.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 72.4 mttt -71.54 -33.77 69.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.816 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -96.88 4.9 51.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.789 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.4 tt0 -56.52 -41.63 77.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.775 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -65.69 -20.99 66.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.551 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -94.61 -39.93 10.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.277 0.561 . . . . 0.0 110.042 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.538 HG22 ' HB ' ' A' ' 39' ' ' VAL . 53.7 mt -67.76 -31.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.313 176.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 44.1 tttp -81.73 -29.15 33.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.306 0.574 . . . . 0.0 109.803 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.39 -52.59 31.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.574 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -71.44 -43.39 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.621 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.576 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 86.6 m-85 -118.59 -23.54 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.14 44.11 7.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.875 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.556 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.3 t -100.99 152.79 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -114.4 116.61 29.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.554 HG22 HD12 ' A' ' 44' ' ' LEU . 39.7 p -76.22 -11.6 59.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -73.68 -20.46 60.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.358 0.599 . . . . 0.0 109.53 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -92.23 -33.0 14.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.327 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.554 HD12 HG22 ' A' ' 41' ' ' THR . 86.6 mt -56.67 111.55 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.959 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 75.8 tttt -84.11 104.35 14.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.71 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.618 ' HA ' HG12 ' A' ' 60' ' ' VAL . 37.7 mt -73.73 112.68 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.546 0.688 . . . . 0.0 111.029 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.6 mt -82.25 -43.5 17.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.065 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -154.04 120.38 5.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.347 -173.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -102.46 130.21 49.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.9 m -157.29 177.03 11.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 11' ' ' LYS . 1.2 pt-20 -158.61 167.05 30.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 171.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -149.01 89.78 1.7 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.107 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.856 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 5.3 tppp? 70.41 -100.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.726 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.625 ' HB3' HG21 ' A' ' 76' ' ' VAL . 65.8 mtt180 -94.71 20.44 8.64 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.73 -0.606 . . . . 0.0 111.451 -171.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -148.63 121.01 8.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.818 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.779 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.0 m-85 -85.78 150.96 24.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 95.05 3.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.8 t -105.86 93.92 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 110.516 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.1 m -80.02 119.9 23.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 46' ' ' ILE . 11.5 m -130.29 158.09 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.31 0.576 . . . . 0.0 111.343 -176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -84.55 123.5 30.37 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.55 4.44 7.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.77 1.32 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.372 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.93 -27.05 39.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.136 0.493 . . . . 0.0 110.473 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.59 -21.62 2.37 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.202 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -66.95 147.89 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.398 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -109.47 110.3 21.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.049 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 56.2 m -108.18 131.43 54.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 34.8 ttmt -101.48 107.18 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.575 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 65.5 m-85 -76.48 84.55 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.184 0.992 . . . . 0.0 110.433 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 1.116 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 21.3 tttp -76.72 89.58 3.39 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.197 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.779 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 mt -87.23 106.22 15.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.494 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.729 ' HB2' HG22 ' A' ' 82' ' ' VAL . 60.3 ttt180 -78.7 18.09 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.462 0.648 . . . . 0.0 110.336 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.624 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.7 mttt 55.43 -157.12 0.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.229 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 32.0 t70 -100.83 56.0 0.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.625 HG21 ' HB3' ' A' ' 54' ' ' ARG . 17.9 t -75.44 -13.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.281 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.8 t70 179.92 -54.63 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.315 -171.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' HD2' ' A' ' 79' ' ' PRO . 10.0 p -120.75 139.03 28.34 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.667 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 78' ' ' VAL . 55.5 Cg_endo -75.16 67.39 6.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.664 2.243 . . . . 0.0 111.86 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -142.03 142.24 32.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.628 0.727 . . . . 0.0 111.985 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.521 ' HG3' HG23 ' A' ' 72' ' ' ILE . 1.5 mpp? -80.7 89.45 5.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.587 173.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 73' ' ' ARG . 35.0 m -58.84 -33.49 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.916 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 1.116 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -92.18 72.8 1.55 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.053 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.576 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -105.39 47.73 0.86 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -115.53 142.1 47.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.979 -170.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.8 m -108.26 132.02 54.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.049 0.452 . . . . 0.0 109.925 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 . . . . . 0 C--N 1.314 -0.958 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.495 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.412 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 26.1 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.291 0.567 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.964 ' HA ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -67.9 131.04 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.597 1.189 . . . . 0.0 113.47 -169.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.614 HG13 HD11 ' A' ' 8' ' ' LEU . 11.1 tp -152.36 15.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.167 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 75' ' ' ASP . 1.8 pp -149.2 157.89 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.462 -1.699 . . . . 0.0 108.184 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.61 -29.31 61.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.318 0.58 . . . . 0.0 109.825 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 40.99 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 24.1 p-10 -157.96 -80.26 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.852 -168.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 6' ' ' ASP . 7.7 mt 175.71 174.14 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.139 0.576 . . . . 0.0 110.252 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.614 HD11 HG13 ' A' ' 2' ' ' ILE . 63.8 mt -100.05 131.63 45.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.156 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -98.46 -30.28 12.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' OD2' ' HG3' ' A' ' 11' ' ' LYS . 6.4 p-10 -80.48 -38.03 30.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.068 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HB2' HD13 ' A' ' 8' ' ' LEU . 57.4 mttp -101.86 67.89 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.652 0.739 . . . . 0.0 109.745 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.763 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.6 pt? -79.25 -36.23 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.344 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.671 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 7.5 ptpt -177.08 101.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.448 0.642 . . . . 0.0 110.851 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.525 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 96.0 mt -100.47 167.51 10.79 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.523 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.6 Cg_endo -64.6 -170.61 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.632 2.221 . . . . 0.0 111.998 173.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 48' ' ' LYS . 2.6 p -63.39 105.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.017 175.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 49' ' ' THR . 3.3 pt -106.07 -177.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.804 -174.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.509 ' OD2' ' HB ' ' A' ' 46' ' ' ILE . 7.9 t70 176.68 -39.58 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -40.41 78.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 112.261 -2.245 . . . . 0.0 113.248 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 78.9 mt 45.7 40.2 5.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.729 0.776 . . . . 0.0 111.035 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.512 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.3 m-85 -117.13 -78.06 0.58 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.127 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.41 90.78 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.491 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HG2' HD12 ' A' ' 46' ' ' ILE . 30.2 mmmt -66.4 -33.29 75.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.364 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 1.5 mm-40 -65.87 -47.14 75.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.607 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 87.0 mt -50.94 -66.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.838 173.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.877 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 34.0 mt -50.89 -33.19 23.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.444 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.28 -48.46 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.195 -0.316 . . . . 0.0 111.074 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 80.0 mttt -67.7 -38.22 83.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.211 0.529 . . . . 0.0 110.496 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 1.5 m-85 -98.54 12.59 34.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.46 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.665 ' NE2' ' HA ' ' A' ' 40' ' ' ASP . 32.2 tt0 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.63 -33.15 71.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.347 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.661 ' O ' ' HD2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -76.58 -46.88 24.4 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.534 178.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.511 HG22 ' HB ' ' A' ' 39' ' ' VAL . 42.5 mt -65.45 -20.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.613 0.72 . . . . 0.0 110.266 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 46.9 tttm -87.66 -40.18 14.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.645 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.89 -47.91 76.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.906 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.661 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 8.0 mttp -82.5 -28.74 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.26 -175.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.492 ' HB2' HG23 ' A' ' 39' ' ' VAL . 67.8 m-85 -133.67 -52.43 0.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.018 0.437 . . . . 0.0 111.526 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.53 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . 106.78 62.53 0.59 Allowed Glycine 0 C--N 1.319 -0.393 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 33' ' ' ILE . 47.3 t -124.45 151.84 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.905 0.383 . . . . 0.0 111.372 -171.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.665 ' HA ' ' NE2' ' A' ' 30' ' ' GLN . 28.7 t70 -103.19 121.33 42.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.54 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.877 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 41.1 p -88.56 -10.69 47.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.946 0.403 . . . . 0.0 112.044 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -68.97 -43.16 75.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -73.84 -24.87 59.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.379 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.7 mt -56.71 123.33 14.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.128 0.49 . . . . 0.0 110.692 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -94.2 111.69 23.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.82 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 60' ' ' VAL . 12.4 mt -72.53 116.88 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.487 0.661 . . . . 0.0 111.184 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.3 mt -86.82 -40.02 15.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.929 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HA ' HG23 ' A' ' 16' ' ' VAL . 41.1 tttm -155.0 140.63 17.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.552 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 54.1 m -142.48 127.54 18.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.7 m -156.57 152.53 27.37 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -123.96 162.7 22.86 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 175.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 10.1 t70 -153.69 -98.99 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.672 171.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -93.57 89.79 6.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.912 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.3 mtt180 75.45 -44.84 0.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.657 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 20.5 m-85 -78.98 133.22 36.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.684 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 1.3 m-85 -103.55 121.77 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.718 164.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 49' ' ' THR . 10.7 m-85 -99.07 86.26 3.41 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 18.8 t -96.25 84.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.133 0.492 . . . . 0.0 110.4 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 23.5 t -82.44 117.57 22.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 46' ' ' ILE . 15.2 m -129.84 156.26 42.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.248 0.547 . . . . 0.0 111.618 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.0 119.53 21.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.23 2.75 14.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.2 -50.44 3.63 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.916 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.94 -35.97 80.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.019 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.97 -31.48 0.89 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.885 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -71.6 161.06 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.066 0.46 . . . . 0.0 111.411 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -119.22 105.15 11.07 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.534 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 55.9 m -103.62 127.27 51.08 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.468 -173.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.8 ttpt -99.13 104.46 16.45 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.761 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 85.6 m-85 -71.43 95.99 1.43 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.656 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.647 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 34.6 tttm -81.9 78.2 8.64 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.426 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 74' ' ' LYS . 57.5 mt -82.61 101.94 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.306 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 38.4 ttp180 -74.22 21.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.535 0.683 . . . . 0.0 109.827 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.684 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.1 mttt 64.3 174.25 0.19 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.564 -174.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.964 ' HB2' ' HA ' ' A' ' 1' ' ' LEU . 2.2 t70 -77.39 43.44 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.937 0.398 . . . . 0.0 110.37 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.406 HG11 ' HG2' ' A' ' 54' ' ' ARG . 6.9 m -64.17 91.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.248 0.547 . . . . 0.0 110.884 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 76.55 -50.68 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.095 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 34.8 m -107.25 146.23 32.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.382 0.61 . . . . 0.0 111.27 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.583 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.0 Cg_endo -90.73 54.61 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.737 2.958 . . . . 0.0 113.915 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -145.46 149.17 34.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.775 0.322 . . . . 0.0 111.221 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.419 ' CG ' HG12 ' A' ' 72' ' ' ILE . 2.6 mpp? -81.66 102.16 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 9.5 p -57.85 -31.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.027 0.442 . . . . 0.0 111.288 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -125.08 148.05 16.67 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.062 -177.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -173.81 54.14 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -98.92 129.05 45.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.226 -168.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -89.79 115.12 26.89 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.603 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 . . . . . 0 C--N 1.308 -1.202 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.045 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.961 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 7.8 t . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.41 78.61 9.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.213 0.53 . . . . 0.0 109.874 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 2' ' ' ILE . 8.9 tp -151.98 87.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 122.085 0.945 . . . . 0.0 110.219 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.9 pt? -127.96 133.4 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.667 0.746 . . . . 0.0 111.705 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' A' ' 8' ' ' LEU . 10.6 t70 -95.9 -19.91 19.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 168.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.37 71.06 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.079 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.3 t70 63.46 31.24 15.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.126 0.965 . . . . 0.0 109.159 -175.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.741 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 31.5 tp 179.69 -174.08 0.23 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.741 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 34.8 tp -148.12 107.66 3.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -100.56 -14.3 18.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.919 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.1 -48.74 80.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.443 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.21 133.49 24.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.307 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.915 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 22.7 tp -153.74 142.02 20.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.343 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.915 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 36.4 mtmt 67.33 30.95 6.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.9 mt -66.31 129.36 94.18 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 52.4 Cg_exo -57.11 -62.7 0.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 123.59 2.86 . . . . 0.0 112.181 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.696 HG23 ' HG3' ' A' ' 48' ' ' LYS . 8.7 p -146.42 145.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.266 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.547 HG13 ' HA ' ' A' ' 50' ' ' SER . 2.3 mt -119.05 163.12 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.948 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -54.3 140.78 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -67.98 -25.55 65.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.039 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.9 tp -68.06 -45.26 74.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.422 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 79.2 t80 -59.9 -37.07 78.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.473 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -67.64 -51.24 37.28 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.419 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.4 mptp? -51.9 -35.28 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 1.4 mm-40 -59.86 -60.04 4.47 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.463 172.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 63.7 mt -47.89 -56.36 7.71 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.889 0.852 . . . . 0.0 110.62 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.655 HD11 HG11 ' A' ' 58' ' ' VAL . 8.0 mp -63.39 -28.26 69.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.578 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 t70 -62.99 -43.15 99.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.536 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -66.11 -21.19 66.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.961 0.41 . . . . 0.0 110.303 177.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.961 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 65.9 m-85 -107.43 2.64 24.45 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.531 HE22 ' HE3' ' A' ' 42' ' ' LYS . 50.6 tt0 -50.99 -44.5 60.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -173.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -69.88 -35.61 74.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.748 0.309 . . . . 0.0 110.79 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.73 -45.14 65.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.759 0.79 . . . . 0.0 109.794 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.576 HG22 ' HB ' ' A' ' 39' ' ' VAL . 91.9 mt -61.18 -40.28 85.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.656 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.624 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 27.7 ttpp -78.8 -21.38 47.86 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 110.13 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.75 -48.31 16.95 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HE2' ' HE3' ' A' ' 81' ' ' MET . 9.7 mtpp -81.87 -34.97 29.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -124.27 -26.44 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 64.85 1.92 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.993 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.624 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -133.34 150.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 122.309 0.244 . . . . 0.0 110.814 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.7 119.53 39.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.91 170.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 26' ' ' LEU . 53.7 p -75.21 -19.47 59.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.981 -175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.531 ' HE3' HE22 ' A' ' 30' ' ' GLN . 10.3 mtmp? -67.99 -43.09 79.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.064 0.459 . . . . 0.0 110.192 178.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -82.46 -35.28 27.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 60' ' ' VAL . 18.6 tp -50.79 121.5 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.782 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 44.6 tttp -90.8 114.44 26.83 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.812 -171.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.607 ' HA ' HG12 ' A' ' 60' ' ' VAL . 18.0 mt -87.18 125.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.352 0.596 . . . . 0.0 111.361 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.5 mt -100.72 -54.44 2.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.166 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.696 ' HG3' HG23 ' A' ' 16' ' ' VAL . 59.8 tttm -139.41 93.45 2.68 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.487 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -74.64 137.53 42.29 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.547 ' HA ' HG13 ' A' ' 17' ' ' ILE . 4.5 p -171.11 -169.31 0.73 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 118.218 0.463 . . . . 0.0 110.962 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.593 ' OE2' ' HA ' ' A' ' 12' ' ' LEU . 7.2 pt-20 -165.45 168.14 16.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.553 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 39.0 t70 -145.68 -76.38 0.21 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 0.0 111.337 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HG3' ' OD2' ' A' ' 52' ' ' ASP . 56.5 mttp -113.01 82.27 1.63 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.961 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.502 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 66.7 mtt180 72.13 -27.88 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.964 0.506 . . . . 0.0 112.163 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 53' ' ' LYS . 9.6 m-85 -97.11 139.2 33.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.707 0.289 . . . . 0.0 111.361 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.7 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.3 m-85 -82.52 147.83 28.44 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.776 170.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.624 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 58.9 m-85 -131.36 99.83 4.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.163 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.655 HG11 HD11 ' A' ' 26' ' ' LEU . 27.6 t -103.46 93.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.2 m -73.71 120.82 19.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.1 m -130.34 160.17 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.619 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 7.0 t0 -85.23 117.0 23.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.83 -1.7 7.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.74 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.28 60.61 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -121.27 5.45 10.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.305 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.85 -20.24 51.11 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.28 129.53 40.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.561 0.344 . . . . 0.0 111.035 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 55.0 mtpt -95.75 86.0 4.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 0.0 109.894 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.969 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 69.4 m -85.79 118.22 25.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.035 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.624 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 36.4 ttmt -92.34 107.2 19.04 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.573 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 30.8 m-85 -73.65 120.98 19.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.211 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 85.4 tttt -103.92 90.66 3.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.509 -173.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.7 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 64.4 mt -86.71 115.35 27.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.963 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.809 ' H ' ' HA ' ' A' ' 81' ' ' MET . 36.0 ttt180 -85.73 38.21 0.74 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.031 0.443 . . . . 0.0 109.992 -174.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.549 ' HB2' HG12 ' A' ' 76' ' ' VAL . 52.2 mttt 37.24 -152.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.522 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 22.4 t70 -97.89 17.97 16.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 74' ' ' LYS . 2.5 p -73.87 94.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.816 0.817 . . . . 0.0 109.176 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 25.2 t70 84.49 -67.44 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.342 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 35.9 m -90.75 149.16 39.95 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -90.44 34.85 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.218 2.612 . . . . 0.0 111.084 173.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -148.46 -166.15 2.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.426 0.631 . . . . 0.0 111.251 -168.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.809 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 20.7 ptt? -111.35 126.7 55.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.123 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.624 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 7.7 p -59.72 -37.2 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.886 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.38 -157.81 13.2 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.426 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -176.54 102.58 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -174.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -120.49 121.45 38.5 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.969 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 2.5 m -76.17 116.68 17.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.451 ' HE ' ' HB3' ' A' ' 87' ' ' ARG . 16.2 mtp180 . . . . . 0 C--N 1.307 -1.257 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.711 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 3' ' ' LEU . 24.1 mt 72.95 -23.96 0.2 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 2' ' ' ILE . 7.7 tp -81.07 25.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.818 0.818 . . . . 0.0 111.603 -170.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.808 HD11 ' H ' ' A' ' 8' ' ' LEU . 9.4 tp 179.51 176.88 0.61 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -147.6 40.54 1.01 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.498 0.666 . . . . 0.0 109.546 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.52 ' HA2' ' H ' ' A' ' 77' ' ' ASP . . . 69.36 16.89 71.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.345 -174.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 11.7 p-10 -96.75 -37.91 10.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.546 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.806 HD11 ' HG3' ' A' ' 54' ' ' ARG . 4.4 mm? 73.98 88.83 0.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.595 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.808 ' H ' HD11 ' A' ' 3' ' ' LEU . 71.8 mt -71.92 -16.69 62.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.827 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 34.2 mmtp 68.48 -74.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.795 -173.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -120.84 126.41 50.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.516 ' HD3' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -94.89 -37.26 11.27 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.99 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 13' ' ' LYS . 2.6 pp -120.44 -34.17 3.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.83 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.552 ' N ' HD12 ' A' ' 12' ' ' LEU . 19.2 ttpp 53.38 46.32 26.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.694 0.759 . . . . 0.0 110.966 175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 12' ' ' LEU . 93.3 mt -105.3 172.3 4.15 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.25 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 51.1 Cg_exo -58.94 -156.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.149 2.566 . . . . 0.0 111.591 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 48' ' ' LYS . 7.8 p -56.04 126.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.746 0.784 . . . . 0.0 109.93 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.639 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 3.3 mt -86.76 152.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.077 -173.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.53 139.49 25.27 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.687 0.617 . . . . 0.0 111.24 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 25.8 p-10 -66.32 -30.05 70.38 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.066 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -63.37 -45.34 91.57 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.242 0.339 . . . . 0.0 110.428 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 88.6 t80 -59.95 -42.14 93.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -62.63 -49.71 70.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.355 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 29.6 mmmt -54.35 -33.37 58.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.667 0.387 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 7.3 mm-40 -60.63 -54.25 47.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.99 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.595 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 10.8 mp -52.88 -60.0 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.697 HD11 HG11 ' A' ' 58' ' ' VAL . 9.4 mp -60.41 -24.6 65.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.565 -173.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.05 -46.97 69.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 82.4 mttt -72.56 -28.65 62.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.18 0.514 . . . . 0.0 110.344 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.711 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 64.0 m-85 -88.97 -3.28 58.78 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.454 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -54.65 -48.9 71.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.581 0.229 . . . . 0.0 111.085 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.93 -33.97 75.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 80' ' ' LYS . 4.7 t70 -71.15 -50.38 33.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.963 0.887 . . . . 0.0 109.843 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.688 HG21 ' HE1' ' A' ' 70' ' ' PHE . 62.7 mt -65.04 -30.96 51.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 48.3 tttm -84.71 -30.91 24.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.05 -51.27 69.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.253 0.549 . . . . 0.0 110.002 171.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -71.26 -58.95 3.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.363 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -107.28 -36.68 6.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.433 -170.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 34' ' ' LYS . . . 103.95 29.33 5.55 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.785 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 41' ' ' THR . 6.9 t -95.36 142.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.1 t70 -105.14 7.49 33.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.451 0.643 . . . . 0.0 110.949 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.612 ' H ' HG12 ' A' ' 39' ' ' VAL . 70.6 p 55.71 -13.78 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 49.1 mtpt -58.65 -36.67 74.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.098 0.408 . . . . 0.0 111.946 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -74.58 -32.37 62.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.317 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.62 115.88 3.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.721 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.736 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 42.9 tttm -92.25 108.86 20.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.01 171.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.597 ' HA ' HG12 ' A' ' 60' ' ' VAL . 41.6 mt -72.25 119.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.493 0.663 . . . . 0.0 111.664 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 61' ' ' ASP . 12.5 mt -91.44 -42.49 10.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.013 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HG3' HG23 ' A' ' 16' ' ' VAL . 63.5 tttm -156.04 104.77 2.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.922 -174.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.639 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 6.4 m -89.39 132.42 34.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -155.94 173.67 16.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.8 150.33 52.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.423 0.63 . . . . 0.0 110.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -133.02 -174.02 3.36 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.252 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -66.68 113.3 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.806 ' HG3' HD11 ' A' ' 7' ' ' LEU . 24.9 ttt180 75.84 -17.04 0.54 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.729 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.445 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 40.1 m-85 -122.23 147.77 45.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 112.231 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.653 ' HD1' ' HG2' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -106.81 150.79 25.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.548 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 89.4 m-85 -134.54 107.15 7.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 26' ' ' LEU . 21.9 t -108.59 96.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.397 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 18.1 t -76.45 130.69 38.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 46' ' ' ILE . 28.8 m -140.58 152.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.206 0.527 . . . . 0.0 111.879 -174.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.3 t70 -76.56 105.86 7.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.99 34.4 1.93 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 167.55 -96.63 0.13 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.079 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -137.39 -4.73 1.84 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.799 0.333 . . . . 0.0 110.688 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.02 -29.63 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.653 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.41 122.38 18.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.352 0.596 . . . . 0.0 111.001 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -101.31 106.69 17.9 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.024 -174.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 4.4 t -99.86 178.04 4.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.622 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.8 ttmt -156.87 113.04 2.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.688 ' HE1' HG21 ' A' ' 33' ' ' ILE . 14.3 m-85 -80.42 114.17 19.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.129 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HE2' ' CD2' ' A' ' 55' ' ' PHE . 82.5 tttt -87.98 89.17 7.89 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.746 0.784 . . . . 0.0 109.733 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.414 HG23 ' CE1' ' A' ' 29' ' ' PHE . 51.3 mt -81.77 100.02 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.624 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 24.2 ttp180 -68.29 100.93 1.11 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.653 ' HG2' ' HD1' ' A' ' 56' ' ' TYR . 86.0 mttt -47.19 124.59 6.74 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 124.033 0.833 . . . . 0.0 110.69 -172.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 4.6 t70 -23.94 81.77 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.53 1.769 . . . . 0.0 112.9 -170.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.553 HG23 HD21 ' A' ' 7' ' ' LEU . 6.0 p -107.51 106.82 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.439 -171.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.52 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 5.0 m-20 71.65 -58.97 0.56 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.697 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.515 ' HB ' ' HD2' ' A' ' 79' ' ' PRO . 13.2 m -122.53 164.08 28.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.218 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HD2' ' HB ' ' A' ' 78' ' ' VAL . 23.5 Cg_endo -91.6 104.45 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.163 2.575 . . . . 0.0 113.227 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 9.0 mtmt -179.87 162.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.589 . . . . 0.0 111.698 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.4 ttp -92.15 142.61 27.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.439 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.624 ' HB ' ' HD3' ' A' ' 73' ' ' ARG . 3.6 p -73.33 -53.79 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.651 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 82' ' ' VAL . . . -155.71 159.14 29.04 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.327 -173.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 84' ' ' ARG . 10.6 ttp180 -125.21 95.81 4.61 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -114.57 112.0 22.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.26 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 11.2 m -80.97 138.13 36.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 . . . . . 0 C--N 1.315 -0.925 0 CA-C-O 121.842 0.83 . . . . 0.0 109.509 -177.021 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 34.4 t . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 121.23 0.538 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 38.1 mt -101.54 26.12 7.66 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.611 HG22 ' HG ' ' A' ' 3' ' ' LEU . 1.8 mp -69.32 -31.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.614 -175.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.796 HD13 ' HA ' ' A' ' 6' ' ' ASP . 77.9 mt -132.39 178.01 7.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.101 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -126.23 73.29 1.36 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.78 36.29 37.44 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.555 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.796 ' HA ' HD13 ' A' ' 3' ' ' LEU . 33.3 t70 69.55 97.03 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.493 0.663 . . . . 0.0 112.164 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.541 ' H ' HD22 ' A' ' 3' ' ' LEU . 93.6 mt -126.87 70.98 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.696 HD11 ' HB2' ' A' ' 54' ' ' ARG . 79.1 mt -64.27 -62.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.944 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 52.87 -99.98 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.89 0.744 . . . . 0.0 110.581 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.06 88.86 4.62 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.321 0.581 . . . . 0.0 109.8 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.718 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -104.4 165.1 11.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.934 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt 59.9 93.67 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.83 0.706 . . . . 0.0 109.229 -174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.33 -153.92 0.41 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.831 -174.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.5 mt -52.48 148.61 12.04 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.54 134.84 54.1 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.993 2.462 . . . . 0.0 111.832 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 48' ' ' LYS . 5.6 p 39.87 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 123.14 1.448 . . . . 0.0 112.688 -171.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.508 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 57.5 mt -68.6 156.32 7.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.431 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -49.74 138.19 14.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -71.25 -19.46 62.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.248 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.39 -45.64 37.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.057 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.481 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 81.4 t80 -58.78 -40.46 84.07 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -63.08 -47.63 86.91 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.127 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -38.55 69.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.25 -47.56 83.2 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.9 mt -56.93 -58.5 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.562 0.696 . . . . 0.0 110.171 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.813 HD11 HG11 ' A' ' 58' ' ' VAL . 9.1 mp -58.8 -34.66 71.73 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.835 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.43 -34.0 74.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.438 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -72.58 -26.96 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.26 3.25 29.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.546 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.41 -50.31 59.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.53 0.732 . . . . 0.0 111.852 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.61 -41.92 82.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.11 -39.7 68.69 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.658 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 94.8 mt -69.42 -20.8 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.51 0.671 . . . . 0.0 110.486 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.5 tttp -89.77 -33.13 16.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.499 0.666 . . . . 0.0 109.882 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.46 -45.04 77.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.311 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.26 -15.35 41.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.475 -173.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.514 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 77.3 m-85 -140.17 -57.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.414 0.626 . . . . 0.0 109.78 177.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 123.38 35.46 0.7 Allowed Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.367 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 41' ' ' THR . 2.8 t -108.27 146.39 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.989 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -98.04 8.91 44.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.621 0.724 . . . . 0.0 110.259 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.643 ' H ' HG12 ' A' ' 39' ' ' VAL . 71.4 p 59.0 -33.69 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.084 1.754 . . . . 0.0 115.253 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -62.83 -29.36 70.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.2 0.524 . . . . 0.0 110.477 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.09 -14.81 60.62 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.185 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.535 HD21 HG11 ' A' ' 39' ' ' VAL . 63.9 mt -81.64 125.0 30.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.292 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG2' HD23 ' A' ' 47' ' ' LEU . 58.3 tttp -81.47 101.21 9.75 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.56 ' HA ' HG12 ' A' ' 60' ' ' VAL . 57.2 mt -69.98 113.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 45' ' ' LYS . 26.1 mt -85.07 -40.05 17.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.583 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HA ' HG23 ' A' ' 16' ' ' VAL . 24.9 ttpp -160.38 103.56 1.42 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.452 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 9.3 m -76.61 122.14 24.21 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.8 m -157.3 -172.29 3.94 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.935 -0.478 . . . . 0.0 110.624 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.49 178.77 8.51 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -112.53 -84.13 0.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.718 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 27.8 mtmm -140.66 107.74 5.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 167.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.792 ' HG3' HG11 ' A' ' 76' ' ' VAL . 35.6 ttm180 78.1 -18.15 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.734 0.646 . . . . 0.0 111.463 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.44 123.55 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 5.4 m-85 -78.13 148.51 34.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.796 0.332 . . . . 0.0 110.409 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.602 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 75.5 m-85 -134.12 94.62 3.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.753 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.813 HG11 HD11 ' A' ' 26' ' ' LEU . 19.3 t -89.06 95.38 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.505 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB2' ' N ' ' A' ' 48' ' ' LYS . 74.2 m -60.08 128.54 37.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.003 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 46' ' ' ILE . 34.8 m -147.57 153.5 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.43 0.634 . . . . 0.0 111.589 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.87 130.73 48.41 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 169.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.751 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -92.44 5.09 52.03 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.152 -173.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.97 -19.23 50.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.646 170.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.639 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 32.9 t70 -103.29 18.92 20.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.88 -22.33 12.15 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.751 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 7.0 pt-20 -70.95 150.48 45.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.16 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -122.26 151.51 41.0 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 24.0 t -146.58 170.83 16.11 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.3 ttpt -157.51 89.43 1.04 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CD1' ' HG2' ' A' ' 84' ' ' ARG . 83.7 m-85 -53.81 112.16 0.88 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.941 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 54.7 tttt -84.92 80.66 9.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.921 0.867 . . . . 0.0 109.385 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 77.5 mt -77.27 102.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.726 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HB2' HG12 ' A' ' 82' ' ' VAL . 46.4 ttt180 -71.63 111.96 7.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.599 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 91.7 mttt -57.16 160.12 3.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.353 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 0' ' ' SER . 17.9 t70 -67.37 74.09 0.14 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.66 0.743 . . . . 0.0 109.705 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.792 HG11 ' HG3' ' A' ' 54' ' ' ARG . 35.6 m -98.75 -4.29 9.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.615 0.722 . . . . 0.0 110.074 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 175.3 -62.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.287 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 79' ' ' PRO . 11.2 p -96.9 137.62 21.33 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.478 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 78' ' ' VAL . 45.8 Cg_endo -83.38 42.25 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.591 2.861 . . . . 0.0 112.645 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -137.88 140.59 40.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.228 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.45 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 4.6 tmm? -65.09 123.65 20.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.033 170.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.533 HG12 ' HB2' ' A' ' 73' ' ' ARG . 14.5 p -79.47 -38.56 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 0.0 111.634 -173.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 84' ' ' ARG . . . -144.52 179.45 21.73 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.954 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.514 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -153.72 93.55 1.68 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 22.1 tptm -73.91 60.82 0.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.78 0.8 . . . . 0.0 112.317 -166.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -104.5 111.0 23.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 . . . . . 0 C--N 1.314 -0.949 0 CA-C-O 121.892 0.853 . . . . 0.0 109.785 -173.213 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.595 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 40.4 t . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 1' ' ' LEU . 0.6 OUTLIER -99.56 109.77 22.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.348 0.594 . . . . 0.0 112.053 -172.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.519 HG23 ' HB3' ' A' ' 74' ' ' LYS . 8.4 tp -173.12 84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.998 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.908 ' HG ' ' H ' ' A' ' 4' ' ' ASP . 1.2 pt? -122.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.177 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.908 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 8.7 m-20 57.64 19.01 5.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.685 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 7' ' ' LEU . . . 111.9 42.94 0.98 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.479 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.22 25.89 11.57 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 5' ' ' GLY . 96.0 mt -137.9 166.21 24.61 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 111.332 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.414 HD22 HG12 ' A' ' 2' ' ' ILE . 35.2 tp -178.73 -93.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.737 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.3 mttt 55.82 33.11 20.88 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -76.08 -59.62 2.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 110.476 -174.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.94 35.27 1.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.675 0.75 . . . . 0.0 110.263 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.639 HD23 ' HE3' ' A' ' 13' ' ' LYS . 29.5 tp -70.63 170.14 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.098 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.639 ' HE3' HD23 ' A' ' 12' ' ' LEU . 1.9 mptt 70.09 15.61 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.348 0.659 . . . . 0.0 111.491 176.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.64 139.47 20.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.094 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.39 -56.49 0.66 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 122.521 2.147 . . . . 0.0 110.358 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 48' ' ' LYS . 13.5 p -128.86 128.13 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.461 -1.7 . . . . 0.0 109.898 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 18' ' ' ASP . 24.5 mt -89.61 177.25 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.258 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.577 ' H ' HG22 ' A' ' 17' ' ' ILE . 4.0 m-20 -50.67 120.24 4.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.492 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -73.21 -36.93 66.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.01 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 68.0 t80 -62.86 -43.96 97.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.563 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -61.58 -45.95 95.28 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 173.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -52.26 -43.93 64.64 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.0 109.915 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.87 -39.89 93.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.227 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 16.9 mt -60.02 -60.12 4.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 58' ' ' VAL . 8.1 mp -60.13 -32.6 71.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.819 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.97 -49.33 77.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.935 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -67.0 -50.48 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.313 0.577 . . . . 0.0 110.291 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.595 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 5.7 m-85 -83.2 13.4 4.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.675 -173.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 40' ' ' ASP . 36.6 tt0 -61.82 -36.28 80.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.76 -35.02 76.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.126 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.647 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 20.7 t70 -74.3 -44.6 51.96 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.16 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' HB ' ' A' ' 39' ' ' VAL . 66.2 mt -69.11 -26.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.406 0.622 . . . . 0.0 110.773 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 54.0 tttp -83.29 -28.93 28.76 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -69.22 -43.14 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.904 170.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.647 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 63.2 mttm -67.85 -47.92 67.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.285 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.663 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 44.0 m-85 -128.4 -56.68 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.481 0.658 . . . . 0.0 110.889 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 34' ' ' LYS . . . 117.42 62.35 0.31 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.789 -170.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG23 ' HB2' ' A' ' 37' ' ' TYR . 45.9 t -124.33 154.59 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.808 0.337 . . . . 0.0 111.143 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.576 ' HA ' HE21 ' A' ' 30' ' ' GLN . 16.4 t70 -105.15 123.38 47.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.564 173.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 24.6 p -88.03 -14.61 38.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.001 0.429 . . . . 0.0 111.725 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -79.76 -7.21 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.951 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -99.76 -21.85 15.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.681 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.1 mt -73.87 124.43 26.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.652 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 82.6 tttt -83.95 112.79 20.48 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.586 ' HA ' HG12 ' A' ' 60' ' ' VAL . 35.4 mt -79.88 116.54 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.692 0.758 . . . . 0.0 111.171 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.6 mt -85.35 -51.02 6.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.39 -176.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HA ' HG23 ' A' ' 16' ' ' VAL . 39.4 ttpt -146.06 111.13 5.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.827 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.3 m -96.0 127.53 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -146.51 163.56 35.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -132.33 161.53 33.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 110.239 172.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.21 -157.91 0.81 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 54' ' ' ARG . 51.2 mttp -72.13 103.17 3.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.679 ' HG2' HG11 ' A' ' 76' ' ' VAL . 53.0 mtt180 74.27 -14.4 0.7 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.695 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -109.85 149.33 30.02 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.947 -0.471 . . . . 0.0 111.984 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 51' ' ' GLU . 2.6 m-85 -116.58 150.4 38.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.738 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.6 m-85 -128.71 103.42 7.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.373 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.729 HG21 HD11 ' A' ' 26' ' ' LEU . 13.3 t -106.16 94.64 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.709 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -79.96 118.8 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -130.48 155.67 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.653 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.512 ' HB2' HD21 ' A' ' 47' ' ' LEU . 36.2 t70 -86.67 103.66 15.34 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -64.71 -26.81 68.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.826 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.43 -23.95 13.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.97 -0.634 . . . . 0.0 111.731 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 25.9 t70 -81.59 -22.7 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.405 0.621 . . . . 0.0 110.21 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.95 -32.33 3.65 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 4.6 pt-20 -62.93 136.26 57.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.637 -0.782 . . . . 0.0 111.842 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -100.38 93.09 5.48 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.914 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 79.8 m -89.25 132.27 34.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.06 0.457 . . . . 0.0 110.586 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 22.8 ttmm -109.18 94.26 4.95 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.301 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 80.1 m-85 -63.4 100.0 0.23 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.923 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.738 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 25.0 tttm -80.69 83.26 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.994 0.902 . . . . 0.0 109.047 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.872 ' HA ' ' HB2' ' A' ' 81' ' ' MET . 70.0 mt -77.71 93.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.434 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.577 ' HB2' HG12 ' A' ' 82' ' ' VAL . 30.4 ttt180 -63.52 123.8 19.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 2' ' ' ILE . 39.6 mttt -59.56 169.08 1.39 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.798 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.721 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 9.9 t0 -72.06 78.36 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.229 1.014 . . . . 0.0 108.904 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.679 HG11 ' HG2' ' A' ' 54' ' ' ARG . 6.4 m -106.11 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.106 174.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.0 t70 84.74 -46.01 0.08 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.891 -175.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.96 146.24 61.27 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 111.119 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HB3' ' OD2' ' A' ' 75' ' ' ASP . 34.1 Cg_endo -92.18 86.17 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.634 2.889 . . . . 0.0 114.138 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -164.69 161.52 20.8 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.01 -0.431 . . . . 0.0 111.329 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.872 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 2.4 ptp -88.1 119.2 28.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.577 HG12 ' HB2' ' A' ' 73' ' ' ARG . 7.7 p -60.4 -38.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.916 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.06 -177.68 26.88 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.952 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.663 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -164.25 42.8 0.09 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -60.83 121.98 13.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.612 -172.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.914 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.4 m -83.21 113.03 20.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 87' ' ' ARG . 17.9 mtp180 . . . . . 0 C--N 1.306 -1.286 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.784 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 34.2 p . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.228 0.061 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 0' ' ' SER . 0.5 OUTLIER 45.97 23.58 0.19 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.766 1.227 . . . . 0.0 113.326 175.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.604 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 10.5 tp -117.02 39.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.012 0.91 . . . . 0.0 110.55 -171.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.822 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 2.5 pt? -92.96 -40.09 10.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.691 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 12.6 t70 66.57 -60.41 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.97 0.794 . . . . 0.0 110.015 -169.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 54.88 0.24 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.105 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.609 ' HA ' HG12 ' A' ' 76' ' ' VAL . 41.3 m-20 49.84 34.91 8.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.748 0.419 . . . . 0.0 111.476 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.582 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 27.8 tp -141.84 176.57 8.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.64 0.257 . . . . 0.0 110.362 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.582 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 6.2 mp -73.83 -59.33 2.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.22 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp 63.64 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.229 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -126.21 106.7 9.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.217 0.532 . . . . 0.0 110.042 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 3.3 ptmm? -118.09 -163.42 0.94 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.358 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.5 mt -41.46 115.95 0.7 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -130.63 21.15 5.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.53 168.03 13.3 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.722 -172.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -69.77 -153.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.471 0.162 0 C-N-CA 123.637 2.892 . . . . 0.0 111.856 167.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.682 HG23 ' HG3' ' A' ' 48' ' ' LYS . 5.4 p -51.17 124.31 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.886 0.85 . . . . 0.0 111.147 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.547 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 11.9 mt -79.93 151.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.916 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.8 152.47 35.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.209 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -64.12 -25.62 68.18 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.813 -178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.64 -46.67 88.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.17 0.188 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 87.0 t80 -59.79 -38.6 82.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -65.52 -49.86 58.12 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 12.9 mmmm -56.81 -28.67 61.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 14.3 mm-40 -68.85 -52.63 27.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 173.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 43.8 mt -53.69 -62.49 1.62 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.621 0.724 . . . . 0.0 110.096 175.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.706 HD11 HG11 ' A' ' 58' ' ' VAL . 9.5 mp -59.08 -28.37 66.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.55 -173.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 13.1 t70 -75.24 -46.93 30.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.09 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 66.5 mttm -57.51 -35.74 70.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.303 0.573 . . . . 0.0 110.558 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.784 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 2.4 m-85 -106.1 12.27 30.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.271 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -60.21 -41.33 92.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 -179.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.89 -32.38 73.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' HD3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -73.4 -48.06 36.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.358 0.599 . . . . 0.0 110.153 177.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.665 HG12 ' HE1' ' A' ' 81' ' ' MET . 72.0 mt -59.76 -41.48 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.559 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.5 tttt -79.94 -29.59 39.74 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.914 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.88 -50.37 66.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.564 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -76.73 -57.58 3.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.453 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 39' ' ' VAL . 20.7 m-85 -102.32 -27.37 12.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -169.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.33 52.96 3.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.636 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 33' ' ' ILE . 21.9 t -118.3 149.14 20.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.518 0.199 . . . . 0.0 110.598 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.41 106.09 14.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.534 ' HA ' HD22 ' A' ' 44' ' ' LEU . 65.6 p -65.69 -16.66 63.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -173.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.3 ttpp -72.06 -23.03 61.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -94.3 -5.98 45.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.767 0.794 . . . . 0.0 109.632 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 41' ' ' THR . 5.1 mp -83.29 138.35 33.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.112 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.55 109.73 22.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.612 ' HA ' HG12 ' A' ' 60' ' ' VAL . 40.9 mt -79.33 116.96 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 110.877 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.439 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 8.1 mt -85.78 -47.32 9.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.086 -175.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.682 ' HG3' HG23 ' A' ' 16' ' ' VAL . 37.7 ttmt -149.6 108.08 3.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.481 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.547 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 13.5 m -85.0 125.39 32.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.3 m -156.55 -170.94 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.464 ' OE2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -156.11 -176.61 6.05 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.69 ' HB3' ' HE2' ' A' ' 57' ' ' TYR . 14.7 t70 -165.45 93.38 0.58 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HG3' HD21 ' A' ' 8' ' ' LEU . 12.4 mptt 68.21 -107.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.921 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.539 ' HG2' HG11 ' A' ' 76' ' ' VAL . 48.0 mtt180 -91.93 19.55 6.56 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.931 -0.481 . . . . 0.0 111.32 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 76.2 m-85 -138.83 140.67 38.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 -173.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.873 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m-85 -100.3 144.08 29.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 166.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.699 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 71.0 m-85 -129.8 96.32 4.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.706 HG11 HD11 ' A' ' 26' ' ' LEU . 5.6 t -104.43 96.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.4 t -74.39 114.61 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 46' ' ' ILE . 12.9 m -133.13 163.93 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.236 0.541 . . . . 0.0 111.368 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.96 127.14 48.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.97 33.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -173.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.09 -46.3 3.06 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.581 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.54 -38.18 68.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.304 0.573 . . . . 0.0 110.934 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -21.85 2.46 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.339 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.38 145.8 33.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 110.804 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -113.96 116.34 29.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.527 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.5 m -117.94 124.96 49.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.824 -171.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.699 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 6.1 tppt? -85.12 96.24 9.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.77 113.5 3.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.309 0.576 . . . . 0.0 110.185 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -93.0 80.72 4.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.622 -174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.873 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 mt -77.68 76.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.642 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.535 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 70.8 ttt180 -53.26 125.79 18.83 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' A' ' 76' ' ' VAL . 96.3 mttt -59.79 171.0 0.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 123.458 0.474 . . . . 0.0 110.263 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 1.7 t70 -72.12 26.45 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.372 0.606 . . . . 0.0 110.694 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 6' ' ' ASP . 30.1 m -78.65 123.12 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.555 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 18.4 t70 70.58 -66.22 0.3 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.548 0.53 . . . . 0.0 111.232 -176.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.586 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 3.4 p -104.28 153.9 38.68 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.656 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.0 Cg_endo -76.32 148.05 29.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.092 1.861 . . . . 0.0 111.515 164.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 4.9 ptpt 73.47 -172.13 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.235 1.014 . . . . 0.0 113.126 167.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.665 ' HE1' HG12 ' A' ' 33' ' ' ILE . 15.5 mtm -77.23 126.89 31.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.178 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.535 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 7.1 p -59.46 -27.81 38.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.56 -161.64 35.36 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.325 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -157.09 151.16 24.83 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.0 tptp -145.25 106.01 4.13 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.942 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.1 m -77.32 111.0 12.52 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 170.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 120.992 0.425 . . . . 0.0 110.593 -169.212 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.742 ' HB3' ' HA ' ' A' ' 75' ' ' ASP . 23.4 t . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.673 0.273 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 28' ' ' LYS . 72.9 mt -83.55 61.94 6.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.004 0.907 . . . . 0.0 112.425 -168.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 74' ' ' LYS . 15.7 tt -160.77 29.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.578 ' CD1' ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -72.22 135.46 46.08 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.464 -163.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.31 -18.56 16.03 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 165.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . 134.36 54.02 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.752 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 8.0 m-20 68.86 22.08 7.35 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -143.0 159.72 41.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.024 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.88 -66.52 1.08 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.643 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HB2' ' HZ2' ' A' ' 9' ' ' LYS . 9.6 mtmp? 66.05 17.11 10.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.86 0.838 . . . . 0.0 108.9 -169.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -152.11 69.39 0.89 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.074 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.61 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 38.5 pttt -49.08 -50.43 36.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.392 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.614 HD12 ' HG3' ' A' ' 51' ' ' GLU . 52.9 tp -153.16 119.08 5.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -169.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -85.67 -77.41 0.3 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.995 0.426 . . . . 0.0 111.362 -176.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 18.8 mt -136.76 176.65 2.63 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -173.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 32.4 Cg_exo -62.69 -147.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.788 2.992 . . . . 0.0 111.615 169.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 49' ' ' THR . 7.1 p -54.75 122.64 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.839 0.828 . . . . 0.0 110.053 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.77 HG13 ' HB ' ' A' ' 49' ' ' THR . 1.1 pt -108.06 -173.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.882 -171.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.86 134.16 37.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.74 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 31.1 p30 -72.88 -21.06 60.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.49 -40.23 57.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.151 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 25' ' ' LEU . 80.1 t80 -61.47 -47.07 87.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -62.64 -43.47 98.94 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.238 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 23.7 tptm -56.42 -36.77 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.306 0.242 . . . . 0.0 110.488 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 4.9 mm-40 -55.81 -53.8 52.29 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 10.2 mp -49.86 -59.01 4.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.276 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.727 HD11 HG11 ' A' ' 58' ' ' VAL . 9.2 mp -59.85 -42.17 93.07 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.964 -175.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.97 -33.41 74.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.999 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 22.0 mttp -64.64 -49.99 68.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.391 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.428 ' O ' HG13 ' A' ' 33' ' ' ILE . 58.3 m-85 -98.49 12.49 34.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.573 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.418 ' OE1' ' HE2' ' A' ' 42' ' ' LYS . 4.9 pt20 -59.87 -31.91 70.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.452 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.17 -34.52 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.16 -39.68 68.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.752 0.787 . . . . 0.0 109.013 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.595 HG22 ' HB ' ' A' ' 39' ' ' VAL . 92.3 mt -61.42 -43.41 96.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.234 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 24.7 ttpt -82.51 -29.71 30.28 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.669 -174.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.46 -55.81 13.89 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 174.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -79.55 -43.36 23.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.922 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.2 -10.09 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.534 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 68.8 41.2 83.88 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.627 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 33' ' ' ILE . 10.8 t -118.24 137.91 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 120.903 0.382 . . . . 0.0 111.113 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -103.47 116.24 32.03 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.467 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.4 p -70.42 -10.5 59.27 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -170.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HE2' ' OE1' ' A' ' 30' ' ' GLN . 66.6 mmtt -71.8 -22.85 61.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.937 0.399 . . . . 0.0 110.333 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.61 -31.23 15.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.463 0.649 . . . . 0.0 110.088 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 41' ' ' THR . 85.5 mt -58.49 126.94 29.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.865 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 57.2 tttm -92.4 106.07 18.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.474 174.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.661 ' HA ' HG12 ' A' ' 60' ' ' VAL . 42.7 mt -72.8 107.53 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.774 0.797 . . . . 0.0 110.565 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 61' ' ' ASP . 11.8 mt -80.78 -49.38 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.983 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 48.9 tttm -144.79 101.17 3.62 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.479 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.77 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.6 m -82.39 124.8 30.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.2 m -145.81 -179.78 6.93 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.137 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.614 ' HG3' HD12 ' A' ' 12' ' ' LEU . 7.9 pt-20 -155.45 174.17 15.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.514 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -150.91 -170.24 3.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -59.49 105.71 0.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 77.18 -9.27 1.55 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.804 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.6 m-85 -114.45 151.08 33.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.117 0.484 . . . . 0.0 111.798 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.813 ' HD1' ' HB3' ' A' ' 74' ' ' LYS . 2.8 m-85 -112.14 143.88 42.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.426 164.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.592 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 32.3 m-85 -131.92 111.67 11.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.413 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 26' ' ' LEU . 21.4 t -110.26 108.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -91.7 120.86 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 46' ' ' ILE . 13.0 m -128.72 154.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.572 ' HB2' HD21 ' A' ' 47' ' ' LEU . 60.1 t0 -90.6 114.67 26.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 169.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HA ' HD23 ' A' ' 44' ' ' LEU . . . -72.56 -14.35 61.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.46 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.34 -113.13 0.54 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.39 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.61 76.27 1.68 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 109.637 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.2 -9.71 3.55 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.511 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -82.47 170.17 15.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -160.54 107.86 1.56 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.842 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 14.7 t -129.66 138.09 51.0 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.701 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.592 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 31.3 ttmt -111.87 114.28 27.12 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -76.39 120.65 21.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.119 0.485 . . . . 0.0 109.947 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.506 ' HG2' ' CG1' ' A' ' 82' ' ' VAL . 79.2 tttt -94.01 94.6 8.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.075 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 60.3 mt -116.41 89.53 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.511 0.672 . . . . 0.0 109.926 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 48.7 ttt180 -63.43 99.09 0.19 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.978 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.813 ' HB3' ' HD1' ' A' ' 56' ' ' TYR . 12.1 ptpt -47.45 112.4 0.54 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.801 -173.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.742 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 15.0 t0 37.57 82.16 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.176 177.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.621 HG11 ' HG2' ' A' ' 73' ' ' ARG . 8.7 m -127.26 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.102 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 74.12 -69.18 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.48 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.9 p -86.88 141.94 33.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.058 0.456 . . . . 0.0 110.348 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 87.5 Cg_endo -79.72 86.94 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.11 2.54 . . . . 0.0 112.581 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 178.86 -175.72 0.22 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.407 0.623 . . . . 0.0 111.841 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 19.9 ptp -84.04 155.33 22.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.438 171.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.506 ' CG1' ' HG2' ' A' ' 71' ' ' LYS . 12.3 p -83.15 -26.04 7.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.91 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -179.86 -173.15 44.63 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.333 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 84' ' ' ARG . 34.7 ttt-85 -156.56 125.71 6.06 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -149.85 135.74 18.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 25.5 m -97.3 114.96 26.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.507 0.67 . . . . 0.0 111.238 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 -174.676 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 5.9 t . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 42.3 mt -133.46 12.86 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.674 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.81 HG13 HD22 ' A' ' 3' ' ' LEU . 8.2 tp -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.978 -166.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 7' ' ' LEU . 2.2 mm? 66.29 57.59 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.93 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.641 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 3.5 p-10 -60.26 -27.17 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.808 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.05 19.63 53.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.234 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.723 ' HA ' HG22 ' A' ' 76' ' ' VAL . 29.2 t70 61.18 75.0 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.783 0.801 . . . . 0.0 110.201 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.986 ' HB2' HD12 ' A' ' 3' ' ' LEU . 67.2 mt -130.97 158.0 41.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.193 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -110.29 -47.27 3.31 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.472 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 64.5 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.934 0.771 . . . . 0.0 110.398 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.84 113.92 14.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 2.8 ttpm? -65.16 -47.66 76.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.742 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.8 tt -146.45 117.58 7.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.572 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 88.8 tttt -88.49 -75.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.445 0.64 . . . . 0.0 111.651 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.572 ' HG ' ' HG2' ' A' ' 13' ' ' LYS . 94.2 mt -106.55 148.78 37.41 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -71.06 120.32 6.94 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 110.08 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.608 HG23 ' HA ' ' A' ' 48' ' ' LYS . 3.7 p 40.52 95.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.998 1.38 . . . . 0.0 112.721 -168.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.12 161.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.128 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.36 143.22 56.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.406 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -65.72 -19.06 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.995 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.79 -49.82 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 67.0 t80 -61.35 -38.22 86.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.705 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.463 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -64.33 -51.38 53.06 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 174.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 27.3 mmtp -52.59 -38.96 61.07 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.343 0.257 . . . . 0.0 111.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.672 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.8 mm-40 -55.22 -55.26 33.29 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 123.257 0.348 . . . . 0.0 111.29 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.524 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 38.8 mt -51.84 -61.57 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.403 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.662 HD11 HG11 ' A' ' 58' ' ' VAL . 8.2 mp -62.43 -31.81 72.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.961 -172.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.39 -34.07 76.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.733 0.301 . . . . 0.0 111.033 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 49.9 mttm -77.64 -24.0 49.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 110.682 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.908 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 96.7 m-85 -103.51 5.2 36.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -49.17 -47.37 45.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.137 0.575 . . . . 0.0 112.404 -173.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.84 -39.26 93.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.875 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.9 -40.18 61.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.404 0.621 . . . . 0.0 109.892 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.588 HG22 ' HB ' ' A' ' 39' ' ' VAL . 98.0 mt -61.21 -36.74 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.428 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.587 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.9 tttm -84.68 -30.91 24.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.238 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.57 -44.12 78.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.907 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -85.55 -47.79 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -111.49 -12.12 14.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.3 44.32 52.68 Favored Glycine 0 C--N 1.328 0.114 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.773 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 33' ' ' ILE . 18.8 t -114.77 146.88 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.873 0.368 . . . . 0.0 111.381 -175.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -103.01 112.85 25.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 72.0 p -73.84 -14.4 61.08 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -81.31 -44.21 17.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.0 109.86 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.42 -21.28 60.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.949 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.721 HD21 HG21 ' A' ' 60' ' ' VAL . 11.1 tp -60.21 133.13 55.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.312 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -95.56 104.6 16.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.151 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.544 ' HA ' HG12 ' A' ' 60' ' ' VAL . 43.6 mt -78.73 121.42 31.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.431 0.634 . . . . 0.0 110.71 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 61' ' ' ASP . 12.2 mt -92.2 -51.28 5.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.266 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HA ' HG23 ' A' ' 16' ' ' VAL . 6.0 ttmt -143.44 114.41 7.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.646 -176.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.7 m -98.41 130.1 45.04 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.334 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 p -163.96 -178.09 5.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.812 0.339 . . . . 0.0 110.599 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 9.8 pt-20 -140.37 159.7 41.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.475 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.509 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 4.3 t70 -138.95 -148.58 0.26 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.874 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 32.2 mmtp -65.45 91.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.044 0.137 . . . . 0.0 110.791 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.698 ' HB3' HG11 ' A' ' 76' ' ' VAL . 62.5 mtt85 71.98 -12.0 0.72 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.062 0.545 . . . . 0.0 112.359 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.47 146.27 33.41 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.208 -0.307 . . . . 0.0 111.082 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.544 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 7.0 m-85 -97.96 142.87 29.16 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 165.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.619 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 66.8 m-85 -126.63 107.55 10.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.073 0.464 . . . . 0.0 110.747 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 26' ' ' LEU . 18.1 t -108.97 99.51 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.532 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 9.5 t -77.31 122.17 24.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.721 HG21 HD21 ' A' ' 44' ' ' LEU . 28.7 m -130.46 155.44 41.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.008 0.432 . . . . 0.0 111.266 -177.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB2' HD21 ' A' ' 47' ' ' LEU . 10.5 t70 -99.88 122.16 42.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -75.95 -0.96 23.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 -39.0 3.14 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.559 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.87 -15.72 61.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.328 0.585 . . . . 0.0 110.307 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.41 -23.98 5.65 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.671 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 62' ' ' ALA . 8.8 pt-20 -74.81 152.86 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.8 mttp -125.13 108.33 11.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.305 0.574 . . . . 0.0 110.122 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.984 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 60.6 m -107.85 133.13 52.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.77 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.619 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.0 tppp? -97.13 102.98 14.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.545 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 20.8 m-85 -67.36 117.36 9.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HG2' ' CG1' ' A' ' 82' ' ' VAL . 31.5 tttm -93.52 72.79 4.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.946 0.879 . . . . 0.0 109.368 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.574 HG12 ' HG2' ' A' ' 81' ' ' MET . 82.9 mt -75.78 91.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.991 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.646 ' HB2' HG12 ' A' ' 82' ' ' VAL . 24.9 ttt180 -62.6 135.76 57.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.667 ' HD3' HD23 ' A' ' 3' ' ' LEU . 99.0 mttt -59.73 172.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.718 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 43.5 t0 -74.5 28.36 0.08 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.783 1.278 . . . . 0.0 108.871 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -74.46 8.87 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 112.967 -1.924 . . . . 0.0 109.901 -174.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.3 t70 167.46 -43.09 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.842 -168.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.33 142.54 40.45 Favored Pre-proline 0 CA--C 1.502 -0.866 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.03 -171.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 67.5 Cg_endo -89.07 15.26 2.06 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.262 1.975 . . . . 0.0 111.803 171.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.908 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 21.4 mtmt -143.3 -179.75 6.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.482 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' HG12 ' A' ' 72' ' ' ILE . 23.2 mtm -81.21 117.34 21.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.404 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' ' 73' ' ' ARG . 9.2 p -56.73 -32.92 39.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.423 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.59 -174.21 34.91 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.643 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -171.97 90.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -107.85 131.5 54.42 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.809 -174.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.984 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 4.0 m -84.88 130.41 34.66 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 . . . . . 0 C--N 1.309 -1.158 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.4 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 29' ' ' PHE . 47.3 t . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.677 0.275 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.83 12.15 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.933 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.479 HG21 ' HE1' ' A' ' 56' ' ' TYR . 2.9 tp -76.72 -13.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.499 0.666 . . . . 0.0 110.69 -171.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.781 HD21 ' HA ' ' A' ' 7' ' ' LEU . 9.7 mp -125.13 -178.71 4.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.9 57.08 1.56 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.884 0.85 . . . . 0.0 109.758 170.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.09 52.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.583 ' CG ' ' H ' ' A' ' 7' ' ' LEU . 7.2 p-10 -130.49 -120.33 0.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.226 -173.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.781 ' HA ' HD21 ' A' ' 3' ' ' LEU . 42.4 tp 175.69 98.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.57 0.623 . . . . 0.0 110.966 -172.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.8 mt -59.81 131.85 52.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.0 110.242 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -124.11 -7.52 7.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.152 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.52 -46.63 89.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -100.5 115.3 29.77 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 166.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.777 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 37.4 tp -178.07 141.61 0.26 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.388 -176.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.777 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 29.0 mtmt 63.91 25.76 14.05 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.957 176.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.23 163.15 19.21 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.573 -174.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -64.74 -158.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.424 2.75 . . . . 0.0 111.942 169.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.49 116.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 122.002 0.906 . . . . 0.0 110.533 175.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.632 HG12 ' HA ' ' A' ' 50' ' ' SER . 10.7 mm -71.41 161.29 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.743 -177.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -49.45 129.75 19.24 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.161 0.288 . . . . 0.0 110.759 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' HA ' HG21 ' A' ' 46' ' ' ILE . 29.6 p-10 -60.23 -33.97 73.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 20' ' ' LEU . 6.6 mt -58.75 -44.86 90.67 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.99 173.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.644 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 72.3 t80 -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.748 0.308 . . . . 0.0 110.334 -177.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -67.13 -45.4 81.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.709 177.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HB2' HG13 ' A' ' 46' ' ' ILE . 7.8 tppt? -63.51 -37.05 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.099 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.64 -57.47 11.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.358 177.321 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 3.6 mt -51.95 -55.82 17.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.117 0.484 . . . . 0.0 109.758 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.894 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 21.9 mt -50.9 -48.34 60.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.427 176.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.36 -40.1 96.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 110.381 -178.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 11.8 mttp -56.92 -51.1 70.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.343 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 0' ' ' SER . 1.3 m-85 -97.72 13.19 31.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.042 -171.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -31.73 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.592 0.234 . . . . 0.0 111.427 -173.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.52 -31.17 68.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.8 0.333 . . . . 0.0 110.674 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -78.88 -43.3 25.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.334 0.588 . . . . 0.0 109.566 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 ' HB ' ' A' ' 39' ' ' VAL . 97.3 mt -60.62 -34.89 60.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.554 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.622 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 1.6 tmtp? -80.9 -40.49 24.57 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 110.051 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.18 -46.3 75.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.995 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.84 -54.81 5.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.463 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.558 ' HB2' HG23 ' A' ' 39' ' ' VAL . 6.5 m-85 -104.98 -31.21 9.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.12 -170.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.51 57.1 2.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.729 -177.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.622 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 22.0 t -124.4 148.4 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.809 0.338 . . . . 0.0 111.055 -175.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.438 ' O ' HD13 ' A' ' 44' ' ' LEU . 11.8 t0 -106.48 112.74 25.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 170.172 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.894 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 45.7 p -74.72 -15.75 60.77 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.83 -173.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.18 -25.52 60.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.152 178.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.72 -23.04 25.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.059 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 41' ' ' THR . 3.6 mp -65.66 109.67 2.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.696 -178.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 18.7 tptm -71.71 114.15 9.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.212 174.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.641 ' HA ' HG12 ' A' ' 60' ' ' VAL . 10.2 mm -71.21 107.34 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.0 mt -78.71 -57.84 3.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.705 0.764 . . . . 0.0 109.407 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -147.92 110.54 4.71 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.199 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 6.5 m -81.87 138.2 35.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.632 ' HA ' HG12 ' A' ' 17' ' ' ILE . 6.1 p -160.57 -175.96 5.3 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 15.2 pt-20 -165.05 167.06 18.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.582 0.706 . . . . 0.0 111.321 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.885 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 8.1 t70 -114.97 -157.99 0.65 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 171.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.605 ' HA ' HD11 ' A' ' 12' ' ' LEU . 86.0 mttt -68.22 -71.88 0.2 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.957 176.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -90.65 17.46 7.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.379 -173.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 97.4 m-85 -146.22 148.32 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -170.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.623 ' CD1' ' HG2' ' A' ' 74' ' ' LYS . 19.2 m-85 -109.46 143.74 38.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.384 169.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.885 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 76.7 m-85 -129.03 92.05 3.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.997 0.427 . . . . 0.0 110.459 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 t -97.33 98.58 7.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 16.6 m -77.47 124.56 28.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -138.55 143.95 31.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -177.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.552 ' HB2' HD21 ' A' ' 47' ' ' LEU . 9.3 t70 -80.39 97.12 6.92 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 173.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.12 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.751 -171.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.08 -11.03 56.65 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.077 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.43 -32.66 71.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.156 0.503 . . . . 0.0 110.244 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.1 -41.09 0.25 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.45 165.84 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.251 0.548 . . . . 0.0 111.464 -178.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -82.39 115.84 21.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.702 167.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -96.02 164.84 12.53 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.257 -169.497 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.533 ' HD3' ' CD1' ' A' ' 57' ' ' TYR . 40.4 ttmt -134.74 102.82 5.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.484 ' CG ' HD21 ' A' ' 26' ' ' LEU . 16.0 m-85 -69.03 106.41 2.77 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.633 0.73 . . . . 0.0 110.179 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.603 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 17.5 tttt -95.42 82.38 3.68 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.838 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.807 HG12 ' HG2' ' A' ' 81' ' ' MET . 52.5 mt -78.68 120.45 29.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.721 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 58.4 ttt180 -79.68 25.01 0.35 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.407 0.622 . . . . 0.0 109.511 -175.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.623 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 93.2 mttt 51.12 -165.46 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.279 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.672 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 11.9 t70 -103.12 47.48 0.88 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 167.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 6' ' ' ASP . 5.3 p -77.64 -2.29 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.14 -174.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 173.0 -54.48 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.983 -168.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 32.4 m -92.15 151.49 41.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.242 175.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.5 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 61.6 Cg_endo -92.71 32.21 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.583 2.855 . . . . 0.0 112.558 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -159.16 -157.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.02 -175.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.807 ' HG2' HG12 ' A' ' 72' ' ' ILE . 5.2 mtm -107.6 132.13 53.62 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 10.4 p -77.81 -37.27 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.209 0.528 . . . . 0.0 110.177 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.603 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -126.85 164.67 20.34 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.539 -174.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.99 25.71 0.06 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 85' ' ' LYS . 60.7 mmtt -88.4 131.78 34.71 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.285 -167.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 6.5 m -83.68 136.85 34.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 173.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 . . . . . 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 0.0 109.977 -172.367 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.684 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 29.4 t . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 72.8 mt 64.3 13.38 7.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.299 173.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 2' ' ' ILE . 9.6 tp -115.0 87.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.238 1.018 . . . . 0.0 109.716 176.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.6 pt? -128.23 -48.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.475 -172.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.506 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.1 m-20 66.34 -64.15 0.23 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 124.017 0.823 . . . . 0.0 110.135 -171.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.33 70.62 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 177.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 35.5 t70 61.72 87.33 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.234 0.54 . . . . 0.0 110.419 -172.066 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 54' ' ' ARG . 13.3 mt 75.29 163.99 0.26 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.068 177.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.63 ' HG ' ' H ' ' A' ' 9' ' ' LYS . 2.0 pt? -153.95 -55.11 0.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.709 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.63 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 10.2 mtmp? 75.69 -54.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 167.334 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.44 8.13 35.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -169.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.7 ttpt -61.82 -72.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.754 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.436 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 26.9 mt -109.03 124.8 51.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.767 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -138.25 29.3 2.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 -171.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -102.02 143.09 25.9 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.461 -177.22 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 26.9 Cg_exo -65.19 130.03 24.46 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.924 2.416 . . . . 0.0 111.72 175.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' A' ' 48' ' ' LYS . 10.0 p 39.83 99.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 123.367 1.556 . . . . 0.0 114.057 -177.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.06 160.03 4.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.637 176.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.22 157.42 31.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.157 -173.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.0 p30 -65.26 -20.01 66.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.18 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.5 tp -65.66 -43.94 87.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 178.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' HE2' ' HE1' ' A' ' 56' ' ' TYR . 73.8 t80 -64.05 -39.04 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.335 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -71.66 -32.89 63.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.143 176.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 23.8 tptt -62.63 -40.75 97.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.6 mm-40 -58.97 -51.49 69.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.101 175.048 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.514 HD12 ' HA2' ' A' ' 22' ' ' GLY . 84.3 mt -51.71 -64.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 175.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.879 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.8 mt -55.75 -31.64 62.73 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.798 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.25 -45.69 83.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.069 0.461 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 56.3 mttm -67.92 -30.57 69.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.684 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 79.7 m-85 -99.42 1.21 44.0 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -53.64 -39.76 65.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.673 0.273 . . . . 0.0 111.093 -177.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.5 -36.03 82.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.632 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 15.0 t70 -80.62 -40.56 25.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.904 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' CD1' HD23 ' A' ' 26' ' ' LEU . 80.8 mt -67.12 -30.26 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.412 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 44.5 tttp -83.48 -23.72 32.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 0.0 109.724 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.28 -45.7 65.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.336 170.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.632 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 51.3 mttm -82.13 -27.02 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.888 -173.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.718 ' HB2' HG23 ' A' ' 39' ' ' VAL . 49.1 m-85 -134.06 -33.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -177.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 97.09 19.96 24.78 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.42 -178.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.718 HG23 ' HB2' ' A' ' 37' ' ' TYR . 38.8 t -82.02 153.49 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.146 0.498 . . . . 0.0 111.908 -174.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.507 ' OD2' ' HB3' ' A' ' 42' ' ' LYS . 26.8 t70 -108.34 106.96 17.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.91 169.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.879 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 40.6 p -69.11 -16.2 63.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.062 -172.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 7.2 ttpm? -63.89 -21.59 66.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.839 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -105.16 -7.36 19.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 76.5 mt -66.86 117.26 8.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.851 -179.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.605 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 87.4 tttt -74.58 97.04 3.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.587 ' HA ' HG12 ' A' ' 60' ' ' VAL . 53.0 mt -77.13 122.0 30.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.638 0.732 . . . . 0.0 111.133 -175.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -94.16 -50.02 5.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.367 -175.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HA ' HG23 ' A' ' 16' ' ' VAL . 34.5 ttmt -145.64 121.36 10.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.271 -173.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.434 HG23 HG22 ' A' ' 58' ' ' VAL . 19.0 m -113.98 135.31 54.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -160.32 174.82 13.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.686 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 12.5 pt-20 -131.25 150.98 51.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.459 0.647 . . . . 0.0 110.322 172.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.27 -151.62 0.48 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -64.75 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.114 177.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.609 ' HA ' HD21 ' A' ' 7' ' ' LEU . 50.7 mtt180 -87.32 11.43 14.39 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.821 -0.55 . . . . 0.0 111.011 178.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 4.2 m-85 -133.18 161.0 35.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.125 -1.03 . . . . 0.0 113.579 -163.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.686 ' CE1' ' HB3' ' A' ' 51' ' ' GLU . 5.5 m-85 -124.18 149.65 46.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.594 169.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.623 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 77.1 m-85 -134.66 102.51 5.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.676 0.274 . . . . 0.0 110.945 -178.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 49' ' ' THR . 9.9 t -112.51 103.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.535 178.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m -87.28 125.02 33.96 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 46' ' ' ILE . 10.1 m -131.19 152.55 37.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 111.507 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.6 t70 -90.34 121.42 32.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 171.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.86 1.97 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.04 -53.31 4.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.338 176.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.55 -23.4 66.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.299 0.571 . . . . 0.0 110.679 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.35 7.97 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.712 -178.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -75.47 150.99 38.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 34.5 ttmt -127.01 107.2 9.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -176.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 34.4 m -106.35 132.06 52.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.339 0.59 . . . . 0.0 110.94 -175.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.623 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.5 tppt? -101.07 100.79 11.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 67.3 m-85 -75.16 106.98 6.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.074 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.636 ' HB3' ' O ' ' A' ' 83' ' ' GLY . 81.1 tttt -98.76 108.86 21.65 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.901 0.857 . . . . 0.0 110.3 -178.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 71.0 mt -105.82 114.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.937 -178.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.803 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 28.9 ttp180 -79.35 29.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.366 0.603 . . . . 0.0 110.485 -172.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.566 ' HG2' ' CD2' ' A' ' 56' ' ' TYR . 84.8 mttt 57.56 -178.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.088 -178.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 2.0 t70 -87.31 42.2 1.02 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.563 . . . . 0.0 109.98 -174.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 73' ' ' ARG . 22.7 m -76.91 105.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.109 0.481 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 69.91 -64.41 0.35 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.294 -175.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -84.96 151.37 57.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.327 . . . . 0.0 110.19 177.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.725 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 60.9 Cg_endo -86.37 29.3 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.039 2.493 . . . . 0.0 111.428 174.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.423 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 1.9 ttmm -132.44 -158.6 0.9 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.376 0.608 . . . . 0.0 111.751 -169.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.522 ' SD ' ' HD3' ' A' ' 84' ' ' ARG . 3.6 ptt? -118.53 166.68 12.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.068 -176.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.803 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 3.6 p -81.55 -52.35 13.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 177.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -177.78 128.21 1.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.247 -177.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.522 ' HD3' ' SD ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -97.83 118.85 35.31 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.382 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -122.49 114.71 21.06 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.982 -169.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 22.6 m -72.22 122.88 21.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.158 173.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 . . . . . 0 C--N 1.303 -1.419 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.873 179.669 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.765 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 38.8 m . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 121.463 0.649 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 1' ' ' LEU . 3.7 pp -88.5 140.24 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.749 -169.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 2' ' ' ILE . 8.5 tp -166.5 45.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.889 1.328 . . . . 0.0 107.487 175.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.452 ' HG ' ' CG ' ' A' ' 75' ' ' ASP . 13.7 mt -82.25 -174.41 5.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.584 -171.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 166.79 -32.0 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.076 -174.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.93 80.66 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.334 176.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 23.4 t70 73.49 11.03 4.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 121.236 0.541 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 42.2 mt 82.86 172.95 0.09 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.427 173.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.7 119.71 7.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.139 -174.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -80.34 95.45 6.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.182 -176.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -85.84 -86.43 0.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -171.69 138.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 111.217 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.08 115.14 7.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.203 172.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 39.9 ttmt -81.72 106.61 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.522 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.64 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 13.0 mt 58.88 173.99 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 123.487 0.715 . . . . 0.0 112.152 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 38.8 Cg_endo -69.8 -19.97 35.24 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.91 1.74 . . . . 0.0 111.495 171.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' A' ' 48' ' ' LYS . 6.7 t -138.49 113.2 8.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.9 176.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.65 HG22 ' H ' ' A' ' 18' ' ' ASP . 12.3 mt -68.77 175.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.942 -178.009 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.65 ' H ' HG22 ' A' ' 17' ' ' ILE . 9.0 m-20 -51.63 -20.71 2.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.663 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 96.3 m-20 73.1 -40.09 0.46 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.389 0.676 . . . . 0.0 110.999 -174.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.59 -35.77 81.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 169.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' O ' HD13 ' A' ' 25' ' ' LEU . 90.9 t80 -59.13 -42.48 90.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -65.55 -42.65 95.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 175.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -51.78 -41.65 61.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.461 0.304 . . . . 0.0 110.857 176.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.4 mm-40 -57.84 -54.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.001 173.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 21' ' ' PHE . 10.8 mp -47.68 -63.93 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.289 174.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.66 HD11 HG21 ' A' ' 58' ' ' VAL . 9.6 mp -59.84 -32.18 70.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.28 -174.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.19 -42.72 93.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 52.0 mttm -71.73 -42.48 67.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 110.646 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CD1' ' HA ' ' A' ' 0' ' ' SER . 2.0 m-30 -87.38 -0.48 56.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.378 -173.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 8.0 tt0 -56.43 -36.97 69.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.132 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.15 -36.08 65.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.009 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.86 -50.08 18.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.315 0.579 . . . . 0.0 109.832 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.655 HG22 ' HB ' ' A' ' 39' ' ' VAL . 45.8 mt -62.79 -31.07 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.993 -177.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 66.5 tttt -89.11 -29.17 19.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.43 -174.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.39 -51.77 33.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 0.0 110.566 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.17 -43.1 54.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.671 -172.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.652 ' HB2' HG23 ' A' ' 39' ' ' VAL . 15.9 m-85 -120.07 -17.95 8.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.824 0.345 . . . . 0.0 111.416 -173.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 81.36 30.74 36.09 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.655 ' HB ' HG22 ' A' ' 33' ' ' ILE . 16.6 t -92.6 147.33 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.954 0.407 . . . . 0.0 111.418 -175.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -108.99 120.67 43.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 44' ' ' LEU . 33.4 p -80.07 -13.78 59.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -170.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -74.81 -20.97 59.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.506 0.669 . . . . 0.0 109.566 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -86.77 -41.17 14.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.352 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 41' ' ' THR . 91.6 mt -53.56 109.49 0.45 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.246 177.065 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 79.1 tttt -77.36 108.89 10.82 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.55 ' HA ' HG12 ' A' ' 60' ' ' VAL . 42.8 mt -73.54 115.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.482 0.658 . . . . 0.0 110.171 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.8 mt -87.33 -39.11 15.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.196 -175.303 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.52 ' HG3' HG22 ' A' ' 16' ' ' VAL . 17.0 ttpp -156.57 104.98 2.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.003 -176.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.663 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 14.8 m -83.9 128.78 34.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -155.17 179.2 9.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 12.2 pt-20 -155.35 -177.07 6.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.851 176.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.641 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t70 -132.27 -88.01 0.45 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.641 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 40.9 mmtm -128.57 -81.52 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 54' ' ' ARG . 67.5 mtt85 -88.69 23.7 2.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 38.8 m-85 -142.95 132.37 23.51 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -169.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.886 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 30.3 m-85 -101.65 149.77 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 166.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -134.36 97.47 3.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.859 0.361 . . . . 0.0 110.091 177.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.66 HG21 HD11 ' A' ' 26' ' ' LEU . 14.0 t -105.16 96.64 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.831 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 11.8 t -76.03 126.5 31.11 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 46' ' ' ILE . 26.9 m -135.65 150.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.457 0.646 . . . . 0.0 112.263 -174.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.5 t70 -99.14 123.93 43.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.092 173.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.68 4.94 10.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.883 -171.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.98 -174.07 45.76 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.81 -36.69 79.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 -177.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.67 -6.4 6.62 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.75 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -75.17 119.74 19.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -178.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -145.1 117.0 8.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.507 -178.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 3.3 m -127.96 159.97 33.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.451 -175.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.3 ttmt -123.62 106.19 10.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 52.6 m-85 -73.45 96.46 2.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.875 0.845 . . . . 0.0 110.51 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 1.017 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 50.8 tttp -82.95 79.64 9.25 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.312 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 45.0 mt -75.5 105.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.398 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.559 ' HD2' HG11 ' A' ' 82' ' ' VAL . 43.1 ttt-85 -74.34 9.72 1.57 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.612 0.72 . . . . 0.0 110.184 -175.061 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 72' ' ' ILE . 94.6 mttt 63.5 177.05 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.482 176.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.856 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 8.0 t0 -80.68 64.35 5.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 177.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 4.0 m -85.98 87.16 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.092 175.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 5.1 m-20 74.69 -53.58 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -174.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.3 p -114.82 135.57 22.42 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.856 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 23.7 Cg_endo -65.59 -50.78 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.052 2.502 . . . . 0.0 112.918 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -46.71 128.97 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.766 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 159.48 6.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.897 -175.229 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.559 HG11 ' HD2' ' A' ' 73' ' ' ARG . 3.8 p -103.62 -27.97 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.573 177.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 1.017 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -118.76 135.61 11.58 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.946 -170.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -155.23 19.03 0.42 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.033 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -71.53 117.83 13.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.196 -168.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 60.6 m -84.42 111.03 19.09 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 . . . . . 0 C--N 1.307 -1.264 0 CA-C-O 122.091 0.948 . . . . 0.0 109.425 179.601 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.551 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 26.8 t . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.797 0.808 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 3' ' ' LEU . 89.2 mt -85.55 11.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.088 175.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.462 HD13 ' HD3' ' A' ' 74' ' ' LYS . 9.2 tt -78.06 65.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.013 170.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.551 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -103.29 154.72 19.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.931 -164.732 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.676 ' HB3' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -174.09 5.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.185 169.149 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.84 62.87 0.71 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -179.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.1 t70 70.29 25.45 4.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.117 0.961 . . . . 0.0 108.672 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.676 HD12 ' HB3' ' A' ' 4' ' ' ASP . 84.0 mt -110.21 109.47 19.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.992 -177.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.723 HD12 ' HD2' ' A' ' 74' ' ' LYS . 2.0 mm? -64.98 -56.34 13.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.134 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 67.52 -62.58 0.33 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.831 0.707 . . . . 0.0 111.178 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.52 85.8 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 0.0 110.576 176.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HA ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -112.72 132.05 55.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 169.224 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 14' ' ' LEU . 67.0 mt -82.8 -169.9 2.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.295 0.569 . . . . 0.0 111.89 -171.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.76 21.23 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.449 -170.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.443 HD11 HD13 ' A' ' 12' ' ' LEU . 1.3 pp -138.16 162.24 54.91 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.888 -167.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.74 -147.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.86 3.04 . . . . 0.0 112.699 171.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.618 ' HB ' ' HG3' ' A' ' 48' ' ' LYS . 11.0 p -47.09 130.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.235 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -97.78 -73.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.446 -175.938 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.653 ' H ' ' HB ' ' A' ' 49' ' ' THR . 5.4 m-20 64.72 12.23 7.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.776 177.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . 58.2 t30 -81.53 61.16 4.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.14 3.0 0.9 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.312 0.645 . . . . 0.0 110.7 -174.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.784 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 4.4 m-85 -63.69 -61.31 2.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.653 -175.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.42 ' N ' HG21 ' A' ' 49' ' ' THR . . . -62.26 -35.59 91.81 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.847 -177.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -68.2 -36.72 80.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.834 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.1 mm-40 -62.3 -53.95 47.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.04 0.536 . . . . 0.0 111.231 175.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 13.0 mt -52.74 -62.59 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.109 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.631 HD22 HG22 ' A' ' 41' ' ' THR . 33.4 mt -58.7 -26.8 64.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.053 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.0 -43.55 82.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 177.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.2 mttm -72.68 -41.11 65.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.829 -179.162 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.551 ' HZ ' ' HB3' ' A' ' 0' ' ' SER . 96.8 m-85 -90.19 0.46 57.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.757 -176.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 34.1 tt0 -50.9 -44.24 59.9 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.966 0.412 . . . . 0.0 110.792 177.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.72 -31.68 73.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.512 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -84.98 -41.4 15.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.51 0.672 . . . . 0.0 110.184 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.681 HG22 ' HB ' ' A' ' 39' ' ' VAL . 95.9 mt -63.07 -34.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.181 177.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 45.6 tttp -81.76 -34.23 30.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.509 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.94 -47.37 77.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.361 174.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -95.36 -42.45 8.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -172.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.626 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 m-85 -111.06 -13.11 14.11 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.502 -170.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.5 50.09 33.9 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.27 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.681 ' HB ' HG22 ' A' ' 33' ' ' ILE . 23.6 t -116.79 152.69 18.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 110.921 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -111.69 118.13 34.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.631 HG22 HD22 ' A' ' 26' ' ' LEU . 40.1 p -75.2 -14.29 60.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.033 0.444 . . . . 0.0 111.734 -173.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -76.93 -17.46 58.9 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.981 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -99.65 -16.21 18.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.372 0.606 . . . . 0.0 109.849 -179.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 41' ' ' THR . 96.6 mt -68.09 121.4 16.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 53.4 tptt -85.03 103.08 13.74 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 176.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.604 ' HA ' HG12 ' A' ' 60' ' ' VAL . 34.1 mt -72.77 114.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.459 0.647 . . . . 0.0 109.96 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.5 mt -87.13 -35.92 18.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.773 -177.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.618 ' HG3' ' HB ' ' A' ' 16' ' ' VAL . 4.1 ttmp? -159.06 108.95 1.95 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.577 -177.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.653 ' HB ' ' H ' ' A' ' 18' ' ' ASP . 20.0 m -86.1 134.42 33.82 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 p -162.57 -179.24 6.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.383 . . . . 0.0 110.517 176.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 5.5 pt-20 -155.67 164.37 38.69 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.328 176.165 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HB3' ' HE2' ' A' ' 57' ' ' TYR . 10.2 t70 -157.5 108.61 2.29 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 56.88 -115.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.097 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.476 ' HG2' HD11 ' A' ' 8' ' ' LEU . 46.4 mtt85 -88.55 16.24 6.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -172.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -138.35 137.6 37.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.924 -171.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.572 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 8.0 m-85 -98.13 140.39 32.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.661 168.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.537 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 97.4 m-85 -124.57 96.49 4.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.415 -178.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 3.4 t -103.26 90.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.6 t -72.97 120.86 19.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.8 m -133.35 155.91 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.204 0.526 . . . . 0.0 111.048 -177.005 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.496 ' HB2' HD21 ' A' ' 47' ' ' LEU . 16.9 t0 -100.55 127.84 46.79 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.026 173.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -7.33 59.21 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.58 -81.61 1.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.015 172.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.21 -22.94 61.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.038 0.447 . . . . 0.0 111.352 -175.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.3 -90.01 0.75 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.821 -174.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -100.38 177.56 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -128.52 126.51 40.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 167.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 1.063 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.6 t -134.14 -177.83 4.76 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.451 0.643 . . . . 0.0 111.316 -167.31 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 37.6 ttmt -159.39 90.23 0.94 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.494 ' CD1' HD21 ' A' ' 26' ' ' LEU . 72.2 m-85 -57.12 111.66 1.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.842 -176.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.9 tttt -94.5 77.36 3.84 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.325 -176.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.673 ' HA ' ' CB ' ' A' ' 81' ' ' MET . 78.3 mt -80.26 92.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.572 -177.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 1.04 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 49.3 ttt180 -56.83 127.48 31.9 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.259 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.723 ' HD2' HD12 ' A' ' 8' ' ' LEU . 95.2 mttt -63.57 179.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' CB ' ' HA ' ' A' ' 3' ' ' LEU . 5.9 t70 -61.43 94.02 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.754 0.788 . . . . 0.0 110.516 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 74' ' ' LYS . 12.4 m -138.29 84.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.814 174.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.2 t70 76.9 -49.48 0.55 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.826 -174.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 m -96.67 150.25 36.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.409 0.623 . . . . 0.0 111.136 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -95.21 29.11 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.245 3.297 . . . . 0.0 110.923 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -137.96 -176.6 4.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.557 -171.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.673 ' CB ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.17 146.07 23.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.875 179.614 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.04 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.6 p -83.0 -26.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.321 0.581 . . . . 0.0 110.282 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.92 -171.31 23.71 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.036 -175.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 24.0 ptt-85 -161.17 71.05 0.39 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 18.5 tptm -59.77 80.64 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.86 -167.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.063 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 27.8 m -92.54 -116.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 64.6 mtt180 . . . . . 0 C--O 1.233 0.219 0 C-N-CA 123.196 0.598 . . . . 0.0 110.772 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 0' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 56.4 m . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 31.0 mt -102.61 -0.55 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.357 -174.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.601 HG23 ' HB2' ' A' ' 74' ' ' LYS . 5.3 tp -78.28 89.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.752 0.787 . . . . 0.0 109.877 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.955 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -71.23 0.87 6.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.054 -175.448 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.45 39.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.278 1.037 . . . . 0.0 109.313 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.569 ' CA ' HG12 ' A' ' 76' ' ' VAL . . . -128.73 -53.81 0.11 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.699 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 28.9 t70 -53.56 -35.78 61.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 166.179 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 7' ' ' LEU . 3.6 mm? -92.78 -57.02 2.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 172.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.6 tp 56.99 72.07 0.53 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.023 0.827 . . . . 0.0 110.962 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.28 -26.4 9.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.067 -177.037 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -154.22 70.97 0.82 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.393 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 11.2 ptmm? -76.96 154.62 33.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 4.7 mp -88.95 174.07 8.13 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.259 -173.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -147.89 30.45 0.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.227 -171.028 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.2 mm? -89.73 147.63 38.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -176.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.7 117.94 4.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.69 2.26 . . . . 0.0 110.858 173.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 48' ' ' LYS . 7.5 p 41.11 99.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.926 1.346 . . . . 0.0 113.162 -171.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 49' ' ' THR . 25.2 mt -65.87 154.34 7.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.925 178.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.48 144.21 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -172.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -62.25 -23.84 66.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.327 -176.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.4 tp -65.68 -41.58 92.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.589 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 65.7 t80 -64.67 -39.34 93.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.535 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.574 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -68.23 -44.05 77.26 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.353 176.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HD2' HD12 ' A' ' 46' ' ' ILE . 4.3 mptp? -53.29 -44.4 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.678 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.3 mm-40 -54.9 -55.84 26.1 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.66 176.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.2 mt -53.4 -60.55 3.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.882 0.849 . . . . 0.0 110.695 178.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.685 HD22 HD11 ' A' ' 46' ' ' ILE . 9.5 mp -59.2 -40.88 87.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.433 -173.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.48 -32.49 73.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.678 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.2 mttm -67.43 -33.3 74.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' HZ ' ' H1 ' ' A' ' 0' ' ' SER . 92.7 m-85 -95.01 0.95 55.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.73 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -36.1 74.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.509 0.195 . . . . 0.0 111.443 -171.222 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.95 -33.98 76.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.22 -41.43 49.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.492 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.534 HG22 ' HB ' ' A' ' 39' ' ' VAL . 90.9 mt -62.83 -37.14 78.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.753 176.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 36.3 ttmt -80.87 -22.76 39.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.042 -177.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.79 -47.14 22.45 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.448 172.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.69 -42.92 57.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.282 -175.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.406 ' HB2' HG23 ' A' ' 39' ' ' VAL . 59.8 m-85 -121.2 -28.3 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.735 0.303 . . . . 0.0 111.731 -174.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 91.88 41.78 4.9 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.986 -178.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 13.1 t -119.42 152.1 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 120.556 0.217 . . . . 0.0 110.838 -176.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.92 136.37 50.04 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.507 HG21 ' O ' ' A' ' 26' ' ' LEU . 32.3 p -79.99 -12.92 59.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -83.31 -3.04 57.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.9 -27.72 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.292 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.53 HD21 HG11 ' A' ' 39' ' ' VAL . 67.8 mt -62.17 125.98 25.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.715 175.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -85.79 102.92 14.08 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.415 -178.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.685 HD11 HD22 ' A' ' 26' ' ' LEU . 22.9 mt -75.66 124.42 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.695 0.759 . . . . 0.0 110.931 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.7 mt -100.1 -53.72 3.07 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.673 -177.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.563 ' HA ' HG23 ' A' ' 16' ' ' VAL . 36.6 ttmt -142.9 104.26 4.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.871 -174.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 58' ' ' VAL . 46.6 m -91.69 125.5 36.43 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.9 m -151.8 -179.12 7.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' OE2' ' HB2' ' A' ' 11' ' ' LYS . 9.4 pt-20 -142.14 143.82 33.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 177.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.02 126.62 10.92 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 58.46 -141.27 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.741 -175.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.586 ' HB3' HG11 ' A' ' 76' ' ' VAL . 73.7 mtt180 -77.71 14.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.527 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 5.0 m-85 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.313 -169.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.569 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 17.3 m-85 -98.26 143.96 28.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.367 166.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.0 m-85 -124.32 105.49 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 26' ' ' LEU . 13.9 t -106.69 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.847 0.356 . . . . 0.0 110.722 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 14.5 t -74.35 128.25 35.08 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.9 m -138.22 153.99 27.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.085 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.13 126.62 34.9 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.75 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 -36.23 2.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.586 174.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -70.83 -14.31 62.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.144 0.497 . . . . 0.0 109.978 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.25 -24.92 4.95 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -78.34 174.26 11.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.912 0.387 . . . . 0.0 110.692 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -138.61 115.74 11.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 1.074 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -107.14 163.26 13.15 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.014 0.435 . . . . 0.0 111.239 -168.395 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.2 ttmt -139.21 93.9 2.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 64.4 m-85 -67.58 108.53 2.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.37 0.605 . . . . 0.0 110.342 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 46.9 tttt -92.2 83.53 5.09 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.044 -176.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.905 HG12 ' HG2' ' A' ' 81' ' ' MET . 55.7 mt -81.05 91.38 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.564 -178.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.703 HH11 HG21 ' A' ' 82' ' ' VAL . 34.8 ttt180 -59.68 111.23 1.35 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.389 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.865 ' HG3' HG13 ' A' ' 76' ' ' VAL . 18.6 ptpt -56.43 166.62 0.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.695 0.622 . . . . 0.0 110.461 -179.179 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 3' ' ' LEU . 38.9 t70 -68.65 75.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.508 0.67 . . . . 0.0 110.166 -178.2 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.865 HG13 ' HG3' ' A' ' 74' ' ' LYS . 29.5 m -100.84 -8.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.445 177.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 176.29 -51.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.833 -169.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -117.15 136.74 23.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.365 0.602 . . . . 0.0 110.323 178.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 43.9 Cg_endo -86.45 46.2 1.52 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 123.805 3.003 . . . . 0.0 113.341 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HA ' ' HE1' ' A' ' 29' ' ' PHE . 27.3 mtmt -150.68 161.7 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.131 0.491 . . . . 0.0 112.19 -177.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.905 ' HG2' HG12 ' A' ' 72' ' ' ILE . 38.2 mtm -63.81 101.51 0.38 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.264 172.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.703 HG21 HH11 ' A' ' 73' ' ' ARG . 9.9 p -55.85 -28.74 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.402 173.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.65 177.41 26.9 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.277 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -177.12 42.27 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.023 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -83.28 120.75 26.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.876 -171.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 1.074 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 29.7 m -65.6 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.569 -177.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.577 0.704 . . . . 0.0 109.245 175.856 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.674 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 32.8 t -101.27 -73.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 0.114 . . . . 0.0 111.008 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 61.94 12.2 4.69 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.805 0.442 . . . . 0.0 110.871 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 tp -90.22 -3.73 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -168.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.849 HD23 HG12 ' A' ' 76' ' ' VAL . 13.6 tp -174.01 71.99 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.302 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -48.63 103.55 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.136 0.898 . . . . 0.0 112.032 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.58 32.5 78.8 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.569 -0.741 . . . . 0.0 113.498 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.758 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.3 t0 56.11 76.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.4 0.619 . . . . 0.0 112.135 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.688 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 94.9 mt -112.25 38.24 2.77 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 3' ' ' LEU . 23.9 tp -71.22 101.03 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.381 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 9' ' ' LYS . 7.4 mtmp? -105.52 -41.38 5.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.23 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -125.37 101.69 7.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.544 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -103.86 -81.39 0.52 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.926 0.393 . . . . 0.0 111.586 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 17' ' ' ILE . 61.5 tp -147.37 126.13 12.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.027 0.441 . . . . 0.0 110.694 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -122.48 11.27 9.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 122.203 1.001 . . . . 0.0 108.765 173.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.3 mt -115.44 171.68 4.34 Favored Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.603 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -61.44 -157.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.191 2.594 . . . . 0.0 112.544 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.534 HG23 ' HG3' ' A' ' 48' ' ' LYS . 4.4 p -49.84 124.54 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.789 0.804 . . . . 0.0 111.306 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.481 HG12 HD13 ' A' ' 12' ' ' LEU . 35.0 mt -69.25 152.12 9.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.2 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 139.38 57.08 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 27.0 p-10 -61.6 -26.05 67.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.476 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt -56.75 -45.56 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.01 -38.24 90.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.201 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -69.34 -37.25 79.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.449 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 30.2 mmmt -64.31 -31.22 72.34 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.24 -47.3 65.11 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 90.9 mt -52.32 -65.52 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.077 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 23.6 mt -53.37 -27.72 25.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.712 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.88 -40.38 63.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 111.024 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -79.27 -35.88 40.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.112 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.674 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 96.4 m-85 -91.99 4.87 52.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.547 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 34.7 tt0 -52.59 -41.9 64.05 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.1 -39.47 94.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.702 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.0 m-20 -67.59 -54.12 22.51 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.63 HG22 ' HB ' ' A' ' 39' ' ' VAL . 65.0 mt -55.89 -35.02 38.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.204 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 9.2 tmtm? -81.77 -37.28 27.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.283 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.46 -53.56 50.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.667 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.702 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 39.1 mttm -69.25 -55.32 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.8 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 84' ' ' ARG . 22.9 m-85 -104.68 -37.08 7.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.079 0.466 . . . . 0.0 111.422 -171.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.24 63.88 1.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.445 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.63 ' HB ' HG22 ' A' ' 33' ' ' ILE . 32.1 t -126.12 155.25 35.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -105.55 119.82 40.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.632 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 26.4 p -84.67 -11.03 56.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -71.21 -35.07 71.4 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.45 -34.53 60.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.349 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.0 mt -49.01 120.11 3.69 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.709 0.766 . . . . 0.0 112.433 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 86.1 tttt -92.24 104.01 16.42 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.135 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.644 HG12 HG12 ' A' ' 60' ' ' VAL . 20.0 mt -78.1 130.76 35.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.495 0.664 . . . . 0.0 111.723 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt -99.97 -45.9 5.53 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.77 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HG3' HG23 ' A' ' 16' ' ' VAL . 58.6 tttm -151.28 110.85 4.0 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.492 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.5 m -90.04 121.54 32.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -155.08 -167.68 2.64 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -169.94 170.03 7.87 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -116.64 -81.11 0.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.173 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.21 -88.53 0.58 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.922 ' HB3' HG21 ' A' ' 76' ' ' VAL . 85.1 mtt180 -91.86 23.96 3.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.49 0.662 . . . . 0.0 110.677 -175.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.489 ' HE2' HG11 ' A' ' 82' ' ' VAL . 54.6 m-85 -147.36 144.58 28.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.673 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.936 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 27.2 m-85 -93.75 152.88 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.567 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 74.7 m-85 -139.09 99.13 3.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.212 0.529 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 t -109.24 97.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.016 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.0 m -66.61 121.69 15.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.962 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.644 HG12 HG12 ' A' ' 46' ' ' ILE . 21.5 m -137.01 151.92 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.115 0.483 . . . . 0.0 111.104 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.2 t70 -88.49 115.51 26.06 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 169.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.12 -2.1 32.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.916 -173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.43 -15.21 13.48 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.471 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -88.95 -1.98 58.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.503 0.668 . . . . 0.0 110.055 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.63 -15.14 58.8 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.541 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 8.6 tp10 -90.67 140.69 29.53 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.859 0.362 . . . . 0.0 110.516 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' H ' ' HG2' ' A' ' 88' ' ' LYS . 67.9 mttm -115.08 85.73 2.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.192 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 15.1 t -89.89 142.09 28.03 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.428 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 40.4 ttmt -102.69 88.06 3.13 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.097 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 12.7 m-85 -47.88 123.04 5.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.135 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.909 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 25.9 ttpp -104.71 87.71 2.75 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 122.049 0.928 . . . . 0.0 110.217 -173.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.936 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 80.6 mt -87.15 89.94 3.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.51 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.716 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 13.7 ttt180 -52.89 114.94 1.59 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.793 ' HB2' HG13 ' A' ' 76' ' ' VAL . 53.9 mttp -60.87 170.31 1.57 Allowed 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.694 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.1 t70 -73.2 32.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.934 0.873 . . . . 0.0 110.149 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.922 HG21 ' HB3' ' A' ' 54' ' ' ARG . 31.4 m -76.85 -7.34 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.011 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -171.97 -51.13 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.981 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 28.4 m -108.57 149.05 38.89 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.263 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.413 ' O ' ' HA2' ' A' ' -1' ' ' GLY . 77.1 Cg_endo -86.81 27.41 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.268 2.645 . . . . 0.0 113.587 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HD2' ' NZ ' ' A' ' 36' ' ' LYS . 23.3 pttm -159.41 -178.77 7.38 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.671 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.432 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -83.65 132.4 34.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 13.7 p -80.51 -38.85 18.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -168.69 -142.93 3.65 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.134 -172.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.909 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 11.8 ptt-85 -172.92 114.58 0.26 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 93' ' ' ASP . 22.0 tptm -80.36 81.33 6.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.466 0.651 . . . . 0.0 110.803 -173.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 68.3 m -76.23 -159.16 0.11 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.728 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 86' ' ' CYS . 62.8 mtp180 76.13 96.76 0.07 Allowed 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 123.985 0.803 . . . . 0.0 109.667 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.498 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 7.7 mtmp? -66.57 -73.3 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.745 -166.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.1 -54.69 6.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.074 -169.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -132.42 113.4 13.11 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.133 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.74 173.9 6.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.319 176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -140.66 -50.89 0.46 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 1.4 m-20 -53.53 129.61 33.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.379 173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.67 -51.17 7.02 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.66 -174.05 50.15 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 170.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.667 ' HB3' ' CE ' ' A' ' 71' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 118.055 0.927 . . . . 0.0 109.765 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 1' ' ' LEU . . . . . . . . 0 N--CA 1.479 1.512 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.778 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 19.1 m -72.42 113.72 9.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.65 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -156.56 135.92 12.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.566 0.222 . . . . 0.0 111.501 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.877 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 5.2 tp 167.56 135.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 124.411 1.07 . . . . 0.0 109.23 173.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.697 HD13 HG23 ' A' ' 2' ' ' ILE . 11.0 mp 82.32 -21.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.609 0.764 . . . . 0.0 111.999 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.542 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 14.3 m-20 62.51 20.82 12.22 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 171.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.91 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . 79.34 -0.22 81.09 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.317 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -88.59 -11.71 44.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.843 0.354 . . . . 0.0 110.448 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.586 ' HA ' HD23 ' A' ' 3' ' ' LEU . 96.9 mt 70.36 32.22 2.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.134 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -60.64 93.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.659 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HG2' ' H ' ' A' ' 9' ' ' LYS . 8.7 pttt -100.41 71.94 1.57 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.599 0.714 . . . . 0.0 110.291 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.93 -30.71 69.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.292 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HB3' HD11 ' A' ' 14' ' ' LEU . 45.4 mmtm -135.96 144.43 45.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.623 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 35.2 tp -167.62 165.55 14.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 26.4 mttt 64.72 20.01 12.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.431 0.634 . . . . 0.0 110.491 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 11' ' ' LYS . 59.4 mt -72.41 155.45 91.28 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.872 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.89 -171.35 0.22 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.824 2.349 . . . . 0.0 110.57 169.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG2' ' HA ' ' A' ' 48' ' ' LYS . 7.2 p -65.21 122.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.212 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.834 HG13 ' HB ' ' A' ' 49' ' ' THR . 4.1 pt -105.89 -178.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.799 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 177.47 -34.45 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -40.02 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 112.919 -1.946 . . . . 0.0 112.891 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 20' ' ' LEU . 22.8 mt 34.65 43.92 0.1 Allowed 'General case' 0 CA--C 1.521 -0.138 0 O-C-N 123.885 0.74 . . . . 0.0 111.987 -173.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -125.94 -66.76 0.91 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.83 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' CA ' HG21 ' A' ' 49' ' ' THR . . . -64.36 -50.19 61.14 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.36 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.17 -36.59 68.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.916 0.388 . . . . 0.0 110.64 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.8 mt-10 -65.3 -50.54 65.28 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.963 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 91.0 mt -47.92 -65.0 0.64 Allowed 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 123.579 0.55 . . . . 0.0 110.891 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 58' ' ' VAL . 7.4 mp -60.95 -38.38 85.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.553 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.72 -33.42 75.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 84.2 mttt -78.48 -46.1 20.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.456 0.646 . . . . 0.0 109.828 175.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.612 ' CE2' HG23 ' A' ' 72' ' ' ILE . 6.8 m-85 -70.33 -9.86 57.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.552 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -52.42 -47.51 66.3 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 122.719 0.407 . . . . 0.0 111.806 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -54.84 -39.64 68.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.103 0.478 . . . . 0.0 110.713 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.23 -43.91 31.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.6 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.439 HD13 ' CE1' ' A' ' 70' ' ' PHE . 55.6 mt -63.42 -33.57 62.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.697 0.76 . . . . 0.0 110.403 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 71.3 tttt -80.86 -29.15 35.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.596 -177.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.13 -50.48 40.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.089 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HE3' ' O ' ' A' ' 81' ' ' MET . 62.8 mttm -66.33 -50.12 64.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.399 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.451 ' HB2' HG23 ' A' ' 39' ' ' VAL . 34.9 m-85 -118.08 -37.62 3.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.877 0.37 . . . . 0.0 111.605 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.62 62.89 1.02 Allowed Glycine 0 C--N 1.323 -0.179 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.845 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.612 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -126.01 150.32 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-O 120.847 0.356 . . . . 0.0 111.584 -173.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.84 128.13 45.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 8.2 p -86.41 -9.48 56.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -169.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -92.22 -10.1 39.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.577 0.703 . . . . 0.0 109.346 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -76.69 -29.32 56.26 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.577 1.18 . . . . 0.0 107.872 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.564 HD13 ' CE2' ' A' ' 70' ' ' PHE . 27.4 mt -77.77 109.15 11.54 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 112.848 -1.978 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 55.4 tttm -72.86 111.97 8.48 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.679 ' HA ' HG12 ' A' ' 60' ' ' VAL . 26.3 mt -74.34 111.67 10.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.587 0.708 . . . . 0.0 110.234 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.8 mt -86.23 -35.94 19.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.678 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . 34.0 tttp -156.88 118.31 3.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.667 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.834 ' HB ' HG13 ' A' ' 17' ' ' ILE . 2.8 m -106.53 126.13 51.87 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.8 m -155.77 170.99 20.78 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.65 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 14.0 pt-20 -139.59 175.69 9.36 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.437 0.637 . . . . 0.0 111.814 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -152.88 -162.2 1.44 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -58.3 103.35 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 77.1 -21.28 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.779 0.674 . . . . 0.0 112.559 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -107.71 142.05 38.29 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.674 ' HD2' ' HG2' ' A' ' 74' ' ' LYS . 4.5 m-85 -109.94 142.44 41.3 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 166.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 70' ' ' PHE . 61.0 m-85 -133.01 115.09 14.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.271 0.558 . . . . 0.0 110.678 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.734 HG22 HG23 ' A' ' 49' ' ' THR . 41.6 t -108.69 98.75 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.565 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 10.3 m -74.44 128.83 36.53 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 46' ' ' ILE . 33.3 m -138.25 156.83 30.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.823 0.344 . . . . 0.0 111.143 -176.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.63 110.95 23.12 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.2 1.27 53.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.783 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.29 -112.91 0.27 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.658 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -116.36 79.0 1.25 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.622 ' O ' ' HE3' ' A' ' 88' ' ' LYS . . . 89.48 4.13 73.96 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.641 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 12.3 mt-10 -79.25 81.98 5.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 122.087 0.946 . . . . 0.0 109.67 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.509 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 28.9 ttmt -82.43 135.54 35.13 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.55 -169.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 26.3 t -138.8 169.11 18.38 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.009 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 39.6 ttpt -146.43 110.81 5.11 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.564 ' CE2' HD13 ' A' ' 44' ' ' LEU . 36.6 m-85 -68.73 122.62 18.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.443 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HD3' ' HA3' ' A' ' 83' ' ' GLY . 83.3 tttt -88.72 71.61 8.73 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.197 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.612 HG23 ' CE2' ' A' ' 29' ' ' PHE . 67.4 mt -80.08 92.76 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.451 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.585 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 46.3 ttt-85 -72.4 8.45 1.37 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.427 0.632 . . . . 0.0 110.087 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.674 ' HG2' ' HD2' ' A' ' 56' ' ' TYR . 64.1 mttt 66.4 172.43 0.24 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.991 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.877 ' HB3' ' H ' ' A' ' 2' ' ' ILE . 2.0 t70 -77.66 87.79 3.94 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.091 0.948 . . . . 0.0 109.131 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.91 ' HA ' ' HA2' ' A' ' 5' ' ' GLY . 2.6 p -115.36 100.8 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.156 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.574 ' H ' ' CA ' ' A' ' 5' ' ' GLY . 33.4 t70 78.07 -59.64 0.43 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.644 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.44 146.86 33.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.17 -53.17 0.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.371 2.048 . . . . 0.0 113.792 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.778 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 11.7 ptpt -65.9 154.29 39.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.392 0.615 . . . . 0.0 112.136 -168.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.468 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -65.07 146.01 55.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.772 -176.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 7.5 p -81.03 -40.9 18.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.542 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.597 ' HA3' ' HD3' ' A' ' 71' ' ' LYS . . . -149.07 161.92 28.83 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.461 -172.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 84' ' ' ARG . 27.5 ttt180 -149.0 92.83 2.02 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.768 ' HE3' ' HB3' ' A' ' 92' ' ' ASP . 9.0 tppt? -105.35 111.26 23.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 110.586 -172.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 8.1 m -103.54 123.83 47.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.743 ' HD3' ' HE2' ' A' ' 96' ' ' TYR . 9.7 mtm180 -87.74 5.01 42.02 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.769 0.795 . . . . 0.0 110.317 -167.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.641 ' HG3' ' HA ' ' A' ' 66' ' ' GLU . 57.1 mmtt -90.22 1.04 56.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.751 168.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -125.85 -52.83 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.467 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -167.02 143.71 4.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.206 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -112.53 132.33 55.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 110.22 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.768 ' HB3' ' HE3' ' A' ' 85' ' ' LYS . 10.2 t70 -124.51 148.65 47.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.286 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -95.47 -6.59 40.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.95 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.29 104.7 3.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 56.71 -118.72 12.51 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.636 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.743 ' HE2' ' HD3' ' A' ' 87' ' ' ARG . 30.9 t80 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 122.816 0.446 . . . . 0.0 110.807 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 6.4 t -89.73 178.15 6.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -165.89 21.32 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.173 0.511 . . . . 0.0 111.293 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -101.15 107.73 21.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 3.2 mm? -120.71 -101.58 0.42 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 112.026 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 10.2 m-20 70.38 10.21 7.17 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.671 0.607 . . . . 0.0 109.702 -169.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 6' ' ' ASP . . . 69.99 97.14 0.05 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.21 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.491 ' HB3' ' O ' ' A' ' 5' ' ' GLY . 24.5 t70 73.57 -2.87 2.63 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.6 0.714 . . . . 0.0 110.1 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.945 HD21 ' HB2' ' A' ' 74' ' ' LYS . 11.2 mp 75.38 171.97 0.26 Allowed 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 166.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.462 HD23 ' HG2' ' A' ' 11' ' ' LYS . 9.7 tp -78.55 3.05 17.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.578 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 15.9 mmtp 73.99 -74.61 0.08 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.413 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -145.4 135.28 23.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HG2' HD23 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -130.47 16.86 5.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.016 176.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 12' ' ' LEU . 13.2 mt -144.43 93.36 2.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.151 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -95.63 36.15 1.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.536 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.755 ' HB2' HG12 ' A' ' 17' ' ' ILE . 48.6 mt -79.39 128.53 75.05 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.231 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.6 Cg_exo -64.43 116.03 3.53 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.77 2.313 . . . . 0.0 110.228 175.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 48' ' ' LYS . 4.3 p 41.23 96.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 123.031 1.396 . . . . 0.0 112.057 -168.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.755 HG12 ' HB2' ' A' ' 14' ' ' LEU . 60.5 mt -74.26 155.42 6.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.225 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -44.76 133.75 5.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 112.206 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -62.73 -29.29 70.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.067 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 tp -68.2 -40.33 82.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.726 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.09 -36.52 81.95 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.5 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -66.06 -50.32 52.65 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -52.59 -35.77 54.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.441 0.297 . . . . 0.0 110.933 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.577 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 8.3 mm-40 -60.19 -54.87 40.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.085 174.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.2 mt -52.34 -63.73 1.05 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.548 0.69 . . . . 0.0 110.313 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.895 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 9.8 mp -56.21 -35.42 67.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.779 -171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.6 -36.44 83.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.072 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 65.2 mttm -70.15 -34.43 73.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.286 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 72' ' ' ILE . 15.0 m-85 -100.54 -1.92 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.083 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.02 -30.81 66.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.737 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.56 -39.18 92.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.781 0.324 . . . . 0.0 110.632 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 2.8 m-20 -84.04 -30.31 26.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.147 0.499 . . . . 0.0 110.276 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 39' ' ' VAL . 85.7 mt -63.98 -31.83 54.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.776 0.798 . . . . 0.0 109.834 173.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.643 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 74.7 tttt -88.69 -38.55 14.67 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 17.1 t70 -59.33 -45.58 90.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.392 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -80.63 -52.64 7.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.168 0.508 . . . . 0.0 112.025 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.554 ' HB2' HG23 ' A' ' 39' ' ' VAL . 24.4 m-85 -105.02 -30.83 9.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.572 -167.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.53 51.1 3.57 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.762 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.643 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 16.2 t -121.83 149.71 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 120.617 0.246 . . . . 0.0 110.885 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.535 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.6 t70 -107.57 117.71 34.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.895 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 58.0 p -79.4 -22.43 44.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -171.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.69 -19.86 51.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.91 -26.8 22.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.664 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 91.5 mt -60.36 145.21 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.945 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -97.22 103.98 15.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.931 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 60' ' ' VAL . 41.6 mt -76.33 122.04 29.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.72 0.772 . . . . 0.0 110.802 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 61' ' ' ASP . 7.7 mt -91.19 -48.17 7.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HG2' ' HB ' ' A' ' 16' ' ' VAL . 23.8 mttp -151.79 109.33 3.62 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.522 -174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.488 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 11.6 m -81.64 128.92 34.45 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 171.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.7 m -154.46 179.28 9.17 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -156.35 160.85 40.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.212 0.53 . . . . 0.0 110.884 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -137.16 -159.18 0.93 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -64.49 107.9 1.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.515 0.198 . . . . 0.0 110.863 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.533 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 84.7 mtm180 74.42 -17.76 0.45 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -119.07 130.26 55.51 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.876 -0.515 . . . . 0.0 111.609 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 1.017 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 16.2 m-85 -78.95 155.67 28.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -139.5 91.93 2.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.023 0.439 . . . . 0.0 110.393 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.676 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.0 t -97.5 97.67 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.428 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 9.2 t -71.54 116.85 12.38 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 46' ' ' ILE . 5.0 m -131.37 159.04 43.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.936 0.398 . . . . 0.0 110.797 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.526 ' HB2' HD21 ' A' ' 47' ' ' LEU . 11.7 t70 -107.22 132.81 52.66 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.64 9.18 14.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.418 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.18 -35.09 5.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.509 174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -93.68 1.78 56.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.31 0.576 . . . . 0.0 110.691 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.53 -20.96 38.19 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.474 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 139.03 58.72 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 53.7 mttp -128.12 144.62 51.12 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.567 0.699 . . . . 0.0 112.083 -170.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.5 ' HB2' HG22 ' A' ' 60' ' ' VAL . 36.9 m -128.18 123.81 35.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.319 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 12.5 tppt? -97.09 68.54 2.27 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.676 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 19.2 m-85 -38.08 105.51 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 124.183 0.927 . . . . 0.0 112.331 -169.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.558 ' HD3' ' HA ' ' A' ' 96' ' ' TYR . 73.8 tttt -90.76 83.76 5.78 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.392 1.092 . . . . 0.0 109.326 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.017 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 70.1 mt -84.03 91.83 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.932 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.993 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.6 ttt180 -57.98 96.05 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.945 ' HB2' HD21 ' A' ' 7' ' ' LEU . 23.1 mttt -59.4 82.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.328 1.018 . . . . 0.0 112.092 -167.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.47 24.84 0.8 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.778 0.831 . . . . 0.0 111.239 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.993 ' HB ' ' HG2' ' A' ' 73' ' ' ARG . 33.9 t -80.21 119.21 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.682 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.0 t70 68.03 -70.25 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 124.072 0.858 . . . . 0.0 111.276 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 79' ' ' PRO . 4.2 m -90.88 175.46 3.61 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.688 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 8.8 Cg_endo -82.92 178.54 5.9 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 121.88 1.72 . . . . 0.0 111.379 170.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 29.4 pttt 57.84 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 169.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.598 ' HB3' HG23 ' A' ' 72' ' ' ILE . 6.3 ptt? -168.73 150.11 4.73 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -171.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.716 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 12.9 p -76.12 -46.32 34.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.265 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.16 137.22 4.62 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 119.233 -1.46 . . . . 0.0 114.385 -173.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.601 ' HG3' ' CE1' ' A' ' 70' ' ' PHE . 9.9 ttp180 -72.89 104.33 4.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.799 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 64.2 tttm -82.05 63.11 6.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.237 0.541 . . . . 0.0 112.435 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.586 ' SG ' ' HG2' ' A' ' 84' ' ' ARG . 1.1 m -101.59 138.99 37.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -172.12 61.26 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 122.702 1.239 . . . . 0.0 108.744 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.474 ' HG3' ' H ' ' A' ' 67' ' ' LYS . 51.7 mmtt -97.44 -4.86 37.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.181 -1.827 . . . . 0.0 110.113 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -144.35 -49.78 0.28 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.586 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -82.3 178.86 8.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.758 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -179.65 102.67 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.161 0.505 . . . . 0.0 110.576 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.26 105.87 7.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.452 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.02 105.78 4.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -150.84 104.06 3.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.419 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.15 -61.08 4.41 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.529 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.799 ' CE1' ' HA ' ' A' ' 85' ' ' LYS . 27.1 p90 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.154 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.8 m -77.4 132.4 38.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 2' ' ' ILE . 50.8 mt -143.5 82.55 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.59 HD12 ' H ' ' A' ' 1' ' ' LEU . 3.7 mp -150.66 -31.51 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.808 0.337 . . . . 0.0 111.757 -170.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.777 HD22 HG12 ' A' ' 76' ' ' VAL . 1.5 tt -154.78 33.61 0.4 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -165.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -48.48 -46.78 38.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.263 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.76 41.81 1.28 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -120.68 -146.32 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.708 -0.246 . . . . 0.0 110.72 -172.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 mt -157.5 -49.63 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.747 0.655 . . . . 0.0 109.974 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 3' ' ' LEU . 74.6 mt 68.47 156.11 0.13 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.003 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -130.19 9.35 5.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.734 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.35 139.25 51.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.111 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -151.25 85.16 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.751 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.461 ' H ' ' CG ' ' A' ' 51' ' ' GLU . 12.2 tp 59.25 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.57 0.748 . . . . 0.0 112.764 165.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 27.2 ttpt -78.65 82.81 4.86 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 91.2 mt 74.55 162.45 0.15 Allowed Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 124.012 0.82 . . . . 0.0 110.961 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 12.0 Cg_endo -56.35 134.17 62.6 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.715 2.277 . . . . 0.0 112.442 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.416 ' CG2' ' HG3' ' A' ' 48' ' ' LYS . 7.7 p 44.16 101.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 122.989 1.376 . . . . 0.0 113.961 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.44 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 51.7 mt -73.21 154.05 7.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.993 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 20' ' ' LEU . 28.3 t70 -62.91 155.95 25.74 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.0 0.428 . . . . 0.0 111.534 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.605 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 8.7 p30 -60.35 -34.06 73.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.693 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' HB2' ' OD1' ' A' ' 18' ' ' ASP . 3.1 mt -57.06 -46.14 82.69 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.249 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 43.7 t80 -60.1 -41.83 93.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 0.0 110.297 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -74.27 -26.79 67.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.805 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.644 ' HB2' HD12 ' A' ' 46' ' ' ILE . 33.4 ttpt -80.89 -29.1 35.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.919 0.39 . . . . 0.0 110.177 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.59 -29.93 68.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.523 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.556 HD12 ' HA2' ' A' ' 22' ' ' GLY . 66.3 mt -65.31 -70.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 166.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.4 mt -47.71 -28.77 2.61 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.626 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.65 -45.82 92.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.999 0.428 . . . . 0.0 110.103 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' HD3' ' HB2' ' A' ' 1' ' ' LEU . 92.7 mttt -65.96 -35.49 80.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.623 0.725 . . . . 0.0 109.535 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.599 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 10.5 m-85 -79.28 -8.0 58.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.911 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.497 ' HG2' ' HD2' ' A' ' 34' ' ' LYS . 17.3 tt0 -74.44 12.59 0.74 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.456 0.646 . . . . 0.0 110.657 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -106.48 -30.57 8.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.375 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 15.2 t70 -88.87 -57.23 2.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.11 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 39' ' ' VAL . 67.6 mt -61.23 -27.62 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.72 0.771 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' HD2' ' HG2' ' A' ' 30' ' ' GLN . 44.9 tttp -80.66 -33.38 35.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.886 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -75.22 -47.83 26.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 49.2 mttm -69.29 -38.22 78.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.84 -175.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.605 ' HB2' HG23 ' A' ' 39' ' ' VAL . 55.3 m-85 -126.86 -23.09 3.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 87.21 39.41 7.38 Favored Glycine 0 C--N 1.322 -0.216 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.94 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 33' ' ' ILE . 27.2 t -100.56 152.75 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.992 0.425 . . . . 0.0 111.319 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 16.4 t70 -115.39 122.72 46.7 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.765 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 75.0 p -88.25 -17.56 30.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.919 0.39 . . . . 0.0 111.513 -172.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.517 ' HB2' ' NZ ' ' A' ' 42' ' ' LYS . 4.9 ttmp? -70.46 -33.16 70.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.466 0.651 . . . . 0.0 109.266 175.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.35 -23.4 46.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.016 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 49.1 mt -61.29 139.97 58.06 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.398 0.618 . . . . 0.0 111.594 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 81.0 tttt -101.32 96.51 7.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.511 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.644 HD12 ' HB2' ' A' ' 23' ' ' LYS . 46.9 mt -78.26 127.5 38.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.431 0.634 . . . . 0.0 111.112 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 10.9 mt -98.19 -51.44 4.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.133 -175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 36.1 ttmt -139.85 117.76 11.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.542 -174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.44 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 31.6 m -99.32 136.03 39.87 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.2 m -153.28 179.03 9.12 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 122.113 -0.367 . . . . 0.0 110.397 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 15.4 pt-20 -154.58 166.73 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -151.52 78.53 1.27 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.063 0.459 . . . . 0.0 109.907 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HE2' ' HB2' ' A' ' 53' ' ' LYS . 2.7 mppt? 56.33 -91.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.199 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.641 ' HG3' HG11 ' A' ' 76' ' ' VAL . 19.4 ttm180 -85.33 12.41 8.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.516 0.674 . . . . 0.0 110.721 -175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 97.5 m-85 -136.23 157.73 46.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.781 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 13.9 m-85 -129.55 146.57 51.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.333 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.436 ' CE1' ' HG3' ' A' ' 71' ' ' LYS . 97.8 m-85 -135.69 103.05 5.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 19.1 t -109.19 95.17 3.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.652 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.6 t -80.34 129.69 34.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.5 m -137.99 155.44 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.156 0.503 . . . . 0.0 111.757 -173.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.6 t70 -90.22 126.68 35.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -87.91 13.24 11.28 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.029 -171.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.11 -40.52 2.66 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.922 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.08 -19.13 65.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.88 -8.96 39.82 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.475 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 46.4 mt-10 -76.78 165.34 24.85 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.351 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.681 ' H ' ' HB2' ' A' ' 88' ' ' LYS . 40.2 ttmt -127.85 109.91 12.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.442 0.639 . . . . 0.0 110.279 -172.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 1.9 t -104.62 174.32 5.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.34 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 35.9 ttmt -149.08 104.68 3.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.423 ' CE1' HD13 ' A' ' 33' ' ' ILE . 73.5 m-85 -71.23 97.22 1.51 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.694 0.759 . . . . 0.0 109.621 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.779 ' HE2' ' HA2' ' A' ' 95' ' ' GLY . 46.2 tttp -82.88 85.91 7.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.149 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.781 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 61.6 mt -82.39 137.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.255 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 18.4 ttt180 -93.16 39.01 1.04 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.624 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 49.5 mttt 57.67 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 113.106 -1.861 . . . . 0.0 111.253 -170.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.689 ' HB3' ' N ' ' A' ' 3' ' ' LEU . 24.4 t0 178.68 26.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.777 HG12 HD22 ' A' ' 3' ' ' LEU . 9.5 m -61.82 95.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.073 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 22.9 t70 77.13 -38.95 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.844 172.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 80' ' ' LYS . 9.6 p -110.7 134.28 20.96 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.521 0.677 . . . . 0.0 110.312 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 78' ' ' VAL . 85.4 Cg_endo -79.79 30.83 0.48 Allowed 'Trans proline' 0 C--N 1.33 -0.441 0 C-N-CA 123.897 3.064 . . . . 0.0 114.757 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' HG2' HG22 ' A' ' 78' ' ' VAL . 57.4 pttt -145.78 153.61 41.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.651 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -70.31 148.66 48.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.52 -173.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 13.7 p -73.07 -43.3 58.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.666 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.57 ' HA3' ' HB2' ' A' ' 96' ' ' TYR . . . -130.39 151.83 19.6 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.79 43.13 0.72 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.709 0.766 . . . . 0.0 108.939 -176.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.621 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 34.8 mttp -96.2 134.81 38.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.115 -171.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -101.39 125.41 48.02 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -121.66 28.55 7.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 122.037 0.923 . . . . 0.0 109.645 -164.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.681 ' HB2' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -63.46 -47.13 83.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.662 -179.044 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -107.22 -48.57 3.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.476 -175.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.33 -174.93 4.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.224 -172.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -127.88 112.83 15.15 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.407 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -110.31 177.46 4.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.893 0.378 . . . . 0.0 111.251 -174.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.74 175.09 8.9 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.87 -33.8 75.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.779 ' HA2' ' HE2' ' A' ' 71' ' ' LYS . . . -88.87 122.68 6.49 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.818 173.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.706 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 12.9 m-30 . . . . . 0 C--O 1.244 0.798 0 CA-C-O 118.503 -0.761 . . . . 0.0 110.076 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.486 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 41.3 t -99.05 163.81 12.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -168.78 40.68 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.553 0.692 . . . . 0.0 110.136 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 56' ' ' TYR . 18.6 tt -104.61 108.84 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.584 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 7' ' ' LEU . 4.4 mm? -75.59 5.25 6.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.561 ' HB3' HG12 ' A' ' 2' ' ' ILE . 27.3 t70 -70.7 -5.44 29.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.717 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 76' ' ' VAL . . . -87.02 -87.35 1.08 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.147 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -48.59 -38.79 21.69 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 3' ' ' LEU . 66.2 mt -92.06 26.39 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.65 0.262 . . . . 0.0 111.334 -174.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 4' ' ' ASP . 7.2 tt -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.938 0.399 . . . . 0.0 110.681 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -120.13 -62.57 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -154.98 116.01 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.918 173.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 17.6 ptmt -129.22 -51.68 1.2 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.527 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 71.3 mt -153.22 155.36 36.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.101 0.477 . . . . 0.0 110.98 -170.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 43.87 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 82.4 mt -108.03 170.22 5.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.14 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 50.2 Cg_exo -58.85 -150.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.86 3.04 . . . . 0.0 113.072 170.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.422 HG23 ' HG3' ' A' ' 48' ' ' LYS . 14.5 p -53.06 125.17 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 122.19 0.995 . . . . 0.0 111.266 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 18' ' ' ASP . 11.7 mt -96.72 173.04 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.395 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' H ' HG22 ' A' ' 17' ' ' ILE . 1.6 m-20 -50.46 122.06 6.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.681 0.277 . . . . 0.0 111.148 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.558 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 25.0 p30 -72.54 -17.21 61.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 110.363 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.23 -39.38 68.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 170.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.569 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 63.1 t80 -61.61 -40.38 94.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.621 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -66.92 -44.27 89.33 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.447 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -55.68 -43.26 76.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.664 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.9 mm-40 -57.16 -49.16 76.81 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.583 176.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 46.1 mt -51.49 -59.54 4.14 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.528 0.68 . . . . 0.0 110.34 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 58' ' ' VAL . 6.9 mp -60.82 -38.8 86.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.579 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.18 -31.86 73.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.457 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.664 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.7 mttm -74.99 -50.01 18.03 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.201 0.524 . . . . 0.0 110.678 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 0' ' ' SER . 7.2 m-85 -92.17 12.14 23.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.797 -171.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -25.89 63.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.278 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.06 -39.97 90.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -36.97 62.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.336 0.589 . . . . 0.0 109.471 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.8 mt -62.24 -38.84 82.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.555 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 35.3 tttm -83.29 -31.69 26.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.359 -177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.83 -47.8 79.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.82 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -79.42 -52.58 7.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.224 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.578 ' CZ ' ' HD2' ' A' ' 84' ' ' ARG . 6.6 m-85 -108.11 -23.97 11.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -169.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.49 57.59 3.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.952 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.669 HG12 ' H ' ' A' ' 41' ' ' THR . 3.7 t -117.03 145.13 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 121.023 0.439 . . . . 0.0 110.908 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.65 -11.32 59.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.111 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.669 ' H ' HG12 ' A' ' 39' ' ' VAL . 33.1 p 58.73 -37.48 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.014 1.726 . . . . 0.0 114.348 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -71.18 -18.19 62.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.352 0.596 . . . . 0.0 109.451 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -74.37 -37.25 63.51 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.899 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.37 106.22 0.43 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.224 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 55.1 tttp -69.97 102.27 1.97 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.147 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.637 HG12 HG12 ' A' ' 60' ' ' VAL . 34.6 mt -74.33 111.99 10.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.793 0.806 . . . . 0.0 110.675 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.3 -46.45 16.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.062 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 59' ' ' SER . 25.8 ttpp -151.5 105.47 3.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.687 -173.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.558 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 87.8 m -79.23 125.6 29.68 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.3 m -151.8 168.99 23.34 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.5 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.24 157.02 35.12 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 53' ' ' LYS . 29.4 t70 -100.74 -83.67 0.44 Allowed 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 52' ' ' ASP . 38.5 mmtm -135.88 -74.85 0.44 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 173.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.697 ' HB3' HG11 ' A' ' 76' ' ' VAL . 98.7 mtt180 -87.93 15.22 7.47 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.969 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -147.32 137.34 23.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.717 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.5 m-85 -98.84 143.84 28.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 167.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.472 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 74.4 m-85 -132.26 100.8 5.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.279 0.561 . . . . 0.0 110.217 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 26' ' ' LEU . 26.0 t -99.07 93.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.139 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.491 ' HB2' ' H ' ' A' ' 48' ' ' LYS . 67.8 m -58.51 126.35 27.22 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.303 174.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.637 HG12 HG12 ' A' ' 46' ' ' ILE . 35.7 m -146.71 149.96 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 111.757 -176.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.0 t70 -91.22 122.99 34.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 169.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . . . -79.98 1.11 28.74 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 -13.69 64.97 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.288 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -131.92 41.16 3.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -27.49 5.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.976 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.659 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 39.6 mt-10 -65.21 128.88 37.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.017 0.436 . . . . 0.0 111.128 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 97.8 mttt -111.59 114.81 28.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.506 0.67 . . . . 0.0 109.924 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 18.6 t -113.92 178.42 4.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.864 -174.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 1.008 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 34.8 ttmt -155.54 82.04 1.04 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 25.6 m-85 -50.31 111.72 0.57 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 112.203 -170.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.6 ' CD ' ' HB3' ' A' ' 96' ' ' TYR . 63.3 tttp -80.76 72.89 7.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.048 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.717 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 60.3 mt -75.89 86.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.221 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.472 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 33.2 ttp180 -61.97 113.42 2.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 81.8 mttt -61.37 174.02 0.79 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.173 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 1.1 m-20 -71.67 64.65 0.46 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.662 0.744 . . . . 0.0 110.192 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.697 HG11 ' HB3' ' A' ' 54' ' ' ARG . 34.7 m -96.77 -1.76 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.198 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -176.87 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.007 -171.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.544 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 7.6 p -117.77 144.7 34.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.865 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 78' ' ' VAL . 39.1 Cg_endo -82.47 53.0 4.3 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.28 2.653 . . . . 0.0 111.301 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -154.07 135.01 13.8 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.287 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.716 ' HG2' ' HA ' ' A' ' 72' ' ' ILE . 12.7 tmm? -57.56 103.84 0.15 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 167.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 11.6 p -60.75 -37.88 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -170.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' ' 81' ' ' MET . . . -175.03 -156.84 15.01 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.641 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.664 ' N ' ' HD3' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -151.37 119.67 6.37 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -168.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 1.008 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 2.4 tttm -86.94 56.92 4.23 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.911 -169.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -87.75 126.3 34.92 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -147.71 -23.78 0.37 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.659 ' HD3' ' HA ' ' A' ' 66' ' ' GLU . 22.0 ttpp 66.22 13.73 9.3 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.731 165.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -151.22 -69.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.496 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.1 133.43 23.19 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -140.42 80.81 1.78 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.711 0.767 . . . . 0.0 111.261 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.85 -23.38 16.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.286 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.27 97.69 0.2 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.313 176.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.89 -47.78 65.0 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.342 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.48 104.16 0.66 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.804 ' CE1' ' HA ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.38 -173.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.822 ' HA3' ' HA ' ' A' ' 4' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.978 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 m -61.27 -58.66 7.36 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.947 HD23 ' HD3' ' A' ' 28' ' ' LYS . 11.0 tp -174.96 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.611 0.57 . . . . 0.0 112.266 160.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.49 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.5 tp -66.02 -25.93 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.941 0.4 . . . . 0.0 111.828 -171.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.802 HD21 ' H ' ' A' ' 8' ' ' LEU . 7.5 tp -140.53 54.59 1.61 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.288 -171.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.822 ' HA ' ' HA3' ' A' ' -1' ' ' GLY . 11.8 t0 -54.58 96.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.618 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.09 40.87 52.23 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.821 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.754 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 30.7 t70 -107.82 -60.5 1.7 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.712 0.291 . . . . 0.0 110.496 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.457 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 25.7 tp 71.76 99.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.068 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.802 ' H ' HD21 ' A' ' 3' ' ' LEU . 6.7 tt -88.92 117.5 27.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.825 -178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -112.37 -5.68 14.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.578 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.31 -41.73 89.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.458 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 47.2 mmtm -97.65 152.11 19.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.357 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.726 ' O ' ' HA ' ' A' ' 52' ' ' ASP . 5.2 mp -117.73 -72.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.44 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.78 103.83 4.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.357 . . . . 0.0 110.053 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.402 HD11 ' HG2' ' A' ' 51' ' ' GLU . 1.1 pp -111.76 163.54 17.32 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.835 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.51 -177.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.478 0.601 0 C-N-CA 123.946 3.097 . . . . 0.0 113.647 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 48' ' ' LYS . 8.1 p -68.91 121.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.594 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 47.9 mt -77.77 152.66 5.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.215 -1.357 . . . . 0.0 108.587 174.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.81 144.84 42.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.693 0.282 . . . . 0.0 110.842 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.571 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 6.5 p30 -56.92 -30.36 63.9 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.766 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.1 tp -60.6 -45.71 92.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.579 0.228 . . . . 0.0 110.946 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 61.5 t80 -62.37 -48.95 77.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.669 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -63.77 -43.87 97.08 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.431 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HB2' HG13 ' A' ' 46' ' ' ILE . 3.8 tptm -58.17 -34.94 70.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.855 0.36 . . . . 0.0 110.233 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.648 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -55.3 -56.44 20.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.041 175.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.6 mp -51.82 -55.61 18.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.656 0.741 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.669 HD13 ' O ' ' A' ' 22' ' ' GLY . 6.7 mp -59.8 -44.91 93.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.011 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HA ' ' OG1' ' A' ' 41' ' ' THR . 21.3 t70 -63.2 -31.73 72.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.058 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.947 ' HD3' HD23 ' A' ' 1' ' ' LEU . 58.3 mttm -69.37 -33.54 73.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.937 0.398 . . . . 0.0 110.738 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' O ' HG13 ' A' ' 33' ' ' ILE . 15.4 m-85 -99.09 7.95 45.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -50.31 -44.14 54.05 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.284 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.12 -38.38 73.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.554 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.97 -41.57 50.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.563 HG22 ' HB ' ' A' ' 39' ' ' VAL . 32.4 mt -63.61 -34.08 65.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.235 178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 33.1 ttpt -83.69 -27.74 28.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.099 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -71.41 -47.04 58.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.496 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -78.02 -62.13 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.068 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HB2' HG23 ' A' ' 39' ' ' VAL . 25.1 m-85 -97.68 -19.2 18.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.116 -167.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.18 46.04 10.75 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.931 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.607 HG23 ' HB2' ' A' ' 37' ' ' TYR . 40.3 t -107.48 145.57 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.032 0.444 . . . . 0.0 111.439 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.593 ' OD1' ' HB2' ' A' ' 42' ' ' LYS . 25.7 t70 -109.24 105.17 14.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.542 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 29.1 p -65.07 -16.75 63.81 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -171.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.593 ' HB2' ' OD1' ' A' ' 40' ' ' ASP . 3.3 mtpm? -67.23 -28.93 68.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -87.31 -18.97 28.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.91 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.542 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 67.8 mt -65.66 132.43 48.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.327 0.584 . . . . 0.0 111.559 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.62 ' HD2' HD23 ' A' ' 47' ' ' LEU . 2.5 tmtp? -94.48 109.38 21.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.124 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.631 ' HA ' HG12 ' A' ' 60' ' ' VAL . 6.1 mm -73.53 108.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.95 0.405 . . . . 0.0 109.925 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 45' ' ' LYS . 17.6 mt -80.11 -54.75 5.48 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.555 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.491 ' HG3' HG23 ' A' ' 16' ' ' VAL . 87.6 tttt -142.1 119.92 11.93 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.742 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.594 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 35.3 m -98.54 141.53 31.27 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 169.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -169.51 -174.68 1.97 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' OE1' ' HB2' ' A' ' 11' ' ' LYS . 8.9 pt-20 -147.68 162.46 39.11 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 -177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.726 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 5.8 t70 -135.01 -173.29 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.713 ' HD3' ' HG ' ' A' ' 12' ' ' LEU . 14.0 mmmm -63.96 111.02 2.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 72.34 -0.97 3.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.169 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.97 152.8 40.53 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.787 0.803 . . . . 0.0 112.989 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.601 ' HD2' ' HA ' ' A' ' 74' ' ' LYS . 6.2 m-85 -114.06 145.08 42.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.368 164.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.547 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 62.8 m-85 -134.23 112.15 10.84 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.037 0.446 . . . . 0.0 110.82 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 5.1 t -111.89 93.47 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.811 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.9 m -76.58 121.83 23.74 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 46' ' ' ILE . 15.8 m -134.44 159.32 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 111.581 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.03 115.67 22.46 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . . . -86.0 -18.44 32.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 64' ' ' ASP . . . 108.87 165.51 20.66 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -171.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 63' ' ' GLY . 9.6 t70 73.11 -52.61 0.71 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 122.927 0.491 . . . . 0.0 110.457 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.84 -17.18 0.22 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 42.9 mt-10 -78.2 150.85 33.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.583 0.706 . . . . 0.0 111.915 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.722 ' H ' ' HB2' ' A' ' 88' ' ' LYS . 98.0 mttt -117.56 117.85 30.54 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.989 176.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 33.6 m -113.81 133.92 55.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.475 -171.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.0 ttpt -102.96 108.51 19.71 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.642 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 43.0 m-85 -68.15 103.55 1.58 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.494 0.664 . . . . 0.0 110.389 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.016 ' HD2' ' HB2' ' A' ' 96' ' ' TYR . 12.8 tttt -88.34 109.45 19.99 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.189 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.457 HG12 ' HG2' ' A' ' 81' ' ' MET . 48.2 mt -123.56 124.79 70.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.517 ' HD2' HG21 ' A' ' 82' ' ' VAL . 16.2 ttt180 -81.01 53.25 1.94 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.459 0.647 . . . . 0.0 110.612 -169.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.601 ' HA ' ' HD2' ' A' ' 56' ' ' TYR . 19.6 mttt 50.75 43.35 28.09 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 114.399 -1.273 . . . . 0.0 113.017 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.738 ' HA ' ' CB ' ' A' ' 0' ' ' SER . 1.9 m-20 55.46 28.62 11.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.761 0.663 . . . . 0.0 112.558 166.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 73' ' ' ARG . 21.3 m -77.36 122.09 31.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.282 0.563 . . . . 0.0 111.839 -176.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 t70 64.29 -77.31 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.456 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -82.82 139.72 43.43 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.978 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 90.8 Cg_endo -80.49 89.19 1.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.179 2.586 . . . . 0.0 112.878 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -176.2 -173.92 0.59 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.586 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.459 ' SD ' HG12 ' A' ' 33' ' ' ILE . 26.6 mtm -100.95 148.96 24.4 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 174.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG13 ' HE2' ' A' ' 71' ' ' LYS . 7.7 p -89.48 4.41 5.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . 152.3 113.1 0.54 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.727 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -95.43 100.78 12.49 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 16.2 tptp -125.14 134.52 52.4 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.829 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 7.6 m -93.74 123.49 37.11 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.583 ' HA ' ' HB2' ' A' ' 91' ' ' ASP . 67.0 ttt180 -113.04 37.83 3.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.993 0.902 . . . . 0.0 108.795 -176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.722 ' HB2' ' H ' ' A' ' 67' ' ' LYS . 1.4 tmtp? -59.95 115.52 3.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.284 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.4 t70 75.74 -76.4 0.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.324 1.015 . . . . 0.0 109.394 -166.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -162.33 154.16 18.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.588 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.583 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 12.1 t70 -152.24 -80.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -132.65 134.78 45.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 87' ' ' ARG . 26.8 t70 -89.3 -58.56 2.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -171.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -53.85 -51.74 62.63 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.009 0.433 . . . . 0.0 111.837 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.98 -145.53 4.3 Favored Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 1.016 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . 14.9 m-85 . . . . . 0 C--O 1.244 0.771 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.917 172.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.741 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 16.8 p -153.57 32.25 0.46 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.856 0.328 . . . . 0.0 111.281 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.848 HD22 ' H ' ' A' ' 1' ' ' LEU . 0.3 OUTLIER -49.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 123.72 0.637 . . . . 0.0 111.667 -174.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' A' ' 56' ' ' TYR . 28.3 mm -144.35 -55.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 123.081 0.238 . . . . 0.0 111.525 -174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.913 HD23 ' HA ' ' A' ' 6' ' ' ASP . 1.1 mp -113.6 -3.14 13.65 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 56.61 45.69 21.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.87 36.76 12.73 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.647 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.913 ' HA ' HD23 ' A' ' 3' ' ' LEU . 30.3 t70 58.08 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 2.2 pp -148.58 19.69 1.04 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.598 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 3' ' ' LEU . 30.4 tp -78.87 99.7 6.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.795 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -124.04 6.32 8.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.532 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.71 -77.3 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HG2' HD11 ' A' ' 8' ' ' LEU . 48.2 pttt -90.2 178.02 6.28 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.0 tp -171.24 -47.43 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.993 0.425 . . . . 0.0 110.31 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 13' ' ' LYS . 21.5 mtmt -123.83 93.73 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.291 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.96 157.4 33.73 Favored Pre-proline 0 N--CA 1.442 -0.872 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.803 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.39 -164.43 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.003 2.469 . . . . 0.0 112.105 175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.8 p -69.3 110.82 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 122.076 0.941 . . . . 0.0 111.601 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.885 HG13 ' HB ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -98.35 170.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.487 173.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 172.65 -8.24 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 21' ' ' PHE . 4.1 m-80 -64.61 63.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.377 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.8 mt 68.74 -27.62 0.15 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.942 0.897 . . . . 0.0 112.454 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.459 ' H ' ' C ' ' A' ' 19' ' ' ASN . 7.9 t80 -54.04 -45.0 71.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -172.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -73.94 -38.56 48.48 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.692 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -70.89 -33.3 70.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 7.7 mm-40 -56.98 -50.6 72.19 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.544 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.546 HD12 ' HA2' ' A' ' 22' ' ' GLY . 60.4 mt -49.72 -67.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.529 175.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.859 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 39.1 mt -53.3 -34.09 55.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.62 -49.09 61.91 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.344 -0.223 . . . . 0.0 111.386 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 36.4 mttm -65.78 -45.07 83.82 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.568 0.699 . . . . 0.0 109.913 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.444 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 3.9 m-85 -93.33 16.14 14.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.78 -171.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -61.0 -42.24 98.07 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -58.85 -38.53 78.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.449 174.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.56 -51.28 36.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.45 0.643 . . . . 0.0 109.932 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.531 HG21 ' HE1' ' A' ' 70' ' ' PHE . 47.1 mt -66.6 -29.49 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.017 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.541 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 38.3 tttp -84.96 -29.34 25.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 110.326 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.28 -47.02 68.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.393 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.808 ' HD3' ' HE3' ' A' ' 81' ' ' MET . 27.8 mttm -65.46 -64.07 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.995 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.538 ' HB2' HG23 ' A' ' 39' ' ' VAL . 30.1 m-85 -107.02 -36.81 6.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.3 -170.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.35 57.89 1.17 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.582 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 34.7 t -111.67 151.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.962 0.41 . . . . 0.0 111.236 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.69 102.65 12.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 56.6 p -77.12 -14.09 59.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.298 0.571 . . . . 0.0 111.513 -173.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -83.97 -8.15 59.23 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.756 0.789 . . . . 0.0 110.134 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -98.82 -10.35 23.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.812 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 41' ' ' THR . 57.1 mt -82.66 129.61 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.02 -175.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.551 ' HD3' HD23 ' A' ' 47' ' ' LEU . 11.8 tmtt? -96.89 119.2 34.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 173.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.561 ' HA ' HG12 ' A' ' 60' ' ' VAL . 39.3 mt -84.5 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.772 0.796 . . . . 0.0 111.4 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.551 HD23 ' HD3' ' A' ' 45' ' ' LYS . 5.9 mt -97.47 -56.06 2.64 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.656 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HA ' HG23 ' A' ' 16' ' ' VAL . 77.0 tttt -143.17 111.74 6.34 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.134 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.885 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.9 m -101.26 140.17 35.92 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 m -156.5 173.66 16.58 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.629 ' HB2' ' HE2' ' A' ' 74' ' ' LYS . 7.5 pt-20 -141.3 143.67 34.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.119 0.485 . . . . 0.0 110.36 175.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -131.03 -146.8 0.31 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.98 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -65.79 95.47 0.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.659 0.266 . . . . 0.0 110.881 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 67.3 -6.43 0.62 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -116.82 134.5 54.7 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.644 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.685 ' CD2' ' HG2' ' A' ' 74' ' ' LYS . 10.5 m-85 -92.23 147.61 22.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.619 169.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.539 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 72.5 m-85 -130.4 97.94 4.55 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.35 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.629 HG22 HG23 ' A' ' 49' ' ' THR . 7.3 t -102.09 93.11 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.143 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.9 t -79.09 117.5 20.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 46' ' ' ILE . 17.3 m -130.02 157.44 42.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.953 0.406 . . . . 0.0 111.121 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.35 126.2 33.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 171.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.43 7.07 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.68 -36.57 4.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.086 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -93.49 -29.99 15.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.239 0.542 . . . . 0.0 111.123 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.516 ' O ' ' HE3' ' A' ' 88' ' ' LYS . . . 140.81 -18.45 2.77 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.426 -175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.517 ' CG ' ' HD2' ' A' ' 88' ' ' LYS . 1.6 tt0 -67.36 134.77 52.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 99.1 mttt -114.32 98.89 7.2 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.893 0.854 . . . . 0.0 110.061 -174.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 1.039 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 10.1 t -93.57 133.88 36.43 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.303 -172.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.1 ttmt -107.43 103.85 13.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.766 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.594 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 44.8 m-85 -69.01 115.53 8.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.002 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.636 ' HD2' ' CD2' ' A' ' 96' ' ' TYR . 86.6 tttt -94.17 98.4 10.94 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.118 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 95.5 mt -100.43 111.63 30.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.848 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 10.8 ttt180 -69.88 104.09 2.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.748 ' HB3' HD13 ' A' ' 3' ' ' LEU . 78.1 mttt -47.7 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 O-C-N 124.241 0.963 . . . . 0.0 111.451 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.903 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 14.0 t70 1.84 77.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 125.194 1.559 . . . . 0.0 112.578 -173.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.528 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . 15.7 m -84.03 -11.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.716 -170.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 26.3 t70 170.63 -67.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.749 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -89.26 148.87 41.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.184 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.656 ' HB2' ' HA2' ' A' ' -1' ' ' GLY . 75.4 Cg_endo -83.14 105.75 1.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.628 2.219 . . . . 0.0 112.406 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HG2' ' HE2' ' A' ' 36' ' ' LYS . 3.1 mtmm 178.43 157.81 0.47 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.275 0.559 . . . . 0.0 111.309 175.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.808 ' HE3' ' HD3' ' A' ' 36' ' ' LYS . 2.3 tmm? -89.32 128.03 35.85 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 5.6 p -66.16 -38.89 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.584 ' HA3' ' OXT' ' A' ' 96' ' ' TYR . . . -178.12 -164.02 30.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.99 -1.576 . . . . 0.0 114.721 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.717 ' O ' ' HG3' ' A' ' 84' ' ' ARG . 11.3 ptt180 -176.05 88.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.552 1.168 . . . . 0.0 107.967 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.677 ' H ' ' HD1' ' A' ' 96' ' ' TYR . 48.4 tttm -78.43 -18.36 55.05 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.921 -170.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.039 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.5 m 58.82 100.64 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.939 0.876 . . . . 0.0 109.887 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.759 ' HG3' ' HB2' ' A' ' 90' ' ' ASP . 22.6 ttt180 -106.52 67.51 0.72 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.947 -166.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.517 ' HD2' ' CG ' ' A' ' 66' ' ' GLU . 61.0 tttt -80.71 -39.11 27.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.778 -175.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -146.13 9.64 1.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.92 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.759 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 2.2 m-20 -66.86 161.45 23.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.77 -87.68 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.563 -171.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -124.74 115.14 20.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -128.47 120.91 27.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.068 0.461 . . . . 0.0 111.845 -167.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.76 -62.46 1.45 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.744 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.532 ' HA2' ' NZ ' ' A' ' 71' ' ' LYS . . . -89.55 128.56 9.25 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.855 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.677 ' HD1' ' H ' ' A' ' 85' ' ' LYS . 5.1 m-85 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.004 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.613 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 13.1 t -83.18 133.54 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 37.0 mt -121.53 -6.91 9.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.247 0.546 . . . . 0.0 110.452 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.741 HG21 ' HE2' ' A' ' 56' ' ' TYR . 6.8 tp -89.21 135.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.511 -169.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.651 HD23 ' HA ' ' A' ' 7' ' ' LEU . 9.8 mp 68.38 91.06 0.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.351 0.407 . . . . 0.0 110.434 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.37 83.22 0.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . 51.5 52.09 34.69 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -169.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' H ' ' HA ' ' A' ' 76' ' ' VAL . 7.4 t70 -137.45 -164.0 1.52 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.235 -0.483 . . . . 0.0 110.874 -161.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.651 ' HA ' HD23 ' A' ' 3' ' ' LEU . 2.7 pp -161.61 133.43 5.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.321 0.581 . . . . 0.0 111.94 -173.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 11' ' ' LYS . 92.1 mt -123.8 -69.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.134 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 70.92 -67.02 0.27 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.638 0.586 . . . . 0.0 111.527 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -97.99 37.64 1.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.966 0.889 . . . . 0.0 109.505 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.739 ' HB3' ' HB3' ' A' ' 8' ' ' LEU . 20.8 pttt -75.53 -28.38 59.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.393 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 3.6 pp -101.33 170.36 8.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.086 -173.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -140.86 34.59 1.77 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.506 0.67 . . . . 0.0 109.868 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -129.56 147.85 66.95 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.338 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.79 -25.55 23.69 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 122.042 1.828 . . . . 0.0 111.531 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.468 HG22 ' HG3' ' A' ' 48' ' ' LYS . 15.3 t -145.61 139.91 21.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 113.67 -1.604 . . . . 0.0 108.743 175.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 49' ' ' THR . 4.2 mt -88.36 160.73 2.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.39 136.4 57.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -68.23 -13.68 62.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.168 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.6 tp -67.88 -41.95 82.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.964 0.411 . . . . 0.0 109.899 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 78.3 t80 -63.22 -36.97 85.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -64.78 -50.89 56.15 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.204 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -52.28 -37.83 56.64 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 122.361 0.264 . . . . 0.0 111.12 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.7 mm-40 -59.51 -50.39 74.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 122.702 0.401 . . . . 0.0 111.679 175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 51.7 mt -53.33 -58.85 5.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.717 0.77 . . . . 0.0 110.316 176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.757 HD11 HG11 ' A' ' 58' ' ' VAL . 8.5 mp -62.54 -35.67 80.17 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 114.722 -1.127 . . . . 0.0 111.057 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.73 -41.5 81.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 87.8 mttt -70.23 -29.37 66.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.503 ' HE1' ' HA ' ' A' ' 80' ' ' LYS . 84.3 m-85 -98.27 1.55 47.31 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -55.16 -43.37 74.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 120.98 0.419 . . . . 0.0 111.002 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -61.51 -34.13 74.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.125 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.92 -40.22 28.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.209 0.528 . . . . 0.0 110.166 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.583 HG22 ' HB ' ' A' ' 39' ' ' VAL . 70.1 mt -63.19 -36.88 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.208 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.9 tttm -80.34 -30.77 38.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.895 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.47 -44.11 89.17 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.093 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -94.4 -41.48 9.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.468 ' HB2' HG23 ' A' ' 39' ' ' VAL . 46.4 m-85 -114.27 -29.66 6.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.0 111.32 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.38 54.26 2.74 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.662 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 33' ' ' ILE . 18.5 t -117.36 151.36 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 0.0 110.81 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.543 ' OD2' ' HG2' ' A' ' 42' ' ' LYS . 9.7 t70 -107.13 125.04 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 26' ' ' LEU . 13.9 p -76.01 -14.27 60.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 8.1 ptpp? -77.61 -17.09 58.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.452 -0.499 . . . . 0.0 109.88 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.99 -22.69 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.294 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -66.77 118.84 10.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.511 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 63.2 tttp -82.77 98.79 9.29 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.249 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.652 ' HA ' HG12 ' A' ' 60' ' ' VAL . 48.2 mt -73.11 119.73 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.543 0.687 . . . . 0.0 110.747 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.7 mt -90.18 -44.46 9.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.099 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.468 ' HG3' HG22 ' A' ' 16' ' ' VAL . 58.2 tttm -149.49 106.02 3.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.192 -172.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.531 ' O ' HG13 ' A' ' 17' ' ' ILE . 11.0 m -86.88 123.9 32.52 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.0 m -160.47 -178.41 6.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' OE1' ' HE2' ' A' ' 11' ' ' LYS . 9.3 pt-20 -138.88 152.96 48.22 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.669 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 30.0 t70 -148.18 125.75 11.75 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HG3' ' OD1' ' A' ' 52' ' ' ASP . 38.7 mttp 60.17 -138.52 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.306 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.844 ' HB3' HG11 ' A' ' 76' ' ' VAL . 73.2 mtm180 -80.16 12.72 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.629 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.617 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 3.8 m-85 -137.15 152.86 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.518 -0.473 . . . . 0.0 112.15 -167.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.741 ' HE2' HG21 ' A' ' 2' ' ' ILE . 14.6 m-85 -91.55 150.71 21.07 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 169.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.669 ' CE2' ' HB3' ' A' ' 52' ' ' ASP . 65.0 m-85 -130.13 98.05 4.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.757 0.313 . . . . 0.0 110.237 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.757 HG11 HD11 ' A' ' 26' ' ' LEU . 21.5 t -100.03 93.14 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.374 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 2.1 t -76.71 124.33 27.51 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 46' ' ' ILE . 11.6 m -134.8 151.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.092 0.473 . . . . 0.0 111.211 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.1 t70 -87.49 117.15 26.09 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.63 -9.43 59.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.811 0.339 . . . . 0.0 111.702 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.74 -28.41 4.46 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.229 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -64.0 -28.03 69.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.308 0.575 . . . . 0.0 110.065 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.74 -27.92 3.15 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.266 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.826 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 24.8 mt-10 -83.62 152.99 24.52 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.201 0.524 . . . . 0.0 111.443 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 53.7 mtpt -103.14 111.71 24.21 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 2.4 t -95.76 168.97 10.33 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.605 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 19.1 ttmm -148.04 94.49 2.34 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 79.0 m-85 -72.56 89.73 1.31 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.899 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.005 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 74.2 tttt -78.6 93.01 4.77 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.742 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 80.4 mt -83.03 105.88 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.53 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.662 ' H ' ' HA ' ' A' ' 81' ' ' MET . 14.5 ttt180 -66.03 121.34 14.91 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.521 ' HE3' ' C ' ' A' ' 55' ' ' PHE . 71.4 mttt -65.73 168.37 7.87 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.301 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.0 7.84 0.64 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 0.0 110.542 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.844 HG11 ' HB3' ' A' ' 54' ' ' ARG . 2.7 p -53.86 -33.15 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 122.441 1.115 . . . . 0.0 109.3 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.561 ' O ' HG12 ' A' ' 78' ' ' VAL . 27.6 t70 -164.84 118.42 1.29 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.872 -1.967 . . . . 0.0 108.387 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 77' ' ' ASP . 8.9 p 54.79 124.67 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.74 0 O-C-N 125.01 1.444 . . . . 0.0 112.683 -173.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 84.7 Cg_endo -79.04 47.44 2.49 Favored 'Trans proline' 0 C--N 1.325 -0.674 0 C-N-CA 123.746 2.964 . . . . 0.0 112.555 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 7.3 mtmt -147.24 146.99 29.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.662 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 8.1 ptt? -57.23 108.47 0.53 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.11 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.659 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 9.1 p -59.91 -40.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.788 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.722 ' HA3' ' HB3' ' A' ' 96' ' ' TYR . . . -145.57 91.36 0.15 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.263 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -76.49 58.47 1.34 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 122.018 0.914 . . . . 0.0 108.635 170.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.814 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 40.1 mmtm -95.97 119.17 34.0 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.882 -167.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -83.87 124.04 30.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.333 0.587 . . . . 0.0 109.535 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.656 ' HB3' ' HA ' ' A' ' 91' ' ' ASP . 6.3 mtp180 -136.07 93.61 2.94 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.826 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 29.7 tttm -79.59 -64.26 1.23 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.34 -1.754 . . . . 0.0 112.372 -158.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.31 -31.32 58.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.748 0.309 . . . . 0.0 110.757 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -162.86 144.73 10.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.656 ' HA ' ' HB3' ' A' ' 87' ' ' ARG . 13.6 p-10 -101.29 -8.45 22.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.789 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.4 t70 67.82 -76.92 0.05 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.925 0.766 . . . . 0.0 112.981 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 94' ' ' ASP . 10.8 t70 -153.09 -156.39 0.69 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -172.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 93' ' ' ASP . 3.2 t70 -79.59 -159.86 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.41 84.35 0.21 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.474 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 1.005 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 6.8 m-85 . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.082 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 112.316 -0.314 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 79' ' ' PRO . 58.0 m -82.36 86.77 6.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 0.0 111.203 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.732 HD22 ' H ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -115.26 97.52 6.24 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.413 HG23 ' CD1' ' A' ' 3' ' ' LEU . 5.4 tp -163.47 -20.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 113.041 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.884 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 3.9 mp -116.98 1.03 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.7 t70 66.97 -62.43 0.3 Allowed 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.655 0.597 . . . . 0.0 111.066 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.36 61.14 0.19 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.599 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 25.7 t0 76.75 23.07 1.07 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.649 0.738 . . . . 0.0 111.077 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.627 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 6.5 tt -98.08 122.95 41.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.617 HD23 HD23 ' A' ' 7' ' ' LEU . 2.2 pt? -41.04 -66.68 0.31 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -167.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.576 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 31.8 mmtp 65.06 -67.8 0.12 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.614 ' HB2' HD23 ' A' ' 12' ' ' LEU . 3.3 p30 -59.17 -54.0 51.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.8 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG2' HD12 ' A' ' 8' ' ' LEU . 42.4 mtpt 53.45 43.97 30.59 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.341 0.4 . . . . 0.0 111.043 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.614 HD23 ' HB2' ' A' ' 10' ' ' ASP . 4.3 mm? -63.52 -86.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.382 175.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.686 ' N ' ' HE2' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 54.41 61.43 3.02 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 109.991 177.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 82.8 mt -134.97 174.69 4.32 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.459 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.2 Cg_endo -63.5 -153.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.896 2.397 . . . . 0.0 111.066 165.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 48' ' ' LYS . 23.8 t -58.75 106.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.757 0.789 . . . . 0.0 109.944 175.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.7 mt -67.59 156.51 6.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.486 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -49.05 133.03 18.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.107 0.479 . . . . 0.0 111.213 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -67.42 -25.52 65.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.729 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -63.38 -50.39 70.09 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 50.8 t80 -59.15 -38.58 80.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.722 177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -64.54 -47.04 88.19 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 174.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 9.2 mmmm -54.77 -36.92 65.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 122.314 0.246 . . . . 0.0 111.027 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.3 mm-40 -60.04 -47.0 87.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.429 0.456 . . . . 0.0 111.492 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 72' ' ' ILE . 89.0 mt -52.46 -63.78 1.03 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.462 174.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.761 HD11 HG11 ' A' ' 58' ' ' VAL . 7.7 mp -59.67 -32.33 70.39 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.292 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.42 -40.29 86.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.216 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 50.6 mttm -75.5 -32.36 60.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.456 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.644 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 91.8 m-85 -96.44 8.47 43.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.335 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -54.04 -39.56 66.31 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.246 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -64.4 -39.78 94.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.664 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -76.52 -38.53 54.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.15 -26.4 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.288 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 82.0 tttt -83.55 -28.17 28.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.614 0.721 . . . . 0.0 109.84 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.94 -46.39 62.5 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.273 172.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -77.73 -39.75 43.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.761 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.625 ' HB2' HG23 ' A' ' 39' ' ' VAL . 90.0 m-85 -114.88 -48.01 2.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.449 0.642 . . . . 0.0 110.966 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.16 39.05 2.35 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.296 -171.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG12 ' H ' ' A' ' 41' ' ' THR . 13.5 t -109.3 150.82 11.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.831 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 42' ' ' LYS . 32.0 t70 -92.99 11.17 28.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.369 0.604 . . . . 0.0 110.132 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.647 ' H ' HG12 ' A' ' 39' ' ' VAL . 46.6 p 56.16 -24.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.7 1.6 . . . . 0.0 114.129 -172.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 42' ' ' LYS . 4.4 ttmp? -72.83 -12.92 61.17 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.31 0.576 . . . . 0.0 110.517 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -83.1 -42.5 17.33 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.759 0.79 . . . . 0.0 108.875 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.62 ' HG ' HG11 ' A' ' 39' ' ' VAL . 57.1 mt -61.67 106.11 0.63 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.376 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.632 ' HD3' HD23 ' A' ' 47' ' ' LEU . 6.1 tmtm? -79.91 116.61 20.15 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.403 ' HA ' HG12 ' A' ' 60' ' ' VAL . 41.3 mt -73.6 128.51 36.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.546 0.688 . . . . 0.0 110.956 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.632 HD23 ' HD3' ' A' ' 45' ' ' LYS . 15.3 mt -97.92 -51.5 4.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.889 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.581 ' HA ' HG13 ' A' ' 16' ' ' VAL . 62.4 tttm -144.73 102.86 3.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.461 -173.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.4 m -78.9 121.72 25.21 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -153.22 -177.78 6.54 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.818 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 1.7 pp20? -162.55 160.83 26.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.808 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.681 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 29.7 t70 -103.78 -86.14 0.45 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.172 0.511 . . . . 0.0 109.735 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -131.33 -79.23 0.52 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 173.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' HB3' HG11 ' A' ' 76' ' ' VAL . 52.5 mtt180 -87.99 16.93 5.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 0.0 110.818 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -144.6 135.62 25.06 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.684 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.9 m-85 -94.88 151.45 19.2 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 168.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.681 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 78.1 m-85 -137.8 109.59 7.12 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.349 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 26' ' ' LEU . 21.8 t -110.7 108.77 26.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 15.1 t -84.27 130.72 34.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 67' ' ' LYS . 26.9 m -135.4 148.29 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.136 0.494 . . . . 0.0 112.167 -174.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.537 ' HB2' HD21 ' A' ' 47' ' ' LEU . 34.7 t70 -90.26 112.88 24.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.93 -63.88 1.13 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.798 -174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.67 -130.27 2.07 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.096 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -102.39 -8.14 21.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.098 0.475 . . . . 0.0 109.813 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.73 -33.95 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.603 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.636 ' OE2' ' HB2' ' A' ' 88' ' ' LYS . 5.3 tp10 -61.45 136.56 58.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.214 0.53 . . . . 0.0 111.132 -177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 42.5 mttp -137.17 106.3 6.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.96 -173.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 1.9 t -96.09 148.0 23.14 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.352 -173.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 5.0 ttmp? -115.03 102.78 10.26 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.71 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 62.1 m-85 -68.44 127.48 33.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.978 ' HD2' ' HA ' ' A' ' 96' ' ' TYR . 56.7 tttp -100.71 83.45 2.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.666 0.746 . . . . 0.0 109.938 -175.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 94.8 mt -81.25 89.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.952 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.654 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 39.7 ttt180 -58.9 117.72 4.96 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.543 ' HB3' HD13 ' A' ' 3' ' ' LEU . 93.9 mttt -60.9 174.07 0.68 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.569 -176.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.884 ' HB3' ' H ' ' A' ' 3' ' ' LEU . 53.1 t0 -71.89 64.26 0.49 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.763 0.792 . . . . 0.0 110.513 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.599 ' HA ' ' N ' ' A' ' 6' ' ' ASP . 31.1 m -99.09 -7.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.438 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -175.16 -61.49 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.024 -171.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.1 151.02 37.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.577 . . . . 0.0 111.186 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 0' ' ' SER . 43.3 Cg_endo -90.34 32.74 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.709 2.94 . . . . 0.0 110.977 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.644 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 3.0 ttmt -150.88 -166.18 2.47 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.178 0.513 . . . . 0.0 111.099 -171.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.546 ' HG3' ' CD2' ' A' ' 29' ' ' PHE . 67.9 mtm -97.04 127.2 42.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.226 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG11 ' HE3' ' A' ' 71' ' ' LYS . 7.6 p -53.01 -33.13 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.455 0.645 . . . . 0.0 109.903 169.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.76 -143.42 8.41 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.919 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.71 ' HB2' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER 176.3 148.78 0.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -176.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -148.49 121.07 8.56 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.945 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 1.4 m -88.19 130.31 35.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -124.28 31.8 5.68 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.067 0.937 . . . . 0.0 109.893 -172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.636 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.69 -36.74 62.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.813 175.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -53.47 -65.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.96 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -159.68 -87.14 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.147 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -153.87 159.92 41.97 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -146.72 143.18 28.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.495 0.188 . . . . 0.0 111.287 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -136.95 116.79 13.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.195 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -171.32 -50.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.839 0.828 . . . . 0.0 109.451 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -164.17 -117.44 0.41 Allowed Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.978 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 44.6 t80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 117.48 -1.247 . . . . 0.0 113.194 164.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.459 ' HA ' ' CE2' ' A' ' 29' ' ' PHE . 28.6 t -108.78 126.92 53.54 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.822 ' H ' ' HE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -125.76 108.59 11.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.742 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.808 HG21 ' HE1' ' A' ' 56' ' ' TYR . 3.3 tp -176.36 -6.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.645 HD11 ' H ' ' A' ' 8' ' ' LEU . 7.1 tp -144.27 -18.25 0.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.319 -0.952 . . . . 0.0 113.405 -171.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 65.41 9.53 5.83 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.887 0.475 . . . . 0.0 112.069 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.719 ' HA2' ' H ' ' A' ' 77' ' ' ASP . . . 71.49 18.11 76.79 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.647 -172.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -103.36 -35.25 8.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.797 0.332 . . . . 0.0 110.812 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.562 ' HA ' ' HG ' ' A' ' 3' ' ' LEU . 6.8 mp 71.03 109.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.517 175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.645 ' H ' HD11 ' A' ' 3' ' ' LEU . 58.0 tp -109.62 88.37 2.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 169.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.586 ' HA ' HD21 ' A' ' 12' ' ' LEU . 9.5 ptpp? -93.35 14.3 18.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.559 -172.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.534 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 20.5 t70 -88.8 -29.71 19.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.219 0.533 . . . . 0.0 110.565 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 -20.98 32.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.299 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.586 HD21 ' HA ' ' A' ' 9' ' ' LYS . 2.3 pp -87.53 45.57 1.29 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.847 0.832 . . . . 0.0 111.692 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.534 ' HD3' ' O ' ' A' ' 10' ' ' ASP . 40.8 mtpt -115.06 21.87 13.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.965 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.41 154.77 46.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.418 -174.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.55 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.255 2.637 . . . . 0.0 110.966 171.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' CG2' ' HG3' ' A' ' 48' ' ' LYS . 3.4 p -54.71 108.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 122.335 1.064 . . . . 0.0 110.38 173.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.822 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 33.3 mt -75.82 149.57 6.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 113.703 -1.59 . . . . 0.0 109.3 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.22 139.64 47.17 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 111.097 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.494 ' O ' HD12 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -60.29 -24.55 65.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.063 -176.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 20' ' ' LEU . 2.6 tm? -70.43 -39.74 74.21 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.581 ' O ' HD13 ' A' ' 25' ' ' LEU . 77.5 t80 -62.02 -43.93 97.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -67.74 -29.67 73.98 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.431 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -70.05 -37.39 75.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 36.2 mm-40 -59.18 -47.75 84.17 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.693 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 21' ' ' PHE . 8.7 mp -50.42 -67.34 0.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.731 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.943 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 26.5 mt -50.38 -30.19 11.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.795 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.25 -45.72 46.12 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 122.372 -0.205 . . . . 0.0 110.72 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 63.6 mttm -65.88 -46.77 77.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.278 0.561 . . . . 0.0 110.41 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.822 ' HE2' ' H ' ' A' ' 1' ' ' LEU . 19.5 m-85 -91.33 13.21 18.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.787 -174.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -55.84 -51.43 67.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 1.7 m-20 -80.74 11.17 4.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.369 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.03 -43.98 5.35 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 169.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.581 HG21 ' HE2' ' A' ' 70' ' ' PHE . 38.8 mt -66.93 -38.2 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.685 174.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -83.05 -22.76 33.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.845 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 15.2 t70 -68.51 -55.3 12.21 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.272 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 81' ' ' MET . 58.2 mttm -69.51 -50.73 42.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.417 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.533 ' OH ' ' HA2' ' A' ' 83' ' ' GLY . 26.9 m-85 -116.71 -6.4 11.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -168.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.92 29.28 73.49 Favored Glycine 0 CA--C 1.516 0.136 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.494 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.577 ' HB ' HG22 ' A' ' 33' ' ' ILE . 28.2 t -97.93 147.72 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.554 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.23 127.57 50.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.943 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 71.8 p -87.94 -20.11 26.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.816 0.341 . . . . 0.0 111.858 -173.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -68.19 -39.74 82.41 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -61.05 -29.01 69.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.862 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 64.2 mt -69.52 149.95 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -175.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -115.01 121.15 42.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.432 172.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.606 HG12 HG12 ' A' ' 60' ' ' VAL . 26.5 mt -84.65 132.25 32.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.512 0.673 . . . . 0.0 111.779 -176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 61' ' ' ASP . 5.7 mt -101.76 -52.04 3.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.733 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 38.4 ttmt -146.35 115.3 6.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.059 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.822 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -91.59 139.04 31.08 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -157.41 -175.41 5.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 12' ' ' LEU . 13.1 pt-20 -163.74 150.8 12.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.298 0.57 . . . . 0.0 111.962 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.76 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 27.8 t70 -99.55 -158.84 0.7 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.793 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 4.0 mptt -73.11 -70.61 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -87.12 13.63 9.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 91.0 m-85 -145.67 152.21 39.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -168.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.808 ' HE1' HG21 ' A' ' 2' ' ' ILE . 30.9 m-85 -108.17 147.01 31.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.009 166.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.76 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 66.1 m-85 -130.37 95.7 3.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.818 0.342 . . . . 0.0 110.329 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 22.0 t -104.7 97.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.049 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.693 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 6.2 t -69.02 114.03 6.93 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 46' ' ' ILE . 13.7 m -129.28 152.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.429 0.633 . . . . 0.0 111.265 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.6 ' HB2' HD21 ' A' ' 47' ' ' LEU . 12.3 t70 -84.41 115.53 22.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.28 -14.5 60.51 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.297 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.99 -42.76 2.35 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.602 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.18 -30.14 64.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.903 0.481 . . . . 0.0 111.293 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.55 -19.46 1.67 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.453 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.587 ' OE2' ' HB3' ' A' ' 86' ' ' CYS . 6.2 pt-20 -104.71 166.17 10.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.321 0.582 . . . . 0.0 112.345 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -111.92 117.66 33.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.153 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 62.1 m -111.84 114.99 28.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.036 0.446 . . . . 0.0 111.19 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.933 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.5 ttmt -88.82 85.28 6.73 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 170.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.581 ' HE2' HG21 ' A' ' 33' ' ' ILE . 5.9 m-85 -47.91 116.3 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.913 -172.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.766 ' H ' ' HA ' ' A' ' 84' ' ' ARG . 62.4 tttt -95.67 69.79 2.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.242 -174.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.842 ' HA ' ' HG3' ' A' ' 81' ' ' MET . 36.7 mt -74.52 91.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.454 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.822 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 24.4 ttt180 -50.58 117.43 2.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.45 ' HE3' ' CE1' ' A' ' 56' ' ' TYR . 43.0 mttp -59.4 166.3 2.37 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.03 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 17.9 t0 -67.68 74.75 0.18 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.632 0.73 . . . . 0.0 109.68 174.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 74' ' ' LYS . 3.7 m -104.31 94.39 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.672 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.719 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 34.5 t70 72.21 -61.14 0.5 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.293 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.67 141.56 22.76 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.322 0.582 . . . . 0.0 110.19 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -91.85 84.29 0.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.463 2.776 . . . . 0.0 113.62 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 5.2 mtmt -165.51 153.55 11.18 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.547 176.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.842 ' HG3' ' HA ' ' A' ' 72' ' ' ILE . 4.5 ttp -82.24 121.39 26.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.811 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.822 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.3 p -60.88 -39.4 81.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.382 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 96' ' ' TYR . . . 178.87 -153.02 11.82 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.895 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.766 ' HA ' ' H ' ' A' ' 71' ' ' LYS . 41.3 mtm180 -151.43 125.75 9.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.933 ' HB3' ' HB3' ' A' ' 69' ' ' LYS . 24.5 tptp -76.28 55.57 0.98 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.339 0.59 . . . . 0.0 110.106 -178.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.587 ' HB3' ' OE2' ' A' ' 66' ' ' GLU . 39.3 m -72.47 -164.63 0.16 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.832 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.666 ' HD2' ' OH ' ' A' ' 96' ' ' TYR . 98.2 mtt180 65.08 97.49 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 2.2 ttpm? -58.35 -20.62 45.01 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -164.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -124.05 -170.66 2.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -70.54 91.03 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.271 0.557 . . . . 0.0 110.487 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 31.8 t70 -136.96 13.61 3.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.847 0.832 . . . . 0.0 109.061 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.508 ' HA ' HH11 ' A' ' 87' ' ' ARG . 8.8 p-10 -96.9 174.08 6.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.005 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -149.71 -150.05 0.33 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.466 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -54.26 -33.35 58.36 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.915 0.486 . . . . 0.0 110.906 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.83 132.48 17.51 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.879 ' CE2' ' HA ' ' A' ' 85' ' ' LYS . 9.6 p90 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 117.088 -1.435 . . . . 0.0 111.063 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.668 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.691 0 N-CA-C 112.294 -0.322 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 79' ' ' PRO . 11.4 p -108.77 -17.72 13.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.1 mp 52.09 -153.05 0.22 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.005 171.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.616 HD13 ' HE2' ' A' ' 56' ' ' TYR . 79.4 mt 79.57 -56.5 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.029 168.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.785 HD13 ' HA ' ' A' ' 7' ' ' LEU . 64.9 mt -105.46 -42.89 5.1 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.848 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 29.6 m-20 60.46 71.81 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.672 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.1 31.34 80.46 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.543 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 25.0 t70 -135.24 -153.36 0.51 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.785 ' HA ' HD13 ' A' ' 3' ' ' LEU . 86.0 mt -154.23 172.29 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.797 0.332 . . . . 0.0 110.668 -171.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.686 HD21 ' HZ3' ' A' ' 74' ' ' LYS . 2.4 pt? -140.4 120.32 13.58 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -100.92 -18.08 16.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.778 -173.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -94.17 -30.14 14.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HA ' HD12 ' A' ' 8' ' ' LEU . 10.4 mtmp? 57.78 -168.78 0.12 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.807 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.41 HD11 ' CE2' ' A' ' 21' ' ' PHE . 84.1 mt -90.47 -74.71 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.677 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HE3' HG23 ' A' ' 17' ' ' ILE . 31.1 pttt -175.93 -161.78 0.09 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.412 -168.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.469 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 10.7 mp -66.76 169.33 8.11 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.367 0.667 . . . . 0.0 112.189 -175.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 98.5 Cg_exo -47.99 159.33 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.811 3.007 . . . . 0.0 113.891 177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 49' ' ' THR . 11.0 p 40.96 104.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 123.482 1.611 . . . . 0.0 113.432 -173.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.732 HG22 ' H ' ' A' ' 18' ' ' ASP . 9.8 mt -87.66 -177.66 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 112.984 -1.917 . . . . 0.0 109.469 -175.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.732 ' H ' HG22 ' A' ' 17' ' ' ILE . 4.0 m-20 -59.99 -4.93 0.85 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.58 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 12.8 m120 72.9 -44.35 0.59 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.485 0.714 . . . . 0.0 110.981 -176.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -59.82 -31.57 69.85 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.779 0.432 . . . . 0.0 110.675 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.521 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 38.5 t80 -65.5 -35.63 81.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 109.754 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -77.11 -27.64 59.76 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 177.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -65.59 -37.66 87.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.6 -48.86 77.59 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.181 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 84.0 mt -49.76 -69.11 0.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.028 173.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.62 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 33.7 mt -52.78 -26.68 15.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.88 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.99 -48.75 67.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 110.958 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -69.3 -40.98 77.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.192 0.52 . . . . 0.0 110.365 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -90.36 3.83 52.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.818 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 31.3 tt0 -54.95 -40.56 70.08 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.619 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -65.86 -26.65 67.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.993 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 35' ' ' ASP . 7.9 t70 -85.57 -40.17 16.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.511 0.672 . . . . 0.0 109.681 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.422 HG22 ' HB ' ' A' ' 39' ' ' VAL . 35.5 mt -69.25 -34.03 61.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.412 177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.492 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 86.4 tttt -75.83 -31.54 59.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 18.7 t70 -59.94 -35.59 75.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.643 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -105.87 -25.31 12.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -173.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' HB2' HG23 ' A' ' 39' ' ' VAL . 74.0 m-85 -128.14 -31.38 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.54 63.3 1.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.111 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 37' ' ' TYR . 46.5 t -120.7 151.51 23.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 -173.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 42' ' ' LYS . 23.1 t70 -108.65 110.14 21.51 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 17.3 p -72.32 -10.43 59.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.501 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 6.3 ttpm? -78.04 -35.0 50.2 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.039 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.32 -28.62 59.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 109.589 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 41' ' ' THR . 1.4 mp -54.11 115.99 2.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.405 176.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 2.8 ttmp? -86.32 108.55 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.972 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.676 ' HA ' HG12 ' A' ' 60' ' ' VAL . 36.4 mt -80.27 122.6 35.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.445 0.641 . . . . 0.0 111.094 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.1 mt -96.03 -51.71 4.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.956 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -142.43 106.31 4.71 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.265 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 11.3 m -91.04 132.13 36.2 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' HG13 ' A' ' 17' ' ' ILE . 69.0 m -152.54 -175.11 5.15 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' OE1' ' HB3' ' A' ' 11' ' ' LYS . 12.5 pt-20 -149.64 158.65 44.36 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.763 0.792 . . . . 0.0 111.519 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.671 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 28.1 t70 -111.56 -164.94 0.95 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 166.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.854 ' HD2' ' H ' ' A' ' 53' ' ' LYS . 1.2 mptt -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 40.0 mtp180 -83.5 -0.1 48.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.584 -172.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 m-85 -148.15 159.71 43.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.237 0.541 . . . . 0.0 112.382 -168.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.731 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 36.0 m-85 -109.24 159.75 16.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 163.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.671 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 94.4 m-85 -137.07 93.78 2.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.936 0.398 . . . . 0.0 110.181 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 49' ' ' THR . 13.3 t -102.51 96.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.588 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 12.9 m -78.4 124.44 28.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 46' ' ' ILE . 17.4 m -141.6 160.57 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.543 -173.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 6.0 t70 -92.17 125.33 36.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.544 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -79.81 -13.96 59.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.45 -31.92 7.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.214 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.58 8.92 4.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.802 0.334 . . . . 0.0 111.23 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.21 -15.08 63.74 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.625 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.571 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 9.6 pt-20 -84.16 142.19 30.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.162 0.506 . . . . 0.0 110.749 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.904 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . 27.8 ttmt -97.62 134.9 40.2 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.9 t -126.63 164.66 20.77 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.25 0.548 . . . . 0.0 110.623 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.637 ' H ' ' HA ' ' A' ' 86' ' ' CYS . 35.7 ttmt -147.43 103.87 3.59 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 26' ' ' LEU . 72.0 m-85 -77.36 88.08 3.76 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.571 0.7 . . . . 0.0 110.529 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.05 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 31.1 tttp -71.63 78.02 0.82 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.924 170.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.731 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 78.9 mt -74.43 95.84 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.247 -176.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.783 ' HB2' HG12 ' A' ' 82' ' ' VAL . 40.5 ttp180 -61.76 101.64 0.21 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.686 ' HZ3' HD21 ' A' ' 8' ' ' LEU . 88.8 mttt -48.72 152.3 1.01 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.369 1.043 . . . . 0.0 109.687 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.848 ' HB3' ' H ' ' A' ' 4' ' ' ASP . 29.3 t0 -69.47 70.78 0.29 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.411 0.624 . . . . 0.0 109.56 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 33.7 m -89.2 -4.34 10.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.865 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.9 t70 178.57 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.732 -169.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.51 HG23 ' HD2' ' A' ' 79' ' ' PRO . 7.1 p -137.29 138.34 24.86 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.326 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.668 ' O ' ' HA2' ' A' ' -1' ' ' GLY . 68.4 Cg_endo -83.06 62.88 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.493 2.796 . . . . 0.0 112.855 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -145.28 128.28 16.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 111.471 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.515 ' HG3' HG23 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -70.59 95.63 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.13 177.183 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.783 HG12 ' HB2' ' A' ' 73' ' ' ARG . 10.0 p -60.58 -41.54 88.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.704 -175.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 1.05 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -89.5 47.76 3.29 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.851 -173.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -81.77 45.53 0.91 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.707 ' HB2' ' HB3' ' A' ' 96' ' ' TYR . 20.6 ttpt -105.01 -26.28 12.21 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.818 -165.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.637 ' HA ' ' H ' ' A' ' 69' ' ' LYS . 49.4 m 66.35 -178.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.906 -171.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.727 ' HG3' ' HB2' ' A' ' 90' ' ' ASP . 63.6 ttt180 -176.86 78.96 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.546 0.688 . . . . 0.0 109.285 -172.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.904 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 22.9 ttpp -81.75 -58.78 2.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.861 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.93 5.16 8.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.439 0.638 . . . . 0.0 109.916 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.727 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 3.2 m-20 -66.66 162.63 20.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.9 -177.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 92' ' ' ASP . 9.1 t70 -96.69 -160.21 0.78 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.42 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 24.0 t70 -69.13 109.99 4.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.161 0.505 . . . . 0.0 111.977 -174.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -112.77 137.82 50.51 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.533 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.75 -55.95 3.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.82 137.28 13.97 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.011 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.707 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 3.8 m-85 . . . . . 0 C--N 1.32 -0.703 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 79' ' ' PRO . 43.1 t -88.69 151.36 22.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 2' ' ' ILE . 27.2 mt -118.59 -144.43 0.37 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.627 HG21 ' HE2' ' A' ' 56' ' ' TYR . 1.3 tp 81.2 -25.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.981 0.912 . . . . 0.0 112.492 169.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.821 HD13 ' HA ' ' A' ' 6' ' ' ASP . 30.8 mt -124.0 161.9 24.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.954 0.407 . . . . 0.0 110.659 176.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.588 ' HB3' HD12 ' A' ' 7' ' ' LEU . 18.7 t70 -121.81 81.01 1.76 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.59 43.78 97.49 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.392 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.821 ' HA ' HD13 ' A' ' 3' ' ' LEU . 34.6 t70 67.14 96.73 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.228 0.537 . . . . 0.0 111.951 -177.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 4' ' ' ASP . 75.6 mt -149.4 100.03 2.97 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.62 HD23 ' HD3' ' A' ' 53' ' ' LYS . 51.7 tp -112.19 -68.19 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 38.0 mtmt 76.77 -66.49 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.564 . . . . 0.0 111.856 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -125.75 134.18 51.83 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.856 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -149.43 3.54 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -172.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.46 128.5 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.165 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 14' ' ' LEU . 59.3 tttt -136.69 165.8 25.07 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' H ' ' HG2' ' A' ' 13' ' ' LYS . 61.9 mt -55.01 159.15 4.04 Favored Pre-proline 0 N--CA 1.45 -0.455 0 C-N-CA 122.654 0.382 . . . . 0.0 111.342 175.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -43.26 138.82 4.45 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.594 2.862 . . . . 0.0 113.5 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p 43.69 102.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 123.129 1.442 . . . . 0.0 113.578 -175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.88 162.31 4.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.124 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.88 133.31 22.27 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.345 0.403 . . . . 0.0 111.126 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -64.01 -20.85 66.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.913 0.387 . . . . 0.0 110.254 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -69.03 -31.55 70.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.418 175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HE1' ' HE1' ' A' ' 56' ' ' TYR . 55.5 t80 -68.6 -40.07 80.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.281 0.562 . . . . 0.0 109.698 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -72.26 -29.85 65.8 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.162 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -67.27 -40.49 86.17 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.2 mm-40 -52.77 -51.72 59.51 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.744 173.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.514 HD13 HD12 ' A' ' 72' ' ' ILE . 68.3 mt -53.97 -66.36 0.41 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.839 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.549 HD22 HG22 ' A' ' 41' ' ' THR . 20.4 mt -54.06 -28.36 38.34 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.46 -50.23 60.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.026 0.441 . . . . 0.0 110.695 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 72.4 mttt -71.54 -33.77 69.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.816 -176.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -96.88 4.9 51.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.789 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.4 tt0 -56.52 -41.63 77.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.775 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -65.69 -20.99 66.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.551 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -94.61 -39.93 10.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.277 0.561 . . . . 0.0 110.042 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.538 HG22 ' HB ' ' A' ' 39' ' ' VAL . 53.7 mt -67.76 -31.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.313 176.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 44.1 tttp -81.73 -29.15 33.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.306 0.574 . . . . 0.0 109.803 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -68.39 -52.59 31.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.574 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -71.44 -43.39 66.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.621 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.576 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 86.6 m-85 -118.59 -23.54 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.14 44.11 7.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.875 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.556 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.3 t -100.99 152.79 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -114.4 116.61 29.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.554 HG22 HD12 ' A' ' 44' ' ' LEU . 39.7 p -76.22 -11.6 59.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -73.68 -20.46 60.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.358 0.599 . . . . 0.0 109.53 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -92.23 -33.0 14.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.327 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.554 HD12 HG22 ' A' ' 41' ' ' THR . 86.6 mt -56.67 111.55 1.04 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.959 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 75.8 tttt -84.11 104.35 14.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.71 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.618 ' HA ' HG12 ' A' ' 60' ' ' VAL . 37.7 mt -73.73 112.68 10.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.546 0.688 . . . . 0.0 111.029 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.6 mt -82.25 -43.5 17.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.065 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -154.04 120.38 5.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.347 -173.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -102.46 130.21 49.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.9 m -157.29 177.03 11.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 11' ' ' LYS . 1.2 pt-20 -158.61 167.05 30.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 171.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -149.01 89.78 1.7 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.107 173.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.856 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 5.3 tppp? 70.41 -100.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.726 175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.625 ' HB3' HG21 ' A' ' 76' ' ' VAL . 65.8 mtt180 -94.71 20.44 8.64 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.73 -0.606 . . . . 0.0 111.451 -171.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -148.63 121.01 8.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.818 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.779 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 21.0 m-85 -85.78 150.96 24.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 168.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 95.05 3.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 8.8 t -105.86 93.92 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 110.516 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.1 m -80.02 119.9 23.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 46' ' ' ILE . 11.5 m -130.29 158.09 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.31 0.576 . . . . 0.0 111.343 -176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 9.9 t70 -84.55 123.5 30.37 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.55 4.44 7.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.26 -45.77 1.32 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.372 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.93 -27.05 39.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.136 0.493 . . . . 0.0 110.473 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.59 -21.62 2.37 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.202 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.778 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 5.7 mt-10 -66.95 147.89 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 111.398 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 97.8 mttt -109.47 110.3 21.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.049 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 56.2 m -108.18 131.43 54.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 34.8 ttmt -101.48 107.18 18.4 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.575 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 65.5 m-85 -76.48 84.55 3.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.184 0.992 . . . . 0.0 110.433 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.116 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 21.3 tttp -76.72 89.58 3.39 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.594 -1.639 . . . . 0.0 109.197 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.779 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 68.0 mt -87.23 106.22 15.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.494 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.729 ' HB2' HG22 ' A' ' 82' ' ' VAL . 60.3 ttt180 -78.7 18.09 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.462 0.648 . . . . 0.0 110.336 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.624 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.7 mttt 55.43 -157.12 0.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.229 173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 32.0 t70 -100.83 56.0 0.87 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.625 HG21 ' HB3' ' A' ' 54' ' ' ARG . 17.9 t -75.44 -13.49 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.281 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.8 t70 179.92 -54.63 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.315 -171.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' HD2' ' A' ' 79' ' ' PRO . 10.0 p -120.75 139.03 28.34 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.667 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 78' ' ' VAL . 55.5 Cg_endo -75.16 67.39 6.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.664 2.243 . . . . 0.0 111.86 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -142.03 142.24 32.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.628 0.727 . . . . 0.0 111.985 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.521 ' HG3' HG23 ' A' ' 72' ' ' ILE . 1.5 mpp? -80.7 89.45 5.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.587 173.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 73' ' ' ARG . 35.0 m -58.84 -33.49 49.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.916 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 1.116 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -92.18 72.8 1.55 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.053 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.576 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -105.39 47.73 0.86 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -115.53 142.1 47.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.979 -170.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 5.8 m -108.26 132.02 54.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.049 0.452 . . . . 0.0 109.925 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.702 ' HD3' ' HA ' ' A' ' 91' ' ' ASP . 94.6 mtt180 -128.42 78.33 1.83 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.778 ' HG3' ' HA ' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -71.2 -41.18 70.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.144 -171.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.41 -59.9 2.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.483 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -171.28 147.54 2.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.719 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.702 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 8.6 t70 -108.95 112.08 24.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -72.01 -90.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.072 0.463 . . . . 0.0 110.862 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -116.07 142.33 46.95 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -82.57 114.07 20.71 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.319 0.58 . . . . 0.0 111.62 -172.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.41 77.91 0.19 Allowed Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.83 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 15.1 m-30 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.701 -173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.488 ' HA2' ' HB2' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.646 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.412 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 26.1 p -140.68 29.02 1.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.291 0.567 . . . . 0.0 109.694 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.964 ' HA ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -67.9 131.04 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.597 1.189 . . . . 0.0 113.47 -169.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.614 HG13 HD11 ' A' ' 8' ' ' LEU . 11.1 tp -152.36 15.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 113.795 -1.548 . . . . 0.0 107.167 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 75' ' ' ASP . 1.8 pp -149.2 157.89 43.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 113.462 -1.699 . . . . 0.0 108.184 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.61 -29.31 61.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.318 0.58 . . . . 0.0 109.825 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 162.09 40.99 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 24.1 p-10 -157.96 -80.26 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.852 -168.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 6' ' ' ASP . 7.7 mt 175.71 174.14 0.29 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.139 0.576 . . . . 0.0 110.252 -174.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.614 HD11 HG13 ' A' ' 2' ' ' ILE . 63.8 mt -100.05 131.63 45.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.156 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -98.46 -30.28 12.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' OD2' ' HG3' ' A' ' 11' ' ' LYS . 6.4 p-10 -80.48 -38.03 30.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.068 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HB2' HD13 ' A' ' 8' ' ' LEU . 57.4 mttp -101.86 67.89 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.652 0.739 . . . . 0.0 109.745 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.763 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.6 pt? -79.25 -36.23 40.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.344 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.671 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 7.5 ptpt -177.08 101.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.448 0.642 . . . . 0.0 110.851 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.525 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 96.0 mt -100.47 167.51 10.79 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.523 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 28.6 Cg_endo -64.6 -170.61 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.632 2.221 . . . . 0.0 111.998 173.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' A' ' 48' ' ' LYS . 2.6 p -63.39 105.59 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.004 0.907 . . . . 0.0 110.017 175.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 49' ' ' THR . 3.3 pt -106.07 -177.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.804 -174.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.509 ' OD2' ' HB ' ' A' ' 46' ' ' ILE . 7.9 t70 176.68 -39.58 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -174.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -40.41 78.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 112.261 -2.245 . . . . 0.0 113.248 176.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 78.9 mt 45.7 40.2 5.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.729 0.776 . . . . 0.0 111.035 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.512 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 27.3 m-85 -117.13 -78.06 0.58 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.127 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.41 90.78 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.491 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HG2' HD12 ' A' ' 46' ' ' ILE . 30.2 mmmt -66.4 -33.29 75.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.627 -0.286 . . . . 0.0 110.364 178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 1.5 mm-40 -65.87 -47.14 75.88 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.607 175.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 87.0 mt -50.94 -66.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.838 173.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.877 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 34.0 mt -50.89 -33.19 23.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.444 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.28 -48.46 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.195 -0.316 . . . . 0.0 111.074 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 80.0 mttt -67.7 -38.22 83.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.211 0.529 . . . . 0.0 110.496 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 1.5 m-85 -98.54 12.59 34.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.46 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.665 ' NE2' ' HA ' ' A' ' 40' ' ' ASP . 32.2 tt0 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.63 -33.15 71.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.347 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.661 ' O ' ' HD2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -76.58 -46.88 24.4 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.534 178.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.511 HG22 ' HB ' ' A' ' 39' ' ' VAL . 42.5 mt -65.45 -20.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.613 0.72 . . . . 0.0 110.266 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HG3' ' HA2' ' A' ' 38' ' ' GLY . 46.9 tttm -87.66 -40.18 14.39 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.645 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.89 -47.91 76.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.906 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.661 ' HD2' ' O ' ' A' ' 32' ' ' ASP . 8.0 mttp -82.5 -28.74 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.26 -175.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.492 ' HB2' HG23 ' A' ' 39' ' ' VAL . 67.8 m-85 -133.67 -52.43 0.87 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.018 0.437 . . . . 0.0 111.526 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.53 ' HA2' ' HG3' ' A' ' 34' ' ' LYS . . . 106.78 62.53 0.59 Allowed Glycine 0 C--N 1.319 -0.393 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -173.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 33' ' ' ILE . 47.3 t -124.45 151.84 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.905 0.383 . . . . 0.0 111.372 -171.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.665 ' HA ' ' NE2' ' A' ' 30' ' ' GLN . 28.7 t70 -103.19 121.33 42.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.54 171.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.877 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 41.1 p -88.56 -10.69 47.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.946 0.403 . . . . 0.0 112.044 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -68.97 -43.16 75.5 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -73.84 -24.87 59.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.379 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 78.7 mt -56.71 123.33 14.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.128 0.49 . . . . 0.0 110.692 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -94.2 111.69 23.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.82 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 60' ' ' VAL . 12.4 mt -72.53 116.88 15.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.487 0.661 . . . . 0.0 111.184 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.3 mt -86.82 -40.02 15.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.929 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HA ' HG23 ' A' ' 16' ' ' VAL . 41.1 tttm -155.0 140.63 17.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.552 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 57' ' ' TYR . 54.1 m -142.48 127.54 18.49 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.7 m -156.57 152.53 27.37 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -123.96 162.7 22.86 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 175.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 10.1 t70 -153.69 -98.99 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.672 171.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -93.57 89.79 6.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.912 -178.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.3 mtt180 75.45 -44.84 0.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.657 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 20.5 m-85 -78.98 133.22 36.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.684 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 1.3 m-85 -103.55 121.77 43.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.718 164.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 49' ' ' THR . 10.7 m-85 -99.07 86.26 3.41 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 70' ' ' PHE . 18.8 t -96.25 84.72 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.133 0.492 . . . . 0.0 110.4 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 23.5 t -82.44 117.57 22.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 46' ' ' ILE . 15.2 m -129.84 156.26 42.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.248 0.547 . . . . 0.0 111.618 -175.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.0 119.53 21.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.23 2.75 14.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.2 -50.44 3.63 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.916 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.94 -35.97 80.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.019 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.554 ' O ' ' HE3' ' A' ' 88' ' ' LYS . . . 151.97 -31.48 0.89 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.885 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.562 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 33.5 mt-10 -71.6 161.06 31.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.066 0.46 . . . . 0.0 111.411 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -119.22 105.15 11.07 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.534 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 55.9 m -103.62 127.27 51.08 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.468 -173.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.8 ttpt -99.13 104.46 16.45 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.761 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 85.6 m-85 -71.43 95.99 1.43 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.656 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.024 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 34.6 tttm -81.9 78.2 8.64 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.426 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 74' ' ' LYS . 57.5 mt -82.61 101.94 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.306 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 38.4 ttp180 -74.22 21.2 0.1 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.535 0.683 . . . . 0.0 109.827 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.684 ' HE2' ' CE2' ' A' ' 56' ' ' TYR . 86.1 mttt 64.3 174.25 0.19 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.564 -174.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.964 ' HB2' ' HA ' ' A' ' 1' ' ' LEU . 2.2 t70 -77.39 43.44 0.38 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.937 0.398 . . . . 0.0 110.37 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.406 HG11 ' HG2' ' A' ' 54' ' ' ARG . 6.9 m -64.17 91.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.248 0.547 . . . . 0.0 110.884 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 76.55 -50.68 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.095 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 34.8 m -107.25 146.23 32.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.382 0.61 . . . . 0.0 111.27 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.583 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.0 Cg_endo -90.73 54.61 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.737 2.958 . . . . 0.0 113.915 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -145.46 149.17 34.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.775 0.322 . . . . 0.0 111.221 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.419 ' CG ' HG12 ' A' ' 72' ' ' ILE . 2.6 mpp? -81.66 102.16 10.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 73' ' ' ARG . 9.5 p -57.85 -31.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.027 0.442 . . . . 0.0 111.288 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -125.08 148.05 16.67 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.062 -177.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -173.81 54.14 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -177.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HB3' ' CE2' ' A' ' 96' ' ' TYR . 34.2 tptt -98.92 129.05 45.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.226 -168.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.88 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.6 m -89.79 115.12 26.89 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.603 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.494 ' HD2' ' OH ' ' A' ' 96' ' ' TYR . 40.9 mtt-85 -119.01 79.91 1.47 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.562 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 48.7 tttt -81.48 -25.71 35.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.606 -171.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -92.58 -55.71 3.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.089 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.02 137.08 32.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.987 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 19.2 t70 -135.73 108.83 7.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.27 0.557 . . . . 0.0 111.717 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.93 2.58 1.35 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.854 0.835 . . . . 0.0 109.27 173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -107.47 130.91 54.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.771 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.472 ' O ' ' HE3' ' A' ' 71' ' ' LYS . 6.6 m-20 -99.6 -10.98 21.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.527 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.32 89.15 1.52 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.537 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 1.024 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 15.1 m-30 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.383 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.961 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.961 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 7.8 t -94.33 84.4 4.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.165 0.482 . . . . 0.0 109.967 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.41 78.61 9.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.213 0.53 . . . . 0.0 109.874 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 2' ' ' ILE . 8.9 tp -151.98 87.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 122.085 0.945 . . . . 0.0 110.219 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.9 pt? -127.96 133.4 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.667 0.746 . . . . 0.0 111.705 -176.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' A' ' 8' ' ' LEU . 10.6 t70 -95.9 -19.91 19.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 168.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.37 71.06 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.079 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.3 t70 63.46 31.24 15.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.126 0.965 . . . . 0.0 109.159 -175.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.741 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 31.5 tp 179.69 -174.08 0.23 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.741 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 34.8 tp -148.12 107.66 3.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 173.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -100.56 -14.3 18.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.919 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.1 -48.74 80.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.443 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.21 133.49 24.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.307 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.915 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 22.7 tp -153.74 142.02 20.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.343 -177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.915 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 36.4 mtmt 67.33 30.95 6.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.9 mt -66.31 129.36 94.18 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 52.4 Cg_exo -57.11 -62.7 0.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.649 0 C-N-CA 123.59 2.86 . . . . 0.0 112.181 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.696 HG23 ' HG3' ' A' ' 48' ' ' LYS . 8.7 p -146.42 145.51 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.266 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.547 HG13 ' HA ' ' A' ' 50' ' ' SER . 2.3 mt -119.05 163.12 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.948 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -54.3 140.78 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.0 111.186 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -67.98 -25.55 65.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.039 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.9 tp -68.06 -45.26 74.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.422 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 79.2 t80 -59.9 -37.07 78.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.473 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -67.64 -51.24 37.28 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.419 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.4 mptp? -51.9 -35.28 44.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.536 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 1.4 mm-40 -59.86 -60.04 4.47 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.463 172.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 63.7 mt -47.89 -56.36 7.71 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.889 0.852 . . . . 0.0 110.62 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.655 HD11 HG11 ' A' ' 58' ' ' VAL . 8.0 mp -63.39 -28.26 69.87 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.578 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 24' ' ' GLU . 13.9 t70 -62.99 -43.15 99.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 174.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.536 ' HD2' ' O ' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -66.11 -21.19 66.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.961 0.41 . . . . 0.0 110.303 177.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.961 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 65.9 m-85 -107.43 2.64 24.45 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.531 HE22 ' HE3' ' A' ' 42' ' ' LYS . 50.6 tt0 -50.99 -44.5 60.82 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -173.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -69.88 -35.61 74.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.748 0.309 . . . . 0.0 110.79 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.73 -45.14 65.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.759 0.79 . . . . 0.0 109.794 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.576 HG22 ' HB ' ' A' ' 39' ' ' VAL . 91.9 mt -61.18 -40.28 85.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.656 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.624 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 27.7 ttpp -78.8 -21.38 47.86 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.601 0.715 . . . . 0.0 110.13 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.75 -48.31 16.95 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HE2' ' HE3' ' A' ' 81' ' ' MET . 9.7 mtpp -81.87 -34.97 29.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -124.27 -26.44 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.54 64.85 1.92 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.993 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.624 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 21.4 t -133.34 150.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 122.309 0.244 . . . . 0.0 110.814 -176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.7 119.53 39.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.91 170.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 26' ' ' LEU . 53.7 p -75.21 -19.47 59.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.981 -175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.531 ' HE3' HE22 ' A' ' 30' ' ' GLN . 10.3 mtmp? -67.99 -43.09 79.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.064 0.459 . . . . 0.0 110.192 178.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -82.46 -35.28 27.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 60' ' ' VAL . 18.6 tp -50.79 121.5 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.782 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 44.6 tttp -90.8 114.44 26.83 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.812 -171.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.607 ' HA ' HG12 ' A' ' 60' ' ' VAL . 18.0 mt -87.18 125.82 40.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.352 0.596 . . . . 0.0 111.361 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 12.5 mt -100.72 -54.44 2.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.166 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.696 ' HG3' HG23 ' A' ' 16' ' ' VAL . 59.8 tttm -139.41 93.45 2.68 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.487 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 4.0 m -74.64 137.53 42.29 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.547 ' HA ' HG13 ' A' ' 17' ' ' ILE . 4.5 p -171.11 -169.31 0.73 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 118.218 0.463 . . . . 0.0 110.962 178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.593 ' OE2' ' HA ' ' A' ' 12' ' ' LEU . 7.2 pt-20 -165.45 168.14 16.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.553 175.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' HG3' ' A' ' 53' ' ' LYS . 39.0 t70 -145.68 -76.38 0.21 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 0.0 111.337 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HG3' ' OD2' ' A' ' 52' ' ' ASP . 56.5 mttp -113.01 82.27 1.63 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.961 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.502 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 66.7 mtt180 72.13 -27.88 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.964 0.506 . . . . 0.0 112.163 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 53' ' ' LYS . 9.6 m-85 -97.11 139.2 33.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.707 0.289 . . . . 0.0 111.361 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.7 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 12.3 m-85 -82.52 147.83 28.44 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.776 170.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.624 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 58.9 m-85 -131.36 99.83 4.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.163 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.655 HG11 HD11 ' A' ' 26' ' ' LEU . 27.6 t -103.46 93.47 2.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 13.2 m -73.71 120.82 19.84 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.1 m -130.34 160.17 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.493 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.619 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 7.0 t0 -85.23 117.0 23.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 167.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.83 -1.7 7.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.74 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.28 60.61 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -121.27 5.45 10.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.305 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.85 -20.24 51.11 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 45.3 mt-10 -63.28 129.53 40.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.561 0.344 . . . . 0.0 111.035 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.662 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 55.0 mtpt -95.75 86.0 4.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 0.0 109.894 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.969 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 69.4 m -85.79 118.22 25.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.035 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.624 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 36.4 ttmt -92.34 107.2 19.04 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.573 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 30.8 m-85 -73.65 120.98 19.99 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.211 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.795 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 85.4 tttt -103.92 90.66 3.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.509 -173.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.7 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 64.4 mt -86.71 115.35 27.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.963 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.809 ' H ' ' HA ' ' A' ' 81' ' ' MET . 36.0 ttt180 -85.73 38.21 0.74 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.031 0.443 . . . . 0.0 109.992 -174.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.549 ' HB2' HG12 ' A' ' 76' ' ' VAL . 52.2 mttt 37.24 -152.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.522 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.631 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 22.4 t70 -97.89 17.97 16.95 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 74' ' ' LYS . 2.5 p -73.87 94.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.816 0.817 . . . . 0.0 109.176 175.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 25.2 t70 84.49 -67.44 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.342 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 35.9 m -90.75 149.16 39.95 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -90.44 34.85 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.218 2.612 . . . . 0.0 111.084 173.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -148.46 -166.15 2.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.426 0.631 . . . . 0.0 111.251 -168.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.809 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 20.7 ptt? -111.35 126.7 55.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.123 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.624 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 7.7 p -59.72 -37.2 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.886 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -170.38 -157.81 13.2 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.426 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -176.54 102.58 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -174.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.67 ' HD2' ' HA ' ' A' ' 96' ' ' TYR . 50.4 mttt -120.49 121.45 38.5 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.671 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.969 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 2.5 m -76.17 116.68 17.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.504 ' NH2' ' HA ' ' A' ' 91' ' ' ASP . 16.2 mtp180 -128.1 81.17 2.01 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.662 ' HA ' ' HB2' ' A' ' 67' ' ' LYS . 42.8 tttm -77.82 -22.17 50.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.39 -169.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -107.36 59.65 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.799 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.8 t70 69.91 155.57 0.14 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.917 175.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.504 ' HA ' ' NH2' ' A' ' 87' ' ' ARG . 11.9 p-10 -131.51 130.55 42.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.422 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.46 -75.01 0.51 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.307 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -105.69 169.96 8.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.561 -1.2 . . . . 0.0 108.608 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -90.28 -99.81 0.1 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.51 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 54.07 81.72 0.06 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.535 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.795 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 6.6 m-30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.894 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.6 ' HA2' ' HB2' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.711 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -106.12 -48.24 3.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.955 0.377 . . . . 0.0 111.821 -177.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 3' ' ' LEU . 24.1 mt 72.95 -23.96 0.2 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 2' ' ' ILE . 7.7 tp -81.07 25.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.818 0.818 . . . . 0.0 111.603 -170.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.808 HD11 ' H ' ' A' ' 8' ' ' LEU . 9.4 tp 179.51 176.88 0.61 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -175.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -147.6 40.54 1.01 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.498 0.666 . . . . 0.0 109.546 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.52 ' HA2' ' H ' ' A' ' 77' ' ' ASP . . . 69.36 16.89 71.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.345 -174.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 11.7 p-10 -96.75 -37.91 10.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.546 -176.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.806 HD11 ' HG3' ' A' ' 54' ' ' ARG . 4.4 mm? 73.98 88.83 0.09 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.595 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.808 ' H ' HD11 ' A' ' 3' ' ' LEU . 71.8 mt -71.92 -16.69 62.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.827 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 34.2 mmtp 68.48 -74.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.795 -173.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -120.84 126.41 50.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.516 ' HD3' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -94.89 -37.26 11.27 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.99 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 13' ' ' LYS . 2.6 pp -120.44 -34.17 3.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.83 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.552 ' N ' HD12 ' A' ' 12' ' ' LEU . 19.2 ttpp 53.38 46.32 26.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.694 0.759 . . . . 0.0 110.966 175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 12' ' ' LEU . 93.3 mt -105.3 172.3 4.15 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.25 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 51.1 Cg_exo -58.94 -156.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.149 2.566 . . . . 0.0 111.591 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 48' ' ' LYS . 7.8 p -56.04 126.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.746 0.784 . . . . 0.0 109.93 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.639 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 3.3 mt -86.76 152.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.077 -173.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.53 139.49 25.27 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.687 0.617 . . . . 0.0 111.24 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 25.8 p-10 -66.32 -30.05 70.38 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.066 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -63.37 -45.34 91.57 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.242 0.339 . . . . 0.0 110.428 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 88.6 t80 -59.95 -42.14 93.39 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -62.63 -49.71 70.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.355 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 29.6 mmmt -54.35 -33.37 58.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.667 0.387 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 7.3 mm-40 -60.63 -54.25 47.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.99 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.595 ' O ' ' HD2' ' A' ' 29' ' ' PHE . 10.8 mp -52.88 -60.0 3.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 173.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.697 HD11 HG11 ' A' ' 58' ' ' VAL . 9.4 mp -60.41 -24.6 65.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.565 -173.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.05 -46.97 69.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 82.4 mttt -72.56 -28.65 62.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.18 0.514 . . . . 0.0 110.344 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.711 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 64.0 m-85 -88.97 -3.28 58.78 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.454 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -54.65 -48.9 71.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.581 0.229 . . . . 0.0 111.085 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.93 -33.97 75.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.939 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 80' ' ' LYS . 4.7 t70 -71.15 -50.38 33.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.963 0.887 . . . . 0.0 109.843 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.688 HG21 ' HE1' ' A' ' 70' ' ' PHE . 62.7 mt -65.04 -30.96 51.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 48.3 tttm -84.71 -30.91 24.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.05 -51.27 69.87 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.253 0.549 . . . . 0.0 110.002 171.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -71.26 -58.95 3.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.363 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -107.28 -36.68 6.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.433 -170.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 34' ' ' LYS . . . 103.95 29.33 5.55 Favored Glycine 0 C--O 1.228 -0.227 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.785 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 41' ' ' THR . 6.9 t -95.36 142.01 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.1 t70 -105.14 7.49 33.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.451 0.643 . . . . 0.0 110.949 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.612 ' H ' HG12 ' A' ' 39' ' ' VAL . 70.6 p 55.71 -13.78 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 49.1 mtpt -58.65 -36.67 74.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.098 0.408 . . . . 0.0 111.946 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -74.58 -32.37 62.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.317 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.62 115.88 3.95 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.721 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.736 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 42.9 tttm -92.25 108.86 20.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.01 171.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.597 ' HA ' HG12 ' A' ' 60' ' ' VAL . 41.6 mt -72.25 119.89 19.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.493 0.663 . . . . 0.0 111.664 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 61' ' ' ASP . 12.5 mt -91.44 -42.49 10.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.013 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HG3' HG23 ' A' ' 16' ' ' VAL . 63.5 tttm -156.04 104.77 2.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.922 -174.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.639 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 6.4 m -89.39 132.42 34.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 169.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -155.94 173.67 16.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.8 150.33 52.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.423 0.63 . . . . 0.0 110.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -133.02 -174.02 3.36 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.252 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -66.68 113.3 4.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.806 ' HG3' HD11 ' A' ' 7' ' ' LEU . 24.9 ttt180 75.84 -17.04 0.54 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.729 175.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.445 ' CD2' ' HE2' ' A' ' 71' ' ' LYS . 40.1 m-85 -122.23 147.77 45.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 112.231 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.653 ' HD1' ' HG2' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -106.81 150.79 25.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.548 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 89.4 m-85 -134.54 107.15 7.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.968 0.413 . . . . 0.0 110.848 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 26' ' ' LEU . 21.9 t -108.59 96.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.397 176.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 18.1 t -76.45 130.69 38.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 46' ' ' ILE . 28.8 m -140.58 152.26 21.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.206 0.527 . . . . 0.0 111.879 -174.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.3 t70 -76.56 105.86 7.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.99 34.4 1.93 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 167.55 -96.63 0.13 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.079 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -137.39 -4.73 1.84 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.799 0.333 . . . . 0.0 110.688 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.02 -29.63 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.653 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.644 ' HG2' ' HD3' ' A' ' 88' ' ' LYS . 47.0 mt-10 -68.41 122.38 18.28 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.352 0.596 . . . . 0.0 111.001 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 96.2 mttt -101.31 106.69 17.9 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.024 -174.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 4.4 t -99.86 178.04 4.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.622 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 40.8 ttmt -156.87 113.04 2.97 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.688 ' HE1' HG21 ' A' ' 33' ' ' ILE . 14.3 m-85 -80.42 114.17 19.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.129 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.081 ' HD2' ' HB3' ' A' ' 96' ' ' TYR . 82.5 tttt -87.98 89.17 7.89 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.746 0.784 . . . . 0.0 109.733 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.414 HG23 ' CE1' ' A' ' 29' ' ' PHE . 51.3 mt -81.77 100.02 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.624 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 24.2 ttp180 -68.29 100.93 1.11 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.653 ' HG2' ' HD1' ' A' ' 56' ' ' TYR . 86.0 mttt -47.19 124.59 6.74 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 124.033 0.833 . . . . 0.0 110.69 -172.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 3' ' ' LEU . 4.6 t70 -23.94 81.77 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.53 1.769 . . . . 0.0 112.9 -170.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.553 HG23 HD21 ' A' ' 7' ' ' LEU . 6.0 p -107.51 106.82 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.439 -171.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.52 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 5.0 m-20 71.65 -58.97 0.56 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.697 -175.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.515 ' HB ' ' HD2' ' A' ' 79' ' ' PRO . 13.2 m -122.53 164.08 28.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.218 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HB2' ' HA2' ' A' ' -1' ' ' GLY . 23.5 Cg_endo -91.6 104.45 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.163 2.575 . . . . 0.0 113.227 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 9.0 mtmt -179.87 162.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.338 0.589 . . . . 0.0 111.698 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.4 ttp -92.15 142.61 27.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.439 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.624 ' HB ' ' HD3' ' A' ' 73' ' ' ARG . 3.6 p -73.33 -53.79 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.651 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 96' ' ' TYR . . . -155.71 159.14 29.04 Favored Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.327 -173.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 84' ' ' ARG . 10.6 ttp180 -125.21 95.81 4.61 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.615 ' HB2' ' OXT' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -114.57 112.0 22.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.26 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 11.2 m -80.97 138.13 36.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 91' ' ' ASP . 15.9 ptm180 -132.94 65.95 1.58 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.842 0.83 . . . . 0.0 109.509 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.644 ' HD3' ' HG2' ' A' ' 66' ' ' GLU . 3.0 ttpm? -63.26 -22.38 66.83 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.355 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -124.28 -76.3 0.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.98 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -125.6 166.49 16.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.654 ' HB2' ' HE2' ' A' ' 96' ' ' TYR . 10.3 p-10 -111.95 -166.65 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.075 0.464 . . . . 0.0 111.508 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.54 -171.9 1.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.505 -173.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.39 -79.49 0.1 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -138.17 -22.71 1.03 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.14 74.74 0.18 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 1.081 ' HB3' ' HD2' ' A' ' 71' ' ' LYS . 26.1 t80 . . . . . 0 N--CA 1.443 -0.786 0 CA-C-O 117.794 -1.098 . . . . 0.0 108.298 -171.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 34.4 t -87.45 96.77 10.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.23 0.538 . . . . 0.0 110.033 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 38.1 mt -101.54 26.12 7.66 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.611 HG22 ' HG ' ' A' ' 3' ' ' LEU . 1.8 mp -69.32 -31.98 51.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.614 -175.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.796 HD13 ' HA ' ' A' ' 6' ' ' ASP . 77.9 mt -132.39 178.01 7.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.101 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -126.23 73.29 1.36 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.78 36.29 37.44 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.555 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.796 ' HA ' HD13 ' A' ' 3' ' ' LEU . 33.3 t70 69.55 97.03 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.493 0.663 . . . . 0.0 112.164 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.541 ' H ' HD22 ' A' ' 3' ' ' LEU . 93.6 mt -126.87 70.98 1.29 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.696 HD11 ' HB2' ' A' ' 54' ' ' ARG . 79.1 mt -64.27 -62.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.944 -175.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 52.87 -99.98 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.89 0.744 . . . . 0.0 110.581 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.06 88.86 4.62 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.321 0.581 . . . . 0.0 109.8 175.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.718 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -104.4 165.1 11.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.934 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt 59.9 93.67 0.04 OUTLIER 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.83 0.706 . . . . 0.0 109.229 -174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.33 -153.92 0.41 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.831 -174.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.5 mt -52.48 148.61 12.04 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.535 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.54 134.84 54.1 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.993 2.462 . . . . 0.0 111.832 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 48' ' ' LYS . 5.6 p 39.87 95.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 123.14 1.448 . . . . 0.0 112.688 -171.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.508 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 57.5 mt -68.6 156.32 7.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 113.094 -1.866 . . . . 0.0 109.431 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -49.74 138.19 14.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -71.25 -19.46 62.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.248 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.39 -45.64 37.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.057 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.481 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 81.4 t80 -58.78 -40.46 84.07 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -63.08 -47.63 86.91 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.127 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -38.55 69.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.25 -47.56 83.2 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.9 mt -56.93 -58.5 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.562 0.696 . . . . 0.0 110.171 175.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.813 HD11 HG11 ' A' ' 58' ' ' VAL . 9.1 mp -58.8 -34.66 71.73 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.835 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.43 -34.0 74.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.438 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -72.58 -26.96 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.969 0.414 . . . . 0.0 111.018 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -105.26 3.25 29.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.546 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -51.41 -50.31 59.93 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.53 0.732 . . . . 0.0 111.852 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.61 -41.92 82.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.831 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.11 -39.7 68.69 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.658 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 94.8 mt -69.42 -20.8 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.51 0.671 . . . . 0.0 110.486 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 58.5 tttp -89.77 -33.13 16.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.499 0.666 . . . . 0.0 109.882 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -67.46 -45.04 77.15 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.311 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.26 -15.35 41.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.475 -173.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.514 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 77.3 m-85 -140.17 -57.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.414 0.626 . . . . 0.0 109.78 177.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 123.38 35.46 0.7 Allowed Glycine 0 C--N 1.32 -0.361 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.367 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.643 HG12 ' H ' ' A' ' 41' ' ' THR . 2.8 t -108.27 146.39 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.795 0.331 . . . . 0.0 110.989 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -98.04 8.91 44.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.621 0.724 . . . . 0.0 110.259 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.643 ' H ' HG12 ' A' ' 39' ' ' VAL . 71.4 p 59.0 -33.69 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.084 1.754 . . . . 0.0 115.253 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -62.83 -29.36 70.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.2 0.524 . . . . 0.0 110.477 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.09 -14.81 60.62 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.185 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.535 HD21 HG11 ' A' ' 39' ' ' VAL . 63.9 mt -81.64 125.0 30.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.292 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG2' HD23 ' A' ' 47' ' ' LEU . 58.3 tttp -81.47 101.21 9.75 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.56 ' HA ' HG12 ' A' ' 60' ' ' VAL . 57.2 mt -69.98 113.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 45' ' ' LYS . 26.1 mt -85.07 -40.05 17.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.583 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HA ' HG23 ' A' ' 16' ' ' VAL . 24.9 ttpp -160.38 103.56 1.42 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.452 -175.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.508 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 9.3 m -76.61 122.14 24.21 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 172.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.8 m -157.3 -172.29 3.94 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.935 -0.478 . . . . 0.0 110.624 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.49 178.77 8.51 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -112.53 -84.13 0.58 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.718 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 27.8 mtmm -140.66 107.74 5.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 167.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.792 ' HG3' HG11 ' A' ' 76' ' ' VAL . 35.6 ttm180 78.1 -18.15 0.52 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.734 0.646 . . . . 0.0 111.463 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.44 123.55 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' A' ' 71' ' ' LYS . 5.4 m-85 -78.13 148.51 34.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.796 0.332 . . . . 0.0 110.409 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.602 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 75.5 m-85 -134.12 94.62 3.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.753 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.813 HG11 HD11 ' A' ' 26' ' ' LEU . 19.3 t -89.06 95.38 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.505 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB2' ' N ' ' A' ' 48' ' ' LYS . 74.2 m -60.08 128.54 37.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.003 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 46' ' ' ILE . 34.8 m -147.57 153.5 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.43 0.634 . . . . 0.0 111.589 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -101.87 130.73 48.41 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 169.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.751 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -92.44 5.09 52.03 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.152 -173.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.97 -19.23 50.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.646 170.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.639 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 32.9 t70 -103.29 18.92 20.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.88 -22.33 12.15 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.751 ' HG3' ' HB3' ' A' ' 62' ' ' ALA . 7.0 pt-20 -70.95 150.48 45.65 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.16 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.594 ' H ' ' HG3' ' A' ' 88' ' ' LYS . 70.1 mmtt -122.26 151.51 41.0 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -175.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 24.0 t -146.58 170.83 16.11 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 85' ' ' LYS . 37.3 ttpt -157.51 89.43 1.04 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CD1' ' HG2' ' A' ' 84' ' ' ARG . 83.7 m-85 -53.81 112.16 0.88 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.941 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.632 ' HD3' ' HB3' ' A' ' 96' ' ' TYR . 54.7 tttt -84.92 80.66 9.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.921 0.867 . . . . 0.0 109.385 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 77.5 mt -77.27 102.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.726 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HB2' HG12 ' A' ' 82' ' ' VAL . 46.4 ttt180 -71.63 111.96 7.35 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.599 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 91.7 mttt -57.16 160.12 3.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.353 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 0' ' ' SER . 17.9 t70 -67.37 74.09 0.14 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.66 0.743 . . . . 0.0 109.705 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.792 HG11 ' HG3' ' A' ' 54' ' ' ARG . 35.6 m -98.75 -4.29 9.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.615 0.722 . . . . 0.0 110.074 -177.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 175.3 -62.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 113.912 -1.495 . . . . 0.0 108.287 -174.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 79' ' ' PRO . 11.2 p -96.9 137.62 21.33 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.478 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 78' ' ' VAL . 45.8 Cg_endo -83.38 42.25 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.591 2.861 . . . . 0.0 112.645 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -137.88 140.59 40.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.228 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.45 ' HA ' ' H ' ' A' ' 73' ' ' ARG . 4.6 tmm? -65.09 123.65 20.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.033 170.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.533 HG12 ' HB2' ' A' ' 73' ' ' ARG . 14.5 p -79.47 -38.56 19.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.368 . . . . 0.0 111.634 -173.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 84' ' ' ARG . . . -144.52 179.45 21.73 Favored Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.954 -170.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.514 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -153.72 93.55 1.68 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -176.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.76 ' HA ' ' CD1' ' A' ' 96' ' ' TYR . 22.1 tptm -73.91 60.82 0.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.78 0.8 . . . . 0.0 112.317 -166.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 0.0 OUTLIER -104.5 111.0 23.5 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.619 ' HD2' ' HA ' ' A' ' 91' ' ' ASP . 19.9 mmt180 -109.61 17.63 21.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.892 0.853 . . . . 0.0 109.785 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.594 ' HG3' ' H ' ' A' ' 67' ' ' LYS . 43.7 mmtm -75.41 -10.24 59.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.284 -1.325 . . . . 0.0 108.633 168.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -114.79 -144.95 0.39 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.223 -1.353 . . . . 0.0 107.625 172.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -58.31 144.09 42.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.905 0.383 . . . . 0.0 111.135 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.619 ' HA ' ' HD2' ' A' ' 87' ' ' ARG . 30.9 t70 -118.92 21.97 12.16 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.425 0.631 . . . . 0.0 111.674 -173.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -127.86 125.23 39.32 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.536 -0.728 . . . . 0.0 111.369 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -155.02 175.88 13.25 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.14 -15.21 14.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.981 0.419 . . . . 0.0 110.024 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -96.05 -85.19 1.72 Allowed Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.543 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.76 ' CD1' ' HA ' ' A' ' 85' ' ' LYS . 6.3 p90 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.171 176.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.595 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 40.4 t -141.39 99.63 3.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 1' ' ' LEU . 0.6 OUTLIER -99.56 109.77 22.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.348 0.594 . . . . 0.0 112.053 -172.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.519 HG23 ' HB3' ' A' ' 74' ' ' LYS . 8.4 tp -173.12 84.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.998 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.908 ' HG ' ' H ' ' A' ' 4' ' ' ASP . 1.2 pt? -122.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.177 -171.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.908 ' H ' ' HG ' ' A' ' 3' ' ' LEU . 8.7 m-20 57.64 19.01 5.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.196 0.522 . . . . 0.0 110.685 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 7' ' ' LEU . . . 111.9 42.94 0.98 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.479 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 57.22 25.89 11.57 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 5' ' ' GLY . 96.0 mt -137.9 166.21 24.61 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 111.332 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.414 HD22 HG12 ' A' ' 2' ' ' ILE . 35.2 tp -178.73 -93.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.737 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 69.3 mttt 55.82 33.11 20.88 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -76.08 -59.62 2.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.83 0.348 . . . . 0.0 110.476 -174.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -93.94 35.27 1.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.675 0.75 . . . . 0.0 110.263 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.639 HD23 ' HE3' ' A' ' 13' ' ' LYS . 29.5 tp -70.63 170.14 12.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.098 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.639 ' HE3' HD23 ' A' ' 12' ' ' LEU . 1.9 mptt 70.09 15.61 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.348 0.659 . . . . 0.0 111.491 176.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.6 mt -103.64 139.47 20.14 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.094 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.39 -56.49 0.66 Allowed 'Trans proline' 0 CA--C 1.51 -0.691 0 C-N-CA 122.521 2.147 . . . . 0.0 110.358 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 48' ' ' LYS . 13.5 p -128.86 128.13 67.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 113.461 -1.7 . . . . 0.0 109.898 172.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 18' ' ' ASP . 24.5 mt -89.61 177.25 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.258 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.577 ' H ' HG22 ' A' ' 17' ' ' ILE . 4.0 m-20 -50.67 120.24 4.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.492 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.7 -21.58 63.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -73.21 -36.93 66.57 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.01 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 68.0 t80 -62.86 -43.96 97.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.563 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -61.58 -45.95 95.28 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 173.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -52.26 -43.93 64.64 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.0 109.915 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.87 -39.89 93.45 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.227 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 16.9 mt -60.02 -60.12 4.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 58' ' ' VAL . 8.1 mp -60.13 -32.6 71.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.819 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.97 -49.33 77.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.935 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -67.0 -50.48 62.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.313 0.577 . . . . 0.0 110.291 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.595 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 5.7 m-85 -83.2 13.4 4.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.675 -173.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 40' ' ' ASP . 36.6 tt0 -61.82 -36.28 80.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 172.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.76 -35.02 76.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.126 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.647 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 20.7 t70 -74.3 -44.6 51.96 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.16 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' HB ' ' A' ' 39' ' ' VAL . 66.2 mt -69.11 -26.74 32.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.406 0.622 . . . . 0.0 110.773 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' CA ' ' A' ' 38' ' ' GLY . 54.0 tttp -83.29 -28.93 28.76 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -69.22 -43.14 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.904 170.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.647 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 63.2 mttm -67.85 -47.92 67.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.285 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.663 ' OH ' ' HD2' ' A' ' 84' ' ' ARG . 44.0 m-85 -128.4 -56.68 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.481 0.658 . . . . 0.0 110.889 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 34' ' ' LYS . . . 117.42 62.35 0.31 Allowed Glycine 0 C--N 1.319 -0.406 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.789 -170.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG23 ' HB2' ' A' ' 37' ' ' TYR . 45.9 t -124.33 154.59 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 120.808 0.337 . . . . 0.0 111.143 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.576 ' HA ' HE21 ' A' ' 30' ' ' GLN . 16.4 t70 -105.15 123.38 47.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.564 173.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.62 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 24.6 p -88.03 -14.61 38.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.001 0.429 . . . . 0.0 111.725 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -79.76 -7.21 58.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.951 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -99.76 -21.85 15.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.681 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.1 mt -73.87 124.43 26.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.652 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 82.6 tttt -83.95 112.79 20.48 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.586 ' HA ' HG12 ' A' ' 60' ' ' VAL . 35.4 mt -79.88 116.54 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.692 0.758 . . . . 0.0 111.171 -176.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.6 mt -85.35 -51.02 6.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.39 -176.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HA ' HG23 ' A' ' 16' ' ' VAL . 39.4 ttpt -146.06 111.13 5.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.827 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.3 m -96.0 127.53 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 m -146.51 163.56 35.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 11.1 pt-20 -132.33 161.53 33.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.063 0.459 . . . . 0.0 110.239 172.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.21 -157.91 0.81 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 54' ' ' ARG . 51.2 mttp -72.13 103.17 3.22 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.679 ' HG2' HG11 ' A' ' 76' ' ' VAL . 53.0 mtt180 74.27 -14.4 0.7 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.695 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -109.85 149.33 30.02 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.947 -0.471 . . . . 0.0 111.984 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 51' ' ' GLU . 2.6 m-85 -116.58 150.4 38.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.738 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.6 m-85 -128.71 103.42 7.06 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.373 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.729 HG21 HD11 ' A' ' 26' ' ' LEU . 13.3 t -106.16 94.64 3.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.709 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -79.96 118.8 22.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -130.48 155.67 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.653 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.512 ' HB2' HD21 ' A' ' 47' ' ' LEU . 36.2 t70 -86.67 103.66 15.34 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.439 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -64.71 -26.81 68.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.826 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.43 -23.95 13.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.97 -0.634 . . . . 0.0 111.731 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 25.9 t70 -81.59 -22.7 37.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.405 0.621 . . . . 0.0 110.21 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.95 -32.33 3.65 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 64' ' ' ASP . 4.6 pt-20 -62.93 136.26 57.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.637 -0.782 . . . . 0.0 111.842 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 89' ' ' ASP . 51.7 mtpt -100.38 93.09 5.48 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.914 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 79.8 m -89.25 132.27 34.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.06 0.457 . . . . 0.0 110.586 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.838 ' HE3' ' HB2' ' A' ' 92' ' ' ASP . 22.8 ttmm -109.18 94.26 4.95 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.301 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 80.1 m-85 -63.4 100.0 0.23 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.923 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.072 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 25.0 tttm -80.69 83.26 6.5 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.994 0.902 . . . . 0.0 109.047 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.872 ' HA ' ' HB2' ' A' ' 81' ' ' MET . 70.0 mt -77.71 93.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.434 -178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.577 ' HB2' HG12 ' A' ' 82' ' ' VAL . 30.4 ttt180 -63.52 123.8 19.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 2' ' ' ILE . 39.6 mttt -59.56 169.08 1.39 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.798 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.721 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 9.9 t0 -72.06 78.36 0.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.229 1.014 . . . . 0.0 108.904 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.679 HG11 ' HG2' ' A' ' 54' ' ' ARG . 6.4 m -106.11 88.33 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.106 174.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.0 t70 84.74 -46.01 0.08 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.891 -175.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -130.96 146.24 61.27 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 111.119 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.482 ' HB3' ' OD2' ' A' ' 75' ' ' ASP . 34.1 Cg_endo -92.18 86.17 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.634 2.889 . . . . 0.0 114.138 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -164.69 161.52 20.8 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.01 -0.431 . . . . 0.0 111.329 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.872 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 2.4 ptp -88.1 119.2 28.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.577 HG12 ' HB2' ' A' ' 73' ' ' ARG . 7.7 p -60.4 -38.02 76.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.916 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.06 -177.68 26.88 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.952 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.663 ' HD2' ' OH ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -164.25 42.8 0.09 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.055 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.846 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 74.7 mttt -60.83 121.98 13.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.612 -172.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.914 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.4 m -83.21 113.03 20.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.478 ' HD3' ' OH ' ' A' ' 96' ' ' TYR . 17.9 mtp180 -117.38 85.59 2.36 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.601 ' HA ' ' HB2' ' A' ' 67' ' ' LYS . 4.8 ttpm? -80.02 109.63 14.65 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.754 -170.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.617 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 7.7 t70 66.87 -156.98 0.24 Allowed 'General case' 0 C--N 1.328 -0.352 0 O-C-N 124.116 0.885 . . . . 0.0 109.763 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' H ' ' CG ' ' A' ' 89' ' ' ASP . 11.2 m-20 63.2 -95.03 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.971 0.415 . . . . 0.0 110.595 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -170.64 149.59 3.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.838 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 11.4 p-10 -110.7 128.95 55.92 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.382 0.611 . . . . 0.0 111.512 -177.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.513 ' HB3' ' H ' ' A' ' 94' ' ' ASP . 3.7 m-20 -103.41 -155.35 0.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.776 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.513 ' H ' ' HB3' ' A' ' 93' ' ' ASP . 3.7 m-20 -118.49 171.56 8.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.284 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' C ' ' HD2' ' A' ' 96' ' ' TYR . . . 85.98 69.59 1.34 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.662 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 1.072 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.854 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 112.194 -0.363 . . . . 0.0 112.194 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.784 ' HA ' ' CE1' ' A' ' 29' ' ' PHE . 34.2 p -149.99 -32.56 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.612 0.206 . . . . 0.0 110.86 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 0' ' ' SER . 0.5 OUTLIER 45.97 23.58 0.19 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.766 1.227 . . . . 0.0 113.326 175.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.604 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 10.5 tp -117.02 39.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.012 0.91 . . . . 0.0 110.55 -171.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.822 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 2.5 pt? -92.96 -40.09 10.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.691 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 12.6 t70 66.57 -60.41 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.97 0.794 . . . . 0.0 110.015 -169.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.02 54.88 0.24 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.105 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.609 ' HA ' HG12 ' A' ' 76' ' ' VAL . 41.3 m-20 49.84 34.91 8.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.748 0.419 . . . . 0.0 111.476 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.582 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 27.8 tp -141.84 176.57 8.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.64 0.257 . . . . 0.0 110.362 -175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.582 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 6.2 mp -73.83 -59.33 2.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.22 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp 63.64 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.229 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -126.21 106.7 9.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.217 0.532 . . . . 0.0 110.042 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 3.3 ptmm? -118.09 -163.42 0.94 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.358 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 29.5 mt -41.46 115.95 0.7 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -130.63 21.15 5.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.53 168.03 13.3 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.722 -172.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -69.77 -153.12 0.03 OUTLIER 'Trans proline' 0 N--CA 1.471 0.162 0 C-N-CA 123.637 2.892 . . . . 0.0 111.856 167.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.682 HG23 ' HG3' ' A' ' 48' ' ' LYS . 5.4 p -51.17 124.31 3.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.886 0.85 . . . . 0.0 111.147 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.547 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 11.9 mt -79.93 151.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.916 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.8 152.47 35.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.829 0.347 . . . . 0.0 111.209 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -64.12 -25.62 68.18 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.813 -178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.64 -46.67 88.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.17 0.188 . . . . 0.0 110.874 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 87.0 t80 -59.79 -38.6 82.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -65.52 -49.86 58.12 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 12.9 mmmm -56.81 -28.67 61.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.775 0.321 . . . . 0.0 111.08 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 14.3 mm-40 -68.85 -52.63 27.77 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 173.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 43.8 mt -53.69 -62.49 1.62 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.621 0.724 . . . . 0.0 110.096 175.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD11 HG11 ' A' ' 58' ' ' VAL . 9.5 mp -59.08 -28.37 66.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.55 -173.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 13.1 t70 -75.24 -46.93 30.64 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.09 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 66.5 mttm -57.51 -35.74 70.64 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.303 0.573 . . . . 0.0 110.558 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.784 ' CE1' ' HA ' ' A' ' 0' ' ' SER . 2.4 m-85 -106.1 12.27 30.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.271 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -60.21 -41.33 92.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 -179.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.89 -32.38 73.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD1' ' HD3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -73.4 -48.06 36.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.358 0.599 . . . . 0.0 110.153 177.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.665 HG12 ' HE1' ' A' ' 81' ' ' MET . 72.0 mt -59.76 -41.48 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.559 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.5 tttt -79.94 -29.59 39.74 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.914 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.88 -50.37 66.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.564 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -76.73 -57.58 3.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.453 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 39' ' ' VAL . 20.7 m-85 -102.32 -27.37 12.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -169.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.33 52.96 3.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.636 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.613 ' HB ' HG22 ' A' ' 33' ' ' ILE . 21.9 t -118.3 149.14 20.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.518 0.199 . . . . 0.0 110.598 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -112.41 106.09 14.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.534 ' HA ' HD22 ' A' ' 44' ' ' LEU . 65.6 p -65.69 -16.66 63.96 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -173.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.3 ttpp -72.06 -23.03 61.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.203 0.525 . . . . 0.0 110.602 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -94.3 -5.98 45.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.767 0.794 . . . . 0.0 109.632 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 41' ' ' THR . 5.1 mp -83.29 138.35 33.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.112 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.55 109.73 22.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.567 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.612 ' HA ' HG12 ' A' ' 60' ' ' VAL . 40.9 mt -79.33 116.96 24.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 110.877 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.439 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 8.1 mt -85.78 -47.32 9.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.086 -175.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.682 ' HG3' HG23 ' A' ' 16' ' ' VAL . 37.7 ttmt -149.6 108.08 3.8 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.481 -174.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.547 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 13.5 m -85.0 125.39 32.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 173.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.3 m -156.55 -170.94 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.464 ' OE2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -156.11 -176.61 6.05 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.69 ' HB3' ' HE2' ' A' ' 57' ' ' TYR . 14.7 t70 -165.45 93.38 0.58 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HG3' HD21 ' A' ' 8' ' ' LEU . 12.4 mptt 68.21 -107.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.921 175.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.539 ' HG2' HG11 ' A' ' 76' ' ' VAL . 48.0 mtt180 -91.93 19.55 6.56 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.931 -0.481 . . . . 0.0 111.32 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 76.2 m-85 -138.83 140.67 38.6 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 -173.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.873 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m-85 -100.3 144.08 29.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 166.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.699 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 71.0 m-85 -129.8 96.32 4.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.706 HG11 HD11 ' A' ' 26' ' ' LEU . 5.6 t -104.43 96.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 8.4 t -74.39 114.61 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 46' ' ' ILE . 12.9 m -133.13 163.93 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.236 0.541 . . . . 0.0 111.368 -177.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -101.96 127.14 48.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.95 -0.97 33.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -173.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.09 -46.3 3.06 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.581 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.54 -38.18 68.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.304 0.573 . . . . 0.0 110.934 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.06 -21.85 2.46 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.339 -176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 88' ' ' LYS . 8.7 pt-20 -79.38 145.8 33.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.248 0.547 . . . . 0.0 110.804 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' H ' ' CG ' ' A' ' 88' ' ' LYS . 46.6 mttp -113.96 116.34 29.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.527 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.5 m -117.94 124.96 49.5 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.824 -171.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.699 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 6.1 tppt? -85.12 96.24 9.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.77 113.5 3.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.309 0.576 . . . . 0.0 110.185 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.737 ' CD ' ' HA ' ' A' ' 96' ' ' TYR . 13.8 ttmm -93.0 80.72 4.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.622 -174.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.873 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 57.9 mt -77.68 76.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.642 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.535 ' CD ' ' HB ' ' A' ' 82' ' ' VAL . 70.8 ttt180 -53.26 125.79 18.83 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 172.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' A' ' 76' ' ' VAL . 96.3 mttt -59.79 171.0 0.98 Allowed 'General case' 0 C--N 1.317 -0.835 0 O-C-N 123.458 0.474 . . . . 0.0 110.263 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.822 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 1.7 t70 -72.12 26.45 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.372 0.606 . . . . 0.0 110.694 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 6' ' ' ASP . 30.1 m -78.65 123.12 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.555 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 18.4 t70 70.58 -66.22 0.3 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.548 0.53 . . . . 0.0 111.232 -176.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.586 ' CG2' ' HD2' ' A' ' 79' ' ' PRO . 3.4 p -104.28 153.9 38.68 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.656 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 71.0 Cg_endo -76.32 148.05 29.87 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.092 1.861 . . . . 0.0 111.515 164.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 4.9 ptpt 73.47 -172.13 0.13 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.235 1.014 . . . . 0.0 113.126 167.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.665 ' HE1' HG12 ' A' ' 33' ' ' ILE . 15.5 mtm -77.23 126.89 31.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.178 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.535 ' HB ' ' CD ' ' A' ' 73' ' ' ARG . 7.1 p -59.46 -27.81 38.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.908 0.385 . . . . 0.0 110.217 173.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.56 -161.64 35.36 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.325 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -157.09 151.16 24.83 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.564 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 14.0 tptp -145.25 106.01 4.13 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.942 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 3.1 m -77.32 111.0 12.52 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 170.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.621 ' HD3' ' CG ' ' A' ' 91' ' ' ASP . 31.2 mtt180 -93.74 29.32 2.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.992 0.425 . . . . 0.0 110.593 -169.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.555 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 12.0 mmmm -76.84 -30.01 56.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.965 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -130.6 -55.23 1.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.705 0.288 . . . . 0.0 111.229 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -116.18 126.76 54.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 111.454 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.621 ' CG ' ' HD3' ' A' ' 87' ' ' ARG . 17.7 t0 -131.7 86.02 2.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.169 0.509 . . . . 0.0 110.982 175.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -162.9 122.18 2.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.574 173.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.668 ' HB3' ' HB3' ' A' ' 96' ' ' TYR . 16.6 t70 -157.43 153.6 27.44 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -95.32 99.97 11.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.206 0.527 . . . . 0.0 109.916 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.5 -47.3 1.03 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -175.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.737 ' HA ' ' CD ' ' A' ' 71' ' ' LYS . 33.1 t80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.106 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.404 ' C ' ' HA ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.478 1.459 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.742 ' HB3' ' HA ' ' A' ' 75' ' ' ASP . 23.4 t -60.9 164.52 4.79 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 122.401 0.281 . . . . 0.0 110.997 -174.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 28' ' ' LYS . 72.9 mt -83.55 61.94 6.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 122.004 0.907 . . . . 0.0 112.425 -168.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 74' ' ' LYS . 15.7 tt -160.77 29.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 169.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.578 ' CD1' ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -72.22 135.46 46.08 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.464 -163.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.31 -18.56 16.03 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 165.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 6' ' ' ASP . . . 134.36 54.02 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.752 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 8.0 m-20 68.86 22.08 7.35 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -174.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -143.0 159.72 41.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.024 -173.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.88 -66.52 1.08 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.643 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HB2' ' HZ2' ' A' ' 9' ' ' LYS . 9.6 mtmp? 66.05 17.11 10.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.86 0.838 . . . . 0.0 108.9 -169.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -152.11 69.39 0.89 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.074 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.61 ' HG3' ' N ' ' A' ' 12' ' ' LEU . 38.5 pttt -49.08 -50.43 36.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.392 -175.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.614 HD12 ' HG3' ' A' ' 51' ' ' GLU . 52.9 tp -153.16 119.08 5.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -169.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -85.67 -77.41 0.3 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.995 0.426 . . . . 0.0 111.362 -176.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 18.8 mt -136.76 176.65 2.63 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.462 -173.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 32.4 Cg_exo -62.69 -147.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.788 2.992 . . . . 0.0 111.615 169.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 49' ' ' THR . 7.1 p -54.75 122.64 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.839 0.828 . . . . 0.0 110.053 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.77 HG13 ' HB ' ' A' ' 49' ' ' THR . 1.1 pt -108.06 -173.25 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.882 -171.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.86 134.16 37.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.74 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 31.1 p30 -72.88 -21.06 60.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.0 tp -75.49 -40.23 57.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.151 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 25' ' ' LEU . 80.1 t80 -61.47 -47.07 87.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -62.64 -43.47 98.94 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.238 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 23.7 tptm -56.42 -36.77 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.306 0.242 . . . . 0.0 110.488 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 4.9 mm-40 -55.81 -53.8 52.29 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 10.2 mp -49.86 -59.01 4.25 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.276 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.727 HD11 HG11 ' A' ' 58' ' ' VAL . 9.2 mp -59.85 -42.17 93.07 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.964 -175.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.97 -33.41 74.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.999 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 22.0 mttp -64.64 -49.99 68.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.391 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' O ' HG13 ' A' ' 33' ' ' ILE . 58.3 m-85 -98.49 12.49 34.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.573 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.418 ' OE1' ' HE2' ' A' ' 42' ' ' LYS . 4.9 pt20 -59.87 -31.91 70.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.452 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.17 -34.52 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.16 -39.68 68.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.752 0.787 . . . . 0.0 109.013 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.595 HG22 ' HB ' ' A' ' 39' ' ' VAL . 92.3 mt -61.42 -43.41 96.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.234 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 24.7 ttpt -82.51 -29.71 30.28 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.669 -174.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.46 -55.81 13.89 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 174.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -79.55 -43.36 23.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.922 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -110.2 -10.09 14.66 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.534 -171.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 68.8 41.2 83.88 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.627 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.595 ' HB ' HG22 ' A' ' 33' ' ' ILE . 10.8 t -118.24 137.91 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 120.903 0.382 . . . . 0.0 111.113 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -103.47 116.24 32.03 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.467 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.4 p -70.42 -10.5 59.27 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -170.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HE2' ' OE1' ' A' ' 30' ' ' GLN . 66.6 mmtt -71.8 -22.85 61.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.937 0.399 . . . . 0.0 110.333 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.61 -31.23 15.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.463 0.649 . . . . 0.0 110.088 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 41' ' ' THR . 85.5 mt -58.49 126.94 29.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.865 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 57.2 tttm -92.4 106.07 18.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.474 174.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.661 ' HA ' HG12 ' A' ' 60' ' ' VAL . 42.7 mt -72.8 107.53 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.774 0.797 . . . . 0.0 110.565 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 61' ' ' ASP . 11.8 mt -80.78 -49.38 11.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.983 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HG3' ' CG2' ' A' ' 16' ' ' VAL . 48.9 tttm -144.79 101.17 3.62 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.479 -173.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.77 ' HB ' HG13 ' A' ' 17' ' ' ILE . 1.6 m -82.39 124.8 30.36 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.2 m -145.81 -179.78 6.93 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.137 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.614 ' HG3' HD12 ' A' ' 12' ' ' LEU . 7.9 pt-20 -155.45 174.17 15.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.514 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -150.91 -170.24 3.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 55' ' ' PHE . 0.1 OUTLIER -59.49 105.71 0.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 77.18 -9.27 1.55 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.804 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.6 m-85 -114.45 151.08 33.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.117 0.484 . . . . 0.0 111.798 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.813 ' HD1' ' HB3' ' A' ' 74' ' ' LYS . 2.8 m-85 -112.14 143.88 42.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.426 164.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.705 ' CE1' ' HA ' ' A' ' 96' ' ' TYR . 32.3 m-85 -131.92 111.67 11.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.413 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.727 HG11 HD11 ' A' ' 26' ' ' LEU . 21.4 t -110.26 108.49 25.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.9 m -91.7 120.86 32.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 46' ' ' ILE . 13.0 m -128.72 154.55 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.572 ' HB2' HD21 ' A' ' 47' ' ' LEU . 60.1 t0 -90.6 114.67 26.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 169.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HA ' HD23 ' A' ' 44' ' ' LEU . . . -72.56 -14.35 61.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.46 -177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.34 -113.13 0.54 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.39 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -132.61 76.27 1.68 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 109.637 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.632 ' O ' ' HE2' ' A' ' 88' ' ' LYS . . . 138.2 -9.71 3.55 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.511 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -82.47 170.17 15.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.908 0.385 . . . . 0.0 110.784 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.825 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 48.1 mtpt -160.54 107.86 1.56 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.842 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 14.7 t -129.66 138.09 51.0 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.701 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.592 ' HD3' ' HB3' ' A' ' 57' ' ' TYR . 31.3 ttmt -111.87 114.28 27.12 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.046 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -76.39 120.65 21.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.119 0.485 . . . . 0.0 109.947 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.789 ' HD2' ' HB2' ' A' ' 96' ' ' TYR . 79.2 tttt -94.01 94.6 8.53 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.075 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' TYR . 60.3 mt -116.41 89.53 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.511 0.672 . . . . 0.0 109.926 -173.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 55' ' ' PHE . 48.7 ttt180 -63.43 99.09 0.19 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.978 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.813 ' HB3' ' HD1' ' A' ' 56' ' ' TYR . 12.1 ptpt -47.45 112.4 0.54 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.801 -173.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.742 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 15.0 t0 37.57 82.16 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.176 177.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.621 HG11 ' HG2' ' A' ' 73' ' ' ARG . 8.7 m -127.26 84.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.102 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 74.12 -69.18 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.027 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.48 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.9 p -86.88 141.94 33.86 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.058 0.456 . . . . 0.0 110.348 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 0' ' ' SER . 87.5 Cg_endo -79.72 86.94 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.11 2.54 . . . . 0.0 112.581 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.2 mtmm 178.86 -175.72 0.22 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.407 0.623 . . . . 0.0 111.841 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 19.9 ptp -84.04 155.33 22.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.438 171.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.506 ' CG1' ' HG2' ' A' ' 71' ' ' LYS . 12.3 p -83.15 -26.04 7.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.91 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -179.86 -173.15 44.63 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.333 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 84' ' ' ARG . 34.7 ttt-85 -156.56 125.71 6.06 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.644 ' HB3' ' CE2' ' A' ' 96' ' ' TYR . 38.1 tttt -149.85 135.74 18.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 25.5 m -97.3 114.96 26.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.507 0.67 . . . . 0.0 111.238 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.566 ' HA ' ' HB3' ' A' ' 91' ' ' ASP . 15.2 ttt180 -101.08 77.77 1.85 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.112 -174.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.825 ' HA ' ' HB2' ' A' ' 67' ' ' LYS . 42.8 tttm -90.21 -45.41 9.1 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.426 -172.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.75 -79.94 0.61 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.426 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -132.1 78.71 1.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.059 0.457 . . . . 0.0 110.628 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.576 ' OD2' ' HG2' ' A' ' 85' ' ' LYS . 28.6 t70 -111.38 88.8 2.88 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.77 154.66 20.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.474 -168.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -163.56 177.86 8.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -76.4 -71.13 0.41 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 96' ' ' TYR . . . -81.14 179.64 53.48 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 168.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.789 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.363 -176.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 CA-C-O 120.41 -0.105 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 5.9 t -81.58 131.89 35.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -174.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 42.3 mt -133.46 12.86 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.674 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.81 HG13 HD22 ' A' ' 3' ' ' LEU . 8.2 tp -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.978 -166.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.986 HD12 ' HB2' ' A' ' 7' ' ' LEU . 2.2 mm? 66.29 57.59 0.74 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.93 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.641 ' HA ' ' O ' ' A' ' 75' ' ' ASP . 3.5 p-10 -60.26 -27.17 67.03 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.808 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.05 19.63 53.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.234 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.723 ' HA ' HG22 ' A' ' 76' ' ' VAL . 29.2 t70 61.18 75.0 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.783 0.801 . . . . 0.0 110.201 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.986 ' HB2' HD12 ' A' ' 3' ' ' LEU . 67.2 mt -130.97 158.0 41.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.193 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -110.29 -47.27 3.31 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.472 175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.4 mttm 64.5 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.934 0.771 . . . . 0.0 110.398 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -130.84 113.92 14.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 2.8 ttpm? -65.16 -47.66 76.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.742 -172.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.8 tt -146.45 117.58 7.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.572 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 88.8 tttt -88.49 -75.95 0.41 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.445 0.64 . . . . 0.0 111.651 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.572 ' HG ' ' HG2' ' A' ' 13' ' ' LYS . 94.2 mt -106.55 148.78 37.41 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.701 -175.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -71.06 120.32 6.94 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 110.08 170.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.608 HG23 ' HA ' ' A' ' 48' ' ' LYS . 3.7 p 40.52 95.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.998 1.38 . . . . 0.0 112.721 -168.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.12 161.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 113.126 -1.852 . . . . 0.0 109.128 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.36 143.22 56.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.406 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -65.72 -19.06 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.995 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.79 -49.82 75.95 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HE2' ' CE1' ' A' ' 56' ' ' TYR . 67.0 t80 -61.35 -38.22 86.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.705 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.463 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -64.33 -51.38 53.06 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 174.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 27.3 mmtp -52.59 -38.96 61.07 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.343 0.257 . . . . 0.0 111.092 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.672 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 10.8 mm-40 -55.22 -55.26 33.29 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 123.257 0.348 . . . . 0.0 111.29 174.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.524 ' O ' ' HD1' ' A' ' 29' ' ' PHE . 38.8 mt -51.84 -61.57 2.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.403 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.662 HD11 HG11 ' A' ' 58' ' ' VAL . 8.2 mp -62.43 -31.81 72.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.961 -172.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.39 -34.07 76.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.733 0.301 . . . . 0.0 111.033 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 49.9 mttm -77.64 -24.0 49.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.89 0.376 . . . . 0.0 110.682 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.908 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 96.7 m-85 -103.51 5.2 36.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -49.17 -47.37 45.9 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.137 0.575 . . . . 0.0 112.404 -173.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.84 -39.26 93.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.875 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -74.9 -40.18 61.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.404 0.621 . . . . 0.0 109.892 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.588 HG22 ' HB ' ' A' ' 39' ' ' VAL . 98.0 mt -61.21 -36.74 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.428 176.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.587 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 53.9 tttm -84.68 -30.91 24.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.238 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.57 -44.12 78.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.907 174.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -85.55 -47.79 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -111.49 -12.12 14.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.3 44.32 52.68 Favored Glycine 0 C--N 1.328 0.114 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.773 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 33' ' ' ILE . 18.8 t -114.77 146.88 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.873 0.368 . . . . 0.0 111.381 -175.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -103.01 112.85 25.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 72.0 p -73.84 -14.4 61.08 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -168.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -81.31 -44.21 17.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.0 109.86 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.42 -21.28 60.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.949 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.721 HD21 HG21 ' A' ' 60' ' ' VAL . 11.1 tp -60.21 133.13 55.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.312 176.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -95.56 104.6 16.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.151 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.544 ' HA ' HG12 ' A' ' 60' ' ' VAL . 43.6 mt -78.73 121.42 31.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.431 0.634 . . . . 0.0 110.71 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 61' ' ' ASP . 12.2 mt -92.2 -51.28 5.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.266 -175.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HA ' HG23 ' A' ' 16' ' ' VAL . 6.0 ttmt -143.44 114.41 7.76 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.646 -176.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.7 m -98.41 130.1 45.04 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.334 173.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 p -163.96 -178.09 5.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.812 0.339 . . . . 0.0 110.599 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 9.8 pt-20 -140.37 159.7 41.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.475 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.509 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 4.3 t70 -138.95 -148.58 0.26 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.874 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 32.2 mmtp -65.45 91.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.044 0.137 . . . . 0.0 110.791 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.698 ' HB3' HG11 ' A' ' 76' ' ' VAL . 62.5 mtt85 71.98 -12.0 0.72 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.062 0.545 . . . . 0.0 112.359 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.47 146.27 33.41 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.208 -0.307 . . . . 0.0 111.082 -176.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.544 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 7.0 m-85 -97.96 142.87 29.16 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 165.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.619 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 66.8 m-85 -126.63 107.55 10.3 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.073 0.464 . . . . 0.0 110.747 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 26' ' ' LEU . 18.1 t -108.97 99.51 8.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.532 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 9.5 t -77.31 122.17 24.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.721 HG21 HD21 ' A' ' 44' ' ' LEU . 28.7 m -130.46 155.44 41.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.008 0.432 . . . . 0.0 111.266 -177.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB2' HD21 ' A' ' 47' ' ' LEU . 10.5 t70 -99.88 122.16 42.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -75.95 -0.96 23.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -173.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.16 -39.0 3.14 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.559 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.87 -15.72 61.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.328 0.585 . . . . 0.0 110.307 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.41 -23.98 5.65 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.671 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 62' ' ' ALA . 8.8 pt-20 -74.81 152.86 38.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.836 0.35 . . . . 0.0 110.672 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.8 mttp -125.13 108.33 11.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.305 0.574 . . . . 0.0 110.122 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.984 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 60.6 m -107.85 133.13 52.66 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.77 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.619 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.0 tppp? -97.13 102.98 14.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.545 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 20.8 m-85 -67.36 117.36 9.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.888 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 31.5 tttm -93.52 72.79 4.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.946 0.879 . . . . 0.0 109.368 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.574 HG12 ' HG2' ' A' ' 81' ' ' MET . 82.9 mt -75.78 91.22 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.991 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.646 ' HB2' HG12 ' A' ' 82' ' ' VAL . 24.9 ttt180 -62.6 135.76 57.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.667 ' HD3' HD23 ' A' ' 3' ' ' LEU . 99.0 mttt -59.73 172.06 0.78 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.786 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.718 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 43.5 t0 -74.5 28.36 0.08 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.783 1.278 . . . . 0.0 108.871 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.723 HG22 ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -74.46 8.87 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 112.967 -1.924 . . . . 0.0 109.901 -174.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 75' ' ' ASP . 27.3 t70 167.46 -43.09 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.842 -168.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -124.33 142.54 40.45 Favored Pre-proline 0 CA--C 1.502 -0.866 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.03 -171.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 0' ' ' SER . 67.5 Cg_endo -89.07 15.26 2.06 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.262 1.975 . . . . 0.0 111.803 171.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.908 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 21.4 mtmt -143.3 -179.75 6.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.482 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' HG12 ' A' ' 72' ' ' ILE . 23.2 mtm -81.21 117.34 21.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.404 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' ' 73' ' ' ARG . 9.2 p -56.73 -32.92 39.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.423 176.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -165.59 -174.21 34.91 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.643 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -171.97 90.89 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.467 ' HB2' ' CG ' ' A' ' 96' ' ' TYR . 24.0 tttp -107.85 131.5 54.42 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.809 -174.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.984 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 4.0 m -84.88 130.41 34.66 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.435 ' HD2' ' OH ' ' A' ' 96' ' ' TYR . 53.1 mtt180 -132.64 83.81 2.1 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 1.7 ttpm? -90.72 15.41 11.16 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.143 -174.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -140.97 -4.82 1.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.266 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -151.6 153.52 34.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -172.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -122.52 -57.01 1.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.736 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -65.56 108.1 1.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.349 0.595 . . . . 0.0 110.553 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.52 176.58 5.1 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.887 -173.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.43 -63.91 1.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.541 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.565 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . -154.23 135.99 5.01 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.085 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.888 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 14.8 m-30 . . . . . 0 C--O 1.245 0.854 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.621 ' H ' ' HA ' ' A' ' 80' ' ' LYS . 47.3 t -58.65 128.4 36.99 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.39 0.276 . . . . 0.0 110.871 -177.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 61.2 mt -130.83 12.15 5.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.933 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.479 HG21 ' HE1' ' A' ' 56' ' ' TYR . 2.9 tp -76.72 -13.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.499 0.666 . . . . 0.0 110.69 -171.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.781 HD21 ' HA ' ' A' ' 7' ' ' LEU . 9.7 mp -125.13 -178.71 4.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.9 57.08 1.56 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.884 0.85 . . . . 0.0 109.758 170.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.55 28.09 52.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.583 ' CG ' ' H ' ' A' ' 7' ' ' LEU . 7.2 p-10 -130.49 -120.33 0.22 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.226 -173.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.781 ' HA ' HD21 ' A' ' 3' ' ' LEU . 42.4 tp 175.69 98.31 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.57 0.623 . . . . 0.0 110.966 -172.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.8 mt -59.81 131.85 52.16 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.818 0.342 . . . . 0.0 110.242 174.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -124.11 -7.52 7.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.152 178.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -61.52 -46.63 89.14 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -100.5 115.3 29.77 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 166.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.777 ' HG ' ' HG3' ' A' ' 13' ' ' LYS . 37.4 tp -178.07 141.61 0.26 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.388 -176.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.777 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 29.0 mtmt 63.91 25.76 14.05 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.957 176.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -99.23 163.15 19.21 Favored Pre-proline 0 N--CA 1.445 -0.721 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.573 -174.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -64.74 -158.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.424 2.75 . . . . 0.0 111.942 169.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.49 116.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 122.002 0.906 . . . . 0.0 110.533 175.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.632 HG12 ' HA ' ' A' ' 50' ' ' SER . 10.7 mm -71.41 161.29 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.743 -177.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -49.45 129.75 19.24 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.161 0.288 . . . . 0.0 110.759 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' HA ' HG21 ' A' ' 46' ' ' ILE . 29.6 p-10 -60.23 -33.97 73.01 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 175.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 20' ' ' LEU . 6.6 mt -58.75 -44.86 90.67 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.99 173.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.644 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 72.3 t80 -63.61 -41.54 98.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.748 0.308 . . . . 0.0 110.334 -177.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -67.13 -45.4 81.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.709 177.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HB2' HG13 ' A' ' 46' ' ' ILE . 7.8 tppt? -63.51 -37.05 85.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.966 0.412 . . . . 0.0 110.099 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.64 -57.47 11.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.358 177.321 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 3.6 mt -51.95 -55.82 17.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.117 0.484 . . . . 0.0 109.758 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.894 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 21.9 mt -50.9 -48.34 60.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.427 176.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.36 -40.1 96.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.946 0.403 . . . . 0.0 110.381 -178.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 11.8 mttp -56.92 -51.1 70.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.343 176.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 0' ' ' SER . 1.3 m-85 -97.72 13.19 31.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.042 -171.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -31.73 69.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.592 0.234 . . . . 0.0 111.427 -173.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.52 -31.17 68.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.8 0.333 . . . . 0.0 110.674 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -78.88 -43.3 25.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.334 0.588 . . . . 0.0 109.566 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG22 ' HB ' ' A' ' 39' ' ' VAL . 97.3 mt -60.62 -34.89 60.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.554 178.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.622 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 1.6 tmtp? -80.9 -40.49 24.57 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 110.051 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.18 -46.3 75.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.995 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.84 -54.81 5.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.463 -176.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.558 ' HB2' HG23 ' A' ' 39' ' ' VAL . 6.5 m-85 -104.98 -31.21 9.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.12 -170.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.51 57.1 2.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.729 -177.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.622 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 22.0 t -124.4 148.4 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.809 0.338 . . . . 0.0 111.055 -175.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.438 ' O ' HD13 ' A' ' 44' ' ' LEU . 11.8 t0 -106.48 112.74 25.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 170.172 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.894 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 45.7 p -74.72 -15.75 60.77 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.83 -173.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.18 -25.52 60.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.152 178.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -86.72 -23.04 25.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.059 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 41' ' ' THR . 3.6 mp -65.66 109.67 2.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.696 -178.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 18.7 tptm -71.71 114.15 9.5 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.212 174.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.641 ' HA ' HG12 ' A' ' 60' ' ' VAL . 10.2 mm -71.21 107.34 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.0 mt -78.71 -57.84 3.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.705 0.764 . . . . 0.0 109.407 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -147.92 110.54 4.71 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.199 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.537 ' HB ' ' HB ' ' A' ' 17' ' ' ILE . 6.5 m -81.87 138.2 35.1 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 171.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.632 ' HA ' HG12 ' A' ' 17' ' ' ILE . 6.1 p -160.57 -175.96 5.3 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 15.2 pt-20 -165.05 167.06 18.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.582 0.706 . . . . 0.0 111.321 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.885 ' HB2' ' HE2' ' A' ' 57' ' ' TYR . 8.1 t70 -114.97 -157.99 0.65 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 171.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.605 ' HA ' HD11 ' A' ' 12' ' ' LEU . 86.0 mttt -68.22 -71.88 0.2 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.957 176.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -90.65 17.46 7.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.379 -173.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 71' ' ' LYS . 97.4 m-85 -146.22 148.32 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -170.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.623 ' CD1' ' HG2' ' A' ' 74' ' ' LYS . 19.2 m-85 -109.46 143.74 38.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.384 169.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.885 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 76.7 m-85 -129.03 92.05 3.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.997 0.427 . . . . 0.0 110.459 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 t -97.33 98.58 7.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.23 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 16.6 m -77.47 124.56 28.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 46' ' ' ILE . 18.7 m -138.55 143.95 31.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -177.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.552 ' HB2' HD21 ' A' ' 47' ' ' LEU . 9.3 t70 -80.39 97.12 6.92 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 173.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.12 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.751 -171.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.08 -11.03 56.65 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.077 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.43 -32.66 71.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.156 0.503 . . . . 0.0 110.244 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.1 -41.09 0.25 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 37.3 mt-10 -115.45 165.84 12.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.251 0.548 . . . . 0.0 111.464 -178.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.766 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 47.2 mttp -82.39 115.84 21.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.702 167.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.1 OUTLIER -96.02 164.84 12.53 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.257 -169.497 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.533 ' HD3' ' CD1' ' A' ' 57' ' ' TYR . 40.4 ttmt -134.74 102.82 5.4 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.484 ' CG ' HD21 ' A' ' 26' ' ' LEU . 16.0 m-85 -69.03 106.41 2.77 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.633 0.73 . . . . 0.0 110.179 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.7 ' HD3' ' HA ' ' A' ' 96' ' ' TYR . 17.5 tttt -95.42 82.38 3.68 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.838 -175.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.807 HG12 ' HG2' ' A' ' 81' ' ' MET . 52.5 mt -78.68 120.45 29.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.721 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 58.4 ttt180 -79.68 25.01 0.35 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.407 0.622 . . . . 0.0 109.511 -175.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.623 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 93.2 mttt 51.12 -165.46 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.279 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.672 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 11.9 t70 -103.12 47.48 0.88 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 167.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 6' ' ' ASP . 5.3 p -77.64 -2.29 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.14 -174.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.6 t70 173.0 -54.48 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.983 -168.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 32.4 m -92.15 151.49 41.77 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.242 175.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.5 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 61.6 Cg_endo -92.71 32.21 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.583 2.855 . . . . 0.0 112.558 174.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.621 ' HA ' ' H ' ' A' ' 0' ' ' SER . 63.8 pttt -159.16 -157.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.02 -175.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.807 ' HG2' HG12 ' A' ' 72' ' ' ILE . 5.2 mtm -107.6 132.13 53.62 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 10.4 p -77.81 -37.27 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.209 0.528 . . . . 0.0 110.177 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.603 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -126.85 164.67 20.34 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.539 -174.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.99 25.71 0.06 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -175.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.704 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 60.7 mmtt -88.4 131.78 34.71 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.285 -167.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.932 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 6.5 m -83.68 136.85 34.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 173.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.575 ' HG3' ' HB3' ' A' ' 91' ' ' ASP . 8.1 ttt180 -129.6 83.21 2.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 0.0 109.977 -172.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.766 ' HE2' ' HB2' ' A' ' 67' ' ' LYS . 33.7 mmtm -140.53 -38.26 0.44 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.108 -176.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -126.08 73.23 1.34 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.104 0.478 . . . . 0.0 110.175 174.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.5 t70 67.11 117.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.002 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 87' ' ' ARG . 22.6 t70 -140.66 141.6 35.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.229 -178.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -162.27 125.04 2.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.848 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.681 ' HB3' ' HB3' ' A' ' 96' ' ' TYR . 12.6 t70 -146.33 164.02 33.69 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.36 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.32 -26.83 24.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.259 0.552 . . . . 0.0 110.426 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.419 ' CA ' HG22 ' A' ' 82' ' ' VAL . . . -109.76 57.12 0.44 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 177.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.704 ' CD2' ' HB2' ' A' ' 85' ' ' LYS . 24.7 t80 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.434 -171.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.684 ' HB2' ' HZ ' ' A' ' 29' ' ' PHE . 29.4 t -81.68 -47.93 12.33 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 72.8 mt 64.3 13.38 7.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.299 173.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 2' ' ' ILE . 9.6 tp -115.0 87.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 122.238 1.018 . . . . 0.0 109.716 176.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.902 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 1.6 pt? -128.23 -48.14 1.32 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.475 -172.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.506 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.1 m-20 66.34 -64.15 0.23 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 124.017 0.823 . . . . 0.0 110.135 -171.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.33 70.62 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 177.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 35.5 t70 61.72 87.33 0.1 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.234 0.54 . . . . 0.0 110.419 -172.066 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 54' ' ' ARG . 13.3 mt 75.29 163.99 0.26 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.068 177.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.63 ' HG ' ' H ' ' A' ' 9' ' ' LYS . 2.0 pt? -153.95 -55.11 0.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.709 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.63 ' H ' ' HG ' ' A' ' 8' ' ' LEU . 10.2 mtmp? 75.69 -54.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 167.334 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.44 8.13 35.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -169.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.559 ' HB2' HD12 ' A' ' 8' ' ' LEU . 30.7 ttpt -61.82 -72.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.999 0.428 . . . . 0.0 110.754 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.436 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 26.9 mt -109.03 124.8 51.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.767 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 pttt -138.25 29.3 2.48 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 -171.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -102.02 143.09 25.9 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.461 -177.22 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 26.9 Cg_exo -65.19 130.03 24.46 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.924 2.416 . . . . 0.0 111.72 175.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' A' ' 48' ' ' LYS . 10.0 p 39.83 99.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 123.367 1.556 . . . . 0.0 114.057 -177.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.7 mt -80.06 160.03 4.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.637 176.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.22 157.42 31.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 111.157 -173.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.0 p30 -65.26 -20.01 66.23 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.18 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.5 tp -65.66 -43.94 87.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.775 178.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' HE2' ' HE1' ' A' ' 56' ' ' TYR . 73.8 t80 -64.05 -39.04 93.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.335 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA2' HD12 ' A' ' 25' ' ' LEU . . . -71.66 -32.89 63.9 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.143 176.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 23.8 tptt -62.63 -40.75 97.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.6 mm-40 -58.97 -51.49 69.81 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.101 175.048 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.514 HD12 ' HA2' ' A' ' 22' ' ' GLY . 84.3 mt -51.71 -64.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 175.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.879 ' HB3' ' HB ' ' A' ' 41' ' ' THR . 18.8 mt -55.75 -31.64 62.73 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.798 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -65.25 -45.69 83.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.069 0.461 . . . . 0.0 110.489 175.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 56.3 mttm -67.92 -30.57 69.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.684 ' HZ ' ' HB2' ' A' ' 0' ' ' SER . 79.7 m-85 -99.42 1.21 44.0 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -53.64 -39.76 65.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.673 0.273 . . . . 0.0 111.093 -177.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.5 -36.03 82.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.632 ' OD1' ' HE2' ' A' ' 36' ' ' LYS . 15.0 t70 -80.62 -40.56 25.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.904 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' CD1' HD23 ' A' ' 26' ' ' LEU . 80.8 mt -67.12 -30.26 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.412 176.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 44.5 tttp -83.48 -23.72 32.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.514 0.673 . . . . 0.0 109.724 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.28 -45.7 65.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.336 170.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.632 ' HE2' ' OD1' ' A' ' 32' ' ' ASP . 51.3 mttm -82.13 -27.02 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.888 -173.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.718 ' HB2' HG23 ' A' ' 39' ' ' VAL . 49.1 m-85 -134.06 -33.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.029 0.443 . . . . 0.0 111.416 -177.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 97.09 19.96 24.78 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.42 -178.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.718 HG23 ' HB2' ' A' ' 37' ' ' TYR . 38.8 t -82.02 153.49 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.146 0.498 . . . . 0.0 111.908 -174.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.507 ' OD2' ' HB3' ' A' ' 42' ' ' LYS . 26.8 t70 -108.34 106.96 17.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.91 169.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.879 ' HB ' ' HB3' ' A' ' 26' ' ' LEU . 40.6 p -69.11 -16.2 63.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.062 -172.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.507 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 7.2 ttpm? -63.89 -21.59 66.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.839 179.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -105.16 -7.36 19.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 41' ' ' THR . 76.5 mt -66.86 117.26 8.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.851 -179.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.605 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 87.4 tttt -74.58 97.04 3.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.094 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.587 ' HA ' HG12 ' A' ' 60' ' ' VAL . 53.0 mt -77.13 122.0 30.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.638 0.732 . . . . 0.0 111.133 -175.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -94.16 -50.02 5.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.367 -175.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HA ' HG23 ' A' ' 16' ' ' VAL . 34.5 ttmt -145.64 121.36 10.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.271 -173.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.434 HG23 HG22 ' A' ' 58' ' ' VAL . 19.0 m -113.98 135.31 54.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.0 m -160.32 174.82 13.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.686 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 12.5 pt-20 -131.25 150.98 51.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.459 0.647 . . . . 0.0 110.322 172.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.27 -151.62 0.48 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -64.75 -84.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.955 0.407 . . . . 0.0 110.114 177.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.609 ' HA ' HD21 ' A' ' 7' ' ' LEU . 50.7 mtt180 -87.32 11.43 14.39 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.821 -0.55 . . . . 0.0 111.011 178.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 4.2 m-85 -133.18 161.0 35.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.125 -1.03 . . . . 0.0 113.579 -163.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.686 ' CE1' ' HB3' ' A' ' 51' ' ' GLU . 5.5 m-85 -124.18 149.65 46.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.594 169.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.623 ' HB3' ' HD2' ' A' ' 69' ' ' LYS . 77.1 m-85 -134.66 102.51 5.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.676 0.274 . . . . 0.0 110.945 -178.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 49' ' ' THR . 9.9 t -112.51 103.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.535 178.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 m -87.28 125.02 33.96 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 46' ' ' ILE . 10.1 m -131.19 152.55 37.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.226 0.536 . . . . 0.0 111.507 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 10.6 t70 -90.34 121.42 32.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 171.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.8 13.86 1.97 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.04 -53.31 4.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.338 176.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.55 -23.4 66.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.299 0.571 . . . . 0.0 110.679 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.44 -7.35 7.97 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.712 -178.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.577 ' HA ' ' CD ' ' A' ' 88' ' ' LYS . 36.6 mt-10 -75.47 150.99 38.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 175.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 67' ' ' LYS . 34.5 ttmt -127.01 107.2 9.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -176.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 34.4 m -106.35 132.06 52.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.339 0.59 . . . . 0.0 110.94 -175.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.623 ' HD2' ' HB3' ' A' ' 57' ' ' TYR . 5.5 tppt? -101.07 100.79 11.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 175.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 67.3 m-85 -75.16 106.98 6.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.074 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.855 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 81.1 tttt -98.76 108.86 21.65 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.901 0.857 . . . . 0.0 110.3 -178.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 71.0 mt -105.82 114.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.937 -178.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.803 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 28.9 ttp180 -79.35 29.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.366 0.603 . . . . 0.0 110.485 -172.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.566 ' HG2' ' CD2' ' A' ' 56' ' ' TYR . 84.8 mttt 57.56 -178.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.088 -178.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.902 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 2.0 t70 -87.31 42.2 1.02 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.281 0.563 . . . . 0.0 109.98 -174.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 73' ' ' ARG . 22.7 m -76.91 105.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.109 0.481 . . . . 0.0 110.046 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.7 t70 69.91 -64.41 0.35 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.294 -175.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -84.96 151.37 57.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.788 0.327 . . . . 0.0 110.19 177.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.725 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . 60.9 Cg_endo -86.37 29.3 0.51 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.039 2.493 . . . . 0.0 111.428 174.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.423 ' HA ' ' HE2' ' A' ' 29' ' ' PHE . 1.9 ttmm -132.44 -158.6 0.9 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.376 0.608 . . . . 0.0 111.751 -169.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.522 ' SD ' ' HD3' ' A' ' 84' ' ' ARG . 3.6 ptt? -118.53 166.68 12.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.068 -176.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.803 ' HB ' ' HB2' ' A' ' 73' ' ' ARG . 3.6 p -81.55 -52.35 13.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.859 177.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 71' ' ' LYS . . . -177.78 128.21 1.27 Allowed Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.247 -177.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.522 ' HD3' ' SD ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -97.83 118.85 35.31 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 173.382 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.903 ' HD2' ' HA ' ' A' ' 96' ' ' TYR . 35.9 tttt -122.49 114.71 21.06 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.982 -169.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 22.6 m -72.22 122.88 21.81 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.158 173.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.477 ' CZ ' ' HA ' ' A' ' 92' ' ' ASP . 11.2 ptm180 -126.61 78.26 1.77 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.597 -1.183 . . . . 0.0 107.873 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.577 ' CD ' ' HA ' ' A' ' 66' ' ' GLU . 29.7 ttpt -74.34 -12.84 60.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.134 -173.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.19 174.35 9.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.585 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -85.53 -20.97 28.83 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -174.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.46 136.09 57.41 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.473 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' HA ' ' CZ ' ' A' ' 87' ' ' ARG . 38.7 t70 -89.98 108.42 19.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.022 0.439 . . . . 0.0 110.599 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 96' ' ' TYR . 7.0 t70 -77.86 154.08 32.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.487 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -124.81 -10.22 7.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.912 0.387 . . . . 0.0 111.025 178.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.56 95.25 0.41 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.903 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 1.7 m-85 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.16 -174.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.765 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 38.8 m -76.31 66.76 2.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.463 0.649 . . . . 0.0 109.586 175.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 1' ' ' LEU . 3.7 pp -88.5 140.24 29.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.749 -169.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 2' ' ' ILE . 8.5 tp -166.5 45.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.889 1.328 . . . . 0.0 107.487 175.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.452 ' HG ' ' CG ' ' A' ' 75' ' ' ASP . 13.7 mt -82.25 -174.41 5.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.584 -171.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 166.79 -32.0 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 112.523 -2.126 . . . . 0.0 106.076 -174.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.93 80.66 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.334 176.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 7' ' ' LEU . 23.4 t70 73.49 11.03 4.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 121.236 0.541 . . . . 0.0 109.724 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 42.2 mt 82.86 172.95 0.09 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.427 173.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -148.7 119.71 7.68 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.139 -174.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -80.34 95.45 6.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.182 -176.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -85.84 -86.43 0.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.686 -178.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -171.69 138.43 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 111.217 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.08 115.14 7.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.203 172.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HG2' ' HG ' ' A' ' 14' ' ' LEU . 39.9 ttmt -81.72 106.61 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.522 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.64 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 13.0 mt 58.88 173.99 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 123.487 0.715 . . . . 0.0 112.152 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 14' ' ' LEU . 38.8 Cg_endo -69.8 -19.97 35.24 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.91 1.74 . . . . 0.0 111.495 171.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' A' ' 48' ' ' LYS . 6.7 t -138.49 113.2 8.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 113.683 -1.599 . . . . 0.0 108.9 176.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.65 HG22 ' H ' ' A' ' 18' ' ' ASP . 12.3 mt -68.77 175.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.942 -178.009 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.65 ' H ' HG22 ' A' ' 17' ' ' ILE . 9.0 m-20 -51.63 -20.71 2.14 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.663 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 96.3 m-20 73.1 -40.09 0.46 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.389 0.676 . . . . 0.0 110.999 -174.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.1 tp -65.59 -35.77 81.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 169.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' O ' HD13 ' A' ' 25' ' ' LEU . 90.9 t80 -59.13 -42.48 90.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 25' ' ' LEU . . . -65.55 -42.65 95.53 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 175.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -51.78 -41.65 61.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.461 0.304 . . . . 0.0 110.857 176.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 4.4 mm-40 -57.84 -54.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.001 173.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 21' ' ' PHE . 10.8 mp -47.68 -63.93 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.289 174.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.66 HD11 HG21 ' A' ' 58' ' ' VAL . 9.6 mp -59.84 -32.18 70.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.28 -174.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.19 -42.72 93.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 52.0 mttm -71.73 -42.48 67.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 110.646 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.765 ' CD1' ' HA ' ' A' ' 0' ' ' SER . 2.0 m-30 -87.38 -0.48 56.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.378 -173.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 8.0 tt0 -56.43 -36.97 69.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.132 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.15 -36.08 65.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.009 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.86 -50.08 18.24 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.315 0.579 . . . . 0.0 109.832 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.655 HG22 ' HB ' ' A' ' 39' ' ' VAL . 45.8 mt -62.79 -31.07 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.993 -177.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 66.5 tttt -89.11 -29.17 19.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.43 -174.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.39 -51.77 33.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.465 0.65 . . . . 0.0 110.566 171.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -75.17 -43.1 54.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.671 -172.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.652 ' HB2' HG23 ' A' ' 39' ' ' VAL . 15.9 m-85 -120.07 -17.95 8.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.824 0.345 . . . . 0.0 111.416 -173.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 81.36 30.74 36.09 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.326 178.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.655 ' HB ' HG22 ' A' ' 33' ' ' ILE . 16.6 t -92.6 147.33 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.954 0.407 . . . . 0.0 111.418 -175.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -108.99 120.67 43.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.536 HG22 HD12 ' A' ' 44' ' ' LEU . 33.4 p -80.07 -13.78 59.03 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -170.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -74.81 -20.97 59.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.506 0.669 . . . . 0.0 109.566 174.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -86.77 -41.17 14.33 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.352 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 41' ' ' THR . 91.6 mt -53.56 109.49 0.45 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.068 -1.424 . . . . 0.0 111.246 177.065 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 79.1 tttt -77.36 108.89 10.82 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.55 ' HA ' HG12 ' A' ' 60' ' ' VAL . 42.8 mt -73.54 115.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.482 0.658 . . . . 0.0 110.171 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.8 mt -87.33 -39.11 15.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.196 -175.303 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.52 ' HG3' HG22 ' A' ' 16' ' ' VAL . 17.0 ttpp -156.57 104.98 2.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.003 -176.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.663 ' OG1' ' HA ' ' A' ' 19' ' ' ASN . 14.8 m -83.9 128.78 34.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 172.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -155.17 179.2 9.37 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 12.2 pt-20 -155.35 -177.07 6.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.851 176.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.641 ' OD1' ' HG2' ' A' ' 53' ' ' LYS . 10.4 t70 -132.27 -88.01 0.45 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.641 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 40.9 mmtm -128.57 -81.52 0.58 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 54' ' ' ARG . 67.5 mtt85 -88.69 23.7 2.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 38.8 m-85 -142.95 132.37 23.51 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -169.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.886 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 30.3 m-85 -101.65 149.77 23.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 166.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -134.36 97.47 3.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.859 0.361 . . . . 0.0 110.091 177.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.66 HG21 HD11 ' A' ' 26' ' ' LEU . 14.0 t -105.16 96.64 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.831 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 11.8 t -76.03 126.5 31.11 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 46' ' ' ILE . 26.9 m -135.65 150.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.457 0.646 . . . . 0.0 112.263 -174.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 45' ' ' LYS . 12.5 t70 -99.14 123.93 43.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.092 173.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.68 4.94 10.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.883 -171.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.98 -174.07 45.76 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -178.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.81 -36.69 79.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.037 0.446 . . . . 0.0 110.747 -177.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.67 -6.4 6.62 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.75 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.656 ' HA ' ' CD ' ' A' ' 88' ' ' LYS . 2.6 mp0 -75.17 119.74 19.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.298 0.571 . . . . 0.0 111.157 -178.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.576 ' H ' ' HG2' ' A' ' 88' ' ' LYS . 7.4 ttpm? -145.1 117.0 8.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.507 -178.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 3.3 m -127.96 159.97 33.33 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.451 -175.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 38.3 ttmt -123.62 106.19 10.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 52.6 m-85 -73.45 96.46 2.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.875 0.845 . . . . 0.0 110.51 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.017 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 50.8 tttp -82.95 79.64 9.25 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.312 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.886 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 45.0 mt -75.5 105.25 4.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.398 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.559 ' HD2' HG11 ' A' ' 82' ' ' VAL . 43.1 ttt-85 -74.34 9.72 1.57 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.612 0.72 . . . . 0.0 110.184 -175.061 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 72' ' ' ILE . 94.6 mttt 63.5 177.05 0.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.482 176.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.856 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 8.0 t0 -80.68 64.35 5.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 177.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 4.0 m -85.98 87.16 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.092 175.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 5.1 m-20 74.69 -53.58 0.67 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -174.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.3 p -114.82 135.57 22.42 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.856 ' HA ' ' HA ' ' A' ' 75' ' ' ASP . 23.7 Cg_endo -65.59 -50.78 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.052 2.502 . . . . 0.0 112.918 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -46.71 128.97 11.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -169.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.766 ' HB2' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 159.48 6.57 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.897 -175.229 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.559 HG11 ' HD2' ' A' ' 73' ' ' ARG . 3.8 p -103.62 -27.97 3.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.573 177.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 1.017 ' HA3' ' HB3' ' A' ' 71' ' ' LYS . . . -118.76 135.61 11.58 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.946 -170.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -155.23 19.03 0.42 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.033 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.581 ' HB2' ' HB3' ' A' ' 96' ' ' TYR . 10.9 tttm -71.53 117.83 13.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.196 -168.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.849 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 60.6 m -84.42 111.03 19.09 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -86.77 66.84 9.64 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 122.091 0.948 . . . . 0.0 109.425 179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.656 ' CD ' ' HA ' ' A' ' 66' ' ' GLU . 51.6 mtmt -92.57 -29.86 15.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.394 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.72 -61.4 1.94 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.583 173.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -168.11 -174.06 2.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -123.08 169.11 11.54 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -108.12 -80.9 0.57 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.497 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.6 t70 179.99 -56.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -176.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -155.99 163.49 39.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.536 176.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.91 75.07 1.02 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -173.126 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.637 ' H ' ' HD3' ' A' ' 71' ' ' LYS . 27.7 m-85 . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.772 -175.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.577 ' HA2' HD22 ' A' ' 25' ' ' LEU . . . . . . . . 0 N--CA 1.487 2.051 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.551 ' HB3' ' HZ ' ' A' ' 29' ' ' PHE . 26.8 t -103.07 2.24 34.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.797 0.808 . . . . 0.0 109.161 174.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 3' ' ' LEU . 89.2 mt -85.55 11.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.088 175.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.462 HD13 ' HD3' ' A' ' 74' ' ' LYS . 9.2 tt -78.06 65.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.013 170.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.551 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -103.29 154.72 19.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.931 -164.732 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.676 ' HB3' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -174.09 5.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.185 169.149 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.84 62.87 0.71 Allowed Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.852 -179.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.1 t70 70.29 25.45 4.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.117 0.961 . . . . 0.0 108.672 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.676 HD12 ' HB3' ' A' ' 4' ' ' ASP . 84.0 mt -110.21 109.47 19.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.992 -177.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.723 HD12 ' HD2' ' A' ' 74' ' ' LYS . 2.0 mm? -64.98 -56.34 13.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.134 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 67.52 -62.58 0.33 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.831 0.707 . . . . 0.0 111.178 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -100.52 85.8 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.082 0.468 . . . . 0.0 110.576 176.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HA ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -112.72 132.05 55.38 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 169.224 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 14' ' ' LEU . 67.0 mt -82.8 -169.9 2.72 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.295 0.569 . . . . 0.0 111.89 -171.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.76 21.23 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.449 -170.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.443 HD11 HD13 ' A' ' 12' ' ' LEU . 1.3 pp -138.16 162.24 54.91 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.888 -167.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.74 -147.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.86 3.04 . . . . 0.0 112.699 171.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.618 ' HB ' ' HG3' ' A' ' 48' ' ' LYS . 11.0 p -47.09 130.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.235 175.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -97.78 -73.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.446 -175.938 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.653 ' H ' ' HB ' ' A' ' 49' ' ' THR . 5.4 m-20 64.72 12.23 7.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.776 177.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HB3' ' HD2' ' A' ' 21' ' ' PHE . 58.2 t30 -81.53 61.16 4.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.14 3.0 0.9 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.312 0.645 . . . . 0.0 110.7 -174.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.784 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 4.4 m-85 -63.69 -61.31 2.39 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.653 -175.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.42 ' N ' HG21 ' A' ' 49' ' ' THR . . . -62.26 -35.59 91.81 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.847 -177.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -68.2 -36.72 80.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.834 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 3.1 mm-40 -62.3 -53.95 47.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.04 0.536 . . . . 0.0 111.231 175.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 13.0 mt -52.74 -62.59 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.109 178.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.631 HD22 HG22 ' A' ' 41' ' ' THR . 33.4 mt -58.7 -26.8 64.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.053 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.0 -43.55 82.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 177.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 62.2 mttm -72.68 -41.11 65.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.829 -179.162 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.551 ' HZ ' ' HB3' ' A' ' 0' ' ' SER . 96.8 m-85 -90.19 0.46 57.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.757 -176.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 34.1 tt0 -50.9 -44.24 59.9 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 120.966 0.412 . . . . 0.0 110.792 177.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.72 -31.68 73.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.512 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -84.98 -41.4 15.88 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.51 0.672 . . . . 0.0 110.184 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.681 HG22 ' HB ' ' A' ' 39' ' ' VAL . 95.9 mt -63.07 -34.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.181 177.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.591 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 45.6 tttp -81.76 -34.23 30.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.509 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.94 -47.37 77.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.361 174.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -95.36 -42.45 8.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -172.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.626 ' HB2' HG23 ' A' ' 39' ' ' VAL . 3.3 m-85 -111.06 -13.11 14.11 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.502 -170.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.5 50.09 33.9 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.27 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.681 ' HB ' HG22 ' A' ' 33' ' ' ILE . 23.6 t -116.79 152.69 18.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.933 0.397 . . . . 0.0 110.921 -176.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -111.69 118.13 34.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.631 HG22 HD22 ' A' ' 26' ' ' LEU . 40.1 p -75.2 -14.29 60.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.033 0.444 . . . . 0.0 111.734 -173.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -76.93 -17.46 58.9 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.981 176.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -99.65 -16.21 18.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.372 0.606 . . . . 0.0 109.849 -179.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 41' ' ' THR . 96.6 mt -68.09 121.4 16.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.727 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 61' ' ' ASP . 53.4 tptt -85.03 103.08 13.74 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.869 176.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.604 ' HA ' HG12 ' A' ' 60' ' ' VAL . 34.1 mt -72.77 114.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.459 0.647 . . . . 0.0 109.96 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 61' ' ' ASP . 14.5 mt -87.13 -35.92 18.37 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.773 -177.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.618 ' HG3' ' HB ' ' A' ' 16' ' ' VAL . 4.1 ttmp? -159.06 108.95 1.95 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.577 -177.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.653 ' HB ' ' H ' ' A' ' 18' ' ' ASP . 20.0 m -86.1 134.42 33.82 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 p -162.57 -179.24 6.76 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.383 . . . . 0.0 110.517 176.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . 5.5 pt-20 -155.67 164.37 38.69 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.328 176.165 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' HB3' ' HE2' ' A' ' 57' ' ' TYR . 10.2 t70 -157.5 108.61 2.29 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 56.88 -115.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.097 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.476 ' HG2' HD11 ' A' ' 8' ' ' LEU . 46.4 mtt85 -88.55 16.24 6.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -172.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -138.35 137.6 37.5 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.924 -171.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.572 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 8.0 m-85 -98.13 140.39 32.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.661 168.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.537 ' HB3' ' HD3' ' A' ' 69' ' ' LYS . 97.4 m-85 -124.57 96.49 4.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.415 -178.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 69' ' ' LYS . 3.4 t -103.26 90.04 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.731 0.3 . . . . 0.0 110.607 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 7.6 t -72.97 120.86 19.18 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.8 m -133.35 155.91 41.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.204 0.526 . . . . 0.0 111.048 -177.005 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.496 ' HB2' HD21 ' A' ' 47' ' ' LEU . 16.9 t0 -100.55 127.84 46.79 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.026 173.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -7.33 59.21 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.58 -81.61 1.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.015 172.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.21 -22.94 61.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.038 0.447 . . . . 0.0 111.352 -175.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.3 -90.01 0.75 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.821 -174.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -100.38 177.56 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.726 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . 39.9 ttmt -128.52 126.51 40.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 167.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 1.063 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 8.6 t -134.14 -177.83 4.76 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.451 0.643 . . . . 0.0 111.316 -167.31 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 37.6 ttmt -159.39 90.23 0.94 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.494 ' CD1' HD21 ' A' ' 26' ' ' LEU . 72.2 m-85 -57.12 111.66 1.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.842 -176.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 56' ' ' TYR . 42.9 tttt -94.5 77.36 3.84 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.325 -176.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.673 ' HA ' ' CB ' ' A' ' 81' ' ' MET . 78.3 mt -80.26 92.48 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.572 -177.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 1.04 ' HD2' ' HB ' ' A' ' 82' ' ' VAL . 49.3 ttt180 -56.83 127.48 31.9 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.259 176.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.723 ' HD2' HD12 ' A' ' 8' ' ' LEU . 95.2 mttt -63.57 179.26 0.48 Allowed 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' CB ' ' HA ' ' A' ' 3' ' ' LEU . 5.9 t70 -61.43 94.02 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.754 0.788 . . . . 0.0 110.516 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 74' ' ' LYS . 12.4 m -138.29 84.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.814 174.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.2 t70 76.9 -49.48 0.55 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.826 -174.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 m -96.67 150.25 36.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.409 0.623 . . . . 0.0 111.136 176.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -95.21 29.11 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.245 3.297 . . . . 0.0 110.923 169.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -137.96 -176.6 4.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.557 -171.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.673 ' CB ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.17 146.07 23.95 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.875 179.614 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.04 ' HB ' ' HD2' ' A' ' 73' ' ' ARG . 12.6 p -83.0 -26.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.321 0.581 . . . . 0.0 110.282 179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.92 -171.31 23.71 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.036 -175.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 24.0 ptt-85 -161.17 71.05 0.39 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -176.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.702 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 18.5 tptm -59.77 80.64 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.86 -167.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.063 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 27.8 m -92.54 -116.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 90' ' ' ASP . 64.6 mtt180 75.47 -17.2 0.52 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.196 0.598 . . . . 0.0 110.772 177.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.726 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 63.6 tttp 75.58 -47.28 0.59 Allowed 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.982 0.801 . . . . 0.0 112.225 168.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -149.38 39.56 0.82 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.43 0.633 . . . . 0.0 109.812 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 39.0 t70 -153.69 148.79 26.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.835 -176.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -106.2 156.25 18.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.347 -177.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.47 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 7.4 t70 -96.64 -158.61 0.67 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -176.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -110.57 101.7 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.18 -0.325 . . . . 0.0 111.682 -175.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.0 t70 65.83 -79.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.699 0.8 . . . . 0.0 111.54 176.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.7 -173.97 38.49 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 174.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.702 ' CE1' ' HA ' ' A' ' 85' ' ' LYS . 21.7 t80 . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.709 -176.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 1' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.658 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 56.4 m -70.73 98.28 1.5 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' -1' ' ' GLY . 31.0 mt -102.61 -0.55 31.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.357 -174.231 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.601 HG23 ' HB2' ' A' ' 74' ' ' LYS . 5.3 tp -78.28 89.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.752 0.787 . . . . 0.0 109.877 178.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.955 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -71.23 0.87 6.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.054 -175.448 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -77.45 39.06 0.25 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.278 1.037 . . . . 0.0 109.313 176.145 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.569 ' CA ' HG12 ' A' ' 76' ' ' VAL . . . -128.73 -53.81 0.11 Allowed Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.699 ' N ' ' HA ' ' A' ' 76' ' ' VAL . 28.9 t70 -53.56 -35.78 61.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 166.179 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 7' ' ' LEU . 3.6 mm? -92.78 -57.02 2.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.014 172.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.6 tp 56.99 72.07 0.53 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 124.023 0.827 . . . . 0.0 110.962 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.28 -26.4 9.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.067 -177.037 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -154.22 70.97 0.82 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.393 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HB2' ' OE2' ' A' ' 51' ' ' GLU . 11.2 ptmm? -76.96 154.62 33.39 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 4.7 mp -88.95 174.07 8.13 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.259 -173.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -147.89 30.45 0.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.227 -171.028 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.2 mm? -89.73 147.63 38.08 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.31 -176.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.7 117.94 4.68 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.69 2.26 . . . . 0.0 110.858 173.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 48' ' ' LYS . 7.5 p 41.11 99.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.926 1.346 . . . . 0.0 113.162 -171.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 49' ' ' THR . 25.2 mt -65.87 154.34 7.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.925 178.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.48 144.21 54.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -172.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -62.25 -23.84 66.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.327 -176.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.4 tp -65.68 -41.58 92.25 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.958 0.409 . . . . 0.0 110.466 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.589 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 65.7 t80 -64.67 -39.34 93.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.535 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.574 ' O ' HD13 ' A' ' 26' ' ' LEU . . . -68.23 -44.05 77.26 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.353 176.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HD2' HD12 ' A' ' 46' ' ' ILE . 4.3 mptp? -53.29 -44.4 68.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.678 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.3 mm-40 -54.9 -55.84 26.1 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.66 176.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 21' ' ' PHE . 22.2 mt -53.4 -60.55 3.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.882 0.849 . . . . 0.0 110.695 178.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.685 HD22 HD11 ' A' ' 46' ' ' ILE . 9.5 mp -59.2 -40.88 87.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.433 -173.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.48 -32.49 73.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.155 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.678 ' HG3' ' O ' ' A' ' 24' ' ' GLU . 51.2 mttm -67.43 -33.3 74.87 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' HE1' ' HA ' ' A' ' 80' ' ' LYS . 92.7 m-85 -95.01 0.95 55.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.73 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -36.1 74.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.509 0.195 . . . . 0.0 111.443 -171.222 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -66.95 -33.98 76.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.22 -41.43 49.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.492 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.534 HG22 ' HB ' ' A' ' 39' ' ' VAL . 90.9 mt -62.83 -37.14 78.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.753 176.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' H ' ' A' ' 39' ' ' VAL . 36.3 ttmt -80.87 -22.76 39.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.042 -177.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -76.79 -47.14 22.45 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.448 172.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.69 -42.92 57.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.282 -175.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' HB2' HG23 ' A' ' 39' ' ' VAL . 59.8 m-85 -121.2 -28.3 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.735 0.303 . . . . 0.0 111.731 -174.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . 91.88 41.78 4.9 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.986 -178.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' H ' ' HA ' ' A' ' 34' ' ' LYS . 13.1 t -119.42 152.1 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 120.556 0.217 . . . . 0.0 110.838 -176.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -110.92 136.37 50.04 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.507 HG21 ' O ' ' A' ' 26' ' ' LEU . 32.3 p -79.99 -12.92 59.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -83.31 -3.04 57.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.9 -27.72 8.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.292 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.53 HD21 HG11 ' A' ' 39' ' ' VAL . 67.8 mt -62.17 125.98 25.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.715 175.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -85.79 102.92 14.08 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.415 -178.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.685 HD11 HD22 ' A' ' 26' ' ' LEU . 22.9 mt -75.66 124.42 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.695 0.759 . . . . 0.0 110.931 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 60' ' ' VAL . 9.7 mt -100.1 -53.72 3.07 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.673 -177.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.563 ' HA ' HG23 ' A' ' 16' ' ' VAL . 36.6 ttmt -142.9 104.26 4.3 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.871 -174.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 58' ' ' VAL . 46.6 m -91.69 125.5 36.43 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.9 m -151.8 -179.12 7.17 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' OE2' ' HB2' ' A' ' 11' ' ' LYS . 9.4 pt-20 -142.14 143.82 33.18 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 177.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -150.02 126.62 10.92 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 58.46 -141.27 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.741 -175.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.586 ' HB3' HG11 ' A' ' 76' ' ' VAL . 73.7 mtt180 -77.71 14.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.527 ' CG ' ' HE3' ' A' ' 71' ' ' LYS . 5.0 m-85 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.313 -169.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.569 ' CE2' ' HE2' ' A' ' 74' ' ' LYS . 17.3 m-85 -98.26 143.96 28.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.367 166.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CE1' ' HD2' ' A' ' 71' ' ' LYS . 97.0 m-85 -124.32 105.49 9.5 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.67 HG21 HD11 ' A' ' 26' ' ' LEU . 13.9 t -106.69 95.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.847 0.356 . . . . 0.0 110.722 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 69' ' ' LYS . 14.5 t -74.35 128.25 35.08 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 46' ' ' ILE . 16.9 m -138.22 153.99 27.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.085 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.13 126.62 34.9 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.75 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -172.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 -36.23 2.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.586 174.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -70.83 -14.31 62.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.144 0.497 . . . . 0.0 109.978 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.25 -24.92 4.95 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.59 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . 2.3 tp10 -78.34 174.26 11.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.912 0.387 . . . . 0.0 110.692 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -138.61 115.74 11.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 1.074 ' HA ' ' HA ' ' A' ' 86' ' ' CYS . 0.4 OUTLIER -107.14 163.26 13.15 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.014 0.435 . . . . 0.0 111.239 -168.395 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.2 ttmt -139.21 93.9 2.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 64.4 m-85 -67.58 108.53 2.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.37 0.605 . . . . 0.0 110.342 -177.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.022 ' HD3' ' HB2' ' A' ' 96' ' ' TYR . 46.9 tttt -92.2 83.53 5.09 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.044 -176.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.905 HG12 ' HG2' ' A' ' 81' ' ' MET . 55.7 mt -81.05 91.38 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.564 -178.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.703 HH11 HG21 ' A' ' 82' ' ' VAL . 34.8 ttt180 -59.68 111.23 1.35 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.389 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.865 ' HG3' HG13 ' A' ' 76' ' ' VAL . 18.6 ptpt -56.43 166.62 0.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.695 0.622 . . . . 0.0 110.461 -179.179 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 3' ' ' LEU . 38.9 t70 -68.65 75.56 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.508 0.67 . . . . 0.0 110.166 -178.2 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.865 HG13 ' HG3' ' A' ' 74' ' ' LYS . 29.5 m -100.84 -8.97 9.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.445 177.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.2 t70 176.29 -51.14 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.833 -169.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 79' ' ' PRO . 14.8 p -117.15 136.74 23.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.365 0.602 . . . . 0.0 110.323 178.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 0' ' ' SER . 43.9 Cg_endo -86.45 46.2 1.52 Allowed 'Trans proline' 0 C--N 1.325 -0.667 0 C-N-CA 123.805 3.003 . . . . 0.0 113.341 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HA ' ' HE1' ' A' ' 29' ' ' PHE . 27.3 mtmt -150.68 161.7 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.131 0.491 . . . . 0.0 112.19 -177.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.905 ' HG2' HG12 ' A' ' 72' ' ' ILE . 38.2 mtm -63.81 101.51 0.38 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.264 172.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.703 HG21 HH11 ' A' ' 73' ' ' ARG . 9.9 p -55.85 -28.74 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.402 173.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.65 177.41 26.9 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.277 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -177.12 42.27 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -179.023 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.845 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 68.7 mmtt -83.28 120.75 26.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.876 -171.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 1.074 ' HA ' ' HA ' ' A' ' 68' ' ' CYS . 29.7 m -65.6 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.569 -177.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.484 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 99.7 mtt180 65.94 65.08 0.53 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.577 0.704 . . . . 0.0 109.245 175.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.59 ' HD2' ' HA ' ' A' ' 66' ' ' GLU . 71.7 tttt -69.54 -66.23 0.61 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.597 -174.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 24.5 t70 -121.24 103.0 8.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.712 -178.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 89' ' ' ASP . 37.1 t70 173.04 -82.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.871 0.732 . . . . 0.0 110.073 174.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -179.77 165.83 1.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 10.8 p-10 -127.84 121.26 29.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.383 0.611 . . . . 0.0 111.357 -179.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.13 157.34 37.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.495 173.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -52.89 -45.55 67.58 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 110.284 176.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.27 141.89 17.08 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.9 -178.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 1.022 ' HB2' ' HD3' ' A' ' 71' ' ' LYS . 4.0 m-85 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.18 177.743 . . . . . . . . 1 1 . 1 stop_ save_